PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Puls, RL; Amin, J; Losso, M; Phanuphak, P; Nwizu, C; Orrell, C; Young, B; Shahar, E; Wolff, M; Gazzard, B; Read, T; Hill, A; Cooper, DA; Emery, S				Puls, Rebekah L.; Amin, Janaki; Losso, Marcelo; Phanuphak, Praphan; Nwizu, Chidi; Orrell, Catherine; Young, Barnaby; Shahar, Eduardo; Wolff, Marcelo; Gazzard, Brian; Read, Tim; Hill, Andrew; Cooper, David A.; Emery, Sean		ENCORE1 Study Grp	Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; CLINICAL-TRIALS; THERAPY; RIFAMPICIN; ZIDOVUDINE; REGIMENS; VALIDITY; OUTCOMES; SCALES	Background The optimum dose of key antiretroviral drugs is often overlooked during product development. The ENCORE1 study compared the efficacy and safety of reduced dose efavirenz with standard dose efavirenz in combination with tenofovir and emtricitabine as first-line treatment for HIV infection. An effective and safe reduced dose could yield meaningful cost savings. Methods ENCORE1 is a continuing non-inferiority trial in HIV-1-infected antiretroviral-naive adults in 38 clinical sites in 13 countries. Participants (plasma HIV-RNA >1000 log(10) copies per mL, CD4 T-cell count 50-500 cells per mu L) were randomly assigned by a computer-generated sequence with a blocking factor of four (stratified by clinical site and by screening viral load) to receive tenofovir plus emtricitabine with either a reduced daily dose (400 mg) or a standard dose (600 mg) of efavirenz. Participants, physicians, and all other trial staff were masked to treatment group. The primary endpoint was the difference in proportions of participants with plasma HIV-RNA of less than 200 copies per mL at 48 weeks. Treatment groups were regarded as non-inferior if the lower limit of the 95% CI for the difference in viral load was less than -10% by modified intention-to-treat analysis. Adverse events were summarised by treatment. This trial is registered with ClinicalTrials.gov, number NCT01011413. Findings The modified intention-to-treat analysis consisted of 630 patients (efavirenz 400=321; efavirenz 600=309). 32% were women; 37% were African, 33% were Asian, and 30% were white. The mean baseline CD4 cell count was 273 cells per mu L (SD 99) and median plasma HIV-RNA was 4.75 log(10) copies per mL (IQR 0.88). The proportion of participants with a viral load below 200 copies per mL at week 48 was 94.1% for efavirenz 400 mg and 92.2% for 600 mg (difference 1.85%, 95% CI -2.1 to 5.79). CD4 T-cell counts at week 48 were significantly higher for the 400 mg group than for the 600 mg group (mean difference 25 cells per mu L, 95% CI 6-44; p=0.01). We recorded no difference in grade or number of patients reporting adverse events (efavirenz 400=89.1%, efavirenz 600=88.4%; difference 0.75%, 95% CI -4.19 to 5.69; p=0.77). Study drug-related adverse events were significantly more frequent in the 600 mg group than in the 400 mg group (146% [47] vs 118 [37]), difference -10.5%, 95% CI -18.2 to -2.8; p=0.01) and significantly fewer patients with these events stopped treatment (400 mg=6 [2%], 600 mg=18 [6%], difference -3.96%, 95% CI -6.96 to -0.95; p=0.01). Interpretation Our findings suggest that a reduced dose of 400 mg efavirenz is non-inferior to the standard dose of 600 mg, when combined with tenofovir and emtricitabine during 48 weeks in ART-naive adults with HIV-1 infection. Adverse events related to the study drug were more frequent with 600 mg efavirenz than with 400 mg. Lower dose efavirenz should be recommended as part of routine care.	[Puls, Rebekah L.] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute	Puls, RL (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	rpuls@kirby.unsw.edu.au	Orrell, Catherine/AAF-3405-2019; Young, Barnaby/GVR-9935-2022; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Orrell, Catherine/0000-0003-1134-7475; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Cunningham, Philip/0000-0003-2613-6910; Boyd, Mark/0000-0002-6848-3307; Crabtree-Ramirez, Brenda/0000-0002-2587-1123; Young, Barnaby/0000-0003-1010-2230; Amin, Janaki/0000-0003-2161-9366; Wolff, Marcelo/0000-0002-9956-8872	Bill & Melinda Gates Foundation; University of New South Wales	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of New South Wales	Bill & Melinda Gates Foundation, University of New South Wales.	[Anonymous], 2005, INT WORLD HLTH ORG C; [Anonymous], 1993, REVISED CLASSIFICATI; [Anonymous], US EF PREGN PUBL HLT; [Anonymous], 2013, GUID US ANT AG HIV 1; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Clifford DB, 2005, ANN INTERN MED, V143, P714, DOI 10.7326/0003-4819-143-10-200511150-00008; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Crawford KW, 2012, LANCET INFECT DIS, V12, P550, DOI 10.1016/S1473-3099(12)70134-2; De Clercq E, 1998, ANTIVIR RES, V38, P153, DOI 10.1016/S0166-3542(98)00025-4; El Hadri K, 2004, J BIOL CHEM, V279, P15130, DOI 10.1074/jbc.M312875200; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gatanaga H, 2009, AIDS, V23, P433, DOI 10.1097/QAD.0b013e32831940e3; Gutierrez-Valencia A, 2009, ANN INTERN MED, V151, P149, DOI 10.7326/0003-4819-151-3-200908040-00127; Haas D, INT C AIDS 1998 GEN; Haas DW, 2004, AIDS, V18, P2391; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Lanzafame M, 2012, HIV MED, V13, P252, DOI 10.1111/j.1468-1293.2011.00964.x; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Orrell C, 2011, ANTIVIR THER, V16, P527, DOI 10.3851/IMP1780; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Ribaudo HJ, 2009, C RETR OPP INF MONTR; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Tovar-y-Romo LB, 2012, J PHARMACOL EXP THER, V343, P696, DOI 10.1124/jpet.112.195701; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WHO, KEY FACTS GLOB HIV E; World Health Organisation, 2013, WHO CONS GUID US ANT; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0	31	127	127	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1474	1482		10.1016/S0140-6736(13)62187-X	http://dx.doi.org/10.1016/S0140-6736(13)62187-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24522178				2022-12-28	WOS:000335325800028
J	Olalde, I; Allentoft, ME; Sanchez-Quinto, F; Santpere, G; Chiang, CWK; DeGiorgio, M; Prado-Martinez, J; Rodriguez, JA; Rasmussen, S; Quilez, J; Ramirez, O; Marigorta, UM; Fernandez-Callejo, M; Prada, ME; Encinas, JMV; Nielsen, R; Netea, MG; Novembre, J; Sturm, RA; Sabeti, P; Marques-Bonet, T; Navarro, A; Willerslev, E; Lalueza-Fox, C				Olalde, Inigo; Allentoft, Morten E.; Sanchez-Quinto, Federico; Santpere, Gabriel; Chiang, Charleston W. K.; DeGiorgio, Michael; Prado-Martinez, Javier; Rodriguez, Juan Antonio; Rasmussen, Simon; Quilez, Javier; Ramirez, Oscar; Marigorta, Urko M.; Fernandez-Callejo, Marcos; Prada, Maria Encina; Encinas, Julio Manuel Vidal; Nielsen, Rasmus; Netea, Mihai G.; Novembre, John; Sturm, Richard A.; Sabeti, Pardis; Marques-Bonet, Tomas; Navarro, Arcadi; Willerslev, Eske; Lalueza-Fox, Carles			Derived immune and ancestral pigmentation alleles in a 7,000-year-old Mesolithic European	NATURE			English	Article							HUNTER-GATHERERS; EYE COLOR; GENOME; DNA; POPULATION; EVOLUTION; GENETICS; SEQUENCE; INSIGHTS; GENES	Ancient genomic sequences have started to reveal the origin and the demographic impact of farmers from the Neolithic period spreading into Europe(1-3). The adoption of farming, stock breeding and sedentary societies during the Neolithic may have resulted in adaptive changes in genes associated with immunity and diet(4). However, the limited data available from earlier hunter-gatherers preclude an understanding of the selective processes associated with this crucial transition to agriculture in recent human evolution. Here we sequence an approximately 7,000-year-old Mesolithic skeleton discovered at the La Brana-Arintero site in Leon, Spain, to retrieve a complete pre-agricultural European human genome. Analysis of this genome in the context of other ancient samples suggests the existence of a common ancient genomic signature across western and central Eurasia from the Upper Paleolithic to the Mesolithic. The La Brana individual carries ancestral alleles in several skin pigmentation genes, suggesting that the light skin of modern Europeans was not yet ubiquitous in Mesolithic times. Moreover, we provide evidence that a significant number of derived, putatively adaptive variants associated with pathogen resistance in modern Europeans were already present in this hunter-gatherer.	[Olalde, Inigo; Sanchez-Quinto, Federico; Santpere, Gabriel; Prado-Martinez, Javier; Rodriguez, Juan Antonio; Quilez, Javier; Ramirez, Oscar; Marigorta, Urko M.; Fernandez-Callejo, Marcos; Navarro, Arcadi; Lalueza-Fox, Carles] CSIC UPF, Inst Biol Evolut, Barcelona 08003, Spain; [Allentoft, Morten E.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark; [Chiang, Charleston W. K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [DeGiorgio, Michael] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [DeGiorgio, Michael] Penn State Univ, Dept Biol, Wartik Lab 502, University Pk, PA 16802 USA; [Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Prada, Maria Encina] Junta Castilla & Leon, IESO Los Salados, E-49600 Benavente, Spain; [Encinas, Julio Manuel Vidal] Junta Castilla & Leon, Serv Cultura Leon, E-24071 Leon, Spain; [Nielsen, Rasmus] Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 Nijmegen, Netherlands; [Novembre, John] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Sturm, Richard A.] Univ Queensland, Melanogenix Grp, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sabeti, Pardis] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Sabeti, Pardis] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Marques-Bonet, Tomas; Navarro, Arcadi] ICREA, Barcelona 08010, Catalonia, Spain; [Navarro, Arcadi] CRG, Barcelona 08003, Catalonia, Spain; [Navarro, Arcadi] Natl Inst Bioinformat INB, Barcelona 08003, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Copenhagen; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Technical University of Denmark; University of California System; University of California Berkeley; Radboud University Nijmegen; Radboud University Nijmegen; University of Chicago; University of Queensland; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark.	ewillerslev@snm.ku.dk; carles.lalueza@upf.edu	Ramirez, Oscar/E-7293-2012; Rodriguez, Juan Antonio/GQP-1484-2022; Sturm, Richard A/C-9943-2009; Marques-Bonet, Tomas/I-4618-2014; Willerslev, Eske/AAA-5686-2019; Marques-Bonet, Tomas/ABF-3734-2020; Sánchez-Quinto, Federico/AAV-8927-2020; Rasmussen, Simon/G-6258-2016; Willerslev, Eske/A-9619-2011; Chiang, Charleston W. K./H-3169-2019; Prado-Martinez, Javier/AAA-6341-2020; Rasmussen, Simon/AAA-2308-2020; Navarro, Arcadi/F-1592-2011; LALUEZA-FOX, CARLES/AAG-5341-2020; Quilez, Javier/J-7107-2015; Sabeti, Pardis/GQH-8610-2022; Santpere, Gabriel/I-9437-2014; Olalde, Iñigo/N-6928-2018; Netea, Mihai/N-5155-2014; Marigorta, Urko/L-9512-2014; Nielsen, Rasmus/D-4405-2009	Ramirez, Oscar/0000-0001-5164-6790; Rodriguez, Juan Antonio/0000-0001-5195-315X; Sturm, Richard A/0000-0003-1301-0294; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075; Sánchez-Quinto, Federico/0000-0002-0201-6204; Rasmussen, Simon/0000-0001-6323-9041; Willerslev, Eske/0000-0002-7081-6748; Chiang, Charleston W. K./0000-0002-0668-7865; Prado-Martinez, Javier/0000-0001-5402-2721; Rasmussen, Simon/0000-0001-6323-9041; Navarro, Arcadi/0000-0003-2162-8246; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Quilez, Javier/0000-0002-0108-2672; Santpere, Gabriel/0000-0001-5909-8637; Olalde, Iñigo/0000-0002-2660-6807; Marigorta, Urko/0000-0002-9087-6609; Allentoft, Morten/0000-0003-4424-3568; Nielsen, Rasmus/0000-0003-0513-6591	Danish National Research Foundation; ERC [260372, 310372]; FEDER; Spanish Government [BFU2012-38236]; Spanish Multiple Sclerosis Netowrk (REEM) of the Instituto de Salud Carlos III [RD12/0032/0011, BFU2011-28549, BFU2012-34157, 300554]; NIH NRSA [F32GM106656]; NIH [R01-HG007089]; NSF [DBI-1103639]; Australian NHMRC; Basque Government (DEUI); ICREA Funding Source: Custom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106656] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); ERC(European Research Council (ERC)European Commission); FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Multiple Sclerosis Netowrk (REEM) of the Instituto de Salud Carlos III(Instituto de Salud Carlos III); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Basque Government (DEUI)(Basque Government); ICREA(ICREA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. A. Grau Lobo (Museo de Leon) for access to the La Brana specimen, M. Rasmussen and H. Schroeder for valid input into the experimental work, and M. Raghavan for early access to Mal'ta genome data. Sequencing was performed at the Danish National High-Throughput DNA-Sequencing Centre, University of Copenhagen. The POPRES data were obtained from dbGaP (accession number 2038). The authors are grateful for financial support from the Danish National Research Foundation, ERC Starting Grant (260372) to TM-B, and (310372) to M.G.N., FEDER and Spanish Government Grants BFU2012-38236, the Spanish Multiple Sclerosis Netowrk (REEM) of the Instituto de Salud Carlos III (RD12/0032/0011) to A.N., BFU2011-28549 to T.M.-B., BFU2012-34157 to C.L.-F., ERC (Marie Curie Actions 300554) to M. E. A., NIH NRSA postdoctoral fellowship (F32GM106656) to C. W. K. C., NIH (R01-HG007089) to J.N., NSF postdoctoral fellowship (DBI-1103639) to M. D., the Australian NHMRC to R. A. S. and a predoctoral fellowship from the Basque Government (DEUI) to I.O.	Abecasis G.R., 2012, NATURE, V491, P56; Allentoft M. E., 2012, P R SOC B, V279, P4824; Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Vidal Encinas J. M., 2010, HOMBRES MESOLITICOS; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005	30	200	202	1	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					225	+		10.1038/nature12960	http://dx.doi.org/10.1038/nature12960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24463515	Green Accepted, Green Submitted			2022-12-28	WOS:000332651800037
J	Rangaraju, V; Calloway, N; Ryan, TA				Rangaraju, Vidhya; Calloway, Nathaniel; Ryan, Timothy A.			Activity-Driven Local ATP Synthesis Is Required for Synaptic Function	CELL			English	Article							ENDOCYTOSIS; PH; MOBILIZATION; EXOCYTOSIS; MECHANISM; PROTEINS; VESICLES; REPORTER; CALCIUM; KINASE	Cognitive function is tightly related to metabolic state, but the locus of this control is not well understood. Synapses are thought to present large ATP demands; however, it is unclear how fuel availability and electrical activity impact synaptic ATP levels and how ATP availability controls synaptic function. We developed a quantitative genetically encoded optical reporter of presynaptic ATP, Syn-ATP, and find that electrical activity imposes large metabolic demands that are met via activity-driven control of both glycolysis and mitochondrial function. We discovered that the primary source of activity-driven metabolic demand is the synaptic vesicle cycle. In metabolically intact synapses, activity-driven ATP synthesis is well matched to the energetic needs of synaptic function, which, at steady state, results in similar to 10(6) free ATPs per nerve terminal. Despite this large reservoir of ATP, we find that several key aspects of presynaptic function are severely impaired following even brief interruptions in activity-stimulated ATP synthesis.	[Rangaraju, Vidhya] Rockefeller Sloan Kettering Weill Cornell Triinst, New York, NY 10065 USA; [Rangaraju, Vidhya; Calloway, Nathaniel; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020; Rangaraju, Vidhya/AAG-6214-2021	Rangaraju, Vidhya/0000-0002-6716-4312; Ryan, Timothy/0000-0003-2533-9548	Tri-Institutional Training Program in Chemical Biology; McKnight Technological Innovations in Neuroscience award; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071293, R01NS036942] Funding Source: NIH RePORTER	Tri-Institutional Training Program in Chemical Biology; McKnight Technological Innovations in Neuroscience award; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank G. A. Rutter for providing us with WT luciferase, B. R. Branchini for thermostable luciferase mutants, M. E. Hatten for cytoplasmic pHluorin construct, and M. Dong for the tetanus toxin light-chain construct. We are also thankful to Ricky Kwan, Yogesh Gera, and Julia Marrs for technical assistance, Ryan lab members, Timothy McGraw, and Jeremy Dittman for input and additional thanks to Jeremy Dittman for help with the graphical abstract. This work was supported by the Tri-Institutional Training Program in Chemical Biology (V. R.), McKnight Technological Innovations in Neuroscience award (T. A. R.), and funding from NINDS (T.A.R.).	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Branchini BR, 1998, BIOCHEMISTRY-US, V37, P15311, DOI 10.1021/bi981150d; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; De Stefano C, 2006, BIOPHYS CHEM, V121, P121, DOI 10.1016/j.bpc.2005.12.016; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Fujii H, 2007, ANAL BIOCHEM, V366, P131, DOI 10.1016/j.ab.2007.04.018; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; HICKS BW, 1992, J NEUROCHEM, V58, P1211, DOI 10.1111/j.1471-4159.1992.tb11331.x; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MARTYS JL, 1995, J BIOL CHEM, V270, P25976, DOI 10.1074/jbc.270.43.25976; MOYER JD, 1983, ANAL BIOCHEM, V131, P187, DOI 10.1016/0003-2697(83)90152-5; Mozhayeva MG, 2004, J NEUROSCI, V24, P1680, DOI 10.1523/JNEUROSCI.3801-03.2004; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; Ryan TA, 1999, J NEUROSCI, V19, P1317; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Svichar N, 2011, J NEUROSCI, V31, P6997, DOI 10.1523/JNEUROSCI.6088-10.2011; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Tsien R., 1989, METHOD ENZYMOL, P230, DOI 10.1016/S0076-6879(89)72017-6; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Zhang ZS, 2010, NEURON, V68, P1097, DOI 10.1016/j.neuron.2010.11.035	39	391	396	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					825	835		10.1016/j.cell.2013.12.042	http://dx.doi.org/10.1016/j.cell.2013.12.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529383	Bronze, Green Accepted			2022-12-28	WOS:000331379800019
J	Cole, TB				Cole, Thomas B.			La Tormenta	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					554	555		10.1001/jama.2013.279320	http://dx.doi.org/10.1001/jama.2013.279320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519281				2022-12-28	WOS:000330941000001
J	Dodd, JM; Turnbull, D; McPhee, AJ; Deussen, AR; Grivell, RM; Yelland, LN; Crowther, CA; Wittert, G; Owens, JA; Robinson, JS				Dodd, Jodie M.; Turnbull, Deborah; McPhee, Andrew J.; Deussen, Andrea R.; Grivell, Rosalie M.; Yelland, Lisa N.; Crowther, Caroline A.; Wittert, Gary; Owens, Julie A.; Robinson, Jeffrey S.		LIMIT Randomised Trial Grp	Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; HEALTH OUTCOMES; PREGNANT-WOMEN; BIRTH-WEIGHT; RISK; INTERVENTIONS; MANAGEMENT	Objective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women. Design Multicentre randomised trial. We utilised a central telephone randomisation server, with computer generated schedule, balanced variable blocks, and stratification for parity, body mass index (BMI) category, and hospital. Setting Three public maternity hospitals across South Australia. Participants 2212 women with a singleton pregnancy, between 10+0 and 20+0 weeks' gestation, and BMI >= 25. Interventions 1108 women were randomised to a comprehensive dietary and lifestyle intervention delivered by research staff; 1104 were randomised to standard care and received pregnancy care according to local guidelines, which did not include such information. Main outcome measures Incidence of infants born large for gestational age (birth weight >= 90th centile for gestation and sex). Prespecified secondary outcomes included birth weight >4000 g, hypertension, pre-eclampsia, and gestational diabetes. Analyses used intention to treat principles. Results 2152 women and 2142 liveborn infants were included in the analyses. The risk of the infant being large for gestational age was not significantly different in the two groups (lifestyle advice 203/1075 (19%) v standard care 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24). Infants born to women after lifestyle advice were significantly less likely to have birth weight above 4000 g (lifestyle advice 164/1075 (15%) v standard care 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04). There were no differences in maternal pregnancy and birth outcomes between the two treatment groups. Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes. Trial registration Australian and New Zealand Clinical Trials Registry (ACTRN12607000161426).	[Dodd, Jodie M.; Deussen, Andrea R.; Grivell, Rosalie M.; Yelland, Lisa N.; Crowther, Caroline A.; Owens, Julie A.; Robinson, Jeffrey S.] Univ Adelaide, Robinson Inst, Adelaide, SA 5006, Australia; [Dodd, Jodie M.; Deussen, Andrea R.; Grivell, Rosalie M.; Yelland, Lisa N.; Crowther, Caroline A.; Owens, Julie A.; Robinson, Jeffrey S.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia; [Dodd, Jodie M.; Grivell, Rosalie M.] Womens & Childrens Hosp, Womens & Babies Div, Dept Perinatal Med, Adelaide, SA 5006, Australia; [Turnbull, Deborah] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [McPhee, Andrew J.] Womens & Childrens Hosp, Womens & Babies Div, Dept Neonatal Med, Adelaide, SA 5006, Australia; [Wittert, Gary] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide	Dodd, JM (corresponding author), Univ Adelaide, Robinson Inst, 72 King William Rd, Adelaide, SA 5006, Australia.	jodie.dodd@adelaide.edu.au	Dodd, Jodie/Y-6849-2019; wittert, gary/AAE-2398-2019; Moran, Lisa J/E-9850-2015; Deussen, Andrea/Y-6173-2019; Yelland, Lisa N/GPP-4533-2022; Grivell, Rosalie/N-6852-2015	Dodd, Jodie/0000-0002-6363-4874; Yelland, Lisa N/0000-0003-3803-8728; Wittert, Gary/0000-0001-6818-6065; Grivell, Rosalie/0000-0002-2447-6519	National Health and Medical Research Council (NHMRC), Australia [519240]; NHMRC [627005]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a four year project grant from the National Health and Medical Research Council (NHMRC), Australia (ID 519240). JMD is supported through a NHMRC Practitioner Fellowship (ID 627005). The funder had no role in the study design, data collection, analysis, interpretation, or writing of the report.	Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y; [Anonymous], 2012, UPBEAT TRIAL; [Anonymous], 2013, S AUSTR PER PRACT GU; Australian Guide to Healthy Eating. Australian Government Department of Health, 2008, AUSTR GUID HLTH EAT; Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x; Bennett P., 1997, PSYCHOL HLTH PROMOTI; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Cedergren MI, 2007, OBSTET GYNECOL, V110, P759, DOI 10.1097/01.AOG.0000279450.85198.b2; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chu SY, 2009, MATERN CHILD HLTH J, V13, P614, DOI 10.1007/s10995-008-0388-3; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Dodd J., 2013, METFORMIN DIETARY AD; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Dodd JM, 2012, AUST NZ J OBSTET GYN, V52, P248, DOI 10.1111/j.1479-828X.2012.01425.x; Dodd JM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-79; Dodd JM, 2011, AUST NZ J OBSTET GYN, V51, P136, DOI 10.1111/j.1479-828X.2010.01272.x; Donahue SMA, 2011, AM J CLIN NUTR, V93, P780, DOI 10.3945/ajcn.110.005801; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Moon RJ, 2013, J CLIN ENDOCR METAB, V98, P299, DOI 10.1210/jc.2012-2482; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Norman JE, 2011, EFFICACY METFORMING; Oteng-Ntim E, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-47; Poston L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2774; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Royal College of Obstetricians and Gynaecologists, 2006, RECR EX PREGN INF YO; Scheil W, 2012, PREGNANCY OUTCOME S; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; THANGARATINAM S, 2012, BMJ-BRIT MED J, V344, pE2088; Tikellis G, 2012, INT J OBESITY, V36, P496, DOI 10.1038/ijo.2011.261; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	42	311	315	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2014	348								g1285	10.1136/bmj.g1285	http://dx.doi.org/10.1136/bmj.g1285			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WO	24513442	Green Published, hybrid			2022-12-28	WOS:000331443900003
J	Jaspars, M				Jaspars, Marcel			FORUM: Microbiology A talented genus	NATURE			English	Editorial Material							COMPLETE GENOME SEQUENCE; POLYKETIDE SYNTHASE; BACTERIAL SYMBIONT; IDENTIFICATION; BIOSYNTHESIS		Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Warwick	Jaspars, M (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	g.l.challis@warwick.ac.uk		Jaspars, Marcel/0000-0002-2426-6028; Challis, Gregory/0000-0001-5976-3545				Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bewley CA, 1998, ANGEW CHEM INT EDIT, V37, P2163, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2162::AID-ANIE2162>3.0.CO;2-2; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P122, DOI 10.1021/op034134j; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; UNSON MD, 1993, EXPERIENTIA, V49, P349, DOI 10.1007/BF01923420; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Yu MJ, 2005, ANTICANCER AGENTS FROM NATURAL PRODUCTS, P241	14	14	14	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					38	39		10.1038/nature13049	http://dx.doi.org/10.1038/nature13049			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24476822				2022-12-28	WOS:000330648100022
J	Warner, M; Gustafsson, JA				Warner, Margaret; Gustafsson, Jan-Ake			On Estrogen, Cholesterol Metabolism, and Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Warner, Margaret; Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA	University of Houston System; University of Houston	Warner, M (corresponding author), Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.			warner, margaret/0000-0002-7946-2675				Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908	2	52	53	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					572	573		10.1056/NEJMcibr1315176	http://dx.doi.org/10.1056/NEJMcibr1315176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499217				2022-12-28	WOS:000331073500015
J	Wilson, MC; Mori, T; Ruckert, C; Uria, AR; Helf, MJ; Takada, K; Gernert, C; Steffens, UAE; Heycke, N; Schmitt, S; Rinke, C; Helfrich, EJN; Brachmann, AO; Gurgui, C; Wakimoto, T; Kracht, M; Crusemann, M; Hentschel, U; Abe, I; Matsunaga, S; Kalinowski, J; Takeyama, H; Piel, J				Wilson, Micheal C.; Mori, Tetsushi; Rueckert, Christian; Uria, Agustinus R.; Helf, Maximilian J.; Takada, Kentaro; Gernert, Christine; Steffens, Ursula A. E.; Heycke, Nina; Schmitt, Susanne; Rinke, Christian; Helfrich, Eric J. N.; Brachmann, Alexander O.; Gurgui, Cristian; Wakimoto, Toshiyuki; Kracht, Matthias; Cruesemann, Max; Hentschel, Ute; Abe, Ikuro; Matsunaga, Shigeki; Kalinowski, Joern; Takeyama, Haruko; Piel, Joern			An environmental bacterial taxon with a large and distinct metabolic repertoire	NATURE			English	Article							COMPLETE GENOME SEQUENCE; MARINE SPONGE; SOFTWARE ENVIRONMENT; MICROBIAL DIVERSITY; THEONELLA-SWINHOEI; GENE CLUSTERS; PEPTIDE; POLYKETIDE; BIOSYNTHESIS; SYMBIONT	Cultivated bacteria such as actinomycetes are a highly useful source of biomedically important natural products. However, such 'talented' producers represent only a minute fraction of the entire, mostly uncultivated, prokaryotic diversity. The uncultured majority is generally perceived as a large, untapped resource of new drug candidates, but so far it is unknown whether taxa containing talented bacteria indeed exist. Here we report the single-cell- and metagenomics-based discovery of such producers. Two phylotypes of the candidate genus 'Entotheonella' with genomes of greater than 9 megabases and multiple, distinct biosynthetic gene clusters co-inhabit the chemically and microbially rich marine sponge Theonella swinhoei. Almost all bioactive polyketides and peptides known from this animal were attributed to a single phylotype. 'Entotheonella' spp. are widely distributed in sponges and belong to an environmental taxon proposed here as candidate phylum 'Tectomicrobia'. The pronounced bioactivities and chemical uniqueness of 'Entotheonella' compounds provide significant opportunities for ecological studies and drug discovery.	[Wilson, Micheal C.; Uria, Agustinus R.; Helf, Maximilian J.; Helfrich, Eric J. N.; Brachmann, Alexander O.; Piel, Joern] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Wilson, Micheal C.; Uria, Agustinus R.; Helf, Maximilian J.; Steffens, Ursula A. E.; Heycke, Nina; Helfrich, Eric J. N.; Gurgui, Cristian; Kracht, Matthias; Cruesemann, Max; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Mori, Tetsushi; Takeyama, Haruko] Waseda Univ, Ctr Adv Biomed Sci, Fac Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Rueckert, Christian; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33594 Bielefeld, Germany; [Takada, Kentaro; Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Gernert, Christine; Hentschel, Ute] Univ Wurzburg, Julius von Sachs Inst Biol Sci, Dept Bot 2, D-97082 Wurzburg, Germany; [Schmitt, Susanne] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Rinke, Christian] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Wakimoto, Toshiyuki; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; Waseda University; University of Bielefeld; University of Tokyo; University of Wurzburg; University of Munich; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Tokyo	Piel, J (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	jpiel@ethz.ch	Mori, Tetsushi/AAN-5656-2020; Takada, Kentaro/AAH-7191-2020; Hentschel, Ute/ABD-6624-2021; Wakimoto, Toshiyuki/Q-3278-2019; Rinke, Christian/AAE-8100-2019; Mori, Tetsushi/C-1973-2017; Abe, Ikuro/E-4449-2010; Hentschel, Ute/H-8343-2013; Rinke, Christian/ABA-3139-2021	Takada, Kentaro/0000-0003-3835-1482; Hentschel, Ute/0000-0003-0596-790X; Rinke, Christian/0000-0003-4632-1187; Mori, Tetsushi/0000-0001-7096-4161; Abe, Ikuro/0000-0002-3640-888X; Hentschel, Ute/0000-0003-0596-790X; Crusemann, Max/0000-0001-6660-2715; Helf, Maximilian/0000-0002-1393-3999; Brachmann, Alexander/0000-0002-9878-9550; Helfrich, Eric Jan Nikolaus/0000-0001-8751-3279; Uria, Agustinus R./0000-0002-9223-7464; Ruckert-Reed, Christian/0000-0002-9722-4435	SNF [31003A_146992]; BMBF [GenBioCom: 0315581I, 0315585J]; DFG [PI 430/1-3, PI 430/9-1, SFB 630-TP A5]; EU (BlueGenics); MIWFT within the BIO.NRW initiative [280371902]; KAKENHI, JSPS [23760755]; Alexander von Humboldt Foundation; German National Academic Foundation; DAAD; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Grants-in-Aid for Scientific Research [25560399, 24651239] Funding Source: KAKEN	SNF; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); EU (BlueGenics); MIWFT within the BIO.NRW initiative; KAKENHI, JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German National Academic Foundation; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Lasken and M.F. Freeman for discussion, R. W. M. van Soest, P. R. Bergquist, and Y. Ise for taxonomic identification of sponges, P. Kiefer for eMZed support, P. Dorrestein and J. Watrous for mass spectrometry networking support, A. Semeniuk and R. Meoded for experimental support, and T. Ravasi, P. Crews, Y. Kashman and M. Aknin for providing sponge specimens. This work was supported by the SNF (31003A_146992) to J.P., BMBF (GenBioCom: 0315581I to J.P. and 0315585J to J.K.), DFG (PI 430/1-3 and PI 430/9-1 to J.P., SFB 630-TP A5 to U.H.), the EU (BlueGenics to J.P.), MIWFT within the BIO.NRW initiative (280371902 to C. Ruckert), the Grants-in-aid for Young Scientists (B), KAKENHI (23760755 to T.M.), JSPS to J.P., S.M. and H.T., Alexander von Humboldt Foundation to M.C.W., German National Academic Foundation to M.J.H. and E.J.N.H., and DAAD to A.R.U. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; Beasley FC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-199; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Brady SF, 2009, NAT PROD REP, V26, P1488, DOI 10.1039/b817078a; Bruck WM, 2008, ISME J, V2, P335, DOI 10.1038/ismej.2007.91; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Crusemann M, 2013, CHEM SCI, V4, P1041, DOI 10.1039/c2sc21722h; Davidsen JM, 2013, J AM CHEM SOC, V135, P1749, DOI 10.1021/ja307710d; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Flowers AE, 1998, CELL TISSUE RES, V292, P597, DOI 10.1007/s004410051089; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Frank AM, 2008, J PROTEOME RES, V7, P113, DOI 10.1021/pr070361e; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; FUSETANI N, 1993, CHEM REV, V93, P1793, DOI 10.1021/cr00021a007; Grindberg RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018565; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; Hochmuth T, 2010, CHEMBIOCHEM, V11, P2572, DOI 10.1002/cbic.201000510; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Kiefer P, 2013, BIOINFORMATICS, V29, P963, DOI 10.1093/bioinformatics/btt080; KOBAYASHI J, 1991, J CHEM SOC CHEM COMM, P1050, DOI 10.1039/c39910001050; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00027; Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Phelan VV, 2009, CHEM BIOL, V16, P473, DOI 10.1016/j.chembiol.2009.04.007; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Poplau P, 2013, ANGEW CHEM INT EDIT, V52, P13215, DOI 10.1002/anie.201307406; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; SPIEGEL M, 1972, EXP CELL RES, V70, P423, DOI 10.1016/0014-4827(72)90155-3; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Zimmermann K, 2009, J AM CHEM SOC, V131, P2780, DOI 10.1021/ja808889k	66	400	409	7	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					58	+		10.1038/nature12959	http://dx.doi.org/10.1038/nature12959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24476823	Green Accepted, hybrid			2022-12-28	WOS:000330648100030
J	El-Zein, A; Jabbour, S; Tekce, B; Zurayk, H; Nuwayhid, I; Khawaja, M; Tell, T; Al Mooji, Y; De-Jong, J; Yassin, N; Hogan, D				El-Zein, Abbas; Jabbour, Samer; Tekce, Belgin; Zurayk, Huda; Nuwayhid, Iman; Khawaja, Marwan; Tell, Tariq; Al Mooji, Yusuf; De-Jong, Jocelyn; Yassin, Nasser; Hogan, Dennis			Health and ecological sustainability in the Arab world: a matter of survival	LANCET			English	Article							CLIMATE-CHANGE; MALE-INFERTILITY; MIDDLE-EAST; WATER; VULNERABILITY; ENVIRONMENT; FRAMEWORK; EXPOSURE; DISEASE; WORKERS	Discussions leading to the Rio+20 UN conference have emphasised the importance of sustainable development and the protection of the environment for future generations. The Arab world faces large-scale threats to its sustainable development and, most of all, to the viability and existence of the ecological systems for its human settlements. The dynamics of population change, ecological degradation, and resource scarcity, and development policies and practices, all occurring in complex and highly unstable geopolitical and economic environments, are fostering the poor prospects. In this report, we discuss the most pertinent population environment development dynamics in the Arab world, and the two-way interactions between these dynamics and health, on the basis of current data. We draw attention to trends that are relevant to health professionals and researchers, but emphasise that the dynamics generating these trends have implications that go well beyond health. We argue that the current discourse on health, population, and development in the Arab world has largely failed to convey a sense of urgency, when the survival of whole communities is at stake. The dismal ecological and development records of Arab countries over the past two decades call for new directions. We suggest that regional ecological integration around exchange of water, energy, food, and labour, though politically difficult to achieve, offers the best hope to improve the adaptive capacity of individual Arab nations. The transformative political changes taking place in the Arab world offer promise, indeed an imperative, for such renewal. We call on policy makers, researchers, practitioners, and international agencies to emphasise the urgency and take action.	[El-Zein, Abbas] Univ Sydney, Sydney, NSW 2006, Australia; [Jabbour, Samer; Zurayk, Huda; Nuwayhid, Iman; Tell, Tariq; De-Jong, Jocelyn; Yassin, Nasser] Amer Univ Beirut, Beirut, Lebanon; [Tekce, Belgin] Bogazici Univ, Istanbul, Turkey; [Khawaja, Marwan; Al Mooji, Yusuf] Econ & Social Commiss Western Asia, Beirut, Lebanon; [Hogan, Dennis] Brown Univ, Providence, RI 02912 USA	University of Sydney; American University of Beirut; Bogazici University; Brown University	El-Zein, A (corresponding author), Univ Sydney, Sch Civil Engn, Sydney, NSW 2006, Australia.	abbas.elzein@sydney.edu.au	Jabbour, Samer/Y-6860-2018; El-Zein, Abbas H/E-5811-2011	Jabbour, Samer/0000-0002-7150-6856; El-Zein, Abbas H/0000-0003-4935-3299	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER; NICHD NIH HHS [R24 HD041020] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abu Naser A. A., 2007, Eastern Mediterranean Health Journal, V13, P994; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Agamben G, 1998, HOMOSACER SOVEREIGN; Al-Houqani M, 2013, ACCIDENT ANAL PREV, V50, P1052, DOI 10.1016/j.aap.2012.08.010; Al-Sabbak M, 2012, B ENVIRON CONTAM TOX, V89, P937, DOI 10.1007/s00128-012-0817-2; Alaani S, 2011, INT J ENV RES PUB HE, V8, P89, DOI 10.3390/ijerph8010089; Alharbi OA, 2012, SCI TOTAL ENVIRON, V421, P163, DOI 10.1016/j.scitotenv.2012.01.050; Andersen I, 2012, MENA DEV REP, P163; Andersen I, 2012, MENA DEV REP, P109; [Anonymous], WORLD DEV REP WDR 20; [Anonymous], 2007, GLOB ENV OUTL GEO 4; [Anonymous], 2011, WORLD POP PROSP 2010; [Anonymous], 2012, MAN RISKS EXTR EV DI; [Anonymous], [No title captured]; [Anonymous], 2009, ENV ASS GAZ STRIP FO; [Anonymous], 2012, GLOB ENV OUTL 2012; [Anonymous], FUT WE WANT OUTC DOC; Arat ZF, 2002, HUM RIGHTS QUART, V24, P177, DOI 10.1353/hrq.2002.0003; Assaad R, 2005, WORLD DEV, V33, P431, DOI 10.1016/j.worlddev.2004.08.007; Australian Agency for International Development UN Human Settlements Programme (UN-Habitat) UN Office for the Coordination of Humanitarian Affairs, 2007, TOM CRIS TOD HUM IMP; Badran M, 2011, J OBES, V2011, DOI 10.1155/2011/686430; Barghouti S, 2010, ARAB ENV WATER SUSTA, P1; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Batterman S, 2009, ENVIRON HEALTH PERSP, V117, P1023, DOI 10.1289/ehp.0800423; Bensassi S, 2011, 635 EC RES FOR; Berer M, 2010, REPROD HEALTH MATTER, V18, P1; Brauch HG, 2007, NATO SCI PEACE SECUR, P121, DOI 10.1007/978-1-4020-5986-5_6; Brown Oli, 2009, RISING TEMPERATURES; Budds J, 2003, ENVIRON URBAN, V15, P87, DOI 10.1177/095624780301500222; Burgut HR, 2010, ULUS TRAVMA ACIL CER, V16, P497; Butler J., 2010, FRAMES WAR; Carballo M, 2001, EMERG INFECT DIS, V7, P556; Carr ER, 2007, INT J SUST DEV WORLD, V14, P543, DOI 10.1080/13504500709469753; Casey JF, 2006, ECOL ECON, V58, P365, DOI 10.1016/j.ecolecon.2005.07.016; Chatila JG, 2010, ARAB ENV WATER SUSTA, P71; Cheterian V, 2011, ENV SECURITY ISSUES; Crebelli R, 2001, OCCUP ENVIRON MED, V58, P165, DOI 10.1136/oem.58.3.165; Dagdeviren H, 2011, DEV POLICY REV, V29, P485, DOI 10.1111/j.1467-7679.2011.00543.x; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; Dewachi O, 2012, PUBLIC HEALTH IN THE ARABWORLD, P467; Droubi A, 2010, ENV OUTL AR REG EOAR, P29; El-Raey M., 2009, ARAB ENV CLIM CHANG, P47; Epstein PR, 2002, EPIDEMIOLOGY, V13, P373, DOI 10.1097/00001648-200207000-00001; Erian E., 2010, DROUGHT VULNERABILIT; Eriksson M, 2012, FEEDING THIRSTY WORL, P39; Falkenmark M, 2012, FEEDING THIRSTY WORL, P13; Fassin D, 2010, HUMANITY, V1, P81, DOI 10.1353/hum.2010.0000; FAWAZ M., 2003, UNDERSTANDING SLUMS; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; Funk C, 2011, NATURE, V476, P7, DOI 10.1038/476007a; Gates S., 2010, CONSEQUENCES ARMED C; Gelvin J. L., 2012, ARAB UPRISINGS WHAT; Ghattas H, 2012, FOOD SEC AR WORLD C; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Golzarand M, 2012, PUBLIC HEALTH NUTR, V15, P1835, DOI 10.1017/S1368980011003673; Gomes J, 2002, OCCUP MED-OXFORD, V52, P121, DOI 10.1093/occmed/52.3.121; Greenberg James B., 1994, J POLITICAL ECOLOGY, V1, P1, DOI [DOI 10.2458/v1i1.21154, 10.2458/v1i1.21154]; Grimmett RF, 2012, 75700 C RES SERV; Habib RR, 2012, PUBLIC HEALTH IN THE ARABWORLD, P286; Habib RR, 2011, J PUBLIC HEALTH-HEID, V19, P171, DOI 10.1007/s10389-010-0368-0; Habib RR, 2006, INT J ENVIRON HEAL R, V16, P99, DOI 10.1080/09603120500538341; Haines A, 2000, CAN MED ASSOC J, V163, P729; Haines A, 2012, LANCET, V379, P2189, DOI 10.1016/S0140-6736(12)60779-X; Hajjeh RA, 2012, PUBLIC HEALTH IN THE ARABWORLD, P136; Hamdy SF, 2008, AM ETHNOL, V35, P553, DOI 10.1111/j.1548-1425.2008.00098.x; Helman CG, 2007, CULTURE HLTH ILLNESS; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Inhorn MC, 2004, MED ANTHROPOL Q, V18, P162, DOI 10.1525/maq.2004.18.2.162; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; International Food Policy Research Institute, 2010, MIDDL E N AFR STRAT; Jagerskog A, 2012, FEEDING THIRSTY WORL, P45; Jurdi M, 2012, PUBLIC HEALTH IN THE ARABWORLD, P47; Kapiszewski A., 2006, UN EXP GROUP M INT M, P10; Kassas M, 2008, ARAB ENV FUTURE CHAL, V7, P95; Khadr Z, 2012, PUBLIC HEALTH IN THE ARABWORLD, P61; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, DOI [10.3402/gha.v2i0.1958, 10.3402/gha.v2i0.2047]; Kobeissi L, 2008, FERTIL STERIL, V90, P340, DOI 10.1016/j.fertnstert.2007.06.061; Kohsaka R, 2010, ECOL RES, V25, P925, DOI 10.1007/s11284-010-0746-7; Koohafkan P, 2008, WATER CEREALS DRYLAN; Kristensen P, 2004, DPSIR FRAM WORKSH AS; Larsen B, 2011, 583 EC RES FOR; Lock M, 2001, AM J HUM BIOL, V13, P494, DOI 10.1002/ajhb.1081; Lock M, 2006, HLTH SOC ANAL ACTION, P58; Luers AL, 2005, GLOBAL ENVIRON CHANG, V15, P214, DOI 10.1016/j.gloenvcha.2005.04.003; M'henni H, 2011, 587 EC RES FOR; Maxim L, 2009, ECOL ECON, V69, P12, DOI 10.1016/j.ecolecon.2009.03.017; McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Montgomery M, 2003, CITIES TRANSFORMED D, P231; Musaiger AO, 2012, PUBLIC HEALTH IN THE ARABWORLD, P123; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Nuwayhid IA, 2005, OCCUP ENVIRON MED, V62, P86, DOI 10.1136/oem.2004.015503; Omar S.A.S., 2000, ENV CONSEQUENCES WAR, P316, DOI [DOI 10.1017/CBO9780511522321.018, 10.1017/CBO9780511522321.018]; Pimentel D, 1998, BIOSCIENCE, V48, P817, DOI 10.2307/1313393; Potter RB, 2009, HABITAT INT, V33, P81, DOI 10.1016/j.habitatint.2008.05.005; Pucher J, 2005, TRANSP POLICY, V12, P185, DOI 10.1016/j.tranpol.2005.02.008; Pyman M, 2012, DEFENCE CO ANTICORRU; Rahim HFA, 2014, LANCET, V383, P356, DOI 10.1016/S0140-6736(13)62383-1; Richards A, 1998, POLITICAL EC MIDDLE, P366; Richards A, 1998, POLITICAL EC MIDDLE, P145; Saab N., 2012, ARAB ENV; Sadik A, 2011, ARAB ENV, P1; Sadowski Y, 1992, MIDDLE E REP, V177, P2; Saleh SS, 2014, LANCET, V383, P368, DOI 10.1016/S0140-6736(13)62339-9; Schuster CJ, 2005, CAN J PUBLIC HEALTH, V96, P254, DOI 10.1007/BF03405157; Soussi N, 2009, UN ENV PROGRAM ENV O, P269; Stern D.I., 2004, ENCY ENERGY, V2, P517; Tabutin D, 2012, PUBLIC HEALTH IN THE ARABWORLD, P35; Tekce B, 1994, PLACE LIVE FAMILIES; The United Nations Department of Economic and Social Affairs, WORLD URB PROSP 2011; The World Bank, 2011, WORLD DEV REP WDR 20; Tonmoy F, 2012, CAUSES IMPACTS SOLUT, P143; Ulijaszek S, 1997, COLLEGIUM ANTROPOL, V21, P3; UN, 2012, GAZ 2020 LIV PLAC RE; UN Department of Economic and Social Affairs, 2012, TREND INT MIGR STOCK; UN Economic and Social Commission for Western Africa, 2012, AR SOC COMP SOC STAT; UN Economic and Social Commission for Western Asia, 2003, GOV SUST DEV AR REG; UN Environment Programme, 2007, LEB POSTC ENV ASS; UN Environment Programme, 2010, ENV OUTL AR REG EOAR; UN Environment Programme, 2006, IR MARSHL OBS SYST; UN Fund for Population Activities, 2012, STAT WORLD POP 2012; UN-Habitat, 2012, STAT AR CIT 2012 CHA; UNDP, 2012, RESILIENT PEOPLE RES; UNDP Regional Bureau for Arab States, 2004, AR HUM DEV REP 2004; UNDP Regional Bureau for Arab States, 2002, AR HUM DEV REP 2002; UNDP Regional Bureau for Arab States, 2003, AR HUM DEV REP 2003; UNDP Regional Bureau for Arab States, 2005, AR HUM DEV REP 2005; UNDP Regional Bureau of Arab States, 2009, AR HUM DEV REP 2009; UNICEF, CHILDINFO MON STAT C; UNICEF, 2009, TRACK PROGR CHILD MA; UNICEF, 2012, STAT WORLDS CHILDR 2; United Nations Department of Economic and Social Affairs, 2004, P UN EXP M WORLD POP; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; United Nations Environment Programme, 2007, SUD POSTC ENV ASS; Verner D, 2012, ADAPTATION CHANGING, P9; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Waterbury J, 1993, EXPOSED INNUMERABLE, P70; Waterbury J., 2013, ARAB HUMAN DEV REPOR; Watts G, HLTH BENEFITS TACKLI; WHO, 2010, GLOB STAT REP NONC D; WHO (World Health Organisation), 2013, WAT QUAL HLTH STRAT; Wiebelt M, 2011, 01139 IFPRI; World Bank, 2012, TURN DOWN HEAT WHY 4; World Bank and FAO, 2009, GRAIN CHAIN FOOD SEC; Zickfeld F, 2012, 2050 DESERT POWER EX; Zurayk R, 2012, MEDITERRA 2012 MEDIT, P155	148	29	30	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					458	476		10.1016/S0140-6736(13)62338-7	http://dx.doi.org/10.1016/S0140-6736(13)62338-7			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452051	Green Accepted			2022-12-28	WOS:000330673700035
J	Obokata, H; Wakayama, T; Sasai, Y; Kojima, K; Vacanti, MP; Niwa, H; Yamato, M; Vacanti, CA				Obokata, Haruko; Wakayama, Teruhiko; Sasai, Yoshiki; Kojima, Koji; Vacanti, Martin P.; Niwa, Hitoshi; Yamato, Masayuki; Vacanti, Charles A.			RETRACTED: Stimulus-triggered fate conversion of somatic cells into pluripotency (Retracted article. See vol. 511, pg. 112, 2014)	NATURE			English	Article; Retracted Publication							STEM-CELLS; HEMATOPOIETIC STEM; MOUSE; DIFFERENTIATION; POPULATION; DERIVATION; INDUCTION; CULTURE; STATE; OCT4	Here we report a unique cellular reprogramming phenomenon, called stimulus-triggered acquisition of pluripotency (STAP), which requires neither nuclear transfer nor the introduction of transcription factors. In STAP, strong external stimuli such as a transient low-pH stressor reprogrammed mammalian somatic cells, resulting in the generation of pluripotent cells. Through real-time imaging of STAP cells derived from purified lymphocytes, as well as gene rearrangement analysis, we found that committed somatic cells give rise to STAP cells by reprogramming rather than selection. STAP cells showed a substantial decrease in DNA methylation in the regulatory regions of pluripotency marker genes. Blastocyst injection showed that STAP cells efficiently contribute to chimaeric embryos and to offspring via germline transmission. We also demonstrate the derivation of robustly expandable pluripotent cell lines from STAP cells. Thus, our findings indicate that epigenetic fate determination of mammalian cells can be markedly converted in a context-dependent manner by strong environmental cues.	[Obokata, Haruko; Kojima, Koji; Vacanti, Martin P.; Vacanti, Charles A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Tissue Engn & Regenerat Med, Boston, MA 02115 USA; [Obokata, Haruko] RIKEN Ctr Dev Biol, Lab Cellular Reprogramming, Kobe, Hyogo 6500047, Japan; [Obokata, Haruko; Wakayama, Teruhiko] RIKEN Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo 6500047, Japan; [Sasai, Yoshiki] RIKEN Ctr Dev Biol, Lab Organogenesis & Neurogenesis, Kobe, Hyogo 6500047, Japan; [Vacanti, Martin P.] Irwin Army Community Hosp, Dept Pathol, Ft Riley, KS 66442 USA; [Niwa, Hitoshi] RIKEN Ctr Dev Biol, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo 6500047, Japan; [Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; RIKEN; RIKEN; RIKEN; RIKEN; Tokyo Women's Medical University	Obokata, H (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Tissue Engn & Regenerat Med, Boston, MA 02115 USA.	obokata@cdb.riken.jp; cvacanti@partners.org			RIKEN; Network Project for Realization of Regenerative Medicine; Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital;  [20062015]	RIKEN; Network Project for Realization of Regenerative Medicine; Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital; 	We thank S. Nishikawa for discussion and J. D. Ross, N. Takata, M. Eiraku, M. Ohgushi, S. Itoh, S. Yonemura, S. Ohtsuka and K. Kakiguchi for help with experiments and analyses. We thank A. Penvose and K. Westerman for comments on the manuscript. H.O. is grateful to T. Okano, S. Tsuneda and K. Kuroda for support and encouragement. Financial support for this research was provided by Intramural RIKEN Research Budget (H.O., T.W. and Y.S.), a Scientific Research in Priority Areas (20062015) to T.W., the Network Project for Realization of Regenerative Medicine to Y.S., and Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital to C.A.V.	Berg JS, 2007, CELL STEM CELL, V1, P359, DOI 10.1016/j.stem.2007.09.007; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Byrnes WM, 2009, MOL REPROD DEV, V76, P912, DOI 10.1002/mrd.21081; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gerhart J, 1996, DEV DYNAM, V205, P245, DOI 10.1002/(SICI)1097-0177(199603)205:3<245::AID-AJA5>3.0.CO;2-I; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gratama JW, 2001, SEMIN HEMATOL, V38, P139, DOI 10.1053/shem.2001.21925; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HOLTFRETER J, 1947, J EXP ZOOL, V106, P197, DOI 10.1002/jez.1401060205; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hurtado C, 2007, DEV BIOL, V307, P282, DOI 10.1016/j.ydbio.2007.04.049; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jentsch I, 2003, CYTOGENET GENOME RES, V103, P84, DOI 10.1159/000076294; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Murakami K, 2011, DEVELOPMENT, V138, P197, DOI 10.1242/dev.056606; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Obokata H, 2011, TISSUE ENG PT A, V17, P607, DOI [10.1089/ten.tea.2010.0385, 10.1089/ten.TEA.2010.0385]; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; SURANI MAH, 1983, SCIENCE, V222, P1034, DOI 10.1126/science.6648518; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thorpe TA, 2007, MOL BIOTECHNOL, V37, P169, DOI 10.1007/s12033-007-0031-3; Wakayama S, 2013, CELL STEM CELL, V12, P293, DOI 10.1016/j.stem.2013.01.005; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	163	186	3	855	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					641	+		10.1038/nature12968	http://dx.doi.org/10.1038/nature12968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476887				2022-12-28	WOS:000330321000032
J	Ray, MW; Ruokokoski, E; Kandel, S; Mottonen, M; Hall, DS				Ray, M. W.; Ruokokoski, E.; Kandel, S.; Mottonen, M.; Hall, D. S.			Observation of Dirac monopoles in a synthetic magnetic field	NATURE			English	Article							SUPERFLUID HE-3; SINGULARITIES	Magnetic monopoles-particles that behave as isolated north or south magnetic poles-have been the subject of speculation since the first detailed observations of magnetism several hundred years ago(1). Numerous theoretical investigations and hitherto unsuccessful experimental searches(2) have followed Dirac's 1931 development of a theory of monopoles consistent with both quantum mechanics and the gauge invariance of the electromagnetic field(3). The existence of even a single Dirac magnetic monopole would have far-reaching physical consequences, most famously explaining the quantization of electric charge(3,4). Although analogues of magnetic monopoles have been found in exotic spin ices(5,6) and other systems(7-9), there has been no direct experimental observation of Dirac monopoles within a medium described by a quantum field, such as superfluid helium-3 (refs 10-13). Here we demonstrate the controlled creation(14) of Dirac monopoles in the synthetic magnetic field produced by a spinor Bose-Einstein condensate. Monopoles are identified, in both experiments and matching numerical simulations, at the termini of vortex lines within the condensate. By directly imaging such a vortex line, the presence of a monopole may be discerned from the experimental data alone. These real-space images provide conclusive and long-awaited experimental evidence of the existence of Dirac monopoles. Our result provides an unprecedented opportunity to observe and manipulate these quantum mechanical entities in a controlled environment.	[Ray, M. W.; Kandel, S.; Hall, D. S.] Amherst Coll, Dept Phys, Amherst, MA 01002 USA; [Ruokokoski, E.; Mottonen, M.] Aalto Univ, Dept Appl Phys, COMP Ctr Excellence, QCD Labs, Aalto 00076, Finland; [Mottonen, M.] Aalto Univ, Low Temp Lab OVLL, Aalto 00076, Finland	Amherst College; Aalto University; Aalto University	Hall, DS (corresponding author), Amherst Coll, Dept Phys, Amherst, MA 01002 USA.	dshall@amherst.edu	Ray, Michael W/A-2217-2014; Möttönen, Mikko/AAW-6120-2021; Möttönen, Mikko/A-6929-2012; Kandel, Saugat/AGH-0469-2022	Möttönen, Mikko/0000-0001-5084-2298; Möttönen, Mikko/0000-0001-5084-2298; Hall, David/0000-0002-2839-7623; Kandel, Saugat/0000-0002-7324-2559; Ray, Michael/0000-0002-8829-1257	National Science Foundation [PHY-0855475, PHY-1205822]; Academy of Finland through its Centres of Excellence Program [251748, 135794, 272806, 141015]; Finnish Doctoral Programme in Computational Sciences; CSC-IT Center for Science Ltd [ay2090]; Division Of Physics [1205822] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Academy of Finland through its Centres of Excellence Program; Finnish Doctoral Programme in Computational Sciences; CSC-IT Center for Science Ltd; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge funding by the National Science Foundation (grants PHY-0855475 and PHY-1205822), by the Academy of Finland through its Centres of Excellence Program (grant no. 251748) and grants (nos 135794, 272806 and 141015), and the Finnish Doctoral Programme in Computational Sciences. CSC-IT Center for Science Ltd is acknowledged for computational resources (project no. ay2090). We thank G. Volovik, M. Krusius, R. H. Romer, M. Nakahara and J. R. Friedman for their comments on the manuscript. We also thank H. Valja for his artistic input. M.W.R. and D.S.H. acknowledge discussions with R. P. Anderson and K. Jagannathan, and experimental assistance from N. B. Bern.	BLAHA S, 1976, PHYS REV LETT, V36, P874, DOI 10.1103/PhysRevLett.36.874; CABRERA B, 1982, PHYS REV LETT, V48, P1378, DOI 10.1103/PhysRevLett.48.1378; CARROLL CE, 1985, J OPT SOC AM B, V2, P1355, DOI 10.1364/JOSAB.2.001355; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Choi JY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.245301; Choi JY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035301; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Fang Z, 2003, SCIENCE, V302, P92, DOI 10.1126/science.1089408; GOLDHABER AS, 1990, MAGNETIC MONOPOLES; Kaufman AM, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.050701; Leanhardt AE, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.190403; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Milde P, 2013, SCIENCE, V340, P1076, DOI 10.1126/science.1234657; Milton KA, 2006, REP PROG PHYS, V69, P1637, DOI 10.1088/0034-4885/69/6/R02; Mottonen M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250406; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Pietila V, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.030401; Pietila V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.080403; Roncaglia M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00043; Ruokokoski E, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063627; SALOMAA MM, 1987, NATURE, V326, P367, DOI 10.1038/326367a0; Savage CM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043604; Shin Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.160406; Vilenkin A., 1994, COSMIC STRINGS OTHER; Volovik G., 1976, JETP LETT, V23, P647; Volovik G., 2003, UNIVERSE HELIUM DROP, P214; WU TT, 1975, PHYS REV D, V12, P3845, DOI 10.1103/PhysRevD.12.3845	29	196	200	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					657	+		10.1038/nature12954	http://dx.doi.org/10.1038/nature12954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476889	Green Submitted			2022-12-28	WOS:000330321000035
J	Dyer, O				Dyer, Owen			THE CHOOSING WISELY CAMPAIGN The challenge of doing less	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE					owen_dyer@hotmail.com						Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Roehr B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5721; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278	4	5	5	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5904	10.1136/bmj.f5904	http://dx.doi.org/10.1136/bmj.f5904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473450				2022-12-28	WOS:000325426300011
J	Roddy, E; Mallen, CD; Doherty, M				Roddy, Edward; Mallen, Christian D.; Doherty, Michael			Gout	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EVIDENCE BASED RECOMMENDATIONS; DOUBLE-BLIND; SERUM URATE; ASYMPTOMATIC HYPERURICEMIA; INCIDENT GOUT; TASK-FORCE; RISK; ARTHRITIS; ALLOPURINOL; DIAGNOSIS		[Roddy, Edward; Mallen, Christian D.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Doherty, Michael] Univ Nottingham, City Hosp, Nottingham NG7 2RD, England	Keele University; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Roddy, E (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	e.roddy@keele.ac.uk		Mallen, Christian/0000-0002-2677-1028	Arthritis Research UK Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Borstad GC, 2004, J RHEUMATOL, V31, P2429; BRAUER GW, 1978, ANN RHEUM DIS, V37, P466, DOI 10.1136/ard.37.5.466; British National Formulary, 2013, 10 1 4 GOUT CYT IND; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, ARTHRITIS RHEUM, V56, P2049, DOI 10.1002/art.22712; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Chowalloor PV, 2013, ANN RHEUM DIS, V72, P638, DOI 10.1136/annrheumdis-2012-202301; Dalbeth N, 2007, SEMIN DIALYSIS, V20, P391, DOI 10.1111/j.1525-139X.2007.00270.x; De Miguel E, 2012, ANN RHEUM DIS, V71, P157, DOI 10.1136/ard.2011.154997; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Edwards N Lawrence, 2008, Cleve Clin J Med, V75 Suppl 5, pS13; Electronic Medicines Compendium (eMC), 2013, SUMM PROD CHAR AD FI; EMMERSON BT, 1992, ANN RHEUM DIS, V51, P375, DOI 10.1136/ard.51.3.375; GOLDTHWAIT JC, 1958, NEW ENGL J MED, V259, P1095, DOI 10.1056/NEJM195812042592301; Hueskes BAA, 2012, SEMIN ARTHRITIS RHEU, V41, P879, DOI 10.1016/j.semarthrit.2011.11.008; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Kullich W, 1989, Rehabilitation (Stuttg), V28, P134; Li-Yu J, 2001, J RHEUMATOL, V28, P577; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Merriman TR, 2011, JOINT BONE SPINE, V78, P35, DOI 10.1016/j.jbspin.2010.02.027; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; National Institute for Health and Care Excellence, 2011, FEB MAN HYP PEOPL GO; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P356, DOI 10.1002/art.10511; Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Roddy E, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-13; Roddy E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3199; Roddy E, 2010, RHEUMATOLOGY, V49, P105, DOI 10.1093/rheumatology/kep332; Rubin BR, 2004, ARTHRITIS RHEUM-US, V50, P598, DOI 10.1002/art.20007; Schlesinger N, 2002, J RHEUMATOL, V29, P331; Schumacher HR, 2002, BMJ-BRIT MED J, V324, P1488, DOI 10.1136/bmj.324.7352.1488; Shoji A, 2004, ARTHRIT RHEUM-ARTHR, V51, P321, DOI 10.1002/art.20405; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Sutaria S, 2006, RHEUMATOLOGY, V45, P1422, DOI 10.1093/rheumatology/kel071; Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493; Tayar JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008653.pub2; Taylor TH, 2012, AM J MED, V125, P1126, DOI 10.1016/j.amjmed.2012.05.025; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Urano W, 2002, J RHEUMATOL, V29, P1950; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wechalekar MD, 2013, COCHRANE DB SYST REV, V4; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033	49	48	51	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5648	10.1136/bmj.f5648	http://dx.doi.org/10.1136/bmj.f5648			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473446				2022-12-28	WOS:000325426300003
J	Brennan, TA; Schroeder, SA				Brennan, Troyen A.; Schroeder, Steven A.			Ending Sales of Tobacco Products in Pharmacies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brennan, Troyen A.] CVS Caremark, Woonsocket, RI 02895 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Brennan, TA (corresponding author), CVS Caremark, One CVS Dr, Woonsocket, RI 02895 USA.	tabrennan@cvs.com						American Pharmacists Association, 2010, J AM PHARM ASSOC, V50, P471; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P133, DOI 10.1001/jama.2013.284534; Katz MH, 2008, JAMA-J AM MED ASSOC, V300, P1451, DOI 10.1001/jama.300.12.1451; Novak SP, 2006, AM J PUBLIC HEALTH, V96, P670, DOI 10.2105/AJPH.2004.061622; Pearce JMS, 2009, EUR NEUROL, V61, P63, DOI 10.1159/000175125; SCHROEDER SA, 1978, AM J PUBLIC HEALTH, V68, P494, DOI 10.2105/AJPH.68.5.494; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE	7	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1105	1106		10.1001/jama.2014.686	http://dx.doi.org/10.1001/jama.2014.686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24500655				2022-12-28	WOS:000333010100010
J	Jost, TS				Jost, Timothy Stoltzfus			Beyond Repeal - A Republican Proposal for Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Three Republican senators have unveiled a proposal that would repeal the Affordable Care Act and replace it with legislation based on Republican health policy principles. The proposal recycles long-standing Republican prescriptions but also offers new ideas. By voting repeatedly to repeal the Affordable Care Act (ACA) over the past 4 years, Republicans have risked being identified as a party without a positive health policy agenda. On January 27, 2014, however, three Republican senators Orrin Hatch (UT), Tom Coburn (OK), and Richard Burr (NC) unveiled a proposal that would not only repeal the ACA, but also replace it with comprehensive legislation based on Republican health policy principles.(1) Although the proposal recycles long-standing Republican prescriptions, it also offers new ideas. The proposal would not entirely repeal the ACA. Republicans seem to be coming to terms with ...	Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Congressional Budget Office, OPTIONS FOR REDUCING; Government Accountability Office, 2013, PRIVATE HEALTH INSUR; Government Accountability Office, 2011, MEDICAID HEALTH OPPO	3	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					894	896		10.1056/NEJMp1401212	http://dx.doi.org/10.1056/NEJMp1401212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC2EB	24520935				2022-12-28	WOS:000332309800005
J	Mesgarani, N; Cheung, C; Johnson, K; Chang, EF				Mesgarani, Nima; Cheung, Connie; Johnson, Keith; Chang, Edward F.			Phonetic Feature Encoding in Human Superior Temporal Gyrus	SCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; VOICE ONSET TIME; SPEECH; RESPONSES; REPRESENTATION; VOWEL; MODEL; DISCRIMINATION; CONSONANTS; PERCEPTION	During speech perception, linguistic elements such as consonants and vowels are extracted from a complex acoustic speech signal. The superior temporal gyrus (STG) participates in high-order auditory processing of speech, but how it encodes phonetic information is poorly understood. We used high-density direct cortical surface recordings in humans while they listened to natural, continuous speech to reveal the STG representation of the entire English phonetic inventory. At single electrodes, we found response selectivity to distinct phonetic features. Encoding of acoustic properties was mediated by a distributed population response. Phonetic features could be directly related to tuning for spectrotemporal acoustic cues, some of which were encoded in a nonlinear fashion or by integration of multiple cues. These findings demonstrate the acoustic-phonetic representation of speech in human STG.	[Mesgarani, Nima; Cheung, Connie; Chang, Edward F.] Univ Calif San Francisco, Dept Physiol, Dept Neurol Surg, San Francisco, CA 94143 USA; [Mesgarani, Nima; Cheung, Connie; Chang, Edward F.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Physiol, Dept Neurol Surg, San Francisco, CA 94143 USA.	changed@neurosurg.ucsf.edu	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121	NIH [R01-DC012379, R00-NS065120, DP2-OD00862]; Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Ren for technical help with data collection and preprocessing. S. Shamma, C. Espy-Wilson, E. Cibelli, K. Bouchard, and I. Garner provided helpful comments on the manuscript. E. F. C. was funded by NIH grants R01-DC012379, R00-NS065120, and DP2-OD00862 and the Ester A. and Joseph Klingenstein Foundation. E. F. C., C. C., and N.M. collected the data. N.M. and C. C. performed the analysis. N.M. and E. F. C. wrote the manuscript. K.J. provided phonetic consultation. E. F. C. supervised the project.	Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Boatman D, 1997, CORTEX, V33, P83, DOI 10.1016/S0010-9452(97)80006-8; Chan AM, 2014, CEREB CORTEX, V24, P2679, DOI 10.1093/cercor/bht127; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chechik G, 2012, P NATL ACAD SCI USA, V109, P18968, DOI 10.1073/pnas.1111242109; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Clements G. N., 1985, PHONOLOGY YB, V2, P225, DOI [10.1017/S0952675700000440., 10.1017/S0952675700000440, DOI 10.1017/S0952675700000440]; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; FOWLER CA, 1986, J PHONETICS, V14, P3, DOI 10.1016/S0095-4470(19)30607-2; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Halle M., 1991, WENNER GREN INT S SE, V59; Ladefoged Peter., 2010, COURSE PHONETICS; LIBERMAN AM, 1996, SPEECH SPECIAL CODE; LISKER L, 1967, LANG SPEECH, V10, P1, DOI 10.1177/002383096701000101; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; MILLER JD, 1989, J ACOUST SOC AM, V85, P2114, DOI 10.1121/1.397862; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Obleser J, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00232; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Steinschneider M, 2005, CEREB CORTEX, V15, P170, DOI 10.1093/cercor/bhh120; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Steinschneider M, 2011, CEREB CORTEX, V21, P2332, DOI 10.1093/cercor/bhr014; Stevens KN, 2002, J ACOUST SOC AM, V111, P1872, DOI 10.1121/1.1458026; SUSSMAN HM, 1986, BRAIN LANG, V28, P12, DOI 10.1016/0093-934X(86)90087-8; SYRDAL AK, 1986, J ACOUST SOC AM, V79, P1086, DOI 10.1121/1.393381; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304	32	460	464	10	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1006	1010		10.1126/science.1245994	http://dx.doi.org/10.1126/science.1245994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24482117	Green Accepted, Green Submitted			2022-12-28	WOS:000332309600041
J	Watts, G				Watts, Geoff			Henry Krum: resisting the pressure	LANCET			English	Biographical-Item																		KRUM H, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					591	591		10.1016/S0140-6736(14)60207-5	http://dx.doi.org/10.1016/S0140-6736(14)60207-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24529461	Bronze			2022-12-28	WOS:000331137700015
J	Croci, DO; Cerliani, JP; Dalotto-Moreno, T; Mendez-Huergo, SP; Mascanfroni, ID; Dergan-Dylon, S; Toscano, MA; Caramelo, JJ; Garcia-Vallejo, JJ; Ouyang, J; Mesri, EA; Junttila, MR; Bais, C; Shipp, MA; Salatino, M; Rabinovich, GA				Croci, Diego O.; Cerliani, Juan P.; Dalotto-Moreno, Tomas; Mendez-Huergo, Santiago P.; Mascanfroni, Ivan D.; Dergan-Dylon, Sebastian; Toscano, Marta A.; Caramelo, Julio J.; Garcia-Vallejo, Juan J.; Ouyang, Jing; Mesri, Enrique A.; Junttila, Melissa R.; Bais, Carlos; Shipp, Margaret A.; Salatino, Mariana; Rabinovich, Gabriel A.			Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors	CELL			English	Article							INHIBITS GROWTH; GALECTIN-1; CELLS; ACTIVATION; MECHANISMS; RESISTANCE; EXPRESSION; GLYCAN; PROGRESSION; METASTASIS	The clinical benefit conferred by vascular endothelial growth factors (VEGF)-targeted therapies is variable, and tumors from treated patients eventually reinitiate growth. Here, we identify a glycosylation-dependent pathway that compensates for the absence of cognate ligand and preserves angiogenesis in response to VEGF blockade. Remodeling of the endothelial cell (EC) surface glycome selectively regulated binding of galectin-1 (Gal1), which upon recognition of complex N-glycans on VEGFR2, activated VEGF-like signaling. Vessels within anti-VEGF-sensitive tumors exhibited high levels of alpha 2-6-linkedsialic acid, which prevented Gal1 binding. In contrast, anti-VEGF refractory tumors secreted increased Gal1 and their associated vasculature displayed glycosylation patterns that facilitated Gal1-EC interactions. Interruption of beta 1-6GlcNAc branching in ECs or silencing of tumor-derived Gal1 converted refractory into anti-VEGF-sensitive tumors, whereas elimination of alpha 2-6-linked sialic acid conferred resistance to anti-VEGF. Disruption of the Gal1-N-glycan axis promoted vascular remodeling, immune cell influx and tumor growth inhibition. Thus, targeting glycosylation-dependent lectin-receptor interactions may increase the efficacy of anti-VEGF treatment.	[Croci, Diego O.; Cerliani, Juan P.; Dalotto-Moreno, Tomas; Mendez-Huergo, Santiago P.; Mascanfroni, Ivan D.; Dergan-Dylon, Sebastian; Toscano, Marta A.; Salatino, Mariana; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Immunopatol, RA-1428 Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Lab Biol Estruct & Celular, RA-1405 Buenos Aires, DF, Argentina; [Garcia-Vallejo, Juan J.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Ouyang, Jing] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol,Miami Ctr AIDS Res, Miami, FL 33136 USA; [Junttila, Melissa R.; Bais, Carlos] Genencor Inc, San Francisco, CA 94080 USA; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Glicom, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Vrije Universiteit Amsterdam; Harvard University; Dana-Farber Cancer Institute; University of Miami; University of Buenos Aires	Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Immunopatol, RA-1428 Buenos Aires, DF, Argentina.	gabyrabi@gmail.com	Garcia-Vallejo, Juan/H-4162-2012; Vallejo, Juan Garcia/AAA-3765-2020; Croci, Diego/AAJ-5709-2021; Toscano, Marta/HGU-4103-2022	Garcia-Vallejo, Juan/0000-0001-6238-7069; Croci, Diego/0000-0002-8623-0645; Toscano, Marta/0000-0003-0502-8929	Argentinean Agency for Promotion of Science and Technology; CONICET; University of Buenos Aires; Sales Foundation	Argentinean Agency for Promotion of Science and Technology; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); Sales Foundation	We thank J. Dennis for Mgat5<SUP>-/-</SUP> mice; J. Paulson for St6gal1<SUP>-/-</SUP> mice; F. Poirier for Lgals1 <SUP>/</SUP> mice; J. Wang for Gal1<SUP>N46D</SUP>; C. Tran for PDAC tumors; J. Stupirski, H. Kalay, C. Leishman, and R. Morales for technical assistance; and J. Ilarregui and A. Gongora for advice. Supported by the Argentinean Agency for Promotion of Science and Technology, CONICET, University of Buenos Aires, Sales Foundation, and donations from Ferioli and Ostry families (to G.A.R.).	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Garcia-Vallejo JJ, 2006, J CELL PHYSIOL, V206, P203, DOI 10.1002/jcp.20458; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Granovsky M, 2000, NAT MED, V6, P306; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Mathieu V, 2012, J INVEST DERMATOL, V132, P2245, DOI 10.1038/jid.2012.142; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Saito T, 2002, J BIOL CHEM, V277, P17002, DOI 10.1074/jbc.M200521200; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Varki A., 2009, ESSENTIALS GLYCOBIOL; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023	50	356	370	1	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					744	758		10.1016/j.cell.2014.01.043	http://dx.doi.org/10.1016/j.cell.2014.01.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529377	Bronze, Green Published			2022-12-28	WOS:000331379800013
J	Kreiter, A				Kreiter, Andreas			Science at the sharp end of oppressive politics	NATURE			English	Editorial Material									Univ Bremen, D-28359 Bremen, Germany	University of Bremen	Kreiter, A (corresponding author), Univ Bremen, D-28359 Bremen, Germany.	kreiter@brain.uni-bremen.de						2014, NATURE, V506, P24	1	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					133	133		10.1038/506133a	http://dx.doi.org/10.1038/506133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA5AK	24522566	Bronze			2022-12-28	WOS:000331107700006
J	Tee, WW; Shen, SS; Oksuz, O; Narendra, V; Reinberg, D				Tee, Wee-Wei; Shen, Steven S.; Oksuz, Ozgur; Narendra, Varun; Reinberg, Danny			Erk1/2 Activity Promotes Chromatin Features and RNAPII Phosphorylation at Developmental Promoters in Mouse ESCs	CELL			English	Article							C-TERMINAL DOMAIN; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR-IIH; POLYMERASE-II; GENOME-WIDE; POSSIBLE INVOLVEMENT; NAIVE PLURIPOTENCY; GROUND-STATE; SELF-RENEWAL; POLYCOMB	Erk1/2 activation contributes to mouse ES cell pluripotency. We found a direct role of Erk1/2 in modulating chromatin features required for regulated developmental gene expression. Erk2 binds to specific DNA sequence motifs typically accessed by Jarid2 and PRC2. Negating Erk1/2 activation leads to increased nucleosome occupancy and decreased occupancy of PRC2 and poised RNAPII at Erk2-PRC2-targeted developmental genes. Surprisingly, Erk2-PRC2-targeted genes are specifically devoid of TFIIH, known to phosphorylate RNA polymerase II (RNAPII) at serine-5, giving rise to its initiated form. Erk2 interacts with and phosphorylates RNAPII at its serine 5 residue, which is consistent with the presence of poised RNAPII as a function of Erk1/2 activation. These findings underscore a key role for Erk1/2 activation in promoting the primed status of developmental genes in mouse ES cells and suggest that the transcription complex at developmental genes is different than the complexes formed at other genes, offering alternative pathways of regulation.	[Tee, Wee-Wei; Shen, Steven S.; Oksuz, Ozgur; Narendra, Varun; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Tee, Wee-Wei; Shen, Steven S.; Oksuz, Ozgur; Narendra, Varun; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Shen, Steven S.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Reinberg, D (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Tee, Wee Wei/H-2288-2014; Wei, Tee Wee/P-6223-2016; Tee, Wee Wei/AAW-9231-2020	Tee, Wee Wei/0000-0003-0829-7841; Shen, Steven/0000-0001-7725-1260; OKSUZ, OZGUR/0000-0001-8393-8501; Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [GM-64844, R37-37120]; NYSTEM [C028105]; Howard Hughes Medical Institute; New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037120, R01GM064844, T32GM007308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York Stem Cell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Genome Technology Center at NYU for help with sequencing, Theodoros Savvidis for technical support, Jinsook Son and Dr. Shuzo Kaneko for reagents, and Drs. Lynne Vales, Philipp Voigt, and Roberto Bonasio for comments on the manuscript. We thank Drs. Yang Shi and Kristian Helin for kind gifts of the Jmjd3 and Utx antibodies, respectively. This work was supported by grants from the National Institutes of Health (GM-64844 and R37-37120), NYSTEM (C028105), and the Howard Hughes Medical Institute (to D. R.). W.-W.T. is a New York Stem Cell Foundation Druckenmiller Fellow. This research was supported by The New York Stem Cell Foundation (to W.-W.T.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bellier S, 1997, MOL CELL BIOL, V17, P1434, DOI 10.1128/MCB.17.3.1434; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonnet F, 1999, NUCLEIC ACIDS RES, V27, P4399, DOI 10.1093/nar/27.22.4399; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brookes E, 2012, CELL CYCLE, V11, P1267, DOI 10.4161/cc.19990; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DUBOIS MF, 1994, EMBO J, V13, P4787, DOI 10.1002/j.1460-2075.1994.tb06804.x; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; FAUST C, 1995, DEVELOPMENT, V121, P273; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Klein AM, 2013, CURR OPIN CELL BIOL, V25, P272, DOI 10.1016/j.ceb.2013.01.002; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Orlando DA, 2012, GENOMICS, V100, P320, DOI 10.1016/j.ygeno.2012.07.006; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; VENETIANER A, 1995, EUR J BIOCHEM, V233, P83, DOI 10.1111/j.1432-1033.1995.083_1.x; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	78	107	108	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					678	690		10.1016/j.cell.2014.01.009	http://dx.doi.org/10.1016/j.cell.2014.01.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529373	Green Accepted, Bronze			2022-12-28	WOS:000331379800008
J	Metcalfe, K; Gershman, S; Ghadirian, P; Lynch, HT; Snyder, C; Tung, N; Kim-Sing, C; Eisen, A; Foulkes, WD; Rosen, B; Sun, P; Narod, SA				Metcalfe, Kelly; Gershman, Shelley; Ghadirian, Parviz; Lynch, Henry T.; Snyder, Carrie; Tung, Nadine; Kim-Sing, Charmaine; Eisen, Andrea; Foulkes, William D.; Rosen, Barry; Sun, Ping; Narod, Steven A.			Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTORS; WOMEN; RISK	Objective To compare the survival rates of women with BRCA associated breast cancer who did and did not undergo mastectomy of the contralateral breast. Design Retrospective analysis. Setting 12 cancer genetics clinics. Participants 390 women with a family history of stage I or II breast cancer who were carriers of BRCA1 and BRCA2 mutations and initially treated with unilateral or bilateral mastectomy. 181 patients had mastectomy of the contralateral breast. Patients were followed for up to 20 years from diagnosis. Main outcome measure Death from breast cancer. Results 79 women died of breast cancer in the follow-up period (18 in the bilateral mastectomy group and 61 in the unilateral mastectomy group). The median follow-up time was 14.3 years (range 0.1-20.0 years). At 20 years the survival rate for women who had mastectomy of the contralateral breast was 88% (95% confidence interval 83% to 93%) and for those who did not was 66% (59% to 73%). In a multivariable analysis, controlling for age at diagnosis, year of diagnosis, treatment, and other prognostic features, contralateral mastectomy was associated with a 48% reduction in death from breast cancer (hazard ratio 0.52, 95% confidence interval 0.29 to 0.93; P=0.03). In a propensity score adjusted analysis of 79 matched pairs, the association was not significant (0.60, 0.34 to 1.06; P=0.08). Based on these results, we predict that of 100 women treated with contralateral mastectomy, 87 will be alive at 20 years compared with 66 of 100 women treated with unilateral mastectomy. Conclusions This study suggests that women who are positive for BRCA mutations and who are treated for stage I or II breast cancer with bilateral mastectomy are less likely to die from breast cancer than women who are treated with unilateral mastectomy. Given the small number of events in this cohort, further research is required to confirm these findings.	[Metcalfe, Kelly; Gershman, Shelley] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5S 1A1, Canada; [Metcalfe, Kelly; Gershman, Shelley; Sun, Ping; Narod, Steven A.] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Ghadirian, Parviz] Ctr Hosp Univ Montreal, Epidemiol Res Unit, Montreal, PQ, Canada; [Lynch, Henry T.; Snyder, Carrie] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kim-Sing, Charmaine] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Eisen, Andrea] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada; [Foulkes, William D.] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Rosen, Barry] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Universite de Montreal; Creighton University; Harvard University; Beth Israel Deaconess Medical Center; British Columbia Cancer Agency; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Narod, SA (corresponding author), Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Foulkes, William D./AAR-9586-2021; Narod, Steven A/AAA-6112-2022	Foulkes, William D./0000-0001-7427-4651; Metcalfe, Kelly/0000-0003-1803-2169	Canadian Breast Cancer Foundation (Ontario Chapter); Canadian Institutes of Health Research; Ontario Women's Health Council	Canadian Breast Cancer Foundation (Ontario Chapter); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council	This research was funded by the Canadian Breast Cancer Foundation (Ontario Chapter). KM is supported by the Canadian Institutes of Health Research and the Ontario Women's Health Council.	Abe O, 2005, LANCET, V366, P2087; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Byrski T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3231; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Lostumbo L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002748.pub3; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Metcalfe K, 2011, BRIT J CANCER, V104, P1384, DOI 10.1038/bjc.2011.120; Metcalfe KA, 2008, J CLIN ONCOL, V26, P1093, DOI 10.1200/JCO.2007.12.6078; Narod SA, 2013, BREAST CANCER RES TR, V138, P273, DOI 10.1007/s10549-013-2429-x; Narod SA, 2011, BREAST CANCER RES TR, V128, P581, DOI 10.1007/s10549-011-1479-1; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323	17	155	158	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2014	348								g226	10.1136/bmj.g226	http://dx.doi.org/10.1136/bmj.g226			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WS	24519767	Green Published, hybrid			2022-12-28	WOS:000331444300023
J	Gornall, J				Gornall, Jonathan			Europe under the influence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALCOHOL					jgornall@mac.com						Alliance for Lobbying Transparency and Ethics Regulation in the European Union, 2013, ALLIANCE LOBBYING TR; Anderson P., 2012, ALCOHOL EUROPEAN UNI; [Anonymous], 2007, REP EUR STRAT SUPP M; [Anonymous], 2012, M COMM NAT ALC POL A; [Anonymous], 2012, HIGH LEV M COMM NAT; Baumberg B, 2007, ALCOHOL ALCOHOLISM, V42, P1, DOI 10.1093/alcalc/ag1105; Brewers of Europe, 2013, EUR BEER PLEDG 1 YEA; Celia Claire, 2012, Rand Health Q, V1, P10; Commission to the Council European Parliament European Economic and Social Committee Committee of the Regions, 2006, EUR STRAT SUPP MEMB; Craplet M, 2014, PARLIAMENT      0115; Ernst & Young, 2013, HOSP SECT EUR; European Parliament, TRANSP REG; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Milieu Law & Policy Consulting, 2012, ASS ADD VAL EU STRAT; Rehm J., 2012, ALCOHOL CONSUMPTION; ROMANUS G, 2006, NORD STUD ALCOHOL DR, V23, P513; Ulstein A, 2006, NORDISK ALKOHOL AN S, V23, P499	17	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2014	348								g1166	10.1136/bmj.g1166	http://dx.doi.org/10.1136/bmj.g1166			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WO	24513563				2022-12-28	WOS:000331443900001
J	Promislow, DEL; Kaeberlein, M				Promislow, Daniel E. L.; Kaeberlein, Matt			Chemical Warfare in the Battle of the Sexes	SCIENCE			English	Editorial Material							DROSOPHILA LIFE-SPAN		[Promislow, Daniel E. L.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Promislow, DEL (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	promislo@uw.edu		Promislow, Daniel/0000-0001-7088-4495	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033598, R01AG031108] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG031108, R01 AG033598] Funding Source: Medline; NIGMS NIH HHS [R01 GM102279] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnqvist G., 2005, MONOGRAPHS BEHAV ECO; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gendron CM, 2014, SCIENCE, V343, P544, DOI 10.1126/science.1243339; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160; PARTRIDGE L, 1985, NATURE, V316, P20, DOI 10.1038/316020a0; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Shi C, 2014, SCIENCE, V343, P536, DOI 10.1126/science.1242958; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49	10	2	2	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					491	492		10.1126/science.1250174	http://dx.doi.org/10.1126/science.1250174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482469				2022-12-28	WOS:000330343700028
J	Ferry, G				Ferry, Georgina			Women in crystallography	NATURE			English	Editorial Material												mgf@georginaferry.com						BRINK C, 1954, NATURE, V174, P1169, DOI 10.1038/1741169a0; CANNON JR, 1954, NATURE, V174, P1168, DOI 10.1038/1741168a0; Farnes P., 1990, WOMEN SCI RIGHTING R, P335; HODGKIN DC, 1955, NATURE, V176, P325, DOI 10.1038/176325a0	4	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					609	611		10.1038/505609a	http://dx.doi.org/10.1038/505609a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24482834	Bronze			2022-12-28	WOS:000330321000015
J	Haig, J; Nott, J; Reichart, GJ				Haig, Jordahna; Nott, Jonathan; Reichart, Gert-Jan			Australian tropical cyclone activity lower than at any time over the past 550-1,500 years	NATURE			English	Article							STABLE-ISOTOPE RATIOS; INTENSITY; VARIABILITY; FREQUENCY; CLIMATE; HURRICANES; TRENDS; RAIN	The assessment of changes in tropical cyclone activity within the context of anthropogenically influenced climate change has been limited by the short temporal resolution of the instrumental tropical cyclone record(1,2) (less than 50 years). Furthermore, controversy exists regarding the robustness of the observational record, especially before 1990(3-5). Here we show, on the basis of a new tropical cyclone activity index (CAI), that the present low levels of storm activity on the mid west and northeast coasts of Australia are unprecedented over the past 550 to 1,500 years. The CAI allows for a direct comparison between the modern instrumental record and long-term palaeotempest (prehistoric tropical cyclone) records derived from the O-18/O-16 ratio of seasonally accreting carbonate layers of actively growing stalagmites. Our results reveal a repeated multicentennial cycle of tropical cyclone activity, the most recent of which commenced around AD 1700. The present cycle includes a sharp decrease in activity after 1960 in Western Australia. This is in contrast to the increasing frequency and destructiveness of Northern Hemisphere tropical cyclones since 1970 in the Atlantic Ocean(6-8) and the western North Pacific Ocean(6,7). Other studies project a decrease in the frequency of tropical cyclones towards the end of the twenty-first century in the southwest Pacific(7,9), southern Indian(9,10) and Australian(11) regions. Our results, although based on a limited record, suggest that this may be occurring much earlier than expected.	[Haig, Jordahna; Nott, Jonathan] James Cook Univ, Cairns, Qld 4870, Australia; [Reichart, Gert-Jan] Univ Utrecht, Dept Geochem, NL-3508 TA Utrecht, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res, Dept Geol, NL-1797 SZ Den Hoorn, Texel, Netherlands	James Cook University; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Haig, J (corresponding author), James Cook Univ, Cairns, Qld 4870, Australia.	jordahna.haig@jcu.edu.au	Reichart, Gert-Jan/N-6308-2018; Nott, Jonathan/H-5156-2011	Reichart, Gert-Jan/0000-0002-7256-2243; Nott, Jonathan/0000-0001-7258-017X; Haig, Jordahna/0000-0003-1350-522X	Australian Research Council (ARC) [DP0772691]; Queensland Smart State Initiative	Australian Research Council (ARC)(Australian Research Council); Queensland Smart State Initiative	Funding for this project was provided by the Australian Research Council (ARC) Discovery Projects Scheme (reference number DP0772691) and financial assistance given as part of the Queensland Smart State Initiative. Analytical procedures were conducted at James Cook University and the University of Utrecht. Special thanks are extended to C. Zwart for his input and advice regarding the development of CAI and his editing of this manuscript. Additional thanks are extended to A. van Dijk and L. Lourens for technical help with IRMS analyses.	Abbs D., 2010, 11 CAF CSIRO; ATKINSON GD, 1977, MON WEATHER REV, V105, P421, DOI 10.1175/1520-0493(1977)105<0421:TCMSLP>2.0.CO;2; Bell GD, 2000, B AM METEOROL SOC, V81, pS1, DOI 10.1175/1520-0477(2000)81[s1:CAF]2.0.CO;2; Bureau of Meteorology, 2012, AUSTR TROP CYCL DAT; Callaghan J, 2011, CLIM DYNAM, V37, P647, DOI 10.1007/s00382-010-0883-2; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Gedzelman S, 2003, MON WEATHER REV, V131, P1112, DOI 10.1175/1520-0493(2003)131<1112:PHWSIO>2.0.CO;2; Griffiths ML, 2009, NAT GEOSCI, V2, P636, DOI 10.1038/NGEO605; Harper BA, 2008, AUST METEOROL MAG, V57, P121; Hassim MEE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001804; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Kamahori H, 2006, SOLA, V2, P104, DOI 10.2151/sola.2006-027; Kantha L, 2006, EOS T AM GEOPHYS UN, V87, P3, DOI DOI 10.1029/2006EO010003; Keenan T. D., 2011, CLIMATE SCI UPDATE R, P3; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kossin JP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028836; Landsea CW, 2006, SCIENCE, V313, P452, DOI 10.1126/science.1128448; Lawrence JR, 1998, J GEOPHYS RES-ATMOS, V103, P11381, DOI 10.1029/97JD03627; Lawrence JR, 2002, J ATMOS CHEM, V41, P67, DOI 10.1023/A:1013808530364; Liu JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014403; Liu KS, 2012, INT J CLIMATOL, V32, P190, DOI 10.1002/joc.2259; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mann ME, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034716; Muhlinghuas C, 2009, GEOCHIM COSMOCHIM AC, V73, P7275, DOI 10.1016/j.gca.2009.09.010; Nicholls N, 1998, METEOROL ATMOS PHYS, V65, P197, DOI 10.1007/BF01030788; NOAA, 2013, HURDAT BEST TRACK DA; Nott J, 2001, NATURE, V413, P508, DOI 10.1038/35097055; Nott J, 2007, EARTH PLANET SC LETT, V255, P367, DOI 10.1016/j.epsl.2006.12.023; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Velden C, 2006, B AM METEOROL SOC, V87, P1195, DOI 10.1175/BAMS-87-9-1195; Willoughby HE, 2004, MON WEATHER REV, V132, P3033, DOI 10.1175/MWR2831.1; Yu JY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039254; Zhao M, 2009, J CLIMATE, V22, P6653, DOI 10.1175/2009JCLI3049.1	37	69	69	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					667	+		10.1038/nature12882	http://dx.doi.org/10.1038/nature12882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476890				2022-12-28	WOS:000330321000038
J	Necsulea, A; Soumillon, M; Warnefors, M; Liechti, A; Daish, T; Zeller, U; Baker, JC; Grutzner, F; Kaessmann, H				Necsulea, Anamaria; Soumillon, Magali; Warnefors, Maria; Liechti, Angelica; Daish, Tasman; Zeller, Ulrich; Baker, Julie C.; Gruetzner, Frank; Kaessmann, Henrik			The evolution of lncRNA repertoires and expression patterns in tetrapods	NATURE			English	Article							LONG NONCODING RNAS; SEQ REVEALS; VERTEBRATE; NETWORK; IDENTIFICATION; CONSERVATION; ARCHITECTURE; SEQUENCES; ALIGNMENT; LINCRNA	Only a very small fraction of long noncoding RNAs (lncRNAs) are well characterized. The evolutionary history of lncRNAs can provide insights into their functionality, but the absence of lncRNA annotations in non-model organisms has precluded comparative analyses. Here we present a large-scale evolutionary study of lncRNA repertoires and expression patterns, in 11 tetrapod species. We identify approximately 11,000 primate-specific lncRNAs and 2,500 highly conserved lncRNAs, including approximately 400 genes that are likely to have originated more than 300 million years ago. We find that lncRNAs, in particular ancient ones, are in general actively regulated and may function predominantly in embryonic development. Most lncRNAs evolve rapidly in terms of sequence and expression levels, but tissue specificities are often conserved. We compared expression patterns of homologous lncRNA and protein-coding families across tetrapods to reconstruct an evolutionarily conserved co-expression network. This network suggests potential functions for lncRNAs in fundamental processes such as spermatogenesis and synaptic transmission, but also in more specific mechanisms such as placenta development through microRNA production.	[Necsulea, Anamaria; Soumillon, Magali; Warnefors, Maria; Liechti, Angelica; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Necsulea, Anamaria; Soumillon, Magali; Warnefors, Maria; Liechti, Angelica; Kaessmann, Henrik] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Daish, Tasman; Gruetzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Robinson Inst, Adelaide, SA 5005, Australia; [Zeller, Ulrich] Humboldt Univ, Fac Agr & Hort, Dept Systemat Zool, D-10099 Berlin, Germany; [Baker, Julie C.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Lausanne; Swiss Institute of Bioinformatics; Robinson Research Institute; University of Adelaide; Humboldt University of Berlin; Stanford University	Necsulea, A (corresponding author), Ecole Polytech Fed Lausanne, Lab Dev Genom, CH-1015 Lausanne, Switzerland.	anamaria.necsulea@epfl.ch; henrik.kaessmann@unil.ch	Kaessmann, Henrik/B-4989-2013; Grutzner, Frank/ABB-2820-2021; Grutzner, Frank/AAD-5834-2020	Kaessmann, Henrik/0000-0001-7563-839X; Grutzner, Frank/0000-0002-3088-7314; 	MRC/Wellcome Trust [099175/Z/12/Z]; European Research Council [242597]; Swiss National Science Foundation [31003A_130287]; FEBS; MRC [G0700089, MC_PC_15004] Funding Source: UKRI; Medical Research Council [MC_PC_15004, G0700089] Funding Source: researchfish	MRC/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FEBS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Froidevaux and D. Cortez for help with genome sequencing, J. Meunier for help with preliminary miRNA analyses, K. Harshman and the Lausanne Genomics Technology Facility for high-throughput sequencing support, I. Xenarios for computational support, S. Bergmann and Z. Kutalik for advice on co-expression analyses. Human embryonic and fetal material was provided by the Joint MRC/Wellcome Trust (grant 099175/Z/12/Z) Human Developmental Biology Resource (http://www.hdbr.org). The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics. This research was supported by grants from the European Research Council (Starting Independent Researcher Grant 242597, SexGenTransEvolution) and the Swiss National Science Foundation (grant 31003A_130287) to H.K. A.N. was supported by a FEBS long-term postdoctoral fellowship.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grant J, 2012, NATURE, V487, P254, DOI 10.1038/nature11171; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nam J. W., 2012, GENOME RES; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; R Development Core Team, 2009, R LANG ENV STAT COMP; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Walker E, 2011, CELL CYCLE, V10, P45, DOI 10.4161/cc.10.1.14389; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	57	659	697	4	294	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					635	+		10.1038/nature12943	http://dx.doi.org/10.1038/nature12943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24463510				2022-12-28	WOS:000330321000031
J	O'Riordan, P; Stevens, PE; Lamb, EJ				O'Riordan, Philly; Stevens, Paul E.; Lamb, Edmund J.			RATIONAL TESTING Estimated glomerular filtration rate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC KIDNEY-DISEASE; CREATININE RATIO; PRIMARY-CARE; ALBUMINURIA; MANAGEMENT; OUTCOMES		[O'Riordan, Philly] City Rd Med Ctr, London, England; [Stevens, Paul E.] East Kent Hosp Univ NHS Fdn Trust, Kent Kidney Care Ctr, Canterbury, Kent, England; [Lamb, Edmund J.] East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England		Lamb, EJ (corresponding author), East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England.	elamb@nhs.net						Abdi Z, 2012, ANN CLIN BIOCHEM, V49, P417, DOI 10.1258/acb.2012.012168; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Fraser CG, 2012, ANN CLIN BIOCHEM, V49, P1, DOI 10.1258/acb.2011.011203; John R, 2004, AM J KIDNEY DIS, V43, P825, DOI 10.1053/j.ajkd.2003.12.046; Kidney Disease Improving Global Outcomes, 2013, KIDNEY INT S, V3, P1; Lamb EJ, 2013, ANN CLIN BIOCHEM, V50, P301, DOI 10.1177/0004563212473284; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McTaggart MP, 2012, AM J KIDNEY DIS, V60, P787, DOI 10.1053/j.ajkd.2012.05.009; National Institute for Health and Care Excellence, 2011, AN MAN PEOPL CHRON K; National Institute for Health and Care Excellence. The National Collaborating Centre for Chronic Conditions, 2008, CHRON KIDN DIS NAT C; National Osteoporosis Society, 2013, VIT D BON HLTH PRACT; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Stevens PE, 2012, NEPHROL DIAL TRANSPL, V27, P5, DOI 10.1093/ndt/gfs103; Uhlig K, 2012, ANN INTERN MED, V156, P599, DOI [10.7326/0003-4819-156-8-201204170-00012, 10.7326/0003-4819-156-8-201204170-00009]	19	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2014	348								g264	10.1136/bmj.g264	http://dx.doi.org/10.1136/bmj.g264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BI	24464281				2022-12-28	WOS:000330298500010
J	Cortazar, P; Zhang, LJ; Untch, M; Mehta, K; Costantino, JP; Wolmark, N; Bonnefoi, H; Cameron, D; Gianni, L; Valagussa, P; Swain, SM; Prowell, T; Loibl, S; Wickerham, DL; Bogaerts, J; Baselga, J; Perou, C; Blumenthal, G; Blohmer, J; Mamounas, EP; Bergh, J; Semiglazov, V; Justice, R; Eidtmann, H; Paik, S; Piccart, M; Sridhara, R; Fasching, PA; Slaets, L; Tang, SH; Gerber, B; Geyer, CE; Pazdur, R; Ditsch, N; Rastogi, P; Eiermann, W; von Minckwitz, G				Cortazar, Patricia; Zhang, Lijun; Untch, Michael; Mehta, Keyur; Costantino, Joseph P.; Wolmark, Norman; Bonnefoi, Herve; Cameron, David; Gianni, Luca; Valagussa, Pinuccia; Swain, Sandra M.; Prowell, Tatiana; Loibl, Sibylle; Wickerham, D. Lawrence; Bogaerts, Jan; Baselga, Jose; Perou, Charles; Blumenthal, Gideon; Blohmer, Jens; Mamounas, Eleftherios P.; Bergh, Jonas; Semiglazov, Vladimir; Justice, Robert; Eidtmann, Holger; Paik, Soonmyung; Piccart, Martine; Sridhara, Rajeshwari; Fasching, Peter A.; Slaets, Leen; Tang, Shenghui; Gerber, Bernd; Geyer, Charles E., Jr.; Pazdur, Richard; Ditsch, Nina; Rastogi, Priya; Eiermann, Wolfgang; von Minckwitz, Gunter			Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis	LANCET			English	Article							DOSE-INTENSIFIED CHEMOTHERAPY; SURGICAL ADJUVANT BREAST; PRIMARY SYSTEMIC THERAPY; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; DARBEPOETIN ALPHA; PREPARE TRIAL; CYCLOPHOSPHAMIDE; DOXORUBICIN; TRASTUZUMAB	Background Pathological complete response has been proposed as a surrogate endpoint for prediction of long-term clinical benefit, such as disease-free survival, event-free survival (EFS), and overall survival (OS). We had four key objectives: to establish the association between pathological complete response and EFS and OS, to establish the definition of pathological complete response that correlates best with long-term outcome, to identify the breast cancer subtypes in which pathological complete response is best correlated with long-term outcome, and to assess whether an increase in frequency of pathological complete response between treatment groups predicts improved EFS and OS. Methods We searched PubMed, Embase, and Medline for clinical trials of neoadjuvant treatment of breast cancer. To be eligible, studies had to meet three inclusion criteria: include at least 200 patients with primary breast cancer treated with preoperative chemotherapy followed by surgery; have available data for pathological complete response, EFS, and OS; and have a median follow-up of at least 3 years. We compared the three most commonly used definitions of pathological complete response-ypT0 ypN0, ypT0/is ypN0, and ypT0/is-for their association with EFS and OS in a responder analysis. We assessed the association between pathological complete response and EFS and OS in various subgroups. Finally, we did a trial-level analysis to assess whether pathological complete response could be used as a surrogate endpoint for EFS or OS. Findings We obtained data from 12 identified international trials and 11955 patients were included in our responder analysis. Eradication of tumour from both breast and lymph nodes (ypT0 ypN0 or ypT0/is ypN0) was better associated with improved EFS (ypT0 ypN0: hazard ratio [HR] 0.44, 95% CI 0.39-0.51; ypT0/is ypN0: 0.48, 0.43-0.54) and OS (0.36, 0.30-0.44; 0.36, 0.31-0.42) than was tumour eradication from the breast alone(ypT0/is; EFS: HR 0.60, 95% CI 0.55-0.66; OS 0.51, 0.45-0.58). We used the ypT0/is ypN0 definition for all subsequent analyses. The association between pathological complete response and long-term outcomes was strongest in patients with triple-negative breast cancer (EFS: HR 0.24, 95% CI 0.18-0.33; OS: 0.16, 0.11-0.25) and in those with HER2-positive, hormone-receptor-negative tumours who received trastuzumab (EFS: 0.15, 0.09-0.27; OS: 0.08, 0.03, 0. 22). In the trial-level analysis, we recorded little association between increases in frequency of pathological complete response and EFS (R-2=0.03, 95% CI 0.00-0.25) and OS (R-2=0.24,0.00-0.70). Interpretation Patients who attain pathological complete response defined as ypT0 ypN0 or ypT0/is ypN0 have improved survival. The prognostic value is greatest in aggressive tumour subtypes. Our pooled analysis could not validate pathological complete response as a surrogate endpoint for improved EFS and OS. Funding US Food and Drug Administration.	[Cortazar, Patricia; Zhang, Lijun; Prowell, Tatiana; Blumenthal, Gideon; Justice, Robert; Sridhara, Rajeshwari; Tang, Shenghui; Pazdur, Richard] US FDA, Silver Spring, MD USA; [Untch, Michael] HELIOS Klin, Berlin, Germany; [Mehta, Keyur; Loibl, Sibylle; von Minckwitz, Gunter] German Breast Grp, Neu Isenburg, Germany; [Costantino, Joseph P.; Wolmark, Norman; Wickerham, D. Lawrence; Paik, Soonmyung; Rastogi, Priya] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA; [Bonnefoi, Herve] Inst Bergonie INSERM U916, Bordeaux, France; [Bonnefoi, Herve] Univ Bordeaux Segalen, Bordeaux, France; [Cameron, David] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh EH8 9YL, Midlothian, Scotland; [Cameron, David] NHS Lothian, Edinburgh, Midlothian, Scotland; [Gianni, Luca] Ist Sci San Raffaele, I-20132 Milan, Italy; [Valagussa, Pinuccia] Fdn Michelangelo, Milan, Italy; [Swain, Sandra M.] Medstar Washington Hosp Ctr, Washington, DC USA; [Bogaerts, Jan; Slaets, Leen] EORTC Headquarters, Brussels, Belgium; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Perou, Charles] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Blohmer, Jens] St Gertrauden Hosp, Berlin, Germany; [Mamounas, Eleftherios P.] MD Anderson Canc Ctr Orlando, Orlando, FL USA; [Bergh, Jonas] KarolinskaInst, Stockholm, Sweden; [Bergh, Jonas] Univ Hosp, Stockholm, Sweden; [Semiglazov, Vladimir] NN Petrov Oncol Res Inst, St Petersburg, Russia; [Eidtmann, Holger] Univ Womens Hosp, Kiel, Germany; [Piccart, Martine] Inst Jules Bordet, B-1000 Brussels, Belgium; [Fasching, Peter A.] Univ Klinikums, Frauenklin, Erlangen, Germany; [Gerber, Bernd] Univ Frauenklin, Rostock, Germany; [Geyer, Charles E., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Ditsch, Nina; Eiermann, Wolfgang] Hosp Ludwig Maximilian Univ Munich, Munich, Germany	US Food & Drug Administration (FDA); Helios Kliniken; German Breast Group; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; University of Edinburgh; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; MedStar Washington Hospital Center; European Organisation for Research & Treatment of Cancer; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; N.N. Petrov Research Institute of Oncology; University of Kiel; Schleswig Holstein University Hospital; Institut Jules Bordet; University of Rostock; Virginia Commonwealth University; University of Munich	Cortazar, P (corresponding author), 10903 New Hampshire Ave,Bldg 22,Room 2333, Silver Spring, MD 20993 USA.	patricia.cortazar@fda.hhs.gov	Fasching, Peter A/ABH-9912-2020; Geyer, Charles/AGY-0119-2022; Perou, Charles M/H-9934-2014	Fasching, Peter A/0000-0003-4885-8471; Geyer, Charles/0000-0002-2379-5702; Perou, Charles M/0000-0001-9827-2247; Blohmer, Jens-Uwe/0000-0002-7969-250X; Bergh, Jonas/0000-0001-5526-1847; Swain, Sandra/0000-0002-1320-3830; Valagussa, Pinuccia/0000-0003-3590-7916	US Food and Drug Administration; CTNeoBC pooled analysis; NATIONAL CANCER INSTITUTE [U10CA180791, U10CA069651, U10CA012027] Funding Source: NIH RePORTER	US Food and Drug Administration; CTNeoBC pooled analysis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partly funded by the US Food and Drug Administration. We thank Janet Woodcock, who provided financial support for the CTNeoBC pooled analysis; all the patients, Breast Cancer Cooperative Groups, investigators, pathologists, and statisticians who participated in the neoadjuvant trials; and Jo Anne Zujewski for her help.	Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; BONADONNA G, 1993, LANCET, V341, P1485, DOI 10.1016/0140-6736(93)90933-8; Bonnefoi H, 2011, LANCET ONCOL, V12, P527, DOI 10.1016/S1470-2045(11)70094-8; Burzykowski T, 2005, EVALUATION SURROGATE; Buyse M, 2008, STAT METHODS MED RES, V17, P467, DOI 10.1177/0962280207081864; Cameron DA, 1997, BRIT J CANCER, V76, P1099, DOI 10.1038/bjc.1997.514; FELDMAN LD, 1986, CANCER RES, V46, P2578; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Mazouni C, 2007, J CLIN ONCOL, V25, P2650, DOI 10.1200/JCO.2006.08.2271; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Prowell TM, 2012, NEW ENGL J MED, V366, P2438, DOI 10.1056/NEJMp1205737; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Untch M, 2011, ANN ONCOL, V22, P1988, DOI 10.1093/annonc/mdq709; Untch M, 2011, ANN ONCOL, V22, P1999, DOI 10.1093/annonc/mdq713; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Untch M, 2010, J CLIN ONCOL, V28, P2024, DOI 10.1200/JCO.2009.23.8451; Untch M, 2009, J CLIN ONCOL, V27, P2938, DOI 10.1200/JCO.2008.20.3133; US Center for Drug Evaluation and Research, 2012, GUID IND PATH COMPL; von Minckwitz G, 2005, J CLIN ONCOL, V23, P2676, DOI 10.1200/JCO.2005.05.078; von Minckwitz G, 2005, ANN ONCOL, V16, P56, DOI 10.1093/annonc/mdi001; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P552, DOI 10.1093/jnci/djn089; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P542, DOI 10.1093/jnci/djn085; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2011, BREAST CANCER RES TR, V125, P145, DOI 10.1007/s10549-010-1228-x; von Minckwitz G, 2010, J CLIN ONCOL, V28, P2015, DOI 10.1200/JCO.2009.23.8303; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	28	2130	2216	8	166	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					164	172		10.1016/S0140-6736(13)62422-8	http://dx.doi.org/10.1016/S0140-6736(13)62422-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24529560	Green Submitted			2022-12-28	WOS:000338921500035
J	Hunt, K; Wyke, S; Gray, CM; Anderson, AS; Brady, A; Bunn, C; Donnan, PT; Fenwick, E; Grieve, E; Leishman, J; Miller, E; Mutrie, N; Rauchhaus, P; White, A; Treweek, S				Hunt, Kate; Wyke, Sally; Gray, Cindy M.; Anderson, Annie S.; Brady, Adrian; Bunn, Christopher; Donnan, Peter T.; Fenwick, Elisabeth; Grieve, Eleanor; Leishman, Jim; Miller, Euan; Mutrie, Nanette; Rauchhaus, Petra; White, Alan; Treweek, Shaun			A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial	LANCET			English	Article							PRIMARY-CARE; MANAGEMENT; INTERVENTIONS; VALIDATION; PROJECT; UTILITY; SF-12	Background The prevalence of male obesity is increasing but few men take part in weight loss programmes. We assessed the effect of a weight loss and healthy living programme on weight loss in football (soccer) fans. Methods We did a two-group, pragmatic, randomised controlled trial of 747 male football fans aged 35-65 years with a body-mass index (BMI) of 28 kg/m(2) or higher from 13 Scottish professional football clubs. Participants were randomly assigned with SAS (version 9.2, block size 2-9) in a 1: 1 ratio, stratified by club, to a weight loss programme delivered by community coaching staff in 12 sessions held every week. The intervention group started a weight loss programme within 3 weeks, and the comparison group were put on a 12 month waiting list. All participants received a weight management booklet. Primary outcome was mean difference in weight loss between groups at 12 months, expressed as absolute weight and a percentage of their baseline weight. Primary outcome assessment was masked. Analyses were based on intention to treat. The trial is registered with Current Controlled Trials, number ISRCTN32677491. Findings 374 men were allocated to the intervention group and 374 to the comparison group. 333 (89%) of the intervention group and 355 (95%) of the comparison group completed 12 month assessments. At 12 months the mean difference in weight loss between groups, adjusted for baseline weight and club, was 4.94 kg (95% CI 3.95-5.94) and percentage weight loss, similarly adjusted, was 4.36% (3.64-5.08), both in favour of the intervention (p<0.0001). Eight serious adverse events were reported, five in the intervention group (lost consciousness due to drugs for pre-existing angina, gallbladder removal, hospital admission with suspected heart attack, ruptured gut, and ruptured Achilles tendon) and three in the comparison group (transient ischaemic attack, and two deaths). Of these, two adverse events were reported as related to participation in the programme (gallbladder removal and ruptured Achilles tendon). Interpretation The FFIT programme can help a large proportion of men to lose a clinically important amount of weight; it offers one effective strategy to challenge male obesity.	[Hunt, Kate] Univ Glasgow, Social & Publ Hlth Sci Unit, Glasgow G12 8RS, Lanark, Scotland; [Wyke, Sally; Gray, Cindy M.; Bunn, Christopher] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RS, Lanark, Scotland; [Anderson, Annie S.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Publ Hlth Nutr Res, Dundee DD1 9SY, Scotland; [Brady, Adrian] Glasgow Royal Infirm, NHS Greater Glasgow & Clyde, Glasgow G4 0SF, Lanark, Scotland; [Donnan, Peter T.; Rauchhaus, Petra] Univ Dundee, Div Populat Hlth Sci, Med Res Inst, Dundee, Scotland; [Fenwick, Elisabeth; Grieve, Eleanor] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Miller, Euan] Premier League Trust, Glasgow, Lanark, Scotland; [Mutrie, Nanette] Univ Edinburgh, Moray House Sch Educ, Edinburgh, Midlothian, Scotland; [White, Alan] Leeds Metropolitan Univ, Ctr Mens Hlth, Fac Hlth & Social Sci, Leeds LS1 3HE, W Yorkshire, England; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Glasgow; University of Dundee; University of Glasgow; University of Dundee; University of Glasgow; University of Edinburgh; Leeds Beckett University; University of Aberdeen	Wyke, S (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RS, Lanark, Scotland.	sally.wyke@glasgow.ac.uk	Treweek, Shaun/AAE-8006-2019; Wyke, Sally/M-7203-2018	Treweek, Shaun/0000-0002-7239-7241; Wyke, Sally/0000-0002-7509-8247; Donnan, Peter/0000-0001-7828-0610; White, Alan/0000-0001-8054-7783; Bunn, Christopher/0000-0001-6604-1305; anderson, annie/0000-0002-0047-4500	Scottish Government; UK Football Pools; National Institute for Health Research Public Health Research Programme [09/3010/06]; MRC [MC_U130059811, MC_UU_12017/3] Funding Source: UKRI; Medical Research Council [MC_U130059811, MC_UU_12017/3] Funding Source: researchfish; National Institute for Health Research [09/3010/06] Funding Source: researchfish; Chief Scientist Office [HSRU2, CZH/4/886, CZG/2/504] Funding Source: researchfish	Scottish Government; UK Football Pools; National Institute for Health Research Public Health Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	Funding Scottish Government and The UK Football Pools funded delivery of the programme through a grant to the Scottish Premier League Trust. The National Institute for Health Research Public Health Research Programme funded the assessment (09/3010/06).	Barclays Premier League, RES INS SEAS 2011 20; Bradshaw P, 2012, SCOTTISH HLTH SURVEY; Brady AJB, 2010, EUR HEART J, V31, P2966; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; British Heart Foundation, 2009, SO YOU WANT LOS WEIG; Emslie C, 2009, PUBLIC HEALTH, V123, P12, DOI 10.1016/j.puhe.2008.06.001; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gray CM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-121; Gray CM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-232; Hunt K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-50; Hunt K, 2013, HEALTH PSYCHOL, V32, P57, DOI 10.1037/a0029537; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Kharroubi SA, 2007, J HEALTH ECON, V26, P597, DOI 10.1016/j.jhealeco.2006.09.002; MAHALIK JR, 2003, PSYCHOL MEN MASCULIN, V4, P3, DOI DOI 10.1037/1524-9220.4.1.3; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; McCabe C, 2006, J HEALTH ECON, V25, P418, DOI 10.1016/j.jhealeco.2005.07.008; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Morgan PJ, 2011, OBESITY, V19, P142, DOI 10.1038/oby.2010.119; National Institute for Health and Care Excellence, 2006, OB PREV ID ASS MAN O; Pagoto SL, 2012, OBESITY, V20, P1234, DOI 10.1038/oby.2011.140; Patrick K, 2011, ANN BEHAV MED, V42, P391, DOI 10.1007/s12160-011-9296-7; Personal Social Services Research Unit, 2011, UN COST HLTH SOC CAR; Pringle A, 2013, PUBLIC HEALTH, V127, P18, DOI 10.1016/j.puhe.2012.10.012; Robertson C, HLTH TECHNO IN PRESS; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Ross HM, 2008, BRIT J GEN PRACT, V58, P548, DOI 10.3399/bjgp08X319710; Stubbs RJ, 2011, OBESITY FACTS, V4, P113, DOI 10.1159/000327249; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098; Young MD, 2012, OBES REV, V13, P393, DOI 10.1111/j.1467-789X.2011.00967.x	34	233	235	1	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1211	1221		10.1016/S0140-6736(13)62420-4	http://dx.doi.org/10.1016/S0140-6736(13)62420-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24457205	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000334104600025
J	Holmes, D				Holmes, David			Ole Petter Ottersen: on health and wealth	LANCET			English	Biographical-Item																		OTTERSEN OP, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					593	593		10.1016/S0140-6736(14)60161-6	http://dx.doi.org/10.1016/S0140-6736(14)60161-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24524781				2022-12-28	WOS:000331137700016
J	Stanley, P				Stanley, Pamela			Galectin-1 Pulls the Strings on VEGFR2	CELL			English	Editorial Material							CANCER; ANGIOGENESIS; PROGRESSION; THERAPY; GLYCANS	Anti-vascular endothelial growth factor (VEGF) cancer immunotherapy targets angiogenesis but development of resistance in patients is common. In this issue of Cell, Croci et al. identify a complex set of mechanisms by which galectin-1 prolongs cell-surface retention of VEGF receptor 2 (VEGFR2) and stimulates VEGF-independent tumor angiogenesis.	Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747				Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Thijssen VL, 2013, CYTOKINE GROWTH F R, V24, P547, DOI 10.1016/j.cytogfr.2013.07.003; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212	10	14	16	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					625	626		10.1016/j.cell.2014.01.059	http://dx.doi.org/10.1016/j.cell.2014.01.059			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529367	Bronze			2022-12-28	WOS:000331379800001
J	Wedzicha, JA; Steinbrook, R; Kassirer, JP				Wedzicha, Jadwiga A.; Steinbrook, Robert; Kassirer, Jerome P.			Should medical journals publish sponsored content?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wedzicha, Jadwiga A.] UCL, London NW3 2PF, England; [Steinbrook, Robert] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA; [Kassirer, Jerome P.] Tufts Univ, Sch Med, Boston, MA 02111 USA	University of London; University College London; Yale University; Tufts University	Wedzicha, JA (corresponding author), UCL, Royal Free Campus, London NW3 2PF, England.	w.wedzicha@ucl.ac.uk; robert.steinbrook@yale.edu			National Institute for Health Research [NF-SI-0513-10077, NF-SI-0510-10270] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Advertising Age, 2013, ADVERTISING AGE; Glick J, 2013, PAID CONTENT    0922; ICMJE, 2013, SUPPL THEM ISS SPEC; KASSIRER JP, 2005, TAKE; Pompeo J, 2013, CAPITAL NEW YOR 0925; Steinbrook R, 2012, J LAW MED ETHICS, V40, P488, DOI 10.1111/j.1748-720X.2012.00681.x; Steinbrook R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5391; Sullivan Margaret, 2013, NY TIMES	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2014	348								g352	10.1136/bmj.g352	http://dx.doi.org/10.1136/bmj.g352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WT	24523382				2022-12-28	WOS:000331444400001
J	Gogala, M; Becker, T; Beatrix, B; Armache, JP; Barrio-Garcia, C; Berninghausen, O; Beckmann, R				Gogala, Marko; Becker, Thomas; Beatrix, Birgitta; Armache, Jean-Paul; Barrio-Garcia, Clara; Berninghausen, Otto; Beckmann, Roland			Structures of the Sec61 complex engaged in nascent peptide translocation or membrane insertion	NATURE			English	Article							PROTEIN-CONDUCTING CHANNEL; CRYO-EM STRUCTURE; ENDOPLASMIC-RETICULUM; ELECTRON-MICROSCOPY; TRANSMEMBRANE SEGMENTS; HUMAN CYTOMEGALOVIRUS; PLUG DOMAIN; RECOGNITION; RIBOSOME; INTEGRATION	The biogenesis of secretory as well as transmembrane proteins requires the activity of the universally conserved protein-conducting channel (PCC), the Sec61 complex (SecY complex in bacteria)(1). In eukaryotic cells the PCC is located in the membrane of the endoplasmic reticulum where it can bind to translating ribosomes for co-translational protein transport. The Sec complex consists of three subunits (Sec61 alpha, beta and gamma) and provides an aqueous environment for the translocation of hydrophilic peptides as well as a lateral opening in the Sec61a subunit that has been proposed to act as a gate for the membrane partitioning of hydrophobic domains(2). A plug helix and a so-called pore ring are believed to seal the PCC against ion flow and are proposed to rearrange for accommodation of translocating peptides(2,3). Several crystal and cryo-electron microscopy structures revealed different conformations of closed and partially open Sec61 and SecY complexes(2,4-8). However, in none of these samples has the translocation state been unambiguously defined biochemically. Here we present cryo-electron microscopy structures of ribosome-bound Sec61 complexes engaged in translocation or membrane insertion of nascent peptides. Our data show that a hydrophilic peptide can translocate through the Sec complex with an essentially closed lateral gate and an only slightly rearranged central channel. Membrane insertion of a hydrophobic domain seems to occur with the Sec complex opening the proposed lateral gate while rearranging the plug to maintain an ion permeability barrier. Taken together, we provide a structural model for the basic activities of the Sec61 complex as a protein-conducting channel.	[Gogala, Marko; Becker, Thomas; Beatrix, Birgitta; Armache, Jean-Paul; Barrio-Garcia, Clara; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Gogala, Marko; Becker, Thomas; Beatrix, Birgitta; Armache, Jean-Paul; Barrio-Garcia, Clara; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Dept Biochem, Ctr integrated Prot Sci Munich, D-81377 Munich, Germany	University of Munich; University of Munich	Beckmann, R (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019	Armache, Jean-Paul/0000-0001-9195-2282	German Research Council [SFB594, SFB646, GRK1721]; Center for Integrated Protein Science; European Research Council	German Research Council(German Research Foundation (DFG)); Center for Integrated Protein Science; European Research Council(European Research Council (ERC)European Commission)	We thank C. Ungewickell for assistance with cryo-electron microscopy, E. van der Sluis for discussions, S. Funes for help with reagent preparation, B. Dobberstein for endoplasmic reticulum membranes, F. Forster and S. Pfeffer for performing mass spectrometry analysis. This work was supported by grants of the German Research Council (SFB594 to R.B. and B.B., SFB646 to T.B. and R.B., GRK1721 to R.B.). R.B. acknowledges support by the Center for Integrated Protein Science and the European Research Council (Advanced Grant CRYOTRANSLATION).	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Martoglio B. H. S., 1997, CELL BIOL LAB HDB, V1, P265; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; Norousi R, 2013, J STRUCT BIOL, V182, P59, DOI 10.1016/j.jsb.2013.02.008; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Saaf A, 1998, EUR J BIOCHEM, V251, P821, DOI 10.1046/j.1432-1327.1998.2510821.x; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	45	151	153	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					107	+		10.1038/nature12950	http://dx.doi.org/10.1038/nature12950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499919				2022-12-28	WOS:000330648100041
J	Gornall, J				Gornall, Jonathan			Under the influence: Scotland's battle over alcohol pricing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; [Anonymous], 2010, SCOTSMAN        0820; [Anonymous], 2012, BBC; [Anonymous], 2005, SCOTSMAN        0901; [Anonymous], 2010, BBC NEWS; [Anonymous], 2013, SWAS HEW SHOULD HAV; [Anonymous], 2009, SCOTSMAN        0310; Barnes E, 2013, SCOTSMAN        1117; Brooks C., 2010, ABERDEEN PRESS  1217; CARDAS, 2008, RESP CARDAS SCOTT GO; Cross-Party Groups Scottish Parliament, SCOTT PARL SCOTCH WH; Gillan E, 2007, ALCOHOL PRICE POLICY; Gordon T, 2011, HERALD          0924; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646, DOI DOI 10.1136/BMJ.F7646; Hastings G, 2013, MARKETING MATRIX COR; MacLeod M., 2010, GUARDIAN; McCambridge J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001431; School of Health and Related Research University of Sheffield, MOD BAS APPR ALC MIN; School of Health and Related Research University of Sheffield, IND REV EFF ALC PRIC; Scotch Whisky Association, 2013, MIN PRIC SCOTL; Scottish Government, 2008, CHANG SCOTL REL ALC; The Scottish Government, 2009, CHANG SCOTL REL ALC; WHO, 2005, ALC POL WHO EUR REG	23	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2014	348								g1274	10.1136/bmj.g1274	http://dx.doi.org/10.1136/bmj.g1274			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4JW	24500499				2022-12-28	WOS:000331062900002
J	Levermann, A				Levermann, Anders			Make supply chains climate-smart	NATURE			English	Editorial Material									[Levermann, Anders] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Levermann, Anders] Univ Potsdam, Inst Phys, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Levermann, A (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	anders.levermann@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704				Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Hallegatte S., 2012, MODELING ROLES HETER; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Ministry of Finance Royal Thai Government and The World Bank, 2012, THAI FLOOD 2011 RAP; Schellnhuber H.J., 2013, TURN HEAT CLIMATE EX; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1	7	43	49	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					27	29		10.1038/506027a	http://dx.doi.org/10.1038/506027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	303BA	24499903	Bronze			2022-12-28	WOS:000330648100013
J	Foiani, M; Bartek, J				Foiani, Marco; Bartek, Jiri			Golgi Feels DNA's Pain	CELL			English	Editorial Material							CANCER	The Golgi apparatus consists of disc-like cisternae, stretching around the nucleus through forces exerted by F-actin and the Golgi membrane protein GOLPH3. Farber-Katz et al. now report that DNA damage triggers Golgi dispersal and inhibits vesicular transport through DNA-PK-mediated GOLPH3 phosphorylation, thereby linking the DNA damage response to Golgi regulation.	[Foiani, Marco] IFOM Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Foiani, Marco] Univ Milan, I-20122 Milan, Italy; [Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77115, Czech Republic	IFOM - FIRC Institute of Molecular Oncology; University of Milan; Danish Cancer Society; Palacky University Olomouc	Foiani, M (corresponding author), IFOM Fdn Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	marco.foiani@ifom.eu; jb@cancer.dk	Bartek, Jiri/G-5870-2014; Foiani, Marco/M-8234-2014	Foiani, Marco/0000-0003-4795-834X	projects: aDDRess, DDResponse,Biomedreg; Danish Council for Independent Research; Lundbeck Foundation; Danish Cancer Society; European Commission; MIUR; Telethon-Italy; AIRC	projects: aDDRess, DDResponse,Biomedreg; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); MIUR(Ministry of Education, Universities and Research (MIUR)); Telethon-Italy(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro)	The work in authors laboratories is supported by grants from AIRC, Telethon-Italy, MIUR, European Commission (projects: aDDRess, DDResponse, Biomedreg), the Danish Cancer Society, the Lundbeck Foundation, and the Danish Council for Independent Research.	Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594	10	8	9	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					392	393		10.1016/j.cell.2014.01.030	http://dx.doi.org/10.1016/j.cell.2014.01.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485446	Bronze			2022-12-28	WOS:000330580800004
J	Boer, DR; Freire-Rios, A; van den Berg, WAM; Saaki, T; Manfield, IW; Kepinski, S; Lopez-Vidrieo, I; Franco-Zorrilla, JM; de Vries, SC; Solano, R; Weijers, D; Coll, M				Roeland Boer, D.; Freire-Rios, Alejandra; van den Berg, Willy A. M.; Saaki, Terrens; Manfield, Iain W.; Kepinski, Stefan; Lopez-Vidrieo, Irene; Manuel Franco-Zorrilla, Jose; de Vries, Sacco C.; Solano, Roberto; Weijers, Dolf; Coll, Miquel			Structural Basis for DNA Binding Specificity by the Auxin-Dependent ARF Transcription Factors	CELL			English	Article							ARABIDOPSIS GENE MONOPTEROS; RESPONSE ELEMENTS; VASCULAR DEVELOPMENT; PLANT DEVELOPMENT; DOMAINS; FAMILY; EMBRYO; EMBRYOGENESIS; DIMERIZATION; RECOGNITION	Auxin regulates numerous plant developmental processes by controlling gene expression via a family of functionally distinct DNA-binding auxin response factors (ARFs), yet the mechanistic basis for generating specificity in auxin response is unknown. Here, we address this question by solving high-resolution crystal structures of the pivotal Arabidopsis developmental regulator ARF5/MONOPTEROS (MP), its divergent paralog ARF1, and a complex of ARF1 and a generic auxin response DNA element (AuxRE). We show that ARF DNA-binding domains also homodimerize to generate cooperative DNA binding, which is critical for in vivo ARF5/MP function. Strikingly, DNA-contacting residues are conserved between ARFs, and we discover that monomers have the same intrinsic specificity. ARF1 and ARF5 homodimers, however, differ in spacing tolerated between binding sites. Our data identify the DNA-binding domain as an ARF dimerization domain, suggest that ARF dimers bind complex sites as molecular calipers with ARF-specific spacing preference, and provide an atomic-scale mechanistic model for specificity in auxin response.	[Roeland Boer, D.; Coll, Miquel] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Roeland Boer, D.; Coll, Miquel] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Freire-Rios, Alejandra; van den Berg, Willy A. M.; Saaki, Terrens; de Vries, Sacco C.; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Manfield, Iain W.; Kepinski, Stefan] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol IWM, Leeds LS2 9JT, W Yorkshire, England; [Manfield, Iain W.; Kepinski, Stefan] Univ Leeds, Fac Biol Sci, Ctr Plant Sci SK, Leeds LS2 9JT, W Yorkshire, England; [Lopez-Vidrieo, Irene; Manuel Franco-Zorrilla, Jose] CSIC, Ctr Nacl Biotecnol, Genom Unit, E-28049 Madrid, Spain; [Lopez-Vidrieo, Irene; Manuel Franco-Zorrilla, Jose] CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, E-28049 Madrid, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Wageningen University & Research; University of Leeds; University of Leeds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Weijers, D (corresponding author), Wageningen Univ, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	dolf.weijers@wur.nl; miquel.coll@irbbarcelona.org	Solano, Roberto/O-5908-2017; Franco-Zorrilla, Jose/M-8361-2015; Weijers, Dolf/A-2076-2010; Boer, Roeland/I-1051-2015; Franco-Zorrilla, Jose Manuel/ABD-5092-2021; Coll, Miquel/L-5999-2014; Weijers, Dolf/ABI-1332-2020	Solano, Roberto/0000-0001-5459-2417; Franco-Zorrilla, Jose/0000-0001-6769-7349; Weijers, Dolf/0000-0003-4378-141X; Boer, Roeland/0000-0001-5949-6627; Franco-Zorrilla, Jose Manuel/0000-0001-6769-7349; Coll, Miquel/0000-0003-4471-8674; Weijers, Dolf/0000-0003-4378-141X; Saaki, Terrens/0000-0002-7318-1784; Manfield, Iain/0000-0003-3765-0325	Netherlands Organization for Scientific Research (NWO) [711.011.002]; Spanish Ministry of Science and Innovation [BFU2011-22588]; Generalitat de Catalunya [SGR2009-1309]; European Commission [GA 260644]; Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/F007418/1] Funding Source: researchfish; BBSRC [BB/F007418/1, BB/F013981/1] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Netherlands Organization for Scientific Research (NWO; ECHO grant 711.011.002 to D. W.), the Spanish Ministry of Science and Innovation (grant BFU2011-22588 to M. C.), the Generalitat de Catalunya (grant SGR2009-1309 to M. C.), and the European Commission (FP7 Cooperation Project SILVER - GA 260644 to M. C.). We thank Vincent Ruigrok and Hans Heilig for technical advice; Silke Lochs and Henri Doornbos for experimental support; Bert De Rybel and Lars Ostergaard for helpful discussion; and the staff of beamlines ID14-1 and ID14-4, in particular Andrew McCarthy at the ESRF (Grenoble, France), and beamline XALOC (ALBA, Cerdanyola del Valles, Spain). Crystallization was performed at the IBMB Platform for Automated Crystallization (Barcelona, Spain).	Adams-Cioaba MA, 2012, FEBS LETT, V586, P859, DOI 10.1016/j.febslet.2012.02.012; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; BERLETH T, 1993, DEVELOPMENT, V118, P575; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Godoy M, 2011, PLANT J, V66, P700, DOI 10.1111/j.1365-313X.2011.04519.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2531, DOI 10.1093/nar/23.13.2531; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogan NT, 2012, NEW PHYTOL, V194, P391, DOI 10.1111/j.1469-8137.2012.04064.x; Lau S, 2011, NAT CELL BIOL, V13, P611, DOI 10.1038/ncb2212; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Lokerse AS, 2009, CURR OPIN PLANT BIOL, V12, P520, DOI 10.1016/j.pbi.2009.07.007; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Rademacher EH, 2011, PLANT J, V68, P597, DOI 10.1111/j.1365-313X.2011.04710.x; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Thimann KV, 1935, NATURE, V135, P101, DOI 10.1038/135101a0; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Yamaguchi N, 2013, DEV CELL, V24, P271, DOI 10.1016/j.devcel.2012.12.017; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x	44	236	242	11	115	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					577	589		10.1016/j.cell.2013.12.027	http://dx.doi.org/10.1016/j.cell.2013.12.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485461	Bronze			2022-12-28	WOS:000330580800022
J	Ebrahim, S; Taylor, FC; Brindle, P				Ebrahim, Shah; Taylor, Fiona C.; Brindle, Peter			Statins for the primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; SAFETY; METAANALYSIS; GUIDELINES; THERAPY; FATIGUE; HEALTH		[Ebrahim, Shah; Taylor, Fiona C.] London Sch Hyg & Trop Hlth, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Brindle, Peter] Bristol Clin Commissioning Grp, Avon Primary Care Res Collaborat, Bristol BS1 3NX, Avon, England	University of London; London School of Hygiene & Tropical Medicine	Taylor, FC (corresponding author), London Sch Hyg & Trop Hlth, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	fiona.taylor@lshtm.ac.uk						Abramson JD, AUTHORS RESPONSE COC; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Beers MH, 2013, MERCK MANUAL DIAGNOS; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Cheung BMY, 2010, LANCET, V376, P1622, DOI 10.1016/S0140-6736(10)61545-0; Cholesterol Treatment Trialists (CTT) Collaboration, 2012, LANCET, V378, P67; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Food and Drug Administration (FDA), 2012, FDA EXP ADV STAT RIS; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V49, P340; Huffman M, SHOULD PEOPLE LOW RI; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Medicines and Healthcare products Regulatory Agency, 2012, DRUG SAFETY UPDATE, V5, pA2; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; National Institute for Health and Care Evidence, 2010, LIP MOD CARD RISK AS, V67; National Institute for Health and Care Excellence, 2006, STAT PREV CARD EV PA, VTA94; Perez AC, 2013, J AM COLL CARDIOL, V61, P1121, DOI 10.1016/j.jacc.2012.12.004; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Smeeth L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3802; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; The Health and Social Care Information Centre, 2011, PRESCR DISP COMM ENG, P1; Wardle J, 1996, BRIT MED J, V313, P75, DOI 10.1136/bmj.313.7049.75; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X	35	12	12	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2014	348								g280	10.1136/bmj.g280	http://dx.doi.org/10.1136/bmj.g280			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AT	24470636	Green Accepted			2022-12-28	WOS:000330647400010
J	Parker, HG; Ostrander, EA				Parker, Heidi G.; Ostrander, Elaine A.			Hiding in Plain View-An Ancient Dog in the Modern World	SCIENCE			English	Editorial Material							TASMANIAN DEVIL; EVOLUTION; HISTORY; ORIGIN		[Parker, Heidi G.; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Parker, HG (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov		Parker, Heidi G./0000-0002-9707-6380; Ostrander, Elaine/0000-0001-6075-9738	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200377] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HG999999] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Derrien T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-62; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; KARLSON AG, 1952, ANN NY ACAD SCI, V54, P1197, DOI 10.1111/j.1749-6632.1952.tb39989.x; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Nowinsky M., 1876, ZENTRALBL MED WISS, V14, P790; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837	10	4	4	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					376	378		10.1126/science.1248812	http://dx.doi.org/10.1126/science.1248812			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458629	Green Accepted			2022-12-28	WOS:000330039300033
J	Weinstein, JN; Akbani, R; Broom, BM; Wang, WY; Verhaak, RGW; McConkey, D; Lerner, S; Morgan, M; Creighton, CJ; Smith, C; Kwiatkowski, DJ; Cherniack, AD; Kim, J; Pedamallu, CS; Noble, MS; Al-Ahmadie, HA; Reuter, VE; Rosenberg, JE; Bajorin, DF; Bochner, BH; Solit, DB; Koppie, T; Robinson, B; Gordenin, DA; Fargo, D; Klimczak, LJ; Roberts, SA; Au, J; Laird, PW; Hinoue, T; Schultz, N; Ramirez, R; Hansel, D; Hoadley, KA; Kim, WY; Damrauer, JS; Baylin, SB; Mungall, AJ; Robertson, AG; Chu, A; Kwiatkowski, DJ; Sougnez, C; Cibulskis, K; Lichtenstein, L; Sivachenko, A; Stewart, C; Lawrence, MS; Getz, G; Lander, E; Gabriel, SB; Creighton, CJ; Donehower, L; Cherniack, AD; Kim, J; Carter, SL; Saksena, G; Schumacher, SE; Sougnez, C; Freeman, SS; Jung, J; Pedamallu, CS; Bhatt, AS; Pugh, T; Getz, G; Beroukhim, R; Gabriel, SB; Meyerson, M; Mungall, AJ; Robertson, AG; Chu, A; Ally, A; Balasundaram, M; Butterfield, YSN; Dhalla, N; Hirst, C; Holt, RA; Jones, SJM; Lee, D; Li, HYI; Marra, MA; Mayo, M; Moore, RA; Schein, JE; Sipahimalani, P; Tam, A; Thiessen, N; Wong, T; Wye, N; Bowlby, R; Chuah, E; Guin, R; Jones, SJM; Marra, MA; Hinoue, T; Shen, H; Bootwalla, MS; Triche, T; Lai, PH; Van den Berg, DJ; Weisenberger, DJ; Laird, PW; Hansel, D; Hoadley, KA; Balu, S; Bodenheimer, T; Damrauer, JS; Hoyle, AP; Jefferys, SR; Meng, SW; Mose, LE; Simons, JV; Soloway, MG; Wu, JY; Kim, WY; Parker, JS; Hayes, DN; Roach, J; Buda, E; Jones, CD; Mieczkowski, PA; Tan, DH; Veluvolu, U; Waring, S; Auman, JT; Perou, CM; Wilkerson, MD; Santoso, N; Parfenov, M; Ren, XJ; Pantazi, A; Hadjipanayis, A; Seidman, J; Kucherlapati, R; Lee, S; Yang, LX; Park, PJ; Baylin, SB; Xu, AW; Protopopov, A; Zhang, JH; Bristow, C; Mahadeshwar, HS; Seth, S; Song, XZ; Tang, JB; Zeng, D; Chin, LD; Guo, C; Weinstein, JN; Akbani, R; Broom, BM; McConkey, D; Casasent, TD; Liu, WB; Ju, ZL; Motter, T; Peng, B; Ryan, M; Wang, WY; Verhaak, RGW; Su, XP; Yang, JY; Lorenzi, PL; Yao, H; Zhang, NX; Zhang, JX; Mills, GB; Kim, J; Noble, MS; Cho, J; DiCara, D; Frazer, S; Gehlenborg, N; Heiman, DI; Lin, P; Liu, YC; Stojanov, P; Voet, D; Zhang, HL; Zou, LH; Chin, LD; Getz, G; Bernard, B; Kreisberg, D; Reynolds, S; Rovira, H; Shmulevich, I; Ramirez, R; Schultz, N; Gao, JJ; Jacobsen, A; Aksoy, BA; Antipin, Y; Ciriello, G; Dresdner, G; Gross, B; Lee, W; Reva, B; Shen, RL; Sinha, R; Sumer, SO; Weinhold, N; Ladanyi, M; Sander, C; Benz, C; Carlin, D; Haussler, D; Ng, S; Paull, EO; Stuart, J; Zhu, J; Liu, YX; Zhang, W; Taylor, BS; Lichtenberg, TM; Zmuda, E; Barr, T; Black, AD; George, M; Hanf, B; Helsel, C; McAllister, C; Ramirez, NC; Tabler, TR; Weaver, S; Wise, L; Bowen, J; Gastier-Foster, JM; Weinstein, JN; Lerner, S; Jian, WG; Tello, S; Ittman, M; Castro, P; McClenden, WD; Morgan, M; Gibbs, R; Liu, YC; Saller, C; Tarvin, K; DiPiero, JM; Owens, J; Bollag, R; Li, Q; Weinberger, P; Czerwinski, C; Huelsenbeck-Dill, L; Iacocca, M; Petrelli, N; Rabeno, B; Swanson, P; Shelton, T; Curley, E; Gardner, J; Mallery, D; Penny, R; Bang, NV; Hanh, PT; Kohl, B; Le, XV; Phu, BD; Thorp, R; Tien, NV; Vinh, LQ; Sandusky, G; Burks, E; Christ, K; Gee, J; Holway, A; Moinzadeh, A; Sorcini, A; Sullivan, T; Al-Ahmadie, HA; Bajorin, DF; Bochner, BH; Garcia-Grossman, IR; Regazzi, AM; Solit, DB; Rosenberg, JE; Reuter, VE; Koppie, T; Boice, L; Rathmell, WK; Thorne, L; Bastacky, S; Davies, B; Dhir, R; Gingrich, J; Hrebinko, R; Maranchie, J; Nelson, J; Parwani, A; Bshara, W; Gaudioso, C; Morrison, C; Alexopoulou, V; Bartlett, J; Engel, J; Kodeeswaran, S; Antic, T; O'Donnell, PH; Smith, ND; Steinberg, GD; Egea, S; Gomez-Fernandez, C; Herbert, L; Jorda, M; Soloway, M; Beaver, A; Carter, S; Kapur, P; Lewis, C; Lotan, Y; Robinson, B; Hansel, D; Guo, C; Bondaruk, J; Czerniak, B; Akbani, R; Broom, BM; Liu, YX; Zhang, W; Weinstein, JN; Lerner, S; Morgan, M; Kim, J; Cherniack, AD; Freeman, SS; Pedamallu, CS; Noble, MS; Kwiatkowski, DJ; Al-Ahmadie, HA; Bajorin, DF; Bochner, BH; Solit, DB; Rosenberg, JE; Reuter, VE; Koppie, T; Robinson, B; Skinner, E; Ramirez, R; Schultz, N; Hansel, D; Kim, WY; Guo, C; Bondaruk, J; Aldape, K; Czerniak, B; Jensen, MA; Kahn, AB; Pihl, TD; Pot, DA; Srinivasan, D; Wan, YH; Ferguson, ML; Zenklusen, JC; Davidsen, T; Demchok, JA; Shaw, KRM; Sheth, M; Tarnuzzer, R; Wang, ZN; Yang, LM; Hutter, C; Ozenberger, BA; Sofia, HJ; Eley, G				Weinstein, John N.; Akbani, Rehan; Broom, Bradley M.; Wang, Wenyi; Verhaak, Roeland G. W.; McConkey, David; Lerner, Seth; Morgan, Margaret; Creighton, Chad J.; Smith, Carolyn; Kwiatkowski, David J.; Cherniack, Andrew D.; Kim, Jaegil; Pedamallu, Chandra Sekhar; Noble, Michael S.; Al-Ahmadie, Hikmat A.; Reuter, Victor E.; Rosenberg, Jonathan E.; Bajorin, Dean F.; Bochner, Bernard H.; Solit, David B.; Koppie, Theresa; Robinson, Brian; Gordenin, Dmitry A.; Fargo, David; Klimczak, Leszek J.; Roberts, Steven A.; Au, Jessie; Laird, Peter W.; Hinoue, Toshinori; Schultz, Nikolaus; Ramirez, Ricardo; Hansel, Donna; Hoadley, Katherine A.; Kim, William Y.; Damrauer, Jeffrey S.; Baylin, Stephen B.; Mungall, Andrew J.; Robertson, A. Gordon; Chu, Andy; Kwiatkowski, David J.; Sougnez, Carrie; Cibulskis, Kristian; Lichtenstein, Lee; Sivachenko, Andrey; Stewart, Chip; Lawrence, Michael S.; Getz, Gad; Lander, Eric; Gabriel, Stacey B.; Creighton, Chad J.; Donehower, Lawrence; Cherniack, Andrew D.; Kim, Jaegil; Carter, Scott L.; Saksena, Gordon; Schumacher, Steven E.; Sougnez, Carrie; Freeman, Samuel S.; Jung, Joonil; Pedamallu, Chandra Sekhar; Bhatt, Ami S.; Pugh, Trevor; Getz, Gad; Beroukhim, Rameen; Gabriel, Stacey B.; Meyerson, Matthew; Mungall, Andrew J.; Robertson, A. Gordon; Chu, Andy; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Dhalla, Noreen; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Thiessen, Nina; Wong, Tina; Wye, Natasja; Bowlby, Reanne; Chuah, Eric; Guin, Ranabir; Jones, Steven J. M.; Marra, Marco A.; Hinoue, Toshinori; Shen, Hui; Bootwalla, Moiz S.; Triche, Timothy, Jr.; Lai, Phillip H.; Van den Berg, David J.; Weisenberger, Daniel J.; Laird, Peter W.; Hansel, Donna; Hoadley, Katherine A.; Balu, Saianand; Bodenheimer, Tom; Damrauer, Jeffrey S.; Hoyle, Alan P.; Jefferys, Stuart R.; Meng, Shaowu; Mose, Lisle E.; Simons, Janae V.; Soloway, Mathew G.; Wu, Junyuan; Kim, William Y.; Parker, Joel S.; Hayes, D. Neil; Roach, Jeffrey; Buda, Elizabeth; Jones, Corbin D.; Mieczkowski, Piotr A.; Tan, Donghui; Veluvolu, Umadevi; Waring, Scot; Auman, J. Todd; Perou, Charles M.; Wilkerson, Matthew D.; Santoso, Netty; Parfenov, Michael; Ren, Xiaojia; Pantazi, Angeliki; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Raju; Lee, Semin; Yang, Lixing; Park, Peter J.; Baylin, Stephen B.; Xu, Andrew Wei; Protopopov, Alexei; Zhang, Jianhua; Bristow, Christopher; Mahadeshwar, Harshad S.; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zeng, Dong; Chin, Lynda; Guo, Charles; Weinstein, John N.; Akbani, Rehan; Broom, Bradley M.; McConkey, David; Casasent, Tod D.; Liu, Wenbin; Ju, Zhenlin; Motter, Thomas; Peng, Bo; Ryan, Michael; Wang, Wenyi; Verhaak, Roeland G. W.; Su, Xiaoping; Yang, Ji-Yeon; Lorenzi, Philip L.; Yao, Hui; Zhang, Nianxiang; Zhang, Jiexin; Mills, Gordon B.; Kim, Jaegil; Noble, Michael S.; Cho, Juok; DiCara, Daniel; Frazer, Scott; Gehlenborg, Nils; Heiman, David I.; Lin, Pei; Liu, Yingchun; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua; Chin, Lynda; Getz, Gad; Bernard, Brady; Kreisberg, Dick; Reynolds, Sheila; Rovira, Hector; Shmulevich, Ilya; Ramirez, Ricardo; Schultz, Nikolaus; Gao, Jianjiong; Jacobsen, Anders; Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gross, Benjamin; Lee, William; Reva, Boris; Shen, Ronglai; Sinha, Rileen; Sumer, S. Onur; Weinhold, Nils; Ladanyi, Marc; Sander, Chris; Benz, Christopher; Carlin, Daniel; Haussler, David; Ng, Sam; Paull, Evan O.; Stuart, Joshua; Zhu, Jing; Liu, Yuexin; Zhang, Wei; Taylor, Barry S.; Lichtenberg, Tara M.; Zmuda, Erik; Barr, Thomas; Black, Aaron D.; George, Myra; Hanf, Benjamin; Helsel, Carmen; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Weaver, Stephanie; Wise, Lisa; Bowen, Jay; Gastier-Foster, Julie M.; Weinstein, John N.; Lerner, Seth; Jian, Weiguo; Tello, Sebrina; Ittman, Michael; Castro, Patricia; McClenden, Whitney D.; Morgan, Margaret; Gibbs, Richard; Liu, Yingchun; Saller, Charles; Tarvin, Katherine; DiPiero, Jennifer M.; Owens, Jennifer; Bollag, Roni; Li, Qiang; Weinberger, Paul; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Rabeno, Brenda; Swanson, Pat; Shelton, Troy; Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert; Nguyen Van Bang; Phan Thi Hanh; Kohl, Bernard; Xuan Van Le; Bui Duc Phu; Thorp, Richard; Nguyen Viet Tien; Le Quang Vinh; Sandusky, George; Burks, Eric; Christ, Kimberly; Gee, Jason; Holway, Antonia; Moinzadeh, Alireza; Sorcini, Andrea; Sullivan, Travis; Al-Ahmadie, Hikmat A.; Bajorin, Dean F.; Bochner, Bernard H.; Garcia-Grossman, Ilana R.; Regazzi, Ashley M.; Solit, David B.; Rosenberg, Jonathan E.; Reuter, Victor E.; Koppie, Theresa; Boice, Lori; Rathmell, Wendy Kimryn; Thorne, Leigh; Bastacky, Sheldon; Davies, Benjamin; Dhir, Rajiv; Gingrich, Jeffrey; Hrebinko, Ronald; Maranchie, Jodi; Nelson, Joel; Parwani, Anil; Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl; Alexopoulou, Vina; Bartlett, John; Engel, Jay; Kodeeswaran, Sugy; Antic, Tatjana; O'Donnell, Peter H.; Smith, Norm D.; Steinberg, Gary D.; Egea, Sophie; Gomez-Fernandez, Carmen; Herbert, Lynn; Jorda, Merce; Soloway, Mark; Beaver, Allison; Carter, Suzie; Kapur, Payal; Lewis, Cheryl; Lotan, Yair; Robinson, Brian; Hansel, Donna; Guo, Charles; Bondaruk, Jolanta; Czerniak, Bogdan; Akbani, Rehan; Broom, Bradley M.; Liu, Yuexin; Zhang, Wei; Weinstein, John N.; Lerner, Seth; Morgan, Margaret; Kim, Jaegil; Cherniack, Andrew D.; Freeman, Samuel S.; Pedamallu, Chandra Sekhar; Noble, Michael S.; Kwiatkowski, David J.; Al-Ahmadie, Hikmat A.; Bajorin, Dean F.; Bochner, Bernard H.; Solit, David B.; Rosenberg, Jonathan E.; Reuter, Victor E.; Koppie, Theresa; Robinson, Brian; Skinner, Eila; Ramirez, Ricardo; Schultz, Nikolaus; Hansel, Donna; Kim, William Y.; Guo, Charles; Bondaruk, Jolanta; Aldape, Kenneth; Czerniak, Bogdan; Jensen, Mark A.; Kahn, Ari B.; Pihl, Todd D.; Pot, David A.; Srinivasan, Deepak; Wan, Yunhu; Ferguson, Martin L.; Zenklusen, Jean Claude; Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Hutter, Carolyn; Ozenberger, Bradley A.; Sofia, Heidi J.; Eley, Greg		Canc Genome Atlas Res Network	Comprehensive molecular characterization of urothelial bladder carcinoma	NATURE			English	Article							GENE FUSIONS; CANCER; MUTATIONS; GENOMES; KINASE; FGFR	Urothelial carcinoma of the bladder is a common malignancy that causes approximately 150,000 deaths per year worldwide. So far, no molecularly targeted agents have been approved for treatment of the disease. As part of The Cancer Genome Atlas project, we report here an integrated analysis of 131 urothelial carcinomasto provide a comprehensive landscape of molecular alterations. There were statistically significant recurrent mutations in 32 genes, including multiple genes involved in cell-cycle regulation, chromatin regulation, and kinase signalling pathways, as well as 9 genes not previously reported as significantly mutated in any cancer. RNA sequencing revealed four expression subtypes, two of which (papillary-like and basal/squamous-like) were also evident in microRNA sequencing and protein data. Whole-genome and RNA sequencing identified recurrent in-frame activating FGFR3-TACC3 fusions and expression or integration of several viruses (including HPV16) that are associated with gene inactivation. Our analyses identified potential therapeutic targets in 69% of the tumours, including 42% with targets in the phosphatidylinositol-3-OH kinase/AKT/mTOR pathway and 45% with targets (including ERBB2) in the RTK/MAPK pathway. Chromatin regulatory genes were more frequently mutated in urothelial carcinoma than in any other common cancer studied so far, indicating the future possibility of targeted therapy for chromatin abnormalities.	[Weinstein, John N.; Akbani, Rehan; Broom, Bradley M.; Wang, Wenyi; Verhaak, Roeland G. W.; Liu, Wenbin; Ju, Zhenlin; Motter, Thomas; Peng, Bo; Ryan, Michael; Su, Xiaoping; Yang, Ji-Yeon; Lorenzi, Philip L.; Yao, Hui; Zhang, Nianxiang; Zhang, Jiexin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Wenbin; Ju, Zhenlin; Yang, Ji-Yeon; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [McConkey, David; Shaw, Kenna R. Mills] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Lerner, Seth; Jian, Weiguo; Tello, Sebrina] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Morgan, Margaret; Jian, Weiguo; Tello, Sebrina; Ittman, Michael; Castro, Patricia; McClenden, Whitney D.; Gibbs, Richard] Baylor Coll Med, TCRB, Houston, TX 77030 USA; [Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Creighton, Chad J.; Donehower, Lawrence] Baylor Coll Med, Human Genome Sequencing Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Smith, Carolyn] Baylor Coll Med, Houston, TX 77030 USA; [Kwiatkowski, David J.; Kwiatkowski, David J.; Cibulskis, Kristian; Lichtenstein, Lee; Sivachenko, Andrey; Stewart, Chip; Lawrence, Michael S.; Getz, Gad; Lander, Eric; Gabriel, Stacey B.; Carter, Scott L.; Saksena, Gordon; Schumacher, Steven E.; Freeman, Samuel S.; Jung, Joonil; Bhatt, Ami S.; Pugh, Trevor; Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda; Cho, Juok; DiCara, Daniel; Frazer, Scott; Gehlenborg, Nils; Heiman, David I.; Lin, Pei; Liu, Yingchun; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Kwiatkowski, David J.; Casasent, Tod D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kwiatkowski, David J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bhatt, Ami S.; Pugh, Trevor; Beroukhim, Rameen; Meyerson, Matthew; Stojanov, Petar] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Garcia-Grossman, Ilana R.; Regazzi, Ashley M.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Koppie, Theresa] Oregon Hlth & Sci Univ, Dept Urol, Portland, OR 97239 USA; Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Gordenin, Dmitry A.; Fargo, David; Klimczak, Leszek J.; Roberts, Steven A.] NIEHS, Res Triangle Pk, NC 27709 USA; [Au, Jessie] OptimumTherapeutics LLC, San Diego, CA 92121 USA; [Shen, Hui; Bootwalla, Moiz S.; Triche, Timothy, Jr.; Lai, Phillip H.; Van den Berg, David J.; Weisenberger, Daniel J.] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90033 USA; [Schultz, Nikolaus; Ramirez, Ricardo; Gao, Jianjiong; Jacobsen, Anders; Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gross, Benjamin; Lee, William; Reva, Boris; Shen, Ronglai; Sinha, Rileen; Sumer, S. Onur; Weinhold, Nils; Ladanyi, Marc; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Hansel, Donna] UCSD Dept Pathol, La Jolla, CA 92093 USA; [Hoadley, Katherine A.; Balu, Saianand; Bodenheimer, Tom; Hoyle, Alan P.; Jefferys, Stuart R.; Meng, Shaowu; Mose, Lisle E.; Simons, Janae V.; Soloway, Mathew G.; Wu, Junyuan; Parker, Joel S.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Parker, Joel S.; Perou, Charles M.; Wilkerson, Matthew D.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Biol Div, Baltimore, MD 21231 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Donehower, Lawrence] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Schumacher, Steven E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Mungall, Andrew J.; Chu, Andy; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Dhalla, Noreen; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Thiessen, Nina; Wong, Tina; Wye, Natasja; Bowlby, Reanne; Chuah, Eric; Guin, Ranabir] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Roach, Jeffrey] Univ N Carolina, Res Comp Ctr, Chapel Hill, NC 27599 USA; [Buda, Elizabeth; Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Mieczkowski, Piotr A.; Tan, Donghui; Veluvolu, Umadevi; Waring, Scot] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Santoso, Netty; Parfenov, Michael; Ren, Xiaojia; Pantazi, Angeliki; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hadjipanayis, Angela; Kucherlapati, Raju; Park, Peter J.; Xu, Andrew Wei] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lee, Semin; Yang, Lixing; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Protopopov, Alexei; Zhang, Jianhua; Bristow, Christopher; Mahadeshwar, Harshad S.; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zeng, Dong] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77030 USA; [Guo, Charles; Bondaruk, Jolanta; Czerniak, Bogdan; Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Bernard, Brady; Kreisberg, Dick; Reynolds, Sheila; Rovira, Hector; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Carlin, Daniel; Haussler, David; Ng, Sam; Paull, Evan O.; Stuart, Joshua; Zhu, Jing] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Liu, Yuexin; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Lichtenberg, Tara M.; Zmuda, Erik; Barr, Thomas; Black, Aaron D.; George, Myra; Hanf, Benjamin; Helsel, Carmen; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Weaver, Stephanie; Wise, Lisa; Bowen, Jay; Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Ramirez, Nilsa C.; Gastier-Foster, Julie M.] Ohio State Univ, Columbus, OH 43210 USA; [Ittman, Michael; Castro, Patricia] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Saller, Charles; Tarvin, Katherine] Analyt Biol Serv Inc, Wilmington, DE 19801 USA; [DiPiero, Jennifer M.; Owens, Jennifer] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Bollag, Roni; Li, Qiang; Weinberger, Paul] Georgia Regents Univ, Canc Ctr, Augusta, GA 30912 USA; [Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Rabeno, Brenda; Swanson, Pat] Christiana Care, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Shelton, Troy; Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Nguyen Van Bang; Phan Thi Hanh; Kohl, Bernard; Xuan Van Le; Bui Duc Phu; Thorp, Richard; Nguyen Viet Tien; Le Quang Vinh] ILSbio LLC, Chestertown, MD 21620 USA; Hue Cent Hosp, Hue City, Vietnam; [Sandusky, George] IU Sch Med, Indianapolis, IN 46202 USA; [Burks, Eric; Christ, Kimberly; Gee, Jason; Holway, Antonia; Moinzadeh, Alireza; Sorcini, Andrea; Sullivan, Travis] Lahey Hosp & Med Ctr, Burlington, MA 01805 USA; [Boice, Lori; Rathmell, Wendy Kimryn; Thorne, Leigh] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Bastacky, Sheldon; Davies, Benjamin; Dhir, Rajiv; Gingrich, Jeffrey; Hrebinko, Ronald; Maranchie, Jodi; Nelson, Joel; Parwani, Anil] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl] Roswell Pk Canc Inst, Buffalo, NY 14063 USA; [Alexopoulou, Vina; Bartlett, John; Engel, Jay; Kodeeswaran, Sugy] St Josephs Healthcare Hamilton, Ontario Tumour Bank, Hamilton, ON L8N 3Z5, Canada; [Antic, Tatjana; O'Donnell, Peter H.; Smith, Norm D.; Steinberg, Gary D.] Univ Chicago, Chicago, IL 60637 USA; [Egea, Sophie; Gomez-Fernandez, Carmen; Herbert, Lynn; Jorda, Merce; Soloway, Mark] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Beaver, Allison; Carter, Suzie; Kapur, Payal; Lewis, Cheryl; Lotan, Yair] UT Southwestern Med Ctr, Dallas, TX 75390 USA; [Skinner, Eila] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Jensen, Mark A.; Kahn, Ari B.; Pihl, Todd D.; Pot, David A.; Srinivasan, Deepak; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Zenklusen, Jean Claude; Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming] NCI, Bethesda, MD 20892 USA; [Hutter, Carolyn; Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, Rockville, MD 20852 USA; [Eley, Greg] Scimentis LLC, Atlanta, GA 30666 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Institute for Systems Biology (ISB); Buck Institute for Research on Aging; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Baylor College of Medicine; Cleveland Clinic Foundation; University System of Georgia; Augusta University; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; International Genomics Consortium; Indiana University System; Indiana University Bloomington; Lahey Hospital & Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Roswell Park Cancer Institute; McMaster University; University of Chicago; University of Miami; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Weinstein, JN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	jweinste@mdanderson.org; slerner@bcm.edu; dk@rics.bwh.harvard.edu	LIU, YING/GZL-7252-2022; Pedamallu, Chandra Sekhar/AAV-6723-2020; wang, edwin/G-5372-2010; Solit, David B./AAC-5309-2019; Perou, Charles M/H-9934-2014; Cherniack, Andrew/AAC-5310-2019; Skanderup, Anders Jacobsen/K-1081-2013; Pedamallu, Chandra Sekhar/AAV-6745-2020; Gao, JianJiong/B-5673-2016; Kucherlapati, Raju/ABC-8807-2021; Castro, Patricia/AAN-3032-2021; Schein, Jacquie E/G-3674-2015; Shen, Hui/AAO-4387-2020; Van Den Berg, David J/G-8598-2017; Dmitry, Gordenin/C-3907-2018; Maranchie, Jodi/AAG-1035-2020; Burks, Eric/ABA-7743-2020; Laird, Peter W/G-8683-2012; Cherniack, Andrew D./AAY-8132-2020; Akbani, Rehan/AAG-1490-2019; Lawrence, Michael/AAC-8202-2020; liu, ying/GXF-4294-2022; Schultz, Nikolaus/ABE-6347-2020; Jones, Steven J/C-3621-2009; Cibulskis, Kristian/AAC-7380-2019; Yao, Huiqin/AAX-3787-2020; Mungall, Andrew J./U-7067-2018; Seth, Sahil/I-5809-2019; Stojanov, Petar/GQI-4462-2022; Weisenberger, Daniel/AAA-8314-2020; Lee, Semin/S-2629-2016; parwani, anil/AAH-5464-2020; Reva, Boris/AAB-8932-2022; Ladanyi, Marc/AAG-8585-2019; Holt, Robert A/C-3303-2009; Damrauer, Jeffrey/AAW-3845-2020; Pugh, Trevor/Y-2535-2019; Marra, Marco A/B-5987-2008; Parker, Joel/AAG-1108-2019; Weinberger, Paul/B-7007-2008	Perou, Charles M/0000-0001-9827-2247; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Gao, JianJiong/0000-0002-5739-1781; Castro, Patricia/0000-0001-5286-8037; Van Den Berg, David J/0000-0002-5404-5218; Dmitry, Gordenin/0000-0002-8399-1836; Burks, Eric/0000-0002-3122-2875; Laird, Peter W/0000-0001-9117-3641; Cherniack, Andrew D./0000-0003-0470-0111; Jones, Steven J/0000-0003-3394-2208; Yao, Huiqin/0000-0003-4742-8971; Mungall, Andrew J./0000-0002-0905-2742; Seth, Sahil/0000-0003-4579-3959; Stojanov, Petar/0000-0001-7815-776X; Weisenberger, Daniel/0000-0001-8303-2603; Lee, Semin/0000-0002-9015-6046; Holt, Robert A/0000-0002-7259-1247; Damrauer, Jeffrey/0000-0001-8148-0285; Pugh, Trevor/0000-0002-8073-5888; Marra, Marco A/0000-0001-7146-7175; Weinberger, Paul/0000-0002-5885-2631; Cibulskis, Kristian/0000-0003-1343-1582; Maranchie, Jodi/0000-0002-8534-9468; Bootwalla, Moiz/0000-0001-6158-7114; Ciriello, Giovanni/0000-0003-2021-8683; Stuart, Joshua/0000-0002-2171-565X; Weinstein, John/0000-0001-9401-6908; Tarnuzzer, Roy/0000-0002-3725-4173; Al-Ahmadie, Hikmat/0000-0002-2938-6627; Heiman, David/0000-0001-7895-4259; Auman, James/0000-0002-9328-8829; Hoadley, Katherine/0000-0002-1216-477X; Kohl, Bernard/0000-0002-4610-0934; Freeman, Samuel/0000-0001-8285-0057; Bowen, Jay/0000-0001-6861-9043; Wang, Wenyi/0000-0003-0617-9438; Jensen, Mark/0000-0001-5215-101X; Meyerson, Matthew/0000-0002-9133-8108; Triche, Tim/0000-0001-5665-946X; Rosenberg, Jonathan/0000-0003-2637-4249; Pot, David/0000-0002-1480-9826; Mieczkowski, Piotr/0000-0003-2418-0096; Shen, Hui/0000-0001-9767-4084; Schultz, Nikolaus/0000-0002-0131-4904; Garcia-Grossman, Ilana/0000-0002-8136-9218; Park, Peter/0000-0001-9378-960X; Gingrich, Jeffrey/0000-0002-4516-2893; Sinha, Rileen/0000-0001-5497-5055; Bhatt, Ami/0000-0001-8099-2975; Bochner, Bernard/0000-0003-0846-0848; Gehlenborg, Nils/0000-0003-0327-8297	United States National Institutes of Health [U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P01 CA120964]; NATIONAL CANCER INSTITUTE [U24CA126554, U24CA144025, P01CA120964, U24CA143840, U24CA143848, U24CA143882, U24CA143835, U24CA143858, U24CA143866, P30CA008748, P30CA016086, U24CA143799, U24CA143883, U24CA143845, U24CA180951, U24CA143867, U24CA143843, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019713] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to all of the patients and families who contributed to this study, as well as C. Gunter and L. Chastain for scientific editing and M. Sheth, J. Zhang and C. Ron Bouchard for administrative support. This work was supported by the following grants from the United States National Institutes of Health: U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025 and P01 CA120964. Additional personnel and funding sources are acknowledged in the Supplementary Information.	Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Ryan MC, 2012, BIOINFORMATICS, V28, P2385, DOI 10.1093/bioinformatics/bts452; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhou JBA, 2011, INT J BIOCHEM CELL B, V43, P1668, DOI 10.1016/j.biocel.2011.09.005	39	1939	1964	3	233	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					315	322		10.1038/nature12965	http://dx.doi.org/10.1038/nature12965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24476821	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000333029000025
J	Christophorou, MA; Castelo-Branco, G; Halley-Stott, RP; Oliveira, CS; Loos, R; Radzisheuskaya, A; Mowen, KA; Bertone, P; Silva, JCR; Zernicka-Goetz, M; Nielsen, ML; Gurdon, JB; Kouzarides, T				Christophorou, Maria A.; Castelo-Branco, Goncalo; Halley-Stott, Richard P.; Oliveira, Clara Slade; Loos, Remco; Radzisheuskaya, Aliaksandra; Mowen, Kerri A.; Bertone, Paul; Silva, Jose C. R.; Zernicka-Goetz, Magdalena; Nielsen, Michael L.; Gurdon, John B.; Kouzarides, Tony			Citrullination regulates pluripotency and histone H1 binding to chromatin	NATURE			English	Article							PEPTIDYLARGININE DEIMINASE 4; MASS; EXPRESSION; PAD4; IDENTIFICATION; LOCALIZATION; NUCLEOSOME; PROTEINS; NANOG; STATE	Citrullination is the post-translational conversion of an arginine residue within a protein to the non-coded amino acid citrulline(1). This modification leads to the loss of a positive charge and reduction in hydrogen-bonding ability. It is carried out by a small family of tissue-specific vertebrate enzymes called peptidylarginine deiminases (PADIs)(2) and is associated with the development of diverse pathological states such as autoimmunity, cancer, neurodegenerative disorders, prion diseases and thrombosis(2,3). Nevertheless, the physiological functions of citrullination remain ill-defined, although citrullination of core histones has been linked to transcriptional regulation and the DNA damage response(4-8). PADI4 (also called PAD4 or PADV), the only PADI with a nuclear localization signal(9), was previously shown to act in myeloid cells where it mediates profound chromatin decondensation during the innate immune response to infection(10). Here we show that the expression and enzymatic activity of Padi4 are also induced under conditions of ground-state pluripotency and during reprogramming in mouse. Padi4 is part of the pluripotency transcriptional network, binding to regulatory elements of key stem-cell genes and activating their expression. Its inhibition lowers the percentage of pluripotent cells in the early mouse embryo and significantly reduces reprogramming efficiency. Using an unbiased proteomic approach we identify linker histone H1 variants, which are involved in the generation of compact chromatin(11), as novel PADI4 substrates. Citrullination of a single arginine residue within the DNA-binding site of H1 results in its displacement from chromatin and global chromatin decondensation. Together, these results uncover a role for citrullination in the regulation of pluripotency and provide new mechanistic insights into how citrullination regulates chromatin compaction.	[Christophorou, Maria A.; Castelo-Branco, Goncalo; Halley-Stott, Richard P.; Oliveira, Clara Slade; Zernicka-Goetz, Magdalena; Gurdon, John B.; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Castelo-Branco, Goncalo] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, SE-17177 Stockholm, Sweden; [Halley-Stott, Richard P.; Gurdon, John B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Oliveira, Clara Slade] EMBRAPA Dairy Cattle Res Ctr, Juiz De Fora, Brazil; [Oliveira, Clara Slade; Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England; [Loos, Remco; Bertone, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Radzisheuskaya, Aliaksandra; Bertone, Paul; Silva, Jose C. R.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Radzisheuskaya, Aliaksandra; Silva, Jose C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Nielsen, Michael L.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Prote, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; Karolinska Institutet; University of Cambridge; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Cambridge; Scripps Research Institute; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Copenhagen; University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Bertone, Paul/A-6600-2013; Castelo-Branco, Goncalo/A-8357-2015; Castelo-Branco, Gonçalo/O-9162-2019; Bertone, Paul/Z-3734-2019; Radzisheuskaya, Aliaksandra/AAI-4975-2021; Silva, Jose/G-1920-2014; Radzisheuskaya, Aliaksandra/J-2073-2015; Silva, Jose C R/X-5140-2019	Bertone, Paul/0000-0001-5059-4829; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bertone, Paul/0000-0001-5059-4829; Silva, Jose/0000-0001-5487-1117; Radzisheuskaya, Aliaksandra/0000-0002-2695-6401; Silva, Jose C R/0000-0001-5487-1117; GURDON, JOHN/0000-0002-5621-3799; Christophorou, Maria/0000-0001-5455-7283; Loos, Remco/0000-0002-9850-6821; Kouzarides, Tony/0000-0002-8918-4162; Halley-Stott, Richard/0000-0003-0620-0882; Nielsen, Michael/0000-0002-0067-9039; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Cancer Research UK; EMBL; Medical Research Council [G1001690]; Wellcome Trust; EMBO; European Union; Swedish Research Council; Human Frontier Science Programme Long-Term Post-Doctoral Fellowship; FAPESP (Foundation for Research Support of the State of Sao Paulo); Novo Nordisk Foundation Center for Protein Research; Lundbeck Foundation; European Commission [HEALTH-F7-2010-242129/SYBOSS]; NIH [AI099728]; MRC [G1001690] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: researchfish; Cancer Research UK [10827, 17001] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0006477] Funding Source: researchfish; Wellcome Trust [101050/Z/13/Z] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Michael Lund Nielsen] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099728] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); EMBL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EMBO(European Molecular Biology Organization (EMBO)); European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Human Frontier Science Programme Long-Term Post-Doctoral Fellowship; FAPESP (Foundation for Research Support of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Novo Nordisk Foundation Center for Protein Research; Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Novo Nordisk Foundation Center for Protein Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by programme grants from Cancer Research UK (T.K.) and EMBL (P.B., R.L.). R.P.H.-S. and J.B.G. are supported by the Medical Research Council (G1001690) and the Wellcome Trust. G.C.-B. was funded by EMBO (Long-Term Post-Doctoral Fellowship), European Union (FP7 Marie Curie Intra-European Fellowship for Career Development) and Swedish Research Council. M.A.C. was funded by an EMBO Long-Term Post-Doctoral Fellowship and a Human Frontier Science Programme Long-Term Post-Doctoral Fellowship. C.S.O. was supported by FAPESP (Foundation for Research Support of the State of Sao Paulo) and mouse embryo work was supported by the Wellcome Trust programme grant to M.Z.-G. M.L.N. was partly supported by the Novo Nordisk Foundation Center for Protein Research, the Lundbeck Foundation, and by and the European Commission's 7th Framework Programme HEALTH-F7-2010-242129/SYBOSS. K.A.M. was funded by NIH grant AI099728. We would like to thank S. Lestari, A. Cook and C. Hill for technical assistance; P. Thompson for providing the TDFA compound; GSK Epinova for Cl-amidine; T. Bartke for the gift of histone octamers and help with nucleosome pull-down assays; A. Finch for help with FPLC chromatography; A. Jedrusik for help with embryo work; R. Walker at the Flow Cytometry Core Facility at Wellcome Trust Centre for Stem Cell Research, University of Cambridge and T. Theunissen for help with the flow cytometry; and members of the Kouzarides laboratory for critical discussions of the work. 2TS22C cells were provided by H. Niwa. The ChIP grade H1.2 antibody was a gift from A. Skoultchi.	Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Brahmajosyula M, 2013, ZYGOTE, V21, P314, DOI 10.1017/S0967199411000633; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Darrah E, 2012, ANN RHEUM DIS, V71, P92, DOI 10.1136/ard.2011.151712; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Halley-Stott RP, 2010, METHODS, V51, P56, DOI 10.1016/j.ymeth.2010.01.035; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Jones JE, 2012, ACS CHEM BIOL, V7, P160, DOI 10.1021/cb200258q; Kan R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-19; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rozen S, 2000, Methods Mol Biol, V132, P365; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tanikawa C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1676; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhang XS, 2012, P NATL ACAD SCI USA, V109, P13331, DOI 10.1073/pnas.1203280109; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	55	253	297	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					104	+		10.1038/nature12942	http://dx.doi.org/10.1038/nature12942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24463520	Green Accepted			2022-12-28	WOS:000332224400051
J	Yaqub, F				Yaqub, Farhat			Playing the Oregon health insurance lottery	LANCET			English	Editorial Material							MEDICAID		The Lancet, London NW1 7BY, England		Yaqub, F (corresponding author), The Lancet, London NW1 7BY, England.	farhat.yaqub@lancet.com						Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Cheung PT, 2012, ANN EMERG MED, V60, P4, DOI 10.1016/j.annemergmed.2012.01.035; Rice T, 2013, HEALT SYST TRANSIT, V15, P1; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	4	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					585	585		10.1016/S0140-6736(14)60117-3	http://dx.doi.org/10.1016/S0140-6736(14)60117-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KP	24529459				2022-12-28	WOS:000331137700010
J	Bonham, KS; Orzalli, MH; Hayashi, K; Wolf, AI; Glanemann, C; Weninger, W; Iwasaki, A; Knipe, DM; Kagan, JC				Bonham, Kevin S.; Orzalli, Megan H.; Hayashi, Kachiko; Wolf, Amaya I.; Glanemann, Christoph; Weninger, Wolfgang; Iwasaki, Akiko; Knipe, David M.; Kagan, Jonathan C.			A Promiscuous Lipid-Binding Protein Diversifies the Subcellular Sites of Toll-like Receptor Signal Transduction	CELL			English	Article							NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-SYSTEM; PHOSPHOINOSITIDE BINDING; MAMMALIAN-CELLS; T-CELLS; RECOGNITION; VIRUS; DNA; SPECIFICITY	The Toll-like receptors (TLRs) of the innate immune system are unusual in that individual family members are located on different organelles, yet most activate a common signaling pathway important for host defense. It remains unclear how this common signaling pathway can be activated from multiple subcellular locations. Here, we report that, in response to natural activators of innate immunity, the sorting adaptor TIRAP regulates TLR signaling from the plasma membrane and endosomes. TLR signaling from both locations triggers the TIRAP-dependent assembly of the myddosome, a protein complex that controls proinflammatory cytokine expression. The actions of TIRAP depend on the promiscuity of its phosphoinositide-binding domain. Different lipid targets of this domain direct TIRAP to different organelles, allowing it to survey multiple compartments for the presence of activated TLRs. These data establish how promiscuity, rather than specificity, can be a beneficial means of diversifying the subcellular sites of innate immune signal transduction.	[Bonham, Kevin S.; Glanemann, Christoph; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Bonham, Kevin S.; Glanemann, Christoph; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Orzalli, Megan H.; Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Hayashi, Kachiko; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Wolf, Amaya I.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Weninger, Wolfgang] Centenary Inst, Immune Imaging Program, Newtown, NSW 2042, Australia; [Weninger, Wolfgang] Univ Sydney, Discipline Dermatol, Sydney, NSW 2006, Australia	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; The Wistar Institute; University of Sydney; Centenary Institute; University of Sydney	Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, 300 Longwood Ave, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu	Iwasaki, Akiko/Z-1591-2019; Bonham, Kevin/I-6092-2019	Iwasaki, Akiko/0000-0002-7824-9856; Bonham, Kevin/0000-0003-3200-7533; Orzalli, Megan/0000-0003-2177-1587; Weninger, Wolfgang/0000-0003-3133-8699	National Science Foundation; NIH [AI093589, AI072955, P30DK34854, AI064705, AI063106]; Bill and Melinda Gates Foundation [OPP1066203]; Cancer Institute New South Wales; NHMRC [APP1010680]; Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106934, R01AI093589, R00AI072955, R01AI063106, R01AI064705, R56AI103082, K99AI072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, T32DK007477] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Cancer Institute New South Wales; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Kagan Lab for helpful discussions and Dr. John W. Tobias (University of Pennsylvania Bioinformatics Core) for his contribution to the microarray data analysis. K. S. B. holds a fellowship from the National Science Foundation. NIH grants AI093589, AI072955, and P30DK34854 and an unrestricted gift from Mead Johnson & Company support the work performed in the lab of J.C.K. J.C.K. is also supported by the Bill and Melinda Gates Foundation (OPP1066203). A. I. is supported by NIH grant AI064705, and D. M. K. is supported by NIH grant AI063106. W. W. is supported by a fellowship from the Cancer Institute New South Wales and NHMRC grant APP1010680. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; BERLIN RD, 1978, CELL, V15, P327, DOI 10.1016/0092-8674(78)90002-8; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; CAI WZ, 1989, J VIROL, V63, P4579, DOI 10.1128/JVI.63.11.4579-4589.1989; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KNIPE DM, 1982, J VIROL, V43, P314, DOI 10.1128/JVI.43.1.314-324.1982; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; van Lint AL, 2010, J VIROL, V84, P10802, DOI 10.1128/JVI.00063-10; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	53	155	172	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					705	716		10.1016/j.cell.2014.01.019	http://dx.doi.org/10.1016/j.cell.2014.01.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529375	Bronze, Green Accepted			2022-12-28	WOS:000331379800010
J	Brubaker, SW; Gauthier, AE; Mills, EW; Ingolia, NT; Kagan, JC				Brubaker, Sky W.; Gauthier, Anna E.; Mills, Eric W.; Ingolia, Nicholas T.; Kagan, Jonathan C.			A Bicistronic MAVS Transcript Highlights a Class of Truncated Variants in Antiviral Immunity	CELL			English	Article							NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; SPLICE VARIANT; BETA ISOFORM; IFN-BETA; TRANSLATION; APOPTOSIS; INITIATION; PATHWAY	Bacterial and viral mRNAs are often polycistronic. Akin to alternative splicing, alternative translation of polycistronic messages is a mechanism to generate protein diversity and regulate gene function. Although a few examples exist, the use of polycistronic messages in mammalian cells is not widely appreciated. Here we report an example of alternative translation as a means of regulating innate immune signaling. MAVS, a regulator of antiviral innate immunity, is expressed from a bicistronic mRNA encoding a second protein, miniMAVS. This truncated variant interferes with interferon production induced by full-length MAVS, whereas both proteins positively regulate cell death. To identify other polycistronic messages, we carried out genome-wide ribosomal profiling and identified a class of antiviral truncated variants. This study therefore reveals the existence of a functionally important bicistronic antiviral mRNA and suggests a widespread role for polycistronic mRNAs in the innate immune system.	[Brubaker, Sky W.; Gauthier, Anna E.; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Brubaker, Sky W.; Gauthier, Anna E.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Mills, Eric W.; Ingolia, Nicholas T.] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Mills, Eric W.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Carnegie Institution for Science; Johns Hopkins University	Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, 300 Longwood Ave, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NIH [AI093589, AI072955, P30DK34854]; Bill and Melinda Gates Foundation [OPP1066203]; Searle Scholars Program; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R00AI072955, K99AI072955, R56AI103082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Searle Scholars Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Priya Dadd and members of the Horng lab for experimental help. We would like to thank Steen Hansen for reagents and advice. Finally, we are indebted to the members of the Kagan lab for experimental help and invaluable advice. The NIH grants AI093589, AI072955, and P30DK34854 and an unrestricted gift from Mead Johnson & Company support the work performed in the lab of J.C.K. J.C.K. and A. E. G. are also supported by the Bill and Melinda Gates Foundation (OPP1066203). N.T.I. is supported by the Searle Scholars Program. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. N.T.I. is an inventor on a patent application covering the ribosome-profiling technique.	Alberts B, 2008, MOL BIOL CELL; [Anonymous], 2003, METH MOL B; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ingolia Nicholas T, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0418s103; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lad SP, 2008, MOL IMMUNOL, V45, P2277, DOI 10.1016/j.molimm.2007.11.018; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Powell ML, 2010, BIOCHEM SOC T, V38, P1558, DOI 10.1042/BST0381558; Raught B, 1996, CANCER RES, V56, P4382; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	43	99	102	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					800	811		10.1016/j.cell.2014.01.021	http://dx.doi.org/10.1016/j.cell.2014.01.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529381	Green Accepted, Bronze			2022-12-28	WOS:000331379800017
J	Menon, S; Dibble, CC; Talbott, G; Hoxhaj, G; Valvezan, AJ; Takahashi, H; Cantley, LC; Manning, BD				Menon, Suchithra; Dibble, Christian C.; Talbott, George; Hoxhaj, Gerta; Valvezan, Alexander J.; Takahashi, Hidenori; Cantley, Lewis C.; Manning, Brendan D.			Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome	CELL			English	Article							RAG GTPASES; FUNCTIONAL ASSESSMENT; MAMMALIAN TARGET; RHEB BINDS; S6 KINASE; ACTIVATION; AKT; RAPAMYCIN; PHOSPHORYLATION; TUBERIN	mTORC1 promotes cell growth in response to nutrients and growth factors. Insulin activates mTORC1 through the PI3K-Akt pathway, which inhibits the TSC1-TSC2-TBC1D7 complex (the TSC complex) to turn on Rheb, an essential activator of mTORC1. However, the mechanistic basis of how this pathway integrates with nutrient-sensing pathways is unknown. We demonstrate that insulin stimulates acute dissociation of the TSC complex from the lysosomal surface, where subpopulations of Rheb and mTORC1 reside. The TSC complex associates with the lysosome in a Rheb-dependent manner, and its dissociation in response to insulin requires Akt-mediated TSC2 phosphorylation. Loss of the PTEN tumor suppressor results in constitutive activation of mTORC1 through the Akt-dependent dissociation of the TSC complex from the lysosome. These findings provide a unifying mechanism by which independent pathways affecting the spatial recruitment of mTORC1 and the TSC complex to Rheb at the lysosomal surface serve to integrate diverse growth signals.	[Menon, Suchithra; Talbott, George; Hoxhaj, Gerta; Valvezan, Alexander J.; Manning, Brendan D.] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Dibble, Christian C.; Takahashi, Hidenori; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Dibble, Christian C.; Takahashi, Hidenori; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Cantley, Lewis C.] Dept Med, Weill Cornell Med Coll, New York, NY 10065 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Cornell University	Manning, BD (corresponding author), Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ccdibble@bidmc.harvard.edu; bmanning@hsph.harvard.edu	Cantley, Lewis C/D-1800-2014; Manning, Brendan/ABD-6528-2021	Cantley, Lewis C/0000-0002-1298-7653; Manning, Brendan/0000-0003-3895-5956; Hoxhaj, Gerta/0000-0001-6179-3583; Dibble, Christian/0000-0002-1122-9017	NIH [T32-HL007893, R01-CA122617, P01-CA120964]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Howell for critical comments on the manuscript, S. G. Kim and J. Blenis for antibody advice, L. Bar-Peled and D. M. Sabatini for the p18-N-terminal construct, D. J. Kwiatkowski for the Tsc2<SUP>-/-</SUP> MEFs, and P. P. Pandolfi for the Pten<SUP>-/-</SUP> MEFs. This work was supported by NIH grants T32-HL007893 (C. C. D.), R01-CA122617 (B. D. M.), and P01-CA120964 (B. D. M. and L. C. C.) and by The Ellison Medical Foundation (B.D.M.).	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hoogeveen-Westerveld M, 2013, HUM MUTAT, V34, P167, DOI 10.1002/humu.22202; Hoogeveen-Westerveld M, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-18; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	46	489	498	6	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					771	785		10.1016/j.cell.2013.11.049	http://dx.doi.org/10.1016/j.cell.2013.11.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529379	Green Accepted, Bronze			2022-12-28	WOS:000331379800015
J	Rayamajhi, M; Miao, EA; Moorman, NJ				Rayamajhi, Manira; Miao, Edward A.; Moorman, Nathaniel J.			miniMAVS, You Complete Me!	CELL			English	Editorial Material							TRANSLATION; CELLS	The functional significance of protein diversification through translational regulation in mammals is largely unexplored. Brubaker et al. now describe the generation of two functionally distinct mammalian proteins, MAVS and miniMAVS, from a single bicistronic mRNA and suggest that non-canonical translation may impact multiple players in innate immune regulation.	[Rayamajhi, Manira; Miao, Edward A.; Moorman, Nathaniel J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Rayamajhi, Manira; Miao, Edward A.; Moorman, Nathaniel J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Rayamajhi, Manira; Miao, Edward A.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Moorman, NJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	nathaniel_moorman@med.unc.edu	Rayamajhi, Manira/M-8416-2014	Miao, Edward/0000-0001-7295-3490	NIAID NIH HHS [R01 AI097518, R01 AI119073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119073, R01AI097518] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801	8	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					629	630		10.1016/j.cell.2014.01.045	http://dx.doi.org/10.1016/j.cell.2014.01.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529369	Green Accepted, Bronze			2022-12-28	WOS:000331379800003
J	Amamoto, R; Arlotta, P				Amamoto, Ryoji; Arlotta, Paola			Development-Inspired Reprogramming of the Mammalian Central Nervous System	SCIENCE			English	Review							INDUCED NEURONAL CELLS; EMBRYONIC STEM-CELLS; IN-VIVO; HUMAN FIBROBLASTS; CEREBRAL-CORTEX; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; DIRECT CONVERSION; NUCLEAR TRANSFER; MOTOR-NEURONS	In 2012, John Gurdon and Shinya Yamanaka shared the Nobel Prize for the demonstration that the identity of differentiated cells is not irreversibly determined but can be changed back to a pluripotent state under appropriate instructive signals. The principle that differentiated cells can revert to an embryonic state and even be converted directly from one cell type into another not only turns fundamental principles of development on their heads but also has profound implications for regenerative medicine. Replacement of diseased tissue with newly reprogrammed cells and modeling of human disease are concrete opportunities. Here, we focus on the central nervous system to consider whether and how reprogramming of cell identity may affect regeneration and modeling of a system historically considered immutable and hardwired.	[Amamoto, Ryoji; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Sherman Fairchild Bldg,7 Divin Ave, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu			U.S. National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Berninger, M. Stadtfeld, H. Wichterle, and members of the Arlotta laboratory for their valuable comments on the manuscript. We apologize to colleagues whose work we could not include due to space limitations. Work in the Arlotta laboratory is funded by the U.S. National Institutes of Health. P.A. is a New York Stem Cell Foundation Robertson Investigator.	Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Aoki H, 2009, DEV DYNAM, V238, P2266, DOI 10.1002/dvdy.22008; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dawkins R., 2009, GREATEST SHOW EARTH; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Makino H, 2005, CLONING STEM CELLS, V7, P45, DOI 10.1089/clo.2005.7.45; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Osada T, 2005, J NEUROSCI, V25, P8368, DOI 10.1523/JNEUROSCI.1591-05.2005; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Spemann H., 1938, EMBRYONIC DEV INDUCT; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	65	67	70	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					504	+	1239882	10.1126/science.1239882	http://dx.doi.org/10.1126/science.1239882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482482	Green Accepted			2022-12-28	WOS:000330343700036
J	Singleton, AB				Singleton, Andrew B.			A Unified Process for Neurological Disease	SCIENCE			English	Editorial Material							HEREDITARY SPASTIC PARAPLEGIA		NIA, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Singleton, AB (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009		Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000957] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018	4	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					497	498		10.1126/science.1250172	http://dx.doi.org/10.1126/science.1250172			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482474	Green Accepted			2022-12-28	WOS:000330343700033
J	Bjordal, M; Arquier, N; Kniazeff, J; Pin, JP; Leopold, P				Bjordal, Marianne; Arquier, Nathalie; Kniazeff, Julie; Pin, Jean Philippe; Leopold, Pierre			Sensing of Amino Acids in a Dopaminergic Circuitry Promotes Rejection of an Incomplete Diet in Drosophila	CELL			English	Article							TRANSCRIPTION FACTOR ATF4; EIF2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; MOLECULAR-MECHANISMS; GABA(B) RECEPTORS; NUTRIENT SENSOR; PIRIFORM CORTEX; GENE-EXPRESSION; S6 KINASE; PROTEIN	The brain is the central organizer of food intake, matching the quality and quantity of the food sources with organismal needs. To ensure appropriate amino acid balance, many species reject a diet lacking one or several essential amino acids (EAAs) and seek out a better food source. Here, we show that, in Drosophila larvae, this behavior relies on innate sensing of amino acids in dopaminergic (DA) neurons of the brain. We demonstrate that the amino acid sensor GCN2 acts upstream of GABA signaling in DA neurons to promote avoidance of the EAA-deficient diet. Using real-time calcium imaging in larval brains, we show that amino acid imbalance induces a rapid and reversible activation of three DA neurons that are necessary and sufficient for food rejection. Taken together, these data identify a central aminoacid- sensing mechanism operating in specific DA neurons and controlling food intake.	[Bjordal, Marianne; Arquier, Nathalie; Leopold, Pierre] Univ Nice Sophia Antipolis, F-06108 Nice, France; [Bjordal, Marianne; Arquier, Nathalie; Leopold, Pierre] CNRS, F-06108 Nice, France; [Bjordal, Marianne; Arquier, Nathalie; Leopold, Pierre] INSERM, Inst Biol Valrose, F-06108 Nice, France; [Kniazeff, Julie; Pin, Jean Philippe] Univ Montpellier 1 & 2, INSERM, CNRS, UMR5203,Inst Genom Fonct,U661, F-34094 Montpellier, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Leopold, P (corresponding author), Univ Nice Sophia Antipolis, F-06108 Nice, France.	leopold@unice.fr	Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Kniazeff, Julie/0000-0002-0426-0999; ARQUIER, Nathalie/0000-0001-6833-2069	CNRS; INSERM; Agence Nationale pour la Recherche (ANR); Fondation pour la Recherche Medicale; European Research Council [268813]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission)	We thank G. Jarretou and B. Polo for technical assistance; Mark N. Wu, Gero Miesenbo " ck, Serge Birman, Scott Waddell, Ping Shen, Dick Na " ssel, the Vienna Drosophila RNAi Center (VDRC), and the Bloomington Stock Center for flies and reagents; and the PRISM platform for providing state-of-the-art imaging resources. The BRET measurements were performed at the ARPEGE (Pharmacology, Screening, Interactome) facility at the Institut de Ge ' nomique Fonctionnelle. We thank T. Preat, C. Ribeiro, and all members of the laboratory for fruitful discussions and comments on the manuscript. This work was supported by the CNRS, INSERM, Agence Nationale pour la Recherche (ANR), Fondation pour la Recherche Medicale, and European Research Council (grant 268813) for M. B. and P. L. M. B. was a former fellow from the Research Council of Norway and ANR.	Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; BOOTH DA, 1971, Q J EXP PSYCHOL, V23, P135, DOI 10.1080/00335557143000149; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Chaveroux C, 2010, BIOCHIMIE, V92, P736, DOI 10.1016/j.biochi.2010.02.020; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fromentin G, 1998, APPETITE, V30, P223, DOI 10.1006/appe.1997.0132; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Geminard C., 2009, CELL METAB, V10, P199; GIETZEN DW, 1992, PHYSIOL BEHAV, V51, P909, DOI 10.1016/0031-9384(92)90069-E; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hao S, 2010, PHARMACOL BIOCHEM BE, V94, P333, DOI 10.1016/j.pbb.2009.09.014; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Itskov PM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00012; Iwatsuki K, 2012, CURR OPIN ENDOCRINOL, V19, P19, DOI 10.1097/MED.0b013e32834ec7f8; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; Qiu HF, 2002, GENE DEV, V16, P1271, DOI 10.1101/gad.979402; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Ritter B, 2004, DEV BRAIN RES, V149, P73, DOI 10.1016/j.devbrainres.2003.12.006; Romero-Calderon R, 2007, DEV NEUROBIOL, V67, P550, DOI 10.1002/dneu.20342; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; Truong BG, 2002, BRAIN RES, V924, P1, DOI 10.1016/S0006-8993(01)03213-9; Valbuena N, 2012, J CELL SCI, V125, P5955, DOI 10.1242/jcs.105395; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vernon E, 2001, MOL CELL NEUROSCI, V17, P637, DOI 10.1006/mcne.2000.0960; Wang YH, 2013, CELL REP, V3, P820, DOI 10.1016/j.celrep.2013.02.003; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	60	93	96	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					510	521		10.1016/j.cell.2013.12.024	http://dx.doi.org/10.1016/j.cell.2013.12.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485457	Bronze			2022-12-28	WOS:000330580800017
J	Park, HY; Lim, H; Yoon, YJ; Follenzi, A; Nwokafor, C; Lopez-Jones, M; Meng, XH; Singer, RH				Park, Hye Yoon; Lim, Hyungsik; Yoon, Young J.; Follenzi, Antonia; Nwokafor, Chiso; Lopez-Jones, Melissa; Meng, Xiuhua; Singer, Robert H.			Visualization of Dynamics of Single Endogenous mRNA Labeled in Live Mouse	SCIENCE			English	Article							LOCALIZATION; GRANULES; STIMULATION; PROTEIN; GROWTH	The transcription and transport of messenger RNA (mRNA) are critical steps in regulating the spatial and temporal components of gene expression, but it has not been possible to observe the dynamics of endogenous mRNA in primary mammalian tissues. We have developed a transgenic mouse in which all beta-actin mRNA is fluorescently labeled. We found that beta-actin mRNA in primary fibroblasts localizes predominantly by diffusion and trapping as single mRNAs. In cultured neurons and acute brain slices, we found that multiple beta-actin mRNAs can assemble together, travel by active transport, and disassemble upon depolarization by potassium chloride. Imaging of brain slices revealed immediate early induction of beta-actin transcription after depolarization. Studying endogenous mRNA in live mouse tissues provides insight into its dynamic regulation within the context of the cellular and tissue microenvironment.	[Park, Hye Yoon; Yoon, Young J.; Nwokafor, Chiso; Lopez-Jones, Melissa; Meng, Xiuhua; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Park, Hye Yoon; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Lim, Hyungsik; Nwokafor, Chiso] CUNY Hunter Coll, Dept Phys & Astron, New York, NY 10065 USA; [Lim, Hyungsik; Nwokafor, Chiso] CUNY, Grad Ctr, New York, NY 10065 USA; [Follenzi, Antonia] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Follenzi, Antonia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Nwokafor, Chiso] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Singer, Robert H.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Singer, Robert H.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine; University of Eastern Piedmont Amedeo Avogadro; City University of New York (CUNY) System; Hunter College (CUNY); Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Park, Hye Yoon/N-9618-2014; Park, Hye Yoon Yoon/AAW-6069-2021	Park, Hye Yoon/0000-0003-4704-8178; Park, Hye Yoon Yoon/0000-0003-4704-8178; Follenzi, Antonia/0000-0001-9780-300X	NIH [EB13571, NS083085-19]; National Research Service [F32-GM87122]; Integrated Imaging Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087122, R01GM084364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; Integrated Imaging Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants EB13571 and NS083085-19 (formerly GM84364) (R. H. S.) and National Research Service Award F32-GM87122 and the Integrated Imaging Program (H.Y.P.).	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bassell GJ, 1998, J NEUROSCI, V18, P251; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Knowles RB, 1996, J NEUROSCI, V16, P7812; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]	17	187	191	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					422	424		10.1126/science.1239200	http://dx.doi.org/10.1126/science.1239200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458643	Green Accepted			2022-12-28	WOS:000330039300050
J	Jaddoe, VWV; de Jonge, LL; Hofman, A; Franco, OH; Steegers, EAP; Gaillard, R				Jaddoe, Vincent W. V.; de Jonge, Layla L.; Hofman, Albert; Franco, Oscar H.; Steegers, Eric A. P.; Gaillard, Romy			First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; SCIENTIFIC STATEMENT; PHYSICAL-ACTIVITY; GESTATIONAL-AGE; CHILDHOOD; PREGNANCY; DISEASE; OBESITY; YOUNG; ATHEROSCLEROSIS	Objective To examine whether first trimester fetal growth restriction correlates with cardiovascular outcomes in childhood. Design Population based prospective cohort study. Setting City of Rotterdam, the Netherlands. Participants 1184 children with first trimester fetal crown to rump length measurements, whose mothers had a reliable first day of their last menstrual period and a regular menstrual cycle. Main outcomes measures Body mass index, total and abdominal fat distribution, blood pressure, and blood concentrations of cholesterol, triglycerides, insulin, and C peptide at the median age of 6.0 (90% range 5.7-6.8) years. Clustering of cardiovascular risk factors was defined as having three or more of: high android fat mass; high systolic or diastolic blood pressure; low high density lipoprotein cholesterol or high triglycerides concentrations; and high insulin concentrations. Results One standard deviation score greater first trimester fetal crown to rump length was associated with a lower total fat mass (-0.30%, 95% confidence interval -0.57% to -0.03%), android fat mass (-0.07%, -0.12% to -0.02%), android/gynoid fat mass ratio (-0.53, -0.89 to -0.17), diastolic blood pressure (-0.43, -0.84 to -0.01, mm Hg), total cholesterol (-0.05, -0.10 to 0, mmol/L), low density lipoprotein cholesterol (-0.04, -0.09 to 0, mmol/L), and risk of clustering of cardiovascular risk factors (relative risk 0.81, 0.66 to 1.00) in childhood. Additional adjustment for gestational age and weight at birth changed these effect estimates only slightly. Childhood body mass index fully explained the associations of first trimester fetal crown to rump length with childhood total fat mass. First trimester fetal growth was not associated with other cardiovascular outcomes. Longitudinal growth analyses showed that compared with school age children without clustering of cardiovascular risk factors, those with clustering had a smaller first trimester fetal crown to rump length and lower second and third trimester estimated fetal weight but higher weight growth from the age of 6 months onwards. Conclusions Impaired first trimester fetal growth is associated with an adverse cardiovascular risk profile in school age children. Early fetal life might be a critical period for cardiovascular health in later life.	[Jaddoe, Vincent W. V.; Gaillard, Romy] Erasmus Univ, Med Ctr, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; de Jonge, Layla L.; Hofman, Albert; Franco, Oscar H.; Gaillard, Romy] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; de Jonge, Layla L.; Gaillard, Romy] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus Univ, Med Ctr, Dept Obstet & Gynaecol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC	Jaddoe, VWV (corresponding author), Erasmus Univ, Med Ctr, Generat Study Grp R, POB 2040, NL-3000 CA Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl	Gaillard, Romy/H-9674-2019; Franco, Óscar H/ABE-2305-2020	Franco, Óscar H/0000-0002-4606-4929	Netherlands Organization of Scientific Research (NWO), Netherlands Organization of Health Research and Development (ZonMw) [VIDI 016.136.361]; Nestle Nutrition; Metagenics; AXA; European Union [289346]	Netherlands Organization of Scientific Research (NWO), Netherlands Organization of Health Research and Development (ZonMw); Nestle Nutrition(Nestle SA); Metagenics; AXA; European Union(European Commission)	VWVJ received funding from the Netherlands Organization of Scientific Research (NWO), Netherlands Organization of Health Research and Development (ZonMw), VIDI 016.136.361. OHF works in ErasmusAGE, a centre for ageing research across the life course funded by Nestle Nutrition, Metagenics, and AXA. RG received funding from the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement No 289346.	World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 1995, MULTILEVEL STAT METH; Aucouturier J, 2009, ARCH PEDIAT ADOL MED, V163, P826, DOI 10.1001/archpediatrics.2009.148; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bottomley C, 2009, HUM REPROD, V24, P284, DOI 10.1093/humrep/den389; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Bukowski R, 2007, AM J EPIDEMIOL, V165, P1216, DOI 10.1093/aje/kwm024; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gaillard R, 2011, EUR HEART J, V32, P3088, DOI 10.1093/eurheartj/ehr275; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Hayman LL, 2007, CIRCULATION, V116, P344, DOI 10.1161/CIRCULATIONAHA.107.184595; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Liu Y, 2004, AM J EPIDEMIOL, V160, P131, DOI 10.1093/aje/kwh188; Livingstone C, 2001, HUMAN EMBRYOLOGY; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; ROBINSON HP, 1973, BMJ-BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5883.28; Royal College of Obstetricians and Gynaecologists, 2000, ROUT ULTR SCREEN PRE; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Taal HR, 2013, OBESITY, V21, P1261, DOI 10.1002/oby.20116; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verburg BO, 2008, PRENATAL DIAG, V28, P323, DOI 10.1002/pd.1972; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E; Wong SN, 2006, BLOOD PRESS MONIT, V11, P281, DOI 10.1097/01.mbp.0000209082.09623.b4	36	184	188	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g14	10.1136/bmj.g14	http://dx.doi.org/10.1136/bmj.g14			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24458585	hybrid, Green Published			2022-12-28	WOS:000330298100004
J	Gartenberg, AJ; Peleg, A; Dhruva, SS; Redberg, RF				Gartenberg, Ari J.; Peleg, Ariel; Dhruva, Sanket S.; Redberg, Rita F.			Presumed safe no more: lessons from the Wingspan saga on regulation of devices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gartenberg, Ari J.; Peleg, Ariel] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Dhruva, Sanket S.] UC Davis Med Ctr, Div Cardiovasc Med, Sacramento, CA 95817 USA; [Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Davis; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, Suite M-1180,505 Parnassus Ave, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu		Gartenberg, Ari/0000-0001-9509-2945				Abdihalim MM, 2013, AM J NEURORADIOL, V34, P2054, DOI 10.3174/ajnr.A3447; Derdeyn CP, 2013, LANCET; Dorsey ER, 2010, ARCH INTERN MED, V170, P96, DOI 10.1001/archinternmed.2009.456; FDA, 2012, SAFETY COMMUNICATION; FDA, 2012, FDA RESPONSE TO PETI; FDA, HUMANITARIAN USE DEV; FDA, WINGSPAN STENTS BENE; FDA, 522 POSTMARKET SURVE; Free State Reporting, 2013, TRANSCRIPT OF NEUROL; Hollmer M., 2012, FIERCE MEDICAL DEVIC; Public Citizen, 2011, PETITION TO THE FDA; Sox HC, 2008, ANN INTERN MED, V149, P279, DOI 10.7326/0003-4819-149-4-200808190-00012; Storz-Pfennig P, 2013, BMJ-BRIT MED J, V346, pf1645; Stryker Neurovascular, 2012, WINGSPAN STENT SYSTE; Stryker Neurovascular, PRODUCT INFORMATION	15	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2014	348								g93	10.1136/bmj.g93	http://dx.doi.org/10.1136/bmj.g93			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AW	24452627				2022-12-28	WOS:000330297300014
J	Wardlaw, T; Aslam, A; Anthony, D; Little, C; Cappa, C				Wardlaw, Tessa; Aslam, Abid; Anthony, David; Little, Celine; Cappa, Claudia			Data, children's rights, and the new development agenda	LANCET			English	Editorial Material									[Wardlaw, Tessa; Cappa, Claudia] UNICEF, Div Policy & Strategy, Data & Analyt Sect, New York, NY 10017 USA; [Anthony, David] UNICEF, Div Policy & Strategy, Social Inclus Policy & Budgeting Sect, New York, NY 10017 USA; [Aslam, Abid; Little, Celine] UNICEF, State Worlds Children Team, Div Commun, New York, NY 10017 USA	UNICEF; UNICEF; UNICEF	Wardlaw, T (corresponding author), UNICEF, Div Policy & Strategy, Data & Analyt Sect, New York, NY 10017 USA.	twardlaw@unicef.org						UNICEF, 2015, COMMITTING CHILD SUR; UNICEF, 2014, STAT WORLDS CHILDR 2; United Nations, 2013, NEW GLOB PARTN ER PO	3	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1618	1619		10.1016/S0140-6736(14)60081-7	http://dx.doi.org/10.1016/S0140-6736(14)60081-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24486188				2022-12-28	WOS:000335670800008
J	Murray, MF				Murray, Michael F.			Why We Should Care About What You Get for "Only $99" From a Personal Genomic Service	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Murray, Michael F.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA	Geisinger Health System	Murray, MF (corresponding author), Genom Med Inst, 100 North Acad Ave,MC 26-20, Danville, PA 17822 USA.	mfmurray1@geisinger.edu						Annes JP, 2010, NEW ENGL J MED, V363, P1100, DOI 10.1056/NEJMp1006029; Borry P, 2010, EUR J HUM GENET, V18, P1271, DOI 10.1038/ejhg.2010.129; Kim JK, 2013, AM J MED, V126, P845, DOI 10.1016/j.amjmed.2013.03.029; Seife C., 2013, SCI AM; Su Pascal, 2013, Yale Journal of Biology and Medicine, V86, P359; U.S. Food and Drug Administration, INSP COMPL ENF CRIM	6	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					507	+		10.7326/M13-2804	http://dx.doi.org/10.7326/M13-2804			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24514942				2022-12-28	WOS:000334093800010
J	Guirguis-Blake, JM; Beil, TL; Senger, CA; Whitlock, EP				Guirguis-Blake, Janelle M.; Beil, Tracy L.; Senger, Caitlyn A.; Whitlock, Evelyn P.			Ultrasonography Screening for Abdominal Aortic Aneurysms: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PRACTICE GUIDELINES; VASCULAR-SURGERY; HIGH PREVALENCE; CLINICAL-TRIAL; SINGLE SCAN; MORTALITY; METAANALYSIS; ULTRASOUND; MEN	Background: Long-term follow-up of population-based randomized, controlled trials (RCTs) has demonstrated that screening for abdominal aortic aneurysms (AAAs) measuring 3 cm or greater decreases AAA-related mortality rates in men aged 65 years or older. Purpose: To systematically review evidence about the benefits and harms of ultrasonography screening for AAAs in asymptomatic primary care patients. Data Sources: MEDLINE, the Database of Abstracts of Reviews of Effects, the Cochrane Central Register of Controlled Trials (January 2004 through January 2013), clinical trial registries, reference lists, experts, and a targeted bridge search for population-based screening RCTs through September 2013. Study Selection: English-language, population-based, fair-to good-quality RCTs and large cohort studies for AAA screening benefits as well as RCTs and cohort and registry studies for harms in adults with AAA. Data Extraction: Dual quality assessment and abstraction of study details and results. Data Synthesis: Reviews of 4 RCTs involving 137 214 participants demonstrated that 1-time invitation for AAA screening in men aged 65 years or older reduced AAA rupture and AAA-related mortality rates for up to 10 and 15 years, respectively, but had no statistically significant effect on all-cause mortality rates up to 15 years. Screening was associated with more overall and elective surgeries but fewer emergency operations and lower 30-day operative mortality rates at up to 10- to 15-year follow-up. One RCT involving 9342 women showed that screening had no benefit on AAA-related or all-cause mortality rates. Limitations: Trials included mostly white men outside of the United States. Information for subgroups and about rescreening was limited. Conclusion: One-time invitation for AAA screening in men aged 65 years or older was associated with decreased AAA rupture and AAA-related mortality rates but had little or no effect on all-cause mortality rates.	Univ Washington, Tacoma, WA USA; Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA; Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA	University of Washington; University of Washington Tacoma; Kaiser Permanente; Kaiser Permanente	Guirguis-Blake, JM (corresponding author), Univ Washington, Dept Family Med, Tacoma Family Med Residency Program, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Anjum A, 2012, BRIT J SURG, V99, P637, DOI 10.1002/bjs.8698; Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Badger SA, 2007, EUR J VASC ENDOVASC, V34, P163, DOI 10.1016/j.ejvs.2007.02.021; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Chun KC, 2013, J VASC SURG, V57, P376, DOI 10.1016/j.jvs.2012.08.038; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Costantino TG, 2005, J EMERG MED, V29, P455, DOI 10.1016/j.jemermed.2005.02.016; d'Audiffret A, 2002, ANN VASC SURG, V16, P534, DOI 10.1007/s10016-001-0283-5; Darwood R, 2012, J VASC SURG, V56, P8, DOI 10.1016/j.jvs.2011.12.069; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Devaraj S, 2008, ANN ROY COLL SURG, V90, P477, DOI 10.1308/003588408X301064; EMERTON ME, 1994, BRIT J SURG, V81, P1112, DOI 10.1002/bjs.1800810810; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Greco G, 2010, ANN SURG, V252, P675, DOI 10.1097/SLA.0b013e3181f621c8; Guirguis-Blake JM, 2014, AHRQ PUBLICATION; Guolo A, 2012, STAT MED, V31, P313, DOI 10.1002/sim.4451; Hafez H, 2008, EUR J VASC ENDOVASC, V36, P553, DOI 10.1016/j.ejvs.2008.06.032; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Kim LG, 2007, ANN INTERN MED, V146, P699, DOI 10.7326/0003-4819-146-10-200705150-00003; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Larsson E, 2009, J VASC SURG, V49, P47, DOI 10.1016/j.jvs.2008.08.012; Lederle FA, 2000, ARCH INTERN MED, V160, P1117, DOI 10.1001/archinte.160.8.1117; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lederle FA, 1997, J VASC SURG, V26, P595, DOI 10.1016/S0741-5214(97)70057-0; Lederle FA, 2011, CIRCULATION, V124, P1097, DOI 10.1161/CIRCULATIONAHA.111.052365; Lesjak M, 2012, AUST J PRIM HEALTH, V18, P284, DOI 10.1071/PY11131; Lindholt JS, 2008, EUR J VASC ENDOVASC, V36, P167, DOI 10.1016/j.ejvs.2008.03.006; Lindholt JS, 2007, EUR J VASC ENDOVASC, V34, P53, DOI 10.1016/j.ejvs.2006.12.031; Lindholt JS, 2010, BRIT J SURG, V97, P826, DOI 10.1002/bjs.7001; Lindholt JS, 2006, EUR J VASC ENDOVASC, V32, P608, DOI 10.1016/j.ejvs.2006.06.008; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P79, DOI 10.1053/ejvs.1999.1087; Lindholt JS, 2002, EUR J VASC ENDOVASC, V23, P55, DOI 10.1053/ejvs.2001.1534; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; Linne A, 2012, J VASC SURG, V56, P305, DOI 10.1016/j.jvs.2012.01.061; Longo Christopher, 2005, Vasc Endovascular Surg, V39, P213, DOI 10.1177/153857440503900301; Lucarotti ME, 1997, EUR J VASC ENDOVASC, V14, P499, DOI 10.1016/S1078-5884(97)80131-1; MACSWEENEY STR, 1993, BRIT J SURG, V80, P582, DOI 10.1002/bjs.1800800510; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Mell MW, 2013, J VASC SURG, V57, P1519, DOI 10.1016/j.jvs.2012.12.034; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Mureebe L, 2008, J VASC SURG, V48, P1101, DOI 10.1016/j.jvs.2008.06.031; National Institute for Health and Care Excellence (NICE), 2012, CLIN GUID DEV METH G; NHS Abdominal Aortic Aneurysm Screening Programme, 2013, NHS ABD AORT AN SCRE; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Ogata T, 2005, J VASC SURG, V42, P891, DOI 10.1016/j.jvs.2005.08.002; Sandiford P, 2011, BRIT J SURG, V98, P645, DOI 10.1002/bjs.7461; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Scott RAP, 2001, EUR J VASC ENDOVASC, V21, P535, DOI 10.1053/ejvs.2001.1368; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Spencer CA, 2004, ANZ J SURG, V74, P1069, DOI 10.1111/j.1445-1433.2004.03270.x; Svensjo S, 2013, BRIT J SURG, V100, P367, DOI 10.1002/bjs.8984; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Takagi H, 2013, INT J CARDIOL, V167, P2331, DOI 10.1016/j.ijcard.2012.11.011; Takagi H, 2010, J VASC SURG, V52, P1103, DOI 10.1016/j.jvs.2010.02.283; Tayal VS, 2003, ACAD EMERG MED, V10, P867, DOI 10.1111/j.1553-2712.2003.tb00630.x; Thompson AR, 2010, BRIT J SURG, V97, P37, DOI 10.1002/bjs.6779; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; U.S. Preventive Services Task Force, 2008, US PREV SERV TASK FO; van Vlijmen-van Keulen CJ, 2002, EUR J VASC ENDOVASC, V24, P105, DOI 10.1053/ejvs.2002.1692; Vardulaki KA, 2002, BRIT J SURG, V89, P861, DOI 10.1046/j.1365-2168.2002.02133.x; Vardulaki KA, 2000, BRIT J SURG, V87, P195, DOI 10.1046/j.1365-2168.2000.01353.x; Wanhainen A, 2004, ANN VASC SURG, V18, P287, DOI 10.1007/s10016-004-0021-x; Wells G., 2013, NEWCASTLE OTTAWA SCA; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wild JB, 2013, EUR J VASC ENDOVASC, V45, P128, DOI 10.1016/j.ejvs.2012.11.024; Wilmink ABM, 2001, EUR J VASC ENDOVASC, V21, P165, DOI 10.1053/ejvs.2000.1285; ZARNKE MD, 1988, SURGERY, V103, P638	77	120	125	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					321	+		10.7326/M13-1844	http://dx.doi.org/10.7326/M13-1844			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24473919				2022-12-28	WOS:000332793900004
J	Kim, TW; Choi, KS				Kim, Tae Woo; Choi, Kyoung-Shin			Nanoporous BiVO4 Photoanodes with Dual-Layer Oxygen Evolution Catalysts for Solar Water Splitting	SCIENCE			English	Article							EFFICIENT; HYDROGEN; CRYSTALLINE; SEPARATION; OXIDATION; KINETICS; BEHAVIOR; ROUTE; MO	Bismuth vanadate (BiVO4) has a band structure that is well-suited for potential use as a photoanode in solar water splitting, but it suffers from poor electron-hole separation. Here, we demonstrate that a nanoporous morphology (specific surface area of 31.8 square meters per gram) effectively suppresses bulk carrier recombination without additional doping, manifesting an electron-hole separation yield of 0.90 at 1.23 volts (V) versus the reversible hydrogen electrode (RHE). We enhanced the propensity for surface-reaching holes to instigate water-splitting chemistry by serially applying two different oxygen evolution catalyst (OEC) layers, FeOOH and NiOOH, which reduces interface recombination at the BiVO4/OEC junction while creating a more favorable Helmholtz layer potential drop at the OEC/electrolyte junction. The resulting BiVO4/FeOOH/NiOOH photoanode achieves a photocurrent density of 2.73 milliamps per square centimenter at a potential as low as 0.6 V versus RHE.	[Kim, Tae Woo; Choi, Kyoung-Shin] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Choi, KS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	kschoi@chem.wisc.edu		Choi, Kyoung-Shin/0000-0003-1945-8794	Center for Chemical Innovation of the National Science Foundation (POWERING THE PLANET) [CHE-1305124]	Center for Chemical Innovation of the National Science Foundation (POWERING THE PLANET)(National Science Foundation (NSF))	We acknowledge support from the Center for Chemical Innovation of the National Science Foundation (POWERING THE PLANET: grant CHE-1305124). We thank M. A. Woo for electrodepositing FeOOH and NiOOH on FTO substrates and testing their electrochemical water oxidation performances.	Abdi FF, 2013, J PHYS CHEM LETT, V4, P2752, DOI 10.1021/jz4013257; Abdi FF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3195; Abdi FF, 2012, J PHYS CHEM C, V116, P9398, DOI 10.1021/jp3007552; Allen T., 1997, PARTICLE SIZE MEASUR, V5th; Berglund SP, 2012, PHYS CHEM CHEM PHYS, V14, P7065, DOI 10.1039/c2cp40807d; Castillo NC, 2010, APPL CATAL B-ENVIRON, V95, P335, DOI 10.1016/j.apcatb.2010.01.012; Chen ZB, 2010, J MATER RES, V25, P3, DOI 10.1557/JMR.2010.0020; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Cummings CY, 2012, CHEM COMMUN, V48, P2027, DOI 10.1039/c2cc16382a; Dotan H, 2011, ENERG ENVIRON SCI, V4, P958, DOI 10.1039/c0ee00570c; Foley JM, 2012, ENERG ENVIRON SCI, V5, P5203, DOI 10.1039/c1ee02518j; Hernandez N, 2005, J PHYS CHEM B, V109, P4470, DOI 10.1021/jp0448954; Jo WJ, 2012, ANGEW CHEM INT EDIT, V51, P3147, DOI 10.1002/anie.201108276; Kudo A, 1999, J AM CHEM SOC, V121, P11459, DOI 10.1021/ja992541y; Liang YQ, 2011, J PHYS CHEM C, V115, P17594, DOI 10.1021/jp203004v; Louie MW, 2013, J AM CHEM SOC, V135, P12329, DOI 10.1021/ja405351s; McDonald KJ, 2012, ENERG ENVIRON SCI, V5, P8553, DOI 10.1039/c2ee22608a; Morrison S. R., 1980, ELECTROCHEMISTRY SEM, P49; NOZIK AJ, 1978, ANNU REV PHYS CHEM, V29, P189, DOI 10.1146/annurev.pc.29.100178.001201; Obregon S, 2013, J MOL CATAL A-CHEM, V376, P40, DOI 10.1016/j.molcata.2013.04.012; Park HS, 2011, J PHYS CHEM C, V115, P17870, DOI 10.1021/jp204492r; Park Y, 2014, PHYS CHEM CHEM PHYS, V16, P1238, DOI 10.1039/c3cp53649a; Park Y, 2013, CHEM SOC REV, V42, P2321, DOI 10.1039/c2cs35260e; Peter LM, 2012, FARADAY DISCUSS, V155, P309, DOI 10.1039/c1fd00079a; REBER JF, 1984, J PHYS CHEM-US, V88, P5903, DOI 10.1021/j150668a032; Rettie AJE, 2013, J AM CHEM SOC, V135, P11389, DOI 10.1021/ja405550k; SARALA R, 1990, INORG CHEM, V29, P1133, DOI 10.1021/ic00331a006; Seabold JA, 2012, J AM CHEM SOC, V134, P2186, DOI 10.1021/ja209001d; Sherman DM, 2005, GEOCHIM COSMOCHIM AC, V69, P3249, DOI 10.1016/j.gca.2005.01.023; Smith RDL, 2013, SCIENCE, V340, P60, DOI 10.1126/science.1233638; Stanbury D. M., 1989, ADV INORG CHEM RA, V33, P69, DOI 10.1016/S0898-8838(08)60194-4; Tong L, 2012, ENERG ENVIRON SCI, V5, P9472, DOI 10.1039/c2ee22866a; Trotochaud L, 2012, J AM CHEM SOC, V134, P17253, DOI 10.1021/ja307507a; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Zhang K, 2012, PHYS CHEM CHEM PHYS, V14, P11119, DOI 10.1039/c2cp40991g; Zhong DK, 2011, J AM CHEM SOC, V133, P18370, DOI 10.1021/ja207348x; Zhou M, 2012, CHEMSUSCHEM, V5, P1420, DOI 10.1002/cssc.201200287	37	2119	2143	147	2838	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					990	994		10.1126/science.1246913	http://dx.doi.org/10.1126/science.1246913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24526312				2022-12-28	WOS:000332309600037
J	Nicklin, C				Nicklin, Chris			Capturing Surface Processes	SCIENCE			English	Editorial Material							X-RAY-DIFFRACTION		Diamond Light Source, Didcot OX11 0DE, Oxon, England	Diamond Light Source	Nicklin, C (corresponding author), Diamond Light Source, Beamline I07, Didcot OX11 0DE, Oxon, England.	chris.nicklin@diamond.ac.uk		Nicklin, Christopher/0000-0001-7481-7003				EWALD PP, 1969, ACTA CRYSTALL A-CRYS, VA 25, P103, DOI 10.1107/S0567739469000155; FEIDENHANSL R, 1989, SURF SCI REP, V10, P105, DOI 10.1016/0167-5729(89)90002-2; Grassian VH, 2008, SURF SCI, V602, P2955, DOI 10.1016/j.susc.2008.07.039; Gustafson J, 2014, SCIENCE, V343, P758, DOI 10.1126/science.1246834; ROBINSON IK, 1986, PHYS REV B, V33, P3830, DOI 10.1103/PhysRevB.33.3830; Schleputz CM, 2005, ACTA CRYSTALLOGR A, V61, P418, DOI 10.1107/S0108767305014790; Vlieg E, 1998, J APPL CRYSTALLOGR, V31, P198, DOI 10.1107/S0021889897009990	7	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					739	740		10.1126/science.1250472	http://dx.doi.org/10.1126/science.1250472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531960				2022-12-28	WOS:000331557800027
J	Page, MT; Hough, SE				Page, Morgan T.; Hough, Susan E.			The New Madrid Seismic Zone: Not Dead Yet	SCIENCE			English	Article							EARTHQUAKE; AFTERSHOCKS; DEFORMATION; MAGNITUDES; CHARLESTON; HAZARD; MODELS	The extent to which ongoing seismicity in intraplate regions represents long-lived aftershock activity is unclear. We examined historical and instrumental seismicity in the New Madrid central U. S. region to determine whether present-day seismicity is composed predominantly of aftershocks of the 1811-1812 earthquake sequence. High aftershock productivity is required both to match the observation of multiple mainshocks and to explain the modern level of activity as aftershocks; synthetic sequences consistent with these observations substantially overpredict the number of events of magnitude >= 6 that were observed in the past 200 years. Our results imply that ongoing background seismicity in the New Madrid region is driven by ongoing strain accrual processes and that, despite low deformation rates, seismic activity in the zone is not decaying with time.	[Page, Morgan T.; Hough, Susan E.] US Geol Survey, Pasadena, CA 91106 USA	United States Department of the Interior; United States Geological Survey	Page, MT (corresponding author), US Geol Survey, Pasadena, CA 91106 USA.	pagem@caltech.edu	Page, Morgan/Y-2726-2019	Page, Morgan/0000-0001-9321-2990				Bakun WH, 2004, B SEISMOL SOC AM, V94, P64, DOI 10.1785/0120020122; Calais E, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004253; Coppersmith K. J., 2012, TECHNICAL REPORT; Ebel J. E., 2000, SEISMOL RES LETT, V71, P283, DOI [DOI 10.1785/GSSRL.71.2.283, 10.1785/gssrl.71.2.283]; Felzer KR, 2003, B SEISMOL SOC AM, V93, P1433, DOI 10.1785/0120020229; Felzer KR, 2004, B SEISMOL SOC AM, V94, P88, DOI 10.1785/0120030069; Frankel A, 2012, B SEISMOL SOC AM, V102, P479, DOI 10.1785/0120100219; Galgana GA, 2010, SEISMOL RES LETT, V81, P699, DOI 10.1785/gssrl.81.5.699; Gerstenberger MC, 2010, PURE APPL GEOPHYS, V167, P877, DOI 10.1007/s00024-010-0082-4; Gupta HK, 2001, SCIENCE, V291, P2101, DOI 10.1126/science.1060197; Hough S. E., 2009, SEISMOL RES LETT, V80, P1045, DOI DOI 10.1785/GSSRL.80.6.1045; Hough SE, 2013, B SEISMOL SOC AM, V103, P2767, DOI 10.1785/0120120285; Hough SE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007783; Johnston AC, 1996, GEOPHYS J INT, V126, P314, DOI 10.1111/j.1365-246X.1996.tb05294.x; Llenos AL, 2009, EARTH PLANET SC LETT, V281, P59, DOI 10.1016/j.epsl.2009.02.011; Mueller K, 2004, NATURE, V429, P284, DOI 10.1038/nature02557; NUTTLI OW, 1973, B SEISMOL SOC AM, V63, P227; Ogata Y, 2006, TECTONOPHYSICS, V413, P13, DOI 10.1016/j.tecto.2005.10.016; OGATA Y, 1992, J GEOPHYS RES-SOL EA, V97, P19845, DOI 10.1029/92JB00708; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Stein S, 2009, NATURE, V462, P87, DOI 10.1038/nature08502; Tuttle MP, 2002, B SEISMOL SOC AM, V92, P2080, DOI 10.1785/0120010227; UTSU T, 1995, J PHYS EARTH, V43, P1, DOI 10.4294/jpe1952.43.1; Utsu T., 1961, GEOPHYS MAG, V30, P521, DOI DOI 10.1007/BF01592930	25	35	35	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					762	764		10.1126/science.1248215	http://dx.doi.org/10.1126/science.1248215			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24457216				2022-12-28	WOS:000331557800037
J	Appleby, J				Appleby, John			DATA BRIEFING Do we have too many hospitals? FEATURE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund Inst, London NW1 7NF, England		Appleby, J (corresponding author), Kings Fund Inst, London NW1 7NF, England.	j.appleby@kingsfund.org.uk						[Anonymous], 2014, COMMUNICATION; [Anonymous], 1980, BMJ, Vi, P734; Appleby J, 2010, IMPROVING HLTH HLTH; Health and Social Care Information Centre, 2014, HOSP EST FAC STAT; Kings C., 1970, VIOLENCE; National Savings and Investment, 2014, HIST ERNIE PREM BOND; NHS London, 2007, HEALTHC LOND FRAM AC; OECD, 2014, OECD HLTH STAT 2013; Tomlinson B., 1992, REPORT INQUIRY LONDO	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2014	348								g1374	10.1136/bmj.g1374	http://dx.doi.org/10.1136/bmj.g1374			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WZ	24525094				2022-12-28	WOS:000331445000003
J	Civaner, MM				Civaner, M. Murat			PERSONAL VIEW What should I tell my students now the law contravenes medical ethics?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Uludag Univ, Dept Med Eth, Sch Med, Bursa, Turkey	Uludag University	Civaner, MM (corresponding author), Uludag Univ, Dept Med Eth, Sch Med, Bursa, Turkey.	mcivaner@gmail.com	/S-4188-2019	/0000-0001-5376-3499				Civaner M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3789; Hurriyet Daily News, 2013, HURRIYET DAILY  1211; Iacopino V, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4933; T urkish Medical Association, 2013, REP ASS HLTH PROBL P; Turkish Medical Association, PHYS PROF COD ETH; World Medical Association, DECL GEN; World Medical Association, INT COD MED ETH	7	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2014	348								g1503	10.1136/bmj.g1503	http://dx.doi.org/10.1136/bmj.g1503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WZ	24525052				2022-12-28	WOS:000331445000008
J	Muzaale, AD; Massie, AB; Wang, MC; Montgomery, RA; McBride, MA; Wainright, JL; Segev, DL				Muzaale, Abimereki D.; Massie, Allan B.; Wang, Mei-Cheng; Montgomery, Robert A.; McBride, Maureen A.; Wainright, Jennifer L.; Segev, Dorry L.			Risk of End-Stage Renal Disease Following Live Kidney Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DONORS; MORTALITY; TRANSPLANTATION; GENDER; MEN	IMPORTANCE Risk of end-stage renal disease (ESRD) in kidney donors has been compared with risk faced by the general population, but the general population represents an unscreened, high-risk comparator. A comparison to similarly screened healthy nondonors would more properly estimate the sequelae of kidney donation. OBJECTIVES To compare the risk of ESRD in kidney donors with that of a healthy cohort of nondonors who are at equally low risk of renal disease and free of contraindications to live donation and to stratify these comparisons by patient demographics. DESIGN, SETTINGS, AND PARTICIPANTS A cohort of 96 217 kidney donors in the United States between April 1994 and November 2011 and a cohort of 20 024 participants of the Third National Health and Nutrition Examination Survey (NHANES III) were linked to Centers for Medicare & Medicaid Services data to ascertain development of ESRD, which was defined as the initiation of maintenance dialysis, placement on the waiting list, or receipt of a living or deceased donor kidney transplant, whichever was identified first. Maximum follow-up was 15.0 years; median follow-up was 7.6 years (interquartile range [IQR], 3.9-11.5 years) for kidney donors and 15.0 years (IQR, 13.7-15.0 years) for matched healthy nondonors. MAIN OUTCOMES AND MEASURES Cumulative incidence and lifetime risk of ESRD. RESULTS Among live donors, with median follow-up of 7.6 years (maximum, 15.0), ESRD developed in 99 individuals in a mean (SD) of 8.6 (3.6) years after donation. Among matched healthy nondonors, with median follow-up of 15.0 years (maximum, 15.0), ESRD developed in 36 nondonors in 10.7 (3.2) years, drawn from 17 ESRD events in the unmatched healthy nondonor pool of 9364. Estimated risk of ESRD at 15 years after donation was 30.8 per 10 000 (95% CI, 24.3-38.5) in kidney donors and 3.9 per 10 000 (95% CI, 0.8-8.9) in their matched healthy nondonor counterparts (P < .001). This difference was observed in both black and white individuals, with an estimated risk of 74.7 per 10 000 black donors (95% CI, 47.8-105.8) vs 23.9 per 10 000 black nondonors (95% CI, 1.6-62.4; P < .001) and an estimated risk of 22.7 per 10 000 white donors (95% CI, 15.6-30.1) vs 0.0 white nondonors (P < .001). Estimated lifetime risk of ESRD was 90 per 10 000 donors, 326 per 10 000 unscreened nondonors (general population), and 14 per 10 000 healthy nondonors. CONCLUSIONS AND RELEVANCE Compared with matched healthy nondonors, kidney donors had an increased risk of ESRD over a median of 7.6 years; however, the magnitude of the absolute risk increase was small. These findings may help inform discussions with persons considering live kidney donation.	[Muzaale, Abimereki D.; Massie, Allan B.; Montgomery, Robert A.; Segev, Dorry L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Wang, Mei-Cheng; Segev, Dorry L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [McBride, Maureen A.; Wainright, Jennifer L.] United Network Organ Sharing, Richmond, VA USA; [Segev, Dorry L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United Network for Organ Sharing; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Segev, DL (corresponding author), Johns Hopkins Med Inst, Dept Transplant Surg, 720 Rutland Ave,Ross 771B, Baltimore, MD 21205 USA.	dorry@jhmi.edu			Health Resources and Services Administration [R01DK096008, 234-2005-370011C]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096008] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant R01DK096008 from the Health Resources and Services Administration contract 234-2005-370011C.	Berger JC, 2011, CLIN J AM SOC NEPHRO, V6, P2887, DOI 10.2215/CJN.04160511; BIA MJ, 1995, TRANSPLANTATION, V60, P322, DOI 10.1097/00007890-199508270-00003; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Cherikh WS, 2011, AM J TRANSPLANT, V11, P1650, DOI 10.1111/j.1600-6143.2011.03609.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delmonico FL, 2007, KIDNEY INT, V71, P608, DOI 10.1038/sj.ki.5002125; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fehrman-Ekholm I, 2006, TRANSPLANTATION, V82, P1646, DOI 10.1097/01.tp.0000250728.73268.e3; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P253, DOI 10.1007/s10654-011-9563-8; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Matas AJ, 2003, AM J TRANSPLANT, V3, P830, DOI 10.1034/j.1600-6143.2003.00126.x; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Muzaale AD, 2012, GASTROENTEROLOGY, V142, P273, DOI 10.1053/j.gastro.2011.11.015; Poggio ED, 2009, CLIN J AM SOC NEPHRO, V4, P1677, DOI 10.2215/CJN.02740409; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; US Renal Data Systems, 2007, USRDS 2006 ANNUAL DA; Van Arendonk KJ, 2013, J PEDIATR SURG, V48, P1277, DOI 10.1016/j.jpedsurg.2013.03.023; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wafa EW, 2011, EXP CLIN TRANSPLANT, V9, P14	27	607	618	2	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					579	586		10.1001/jama.2013.285141	http://dx.doi.org/10.1001/jama.2013.285141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519297	Bronze, Green Accepted			2022-12-28	WOS:000330941000013
J	Ohringer, G; Burke, T; Shaikh, A				Ohringer, Guy; Burke, Tomas; Shaikh, Asifa			Unilateral headache and loss of vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANGLE-CLOSURE GLAUCOMA		[Ohringer, Guy] Stoke Mandeville Hosp, Aylesbury HP21 8AL, Bucks, England; [Burke, Tomas; Shaikh, Asifa] Stoke Mandeville Hosp, Dept Ophthalmol, Aylesbury HP21 8AL, Bucks, England		Burke, T (corresponding author), Stoke Mandeville Hosp, Dept Ophthalmol, Aylesbury HP21 8AL, Bucks, England.	tomasburke@nhs.net						Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; SAUNDERS DC, 1990, BRIT J OPHTHALMOL, V74, P523, DOI 10.1136/bjo.74.9.523; Seah SKL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1436, DOI 10.1001/archopht.1997.01100160606014; TEIKARI J, 1987, GRAEF ARCH CLIN EXP, V225, P357, DOI 10.1007/BF02153405	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g1188	10.1136/bmj.g1188	http://dx.doi.org/10.1136/bmj.g1188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496228				2022-12-28	WOS:000331060200001
J	Patton, GC; Ross, DA; Santelli, JS; Sawyer, SM; Viner, RM; Kleinert, S				Patton, George C.; Ross, David A.; Santelli, John S.; Sawyer, Susan M.; Viner, Russell M.; Kleinert, Sabine			Next steps for adolescent health: a Lancet Commission	LANCET			English	Editorial Material									[Patton, George C.; Sawyer, Susan M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth,Dept Paediat, Parkville, Vic 3052, Australia; [Ross, David A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [Santelli, John S.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Viner, Russell M.] UCL, Inst Child Hlth, London, England; [Kleinert, Sabine] The Lancet, London NW1 7BY, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine; Columbia University; University of London; University College London	Patton, GC (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth,Dept Paediat, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Ribeiro, Ana Cristina/HHN-7466-2022; Viner, Russell M/A-1441-2009; Santelli, John/AAG-3046-2021; Patton, George C/B-5246-2013	Ribeiro, Ana Cristina/0000-0002-0493-8376; Viner, Russell M/0000-0003-3047-2247; Patton, George C/0000-0001-5039-8326	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R13HD081897] Funding Source: NIH RePORTER; NICHD NIH HHS [R13 HD081897] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Broutet N, 2013, J ADOLESCENT HEALTH, V53, P6, DOI 10.1016/j.jadohealth.2013.02.022; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Independent Expert Review Group on Information and Accountability, 2013, EV WOM EV CHILD STRE; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; LLOYD CB, 2004, GROWING GLOBAL CHANG; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; UN, 2013, NEW GLOB PARTN ERAD; UNICEF, 2012, PROGR CHILDR REP CAR; United Nations, 1994, INT C POP DEV; United Nations, 2003, WORLD YOUTH REP 2003; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Wiliamson N., 2013, MOTHERHOOD CHILDHOOD; World Bank, 2007, WORLD DEV REP 2007 D; World Health Organization, 1986, YOUNG PEOPL HLTH CHA; World Health Organization, 1999, TECHNICAL REPORT SER	17	42	44	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					385	386		10.1016/S0140-6736(14)60039-8	http://dx.doi.org/10.1016/S0140-6736(14)60039-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24485572				2022-12-28	WOS:000330673700005
J	Crossfield, IJM; Biller, B; Schlieder, JE; Deacon, NR; Bonnefoy, M; Homeier, D; Allard, F; Buenzli, E; Henning, T; Brandner, W; Goldman, B; Kopytova, T				Crossfield, I. J. M.; Biller, B.; Schlieder, J. E.; Deacon, N. R.; Bonnefoy, M.; Homeier, D.; Allard, F.; Buenzli, E.; Henning, Th.; Brandner, W.; Goldman, B.; Kopytova, T.			A global cloud map of the nearest known brown dwarf	NATURE			English	Article							ATMOSPHERIC DYNAMICS; INFRARED-SPECTRA; STELLAR SURFACES; CARBON-MONOXIDE; 2 PC; TEMPERATURE; CO; BINARY; BAND; TRANSPORT	Brown dwarfs-substellar bodies more massive than planets but not massive enough to initiate the sustained hydrogen fusion that powers self-luminous stars(1,2)-are born hot and slowly cool as they age. As they cool below about 2,300 kelvin, liquid or crystalline particles composed of calcium aluminates, silicates and iron condense into atmospheric 'dust'(3,4), which disappears at still cooler temperatures (around 1,300 kelvin)(5,6). Models to explain this dust dispersal include both an abrupt sinking of the entire cloud deck into the deep, unobservable atmosphere(5,7) and breakup of the cloud into scattered patches(6,8) (as seen on Jupiter and Saturn(9)). However, hitherto observations of brown dwarfs have been limited to globally integrated measurements(10), which can reveal surface inhomogeneities but cannot unambiguously resolve surface features(11). Here we report a two-dimensional map of a brown dwarf's surface that allows identification of large-scale bright and dark features, indicative of patchy clouds. Monitoring suggests that the characteristic timescale for the evolution of global weather patterns is approximately one day.	[Crossfield, I. J. M.; Biller, B.; Schlieder, J. E.; Deacon, N. R.; Bonnefoy, M.; Buenzli, E.; Henning, Th.; Brandner, W.; Goldman, B.; Kopytova, T.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Biller, B.] Univ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Bonnefoy, M.] UJF Grenoble 1, CNRS INSU, UMR5274, IPAG, F-38041 Grenoble, France; [Homeier, D.; Allard, F.] CRAL ENS, F-69364 Lyon 07, France; [Kopytova, T.] Heidelberg Univ, Int Max Planck Res Sch Astron & Cosm Phys, D-69117 Heidelberg, Germany	Max Planck Society; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Max Planck Society; Ruprecht Karls University Heidelberg	Crossfield, IJM (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	ianc@mpia.de	Henning, Thomas K/O-4372-2018; Brandner, Wolfgang/AFR-1606-2022	Henning, Thomas K/0000-0002-1493-300X; Brandner, Wolfgang/0000-0003-1939-6351; Kopytova, Taisiya/0000-0002-5723-9763; Homeier, Derek/0000-0002-8546-9128; Buenzli, Esther/0000-0003-3306-1486; Goldman, Bertrand/0000-0002-2729-7276	European Research Council under the European Community [247060]; French National Research Agency (ANR) [ANR10-BLANC0504-01]; Swiss National Science Foundation (SNSF); European Southern Observatory Telescopes at the Paranal Observatory [ID 291.C-5006(A)]	European Research Council under the European Community(European Research Council (ERC)); French National Research Agency (ANR)(French National Research Agency (ANR)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Southern Observatory Telescopes at the Paranal Observatory	We thank A. Hatzes for advice on Doppler imaging analysis, J. Smoker for helping to plan and execute our observations and E. Mills for help in designing figures. This work is based on Director's Discretionary observations made with the European Southern Observatory Telescopes at the Paranal Observatory under programme ID 291.C-5006(A); data are available in the European Southern Observatory Data Archive at http://archive.eso.org/. D.H. received support from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 Grant Agreement number 247060). M.B., D.H. and F.A. acknowledge support from the French National Research Agency (ANR) through project grant ANR10-BLANC0504-01. E.B. is supported by the Swiss National Science Foundation (SNSF). Atmosphere models have been computed on the Pole Scientifique de Modelisation Numerique at the Ecole Normale Superieure (ENS) de Lyon, and at the Gesellschaft fur Wissenschaftliche Datenverarbeitung Gottingen in co-operation with the Institut fur Astrophysik Gottingen. IRAF (the Image Reduction and Analysis Facility) is distributed by the National Optical Astronomy Observatory, which is operated by the Association of Universities for Research in Astronomy (AURA) under cooperative agreement with the National Science Foundation. PyRAF (Python-based IRAF) is a product of the Space Telescope Science Institute, which is operated by AURA for NASA. We also thank contributors to SciPy, Matplotlib, AstroPy and the Python programming language.	Ackerman AS, 2001, ASTROPHYS J, V556, P872, DOI 10.1086/321540; Agundez M, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220365; Allard F, 2013, MEMORIE SOC ASTRON S, V24, P128; Apai D, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/121; Artigau E., 2011, ASP C SER, V448, P771; Bean JL, 2010, ASTROPHYS J, V713, P410, DOI 10.1088/0004-637X/713/1/410; BECKLIN EE, 1988, NATURE, V336, P656, DOI 10.1038/336656a0; Biller BA, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L10; Blake CH, 2007, ASTROPHYS J, V666, P1198, DOI 10.1086/520124; BOUANICH JP, 1972, J QUANT SPECTROSC RA, V12, P1609, DOI 10.1016/0022-4073(72)90102-1; Buenzli E, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L31; Burgasser AJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/129; Burgasser AJ, 2002, ASTROPHYS J, V571, pL151, DOI 10.1086/341343; Burrows A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/47; Cho JYK, 2003, ASTROPHYS J, V587, pL117, DOI 10.1086/375016; Collier Cameron A., 1995, MON NOT R ASTRON SOC, V269, P814; de Wit J, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219060; Devi VM, 2012, J QUANT SPECTROSC RA, V113, P1013, DOI 10.1016/j.jqsrt.2012.02.010; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P658, DOI 10.1093/mnras/291.4.658; DRAEGERT DA, 1968, J OPT SOC AM, V58, P1399, DOI 10.1364/JOSA.58.001399; Dupuy TJ, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/122; Faure A, 2013, J QUANT SPECTROSC RA, V116, P79, DOI 10.1016/j.jqsrt.2012.09.015; Fletcher LN, 2009, ICARUS, V200, P154, DOI 10.1016/j.icarus.2008.11.019; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Freytag B, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913354; Freytag B., 2011, ASP C SER, V448, P855; Gillon M, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321620; Grey D. F., 2005, OBSERVATION ANAL STE; Hinkle K. H., 2003, BAAS, V35, P1260; Jones HRA, 2005, MON NOT R ASTRON SOC, V358, P105, DOI 10.1111/j.1365-2966.2005.08736.x; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Kirkpatrick JD, 1999, ASTROPHYS J, V519, P802, DOI 10.1086/307414; Kniazev AY, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/124; Konopacky QM, 2010, ASTROPHYS J, V711, P1087, DOI 10.1088/0004-637X/711/2/1087; KUMAR SS, 1963, ASTROPHYS J, V137, P1121, DOI 10.1086/147589; Luhman KL, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L1; LUNINE JI, 1986, ASTROPHYS J, V310, P238, DOI 10.1086/164678; Majeau C, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L20; NARAYAN R, 1986, ANNU REV ASTRON ASTR, V24, P127, DOI 10.1146/annurev.aa.24.090186.001015; Predoi-Cross A, 2000, J CHEM PHYS, V113, P158, DOI 10.1063/1.481783; Rice JB, 2000, ASTRON ASTROPHYS SUP, V147, P151, DOI 10.1051/aas:2000366; Rice JB, 2002, ASTRON NACHR, V323, P220, DOI 10.1002/1521-3994(200208)323:3/4<220::AID-ASNA220>3.0.CO;2-P; RICE JB, 1989, ASTRON ASTROPHYS, V208, P179; Schweitzer A, 2002, ASTROPHYS J, V566, P435, DOI 10.1086/338035; Showman AP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/85; Tsuji T, 2004, ASTROPHYS J, V607, P511, DOI 10.1086/383300; UNRUH YC, 1995, MON NOT R ASTRON SOC, V273, P1; Vasavada AR, 2005, REP PROG PHYS, V68, P1935, DOI 10.1088/0034-4885/68/8/R06; Vogt S. S, 1988, IMPACT VERY HIGH S N, P253; VOGT SS, 1987, ASTROPHYS J, V321, P496, DOI 10.1086/165647; Wheelwright HE, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116996	52	107	107	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					654	+		10.1038/nature12955	http://dx.doi.org/10.1038/nature12955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476888	Green Submitted			2022-12-28	WOS:000330321000034
J	Finch, CE; Tower, J				Finch, Caleb E.; Tower, John			Sex-Specific Aging in Flies, Worms, and Missing Great-Granddads	CELL			English	Editorial Material							ANTAGONISTIC PLEIOTROPY; DISEASE; P53	Two recent studies identify how sex-specific pheromonal factors in flies and worms alter lifespan through metabolic pathways that are shared with mammals. Sex differences in human lifespans imply nonautonomous effects modulated by sex-specific gene-environment interactions that could still include pheromonal mechanisms.	[Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Finch, CE (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	cefinch@usc.edu; jtower@usc.edu	Finch, Caleb/AAA-7250-2022		NATIONAL INSTITUTE ON AGING [R21AG040753, P01AG026572] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011833, AG040753, AG026572, R21 AG040753, P01 AG026572] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Di Pietro F, 2013, J GERONTOL A-BIOL, V68, P539, DOI 10.1093/gerona/gls223; Gendron C. M., 2013, SCIENCE; Hoskison EE, 2013, J LARYNGOL OTOL, V127, P1156, DOI 10.1017/S0022215113002545; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Maures T. J., 2013, SCIENCE; Ross JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038425; Shen J, 2013, CELL CYCLE, V12, P3237, DOI 10.4161/cc.26354; Tower J, 2010, CELL CYCLE, V9, P3840, DOI 10.4161/cc.9.19.13464; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Waskar M, 2009, AGING-US, V1, P903, DOI 10.18632/aging.100099; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	12	5	5	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					398	399		10.1016/j.cell.2014.01.028	http://dx.doi.org/10.1016/j.cell.2014.01.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485449	Green Accepted, Bronze			2022-12-28	WOS:000330580800007
J	Kaufmann, A; Beier, V; Franquelim, HG; Wollert, T				Kaufmann, Anna; Beier, Viola; Franquelim, Henri G.; Wollert, Thomas			Molecular Mechanism of Autophagic Membrane-Scaffold Assembly and Disassembly	CELL			English	Article							VACUOLE TARGETING PATHWAY; FAMILY INTERACTING MOTIF; ATG12-ATG5 CONJUGATE; PROTEIN LIPIDATION; YEAST AUTOPHAGY; ATG8; CYTOPLASM; COMPLEX; BINDING; MACROAUTOPHAGY	Autophagy is a catabolic pathway that sequesters undesired cellular material into autophagosomes for delivery to lysosomes for degradation. A key step in the pathway is the covalent conjugation of the ubiquitin-related protein Atg8 to phosphatidylethanolamine (Atg8-PE) in autophagic membranes by a complex consisting of Atg16 and the Atg12Atg5 conjugate. Atg8 controls the expansion of autophagic precursor membranes, but the underlying mechanism remains unclear. Here, we reconstitute Atg8 conjugation on giant unilamellar vesicles and supported lipid bilayers. We found that Atg8-PE associates with Atg12-Atg5-Atg16 into a membrane scaffold. By contrast, scaffold formation is counteracted by the mitochondrial cargo adaptor Atg32 through competition with Atg12-Atg5 for Atg8 binding. Atg4, previously known to recycle Atg8 from membranes, disassembles the scaffold. Importantly, mutants of Atg12 and Atg16 deficient in scaffold formation in vitro impair autophagy in vivo. This suggests that autophagic scaffolds are critical for phagophore biogenesis and thus autophagy.	[Kaufmann, Anna; Beier, Viola; Franquelim, Henri G.; Wollert, Thomas] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Wollert, T (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	wollert@biochem.mpg.de	Franquelim, Henri/P-4985-2017	Franquelim, Henri/0000-0001-6229-4276; Wollert, Thomas/0000-0001-9732-4789	Max Planck Society	Max Planck Society(Max Planck Society)	We thank Petra Schwille for access to the AFM; Reinhard Fassler for access to microscopes; Roland Wedlich-Soldner for access to microscopes, yeast strains, vectors, technical advice, and helpful discussion; Felix Spira and Nikola Muller for Matlab scripts to evaluate FRAP data; Elisabeth WeyherStingl for electrospray ionization mass spectrometry analysis; Nena Matscheko for providing purified Atg32; and Michael Thumm for providing reagents. We also thank Stefan Jentsch for critically reading the manuscript. This work was funded by the Max Planck Society (T. W.).	Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Geng JF, 2008, J CELL BIOL, V182, P129, DOI 10.1083/jcb.200711112; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nakatogawa H, 2012, METHODS MOL BIOL, V832, P519, DOI 10.1007/978-1-61779-474-2_37; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	35	160	165	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					469	481		10.1016/j.cell.2013.12.022	http://dx.doi.org/10.1016/j.cell.2013.12.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485455	Bronze			2022-12-28	WOS:000330580800014
J	Smith, A				Smith, Austin			CELL BIOLOGY Potency unchained	NATURE			English	Editorial Material							SEE VOL. 511; PG. 112; PLURIPOTENCY		[Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk						Gilbert S. F, 2009, DEV BIOL; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; HOLTFRETER J, 1947, J EXP ZOOL, V106, P197, DOI 10.1002/jez.1401060205; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; Obokata H, 2014, NATURE, V505, P676, DOI 10.1038/nature12969; Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stuart H. T., 2014, CURR BIOL; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022	11	4	4	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					622	623		10.1038/505622a	http://dx.doi.org/10.1038/505622a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476883	Bronze			2022-12-28	WOS:000330321000026
J	Arnold, C				Arnold, Carrie			Funding: Ludwig trust gives its final gift to cancer research	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					296	296		10.1016/S0140-6736(14)60091-X	http://dx.doi.org/10.1016/S0140-6736(14)60091-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24475482				2022-12-28	WOS:000330212600014
J	Barbier, EB; Moreno-Mateos, D; Rogers, AD; Aronson, J; Pendleton, L; Danovaro, R; Henry, LA; Morato, T; Ardron, J; Van Dover, CL				Barbier, Edward B.; Moreno-Mateos, David; Rogers, Alex D.; Aronson, James; Pendleton, Linwood; Danovaro, Roberto; Henry, Lea-Anne; Morato, Telmo; Ardron, Jeff; Van Dover, Cindy L.			Protect the deep sea	NATURE			English	Editorial Material									[Barbier, Edward B.] Univ Wyoming, Laramie, WY 82071 USA; [Moreno-Mateos, David; Aronson, James] CNRS Ctr Evolutionary & Funct Ecol, Montpellier, France; [Rogers, Alex D.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England; [Aronson, James] Missouri Bot Garden, St Louis, MO USA; [Pendleton, Linwood] Duke Univ, Nicholas Inst Environm Policy Solut, Ocean & Coastal Policy Program, Durham, NC USA; [Danovaro, Roberto] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Danovaro, Roberto] Anton Dohrn Zool Stn, Naples, Italy; [Henry, Lea-Anne] Heriot Watt Univ, Sch Life Sci, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland; [Morato, Telmo] Univ Azores, Dept Oceanog & Fisheries, Inst Marine Res, Horta, Portugal; [Ardron, Jeff] Inst Adv Sustainabil Studies, Potsdam, Germany; [Van Dover, Cindy L.] Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC USA	University of Wyoming; Centre National de la Recherche Scientifique (CNRS); University of Oxford; Missouri Botanical Gardens; Duke University; Marche Polytechnic University; Stazione Zoologica Anton Dohrn di Napoli; Heriot Watt University; Universidade dos Acores; Duke University	Barbier, EB (corresponding author), Univ Wyoming, Laramie, WY 82071 USA.	ebarbier@uwyo.edu	Mateos, David Moreno/J-5626-2014; Ardron, Jeff/ABI-7397-2020; Morato, Telmo/A-4548-2009	Mateos, David Moreno/0000-0002-1539-5848; Morato, Telmo/0000-0003-2393-4773; Van Dover, Cindy/0000-0001-9845-8391				Dahl M., 2013, 5 U GOTH; Jobstvogt N, 2014, ECOL ECON, V97, P10, DOI 10.1016/j.ecolecon.2013.10.019; Priede IG, 2011, ICES J MAR SCI, V68, P281, DOI 10.1093/icesjms/fsq045; Ressurreicao A, 2011, ECOL ECON, V70, P729, DOI 10.1016/j.ecolecon.2010.11.009; Sandrea R, 2010, OIL GAS J, V108, P48; Stromberg SM, 2010, J EXP MAR BIOL ECOL, V395, P153, DOI 10.1016/j.jembe.2010.08.028; Sumaila UR, 2010, MAR POLICY, V34, P495, DOI 10.1016/j.marpol.2009.10.004; Van Dover CL, 2014, MAR POLICY, V44, P98, DOI 10.1016/j.marpol.2013.07.006; Van Dover CL, 2011, NATURE, V470, P31, DOI 10.1038/470031a; Wattage P, 2011, FISH RES, V107, P59, DOI 10.1016/j.fishres.2010.10.007	10	78	79	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					475	477		10.1038/505475a	http://dx.doi.org/10.1038/505475a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	293SW	24459714	Bronze			2022-12-28	WOS:000329995000012
J	Meijer, CA; Stijnen, T; Wasser, MNJM; Hamming, JF; van Bockel, H; Lindeman, JHN				Meijer, C. Arnoud; Stijnen, Theo; Wasser, Martin N. J. M.; Hamming, Jaap F.; van Bockel, Hajo; Lindeman, Jan H. N.		Pharmaceutical Aneurysm	Doxycycline for Stabilization of Abdominal Aortic Aneurysms A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MATRIX METALLOPROTEINASES; ULTRASOUND MEASUREMENT; RISK-FACTORS; SURVEILLANCE; GROWTH; INHIBITION; REPAIR; REPRODUCIBILITY; TETRACYCLINES; MANAGEMENT	Background: Doxycycline inhibits formation and progression of abdominal aortic aneurysms (AAAs) in preclinical models of the disease, but it is unclear whether and how this observation translates to humans. Objective: To test whether doxycycline inhibits AAA progression in humans. Design: Randomized, placebo-controlled, double-blind trial. (Dutch Trial Registry: NTR 1345) Setting: 14 Dutch hospitals. Patients: 286 patients with small AAAs between October 2008 and June 2011. Intervention: Daily dose of 100 mg of doxycycline (n = 144) or placebo (n = 142) for 18 months. Measurements: The primary outcome measure was aneurysm growth at 18 months, as estimated by repeated single-observer ultrasonography. Secondary outcomes included growth at 6 and 12 months and the need for elective surgery. Results: Mean aneurysm diameter (approximately 43 mm) and other baseline characteristics were similar in both groups. Doxycycline treatment was associated with increased aneurysm growth (4.1 mm in the doxycycline group vs. 3.3 mm in the placebo group at 18 months; difference, 0.8 mm [95% CI, 0.1 to 1.4 mm]; P = 0.016 mm). Twenty-one patients receiving doxycycline and 22 patients receiving placebo had elective surgical repair (Kaplan-Meier estimates were 16.1% for those receiving doxycycline and 16.5% for those receiving placebo; difference, -0.4% [CI, -9.3% to 8.5%]; P = 0.83). Time to repair was similar in the groups (P = 0.92). Limitations: This study focuses on patients with small AAAs. As such, whether the data can be extrapolated to larger AAAs (>55 mm) is unclear. The high number of elective repairs (n = 43) was unanticipated. Moreover, the study did not follow patients who withdrew because of an adverse effect. Conclusion: This trial found that 18 months of doxycycline therapy did not reduce aneurysm growth and did not influence the need for AAA repair or time to repair.	[Meijer, C. Arnoud; Stijnen, Theo; Wasser, Martin N. J. M.; Hamming, Jaap F.; van Bockel, Hajo; Lindeman, Jan H. N.; Pharmaceutical Aneurysm] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lindeman, JHN (corresponding author), Leiden Univ, Med Ctr, Dept Vasc Surg, POB 9600, NL-2300 RC Leiden, Netherlands.	Lindeman@LUMC.nl	wasser, martin/GQR-0503-2022	wasser, martin/0000-0002-7020-5242; Meijer, Arnoud/0000-0001-5521-1575	Netherlands Organisation for Health Research and Development; NutsOhra Fund	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NutsOhra Fund	Primary Funding Source: The Netherlands Organisation for Health Research and Development, and the NutsOhra Fund.	AKKERSDIJK GJM, 1994, BRIT J SURG, V81, P376, DOI 10.1002/bjs.1800810317; Aziz F, 2007, ANN VASC SURG, V21, P392, DOI 10.1016/j.avsg.2006.11.001; Bartoli MA, 2006, ANN VASC SURG, V20, P228, DOI 10.1007/s10016-006-9017-z; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Beales L, 2011, BRIT J SURG, V98, P1517, DOI 10.1002/bjs.7628; Bergqvist D, 2011, EUR J VASC ENDOVASC, V41, P663, DOI 10.1016/j.ejvs.2011.01.009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Cao P, 2005, EUR J VASC ENDOVASC, V30, P245, DOI 10.1016/j.ejvs.2005.05.043; Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7; Dodd BR, 2011, CURR VASC PHARMACOL, V9, P471; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Hartshorne TC, 2011, EUR J VASC ENDOVASC, V42, P195, DOI 10.1016/j.ejvs.2011.02.030; Kauffmann C, 2012, EUR J RADIOL, V81, P1688, DOI 10.1016/j.ejrad.2011.04.044; Kloppenburg M, 1996, ANTIMICROB AGENTS CH, V40, P934, DOI 10.1128/AAC.40.4.934; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Manning BJ, 2009, J VASC SURG, V50, P263, DOI 10.1016/j.jvs.2009.02.243; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Monk E, 2011, PHARMACOL RES, V63, P130, DOI 10.1016/j.phrs.2010.10.007; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Ouriel K, 2009, J VASC SURG, V49, P266, DOI 10.1016/j.jvs.2008.11.048; Panel on Handling Missing Data in Clinical Trials, 2010, PREV TREATM MISS DAT; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Powell JT, 2011, BRIT J SURG, V98, P609, DOI 10.1002/bjs.7465; Powell JT, 2003, NEW ENGL J MED, V348, P1895, DOI 10.1056/NEJMcp012641; Powell JT, 1998, LANCET, V352, P1649; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1, DOI 10.1201/b12208; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Thompson Robert W, 2002, Curr Probl Surg, V39, P110, DOI 10.1067/msg.2002.121421; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Verbeke G, 2009, SPRINGER SER STAT, P1; 2002, J VASC SURG, V35, P72	42	142	144	2	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					815	+		10.7326/0003-4819-159-12-201312170-00007	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24490266				2022-12-28	WOS:000329735300014
J	Finnerup, NB; Baastrup, C				Finnerup, Nanna Brix; Baastrup, Cathrine			Angiotensin II: from blood pressure to pain control	LANCET			English	Editorial Material							NEUROPATHIC PAIN; RECEPTOR		[Finnerup, Nanna Brix; Baastrup, Cathrine] Aarhus Univ, Danish Pain Res Ctr, DK-8000 Aarhus C, Denmark	Aarhus University	Finnerup, NB (corresponding author), Aarhus Univ, Danish Pain Res Ctr, DK-8000 Aarhus C, Denmark.	finnerup@ki.au.dk	Finnerup, Nanna Brix/ABA-8219-2020	Finnerup, Nanna Brix/0000-0001-5541-0240				Cepeda MS, 2012, PAIN MED, V13, P575, DOI 10.1111/j.1526-4637.2012.01340.x; Chakrabarty A, 2013, J PAIN, V14, P1053, DOI 10.1016/j.jpain.2013.04.002; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Goldstein DJ, 2001, CLIN NEUROPHARMACOL, V24, P16, DOI 10.1097/00002826-200101000-00004; Kalliomaki J, 2013, SCAND J PAIN, V4, P77, DOI 10.1016/j.sjpain.2012.10.003; Ostenfeld T, 2013, EUR J PAIN, V17, P844, DOI 10.1002/j.1532-2149.2012.00256.x; Rice ASC, 2014, LANCET; Smith MT, 2013, PAIN MED, V14, P1557, DOI 10.1111/pme.12157; Steckelings UM, 2005, PEPTIDES, V26, P1401, DOI 10.1016/j.peptides.2005.03.010; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008	11	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1613	1614		10.1016/S0140-6736(13)62638-0	http://dx.doi.org/10.1016/S0140-6736(13)62638-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24507378				2022-12-28	WOS:000335670800005
J	Greenhawt, MJ				Greenhawt, Matthew J.			STOPping peanut allergy: the saga of food oral immunotherapy	LANCET			English	Editorial Material									Univ Michigan, Food Allergy Ctr, Div Allergy & Clin Immunol, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Greenhawt, MJ (corresponding author), Univ Michigan, Food Allergy Ctr, Div Allergy & Clin Immunol, Ann Arbor, MI 48106 USA.	mgreenha@med.umich.edu		Greenhawt, Matthew/0000-0002-2365-9372				Anagnostou K, 2011, CLIN EXP ALLERGY, V41, P1273, DOI 10.1111/j.1365-2222.2011.03699.x; Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Blumchen K, 2010, J ALLERGY CLIN IMMUN, V126, P83, DOI 10.1016/j.jaci.2010.04.030; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; EAACI, 2013, FOOD ALL AN PUBL DEC; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hofmann AM, 2009, J ALLERGY CLIN IMMUN, V124, P286, DOI 10.1016/j.jaci.2009.03.045; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Keet CA, 2013, J ALLERGY CLIN IMMUN, V132, P737, DOI 10.1016/j.jaci.2013.05.006; Moran TP, 2013, CURR OPIN IMMUNOL, V25, P781, DOI 10.1016/j.coi.2013.07.011; Narisety SD, 2009, J ALLERGY CLIN IMMUN, V124, P610, DOI 10.1016/j.jaci.2009.06.025; Sampson HA, 2013, J ALLER CL IMM-PRACT, V1, P15, DOI 10.1016/j.jaip.2012.10.009; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111	15	8	9	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1272	1274		10.1016/S0140-6736(13)62671-9	http://dx.doi.org/10.1016/S0140-6736(13)62671-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24485710	hybrid			2022-12-28	WOS:000334104900005
J	Gudzune, KA; Monroe, AK; Sharma, R; Ranasinghe, PD; Chelladurai, Y; Robinson, KA				Gudzune, Kimberly A.; Monroe, Anne K.; Sharma, Ritu; Ranasinghe, Padmini D.; Chelladurai, Yohalakshmi; Robinson, Karen A.			Effectiveness of Combination Therapy With Statin and Another Lipid-Modifying Agent Compared With Intensified Statin Monotherapy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							DENSITY-LIPOPROTEIN-CHOLESTEROL; LOWERING TREATMENT STRATEGIES; EZETIMIBE/SIMVASTATIN 10/20 MG; TYPE-2 DIABETES-MELLITUS; EXTENDED-RELEASE NIACIN; CORONARY-HEART-DISEASE; ATORVASTATIN 20 MG; LDL-CHOLESTEROL; COMPARATIVE EFFICACY; DOUBLE-BLIND	Background: Some patients do not tolerate or respond to high-intensity statin monotherapy. Lower-intensity statin combined with nonstatin medication may be an alternative, but the benefits and risks compared with those of higher-intensity statin monotherapy are unclear. Purpose: To compare the clinical benefits, adherence, and harms of lower-intensity statin combination therapy with those of higher-intensity statin monotherapy among adults at high risk for atherosclerotic cardiovascular disease (ASCVD). Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to July 2013, with an updated MEDLINE search through November 2013. Study Selection: Randomized, controlled trials published in English. Data Extraction: Two reviewers extracted information on study design, population characteristics, interventions, and outcomes (deaths, ASCVD events, low-density lipoprotein [LDL] cholesterol level, adherence, and adverse events). Two independent reviewers assessed risk of bias. Data Synthesis: A total of 36 trials were included. Low-intensity statin plus bile acid sequestrant decreased LDL cholesterol level 0% to 14% more than mid-intensity monotherapy among high-risk hyperlipidemic patients. Mid-intensity statin plus ezetimibe decreased LDL cholesterol level 5% to 15% and 3% to 21% more than high-intensity monotherapy among patients with ASCVD and diabetes mellitus, respectively. Evidence was insufficient to evaluate LDL cholesterol for fibrates, niacin, and omega-3 fatty acids. Evidence was insufficient for long-term clinical outcomes, adherence, and harms for all regimens. Limitation: Many trials had short durations and high attrition rates, lacked blinding, and did not assess long-term clinical benefits or harms. Conclusion: Clinicians could consider using lower-intensity statin combined with bile acid sequestrant or ezetimibe among high-risk patients intolerant of or unresponsive to statins; however, this strategy should be used with caution given the lack of evidence on long-term clinical benefits and harms.	Johns Hopkins Univ, Sch Med, Johns Hopkins Med Inst, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gudzune, KA (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 East Monument St,Room 2-611, Baltimore, MD 21287 USA.	gudzune@jhu.edu			Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA290201200007I]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under contract HHSA290201200007I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.	[Anonymous], 1993, Arch Intern Med, V153, P1321; Araujo DB, 2010, J CARDIOVASC PHARM, V55, P1, DOI 10.1097/FJC.0b013e3181bfb1a2; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Athyros VG, 2002, J CARDIOVASC RISK, V9, P33, DOI 10.1097/00043798-200202000-00005; Averna M, 2010, J CLIN LIPIDOL, V4, P272, DOI 10.1016/j.jacl.2010.05.002; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BARBI G, 1992, DRUG DEVELOP RES, V27, P297, DOI 10.1002/ddr.430270309; Bardini G, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-20; Barrios V, 2005, INT J CLIN PRACT, V59, P1377, DOI 10.1111/j.1368-5031.2005.00714.x; Bays Harold E, 2003, Prev Cardiol, V6, P179, DOI 10.1111/j.1520-037X.2003.03142.x; Bays HE, 2013, AM J CARDIOL, V112, P1885, DOI 10.1016/j.amjcard.2013.08.031; Ben-Yehuda O, 2011, J GERIATR CARDIOL, V8, P1, DOI 10.3724/SP.J.1263.2011.00001; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Cho YK, 2011, KOREAN CIRC J, V41, P149, DOI 10.4070/kcj.2011.41.3.149; Constance C, 2007, DIABETES OBES METAB, V9, P575, DOI 10.1111/j.1463-1326.2007.00725.x; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Farnier M, 2011, CLIN THER, V33, P1, DOI 10.1016/j.clinthera.2011.02.006; Foody JM, 2010, AM J CARDIOL, V106, P1255, DOI 10.1016/j.amjcard.2010.06.051; Gaudiani LM, 2005, DIABETES OBES METAB, V7, P88, DOI 10.1111/j.1463-1326.2004.00420.x; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldberg RB, 2006, MAYO CLIN PROC, V81, P1579, DOI 10.4065/81.12.1579; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guyton JR, 2008, J CLIN LIPIDOL, V2, P19, DOI 10.1016/j.jacl.2007.12.004; Hamdan Righab, 2011, J Med Liban, V59, P65; Higgins JPT, 2011, COCHRANE HANDBOOK FO; Hou R, 2009, ENDOCRIN METAB CLIN, V38, P79, DOI 10.1016/j.ecl.2008.11.007; Hunninghake DB, 2003, CLIN CARDIOL, V26, P112, DOI 10.1002/clc.4960260304; Insull W, 2004, ARCH INTERN MED, V164, P1121, DOI 10.1001/archinte.164.10.1121; ISMAIL F, 1990, CLIN THER, V12, P427; Jacobson TA, 2007, AM J CARDIOL, V99, p47C, DOI 10.1016/j.amjcard.2006.11.022; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jimenez JG, 2013, DIABETES OBES METAB, V15, P513, DOI 10.1111/dom.12059; JOHANSSON J, 1995, NUTR METAB CARDIOVAS, V5, P39; Jones PH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001800; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kawagoe Y, 2011, ENDOCR J, V58, P171, DOI 10.1507/endocrj.K10E-289; Knapp HH, 2001, AM J MED, V110, P352, DOI 10.1016/S0002-9343(01)00638-6; Lee JH, 2013, AM J CARDIOVASC DRUG, V13, P343, DOI 10.1007/s40256-013-0031-6; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Maggo SDS, 2011, DRUG SAFETY, V34, P1, DOI 10.2165/11584380-000000000-00000; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; Matsue Y, 2013, CIRC J, V77, P1791, DOI 10.1253/circj.CJ-13-0033; McKenney JM, 2007, ATHEROSCLEROSIS, V192, P432, DOI 10.1016/j.atherosclerosis.2006.11.037; Monroe AK, 2013, PREPARED BY THE JHU; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Okada K, 2011, CIRC J, V75, P2496, DOI 10.1253/circj.CJ-11-0391; Ostad MA, 2009, ATHEROSCLEROSIS, V205, P227, DOI 10.1016/j.atherosclerosis.2008.11.032; PAZZUCCONI F, 1995, ATHEROSCLEROSIS, V117, P189, DOI 10.1016/0021-9150(95)05571-D; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Pesaro AEP, 2013, J CARDIOVASC PHARM T, V18, P447, DOI 10.1177/1074248413489771; Pesaro AEP, 2012, INT J CARDIOL, V158, P400, DOI 10.1016/j.ijcard.2011.01.062; Piorkowski M, 2007, J AM COLL CARDIOL, V49, P1035, DOI 10.1016/j.jacc.2006.10.064; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Rosen JB, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-103; Rosen JB, 2013, DIABETES VASC DIS RE, V10, P277, DOI 10.1177/1479164112465212; Rudofsky G, 2012, ATHEROSCLEROSIS, V223, P190, DOI 10.1016/j.atherosclerosis.2012.04.003; SCHROTT HG, 1995, AM J CARDIOL, V75, P34, DOI 10.1016/S0002-9149(99)80523-2; Shah Hetal D, 2007, Exp Clin Cardiol, V12, P91; Sharma M, 2009, ANN INTERN MED, V151, P622, DOI 10.7326/0003-4819-151-9-200911030-00144; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tomassini JE, 2009, DIABETES OBES METAB, V11, P855, DOI 10.1111/j.1463-1326.2009.01061.x; Torimoto K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-137; van Lennep HWOR, 2008, CURR MED RES OPIN, V24, P685, DOI [10.1185/030079908X273273, 10.1185/03007990SX273273]; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; Yamazaki D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-9; Zieve F, 2010, AM J CARDIOL, V105, P656, DOI 10.1016/j.amjcard.2009.10.029	73	47	51	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					468	+		10.7326/M13-2526	http://dx.doi.org/10.7326/M13-2526			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24514899				2022-12-28	WOS:000334093800004
J	Downs, J; Good, C				Downs, John; Good, Chester			New Cholesterol Guidelines: Has Godot Finally Arrived?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; Univ Pittsburgh, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Downs, J (corresponding author), South Texas Vet Hlth Care Syst, Med Serv 111, 7400 Merton Minter, San Antonio, TX 78229 USA.	john.downs@va.gov	Good, Chester B/K-2818-2019	Good, Chester B/0000-0003-4388-4558				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Kolata G., 2013, NY TIMES; Stone NJ., 2014, J AM COLL CARDIOL, V63, P2889	9	13	13	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					354	+		10.7326/M13-2850	http://dx.doi.org/10.7326/M13-2850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24473934				2022-12-28	WOS:000332793900008
J	Hyde, JL; Gardner, CL; Kimura, T; White, JP; Liu, G; Trobaugh, DW; Huang, C; Tonelli, M; Paessler, S; Takeda, K; Klimstra, WB; Amarasinghe, GK; Diamond, MS				Hyde, Jennifer L.; Gardner, Christina L.; Kimura, Taishi; White, James P.; Liu, Gai; Trobaugh, Derek W.; Huang, Cheng; Tonelli, Marco; Paessler, Slobodan; Takeda, Kiyoshi; Klimstra, William B.; Amarasinghe, Gaya K.; Diamond, Michael S.			A Viral RNA Structural Element Alters Host Recognition of Nonself RNA	SCIENCE			English	Article							VENEZUELAN EQUINE ENCEPHALITIS; MESSENGER-RNA; ALPHA/BETA-INTERFERON; NUCLEOTIDE; PROTEIN; REGION; IFIT; NEUROVIRULENCE; ATTENUATION; SEQUENCE	Although interferon (IFN) signaling induces genes that limit viral infection, many pathogenic viruses overcome this host response. As an example, 2'-O methylation of the 5' cap of viral RNA subverts mammalian antiviral responses by evading restriction of Ifit1, an IFN-stimulated gene that regulates protein synthesis. However, alphaviruses replicate efficiently in cells expressing Ifit1 even though their genomic RNA has a 5' cap lacking 2'-O methylation. We show that pathogenic alphaviruses use secondary structural motifs within the 5' untranslated region (UTR) of their RNA to alter Ifit1 binding and function. Mutations within the 5'-UTR affecting RNA structural elements enabled restriction by or antagonism of Ifit1 in vitro and in vivo. These results identify an evasion mechanism by which viruses use RNA structural motifs to avoid immune restriction.	[Hyde, Jennifer L.; White, James P.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gardner, Christina L.; Trobaugh, Derek W.; Klimstra, William B.] Univ Pittsburgh, Ctr Vaccine Res, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Kimura, Taishi; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Huang, Cheng; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Liu, Gai; Amarasinghe, Gaya K.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tonelli, Marco] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Osaka University; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Trobaugh, Derek W./H-8044-2019; Diamond, Michael/AAH-1733-2019; Huang, Cheng/R-6619-2017	Trobaugh, Derek W./0000-0002-7312-0260; Diamond, Michael/0000-0002-8791-3165; Huang, Cheng/0000-0001-5402-353X; Takeda, Kiyoshi/0000-0002-1778-6332	NIH [U19 AI083019, R01 AI104972, R01 AI083383, AI049820, P41RR02301, P41GM66326]; Institute for Human Infections and Immunity, University of Texas Medical Branch [UL1TR000071]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095436, U19AI083019, R01AI083383, T32AI049820, R01AI104972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Human Infections and Immunity, University of Texas Medical Branch; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants U19 AI083019 (M. S. D.), R01 AI104972 (M. S. D.), R01 AI083383 (W. B. K.), and Training Grant AI049820 (D. W. T.) and the Institute for Human Infections and Immunity, University of Texas Medical Branch (UL1TR000071) supported this work. The authors thank I. Frolov, M. MacDonald, and C. Rice for their generosity with alphavirus reagents and experimental advice. This study made use of the National Magnetic Resonance Facility at Madison, Wisconsin, which is supported by NIH grants P41RR02301 (Biomedical Research Technology Program/National Center for Research Resources) and P41GM66326 (National Institute of General Medical Sciences). The luciferase reporter gene constructs and virulent VEEV strains are subject to material transfer agreements with the University of Pittsburgh and the University of Texas Medical Branch, respectively. Use of the virulent VEEV strain (TRD) requires Biosafety Level 3 facilities and U. S. Department of Agriculture approval. The authors have no financial conflicts to disclose. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; HEFTI E, 1976, J VIROL, V17, P149, DOI 10.1128/JVI.17.1.149-159.1976; JOHNSON BJB, 1986, J GEN VIROL, V67, P1951, DOI 10.1099/0022-1317-67-9-1951; Karki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037398; Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Kobiler D, 1999, J VIROL, V73, P10440, DOI 10.1128/JVI.73.12.10440-10446.1999; Kulasegaran-Shylini R, 2009, J VIROL, V83, P8327, DOI 10.1128/JVI.00586-09; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; McKnight KL, 1996, J VIROL, V70, P1981, DOI 10.1128/JVI.70.3.1981-1989.1996; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Pavlopoulos GA, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt254; PETTERSSON RF, 1980, EUR J BIOCHEM, V105, P435, DOI 10.1111/j.1432-1033.1980.tb04518.x; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Tesfay MZ, 2008, J VIROL, V82, P2620, DOI 10.1128/JVI.01784-07; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001; Yin J, 2009, J VIROL, V83, P10036, DOI 10.1128/JVI.01209-09; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	29	107	110	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					783	787		10.1126/science.1248465	http://dx.doi.org/10.1126/science.1248465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24482115	Green Accepted			2022-12-28	WOS:000331557800043
J	Roehr, B				Roehr, Bob			FDA faces regulatory challenges with new approaches to medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Dobbs D., 2014, NEW YORKER; Eichler HG, 2013, NAT REV DRUG DISCOV, V12, P907, DOI 10.1038/nrd4129; McCarthy M, 2013, BMJ-BRIT MED J, V347, pf5203, DOI [10.1136/bmj.f5203, DOI 10.1136/BMJ.F5203)]; Presidential Commission for the Study of Bioethical Issues, ANT COMM ETH MAN INC; Tabarrok A., 2013, MARGINAL REVOLUT NOV; U.S. Food and Drug Administration, GUID IND ENF POL REG; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2014	348								g1530	10.1136/bmj.g1530	http://dx.doi.org/10.1136/bmj.g1530			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9XG	24531207				2022-12-28	WOS:000331445700001
J	Ackland, P				Ackland, Penny			ABC of Kidney Disease, 2nd Edition Prevalence, Detection, Evaluation and Management of Chronic Kidney Disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-POPULATION; RENAL RISK		Nunhead Surg Nunhead Grove South East London, London, England		Ackland, P (corresponding author), Nunhead Surg Nunhead Grove South East London, London, England.							Anandarajah S, 2005, NEPHROL DIAL TRANSPL, V20, P2089, DOI 10.1093/ndt/gfi006; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; BAUS/RA Guidelines, 2008, JOINT CONSENSUS STAT; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Gerstein HC, 2000, LANCET, V355, P253; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Halbesma N, 2011, CLIN J AM SOC NEPHRO, V6, P1731, DOI 10.2215/CJN.08590910; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; NICE, 2006, CLINICAL GUIDELINE 3; NICE, 2009, CLINICAL GUIDELINE 8; NICE, 2008, CLINICAL GUIDELINE 7; NICE, 2011, CLINICAL GUIDELINE 1; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Taal MW, 2011, CLIN J AM SOC NEPHRO, V6, P1523, DOI 10.2215/CJN.04200511; UK Renal Registry, 2009, ANNUAL REPORT; Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141	19	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2014	348								f7688	10.1136/bmj.f7688	http://dx.doi.org/10.1136/bmj.f7688			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WZ	24524925				2022-12-28	WOS:000331445000001
J	Fromer, M; Pocklington, AJ; Kavanagh, DH; Williams, HJ; Dwyer, S; Gormley, P; Georgieva, L; Rees, E; Palta, P; Ruderfer, DM; Carrera, N; Humphreys, I; Johnson, JS; Roussos, P; Barker, DD; Banks, E; Milanova, V; Grant, SG; Hannon, E; Rose, SA; Chambert, K; Mahajan, M; Scolnick, EM; Moran, JL; Kirov, G; Palotie, A; McCarroll, SA; Holmans, P; Sklar, P; Owen, MJ; Purcell, SM; O'Donovan, MC				Fromer, Menachem; Pocklington, Andrew J.; Kavanagh, David H.; Williams, Hywel J.; Dwyer, Sarah; Gormley, Padhraig; Georgieva, Lyudmila; Rees, Elliott; Palta, Priit; Ruderfer, Douglas M.; Carrera, Noa; Humphreys, Isla; Johnson, Jessica S.; Roussos, Panos; Barker, Douglas D.; Banks, Eric; Milanova, Vihra; Grant, Seth G.; Hannon, Eilis; Rose, Samuel A.; Chambert, Kimberly; Mahajan, Milind; Scolnick, Edward M.; Moran, Jennifer L.; Kirov, George; Palotie, Aarno; McCarroll, Steven A.; Holmans, Peter; Sklar, Pamela; Owen, Michael J.; Purcell, Shaun M.; O'Donovan, Michael C.			De novo mutations in schizophrenia implicate synaptic networks	NATURE			English	Article							AUTISM SPECTRUM DISORDERS; COPY-NUMBER VARIANTS; INTELLECTUAL DISABILITY; DISEASE; GENE; PLASTICITY; MECHANISMS; COMPLEXITY; PATTERNS; RATES	Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one ora few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-D-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.	[Fromer, Menachem; Ruderfer, Douglas M.; Johnson, Jessica S.; Roussos, Panos; Mahajan, Milind; Sklar, Pamela; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Johnson, Jessica S.; Roussos, Panos; Mahajan, Milind; Sklar, Pamela; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Fromer, Menachem; Barker, Douglas D.; Rose, Samuel A.; Chambert, Kimberly; Scolnick, Edward M.; Moran, Jennifer L.; McCarroll, Steven A.; Purcell, Shaun M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Pocklington, Andrew J.; Kavanagh, David H.; Williams, Hywel J.; Dwyer, Sarah; Georgieva, Lyudmila; Rees, Elliott; Ruderfer, Douglas M.; Carrera, Noa; Humphreys, Isla; Hannon, Eilis; Kirov, George; Holmans, Peter; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Med Res Council Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales; [Gormley, Padhraig; Palta, Priit; Palotie, Aarno] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Gormley, Padhraig; Banks, Eric; Palotie, Aarno; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Palta, Priit] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, EE-51010 Tartu, Estonia; [Palta, Priit; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Milanova, Vihra] Med Univ, Dept Psychiat, Sofia 1431, Bulgaria; [Grant, Seth G.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Purcell, Shaun M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cardiff University; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tartu; University of Helsinki; Medical University Sofia; University of Edinburgh; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital	Owen, MJ (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, Med Res Council Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales.	owenmj@cardiff.ac.uk	Gormley, Padhraig/L-1949-2018; Holmans, Peter/F-4518-2015; Hannon, Eilis/T-1349-2019; Palta, Priit/W-2477-2019; O'Donovan, Michael C/P-7005-2018; Williams, Hywel/AAL-2440-2021; Ruderfer, Douglas M/M-5795-2016	Gormley, Padhraig/0000-0002-8908-6968; Holmans, Peter/0000-0003-0870-9412; Hannon, Eilis/0000-0001-6840-072X; Palta, Priit/0000-0001-9320-7008; O'Donovan, Michael C/0000-0001-7073-2379; Williams, Hywel/0000-0001-7758-0312; Ruderfer, Douglas M/0000-0002-2365-386X; Rees, Elliott/0000-0002-6168-9222; Johnson, Jessica/0000-0002-4519-3120; Grant, Seth/0000-0001-8732-8735; Rose, Samuel/0000-0001-9701-0050; McCarroll, Steven/0000-0002-6954-8184; Palotie, Aarno/0000-0002-2527-5874; Moran, Jennifer/0000-0002-5664-4716; Kirov, George/0000-0002-3427-3950; Pocklington, Andrew/0000-0002-2137-0452	Medical Research Council (MRC) Centre [G0800509, G0801418]; European Community [HEALTH-F2-2010-241909]; NIMH [2 P50 MH066392-05A1]; Friedman Brain Institute; Institute for Genomics and Multiscale Biology; National Institutes of Health [R01HG005827, R01MH099126, R01MH071681]; Fidelity Foundations; Sylvan Herman Foundation; Stanley Medical Research Institute; Wellcome Trust [WT089062, WT098051]; European Commission [261123]; MRC [G0802238, G0801418, G0800509] Funding Source: UKRI; Medical Research Council [G0801418, G0800509, MR/L010305/1, G0801418B, G0802238] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH099126, R01MH071681] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	Medical Research Council (MRC) Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Friedman Brain Institute; Institute for Genomics and Multiscale Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fidelity Foundations; Sylvan Herman Foundation; Stanley Medical Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	Work in Cardiff was supported by Medical Research Council (MRC) Centre (G0800509) and Program Grants (G0801418), the European Community's Seventh Framework Programme (HEALTH-F2-2010-241909 (Project EU-GEI)), and NIMH (2 P50 MH066392-05A1). Work at the Icahn School of Medicine at Mount Sinai was supported by the Friedman Brain Institute, the Institute for Genomics and Multiscale Biology (including computational resources and staff expertise provided by the Department of Scientific Computing), and National Institutes of Health grants R01HG005827 (S. M. P.), R01MH099126 (S. M. P.), and R01MH071681 (P. S.). Work at the Broad Institute was funded by Fidelity Foundations, the Sylvan Herman Foundation, philanthropic gifts from K. and E. Dauten, and the Stanley Medical Research Institute. Work at the Wellcome Trust Sanger Institute was supported by The Wellcome Trust (grant numbers WT089062 and WT098051) and also by the European Commission FP7 project gEUVADIS no. 261123 (P. P.). We would like to thank M. Daly, B. Neale and K. Samocha for discussions and providing unpublished autism data. We would also like to acknowledge M. DePristo, S. Gabriel, T. J. Fennel, K. Shakir, C. Tolonen and H. Shah for their help in generating and processing the various data sets.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Coba MP, 2012, J NEUROSCI, V32, P13987, DOI 10.1523/JNEUROSCI.2433-12.2012; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Insel T. R., 2013, NIMH DIRECTORS BLOG; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malhotra D, 2012, NATURE, V485, P318, DOI 10.1038/485318a; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Pocklington A. J., 2006, Briefings in Functional Genomics & Proteomics, V5, P66, DOI 10.1093/bfgp/ell013; Purcell S. M., 2014, NATURE          0122; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rees E, 2011, BIOL PSYCHIAT, V70, P1109, DOI 10.1016/j.biopsych.2011.07.011; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; von Eichborn J, 2013, NUCLEIC ACIDS RES, V41, pD834, DOI 10.1093/nar/gks1040; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446	43	1077	1087	2	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					179	+		10.1038/nature12929	http://dx.doi.org/10.1038/nature12929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24463507	Green Accepted			2022-12-28	WOS:000331107700029
J	Gungor, S; Topal, I				Gungor, Sule; Topal, Ilteris			Tripe Palms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 67-year-old man presented with a 2-month history of widespread thickening of his skin and multiple cutaneous nodules in the right infraauricular region. Examination of his palms revealed velvety, thickened ridges resembling tripe. A 67-year-old man presented with a 2-month history of widespread thickening of his skin and a 2-week history of multiple cutaneous nodules in the right infraauricular region. He had a history of squamous-cell carcinoma of the tongue base. Examination of the palmar side of his hands revealed velvety, thickened ridges resembling tripe (Panel A). Hyperpigmentation and accentuation of skin markings were noted at multiple locations, including the joints of his hands (Panel B), suggesting acanthosis nigricans. A 4-cm subcutaneous nodule (Panel C, short arrow) and approximately 10 skin-colored papules (Panel C, long arrow) were noted in the right preauricular and ...	[Gungor, Sule; Topal, Ilteris] Okmeydani Training & Res Hosp, Istanbul, Turkey	Istanbul Okmeydani Training & Research Hospital	Gungor, S (corresponding author), Okmeydani Training & Res Hosp, Istanbul, Turkey.	drsulegungor@yahoo.com	Güngör, Şule/AAP-7820-2021; Güngör, Şule/AAP-6839-2021						0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					558	558		10.1056/NEJMicm1307034	http://dx.doi.org/10.1056/NEJMicm1307034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499214				2022-12-28	WOS:000331073500012
J	Schmidt, B; Davis, PG; Asztalos, EV; Solimano, A; Roberts, RS				Schmidt, Barbara; Davis, Peter G.; Asztalos, Elizabeth V.; Solimano, Alfonso; Roberts, Robin S.			Association Between Severe Retinopathy of Prematurity and Nonvisual Disabilities at Age 5 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INFANTS; TRIAL		[Schmidt, Barbara] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Davis, Peter G.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Asztalos, Elizabeth V.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Solimano, Alfonso] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Roberts, Robin S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Melbourne; University of Toronto; University of British Columbia; McMaster University	Schmidt, B (corresponding author), Hosp Univ Penn, Div Neonatol, 3400 Spruce St,Ravdin 8, Philadelphia, PA 19104 USA.	barbara.schmidt@uphs.upenn.edu	Asztalos, Elizabeth/L-8834-2019	Asztalos, Elizabeth/0000-0002-9468-2860	Canadian Institutes of Health Research [MCT 13288] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Doyle LW, 2011, ARCH DIS CHILD-FETAL, V96, pF443, DOI 10.1136/adc.2010.200576; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Msall ME, 2000, PEDIATRICS, V106, P998, DOI 10.1542/peds.106.5.998; Palmer EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P595; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024	6	48	49	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					523	525		10.1001/jama.2013.282153	http://dx.doi.org/10.1001/jama.2013.282153			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24496539				2022-12-28	WOS:000330589800026
J	Cummer, SA				Cummer, Steven A.			Selecting the Direction of Sound Transmission	SCIENCE			English	Editorial Material									Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Duke University	Cummer, SA (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	cummer@duke.edu	Cummer, Steven A/A-6118-2008; Cummer, Steven/AAJ-6761-2020	Cummer, Steven A/0000-0002-0002-0613; 				Budden K. G., 1961, RADIO WAVES IONOSPHE; CASIMIR HBG, 1945, REV MOD PHYS, V17, P343, DOI 10.1103/RevModPhys.17.343; Fleury R, 2014, SCIENCE, V343, P516, DOI 10.1126/science.1246957; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Maznev AA, 2013, WAVE MOTION, V50, P776, DOI 10.1016/j.wavemoti.2013.02.006; Pozar DM, 2012, MICROWAVE ENG; Roberts NA, 2011, INT J THERM SCI, V50, P648, DOI 10.1016/j.ijthermalsci.2010.12.004	8	25	26	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					495	496		10.1126/science.1249616	http://dx.doi.org/10.1126/science.1249616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482472				2022-12-28	WOS:000330343700031
J	Cunha, C; Aversa, F; Lacerda, JF; Busca, A; Kurzai, O; Grube, M; Loffler, J; Maertens, JA; Bell, AS; Inforzato, A; Barbati, E; Almeida, B; Sousa, PSE; Barbui, A; Potenza, L; Caira, M; Rodrigues, F; Salvatori, G; Pagano, L; Luppi, M; Mantovani, A; Velardi, A; Romani, L; Carvalho, A				Cunha, Cristina; Aversa, Franco; Lacerda, Joao F.; Busca, Alessandro; Kurzai, Oliver; Grube, Matthias; Loeffler, Juergen; Maertens, Johan A.; Bell, Alain S.; Inforzato, Antonio; Barbati, Elisa; Almeida, Bruno; Santos e Sousa, Pedro; Barbui, Anna; Potenza, Leonardo; Caira, Morena; Rodrigues, Fernando; Salvatori, Giovanni; Pagano, Livio; Luppi, Mario; Mantovani, Alberto; Velardi, Andrea; Romani, Luigina; Carvalho, Agostinho			Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG PENTRAXIN PTX3; SURVEILLANCE NETWORK TRANSNET; INVASIVE FUNGAL-INFECTIONS; COMPETING RISK; PROTECTIVE ACTIVITY; RECIPIENTS; FUMIGATUS; ORGANIZATION; INFLAMMATION; DEFINITIONS	BackgroundThe soluble pattern-recognition receptor known as long pentraxin 3 (PTX3) has a nonredundant role in antifungal immunity. The contribution of single-nucleotide polymorphisms (SNPs) in PTX3 to the development of invasive aspergillosis is unknown. MethodsWe screened an initial cohort of 268 patients undergoing hematopoietic stem-cell transplantation (HSCT) and their donors for PTX3 SNPs modifying the risk of invasive aspergillosis. The analysis was also performed in a multicenter study involving 107 patients with invasive aspergillosis and 223 matched controls. The functional consequences of PTX3 SNPs were investigated in vitro and in lung specimens from transplant recipients. ResultsReceipt of a transplant from a donor with a homozygous haplotype (h2/h2) in PTX3 was associated with an increased risk of infection, in both the discovery study (cumulative incidence, 37% vs. 15%; adjusted hazard ratio, 3.08; P=0.003) and the confirmation study (adjusted odds ratio, 2.78; P=0.03), as well as with defective expression of PTX3. Functionally, PTX3 deficiency in h2/h2 neutrophils, presumably due to messenger RNA instability, led to impaired phagocytosis and clearance of the fungus. ConclusionsGenetic deficiency of PTX3 affects the antifungal capacity of neutrophils and may contribute to the risk of invasive aspergillosis in patients treated with HSCT. (Funded by the European Society of Clinical Microbiology and Infectious Diseases and others.)	[Cunha, Cristina; Velardi, Andrea; Romani, Luigina; Carvalho, Agostinho] Univ Perugia, Dept Expt Med & Biochem Sci, I-06132 Perugia, Italy; [Bell, Alain S.] Univ Perugia, Dept Clin & Expt Med, I-06132 Perugia, Italy; [Aversa, Franco] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Inforzato, Antonio; Barbati, Elisa; Mantovani, Alberto] AO Citta Salute Sci, Dept Inflammat & Immunol, Humanitas Clin & Res Ctr, Turin, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Potenza, Leonardo; Luppi, Mario] Univ Modena & Reggio Emilia, AOU Policlin, Dept Med & Surg Sci, Modena, Italy; [Caira, Morena; Pagano, Livio] Univ Cattolica Sacro Cuore, Ist Ematol, Rome, Italy; [Salvatori, Giovanni] Sigma Tau Ind Farmaceut Riunite, Pomezia, Italy; [Lacerda, Joao F.; Santos e Sousa, Pedro] Univ Lisbon, Hosp Santa Maria, P-1699 Lisbon, Portugal; [Almeida, Bruno] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [Rodrigues, Fernando; Carvalho, Agostinho] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Rodrigues, Fernando; Carvalho, Agostinho] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Kurzai, Oliver] Univ Jena, Sept Res Ctr, Jena, Germany; [Kurzai, Oliver] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Grube, Matthias] Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany; [Loeffler, Juergen] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, D-97070 Wurzburg, Germany; [Maertens, Johan A.] Univ Ziekenhuizen Leuven, Dept Hematol, Louvain, Belgium	University of Perugia; University of Perugia; University of Parma; University Hospital of Parma; A.O.U. Citta della Salute e della Scienza di Torino; University of Milan; Universita di Modena e Reggio Emilia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universidade de Lisboa; Hospital Santa Maria; Universidade do Porto; Universidade do Minho; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; KU Leuven; University Hospital Leuven	Carvalho, A (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06132 Perugia, Italy.	agostinho.carvalho@unipg.it	Romani, Luigina/O-9987-2018; Rodrigues, Fernando/T-5299-2018; Cunha, Cristina/D-2687-2009; Mantovani, Alberto/HCI-7449-2022; Potenza, Leonardo/P-9579-2016; Almeida, Bruno/T-5135-2018; pagano, livio/A-2024-2008; Carvalho, Agostinho/D-2667-2009; Luppi, Mario/J-3668-2016; Inforzato, Antonio/ABG-4513-2020; Cunha, Cristina/AAH-9951-2021; pagano, livio/J-3020-2018; Rodrigues, Fernando/A-3123-2011	Rodrigues, Fernando/0000-0001-8436-9398; Cunha, Cristina/0000-0002-6002-5782; Mantovani, Alberto/0000-0001-5578-236X; Potenza, Leonardo/0000-0002-2738-6105; Almeida, Bruno/0000-0002-9757-4240; Carvalho, Agostinho/0000-0001-8935-8030; Luppi, Mario/0000-0002-0373-1154; Inforzato, Antonio/0000-0001-8110-0027; Cunha, Cristina/0000-0002-6002-5782; pagano, livio/0000-0001-8287-928X; Romani, Luigina/0000-0002-1356-525X; Lacerda, Joao/0000-0003-1351-2809; Aversa, Franco/0000-0002-8871-6817; Kurzai, Oliver/0000-0002-7277-2646	European Society of Clinical Microbiology and Infectious Diseases (ESCMID); German Ministry for Education and Science [03Z2JN21]; European Commission [FP7-HEALTH-2009-260338, FP7-HEALTH-2011-280873]; European Research Council [ERC-2008-AdG-233417, ERC-2011-AdG-293714]; Associazione Italiana per la Ricerca sul Cancro [99629]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/46292/2008, SFRH/BD/65962/2009, SFRH/BPD/70783/2010]	European Society of Clinical Microbiology and Infectious Diseases (ESCMID); German Ministry for Education and Science; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Supported by grants from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (to Dr. Carvalho); the German Ministry for Education and Science (03Z2JN21, to Dr. Kurzai); the European Commission (FP7-HEALTH-2009-260338, to Dr. Romani; FP7-HEALTH-2011-280873, to Dr. Mantovani), the European Research Council (ERC-2008-AdG-233417, to Dr. Mantovani; ERC-2011-AdG-293714, to Dr. Romani), Associazione Italiana per la Ricerca sul Cancro (99629, to Dr. Mantovani); and Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/46292/2008, to Dr. Carvalho; SFRH/BD/65962/2009, to Dr. Cunha; and SFRH/BPD/70783/2010, to Dr. Almeida).	Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Diamond JM, 2012, AM J RESP CRIT CARE, V186, P546, DOI 10.1164/rccm.201204-0692OC; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lo Giudice P, 2012, ANTIMICROB AGENTS CH, V56, P6400, DOI 10.1128/AAC.01000-12; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Pagano L, 2007, CLIN INFECT DIS, V45, P1161, DOI 10.1086/522189; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Salvatori G, 2012, MED MYCOL, V50, P225, DOI 10.3109/13693786.2011.648215; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085	30	216	226	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					421	432		10.1056/NEJMoa1211161	http://dx.doi.org/10.1056/NEJMoa1211161			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476432	Green Submitted, Green Published			2022-12-28	WOS:000330645400007
J	Vogt, MC; Paeger, L; Hess, S; Steculorum, SM; Awazawa, M; Hampel, B; Neupert, S; Nicholls, HT; Mauer, J; Hausen, AC; Predel, R; Kloppenburg, P; Horvath, TL; Bruning, JC				Vogt, Merly C.; Paeger, Lars; Hess, Simon; Steculorum, Sophie M.; Awazawa, Motoharu; Hampel, Brigitte; Neupert, Susanne; Nicholls, Hayley T.; Mauer, Jan; Hausen, A. Christine; Predel, Reinhard; Kloppenburg, Peter; Horvath, Tamas L.; Bruening, Jens C.			Neonatal Insulin Action Impairs Hypothalamic Neurocircuit Formation in Response to Maternal High-Fat Feeding	CELL			English	Article							GESTATIONAL DIABETES-MELLITUS; AUTONOMIC NERVOUS-SYSTEM; PARAVENTRICULAR NUCLEUS; APPETITE REGULATORS; LEPTIN SENSITIVITY; EXPRESSING NEURONS; NEURITE GROWTH; OBESITY; DIET; BRAIN	Maternal metabolic homeostasis exerts long-term effects on the offspring's health outcomes. Here, we demonstrate that maternal high-fat diet (HFD) feeding during lactation predisposes the offspring for obesity and impaired glucose homeostasis in mice, which is associated with an impairment of the hypothalamic melanocortin circuitry. Whereas the number and neuropeptide expression of anorexigenic proopiomelanocortin (POMC) and orexigenic agouti-related peptide (AgRP) neurons, electrophysiological properties of POMC neurons, and posttranslational processing of POMC remain unaffected in response to maternal HFD feeding during lactation, the formation of POMC and AgRP projections to hypothalamic target sites is severely impaired. Abrogating insulin action in POMC neurons of the offspring prevents altered POMCprojections to the preautonomic paraventricular nucleus of the hypothalamus (PVH), pancreatic parasympathetic innervation, and impaired glucosestimulated insulin secretion in response to maternal overnutrition. These experiments reveal a critical timing, when altered maternal metabolism disrupts metabolic homeostasis in the offspring via impairing neuronal projections, and show that abnormal insulin signaling contributes to this effect.	[Vogt, Merly C.; Steculorum, Sophie M.; Awazawa, Motoharu; Hampel, Brigitte; Nicholls, Hayley T.; Mauer, Jan; Hausen, A. Christine; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Vogt, Merly C.; Steculorum, Sophie M.; Awazawa, Motoharu; Hampel, Brigitte; Nicholls, Hayley T.; Mauer, Jan; Hausen, A. Christine; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, D-50674 Cologne, Germany; [Paeger, Lars; Hess, Simon; Neupert, Susanne; Predel, Reinhard; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, D-50674 Cologne, Germany; [Vogt, Merly C.; Paeger, Lars; Hess, Simon; Steculorum, Sophie M.; Awazawa, Motoharu; Hampel, Brigitte; Nicholls, Hayley T.; Mauer, Jan; Hausen, A. Christine; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, D-50674 Cologne, Germany; [Vogt, Merly C.; Paeger, Lars; Hess, Simon; Steculorum, Sophie M.; Awazawa, Motoharu; Hampel, Brigitte; Nicholls, Hayley T.; Mauer, Jan; Hausen, A. Christine; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50924 Cologne, Germany; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Comparat Med Sect,Program Integrat Cell Signallin, New Haven, CT 06510 USA	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Comparat Med Sect,Program Integrat Cell Signallin, New Haven, CT 06510 USA.	tamas.horvath@yale.edu; bruening@nf.mpg.de	Predel, Reinhard/O-5243-2015; Vogt, Merly/AAF-3789-2021	Paeger, Lars/0000-0001-8716-3483; Mauer, Jan/0000-0002-0189-5876	DFG [SFB 612, SFB 670, PR 766/ 10-1]; DFG within the Excellence Initiative; Cologne Center for Molecular Medicine Cologne (CMMC); NIH [DP1 DK006850, R01AG040236, P01NS062686]; American Diabetes Association, the Helmholtz Society (ICEMED); Klarman Foundation; European Union Seventh Framework Programme [266408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); DFG within the Excellence Initiative(German Research Foundation (DFG)); Cologne Center for Molecular Medicine Cologne (CMMC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association, the Helmholtz Society (ICEMED); Klarman Foundation; European Union Seventh Framework Programme(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank Julia Goldau, Sigrid Irlenbusch, and Pia Scholl for outstanding technical assistance. This work was supported by the DFG (SFB 612 and SFB 670 to J.C.B., PR 766/ 10-1 to R.P.), the Leibniz Preis (BR 1492/ 7-1 to J.C.B.), the Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD; funded by the DFG within the Excellence Initiative by German Federal and State Governments), and the Cologne Center for Molecular Medicine Cologne (CMMC). T. L. H. was supported by NIH (DP1 DK006850, R01AG040236, and P01NS062686), the American Diabetes Association, the Helmholtz Society (ICEMED), and The Klarman Foundation. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/ 2007-2013) under grant agreement n degrees 266408. Images from the graphical abstract were used and adapted from Servier Medical Art.	Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Belgardt BF, 2010, ANN NY ACAD SCI, V1212, P97, DOI 10.1111/j.1749-6632.2010.05799.x; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Bouyer K, 2013, J NEUROSCI, V33, P840, DOI 10.1523/JNEUROSCI.3215-12.2013; Broberger C, 2001, PHYSIOL BEHAV, V74, P669, DOI 10.1016/S0031-9384(01)00611-4; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Deierlein AL, 2011, DIABETES CARE, V34, P480, DOI 10.2337/dc10-1766; Fekete C, 2001, ENDOCRINOLOGY, V142, P2606, DOI 10.1210/en.142.6.2606; Fekete C, 2000, J NEUROSCI, V20, P1550; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grant WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048119; Gravena C, 2007, NUTR NEUROSCI, V10, P79, DOI 10.1080/10284150701308693; Grayson BE, 2006, NEUROSCIENCE, V143, P975, DOI 10.1016/j.neuroscience.2006.08.055; Greenfield JR, 2008, CURR PHARM DESIGN, V14, P1815, DOI 10.2174/138161208784746716; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Grove KL, 2005, J CLIN INVEST, V115, P3393, DOI 10.1172/JCI27211; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825; Harder T, 1999, Endocr Regul, V33, P25; Horvath TL, 2006, NAT MED, V12, P52, DOI 10.1038/nm0106-52; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; King CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025864; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027; Koutcherov Y, 2003, J CHEM NEUROANAT, V26, P253, DOI 10.1016/j.jchemneu.2003.07.002; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Mumtaz M, 2000, Malays J Med Sci, V7, P4; PEDERSEN J, 1971, POSTGRAD MED J, V47, P66; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P91, DOI 10.1055/s-0029-1211143; Plagemann A, 2012, PERINATAL PROGRAMMIN; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; Rossi J, 2005, DIABETES, V54, P1324, DOI 10.2337/diabetes.54.5.1324; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sabin MA, 2008, FRONT HORM RES, V36, P85, DOI 10.1159/000115356; Sasaki A, 2013, NEUROSCIENCE, V240, P1, DOI 10.1016/j.neuroscience.2013.02.044; Schechter R, 1999, DEV BRAIN RES, V116, P159, DOI 10.1016/S0165-3806(99)00089-9; SEGERSON TP, 1987, ENDOCRINOLOGY, V121, P98, DOI 10.1210/endo-121-1-98; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Steculorum SM, 2013, ENDOCRIN METAB CLIN, V42, P149, DOI 10.1016/j.ecl.2012.10.002; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; TORANALLERAND CD, 1988, DEV BRAIN RES, V41, P87, DOI 10.1016/0165-3806(88)90172-1; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	68	202	205	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					495	509		10.1016/j.cell.2014.01.008	http://dx.doi.org/10.1016/j.cell.2014.01.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24462248	Green Accepted, Bronze			2022-12-28	WOS:000330580800016
J	Muneer, A; Kalsi, J; Nazareth, I; Arya, M				Muneer, Asif; Kalsi, Jas; Nazareth, Irwin; Arya, Manit			Erectile dysfunction	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEXUAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; INTERNATIONAL INDEX; RED GINSENG; MEN; METAANALYSIS; EFFICACY; SILDENAFIL; MANAGEMENT; SAFETY		[Muneer, Asif; Arya, Manit] Univ Coll Hosp, London NW1 2PG, England; [Kalsi, Jas] Wexham Pk Hosp, Slough SL2 4HL, Berks, England; [Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London WC1E 6BT, England; [Arya, Manit] Queen Mary Univ London, London, England	University of London; University College London; University of London; University College London; University of London; Queen Mary University London	Muneer, A (corresponding author), Univ Coll Hosp, London NW1 2PG, England.	mramuneer@gmail.com		Nazareth, Irwin/0000-0003-2146-9628				Andersen I, 2008, J SEX MED, V5, P2053, DOI 10.1111/j.1743-6109.2008.00920.x; Babaev A, 2012, J INVASIVE CARDIOL, V24, P236; Bacon CG, 2002, DIABETES CARE, V25, P1458, DOI 10.2337/diacare.25.8.1458; Berner MM, 2006, INT J IMPOT RES, V18, P229, DOI 10.1038/sj.ijir.3901395; British Society Sexual Medicine, 2007, GUID MAN ER DYSF; Brock GB, 2002, J UROLOGY, V168, P1332, DOI 10.1016/S0022-5347(05)64442-4; Cao SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060443; Carson CC, 2000, J UROLOGY, V164, P376, DOI 10.1016/S0022-5347(05)67364-8; Cheng JYW, 2007, INT J IMPOT RES, V19, P245, DOI 10.1038/sj.ijir.3901521; Choi YD, 1999, J UROLOGY, V162, P1508, DOI 10.1016/S0022-5347(05)68349-8; COOKSON MS, 1993, J UROLOGY, V149, P290, DOI 10.1016/S0022-5347(17)36059-7; Cortes-Gonzalez JR, 2010, BJU INT, V105, P225, DOI 10.1111/j.1464-410X.2009.08748.x; DeBusk R, 2000, AM J CARDIOL, V86, P175, DOI 10.1016/S0002-9149(00)00896-1; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Eardley I, 2005, BJU INT, V96, P1323, DOI 10.1111/j.1464-410X.2005.05892.x; Ernst E, 1998, J UROLOGY, V159, P433, DOI 10.1016/S0022-5347(01)63942-9; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; European Association of Urology, 2013, GUID MAL SEX DYSF; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gupta BP, 2011, ARCH INTERN MED, V171, P1797, DOI 10.1001/archinternmed.2011.440; Humphery S, 2001, FAM PRACT, V18, P516, DOI 10.1093/fampra/18.5.516; Isidori AM, 2013, EUR UROL; Jang DJ, 2008, BRIT J CLIN PHARMACO, V66, P444, DOI 10.1111/j.1365-2125.2008.03236.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Kostis JB, 2005, AM J CARDIOL, V96, P313, DOI 10.1016/j.amjcard.2005.03.065; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; Marceau L, 2001, INT J IMPOT RES, V13, P298, DOI 10.1038/sj.ijir.3900733; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; Nazareth I, 2003, BRIT MED J, V327, P423, DOI 10.1136/bmj.327.7412.423; Nehra A, 2012, MAYO CLIN PROC, V87, P766, DOI 10.1016/j.mayocp.2012.06.015; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Sommer F, 2010, J SEX MED, V7, P2346, DOI 10.1111/j.1743-6109.2009.01664.x; Vardi Y, 2012, J UROLOGY, V187, P1769, DOI 10.1016/j.juro.2011.12.117; WHO, 2002, DEV SEX HLTH PROGR F	37	40	43	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2014	348								g129	10.1136/bmj.g129	http://dx.doi.org/10.1136/bmj.g129			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AT	24468580				2022-12-28	WOS:000330647400009
J	Akbalik, G; Schuman, EM				Akbalik, Gueney; Schuman, Erin M.			mRNA, Live and Unmasked	SCIENCE			English	Editorial Material							PARTICLES; TRANSCRIPTS; DENDRITES; NEURONS		[Akbalik, Gueney; Schuman, Erin M.] Max Planck Inst Brain Res, D-60438 Frankfurt, Germany	Max Planck Society	Akbalik, G (corresponding author), Max Planck Inst Brain Res, D-60438 Frankfurt, Germany.	erin.schuman@brain.mpg.de	Schuman, Erin M/D-6204-2011	Akbalik, Guney/0000-0002-3219-401X				Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Tubing F, 2010, J NEUROSCI, V30, P4160, DOI 10.1523/JNEUROSCI.3537-09.2010; Weil TT, 2010, TRENDS CELL BIOL, V20, P380, DOI 10.1016/j.tcb.2010.03.006; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	13	8	8	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					375	376		10.1126/science.1249623	http://dx.doi.org/10.1126/science.1249623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458628				2022-12-28	WOS:000330039300032
J	Gaiha, GD; Brass, AL				Gaiha, Gaurav D.; Brass, Abraham L.			The Fiery Side of HIV-Induced T Cell Death	SCIENCE			English	Editorial Material							PYROPTOSIS; INFECTION; APOPTOSIS; INFLAMMASOME; DEPLETION; SENSOR; IFI16		[Gaiha, Gaurav D.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard U, Cambridge, MA 02139 USA; [Brass, Abraham L.] Univ Massachusetts, Sch Med, Microbiol & Physiol Syst Dept, Worcester, MA 01655 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Massachusetts System; University of Massachusetts Worcester	Gaiha, GD (corresponding author), Ragon Inst Massachusetts Gen Hosp MIT & Harvard U, Cambridge, MA 02139 USA.	abraham.brass@umassmed.edu						Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344; Wu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-88	14	9	10	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					383	384		10.1126/science.1250175	http://dx.doi.org/10.1126/science.1250175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458634				2022-12-28	WOS:000330039300038
J	Kuchenreuther, JM; Myers, WK; Suess, DLM; Stich, TA; Pelmenschikov, V; Shiigi, SA; Cramer, SP; Swartz, JR; Britt, RD; George, SJ				Kuchenreuther, Jon M.; Myers, William K.; Suess, Daniel L. M.; Stich, Troy A.; Pelmenschikov, Vladimir; Shiigi, Stacey A.; Cramer, Stephen P.; Swartz, James R.; Britt, R. David; George, Simon J.			The HydG Enzyme Generates an Fe(CO)(2)(CN) Synthon in Assembly of the FeFe Hydrogenase H-Cluster	SCIENCE			English	Article							ELECTRON-PARAMAGNETIC-RES; CARBON-MONOXIDE; IRON	Three iron-sulfur proteins-HydE, HydF, and HydG-play a key role in the synthesis of the [2Fe](H) component of the catalytic H-cluster of FeFe hydrogenase. The radical S-adenosyl-L-methionine enzyme HydG lyses free tyrosine to produce p-cresol and the CO and CN- ligands of the [2Fe](H) cluster. Here, we applied stopped-flow Fourier transform infrared and electron-nuclear double resonance spectroscopies to probe the formation of HydG-bound Fe-containing species bearing CO and CN- ligands with spectroscopic signatures that evolve on the 1- to 1000-second time scale. Through study of the C-13, N-15, and Fe-57 isotopologs of these intermediates and products, we identify the final HydG-bound species as an organometallic Fe(CO)(2)(CN) synthon that is ultimately transferred to apohydrogenase to form the [2Fe](H) component of the H-cluster.	[Kuchenreuther, Jon M.; Myers, William K.; Suess, Daniel L. M.; Stich, Troy A.; Cramer, Stephen P.; Britt, R. David; George, Simon J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Pelmenschikov, Vladimir] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Shiigi, Stacey A.; Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	University of California System; University of California Davis; Technical University of Berlin; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University	Britt, RD (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	rdbritt@ucdavis.edu; sjgeorge@ucdavis.edu	Pelmenschikov, Vladimir/O-7640-2019; Suess, Daniel/GYJ-3243-2022	Pelmenschikov, Vladimir/0000-0002-0523-4418; George, Simon/0000-0002-4864-5479; Myers, William/0000-0001-5935-9112	NIH [GM072623, GM65440]; Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy (DOE) [DE-FG02-09ER46632]; Office of Biological and Environmental Research of the DOE; UniCat Cluster of Excellence of the German Research Council; EPSRC [EP/D048559/1, EP/L011972/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, EP/L011972/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065440, R01GM072623, R01GM104543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy (DOE); Office of Biological and Environmental Research of the DOE; UniCat Cluster of Excellence of the German Research Council; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NIH (R.D.B., no GM072623; S.P.C., no. GM65440) and by the Division of Material Sciences and Engineering (J.R.S., award no. DE-FG02-09ER46632) of the Office of Basic Energy Sciences of the U.S. Department of Energy (DOE), by the Office of Biological and Environmental Research of the DOE (S.P.C.), and the UniCat Cluster of Excellence of the German Research Council (V.P.).	Adams MWW, 2000, CURR OPIN CHEM BIOL, V4, P214, DOI 10.1016/S1367-5931(99)00077-0; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; DARENSBOURG DJ, 1972, INORG CHEM, V11, P1606, DOI 10.1021/ic50113a029; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Kuchenreuther JM, 2013, SCIENCE, V342, P472, DOI 10.1126/science.1241859; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Pereira AS, 2001, J AM CHEM SOC, V123, P2771, DOI 10.1021/ja003176+; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; PIPER TS, 1955, J INORG NUCL CHEM, V1, P165, DOI 10.1016/0022-1902(55)80053-X; Popescu CV, 1999, J AM CHEM SOC, V121, P7877, DOI 10.1021/ja991243y; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2007, J AM CHEM SOC, V129, P11447, DOI 10.1021/ja072592s; TELSER J, 1986, J BIOL CHEM, V261, P3536; TELSER J, 1987, J BIOL CHEM, V262, P6589; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; WEIGEL JA, 1989, J AM CHEM SOC, V111, P9246, DOI 10.1021/ja00208a027	26	87	87	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					424	427		10.1126/science.1246572	http://dx.doi.org/10.1126/science.1246572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458644	Green Accepted, Green Submitted			2022-12-28	WOS:000330039300051
J	Volpp, KG; Galvin, R				Volpp, Kevin G.; Galvin, Robert			Reward-Based Incentives for Smoking Cessation How a Carrot Became a Stick	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FINANCIAL INCENTIVES		[Volpp, Kevin G.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.] Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Galvin, Robert] Equ Healthcare, Blackstone Grp, Philadelphia, PA USA; [Galvin, Robert] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Yale University	Volpp, KG (corresponding author), Univ Penn, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, 423 Guardian Dr,1120 Blockley Hall, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Volpp, Kevin/0000-0003-1423-4599	NIA NIH HHS [P30 AG034546] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Kahneman D, PROSPECT THEORY ANAL; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P1375, DOI 10.1001/jama.2012.387; Madison K, 2013, JAMA-J AM MED ASSOC, V310, P143, DOI 10.1001/jama.2013.7617; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Watson Towers, TOW WATS SURV PURCH	7	32	32	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					909	910		10.1001/jama.2014.418	http://dx.doi.org/10.1001/jama.2014.418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24493405	Green Accepted			2022-12-28	WOS:000332170800015
J	Chen, HY; Yuan, H; Gao, RB; Zhang, JX; Wang, DY; Xiong, Y; Fan, GY; Yang, F; Li, XD; Zhou, JF; Zou, SM; Yang, L; Chen, T; Dong, LB; Bo, H; Zhao, X; Zhang, Y; Lan, Y; Bai, T; Dong, J; Li, Q; Wang, SW; Zhang, YP; Li, H; Gong, T; Shi, Y; Ni, XS; Li, JX; Zhou, J; Fan, JY; Wu, JW; Zhou, XF; Hu, MH; Wan, JG; Yang, WZ; Li, DX; Wu, GZ; Feng, ZJ; Gao, GF; Wang, Y; Jin, Q; Liu, MB; Shu, YL				Chen, HaiYing; Yuan, Hui; Gao, Rongbao; Zhang, Jinxiang; Wang, Dayan; Xiong, Ying; Fan, GuoYin; Yang, Fan; Li, Xiaodan; Zhou, Jianfang; Zou, Shumei; Yang, Lei; Chen, Tao; Dong, Libo; Bo, Hong; Zhao, Xiang; Zhang, Ye; Lan, Yu; Bai, Tian; Dong, Jie; Li, Qun; Wang, ShiWen; Zhang, YanPing; Li, Hui; Gong, Tian; Shi, Yong; Ni, Xiansheng; Li, Jianxiong; Zhou, Jun; Fan, Jiyi; Wu, Jingwen; Zhou, Xianfeng; Hu, Maohong; Wan, Jianguo; Yang, WeiZhong; Li, DeXin; Wu, Guizhen; Feng, ZiJian; Gao, George F.; Wang, Yu; Jin, Qi; Liu, Mingbin; Shu, Yuelong			Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection : a descriptive study	LANCET			English	Article							TO-PERSON TRANSMISSION; H5N1 VIRUS; H7N9; SEQUENCE; GENES; CHINA	Background Human infections with different avian influenza viruses-eg, H5N1, H9N2, and H7N9-have raised concerns about pandemic potential worldwide. We report the first human infection with a novel reassortant avian influenza A H10N8 virus. Methods We obtained and analysed clinical, epidemiological, and virological data from a patient from Nanchang City, China. Tracheal aspirate specimens were tested for influenza virus and other possible pathogens by RT-PCR, viral culture, and sequence analyses. A maximum likelihood phylogenetic tree was constructed. Findings A woman aged 73 years presented with fever and was admitted to hospital on Nov 30, 2013. She developed multiple organ failure and died 9 days after illness onset. A novel reassortant avian influenza A H10N8 virus was isolated from the tracheal aspirate specimen obtained from the patient 7 days after onset of illness. Sequence analyses revealed that all the genes of the virus were of avian origin, with six internal genes from avian influenza A H9N2 viruses. The aminoacid motif GlnSerGly at residues 226-228 of the haemagglutinin protein indicated avian-like receptor binding preference. A mixture of glutamic acid and lysine at residue 627 in PB2 protein-which is associated with mammalian adaptation-was detected in the original tracheal aspirate samples. The virus was sensitive to neuraminidase inhibitors. Sputum and blood cultures and deep sequencing analysis indicated no co-infection with bacteria or fungi. Epidemiological investigation established that the patient had visited a live poultry market 4 days before illness onset. Interpretation The novel reassortant H10N8 virus obtained is distinct from previously reported H10N8 viruses. The virus caused human infection and could have been associated with the death of a patient.	[Chen, HaiYing; Fan, GuoYin; Li, Hui; Ni, Xiansheng; Wu, Jingwen; Zhou, Xianfeng; Hu, Maohong; Liu, Mingbin] Nanchang City Dis Control & Prevent, Nanchang, Peoples R China; [Yuan, Hui; Xiong, Ying; Gong, Tian; Shi, Yong; Li, Jianxiong; Zhou, Jun] Jiangxi Prov Dis Control & Prevent, Nanchang, Peoples R China; [Gao, Rongbao; Wang, Dayan; Li, Xiaodan; Zhou, Jianfang; Zou, Shumei; Yang, Lei; Chen, Tao; Dong, Libo; Bo, Hong; Zhao, Xiang; Zhang, Ye; Lan, Yu; Bai, Tian; Dong, Jie; Wang, ShiWen; Li, DeXin; Wu, Guizhen; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing 102206, Peoples R China; [Zhang, Jinxiang; Wan, Jianguo] First Hosp Nanchang, Nanchang, Peoples R China; [Yang, Fan; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yang, Fan; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Qun; Zhang, YanPing; Yang, WeiZhong; Feng, ZiJian; Gao, George F.; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Fan, Jiyi] Donghu Dist Ctr Dis Control & Prevent, Nanchang, Peoples R China; [Shu, Yuelong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, 155 Changbai Rd, Beijing 102206, Peoples R China.	yshu@cnic.org.cn	Yang, Lei/GSD-3834-2022; Gao, George Fu/ABD-5229-2021	Zhou, Xianfeng/0000-0002-7756-9460	National Basic Research Program of China; National Mega-projects for Infectious Diseases; National Basic Research Program (973) of China [2011CB504704]; National Ministry of Science and Technology [KJYJ-2013-01-01]; National Mega-projects for Infectious Diseases [2013ZX10004-101, 2012ZX10004215]; Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) collaborative project from the CDC China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases [5U51IP000334-03]; National Natural Science Foundation of China [81373107]; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000334] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Mega-projects for Infectious Diseases; National Basic Research Program (973) of China(National Basic Research Program of China); National Ministry of Science and Technology; National Mega-projects for Infectious Diseases; Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) collaborative project from the CDC China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Emergency Research Project on human infection with avian influenza H7N9 virus, the National Basic Research Program of China, and the National Mega-projects for Infectious Diseases.; This study was supported by the National Basic Research Program (973) of China (2011CB504704, to YShu), the Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (KJYJ-2013-01-01 to YShu), the National Mega-projects for Infectious Diseases (2013ZX10004-101 to DL and 2012ZX10004215 partly to DW), the Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) collaborative project 5U51IP000334-03 from the CDC China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases, and the National Natural Science Foundation of China (81373107 to RG).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Barrera-Badillo Gisela, 2012, Morbidity and Mortality Weekly Report, V61, P726; Chinese National Influenza Center, 2014, WEEKL REP; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiao PR, 2012, J VIROL, V86, P7716, DOI 10.1128/JVI.00959-12; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Pan American Health Organization, 2004, AV INFL VIR H10N7 CI; Peng F, 2014, CHINA REPORTS 2 H10N; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; World Health Organization, CUM NUMB CONF HUM CA; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455	32	430	495	5	194	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					714	721		10.1016/S0140-6736(14)60111-2	http://dx.doi.org/10.1016/S0140-6736(14)60111-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24507376				2022-12-28	WOS:000331653300032
J	Gustafson, J; Shipilin, M; Zhang, C; Stierle, A; Hejral, U; Ruett, U; Gutowski, O; Carlsson, PA; Skoglundh, M; Lundgren, E				Gustafson, J.; Shipilin, M.; Zhang, C.; Stierle, A.; Hejral, U.; Ruett, U.; Gutowski, O.; Carlsson, P. -A.; Skoglundh, M.; Lundgren, E.			High-Energy Surface X-ray Diffraction for Fast Surface Structure Determination	SCIENCE			English	Article							PRESSURES. 2. PALLADIUM; PT-GROUP METALS; ULTRAHIGH-VACUUM; CO OXIDATION; CHEMISTRY; PLATINUM; OXIDE	Understanding the interaction between surfaces and their surroundings is crucial in many materials-science fields, such as catalysis, corrosion, and thin-film electronics, but existing characterization methods have not been capable of fully determining the structure of surfaces during dynamic processes, such as catalytic reactions, in a reasonable time frame. We demonstrate an x-ray-diffraction-based characterization method that uses high-energy photons (85 kiloelectron volts) to provide unexpected gains in data acquisition speed by several orders of magnitude and enables structural determinations of surfaces on time scales suitable for in situ studies. We illustrate the potential of high-energy surface x-ray diffraction by determining the structure of a palladium surface in situ during catalytic carbon monoxide oxidation and follow dynamic restructuring of the surface with subsecond time resolution.	[Gustafson, J.; Shipilin, M.; Zhang, C.; Lundgren, E.] Lund Univ, Synchrotron Radiat Res, SE-22100 Lund, Sweden; [Stierle, A.; Hejral, U.; Ruett, U.; Gutowski, O.] Deutsch Elektronen Synchrotron DESY, D-22603 Hamburg, Germany; [Stierle, A.; Hejral, U.] Univ Hamburg, Fachbereich Phys, D-20355 Hamburg, Germany; [Carlsson, P. -A.; Skoglundh, M.] Chalmers, Competence Ctr Catalysis, SE-41296 Gothenburg, Sweden	Lund University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Chalmers University of Technology	Gustafson, J (corresponding author), Lund Univ, Synchrotron Radiat Res, Box 118, SE-22100 Lund, Sweden.	johan.gustafson@sljus.lu.se	Lundgren, Edvin/F-5551-2010; Carlsson, Per-Anders/B-6777-2016; Hejral, Uta/ABE-1637-2020; Stierle, Andreas/Q-2679-2018; Shipilin, Mikhail/J-7135-2015; Skoglundh, Magnus/J-2472-2012	Carlsson, Per-Anders/0000-0001-6318-7966; Stierle, Andreas/0000-0002-0303-6282; Shipilin, Mikhail/0000-0003-1623-1578; Hejral, Uta/0000-0002-4393-0983; Skoglundh, Magnus/0000-0001-7946-7137	Swedish Research Council; Swedish Foundation for Strategic Research; Crafoord Foundation; Knut and Alice Wallenberg Foundation; Anna and Edwin Berger Foundation; German Federal Ministry of Education and Research (BMBF) [05K10PS1 NanoXcat]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Crafoord Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Anna and Edwin Berger Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work is done within the Rontgen-Angstrom collaboration "Catalysis on the atomic scale". The authors thank the Swedish Research Council, the Swedish Foundation for Strategic Research, the Crafoord Foundation, the Knut and Alice Wallenberg Foundation, the Anna and Edwin Berger Foundation, and the German Federal Ministry of Education and Research (BMBF) (project 05K10PS1 NanoXcat) for financial support. The raw diffraction data are available in databases S1 to S3.	Blomberg S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.117601; DOSCH H, 1988, PHYS REV LETT, V60, P2382, DOI 10.1103/PhysRevLett.60.2382; Ekerdt JG, 1996, CHEM REV, V96, P1499, DOI 10.1021/cr950236z; Ertl G., 2010, REACTIONS SOLID SURF; FEIDENHANSL R, 1989, SURF SCI REP, V10, P105, DOI 10.1016/0167-5729(89)90002-2; Gao F, 2010, J PHYS CHEM C, V114, P6874, DOI 10.1021/jp100134e; Kan HH, 2008, SURF SCI, V602, pL53, DOI 10.1016/j.susc.2008.03.007; Kostelnik P, 2007, SURF SCI, V601, P1574, DOI 10.1016/j.susc.2007.01.026; Luth H., 1993, SURFACES INTERFACES; ROBINSON IK, 1983, PHYS REV LETT, V50, P1145, DOI 10.1103/PhysRevLett.50.1145; Seriani N, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3187935; Sinfelt JH, 2002, SURF SCI, V500, P923, DOI 10.1016/S0039-6028(01)01532-1; Somorjai GA, 2011, P NATL ACAD SCI USA, V108, P917, DOI 10.1073/pnas.1006669107; Todorova M, 2003, SURF SCI, V541, P101, DOI 10.1016/S0039-6028(03)00873-2; van Rijn R, 2011, PHYS CHEM CHEM PHYS, V13, P13167, DOI 10.1039/c1cp20989b; van Rijn R, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3290420; van Rijn R, 2010, J PHYS CHEM C, V114, P6875, DOI 10.1021/jp911406x; Vlieg E, 2000, J APPL CRYSTALLOGR, V33, P401, DOI 10.1107/S0021889899013655; Zangwill A., 1988, PHYS SURFACES	19	112	111	2	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					758	761		10.1126/science.1246834	http://dx.doi.org/10.1126/science.1246834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24482118				2022-12-28	WOS:000331557800036
J	Kondo, S				Kondo, Shigeru			Self-Organizing Somites	SCIENCE			English	Editorial Material							VERTEBRATE SEGMENTATION; CLOCK; GENE; NUMBER		Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Kondo, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	shigerukondo@gmail.com		Kondo, Shigeru/0000-0003-0192-5526				COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dias AS, 2014, SCIENCE, V343, P791, DOI 10.1126/science.1247575; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Harima Y, 2013, CELL REP, V3, P1, DOI 10.1016/j.celrep.2012.11.012; LIM TM, 1987, DEVELOPMENT, V100, P525; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071	8	4	4	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					736	737		10.1126/science.1250245	http://dx.doi.org/10.1126/science.1250245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531958				2022-12-28	WOS:000331557800025
J	Zhao, L; Saelao, P; Jones, CD; Begun, DJ				Zhao, Li; Saelao, Perot; Jones, Corbin D.; Begun, David J.			Origin and Spread of de Novo Genes in Drosophila melanogaster Populations	SCIENCE			English	Article							YAKUBA	Comparative genomic analyses have revealed that genes may arise from ancestrally nongenic sequence. However, the origin and spread of these de novo genes within populations remain obscure. We identified 142 segregating and 106 fixed testis-expressed de novo genes in a population sample of Drosophila melanogaster. These genes appear to derive primarily from ancestral intergenic, unexpressed open reading frames, with natural selection playing a significant role in their spread. These results reveal a heretofore unappreciated dynamism of gene content.	[Zhao, Li; Saelao, Perot; Begun, David J.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhao, L (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	lizzhao@ucdavis.edu; djbegun@ucdavis.edu	Zhao, Li/E-8117-2015	Zhao, Li/0000-0001-6776-1996; SAELAO, PEROT/0000-0003-1171-9187	NIH [GM084056]; NSF [0920090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Begun lab for valuable comments, especially N. Svetec, J. Cridland, A. Sedghifar, T. Seher, and Y. Brandvain. We also thank three anonymous reviewers and M. W. Hahn, C. H. Langley, J. Anderson, and A. Kopp for comments and suggestions. We acknowledge Phyllis Wescott (1950-2011) for more than 30 years of service in the Drosophila media kitchen at UC Davis. Funded by NIH grant GM084056 (D.J.B.) and NSF grant 0920090 (C.D.J and D.J.B.).	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Graze RM, 2012, MOL BIOL EVOL, V29, P1521, DOI 10.1093/molbev/msr318; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Heinen TJAJ, 2009, CURR BIOL, V19, P1527, DOI 10.1016/j.cub.2009.07.049; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; KAPLAN NL, 1989, GENETICS, V123, P887; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; SCHWARTZ D, 1971, GENETICS, V67, P411; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Xiao WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004603; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	22	138	139	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					769	772		10.1126/science.1248286	http://dx.doi.org/10.1126/science.1248286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24457212	Green Accepted, Green Submitted			2022-12-28	WOS:000331557800039
J	Hobley, L; Kim, SH; Maezato, Y; Wyllie, S; Fairlamb, AH; Stanley-Wall, NR; Michael, AJ				Hobley, Laura; Kim, Sok Ho; Maezato, Yukari; Wyllie, Susan; Fairlamb, Alan H.; Stanley-Wall, Nicola R.; Michael, Anthony J.			Norspermidine Is Not a Self-Produced Trigger for Biofilm Disassembly	CELL			English	Article							BACILLUS-SUBTILIS BIOFILM; BIOSYNTHETIC-PATHWAY; ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; GAMMA-AMINOBUTYRATE; MICROBIAL BIOFILMS; VIBRIO-CHOLERAE; AMYLOID FIBERS; POLYAMINES; EXPRESSION	Formation of Bacillus subtilis biofilms, consisting of cells encapsulated within an extracellular matrix of exopolysaccharide and protein, requires the polyamine spermidine. A recent study reported that (1) related polyamine norspermidine is synthesized by B. subtilis using the equivalent of the Vibrio cholerae biosynthetic pathway, (2) exogenous norspermidine at 25 mu M prevents B. subtilis biofilm formation, (3) endogenous norspermidine is present in biofilms at 50-80 mu M, and (4) norspermidine prevents biofilm formation by condensing biofilm exopolysaccharide. In contrast, we find that, at concentrations up to 200 mu M, exogenous norspermidine promotes biofilm formation. We find that norspermidine is absent in wild-type B. subtilis biofilms at all stages, and higher concentrations of exogenous norspermidine eventually inhibit planktonic growth and biofilm formation in an exopolysaccharide-independent manner. Moreover, orthologs of the V. cholerae norspermidine biosynthetic pathway are absent from B. subtilis, confirming that norspermidine is not physiologically relevant to biofilm function in this species.	[Hobley, Laura; Stanley-Wall, Nicola R.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Kim, Sok Ho; Maezato, Yukari; Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wyllie, Susan; Fairlamb, Alan H.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland	University of Dundee; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Dundee	Stanley-Wall, NR (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.	n.r.stanleywall@dundee.ac.uk; anthony.michael@utsouthwestern.edu	Wyllie, Susan/AAI-4430-2021; Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329; Hobley, Laura/0000-0002-2153-0946; Wyllie, Susan/0000-0001-8810-5605; Stanley-Wall, Nicola/0000-0002-5936-9721	Biotechnology and Biological Sciences Research Council, UK [BB/I019464/1]; Wellcome Trust [079838, 098439/Z/12/(Z)]; High Impact/High Risk Award from UT South-western Medical Center; Biotechnology and Biological Sciences Research Council [BB/I019464/1] Funding Source: researchfish; BBSRC [BB/I019464/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); High Impact/High Risk Award from UT South-western Medical Center; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank David Mangelsdorf for helpful discussions and http://www.sarahjcgillespie.com for design work on the graphical abstract. This work was supported by grant BB/I019464/1 from the Biotechnology and Biological Sciences Research Council, UK (to N.R.S.-W.), by grant 079838 from the Wellcome Trust (to A. H. F.), and by a High Impact/High Risk Award from UT South-western Medical Center (to A.J.M.). Genome sequencing and analysis were performed at the Genomic Sequencing Unit, University of Dundee, which is funded by the Wellcome Trust Strategic Grant (098439/Z/12/(Z)). We thank Prof. Richard Losick for providing strain NCIB3610-H.	Belitsky BR, 2002, MOL MICROBIOL, V45, P569, DOI 10.1046/j.1365-2958.2002.03036.x; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; DOVER S, 1974, J BACTERIOL, V117, P494, DOI 10.1128/JB.117.2.494-501.1974; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Ikai H, 1997, J BACTERIOL, V179, P5118, DOI 10.1128/jb.179.16.5118-5125.1997; IKAI H, 1994, FEMS MICROBIOL LETT, V124, P225, DOI 10.1111/j.1574-6968.1994.tb07288.x; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Karatan E, 2013, BIOTECHNOL LETT, V35, P1715, DOI 10.1007/s10529-013-1286-3; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; Konkol MA, 2013, J BACTERIOL, V195, P4085, DOI 10.1128/JB.00696-13; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; MOUNTAIN A, 1986, J BACTERIOL, V165, P1026, DOI 10.1128/jb.165.3.1026-1028.1986; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021	38	42	48	2	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					844	854		10.1016/j.cell.2014.01.012	http://dx.doi.org/10.1016/j.cell.2014.01.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529384	Green Published, hybrid			2022-12-28	WOS:000331379800021
J	Morton, DC; Nagol, J; Carabajal, CC; Rosette, J; Palace, M; Cook, BD; Vermote, EF; Harding, DJ; North, PRJ				Morton, Douglas C.; Nagol, Jyoteshwar; Carabajal, Claudia C.; Rosette, Jacqueline; Palace, Michael; Cook, Bruce D.; Vermote, Eric F.; Harding, David J.; North, Peter R. J.			Amazon forests maintain consistent canopy structure and greenness during the dry season	NATURE			English	Article							TROPICAL FOREST; LEAF-AREA; CARBON; ALLOMETRY; FLUXES; MODIS; CO2; VARIABILITY; EMISSIONS; DROUGHT	The seasonality of sunlight and rainfall regulates net primary production in tropical forests(1). Previous studies have suggested that light is more limiting than water for tropical forest productivity(2), consistent with greening of Amazon forests during the dry season in satellite data(3-7). We evaluated four potential mechanisms for the seasonal green-up phenomenon, including increases in leaf area(5-7) or leaf reflectance(3,4,6), using a sophisticated radiative transfer model(8) and independent satellite observations from lidar and optical sensors. Here we show that the apparent green up of Amazon forests in optical remote sensing data resulted from seasonal changes in near-infrared reflectance, an artefact of variations in sun-sensor geometry. Correcting this bidirectional reflectance effect eliminated seasonal changes in surface reflectance, consistent with independent lidar observations and model simulations with unchanging canopy properties. The stability of Amazon forest structure and reflectance over seasonal timescales challenges the paradigm of light-limited net primary production in Amazon forests and enhanced forest growth during drought conditions. Correcting optical remote sensing data for artefacts of sun-sensor geometry is essential to isolate the response of global vegetation to seasonal and interannual climate variability.	[Morton, Douglas C.; Carabajal, Claudia C.; Rosette, Jacqueline; Cook, Bruce D.; Vermote, Eric F.; Harding, David J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Nagol, Jyoteshwar; Rosette, Jacqueline] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Nagol, Jyoteshwar] Global Land Cover Facil, College Pk, MD 20740 USA; [Carabajal, Claudia C.] Sigma Space Corp, Lanham, MD 20706 USA; [Rosette, Jacqueline; North, Peter R. J.] Swansea Univ, Dept Geog, Swansea SA2 8PP, W Glam, Wales; [Palace, Michael] Univ New Hampshire, Earth Syst Res Ctr, Durham, NH 03824 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Swansea University; University System Of New Hampshire; University of New Hampshire	Morton, DC (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	douglas.morton@nasa.gov	Nagol, Jyoteshwar/P-2026-2015; Vermote, Eric/K-3733-2012; Morton, Douglas C/D-5044-2012; Harding, David/F-5913-2012; North, Peter R.J./A-1616-2009; North, Peter/M-9794-2019	Nagol, Jyoteshwar/0000-0003-0497-7874; North, Peter R.J./0000-0001-9933-6935; North, Peter/0000-0001-9933-6935; Rosette, Jacqueline/0000-0002-2589-0244	NASA; NASA Postdoctoral Program; NERC National Centre for Earth Observation; Natural Environment Research Council [NE/F021437/1] Funding Source: researchfish; NERC [NE/F021437/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this research was provided by NASA, the NASA Postdoctoral Program and the NERC National Centre for Earth Observation. We thank G. P. Asner for providing Amazon leaf reflectance data.	Asner GP, 2002, BIOTROPICA, V34, P483, DOI 10.1111/j.1744-7429.2002.tb00568.x; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Breon FM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001094; Carabajal CC, 2006, PHOTOGRAMM ENG REM S, V72, P287, DOI 10.14358/PERS.72.3.287; Chevallier F, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049899; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DOUGHTY CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI DOI 10.1029/2007JG000590; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Gatti LV, 2010, TELLUS B, V62, P581, DOI 10.1111/j.1600-0889.2010.00484.x; Harding DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023471; Hilker T, 2012, REMOTE SENS ENVIRON, V127, P370, DOI 10.1016/j.rse.2012.08.035; Hilker T, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001692; Hofton MA, 2000, IEEE T GEOSCI REMOTE, V38, P1989, DOI 10.1109/36.851780; Huete A. R., 2008, LBA ECO LC 19 FIELD; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Joiner J, 2011, BIOGEOSCIENCES, V8, P637, DOI 10.5194/bg-8-637-2011; Keller M, 2001, FOREST ECOL MANAG, V154, P371, DOI 10.1016/S0378-1127(01)00509-6; Kim Y, 2012, GLOBAL CHANGE BIOL, V18, P1322, DOI 10.1111/j.1365-2486.2011.02629.x; KING DA, 1990, FUNCT ECOL, V4, P27, DOI 10.2307/2389648; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Morton DC, 2011, REMOTE SENS ENVIRON, V115, P1706, DOI 10.1016/j.rse.2011.03.002; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; North PRJ, 2010, INT J REMOTE SENS, V31, P1343, DOI 10.1080/01431160903380664; North PRJ, 1996, IEEE T GEOSCI REMOTE, V34, P946, DOI 10.1109/36.508411; Osunkoya OO, 2007, AM J BOT, V94, P1951, DOI 10.3732/ajb.94.12.1951; Palace M, 2008, BIOTROPICA, V40, P141, DOI 10.1111/J.1744-7429.2007.00353.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rahman AF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024127; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Samanta A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001818; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Schutz BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024009; Toomey M, 2009, REMOTE SENS ENVIRON, V113, P1787, DOI 10.1016/j.rse.2009.04.002; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vermote E, 2009, IEEE T GEOSCI REMOTE, V47, P898, DOI 10.1109/TGRS.2008.2005977; Vermote EF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009662; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	49	294	305	16	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					221	+		10.1038/nature13006	http://dx.doi.org/10.1038/nature13006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24499816	Green Published			2022-12-28	WOS:000331107700038
J	Wang, GY; Divall, S; Radovick, S; Paige, D; Ning, Y; Chen, Z; Ji, YL; Hong, XM; Walker, SO; Caruso, D; Pearson, C; Wang, MC; Zuckerman, B; Cheng, TL; Wang, XB				Wang, Guoying; Divall, Sara; Radovick, Sally; Paige, David; Ning, Yi; Chen, Zhu; Ji, Yuelong; Hong, Xiumei; Walker, Sheila O.; Caruso, Deanna; Pearson, Colleen; Wang, Mei-Cheng; Zuckerman, Barry; Cheng, Tina L.; Wang, Xiaobin			Preterm Birth and Random Plasma Insulin Levels at Birth and in Early Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR RISK-FACTORS; GLUCOSE-TOLERANCE; PREMATURE BIRTH; GENDER; GROWTH; FETAL; POLYMORPHISM; ASSOCIATION; SENSITIVITY; POPULATION	IMPORTANCE Although previous reports have linked preterm birth with insulin resistance in children and adults, it is not known whether altered insulin homeostasis is detectable at birth and tracks from birth through childhood. OBJECTIVE To investigate whether preterm birth is associated with elevated plasma insulin levels at birth and whether this association persists into early childhood. DESIGN, SETTING, AND PARTICIPANTS A prospective birth cohort of 1358 children recruited at birth from 1998 to 2010 and followed-up with prospectively from 2005 to 2012 at the Boston Medical Center in Massachusetts. MAIN OUTCOMES AND MEASURES Random plasma insulin levels were measured at 2 time points: at birth (cord blood) and in early childhood (venous blood). The median age was 1.4 years (interquartile range [IQR], 0.8-3.3) among 4 gestational age groups: full term (>= 39 wk), early term (37-38 wk), late preterm (34-36 wk), and early preterm (<34 wk). RESULTS The geometric mean of insulin levels at birth were 9.2 mu IU/mL (95% CI, 8.4-10.0) for full term; 10.3 mu IU/mL (95% CI, 9.3-11.5) for early term; 13.2 mu IU/mL (95% CI, 11.8-14.8) for late preterm; and 18.9 mu IU/mL (95% CI, 16.6-21.4) for early preterm. In early childhood, these levels were 11.2 mu IU/mL (95% CI, 10.3-12.0) for full term; 12.4 mu IU/mL (95% CI, 11.3-13.6) for early term; 13.3 mu IU/mL (95% CI, 11.9-14.8) for late preterm; and 14.6 mu IU/mL (95% CI, 12.6-16.9) for early preterm. Insulin levels at birth were higher by 1.13-fold (95% CI, 0.97-1.28) for early term, 1.45-fold (95% CI, 1.25-1.65) for late preterm, and 2.05-fold (95% CI, 1.69-2.42) for early preterm than for those born full term. In early childhood, random plasma insulin levels were 1.12-fold (95% CI, 0.99-1.25) higher for early term, 1.19-fold (95% CI, 1.02-1.35) for late preterm, and 1.31-fold (95% CI, 1.10-1.52) for early preterm than those born full term. The association was attenuated after adjustment for postnatal weight gain and was not significant after adjustment for insulin levels at birth. Infants ranked in the top insulin tertile at birth were more likely to remain in the top tertile (41.2%) compared with children ranked in the lowest tertile (28.6%) in early childhood. CONCLUSIONS AND RELEVANCE There was an inverse association between gestational age and elevated plasma insulin levels at birth and in early childhood. The implications for future development of insulin resistance and type 2 diabetes warrant further investigation.	[Wang, Guoying; Paige, David; Chen, Zhu; Ji, Yuelong; Hong, Xiumei; Walker, Sheila O.; Caruso, Deanna; Wang, Xiaobin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Early Life Origins Dis, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Divall, Sara; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21205 USA; [Ning, Yi] Virginia Commonwealth Univ, Sch Med, Div Epidemiol, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA; [Pearson, Colleen; Zuckerman, Barry] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Pearson, Colleen; Zuckerman, Barry] Boston Med Ctr, Boston, MA USA; [Wang, Mei-Cheng] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Cheng, Tina L.; Wang, Xiaobin] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Gen Pediat & Adolescent Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Virginia Commonwealth University; Boston University; Boston Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wang, XB (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Early Life Origins Dis, 615 N Wolfe St,E4132, Baltimore, MD 21205 USA.	xiwang@jhsph.edu	Chen, Zhu/M-3834-2015; Wang, Guoying/F-8908-2011	JI, Yuelong/0000-0001-6901-5030	March of Dimes PERI [20-FY02-56, 21-FY07-605]; Food Allergy Initiative; National Institutes of Health [R21 ES011666, R01 HD041702, R21HD066471, R21AI088609, U01AI090727]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041702, R24HD042854] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088609, U01AI090727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES011666] Funding Source: NIH RePORTER	March of Dimes PERI(March of Dimes); Food Allergy Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Boston Birth Cohort (the parent study) is supported in part by the March of Dimes PERI grants (20-FY02-56, #21-FY07-605), the Food Allergy Initiative, and the National Institutes of Health grants R21 ES011666, R01 HD041702, R21HD066471, R21AI088609, U01AI090727. We also acknowledge generous philanthropic support from the Ludwig Family Foundation.	Aldasouqi SA, 2013, JAMA INTERN MED, V173, P936, DOI 10.1001/jamainternmed.2013.398; [Anonymous], 2013, Obstet Gynecol, V121, P908, DOI 10.1097/01.AOG.0000428648.75548.00; [Anonymous], CHILD GROWTH STANDAR; Behrman RE, 2007, PRETERM BIRTH CAUSES; Casella G, 2002, STATISTICAL INFERENC; Centers for Disease Control and Prevention, GROWTH CHARTS; Centers for Disease Control and Prevention, MORBIDITY AND MORTAL; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Cutfield W, 2004, PEDIATR DIABETES, V5, P113; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hassink SG, 1996, PEDIATRICS, V98, P201; He J, 1999, ARCH INTERN MED, V159, P498, DOI 10.1001/archinte.159.5.498; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hong X, 2011, J ALLERGY CLIN IMMUN, V128; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hu G., 2004, DIABETOLOGIA, V47, P1245; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Hernandez MI, 2012, J PEDIATR ENDOCR MET, V25, P951, DOI 10.1515/jpem-2012-0184; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Khan I Y, 2003, J Matern Fetal Neonatal Med, V13, P292, DOI 10.1080/jmf.13.5.292.299; Kumar P, 2011, EARLY HUM DEV, V87, P559, DOI 10.1016/j.earlhumdev.2011.04.013; Kumar R, 2009, J ALLERGY CLIN IMMUN, V124, p[1031, e1]; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Martin SS, 2013, JAMA INTERN MED, V173, P935, DOI 10.1001/jamainternmed.2013.383; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Ouyang FX, 2013, OBESITY, V21, P609, DOI 10.1002/oby.20254; Perry IJ, 1996, AM J EPIDEMIOL, V144, P224, DOI 10.1093/oxfordjournals.aje.a008917; Perry IJ, 1999, INT J EPIDEMIOL, V28, P735, DOI 10.1093/ije/28.4.735; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Pisprasert V, 2013, DIABETES CARE, V36, P845, DOI 10.2337/dc12-0840; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Silva D, 2014, PEDIATRICS, V133, pE14, DOI 10.1542/peds.2013-1434; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Wang L, 2006, AM J HUM GENET, V78, P770, DOI 10.1086/503712; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; Wannamethee SG, 1999, STROKE, V30, P1780, DOI 10.1161/01.STR.30.9.1780; Yu YX, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.003; Zhang SC, 2009, J CLIN ENDOCR METAB, V94, P3497, DOI 10.1210/jc.2009-1060	41	113	114	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					587	596		10.1001/jama.2014.1	http://dx.doi.org/10.1001/jama.2014.1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519298	Bronze, Green Accepted			2022-12-28	WOS:000330941000014
J	Spence, D				Spence, Des			FROM THE FRONTLINE Scotland be brave: why I'm a unionist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2014	348								g1489	10.1136/bmj.g1489	http://dx.doi.org/10.1136/bmj.g1489			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WS	24518988				2022-12-28	WOS:000331444300019
J	Moghal, N				Moghal, Nadeem			Allowing patients to choose the ethnicity of attending doctors is institutional racism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									George Eliot Hosp, Nuneaton CV10 7DJ, Warwick, England		Moghal, N (corresponding author), George Eliot Hosp, Coll St, Nuneaton CV10 7DJ, Warwick, England.	nemoghal@googlemail.com						[Anonymous], 2013, NEWSMAX HLTH    0222; Stephen Lawrence Inquiry, 1999, REPORT INQUIRY W MAC	2	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g265	10.1136/bmj.g265	http://dx.doi.org/10.1136/bmj.g265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496385				2022-12-28	WOS:000331060200014
J	Jabbour, S				Jabbour, Samer			Health and contemporary change in the Arab world	LANCET			English	Editorial Material							COUNTRIES		Amer Univ Beirut, Fac Hlth Sci, Beirut 11072020, Lebanon	American University of Beirut	Jabbour, S (corresponding author), Amer Univ Beirut, Fac Hlth Sci, POB 11-0236, Beirut 11072020, Lebanon.	sjabbour@aub.edu.lb	Jabbour, Samer/Y-6860-2018	Jabbour, Samer/0000-0002-7150-6856				[Anonymous], 2013, BELL M RES HLTH DRIV; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Benamer HTS, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-26; Bredan A, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.6325; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; El-Jardali F, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-39; El-Zein A, 2014, LANCET, V383, P458, DOI 10.1016/S0140-6736(13)62338-7; Ghannem Hassen, 2011, East Mediterr Health J, V17, P260; Jabbour S, 2012, PUBLIC HTLH ARAB WOR; Jabbour S, 2006, BMJ-BRIT MED J, V333, P837, DOI 10.1136/bmj.38980.664074.94; Kennedy A., 2008, Eastern Mediterranean Health Journal, V14, P502; Saleh SS, 2014, LANCET, V383, P368, DOI 10.1016/S0140-6736(13)62339-9; Smith R, 2013, BMJ GROUP BLOGS 0305; Tell T, 2014, LANCET, V383, P480, DOI 10.1016/S0140-6736(13)62548-9	14	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					477	479		10.1016/S0140-6736(13)62567-2	http://dx.doi.org/10.1016/S0140-6736(13)62567-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452052				2022-12-28	WOS:000330673700036
J	Zurayk, H; Giacaman, R; Jabbour, S; Husseini, A; DeJong, J; Hogan, D; Khawaja, M; Obermeyer, CM; Nuwayhid, I; Rashad, H; Tekce, B				Zurayk, Huda; Giacaman, Rita; Jabbour, Samer; Husseini, Abdullatif; DeJong, Jocelyn; Hogan, Dennis; Khawaja, Marwan; Obermeyer, Carla Makhlouf; Nuwayhid, Iman; Rashad, Hoda; Tekce, Belgin			The making of the Lancet Series on health in the Arab world	LANCET			English	Editorial Material									[Zurayk, Huda; Jabbour, Samer; DeJong, Jocelyn; Obermeyer, Carla Makhlouf; Nuwayhid, Iman] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon; [Giacaman, Rita; Husseini, Abdullatif] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Hogan, Dennis] Brown Univ, Providence, RI 02912 USA; [Khawaja, Marwan] United Nations Econ & Social Commiss Western Asia, Beirut, Lebanon; [Rashad, Hoda] Amer Univ Cairo, Social Res Ctr, New Cairo, Egypt; [Tekce, Belgin] Bogazici Univ, Fac Arts & Sci, Istanbul, Turkey	American University of Beirut; Birzeit University; Brown University; Egyptian Knowledge Bank (EKB); American University Cairo; Bogazici University	Zurayk, H (corresponding author), Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon.	hzurayk@aub.edu.lb	Jabbour, Samer/Y-6860-2018; Husseini, Abdullatif/E-8377-2015	Jabbour, Samer/0000-0002-7150-6856; Husseini, Abdullatif/0000-0001-8767-5956				Jabbour S, 2012, PUBLIC HEALTH IN THE ARABWORLD, P1	1	1	1	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					393	395		10.1016/S0140-6736(13)62370-3	http://dx.doi.org/10.1016/S0140-6736(13)62370-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452047				2022-12-28	WOS:000330673700010
J	Wan, Y; Qu, K; Zhang, QC; Flynn, RA; Manor, O; Ouyang, ZQ; Zhang, JJ; Spitale, RC; Snyder, MP; Segal, E; Chang, HY				Wan, Yue; Qu, Kun; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Manor, Ohad; Ouyang, Zhengqing; Zhang, Jiajing; Spitale, Robert C.; Snyder, Michael P.; Segal, Eran; Chang, Howard Y.			Landscape and variation of RNA secondary structure across the human transcriptome	NATURE			English	Article							REVEALS; ALIGNMENT; SHAPE	In parallel to the genetic code for protein synthesis, a second layer of information is embedded in all RNA transcripts in the form of RNA structure. RNA structure influences practically every step in the gene expression program(1). However, the nature of most RNA structures or effects of sequence variation on structure are not known. Here we report the initial landscape and variation of RNA secondary structures (RSSs) in a human family trio (mother, father and their child). This provides a comprehensive RSS map of human coding and non-coding RNAs. We identify unique RSS signatures that demarcate open reading frames and splicing junctions, and define authentic micro RNA-binding sites. Comparison of native deproteinized RNA isolated from cells versus refolded purified RNA suggests that the majority of the RSS information is encoded within RNA sequence. Over 1,900 transcribed single nucleotide variants (approximately 15% of all transcribed single nucleotide variants) alter local RNA structure. We discover simple sequence and spacing rules that determine the ability of point mutations to impact RSSs. Selective depletion of 'riboSNitches' versus structurally synonymous variants at precise locations suggests selection for specific RNA shapes at thousands of sites, including 3' untranslated regions, binding sites of microRNAs and RNA-binding proteins genome-wide. These results highlight the potentially broad contribution of RNA structure and its variation to gene regulation.	[Wan, Yue; Qu, Kun; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Ouyang, Zhengqing; Zhang, Jiajing; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wan, Yue; Qu, Kun; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Ouyang, Zhengqing; Zhang, Jiajing; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Wan, Yue] Genome Inst Singapore, Singapore 138672, Singapore; [Manor, Ohad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Weizmann Institute of Science; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	wany@gis.a-star.edu.sg; howchang@stanford.edu	Segal, Eran/AAF-4855-2019; Zhang, Qiangfeng/C-2902-2011; Qu, Kun/G-3359-2012	Snyder, Michael/0000-0003-0784-7987; Segal, Eran/0000-0002-6859-1164; Flynn, Ryan/0000-0001-5013-0442	NIH [R01-HG004361]; NATIONAL CANCER INSTITUTE [P30CA034196, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Chang laboratory, S. Rouskin, and J. Weissman, A. Mele and R. Darnell for discussion. This work is supported by NIH R01-HG004361 (H.Y.C. and E.S.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Marin RM, 2012, RNA, V18, P1760, DOI 10.1261/rna.033282.112; Ouyang ZQ, 2013, GENOME RES, V23, P377, DOI 10.1101/gr.138545.112; Ritz J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S6; Salari R, 2013, NUCLEIC ACIDS RES, V41, P44, DOI 10.1093/nar/gks1009; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249	26	358	366	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					706	+		10.1038/nature12946	http://dx.doi.org/10.1038/nature12946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476892	Green Submitted, Green Accepted			2022-12-28	WOS:000330321000046
J	Sorita, A; Ahmed, A; Starr, SR; Thompson, KM; Reed, DA; Prokop, L; Shah, ND; Murad, MH; Ting, HH				Sorita, Atsushi; Ahmed, Adil; Starr, Stephanie R.; Thompson, Kristine M.; Reed, Darcy A.; Prokop, Larry; Shah, Nilay D.; Murad, M. Hassan; Ting, Henry H.			Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; IN-HOSPITAL MORTALITY; ROUTINE DUTY HOURS; PRIMARY ANGIOPLASTY; SYMPTOM ONSET; UNITED-STATES; WORKING HOURS; DOOR; CARE	Objective To assess the association between off-hour (weekends and nights) presentation, door to balloon times, and mortality in patients with acute myocardial infarction. Data sources Medline in-process and other non-indexed citations, Medline, Embase, Cochrane Database of Systematic Reviews, and Scopus through April 2013. Study selection Any study that evaluated the association between time of presentation to a healthcare facility and mortality or door to balloon times among patients with acute myocardial infarction was included. Data extraction Studies' characteristics and outcomes data were extracted. Quality of studies was assessed with the Newcastle-Ottawa scale. A random effect meta-analysis model was applied. Heterogeneity was assessed using the Q statistic and I-2. Results 48 studies with fair quality, enrolling 1 896 859 patients, were included in the meta-analysis. 36 studies reported mortality outcomes for 1 892 424 patients with acute myocardial infarction, and 30 studies reported door to balloon times for 70 534 patients with ST elevation myocardial infarction (STEMI). Off-hour presentation for patients with acute myocardial infarction was associated with higher short term mortality (odds ratio 1.06, 95% confidence interval 1.04 to 1.09). Patients with STEMI presenting during off-hours were less likely to receive percutaneous coronary intervention within 90 minutes (odds ratio 0.40, 0.35 to 0.45) and had longer door to balloon time by 14.8 (95% confidence interval 10.7 to 19.0) minutes. A diagnosis of STEMI and countries outside North America were associated with larger increase in mortality during off-hours. Differences in mortality between off-hours and regular hours have increased in recent years. Analyses were associated with statistical heterogeneity. Conclusion This systematic review suggests that patients with acute myocardial infarction presenting during off-hours have higher mortality, and patients with STEMI have longer door to balloon times. Clinical performance measures may need to account for differences arising from time of presentation to a healthcare facility.	[Sorita, Atsushi; Murad, M. Hassan] Mayo Clin, Div Prevent Med, Rochester, MN 55905 USA; [Ahmed, Adil] Mayo Clin, Div Pulm & Crit Care, Rochester, MN 55905 USA; [Starr, Stephanie R.] Mayo Clin, Div Community Pediat & Adolescent Med, Rochester, MN 55905 USA; [Thompson, Kristine M.] Mayo Clin, Dept Emergency Med, Jacksonville, FL 32224 USA; [Reed, Darcy A.] Mayo Clin, Div Primary Care Internal Med, Rochester, MN 55905 USA; [Prokop, Larry] Mayo Clin, Mayo Clin Lib, Rochester, MN 55905 USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA; [Ting, Henry H.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ting, HH (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	Ting.Henry@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Murad, Mohammad Hassan/0000-0001-5502-5975	Mayo Clinic Division of Cardiovascular Diseases; Mayo Clinic Quality Academy; Mayo Clinic College of Medicine; Mayo Clinic Center for Science of Healthcare Delivery	Mayo Clinic Division of Cardiovascular Diseases; Mayo Clinic Quality Academy; Mayo Clinic College of Medicine; Mayo Clinic Center for Science of Healthcare Delivery	Mayo Clinic Division of Cardiovascular Diseases, Mayo Clinic Quality Academy, Mayo Clinic College of Medicine, and Mayo Clinic Center for Science of Healthcare Delivery. Researchers were independent from funders and sponsors, and the study sponsor did not have any influence on the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit it for publication.	Abi Rafeh Nidal, 2009, J Healthc Qual, V31, P35; Afolabi BA, 2007, EMERG MED J, V24, P588, DOI 10.1136/emj.2007.047373; Ahmar W, 2008, INTERN MED J, V38, P714, DOI 10.1111/j.1445-5994.2007.01476.x; Al Faleh HF, 2012, ANN SAUDI MED, V32, P366, DOI 10.5144/0256-4947.2012.366; Albuquerque Gustavo Oliveira de, 2009, Rev. Bras. Cardiol. Invasiva, V17, P52, DOI 10.1590/S2179-83972009000100011; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; [Anonymous], 2012, ACUTE MYOCARDIAL INF; Assali AR, 2006, CATHETER CARDIO INTE, V67, P221, DOI 10.1002/ccd.20608; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Becker D, 2009, CROAT MED J, V50, P476, DOI 10.3325/cmj.2009.50.476; Becker DJ, 2007, HEALTH SERV RES, V42, P1589, DOI 10.1111/j.1475-6773.2006.00663.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Beohar N, 2001, J Invasive Cardiol, V13, P669; Berger A, 2008, AM J CARDIOL, V101, P422, DOI 10.1016/j.amjcard.2007.09.092; Cardoso Cristiano de Oliveira, 2010, Rev. Bras. Cardiol. Invasiva, V18, P273, DOI 10.1590/S2179-83972010000300008; Casella G, 2011, JACC-CARDIOVASC INTE, V4, P270, DOI 10.1016/j.jcin.2010.11.012; Cavallazzi R, 2010, CHEST, V138, P68, DOI 10.1378/chest.09-3018; Clarke MS, 2010, INTERN MED J, V40, P777, DOI 10.1111/j.1445-5994.2009.02067.x; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Cubeddu RJ, 2013, AM J CARDIOL, V111, P946, DOI 10.1016/j.amjcard.2012.11.062; Cubeddu RJ, 2009, J INVASIVE CARDIOL, V21, P518; de Boer SPM, 2012, EUR HEART J-ACUTE CA, V1, P33, DOI 10.1177/2048872612441581; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Detsky AS, 2013, JAMA-J AM MED ASSOC, V309, P987, DOI 10.1001/jama.2013.620; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Evangelista Patricia Alves, 2008, Arq Bras Cardiol, V90, P119; Garceau P, 2007, CAN J CARDIOL, V23, p53B, DOI 10.1016/S0828-282X(07)71011-5; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Glaser R, 2008, JACC-CARDIOVASC INTE, V1, P681, DOI 10.1016/j.jcin.2008.08.020; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gonzalez MA, 2010, CATHETER CARDIO INTE, V76, P484, DOI 10.1002/ccd.22515; Graham MM, 2011, BMJ QUAL SAF, V20, P60, DOI 10.1136/bmjqs.2010.041137; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Hansen KW, 2013, INT J CARDIOL, V168, P1167, DOI 10.1016/j.ijcard.2012.11.071; Henriques JPS, 2003, J AM COLL CARDIOL, V41, P2138, DOI 10.1016/S0735-1097(03)00461-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P88, DOI 10.1016/j.jcin.2007.10.002; Hong JS, 2010, CIRC J, V74, P496, DOI 10.1253/circj.CJ-09-0678; Horst MA, 2012, AM J MED QUAL, V27, P16, DOI 10.1177/1062860611409199; Jneid H, 2008, CIRCULATION, V117, P2502, DOI 10.1161/CIRCULATIONAHA.107.752113; Khot UN, 2007, CIRCULATION, V116, P67, DOI 10.1161/CIRCULATIONAHA.106.677401; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Kruth P, 2008, CLIN RES CARDIOL, V97, P742, DOI 10.1007/s00392-008-0671-8; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Kulkarni VT, 2013, CIRC-CARDIOVASC QUAL, V6, P352, DOI 10.1161/CIRCOUTCOMES.113.000214; Lairez O, 2009, ARCH CARDIOVASC DIS, V102, P811, DOI 10.1016/j.acvd.2009.09.010; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Maier B, 2010, CLIN RES CARDIOL, V99, P565, DOI 10.1007/s00392-010-0158-2; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Murad MH, 2008, J VASC SURG, V48, p26S, DOI 10.1016/j.jvs.2008.08.045; Nakamura M, 2013, CARDIOVASC INTERV TH, V28, P30, DOI 10.1007/s12928-012-0128-x; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Noman A, 2012, EUR HEART J, V33, P3046, DOI 10.1093/eurheartj/ehs261; Ortolani P, 2007, AM HEART J, V154, P366, DOI 10.1016/j.ahj.2007.04.025; Parikh SV, 2008, AM HEART J, V155, P290, DOI 10.1016/j.ahj.2007.10.021; Pathak EB, 2008, AM J CARDIOL, V102, P802, DOI 10.1016/j.amjcard.2008.05.023; Pedersen S, 2009, CIRC-CARDIOVASC INTE, V2, P392, DOI 10.1161/CIRCINTERVENTIONS.108.845636; Peterson J., 2000, NEWCASTLE OTTAWA SCA; Pollack Charles V Jr, 2009, Crit Pathw Cardiol, V8, P29, DOI 10.1097/HPC.0b013e3181980f9f; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Rodriguez-Leor O, 2011, REV ESP CARDIOL, V64, P476, DOI [10.1016/j.recesp.2011.02.007, 10.1016/j.rec.2011.02.011]; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; Sadeghi HM, 2004, AM J CARDIOL, V94, P637, DOI 10.1016/j.amjcard.2004.05.030; Siudak Z, 2011, KARDIOL POL, V69, P1017; Slonka G, 2007, KARDIOL POL, V65, P1171; Srimahachota Suphot, 2007, Journal of the Medical Association of Thailand, V90, P45; Ting HH, 2008, ARCH INTERN MED, V168, P959, DOI 10.1001/archinte.168.9.959; Ting HH, 2010, ARCH INTERN MED, V170, P1834, DOI 10.1001/archinternmed.2010.385; Uyarel H, 2009, CATHETER CARDIO INTE, V74, P826, DOI 10.1002/ccd.22154; Wong HJ, 2011, J GEN INTERN MED, V26, P1050, DOI 10.1007/s11606-011-1715-8; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	76	135	141	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2014	348								f7393	10.1136/bmj.f7393	http://dx.doi.org/10.1136/bmj.f7393			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AS	24452368	hybrid, Green Published			2022-12-28	WOS:000330296900001
J	Chen, Y; Copeland, WK; Vedanthan, R; Grant, E; Lee, JE; Gu, DF; Gupta, PC; Ramadas, K; Inoue, M; Tsugane, S; Tamakoshi, A; Gao, YT; Yuan, JM; Shu, XO; Ozasa, K; Tsuji, I; Kakizaki, M; Tanaka, H; Nishino, Y; Chen, CJ; Wang, RW; Yoo, KY; Ahn, YO; Ahsan, H; Pan, WH; Chen, CS; Pednekar, MS; Sauvaget, C; Sasazuki, S; Yang, G; Koh, WP; Xiang, YB; Ohishi, W; Watanabe, T; Sugawara, Y; Matsuo, K; You, SL; Park, SK; Kim, DH; Parvez, F; Chuang, SY; Ge, WZ; Rolland, B; McLerran, D; Sinha, R; Thornquist, M; Kang, D; Feng, Z; Boffetta, P; Zheng, W; He, J; Potter, JD				Chen, Yu; Copeland, Wade K.; Vedanthan, Rajesh; Grant, Eric; Lee, Jung Eun; Gu, Dongfeng; Gupta, Prakash C.; Ramadas, Kunnambath; Inoue, Manami; Tsugane, Shoichiro; Tamakoshi, Akiko; Gao, Yu-Tang; Yuan, Jian-Min; Shu, Xiao-Ou; Ozasa, Kotaro; Tsuji, Ichiro; Kakizaki, Masako; Tanaka, Hideo; Nishino, Yoshikazu; Chen, Chien-Jen; Wang, Renwei; Yoo, Keun-Young; Ahn, Yoon-Ok; Ahsan, Habibul; Pan, Wen-Harn; Chen, Chung-Shiuan; Pednekar, Mangesh S.; Sauvaget, Catherine; Sasazuki, Shizuka; Yang, Gong; Koh, Woon-Puay; Xiang, Yong-Bing; Ohishi, Waka; Watanabe, Takashi; Sugawara, Yumi; Matsuo, Keitaro; You, San-Lin; Park, Sue K.; Kim, Dong-Hyun; Parvez, Faruque; Chuang, Shao-Yuan; Ge, Wenzhen; Rolland, Betsy; McLerran, Dale; Sinha, Rashmi; Thornquist, Mark; Kang, Daehee; Feng, Ziding; Boffetta, Paolo; Zheng, Wei; He, Jiang; Potter, John D.			Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; INDIVIDUAL PATIENT DATA; ALL-CAUSE MORTALITY; MIDDLE-AGED MEN; FAT-FREE MASS; RISK-FACTORS; FOLLOW-UP; WEIGHT CHANGE; HEMORRHAGIC STROKE; ISCHEMIC-STROKE	Objective To evaluate the association between body mass index and mortality from overall cardiovascular disease and specific subtypes of cardiovascular disease in east and south Asians. Design Pooled analyses of 20 prospective cohorts in Asia, including data from 835 082 east Asians and 289 815 south Asians. Cohorts were identified through a systematic search of the literature in early 2008, followed by a survey that was sent to each cohort to assess data availability. Setting General populations in east Asia (China, Taiwan, Singapore, Japan, and Korea) and south Asia (India and Bangladesh). Participants 1 124 897 men and women (mean age 53.4 years at baseline). Main outcome measures Risk of death from overall cardiovascular disease, coronary heart disease, stroke, and (in east Asians only) stroke subtypes. Results 49 184 cardiovascular deaths (40 791 in east Asians and 8393 in south Asians) were identified during a mean follow-up of 9.7 years. East Asians with a body mass index of 25 or above had a raised risk of death from overall cardiovascular disease, compared with the reference range of body mass index (values 22.5-24.9; hazard ratio 1.09 (95% confidence interval 1.03 to 1.15), 1.27 (1.20 to 1.35), 1.59 (1.43 to 1.76), 1.74 (1.47 to 2.06), and 1.97 (1.44 to 2.71) for body mass index ranges 25.0-27.4, 27.5-29.9, 30.0-32.4, 32.5-34.9, and 35.0-50.0, respectively). This association was similar for risk of death from coronary heart disease and ischaemic stroke; for haemorrhagic stroke, the risk of death was higher at body mass index values of 27.5 and above. Elevated risk of death from cardiovascular disease was also observed at lower categories of body mass index (hazard ratio 1.19 (95% confidence interval 1.02 to 1.39) and 2.16 (1.37 to 3.40) for body mass index ranges 15.0-17.4 and <15.0, respectively), compared with the reference range. In south Asians, the association between body mass index and mortality from cardiovascular disease was less pronounced than that in east Asians. South Asians had an increased risk of death observed for coronary heart disease only in individuals with a body mass index greater than 35 (hazard ratio 1.90, 95% confidence interval 1.15 to 3.12). Conclusions Body mass index shows a U shaped association with death from overall cardiovascular disease among east Asians: increased risk of death from cardiovascular disease is observed at lower and higher ranges of body mass index. A high body mass index is a risk factor for mortality from overall cardiovascular disease and for specific diseases, including coronary heart disease, ischaemic stroke, and haemorrhagic stroke in east Asians. Higher body mass index is a weak risk factor for mortality from cardiovascular disease in south Asians.	[Chen, Yu; Ge, Wenzhen] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Copeland, Wade K.; Rolland, Betsy; McLerran, Dale; Thornquist, Mark; Potter, John D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Vedanthan, Rajesh] Icahn Sch Med Mt Sinai, Zena & Michael Wiener Cardiovasc Inst, New York, NY USA; [Grant, Eric; Ozasa, Kotaro] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan; [Lee, Jung Eun] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Gu, Dongfeng] Chinese Acad Med Sci, Dept Evidence Based Med, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Dept Populat Genet & Prevent, Fu Wai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gupta, Prakash C.; Pednekar, Mangesh S.] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India; [Ramadas, Kunnambath] Reg Canc Ctr, Div Radiat Oncol, Trivandrum 695011, Kerala, India; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Yuan, Jian-Min; Wang, Renwei] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Shu, Xiao-Ou; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Sch Med, Dept Med,Div Epidemiol, Vanderbilt Epidemiol Ctr,Vanderbilt Ingram Canc C, Nashville, TN 37212 USA; [Tsuji, Ichiro; Kakizaki, Masako] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Tanaka, Hideo; Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Sendai, Miyagi, Japan; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yoo, Keun-Young; Ahn, Yoon-Ok; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Human Genet, Chicago, IL 60637 USA; [Pan, Wen-Harn; Chuang, Shao-Yuan] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chung-Shiuan; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Sauvaget, Catherine] Int Agcy Res Canc, Screening Grp, F-69372 Lyon, France; [Koh, Woon-Puay] Natl Univ Singapore, Duke NUS Grad Med Sch Singapore, Singapore 117548, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan; [Watanabe, Takashi; Sugawara, Yumi] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [You, San-Lin] Fu Jen Catholic Univ, Dept Publ Hlth, Taipei, Taiwan; [Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Canc Res Inst, Seoul, South Korea; [Kim, Dong-Hyun] Hallym Univ, Coll Med, Dept Social & Prevent Med, Seoul, South Korea; [Parvez, Faruque] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst & Inst Translat Epidemiol, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Potter, John D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	New York University; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Radiation Effects Research Foundation - Japan; Sookmyung Women's University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Cancer Center - Japan; Hokkaido University; University of Tokyo; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Tohoku University; Aichi Cancer Center; Miyagi Cancer Center; Academia Sinica - Taiwan; National Taiwan University; Seoul National University (SNU); Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; Tulane University; World Health Organization; International Agency for Research on Cancer (IARC); National University of Singapore; National University of Singapore; Radiation Effects Research Foundation - Japan; Tohoku University; Fu Jen Catholic University; Seoul National University (SNU); Hallym University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai; Massey University; University of Texas System; UTMD Anderson Cancer Center; Kyushu University; University of Washington; University of Washington Seattle	Potter, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	yu.chen@nyumc.org	Chuang, Shao-Yuan/B-3478-2011; Lee, Jung Eun/AAC-5634-2020; Gao, Y./GWZ-3665-2022; Chen, Chien-Jen/C-6976-2008; Sinha, Rashmi/G-7446-2015; Tsugane, Shoichiro/A-2424-2015; Pan, Wen-Harn/F-9972-2010; Kakizaki, Masako/GWV-7453-2022; He, Jiang/AAF-5303-2020; Boffetta, Paolo/AAI-7767-2021; Ge, Wenzhen/J-4689-2019; Gao, Yu/HGE-1937-2022; Kakizaki, Masako/AAG-1368-2020; OZASA, Kotaro/ABF-3001-2020; Tanaka, Hideo/A-8145-2016; Chen, Chien-Jen/N-4723-2019; gao, yi/HCI-8298-2022; Matsuo, Keitaro/H-6758-2019; Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022; CHUANG, shao-yuan/ABB-4057-2020	Lee, Jung Eun/0000-0003-1141-878X; Sinha, Rashmi/0000-0002-2466-7462; Tsugane, Shoichiro/0000-0003-4105-2774; Pan, Wen-Harn/0000-0001-9136-0658; Kakizaki, Masako/0000-0001-6030-8953; He, Jiang/0000-0002-8286-9652; Boffetta, Paolo/0000-0002-3811-2791; Kakizaki, Masako/0000-0001-6030-8953; OZASA, Kotaro/0000-0002-5637-1383; Matsuo, Keitaro/0000-0003-1761-6314; Zheng, Wei/0000-0003-1226-070X; CHUANG, shao-yuan/0000-0003-2138-4771; You, San-Lin/0000-0002-3192-3356; Sauvaget, Catherine/0000-0002-8053-4963; Chen, Yu/0000-0002-1519-4894; Vedanthan, Rajesh/0000-0001-7138-2382; Potter, John/0000-0001-5439-1500; Kang, Daehee/0000-0003-4031-5878; Yuan, Jian-Min/0000-0002-4620-3108; Pednekar, Mangesh/0000-0001-6266-5356	US National Cancer Institute at the National Institutes of Health [R03CA150038]; Fred Hutchinson Cancer Research Center; Ministry of Health, Labour and Welfare, Japan; Radiation Effects Research Foundation (RERF); Ministry of Education, Culture, Sports, Science and Technology, Japan; China National Hypertension Survey Epidemiology Follow-up Study (CHEFS); American Heart Association [9750612N]; National Heart, Lung, and Blood Institute [U01 HL072507]; Chinese Academy of Medical Sciences Shanghai Cohort Study (SCS); National Institutes for Health [R01CA0403092, R01CA144034, R37CA70867, R01CA55069, R35CA53890, R01CA80205, P42ES010349, R01CA102484, R01CA107431]; Shanghai Men's Health Study (SMHS; National Institutes for Health [RO1 CA 82729]; Shanghai Women's Health Study (SWHS); Community-Based Cancer Screening Project (CBCSP); National Science Council and Department of Health, Taiwan; Disease risk FACtor Two-township Study (CVDFACTS); Department of Health, Taiwan [DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, DOH84-TD-006]; Korea Multi-center Cancer Cohort (KMCC); Ministry of Education, Science and Technology, Korea [2009-0087452]; National Research Foundation of Korea [2009-0087452]; Singapore Chinese Health Study (SCHS); Health Effects of Arsenic Longitudinal Study (HEALS); Trivandrum Oral Cancer Screening (TOCS) trial (Association for International Cancer Research, Scotland, UK; and Cancer Research UK); Mumbai Cohort Study (MCS); International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, UK; World Health Organisation, Geneva, Switzerland; FOGARTY INTERNATIONAL CENTER [K01TW009218] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA082729, R01CA055069, R01CA144034, R01CA107431, P30CA016672, UM1CA173640, R01CA102484, R37CA070867, R01CA080205, R35CA053890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	US National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fred Hutchinson Cancer Research Center; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Radiation Effects Research Foundation (RERF); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China National Hypertension Survey Epidemiology Follow-up Study (CHEFS); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chinese Academy of Medical Sciences Shanghai Cohort Study (SCS); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Men's Health Study (SMHS; National Institutes for Health; Shanghai Women's Health Study (SWHS); Community-Based Cancer Screening Project (CBCSP); National Science Council and Department of Health, Taiwan; Disease risk FACtor Two-township Study (CVDFACTS); Department of Health, Taiwan; Korea Multi-center Cancer Cohort (KMCC); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Singapore Chinese Health Study (SCHS); Health Effects of Arsenic Longitudinal Study (HEALS); Trivandrum Oral Cancer Screening (TOCS) trial (Association for International Cancer Research, Scotland, UK; and Cancer Research UK); Mumbai Cohort Study (MCS); International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, UK; World Health Organisation, Geneva, Switzerland(World Health Organization); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the US National Cancer Institute at the National Institutes of Health (R03CA150038) and by the Fred Hutchinson Cancer Research Center. The cohorts participating in the pooled analysis were supported by the following grants: 3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC), Japan Public Health Center-Based Study 1 (JPHC1), Japan Public Health Center-Based Study 2 (JPHC2), and 3-Prefecture Miyagi, Miyagi, Ohsaki (National Cancer Center Research and Development Fund, A Grant-in-Aid for Cancer Research; Grant for Health Services and Grant for Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare, Japan; Grant for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan); Radiation Effects Research Foundation (RERF; Hiroshima and Nagasaki, Japan is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour, and Welfare and the US Department of Energy; grant for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan); China National Hypertension Survey Epidemiology Follow-up Study (CHEFS; American Heart Association (9750612N); National Heart, Lung, and Blood Institute (U01 HL072507)); Chinese Academy of Medical Sciences Shanghai Cohort Study (SCS; National Institutes for Health (R01CA0403092, R01CA144034)); Shanghai Men's Health Study (SMHS; National Institutes for Health (RO1 CA 82729)); Shanghai Women's Health Study (SWHS; National Institutes for Health (R37CA70867)); Community-Based Cancer Screening Project (CBCSP; National Science Council and Department of Health, Taiwan); Disease risk FACtor Two-township Study (CVDFACTS; Department of Health, Taiwan (DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, and DOH84-TD-006)); Korea Multi-center Cancer Cohort (KMCC; Ministry of Education, Science and Technology, Korea (2009-0087452), National Research Foundation of Korea (2009-0087452)); Singapore Chinese Health Study (SCHS; National Institutes for Health (R01CA55069, R35CA53890, R01CA80205, R01CA144034)); Health Effects of Arsenic Longitudinal Study (HEALS; National Institutes for Health (P42ES010349, R01CA102484, R01CA107431)); Trivandrum Oral Cancer Screening (TOCS) trial (Association for International Cancer Research, Scotland, UK; and Cancer Research UK); Mumbai Cohort Study (MCS; International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, UK; World Health Organisation, Geneva, Switzerland).	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; Boffetta P, 2012, ANN ONCOL, V23, P1894, DOI 10.1093/annonc/mdr562; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bonaventure A, 2010, ATHEROSCLEROSIS, V210, P243, DOI 10.1016/j.atherosclerosis.2009.10.043; Chei CL, 2008, INT J OBESITY, V32, P144, DOI 10.1038/sj.ijo.0803686; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Chen ZM, 2006, INT J EPIDEMIOL, V35, P141, DOI 10.1093/ije/dyi215; Cho LY, 2009, ANN EPIDEMIOL, V19, P644, DOI 10.1016/j.annepidem.2009.04.011; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; COX DR, 1972, J R STAT SOC B, V34, P187; Cui RZ, 2005, STROKE, V36, P1377, DOI 10.1161/01.STR.0000169925.57251.4e; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; FOX AJ, 1982, J EPIDEMIOL COMMUN H, V36, P69, DOI 10.1136/jech.36.2.69; FREEDMAN LS, 1992, AM J EPIDEMIOL, V136, P1148, DOI 10.1093/oxfordjournals.aje.a116581; Funada S, 2008, PREV MED, V47, P66, DOI 10.1016/j.ypmed.2008.03.010; Goldstein LB, 2001, CIRCULATION, V103, P163; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jood K, 2004, STROKE, V35, P2764, DOI 10.1161/01.STR.0000147715.58886.ad; KAGAN A, 1980, STROKE, V11, P14, DOI 10.1161/01.STR.11.1.14; KONISHI M, 1993, STROKE, V24, P954, DOI 10.1161/01.STR.24.7.954; Kuriyama S, 2004, J EPIDEMIOL, V14, pS33, DOI 10.2188/jea.14.S33; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Marugame T, 2005, CANCER SCI, V96, P120, DOI 10.1111/j.1349-7006.2005.00013.x; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Njolstad I, 1996, CIRCULATION, V94, P2877; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Oki I, 2006, CEREBROVASC DIS, V22, P409, DOI 10.1159/000094860; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Rodriguez BL, 2002, STROKE, V33, P230, DOI 10.1161/hs0102.101081; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Saito I, 2011, INT J OBESITY, V35, P283, DOI 10.1038/ijo.2010.131; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Singh PN, 1999, AM J EPIDEMIOL, V150, P1152, DOI 10.1093/oxfordjournals.aje.a009942; Smith CT, 2005, J EVAL CLIN PRACT, V11, P468, DOI 10.1111/j.1365-2753.2005.00559.x; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; STOKES J, 1987, CIRCULATION, V75, P65; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Suh I, 2001, LANCET, V357, P922, DOI 10.1016/S0140-6736(00)04213-6; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Sullivan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024898; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Tamakoshi A, 2005, J EPIDEMIOL, V15, pS4, DOI 10.2188/jea.15.S4; TERRY RB, 1992, INT J OBESITY, V16, P417; Tsuji I, 1998, J Epidemiol, V8, P258; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Watanabe S, 2001, J Epidemiol, V11, pS75; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Woodward M, 2005, EUR J CARDIOV PREV R, V12, P484; World Health Organization, 2004, ATLAS HEART DIS STRO; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang G, 2007, J HUM HYPERTENS, V21, P45, DOI 10.1038/sj.jhh.1002099; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zhang XH, 2007, STROKE, V38, P3139, DOI 10.1161/STROKEAHA.107.494336; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	91	188	196	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5446	10.1136/bmj.f5446	http://dx.doi.org/10.1136/bmj.f5446			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473060	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000325426300001
J	Shlush, LI; Zandi, S; Mitchell, A; Chen, WC; Brandwein, JM; Gupta, V; Kennedy, JA; Schimmer, AD; Schuh, AC; Yee, KW; McLeod, JL; Doedens, M; Medeiros, JJF; Marke, R; Kim, HJ; Lee, K; McPherson, JD; Hudson, TJ; Brown, AMK; Trinh, QM; Stein, LD; Minden, MD; Wang, JCY; Dick, JE				Shlush, Liran I.; Zandi, Sasan; Mitchell, Amanda; Chen, Weihsu Claire; Brandwein, Joseph M.; Gupta, Vikas; Kennedy, James A.; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; McLeod, Jessica L.; Doedens, Monica; Medeiros, Jessie J. F.; Marke, Rene; Kim, Hyeoung Joon; Lee, Kwon; McPherson, John D.; Hudson, Thomas J.; Brown, Andrew M. K.; Trinh, Quang M.; Stein, Lincoln D.; Minden, Mark D.; Wang, Jean C. Y.; Dick, John E.		HALT Pan-Leukemia Gene Panel	Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; CLONAL EVOLUTION; DNMT3A MUTATIONS; DNA METHYLTRANSFERASE; ORIGIN; DIFFERENTIATION; HETEROGENEITY; PATHOGENESIS; ARCHITECTURE; METASTASIS	In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukaemic phase. Here, highly purified haematopoietic stem cells (HSCs), progenitor and mature cell fractions from the blood of AML patients were found to contain recurrent DNMT3A mutations (DNMT3A(mut)) at high allele frequency, but without coincident NPM1 mutations (NPM1c) present in AML blasts. DNMT3A(mut)-bearing HSCs showed a multilineage repopulation advantage over non-mutated HSCs in xenografts, establishing their identity as pre-leukaemic HSCs. Pre-leukaemic HSCs were found in remission samples, indicating that they survive chemotherapy. Therefore DNMT3A(mut) arises early in AML evolution, probably in HSCs, leading to a clonally expanded pool of pre-leukaemic HSCs from which AML evolves. Our findings provide a paradigm for the detection and treatment of pre-leukaemic clones before the acquisition of additional genetic lesions engenders greater therapeutic resistance.	[Shlush, Liran I.; Zandi, Sasan; Mitchell, Amanda; Chen, Weihsu Claire; Brandwein, Joseph M.; Gupta, Vikas; Kennedy, James A.; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; McLeod, Jessica L.; Doedens, Monica; Medeiros, Jessie J. F.; Marke, Rene; Minden, Mark D.; Wang, Jean C. Y.; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Brandwein, Joseph M.; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Minden, Mark D.; Wang, Jean C. Y.] Univ Toronto, Dept Med, Toronto, ON M5S 2J7, Canada; [Brandwein, Joseph M.; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Minden, Mark D.; Wang, Jean C. Y.] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; [Schimmer, Aaron D.; McPherson, John D.; Hudson, Thomas J.; Minden, Mark D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Marke, Rene] Radboud Univ Nijmegen, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Kim, Hyeoung Joon; Lee, Kwon] Chonnam Natl Univ, Hwasun Hosp, Genome Res Ctr Hematopoiet Dis, Gwangju 519809, South Korea; [McPherson, John D.; Hudson, Thomas J.; Brown, Andrew M. K.; Trinh, Quang M.; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Hudson, Thomas J.; Stein, Lincoln D.; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Radboud University Nijmegen; Chonnam National University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	jdick@uhnresearch.ca	Marra, Marco A/B-5987-2008; Marke, Rene/C-6899-2018; McPherson, John D/D-2633-2017	Marra, Marco A/0000-0001-7146-7175; McPherson, John D/0000-0001-8049-9347; Trinh, Quang/0000-0002-3602-2290; Wang, Jean/0000-0001-7543-3917; Dick, John/0000-0002-9527-8317; Zandi, Sasan/0000-0002-8448-094X; Eppert, Kolja/0000-0001-9061-8856; Schimmer, Aaron/0000-0003-4023-3899; Hogge, Donna/0000-0002-5205-9982	McEwen Centre for Regenerative Medicine; Gentle Ben Charity; Canadian Institutes for Health Research (CIHR); Aplastic Anemia and Myelodysplasia Association of Canada; Vetenskapsradet; CIHR; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Government of Canada through Ontario Genomics Institute [OGI-047]; Government of Canada through Canadian Institutes of Health Research [CSC-105367]; NATIONAL CANCER INSTITUTE [R21CA152613] Funding Source: NIH RePORTER	McEwen Centre for Regenerative Medicine; Gentle Ben Charity; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Aplastic Anemia and Myelodysplasia Association of Canada; Vetenskapsradet(Swedish Research Council); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Government of Canada through Ontario Genomics Institute; Government of Canada through Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Dick laboratory for critical assessment of this work, A. Khandani, P. Penttila, N. Simard, T. Velauthapillai and the SickKids-UHN flow facility for technical support, J. Claudio for management of the HALT studies that enabled the genetic analysis described herein, and J. Cui and X.-Z. Yang for curating the human AML samples used in these studies. This work was supported by a Postdoctoral Fellowship Award from the McEwen Centre for Regenerative Medicine with funding made available through the Gentle Ben Charity (L. I. S.), a Canadian Institutes for Health Research (CIHR) fellowship in partnership with the Aplastic Anemia and Myelodysplasia Association of Canada and an award from Vetenskapsradet (S.Z.), and by grants from CIHR, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, a Canada Research Chair, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. This work was also supported by the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and through the Canadian Institutes of Health Research (CSC-105367). Contributors to the HALT Pan-Leukemia Gene Panel are listed in Supplementary Note 1.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; BALABAN GB, 1986, CANCER GENET CYTOGEN, V19, P113, DOI 10.1016/0165-4608(86)90378-X; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chan SM, 2013, INT J HEMATOL, V98, P648, DOI 10.1007/s12185-013-1407-8; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; FIALKOW PJ, 1991, BLOOD, V77, P1415; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; FIALKOW PJ, 1987, NEW ENGL J MED, V317, P468, DOI 10.1056/NEJM198708203170802; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heinrich V, 2012, NUCLEIC ACIDS RES, V40, P2426, DOI 10.1093/nar/gkr1073; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Kim HJ, 2000, BLOOD, V96, P1; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Kottaridis PD, 2002, BLOOD, V100, P2393, DOI 10.1182/blood-2002-02-0420; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; MCCULLOCH EA, 1979, BLOOD CELLS, V5, P261; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Sgroi DC, 2010, ANNU REV PATHOL-MECH, V5, P193, DOI 10.1146/annurev.pathol.4.110807.092306; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2012, BLOOD, V120, P603, DOI 10.1182/blood-2011-10-388629; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wistuba II, 2002, ONCOGENE, V21, P7298, DOI 10.1038/sj.onc.1205806; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yasuda T, 2014, LEUKEMIA, V28, P426, DOI 10.1038/leu.2013.278; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	51	968	990	5	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					328	+		10.1038/nature13038	http://dx.doi.org/10.1038/nature13038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522528	Green Accepted, Green Submitted			2022-12-28	WOS:000331477800033
J	Sherwood, S; Fu, Q				Sherwood, Steven; Fu, Qiang			A Drier Future?	SCIENCE			English	Editorial Material							WARMING CONTRAST		[Sherwood, Steven] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Fu, Qiang] Lanzhou Univ, Coll Atmospher Sci, Lanzhou 730000, Peoples R China; [Fu, Qiang] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Lanzhou University; University of Washington; University of Washington Seattle	Sherwood, S (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia.	ssherwood@alum.mit.edu	Fu, Qiang/W-5836-2019; Sherwood, Steven/B-5673-2008	Sherwood, Steven/0000-0001-7420-8216				Byrne MP, 2013, J CLIMATE, V26, P4000, DOI 10.1175/JCLI-D-12-00262.1; Collins M., 2013, CLIMATE CHANGE 2013, P1029; Dai A, 2006, J CLIMATE, V19, P3589, DOI 10.1175/JCLI3816.1; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Joshi MM, 2008, CLIM DYNAM, V30, P455, DOI 10.1007/s00382-007-0306-1; O'Gorman PA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025207; Prudhomme C, 2014, P NATL ACAD SCI USA, V111, P3262, DOI 10.1073/pnas.1222473110; Rowell DP, 2006, CLIM DYNAM, V27, P281, DOI 10.1007/s00382-006-0125-9; Scheff J, 2014, J CLIMATE, V27, P1539, DOI 10.1175/JCLI-D-13-00233.1; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Seneviratne SI, 2013, GEOPHYS RES LETT, V40, P5212, DOI 10.1002/grl.50956; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953	16	355	369	14	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					737	739		10.1126/science.1247620	http://dx.doi.org/10.1126/science.1247620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531959				2022-12-28	WOS:000331557800026
J	West, AP; Scharf, L; Scheid, JF; Klein, F; Bjorkman, PJ; Nussenzweig, MC				West, Anthony P., Jr.; Scharf, Louise; Scheid, Johannes F.; Klein, Florian; Bjorkman, Pamela J.; Nussenzweig, Michel C.			Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy	CELL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODY; PROXIMAL EXTERNAL REGION; N-GLYCAN RECOGNITION; B-CELL RESPONSES; ENVELOPE GLYCOPROTEIN; CD4-BINDING SITE; CONFORMATIONAL EPITOPE; ANTIRETROVIRAL THERAPY	Despite 30 years of effort, there is no effective vaccine for HIV-1. However, antibodies can prevent HIV-1 infection in humanized mice and macaques when passively transferred. New single-cell-based methods have uncovered many broad and potent donor-derived antibodies, and structural studies have revealed the molecular bases for their activities. The new data suggest why such antibodies are difficult to elicit and inform HIV-1 vaccine development efforts. In addition to protecting against infection, the newly identified antibodies can suppress active infections in mice and macaques, suggesting they could be valuable additions to anti-HIV-1 therapies and to strategies to eradicate HIV-1 infection.	[West, Anthony P., Jr.; Scharf, Louise; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Scheid, Johannes F.; Klein, Florian; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	California Institute of Technology; Rockefeller University; California Institute of Technology; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University	West, AP (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	apwest@caltech.edu; nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019		Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill and Melinda Gates Foundation [1040753]; National Institutes of Health [HIVRAD P01 AI100148, DP1OD006961]; NIH Center for HIV/AID Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; American Cancer Society [PF-13-076-01-MPC]; Stavros Niarchos Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI100148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035082] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006961] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill and Melinda Gates Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AID Vaccine Immunology and Immunogen Discovery (CHAVI-ID); American Cancer Society(American Cancer Society); Stavros Niarchos Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Susan Zolla-Pazner for helpful discussions and critical review. This work was supported by a Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill and Melinda Gates Foundation (Grant ID: 1040753 to P.J.B. and M.C.N.), National Institutes of Health grant HIVRAD P01 AI100148 (P.J.B. and M.C.N.) and award number DP1OD006961 (to P.J.B.), NIH Center for HIV/AID Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N.), and the American Cancer Society (Grant PF-13-076-01-MPC to L. S.). F. K. was supported by the Stavros Niarchos Foundation.	Alam SM, 2013, P NATL ACAD SCI USA, V110, P18214, DOI 10.1073/pnas.1317855110; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen Y, 2013, J IMMUNOL, V191, P1260, DOI 10.4049/jimmunol.1300770; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; COOPER DA, 1987, J INFECT DIS, V155, P1113, DOI 10.1093/infdis/155.6.1113; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; DAVEY RT, 1993, P NATL ACAD SCI USA, V90, P5608, DOI 10.1073/pnas.90.12.5608; de Silva TI, 2012, J VIROL, V86, P930, DOI 10.1128/JVI.06126-11; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Euler Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054684; Finton KAK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003639; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Grant PM, 2010, CURR OPIN INVEST DR, V11, P901; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gruell H, 2013, J VIROL, V87, P8535, DOI 10.1128/JVI.00868-13; Hamlyn E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043754; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kong R, 2012, J VIROL, V86, P12115, DOI 10.1128/JVI.01632-12; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Loving R, 2013, J VIROL, V87, P7000, DOI 10.1128/JVI.00530-13; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Olender Susan, 2012, Top Antivir Med, V20, P61; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; PRINCE AM, 1991, AIDS RES HUM RETROV, V7, P971, DOI 10.1089/aid.1991.7.971; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; SAFRIT JT, 1993, AIDS, V7, P15, DOI 10.1097/00002030-199301000-00002; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sahin GO, 2012, J VIROL, V86, P961, DOI 10.1128/JVI.06315-11; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2012, J VIROL, V86, P12676, DOI 10.1128/JVI.01893-12; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; SATTENTAU QJ, 1995, VIROLOGY, V206, P713, DOI 10.1016/S0042-6822(95)80094-8; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; SCOTT CF, 1990, P NATL ACAD SCI USA, V87, P8597, DOI 10.1073/pnas.87.21.8597; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; TILLEY SA, 1991, RES VIROLOGY, V142, P247, DOI 10.1016/0923-2516(91)90010-Z; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Vergidis PI, 2009, INFECT DIS CLIN N AM, V23, P295, DOI 10.1016/j.idc.2009.01.013; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Walker B., 2012, COLD SPRING HARB PER, V2; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YJ, 2013, CELL REP, V5, P1443, DOI 10.1016/j.celrep.2013.11.015; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	159	251	271	0	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					633	648		10.1016/j.cell.2014.01.052	http://dx.doi.org/10.1016/j.cell.2014.01.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529371	Green Accepted, Bronze			2022-12-28	WOS:000331379800005
J	Ashack, KA; Jansen, RM; Lim, HW				Ashack, Kurt A.; Jansen, Rebecca M.; Lim, Henry W.			Abdominal Pain and Subcutaneous Nodules	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PANCREATIC PANNICULITIS		[Ashack, Kurt A.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Jansen, Rebecca M.; Lim, Henry W.] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA	Michigan State University; Michigan State University College of Human Medicine; Henry Ford Health System; Henry Ford Hospital	Lim, HW (corresponding author), Henry Ford Med Ctr New Ctr One, Dept Dermatol, 3031 W Grand Blvd,Ste 800, Detroit, MI 48202 USA.	hlim1@hfhs.org	Lim, HW/GRY-3517-2022					Aronson IK, 2012, FITZPATRICK S DERMAT, P732; Bolongia JL, 2012, DERMATOLOGY, V2, P1649; DAHL PR, 1995, J AM ACAD DERMATOL, V33, P413, DOI 10.1016/0190-9622(95)91385-8; HUDSONPEACOCK MJ, 1994, J ROY SOC MED, V87, P361; Kirkland EB, 2011, J CUTAN PATHOL, V38, P814, DOI 10.1111/j.1600-0560.2011.01742.x; Narvaez J, 2010, SEMIN ARTHRITIS RHEU, V39, P417, DOI 10.1016/j.semarthrit.2008.10.001; Pfaundler N, 2013, LIVER INT, V33, P648, DOI 10.1111/liv.12119; Requena L, 2012, J AM ACAD DERMATOL, V66, P975, DOI 10.1016/j.jaad.2011.06.024	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					615	617		10.1001/jama.2013.284966	http://dx.doi.org/10.1001/jama.2013.284966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519301				2022-12-28	WOS:000330941000017
J	Lee, AJ; You, LC				Lee, Anna Jisu; You, Lingchong			Cells Listen to Their Inner Voice	SCIENCE			English	Editorial Material							QUORUM; COMMUNICATION; DIFFUSION; ECOSYSTEM		[Lee, Anna Jisu; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University	Lee, AJ (corresponding author), Duke Univ, Dept Biomed Engn, CIEMAS 2355,101 Sci Dr, Durham, NC 27708 USA.	you@duke.edu						Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Landau L., 1987, COURSE OF THEORETICA, V6; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Pai A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.43; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16; Youk I. H., 2014, SCIENCE, V343, DOI [10.1126/science.1242782, DOI 10.1126/SCIENCE.1242782]	16	3	3	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					624	625		10.1126/science.1250244	http://dx.doi.org/10.1126/science.1250244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503846				2022-12-28	WOS:000330724000033
J	Fleury, R; Sounas, DL; Sieck, CF; Haberman, MR; Alu, A				Fleury, Romain; Sounas, Dimitrios L.; Sieck, Caleb F.; Haberman, Michael R.; Alu, Andrea			Sound Isolation and Giant Linear Nonreciprocity in a Compact Acoustic Circulator	SCIENCE			English	Article							OPTICAL ISOLATION; NON-RECIPROCITY	Acoustic isolation and nonreciprocal sound transmission are highly desirable in many practical scenarios. They may be realized with nonlinear or magneto-acoustic effects, but only at the price of high power levels and impractically large volumes. In contrast, nonreciprocal electromagnetic propagation is commonly achieved based on the Zeeman effect, or modal splitting in ferromagnetic atoms induced by a magnetic bias. Here, we introduce the acoustic analog of this phenomenon in a subwavelength meta-atom consisting of a resonant ring cavity biased by a circulating fluid. The resulting angular momentum bias splits the ring's azimuthal resonant modes, producing giant acoustic nonreciprocity in a compact device. We applied this concept to build a linear, magnetic-free circulator for airborne sound waves, observing up to 40-decibel nonreciprocal isolation at audible frequencies.	[Fleury, Romain; Sounas, Dimitrios L.; Sieck, Caleb F.; Alu, Andrea] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Sieck, Caleb F.; Haberman, Michael R.] Univ Texas Austin, Appl Res Labs, Austin, TX 78758 USA; [Haberman, Michael R.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Alu, A (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.	alu@mail.utexas.edu	Haberman, Michael/K-4989-2015; Haberman, Michael R./AAH-9133-2020; Alu, Andrea/A-1328-2007	Haberman, Michael R./0000-0002-7159-9773; Alu, Andrea/0000-0002-4297-5274	Defense Threat Reduction Agency [HDTRA1-12 1-0022]; Air Force Office of Scientific Research [FA9550-11-1-0009]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work has been supported by the Defense Threat Reduction Agency Young Investigator Program (YIP) award HDTRA1-12 1-0022 and the Air Force Office of Scientific Research YIP award FA9550-11-1-0009. A provisional U.S. patent has been filed with title "Nonreciprocal acoustic devices based on angular momentum bias" (61/868,178). R. F., D. L. S., and A. A. developed the concept presented in this paper. R. F. and D. L. S. carried out the analytical and numerical modeling and built the device. R. F. and C. F. S. conducted the measurements. M. R. H. contributed to the design and realization of the experimental set-up. A. A. supervised the entire project. All authors discussed the results and commented on the article.	Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Boechler N, 2011, NAT MATER, V10, P665, DOI [10.1038/NMAT3072, 10.1038/nmat3072]; Brekhovskikh L.M., 2003, FUNDAMENTALS OCEAN A, V3; CASIMIR HBG, 1945, REV MOD PHYS, V17, P343, DOI 10.1103/RevModPhys.17.343; Cicek A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694020; Fan L, 2012, SCIENCE, V335, P447, DOI 10.1126/science.1214383; He ZJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3562306; Hwan Oh J., 2012, APPL PHYS LETT, V100; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Kamal A, 2011, NAT PHYS, V7, P311, DOI [10.1038/nphys1893, 10.1038/NPHYS1893]; Kang MS, 2011, NAT PHOTONICS, V5, P549, DOI [10.1038/nphoton.2011.180, 10.1038/NPHOTON.2011.180]; KITTEL C, 1958, PHYS REV, V110, P836, DOI 10.1103/PhysRev.110.836; Kodera T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3615688; Laloe F, 2005, QUANTUM MECH; Lepri S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.164101; Li XF, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.084301; Liang B, 2010, NAT MATER, V9, P989, DOI 10.1038/NMAT2881; Liang B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.104301; Lira H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033901; Maznev AA, 2013, WAVE MOTION, V50, P776, DOI 10.1016/j.wavemoti.2013.02.006; Shadrivov IV, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033025; Soljacic M, 2003, OPT LETT, V28, P637, DOI 10.1364/OL.28.000637; Sounas DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3407; Sun HX, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693374; Wang DW, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.093901; Wang Z, 2005, APPL PHYS B-LASERS O, V81, P369, DOI 10.1007/s00340-005-1846-x; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273; Yuan B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739081; Zhu XF, 2010, J APPL PHYS, V108, DOI 10.1063/1.3520491	29	669	682	19	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					516	519		10.1126/science.1246957	http://dx.doi.org/10.1126/science.1246957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482477				2022-12-28	WOS:000330343700040
J	Goddard, LM; Murphy, TJ; Org, T; Enciso, JM; Hashimoto-Partyka, MK; Warren, CM; Domigan, CK; McDonald, AI; He, HH; Sanchez, LA; Allen, NC; Orsenigo, F; Chao, LC; Dejana, E; Tontonoz, P; Mikkola, HKA; Iruela-Arispe, ML				Goddard, Lauren M.; Murphy, Thomas J.; Org, Toenis; Enciso, Josephine M.; Hashimoto-Partyka, Minako K.; Warren, Carmen M.; Domigan, Courtney K.; McDonald, Austin I.; He, Huanhuan; Sanchez, Lauren A.; Allen, Nancy C.; Orsenigo, Fabrizio; Chao, Lily C.; Dejana, Elisabetta; Tontonoz, Peter; Mikkola, Hanna K. A.; Iruela-Arispe, M. Luisa			Progesterone Receptor in the Vascular Endothelium Triggers Physiological Uterine Permeability Preimplantation	CELL			English	Article							HUMAN ENDOMETRIUM; GROWTH-FACTOR; GENE-EXPRESSION; MENSTRUAL-CYCLE; VE-CADHERIN; ESTROGEN; DECIDUALIZATION; MECHANISMS; COMPLEX; ANGIOGENESIS	Vascular permeability is frequently associated with inflammation and is triggered by a cohort of secreted permeability factors such as vascular endothelial growth factor (VEGF). Here, we show that the physiological vascular permeability that precedes implantation is directly controlled by progesterone receptor (PR) and is independent of VEGF. Global or endothelial- specific deletion of PR blocks physiological vascular permeability in the uterus, whereas misexpression of PR in the endothelium of other organs results in ectopic vascular leakage. Integration of an endothelial genome-wide transcriptional profile with chromatin immunoprecipitation sequencing revealed that PR induces an NR4A1 (Nur77/TR3)dependent transcriptional program that broadly regulates vascular permeability in response to progesterone. Silencing of NR4A1 blocks PR-mediated permeability responses, indicating a direct link between PR and NR4A1. This program triggers concurrent suppression of several junctional proteins and leads to an effective, timely, and venous-specific regulation of vascular barrier function that is critical for embryo implantation.	[Goddard, Lauren M.; Org, Toenis; Hashimoto-Partyka, Minako K.; Warren, Carmen M.; Domigan, Courtney K.; Sanchez, Lauren A.; Allen, Nancy C.; Mikkola, Hanna K. A.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Murphy, Thomas J.; McDonald, Austin I.; Mikkola, Hanna K. A.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Enciso, Josephine M.] Univ Calif Los Angeles, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [He, Huanhuan] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Chao, Lily C.; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; [Orsenigo, Fabrizio; Dejana, Elisabetta] Fdn FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; IFOM - FIRC Institute of Molecular Oncology	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	arispe@mcdb.ucla.edu	Org, Tõnis/E-8596-2010; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Dejana, Elisabetta/A-6274-2016	Org, Tõnis/0000-0003-3071-2183; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Orsenigo, Fabrizio/0000-0001-9135-8478; He, Huanhuan/0000-0002-5903-0840; McDonald, Austin/0000-0002-3161-5388; Sanchez, Lauren/0000-0001-9062-8181; DEJANA, ELISABETTA/0000-0002-0007-0426	National Institutes of Health [RO1HL74455-01, RO1HL097766, T32HL69766]; American Heart Association [AHA11PRE7300043]; Iris Cantor-UCLA Women's Health Center; European Social Fund [MJD284]; Leukemia and Lymphoma Society [5737-13]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074455, T32HL069766, R01HL097766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R25GM055052, T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Iris Cantor-UCLA Women's Health Center; European Social Fund(European Social Fund (ESF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Kari Alitalo for providing the tie1 construct, Liman Zhao for mouse husbandry, and the Tissue Procurement Core Laboratory Shared Resource. This study was supported by grants from the National Institutes of Health (RO1HL74455-01 to M. L. I.-A., RO1HL097766 to H. K. A. M., and T32HL69766 to L. M. G.), the American Heart Association (AHA11PRE7300043 to L. M. G.), the Iris Cantor-UCLA Women's Health Center (L. M. G.), the European Social Fund (Mobilitas grant MJD284 to T. O.), and the Leukemia and Lymphoma Society (5737-13 to T. O.). The UCLA Vector Core generated lentiviral vectors (supported by JCCC/P30 CA016042 and CURE/P30 DK041301).	Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Atkins GB, 2011, ARTERIOSCL THROM VAS, V31, P1476, DOI 10.1161/ATVBAHA.111.228999; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Chappell JC, 2010, CURR TOP DEV BIOL, V90, P43, DOI 10.1016/S0070-2153(10)90002-1; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dvorak HF, 2010, CURR OPIN HEMATOL, V17, P225, DOI 10.1097/MOH.0b013e3283386638; EDWARDS DP, 1995, J STEROID BIOCHEM, V53, P449, DOI 10.1016/0960-0760(95)00091-D; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hickey M, 2002, HUM REPROD, V17, P2428, DOI 10.1093/humrep/17.9.2428; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hyder SM, 1996, CANCER RES, V56, P3954; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Ismail PM, 2002, MOL ENDOCRINOL, V16, P2475, DOI 10.1210/me.2002-0169; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kovacs G, 1996, HUM REPROD, V11, P20, DOI 10.1093/humrep/11.suppl_2.20; Krikun G, 2005, J CLIN ENDOCR METAB, V90, P1812, DOI 10.1210/jc.2004-1814; Large MJ, 2012, MOL CELL ENDOCRINOL, V358, P155, DOI 10.1016/j.mce.2011.07.027; Lydon JP, 1996, J STEROID BIOCHEM, V56, P67, DOI 10.1016/0960-0760(95)00254-5; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Maybin JA, 2004, REPRODUCTION, V128, P423, DOI 10.1530/rep.1.00051; McKenna NJ, 2000, J STEROID BIOCHEM, V74, P351, DOI 10.1016/S0960-0760(00)00112-6; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; PERROTAPPLANAT M, 1995, CIRCULATION, V92, P2975, DOI 10.1161/01.CIR.92.10.2975; Regan ER, 2012, CIRC RES, V111, P110, DOI 10.1161/CIRCRESAHA.111.261701; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Runic R, 2000, J CLIN ENDOCR METAB, V85, P3853, DOI 10.1210/jc.85.10.3853; Shifren JL, 1996, J CLIN ENDOCR METAB, V81, P3112, DOI 10.1210/jc.81.8.3112; SHOUPE D, 1991, OBSTET GYNECOL, V77, P256, DOI 10.1097/00006250-199102000-00018; Strauss JF, 2009, YEN JAFFES REPROD EN, V6th; Sugino N, 2002, REPRODUCTION, V123, P379, DOI 10.1530/reprod/123.3.379; Vazquez F, 1999, J BIOL CHEM, V274, P2185, DOI 10.1074/jbc.274.4.2185; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	42	46	48	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					549	562		10.1016/j.cell.2013.12.025	http://dx.doi.org/10.1016/j.cell.2013.12.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485460	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000330580800020
J	Gordon, LB; Rothman, FG; Lopez-Otin, C; Misteli, T				Gordon, Leslie B.; Rothman, Frank G.; Lopez-Otin, Carlos; Misteli, Tom			Progeria: A Paradigm for Translational Medicine	CELL			English	Article							HUTCHINSON-GILFORD-PROGERIA; DNA-DAMAGE RESPONSES; ADULT STEM-CELLS; MUTANT LAMIN-A; FARNESYLTRANSFERASE INHIBITOR; MOUSE MODEL; DEFECTIVE MATURATION; TELOMERE DYSFUNCTION; AMELIORATES DISEASE; EXTENDS LONGEVITY	Rare diseases are powerful windows into biological processes and can serve as models for the development of therapeutic strategies. The progress made on the premature aging disorder Progeria is a shining example of the impact that studies of rare diseases can have.	[Gordon, Leslie B.] Boston Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Gordon, Leslie B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gordon, Leslie B.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI 02912 USA; [Gordon, Leslie B.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Rothman, Frank G.] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hasbro Children's Hospital; Brown University; Brown University; University of Oviedo; Instituto Universitario de Oncologia de Asturias; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gordon, LB (corresponding author), Boston Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA.	leslie_gordon@brown.edu; mistelit@mail.nih.gov	López-Otín, Carlos/AAB-2106-2020; Gordon, Leslie B./AAJ-5793-2021	López-Otín, Carlos/0000-0001-6964-1904; 	Intramural NIH HHS [ZIA BC010309-14, ZIA BC010309-15] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Benson EK, 2010, J CELL SCI, V123, P2605, DOI 10.1242/jcs.067306; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Cenni V, 2011, EUR J HISTOCHEM, V55, P200, DOI 10.4081/ejh.2011.e36; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Cleveland RH, 2012, PEDIATR RADIOL, V42, P1089, DOI 10.1007/s00247-012-2423-1; Dahl KN, 2010, MICROCIRCULATION, V17, P179, DOI 10.1111/j.1549-8719.2009.00016.x; de la Rosa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3268; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Gerhard-Herman M, 2012, HYPERTENSION, V59, P92, DOI 10.1161/HYPERTENSIONAHA.111.180919; Gilford H, 1904, PRACTITIONER, V73, P188; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon CM, 2011, J BONE MINER RES, V26, P1670, DOI 10.1002/jbmr.392; Gordon L. B., 2013, PRF NUMBERS; Gordon LB, 2005, J PEDIATR-US, V146, P336, DOI 10.1016/j.jpeds.2004.10.064; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Havelka GE, 2011, VASC ENDOVASC SURG, V45, P381, DOI 10.1177/1538574411407698; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Hutchinson J, 1886, Med Chir Trans, V69, P473; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; King AA, 2013, NEUROLOGY, V81, P408, DOI 10.1212/WNL.0b013e31829d87cd; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kudlow BA, 2008, MOL BIOL CELL, V19, P5238, DOI 10.1091/mbc.E08-05-0492; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu YW, 2013, CIRC RES, V112, pE99, DOI 10.1161/CIRCRESAHA.111.300543; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mackenzie N C W, 2011, Curr Aging Sci, V4, P128; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Marino G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nissan X, 2012, CELL REP, V2, P1, DOI 10.1016/j.celrep.2012.05.015; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Silvera VM, 2013, AM J NEURORADIOL, V34, P1091, DOI 10.3174/ajnr.A3341; SINENSKY M, 1994, J CELL SCI, V107, P61; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Ullrich NJ, 2013, NEUROLOGY, V81, P427, DOI 10.1212/WNL.0b013e31829d85c0; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wenzel V, 2012, BIOL OPEN, V1, P516, DOI 10.1242/bio.20121149; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	71	159	163	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					400	407		10.1016/j.cell.2013.12.028	http://dx.doi.org/10.1016/j.cell.2013.12.028			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485450	Green Accepted, Bronze			2022-12-28	WOS:000330580800008
J	Morr, DK				Morr, Dirk K.			Lifting the Fog of Complexity	SCIENCE			English	Editorial Material							QUANTUM CRITICAL-POINT; FERMI-LIQUID; SUPERCONDUCTIVITY; DENSITY; BEHAVIOR		Univ Illinois, Dept Phys, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Morr, DK (corresponding author), Univ Illinois, Dept Phys, Chicago, IL 60607 USA.	dkmorr@uic.edu	Morr, Dirk/B-8887-2019	Morr, Dirk/0000-0003-3692-2835				Alford MG, 2008, REV MOD PHYS, V80, P1455, DOI 10.1103/RevModPhys.80.1455; Castellani C, 1997, Z PHYS B CON MAT, V103, P137, DOI 10.1007/s002570050347; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; Kyung B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165114; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Mazzocchi F, 2008, EMBO REP, V9, P10, DOI 10.1038/sj.embor.7401147; Schmalian J, 1998, PHYS REV LETT, V80, P3839, DOI 10.1103/PhysRevLett.80.3839; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0	12	3	3	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					382	383		10.1126/science.1248868	http://dx.doi.org/10.1126/science.1248868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458633				2022-12-28	WOS:000330039300037
J	Bibby, J; Tomkins, C				Bibby, Jo; Tomkins, Christine			Would criminalising healthcare professionals for wilful neglect improve patient care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bibby, Jo] Hlth Fdn, London WC2E 9RA, England; [Tomkins, Christine] Med Def Union, London SE1 8PJ, England		Bibby, J (corresponding author), Hlth Fdn, London WC2E 9RA, England.	Jo.Bibby@health.org.uk; christine.tomkins@themdu.com						Avineri E, 2010, INDIVIDUAL BEHAV CHA; Broughton J., 2003, 563 TRL; Department of Health, 2013, HARD TRUTHS JOURN PU, V1; Department of Health, 2013, MIDSTAFF NHS FDN TRU; Department of Health, 2013, HARD TRUTHS JOURN PU; Department of Health, 2013, BERW REV PAT SAF; General Medical Council, 2006, GOOD MED PRACT; Health Committee, FRANC MAK DIFF, P657; Horder J, BMJ QUALITY IN PRESS; Isle of Wight Country Press, CAR WORK FILM ATT EL; Office for National Statistics, 2013, REP DRINK DRIV ACC C; Vaughan D, 1996, CHALLENGER LAUNCH DE; Vincent C., 2013, MEASUREMENT MONITORI	13	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g133	10.1136/bmj.g133	http://dx.doi.org/10.1136/bmj.g133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24458584				2022-12-28	WOS:000330298100003
J	Vernot, B; Akey, JM				Vernot, Benjamin; Akey, Joshua M.			Resurrecting Surviving Neandertal Lineages from Modern Human Genomes	SCIENCE			English	Article							HUMAN-POPULATIONS; ADMIXTURE; INTROGRESSION; HYBRIDIZATION; EUROPEANS; CANDIDATE; SEQUENCE; HISTORY; AFRICA; GENE	Anatomically modern humans overlapped and mated with Neandertals such that non-African humans inherit similar to 1 to 3% of their genomes from Neandertal ancestors. We identified Neandertal lineages that persist in the DNA of modern humans, in whole-genome sequences from 379 European and 286 East Asian individuals, recovering more than 15 gigabases of introgressed sequence that spans similar to 20% of the Neandertal genome (false discovery rate = 5%). Analyses of surviving archaic lineages suggest that there were fitness costs to hybridization, admixture occurred both before and after divergence of non-African modern humans, and Neandertals were a source of adaptive variation for loci involved in skin phenotypes. Our results provide a new avenue for paleogenomics studies, allowing substantial amounts of population-level DNA sequence information to be obtained from extinct groups, even in the absence of fossilized remains.	[Vernot, Benjamin; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	akeyj@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Akey, Joshua/0000-0002-4411-1330				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Cabral A, 2003, J BIOL CHEM, V278, P17792, DOI 10.1074/jbc.M300508200; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Takemoto H, 2010, J DERMATOL SCI, V60, P203, DOI 10.1016/j.jdermsci.2010.10.006; Twyford AD, 2012, HEREDITY, V108, P179, DOI 10.1038/hdy.2011.68; Vanhoutteghem A, 2006, P NATL ACAD SCI USA, V103, P12423, DOI 10.1073/pnas.0605086103; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301	23	321	336	3	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1017	1021		10.1126/science.1245938	http://dx.doi.org/10.1126/science.1245938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24476670				2022-12-28	WOS:000332309600044
J	Pretorius, E; Vermeulen, N; Bester, J; du Plooy, JL; Gericke, GS				Pretorius, Etheresia; Vermeulen, Natasha; Bester, Janette; du Plooy, Jeanette L.; Gericke, George S.			The effect of iron overload on red blood cell morphology	LANCET			English	Editorial Material									[Pretorius, Etheresia; Vermeulen, Natasha; Bester, Janette; du Plooy, Jeanette L.] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, South Africa; [Gericke, George S.] AMPATH Natl Reference Lab, ZA-0046 Centurion, South Africa	University of Pretoria	Pretorius, E (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Physiol, Private Bag X323, ZA-0007 Arcadia, South Africa.	resia.pretorius@up.ac.za	Pretorius, Etheresia/ACH-6368-2022; Pretorius, Etheresia/P-2978-2016	Pretorius, Etheresia/0000-0002-9108-2384; Pretorius, Etheresia/0000-0002-9108-2384; Bester, Janette/0000-0002-8931-9194					0	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					722	722		10.1016/S0140-6736(13)61208-8	http://dx.doi.org/10.1016/S0140-6736(13)61208-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24486189				2022-12-28	WOS:000331653300033
J	Benjamin, D; Hall, MN				Benjamin, Don; Hall, Michael N.			mTORC1: Turning Off Is Just as Important as Turning On	CELL			English	Editorial Material							RAG GTPASES	mTORC1 is activated primarily on the lysosome. Menon et al. and Demetriades et al. show that mTORC1 deactivation on the lysosome is determined by recruitment of its negative regulator, the tumor suppressor complex TSC1-TSC2. These reports highlight the importance of subcellular localization in the regulation of mTORC1.	[Benjamin, Don; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757				Bar-Peled L, 2012, CELL, V151, P1390, DOI 10.1016/j.cell.2012.11.038; Benjamin D, 2013, NAT CELL BIOL, V15, P1135, DOI 10.1038/ncb2849; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822	8	18	20	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					627	628		10.1016/j.cell.2014.01.057	http://dx.doi.org/10.1016/j.cell.2014.01.057			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529368	Bronze			2022-12-28	WOS:000331379800002
J	Muller-Landau, HC				Muller-Landau, Helene C.			ECOLOGY Plant diversity rooted in pathogens	NATURE			English	Editorial Material							DENSITY-DEPENDENCE; HERBIVORES		Smithsonian Trop Res Inst, Panama City, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Muller-Landau, HC (corresponding author), Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Panama City, Panama.	mullerh@si.edu		Muller-Landau, Helene C./0000-0002-3526-9021				Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Visser MD, 2011, ECOL LETT, V14, P1093, DOI 10.1111/j.1461-0248.2011.01677.x	11	3	4	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					44	45		10.1038/nature12851	http://dx.doi.org/10.1038/nature12851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24463509				2022-12-28	WOS:000330648100027
J	Kontopantelis, E; Springate, D; Reeves, D; Ashcroft, DM; Valderas, JM; Doran, T				Kontopantelis, Evangelos; Springate, David; Reeves, David; Ashcroft, Darren M.; Valderas, Jose M.; Doran, Tim			Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINANCIAL INCENTIVES; LONGITUDINAL ANALYSIS; PAY; CARE; ENGLAND	Objectives To investigate the effect of withdrawing incentives on recorded quality of care, in the context of the UK Quality and Outcomes Framework pay for performance scheme. Design Retrospective longitudinal study. Setting Data for 644 general practices, from 2004/05 to 2011/12, extracted from the Clinical Practice Research Datalink. Participants All patients registered with any of the practices over the study period-13 772 992 in total. Intervention Removal of financial incentives for aspects of care for patients with asthma, coronary heart disease, diabetes, stroke, and psychosis. Main outcome measures Performance on eight clinical quality indicators withdrawn from a national incentive scheme: influenza immunisation (asthma) and lithium treatment monitoring (psychosis), removed in April 2006; blood pressure monitoring (coronary heart disease, diabetes, stroke), cholesterol concentration monitoring (coronary heart disease, diabetes), and blood glucose monitoring (diabetes), removed in April 2011. Multilevel mixed effects multiple linear regression models were used to quantify the effect of incentive withdrawal. Results Mean levels of performance were generally stable after the removal of the incentives, in both the short and long term. For the two indicators removed in April 2006, levels in 2011/12 were very close to 2005/06 levels, although a small but statistically significant drop was estimated for influenza immunisation. For five of the six indicators withdrawn from April 2011, no significant effect on performance was seen following removal and differences between predicted and observed scores were small. Performance on related outcome indicators retained in the scheme (such as blood pressure control) was generally unaffected. Conclusions Following the removal of incentives, levels of performance across a range of clinical activities generally remained stable. This indicates that health benefits from incentive schemes can potentially be increased by periodically replacing existing indicators with new indicators relating to alternative aspects of care. However, all aspects of care investigated remained indirectly or partly incentivised in other indicators, and further work is needed to assess the generalisability of the findings when incentives are fully withdrawn.	[Kontopantelis, Evangelos; Springate, David; Reeves, David] Univ Manchester, Inst Populat Hlth, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester M13 9PL, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9PL, Lancs, England; [Springate, David; Reeves, David] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Pharm Sch, Ctr Pharmacoepidemiol & Drug Safety Res, Manchester M13 9PL, Lancs, England; [Valderas, Jose M.] Univ Exeter, UE Med Sch, Inst Hlth Serv Res, Exeter, Devon, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Exeter; University of York - UK	Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester M13 9PL, Lancs, England.	e.kontopantelis@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Valderas, Jose M/Y-9814-2019; Reeves, David/H-6203-2014; Valderas, Jose M/G-7967-2014; Ashcroft, Darren M/G-3244-2015	Kontopantelis, Evangelos/0000-0001-6450-5815; Reeves, David/0000-0001-6377-6859; Valderas, Jose M/0000-0002-9299-1555; Ashcroft, Darren M/0000-0002-2958-915X	Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: Medline; Department of Health [NIHR/CS/010/024, CDF-2011-04-016] Funding Source: Medline; National Institute for Health Research [CDF-2011-04-016, NIHR/CS/010/024, SPCR-006] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Bueving HJ, 2004, AM J RESP CRIT CARE, V169, P488, DOI 10.1164/rccm.200309-1251OC; Cates CJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000364.pub3; Collet D., 1991, MODELLING BINARY DAT, V2nd; Communities and Local Government, 2011, ENGL IND DEPR 2010 T; Deci EL, 1999, PSYCHOL BULL, V125, P692, DOI 10.1037/0033-2909.125.6.692; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran Tim, 2010, Br J Gen Pract, V60, pe335, DOI 10.3399/bjgp10X515340; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Jain SH, 2010, JAMA-J AM MED ASSOC, V304, P1009, DOI 10.1001/jama.2010.1250; Kontopantelis E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003190; Kontopantelis E, 2013, J STAT SOFTW, V55, P1; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Kontopantelis E, 2012, HEALTH SERV RES, V47, P1117, DOI 10.1111/j.1475-6773.2011.01362.x; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; Le Grand J., 2006, MOTIVATION AGENCY PU; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; Meacock R., 2013, HEALTH ECON, V23, P1; National Health Service Information Centre, 2012, QUAL OUTC FRAM; Norbury M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583146; Reeves D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1717; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	30	36	37	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2014	348								g330	10.1136/bmj.g330	http://dx.doi.org/10.1136/bmj.g330			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303AT	24468469	Green Published, hybrid			2022-12-28	WOS:000330647400017
J	Haruta, M; Sabat, G; Stecker, K; Minkoff, BB; Sussman, MR				Haruta, Miyoshi; Sabat, Grzegorz; Stecker, Kelly; Minkoff, Benjamin B.; Sussman, Michael R.			A Peptide Hormone and Its Receptor Protein Kinase Regulate Plant Cell Expansion	SCIENCE			English	Article							MEMBRANE H+-ATPASE; ARABIDOPSIS SEEDLINGS; PHOSPHORYLATION; GROWTH; SITE; IDENTIFICATION; ELONGATION; HYPOCOTYL; ATRALF1; AUXIN	Plant cells are immobile; thus, plant growth and development depend on cell expansion rather than cell migration. The molecular mechanism by which the plasma membrane initiates changes in the cell expansion rate remains elusive. We found that a secreted peptide, RALF (rapid alkalinization factor), suppresses cell elongation of the primary root by activating the cell surface receptor FERONIA in Arabidopsis thaliana. A direct peptide-receptor interaction is supported by specific binding of RALF to FERONIA and reduced binding and insensitivity to RALF-induced growth inhibition in feronia mutants. Phosphoproteome measurements demonstrate that the RALF-FERONIA interaction causes phosphorylation of plasma membrane H+-adenosine triphosphatase 2 at Ser(899), mediating the inhibition of proton transport. The results reveal a molecular mechanism for RALF-induced extracellular alkalinization and a signaling pathway that regulates cell expansion.	[Haruta, Miyoshi; Sabat, Grzegorz; Stecker, Kelly; Minkoff, Benjamin B.; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Haruta, Miyoshi; Stecker, Kelly; Minkoff, Benjamin B.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sussman, MR (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA.	msussman@wisc.edu		Sabat, Grzegorz/0000-0001-7668-7767; Stecker, Kelly/0000-0002-8374-689X; Haruta, Miyoshi/0000-0003-1686-1860	NSF [MCB-0929395, DGE-1256259]; U.S. Department of Energy Office of Basic Energy Sciences [DEFG02-88ER13938]; National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH) [5T32HG002760]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Burch for technical assistance; M. Ivancic for advice on mass spectrometry data analyses; R. Wrobel, B. Fox (National Institute of General Medical Sciences Protein Structure Initiative, U54 GM074901), and S. Litscher for assistance with E. coli expression experiments; G. Barrett-Wilt for mass spectrometric instrumentation; M. A. Beg, M. Hoffman, and O. Ginther for assistance with the iodination experiments; F. Li for advice on Nicotiana expression; S.-H. Su and the Plant Imaging Center for assistance with microscopy; and W. Aylward for advice on Etruscan mythology. Supported by NSF grant MCB-0929395 and U.S. Department of Energy Office of Basic Energy Sciences grant DEFG02-88ER13938 (M. R. S.), NSF grant DGE-1256259 (K. S.), and the National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH grant 5T32HG002760, B. B. M.). Phosphoproteome data are deposited in PRIDE (Proteomics Identification Database) with accession numbers 31655 to 31656 and ProteomeXchange accession number PXD000515. Microarray data are deposited in ArrayExpress (E-MEXP-3994).	BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; COSGROVE DJ, 1993, PLANT PHYSIOL, V103, P1321, DOI 10.1104/pp.103.4.1321; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Haruta M, 2003, PLANT PHYSIOL, V131, P814, DOI 10.1104/pp.014597; Haruta M, 2008, BIOCHEMISTRY-US, V47, P6311, DOI 10.1021/bi8001488; Haruta M, 2010, J BIOL CHEM, V285, P17918, DOI 10.1074/jbc.M110.101733; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Kline-Jonakin KG, 2011, CURR OPIN PLANT BIOL, V14, P507, DOI 10.1016/j.pbi.2011.06.008; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Lindner H, 2012, CURR OPIN PLANT BIOL, V15, P659, DOI 10.1016/j.pbi.2012.07.003; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; Sanchez-Serrano J. J., 2013, ARABIDOPSIS PROTOCOL; Takahashi K, 2012, PLANT PHYSIOL, V159, P632, DOI 10.1104/pp.112.196428; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x	25	444	460	20	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					408	411		10.1126/science.1244454	http://dx.doi.org/10.1126/science.1244454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458638	Green Accepted			2022-12-28	WOS:000330039300045
J	Lunshof, JE; Church, GM; Prainsack, B				Lunshof, Jeantine E.; Church, George M.; Prainsack, Barbara			Raw Personal Data: Providing Access	SCIENCE			English	Editorial Material							INCIDENTAL FINDINGS; RECOMMENDATIONS		[Lunshof, Jeantine E.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [Prainsack, Barbara] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England	Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam; University of London; King's College London	Lunshof, JE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jelunshof@genetics.med.harvard.edu	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532; Lunshof, Jeantine E/0000-0002-5630-7947; church, george/0000-0001-6232-9969				Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bloss CS, 2013, J MED GENET, V50, P393, DOI 10.1136/jmedgenet-2012-101207; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gutierrez A, 2013, COMMUNICATION; Levelt Committee Noort Committee & Drent Committee, 2012, FLAW SCI FRAUD RES P; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research US Department of Health Education and Welfare, 1979, ETH PRINC GUID PROT; Prainsack B, 2013, MED LAW REV, V21, P71, DOI 10.1093/medlaw/fws040; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; van El CG, 2013, EUR J HUM GENET, V21, P580, DOI 10.1038/ejhg.2013.46; Wasson K, 2013, J COMMUN GENET, V4, P495, DOI 10.1007/s12687-013-0156-y	11	46	46	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					373	374		10.1126/science.1249382	http://dx.doi.org/10.1126/science.1249382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	294IR	24458627				2022-12-28	WOS:000330039300031
J	Rosenfeld, D; Sherwood, S; Wood, R; Donner, L				Rosenfeld, Daniel; Sherwood, Steven; Wood, Robert; Donner, Leo			Climate Effects of Aerosol-Cloud Interactions	SCIENCE			English	Editorial Material									[Rosenfeld, Daniel] Hebrew Univ Jerusalem, IL-91904 Jerusalem, Israel; [Sherwood, Steven] Univ New S Wales, Sydney, NSW 2052, Australia; [Wood, Robert] Univ Washington, Seattle, WA 98195 USA; [Donner, Leo] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	Hebrew University of Jerusalem; University of New South Wales Sydney; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, IL-91904 Jerusalem, Israel.	daniel.rosen-feld@huji.ac.il	Rosenfeld, Daniel/AAJ-4617-2021; Sherwood, Steven/B-5673-2008; Rosenfeld, Daniel/F-6077-2016; Wood, Robert/A-2989-2008	Rosenfeld, Daniel/0000-0002-0784-7656; Sherwood, Steven/0000-0001-7420-8216; Rosenfeld, Daniel/0000-0002-0784-7656; Wood, Robert/0000-0002-1401-3828	Div Atmospheric & Geospace Sciences [0968609] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		ACKERMAN AS, 1993, SCIENCE, V262, P226, DOI 10.1126/science.262.5131.226; Anderson TL, 2003, SCIENCE, V300, P1103, DOI 10.1126/science.1084777; Andreae M. O., 2009, AEROSOLS CLOUDS PREC; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Goren T, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017981; IPCC, 2013, CLIMATE CHANGE 2022; Isaksen ISA, 2009, ATMOS ENVIRON, V43, P5138, DOI 10.1016/j.atmosenv.2009.08.003; Koren I, 2010, ATMOS CHEM PHYS, V10, P5001, DOI 10.5194/acp-10-5001-2010; Renno NO, 2013, B AM METEOROL SOC, V94, P685, DOI 10.1175/BAMS-D-11-00239.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Wang M, 2011, ATMOS CHEM PHYS, V11, P5431, DOI 10.5194/acp-11-5431-2011; Winker DM, 2009, J ATMOS OCEAN TECH, V26, P2310, DOI 10.1175/2009JTECHA1281.1	13	268	274	5	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					379	380		10.1126/science.1247490	http://dx.doi.org/10.1126/science.1247490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458631				2022-12-28	WOS:000330039300035
J	Worobey, M; Han, GZ; Rambaut, A				Worobey, Michael; Han, Guan-Zhu; Rambaut, Andrew			A synchronized global sweep of the internal genes of modern avian influenza virus	NATURE			English	Article							EQUINE INFLUENZA; A VIRUS; EVOLUTION; DATES; DNA; TRANSMISSION; EMERGENCE	Zoonotic infectious diseases such as influenza continue to pose a grave threat to human health(1). However, the factors that mediate the emergence of RNA viruses such as influenza A virus (IAV) are still incompletely understood(2,3). Phylogenetic inference is crucial to reconstructing the origins and tracing the flow of IAV within and between hosts(3-8). Here we show that explicitly allowing IAV host lineages to have independent rates of molecular evolution is necessary for reliable phylogenetic inference of IAV and that methods that do not do so, including 'relaxed' molecular clock models(9), can be positively misleading. A phylogenomic analysis using a host-specific local clock model recovers extremely consistent evolutionary histories across all genomic segments and demonstrates that the equine H7N7 lineage is a sister clade to strains from birds-as well as those from humans, swine and the equine H3N8 lineage-sharing an ancestor with them in the mid to late 1800s. Moreover, major western and eastern hemisphere avian influenza lineages inferred for each gene coalesce in the late 1800s. On the basis of these phylogenies and the synchrony of these key nodes, we infer that the internal genes of avian influenza virus (AIV) underwent a global selective sweep beginning in the late 1800s, a process that continued throughout the twentieth century and up to the present. The resulting western hemispheric AIV lineage subsequently contributed most of the genomic segments to the 1918 pandemic virus and, independently, the 1963 equine H3N8 panzootic lineage. This approach provides a clear resolution of evolutionary patterns and processes in IAV, including the flow of viral genes and genomes within and between host lineages.	[Worobey, Michael; Han, Guan-Zhu] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Arizona; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Worobey, M (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	worobey@email.arizona.edu; a.rambaut@ed.ac.uk	Rambaut, Andrew/B-2481-2009; Han, Guan-Zhu/P-4188-2019; Han, Guan-Zhu/A-6818-2011	Rambaut, Andrew/0000-0003-4337-3707; Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X	David and Lucile Packard Foundation; Wellcome Trust [092807]; European Union [278433-PREDEMICS]; European Research Council [260864]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI084691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084691] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Barnes, S. Meno, M. Shaw, R. Donis, S. Krauss, K. Friedman, R. Webster, Y. Muramoto and Y. Kawaoka for assistance in locating and sequencing A/equine/Detroit/3/1964(H7N7), A/chicken/Japan/1925(H7N7) and A/duck/Manitoba/1953(H10N7); M. Sanderson for comments on the HSLC model; S. Zohari for discussions of the NS1/2 A and B lineages; and M. Nachman, Y. Kawaoka, T. Watts, J. Cox, and D. Gill for comments. This work was supported by grants from the David and Lucile Packard Foundation to M. W., and the Wellcome Trust (grant no. 092807) to A. R. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278433-PREDEMICS and European Research Council grant agreement no. 260864. The methodological approach was developed in part with support from a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. (R01AI084691).	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fries AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059216; Han GZ, 2011, VIRUSES-BASEL, V3, P1358, DOI 10.3390/v3081358; HASEGAWA M, 1989, J HUM EVOL, V18, P461, DOI 10.1016/0047-2484(89)90075-4; Holmes E., 2009, EVOLUTION EMERGENCE; Judson A B, 1873, Public Health Pap Rep, V1, P88; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P373, DOI 10.1111/j.1750-2659.2010.00181.x; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P327, DOI 10.1111/j.1750-2659.2010.00148.x; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Perroncito CE., 1878, ANN ACCAD AGR, V21, P87; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; SCHOLTENS RG, 1964, PUBLIC HEALTH REP, V79, P393, DOI 10.2307/4592142; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SOVINOVA O, 1958, Acta Virol, V2, P52; Swayne D.E., 2008, AVIAN INFLUENZA, V1st ed., P145; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	44	153	156	4	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					254	+		10.1038/nature13016	http://dx.doi.org/10.1038/nature13016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24531761	Green Accepted			2022-12-28	WOS:000333979900046
J	Shen, EZ; Song, CQ; Lin, Y; Zhang, WH; Su, PF; Liu, WY; Zhang, P; Xu, JJ; Lin, N; Zhan, C; Wang, XH; Shyr, Y; Cheng, HP; Dong, MQ				Shen, En-Zhi; Song, Chun-Qing; Lin, Yuan; Zhang, Wen-Hong; Su, Pei-Fang; Liu, Wen-Yuan; Zhang, Pan; Xu, Jiejia; Lin, Na; Zhan, Cheng; Wang, Xianhua; Shyr, Yu; Cheng, Heping; Dong, Meng-Qiu			Mitoflash frequency in early adulthood predicts lifespan in Caenorhabditis elegans	NATURE			English	Article							MITOCHONDRIA; LONGEVITY; METABOLISM; DECLINE; GENES	It has been theorized for decades that mitochondria act as the biological clock of ageing(1), but the evidence is incomplete. Here we show a strong coupling between mitochondrial function and ageing by in vivo visualization of the mitochondrial flash (mitoflash), a frequency-coded optical readout reflecting free-radical production and energy metabolism at the single-mitochondrion level(2,3). Mitoflash activity in Caenorhabditis elegans pharyngeal muscles peaked on adult day 3 during active reproduction and on day 9 when animals started to die off. A plethora of genetic mutations and environmental factors inversely modified the lifespan and the day-3 mitoflash frequency. Even within an isogenic population, the day-3 mitoflash frequency was negatively correlated with the lifespan of individual animals. Furthermore, enhanced activity of the glyoxylate cycle contributed to the decreased day-3 mitoflash frequency and the longevity of daf-2 mutant animals. These results demonstrate that the day-3 mitoflash frequency is a powerful predictor of C. elegans lifespan across genetic, environmental and stochastic factors. They also support the notion that the rate of ageing, although adjustable in later life, has been set to a considerable degree before reproduction ceases.	[Shen, En-Zhi; Song, Chun-Qing] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Shen, En-Zhi; Song, Chun-Qing; Zhang, Wen-Hong; Liu, Wen-Yuan; Zhang, Pan; Zhan, Cheng; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Lin, Yuan; Xu, Jiejia; Lin, Na; Wang, Xianhua; Cheng, Heping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Peking Tsinghua Ctr Life Sci,Beijing Key Lab Card, Beijing 100871, Peoples R China; [Su, Pei-Fang] Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan; [Shyr, Yu] Vanderbilt Univ, Vanderbilt Ctr Quantitat Sci, Nashville, TN 37232 USA	China Agricultural University; National Institute of Biological Sciences, Beijing; Peking University; National Cheng Kung University; Vanderbilt University	Dong, MQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	chengp@pku.edu.cn; dongmengqiu@nibs.ac.cn	Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011; liu, wen/HGE-3071-2022	Heping, Cheng/0000-0002-9604-6702; Xu, Jiejia/0000-0003-3885-3546; Lin, Yuan/0000-0001-9147-8031; zhan, cheng/0000-0001-9397-0871; , Enzhi/0000-0002-6095-7803	Ministry of Science and Technology of China (973) [2010CB835203, 2013CB531200]; National Natural Science Foundation of China [31130067, 31221002]; municipal government of Beijing; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Medical Research Council [MR/J013617/1] Funding Source: researchfish; MRC [MR/J013617/1] Funding Source: UKRI	Ministry of Science and Technology of China (973)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); municipal government of Beijing; National Institutes of Health Office of Research Infrastructure Programs; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. D. Lemire for providing pSDH2(P-2)GFP; H. Jiang for providing KillerRed; the Caenorhabditis Genetics Center (funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440)), D. Gems, P. Zhangand C. Kenyon for providing C. elegans strains; L. Miao, P. Liu, F. Yang, J. Li and J.-W. Lu for help with the electron microscopy and mitochondrial purification; L.-L. Du for suggestions; S. Sa, I. Bruce and X. Wang for critical reading of the manuscript; X. He for help with experiments; N. Yang for drawing the model in Fig. 4f; and S. Ji for discussion. This work was funded by the Ministry of Science and Technology of China (973 grants 2010CB835203 to M.-Q. D. and 2013CB531200 to H. C.), the National Natural Science Foundation of China (grants 31130067 and 31221002 to H. C.) and the municipal government of Beijing.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Choi SS, 2011, NUTR RES PRACT, V5, P214, DOI 10.4162/nrp.2011.5.3.214; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Gavrilov Leonid A, 2003, Sci Aging Knowledge Environ, V2003, pRE5, DOI 10.1126/sageke.2003.28.re5; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hou Y., 2013, NEUROBIOL AGING; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Maier W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000376; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	34	101	108	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					128	+		10.1038/nature13012	http://dx.doi.org/10.1038/nature13012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24522532				2022-12-28	WOS:000333609900056
J	Haberle, V; Li, N; Hadzhiev, Y; Plessy, C; Previti, C; Nepal, C; Gehrig, J; Dong, XJ; Akalin, A; Suzuki, AM; van IJcken, WFJ; Armant, O; Ferg, M; Strahle, U; Carninci, P; Muller, F; Lenhard, B				Haberle, Vanja; Li, Nan; Hadzhiev, Yavor; Plessy, Charles; Previti, Christopher; Nepal, Chirag; Gehrig, Jochen; Dong, Xianjun; Akalin, Altuna; Suzuki, Ana Maria; van IJcken, Wilfred F. J.; Armant, Olivier; Ferg, Marco; Straehle, Uwe; Carninci, Piero; Mueller, Ferenc; Lenhard, Boris			Two independent transcription initiation codes overlap on vertebrate core promoters	NATURE			English	Article							GENE-EXPRESSION; CPG ISLANDS; CAP ANALYSIS; ZEBRAFISH; ORGANIZATION; ARCHITECTURE; RESOLUTION; TBP2	A core promoter is a stretch of DNA surrounding the transcription start site (TSS) that integrates regulatory inputs(1) and recruits general transcription factors to initiate transcription(2). The nature and causative relationship of the DNA sequence and chromatin signals that govern the selection of most TSSs by RNA polymerase II remain unresolved. Maternal to zygotic transition represents the most marked change of the transcriptome repertoire in the vertebrate life cycle(3-6). Early embryonic development in zebrafish is characterized by a series of transcriptionally silent cell cycles regulated by inherited maternal gene products: zygotic genome activation commences at the tenth cell cycle, marking the mid-blastula transition(7). This transition provides a unique opportunity to study the rules of TSS selection and the hierarchy of events linking transcription initiation with key chromatin modifications. We analysed TSS usage during zebrafish early embryonic development at high resolution using cap analysis of gene expression(8), and determined the positions of H3K4me3-marked promoter-associated nucleosomes(9). Here we show that the transition from the maternal to zygotic transcriptome is characterized by a switch between two fundamentally different modes of defining transcription initiation, which drive the dynamic change of TSS usage and promoter shape. A maternal-specific TSS selection, which requires an A/T-rich (W-box) motif, is replaced with a zygotic TSS selection grammar characterized by broader patterns of dinucleotide enrichments, precisely aligned with the first downstream (11) nucleosome. The developmental dynamics of the H3K4me3-marked nucleosomes reveal their DNA-sequence-associated positioning at promoters before zygotic transcription and subsequent transcription independent adjustment to the final position downstream of the zygotic TSS. The two TSS-defining grammars coexist, often physically overlapping, in core promoters of constitutively expressed genes to enable their expression in the two regulatory environments. The dissection of overlapping core promoter determinants represents a framework for future studies of promoter structure and function across different regulatory contexts.	[Haberle, Vanja] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Haberle, Vanja; Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Clin Sci, London W12 0NN, England; [Haberle, Vanja; Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Fac Med, London W12 0NN, England; [Li, Nan; Hadzhiev, Yavor; Gehrig, Jochen; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Plessy, Charles; Suzuki, Ana Maria; Carninci, Piero] RIKEN Om Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Plessy, Charles; Suzuki, Ana Maria; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Previti, Christopher; Nepal, Chirag; Dong, Xianjun; Akalin, Altuna] Univ Bergen, Uni Res AS, Computat Biol Unit, N-5008 Bergen, Norway; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, NL-3015 GE Rotterdam, Netherlands; [Armant, Olivier; Ferg, Marco; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Lenhard, Boris] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	University of Bergen; Imperial College London; Imperial College London; University of Birmingham; RIKEN; RIKEN; University of Bergen; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Karlsruhe Institute of Technology; University of Bergen	Lenhard, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Clin Sci, London W12 0NN, England.	carninci@riken.jp; f.mueller@bham.ac.uk; b.lenhard@imperial.ac.uk	Muller, Ferenc/C-6426-2009; Plessy, Charles/N-5054-2015; van ijcken, willem/N-9805-2018; Carninci, Piero/K-1568-2014; Nepal, Chirag/K-5866-2019; Dong, Xianjun/N-3867-2014; Straehle, Uwe/K-7054-2013; AKALIN, ALTUNA/A-4424-2012	Plessy, Charles/0000-0001-7410-6295; van ijcken, willem/0000-0002-0421-8301; Carninci, Piero/0000-0001-7202-7243; Dong, Xianjun/0000-0002-8052-9320; AKALIN, ALTUNA/0000-0002-0468-0117; Hadzhiev, Yavor/0000-0002-1134-4904; Lenhard, Boris/0000-0002-1114-1509; Nepal, Chirag/0000-0001-8402-3805; armant, olivier/0000-0001-7101-9209; Haberle, Vanja/0000-0003-4191-3714; Gehrig, Jochen/0000-0002-1193-1324; mueller, ferenc/0000-0002-0996-774X	Norwegian Research Council (YFF); Bergen Research Foundation; European Union (EU); Medical Research Council UK; EU; MEXT; MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	Norwegian Research Council (YFF)(Research Council of Norway); Bergen Research Foundation; European Union (EU)(CGIAREuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to L. Tora, E. Kenyon, G. Chalancon and J. C.-y. Chen for comments on the manuscript, to M. Reischl for Zebrafish Miner software, and to L. O'Neill for technical advice. V. H., C.N., C.Pr., A. A. and X. D. were supported by grants from the Norwegian Research Council (YFF) and the Bergen Research Foundation, awarded to B. L. F. M., U. S. and B. L. acknowledge support from European Union (EU) FP6 integrated project EuTRACC and FP7 integrated project ZF Health. B. L. was additionally supported by the Medical Research Council UK, F. M. and P. C. by the EU FP7 project Dopaminet and U. S. by the EU FP6 project NeuroXSys. C.Pl., A. M. S. and P. C. were supported by a Research Grant from MEXT to RIKEN CLST. (RIKEN Omics Science Center ceased to exist on 1 April 2013 owing to reorganization of RIKEN.)	Abe G, 2011, METHOD CELL BIOL, V104, P23, DOI 10.1016/B978-0-12-374814-0.00002-1; Akhtar W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-45; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Ferg M., 2008, THESIS HEIDELBERG U; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; KANE DA, 1993, DEVELOPMENT, V119, P447; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Nozaki T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-416; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; R Development Core Team, 2013, R LANG ENV STAT COMP, V1; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Soler E, 2011, METHODS, V53, P151, DOI 10.1016/j.ymeth.2010.08.002; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Zaugg JB, 2012, GENOME RES, V22, P84, DOI 10.1101/gr.124099.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	102	105	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					381	+		10.1038/nature12974	http://dx.doi.org/10.1038/nature12974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24531765	Green Accepted			2022-12-28	WOS:000333029000039
J	Westphalen, K; Gusarova, GA; Islam, MN; Subramanian, M; Cohen, TS; Prince, AS; Bhattacharya, J				Westphalen, Kristin; Gusarova, Galina A.; Islam, Mohammad N.; Subramanian, Manikandan; Cohen, Taylor S.; Prince, Alice S.; Bhattacharya, Jahar			Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity	NATURE			English	Article							DENDRITIC CELLS; LUNG; ACTIVATION; ATHEROSCLEROSIS; DETERMINES; SECRETION; PROTECTS; INJURY	The tissue-resident macrophages of barrier organs constitute the first line of defence against pathogens at the systemic interface with the ambient environment. In the lung, resident alveolar macrophages (AMs) provide a sentinel function against inhaled pathogens(1). Bacterial constituents ligate Toll-like receptors (TLRs) on AMs(2), causing AMs to secrete proinflammatory cytokines(3) that activate alveolar epithelial receptors(4), leading to recruitment of neutrophils that engulf pathogens(5,6). Because the AM-induced response could itself cause tissue injury, it is unclear how AMs modulate the response to prevent injury. Here, using real-time alveolar imaging in situ, we show that a subset of AMs attached to the alveolar wall form connexin 43 (Cx43)-containing gap junction channels with the epithelium. During lipopolysaccharide-induced inflammation, the AMs remained sessile and attached to the alveoli, and they established intercommunication through synchronized Ca2+ waves, using the epithelium as the conducting pathway. The intercommunication was immunosuppressive, involving Ca2+-dependent activation of Akt, because AM-specific knockout of Cx43 enhanced alveolar neutrophil recruitment and secretion of proinflammatory cytokines in the bronchoalveolar lavage. A picture emerges of a novel immunomodulatory process in which a subset of alveolus-attached AMs intercommunicates immunosuppressive signals to reduce endotoxin-induced lung inflammation.	[Westphalen, Kristin; Gusarova, Galina A.; Islam, Mohammad N.; Bhattacharya, Jahar] Columbia Univ, Dept Med, Med Ctr, Lung Biol Lab,Div Pulm Allergy & Crit Care, New York, NY 10032 USA; [Subramanian, Manikandan] Columbia Univ, Med Ctr, Div Mol Med, Dept Med, New York, NY 10032 USA; [Cohen, Taylor S.; Prince, Alice S.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Bhattacharya, Jahar] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Bhattacharya, J (corresponding author), Columbia Univ, Dept Med, Med Ctr, Lung Biol Lab,Div Pulm Allergy & Crit Care, New York, NY 10032 USA.	jb39@columbia.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903; Islam, Mohammad Naimul/0000-0001-7929-9444; Subramanian, Manikandan/0000-0002-2608-3890	US National Institutes of Health [HL78645, HL57556, HL64896, HL73989]; Parker B. Francis Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078645, R01HL064896, R01HL057556, R01HL073989, R01HL079395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Reizis for providing the Cd11c-cre mice and J. Whitsett for providing the Spc-cre mice. We thank I. Tabas for discussions. This study was supported by US National Institutes of Health grants HL78645, HL57556 and HL64896 to J. B., HL73989 to A. S. P., and Parker B. Francis Fellowships to T. S. C. and M.N.I.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P992; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Decrock E, 2013, BBA-MOL CELL RES, V1833, P1772, DOI 10.1016/j.bbamcr.2012.12.016; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Huang BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061430; Ichimura H, 2006, AM J PHYSIOL-LUNG C, V291, pL596, DOI 10.1152/ajplung.00036.2006; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Kuebler WM, 2000, J CLIN INVEST, V105, P905, DOI 10.1172/JCI8604; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pfenniger A, 2013, BBA-BIOMEMBRANES, V1828, P157, DOI 10.1016/j.bbamem.2012.05.011; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wang LM, 2012, J CLIN INVEST, V122, P4218, DOI 10.1172/JCI59176; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	31	255	258	7	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					503	+		10.1038/nature12902	http://dx.doi.org/10.1038/nature12902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24463523	Green Accepted			2022-12-28	WOS:000332165100041
J	Herrmann, M				Herrmann, Mark			PLASMA PHYSICS A promising advance in nuclear fusion	NATURE			English	Editorial Material									Sandia Natl Labs, Pulsed Power Sci Ctr, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Herrmann, M (corresponding author), Sandia Natl Labs, Pulsed Power Sci Ctr, POB 5800, Albuquerque, NM 87185 USA.	mherrma@sandia.gov						Betti R, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3380857; Brumfiel G, 2012, NATURE, V483; Hurricane OA, 2014, NATURE, V506, P343, DOI 10.1038/nature13008; LAWSON JD, 1957, P PHYS SOC LOND B, V70, P6, DOI 10.1088/0370-1301/70/1/303	4	6	6	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					302	303		10.1038/nature13057	http://dx.doi.org/10.1038/nature13057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB0JL	24522529				2022-12-28	WOS:000331477800026
J	Johnston, RJ; Desplan, C				Johnston, Robert J., Jr.; Desplan, Claude			Interchromosomal Communication Coordinates Intrinsically Stochastic Expression Between Alleles	SCIENCE			English	Article							DROSOPHILA; SPINELESS	Sensory systems use stochastic mechanisms to diversify neuronal subtypes. In the Drosophila eye, stochastic expression of the PAS-bHLH transcription factor Spineless (Ss) determines a random binary subtype choice in R7 photoreceptors. Here, we show that a stochastic, cell-autonomous decision to express ss is made intrinsically by each ss locus. Stochastic on or off expression of each ss allele is determined by combinatorial inputs from one enhancer and two silencers acting at long range. However, the two ss alleles also average their frequency of expression through up-regulatory and down-regulatory interallelic cross-talk. This inter-or intrachromosomal long-range regulation does not require endogenous ss chromosomal positioning or pairing. Therefore, although individual ss alleles make independent stochastic choices, interchromosomal communication coordinates expression state between alleles, ensuring that they are both expressed in the same random subset of R7s.	[Johnston, Robert J., Jr.; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NIH [R01 EY13010]; Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship; NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are very grateful to S. Britt, I. Duncan, C. Zuker, and the Bloomington Stock Center for reagents. We thank C. Tsanis and T. Blackman for technical assistance and E. Heard, O. Hobert, J. Kassis, P. O'Farrell, V. Pirrotta, and members of the Desplan laboratory for helpful discussion concerning the project and manuscript. C. D. was supported by NIH R01 EY13010. R. J. J. Jr. was supported by a Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship.	Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Emmons RB, 2007, DEV BIOL, V302, P412, DOI 10.1016/j.ydbio.2006.09.044; Johnston RJ, 2008, CURR OPIN NEUROBIOL, V18, P20, DOI 10.1016/j.conb.2008.04.004; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Thanawala SU, 2013, DEV CELL, V25, P93, DOI 10.1016/j.devcel.2013.02.016; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615	11	49	50	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					661	665		10.1126/science.1243039	http://dx.doi.org/10.1126/science.1243039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503853	Green Accepted			2022-12-28	WOS:000330724000043
J	Kong, XB				Kong, Xiangbin			China must protect high-quality arable land	NATURE			English	Editorial Material									China Agr Univ, Coll Resources & Environm, Beijing 100094, Peoples R China	China Agricultural University	Kong, XB (corresponding author), China Agr Univ, Coll Resources & Environm, Beijing 100094, Peoples R China.	kxb@cau.edu.cn		Kong, Xiangbin/0000-0002-6471-928X					0	134	161	17	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					7	7		10.1038/506007a	http://dx.doi.org/10.1038/506007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	303BA	24499883	Bronze			2022-12-28	WOS:000330648100004
J	Badireddi, S; Boddu, NJ				Badireddi, Sridhar; Boddu, Neeraja J.			Mandibular Tori	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 79-year-old man was admitted to the ICU because of acute respiratory failure, cardiogenic shock, acute kidney injury, and urinary tract infection. Bony outgrowths were noted on the lower jaw. A 79-year-old man was admitted to the medical intensive care unit because of acute respiratory failure, cardiogenic shock, acute kidney injury, and urinary tract infection. He had a long-standing history of cor pulmonale. Incidentally, he was noted to have abnormalities on the lingual surface of the lower jaw. Three bony outgrowths were seen and diagnosed as mandibular tori (also known as tori mandibulares). The patient reported no history of a chewing disability, dysphagia, dysarthria, oral ulcers, or sleep disturbances associated with the oral findings. The patient recovered from cardiogenic shock and was discharged home. Tori are benign exostoses, and in ...	[Badireddi, Sridhar] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Boddu, Neeraja J.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Badireddi, S (corresponding author), Univ Arkansas Med Sci, Little Rock, AR 72205 USA.	sbadireddi@gmail.com							0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					E8	E8		10.1056/NEJMicm1308354	http://dx.doi.org/10.1056/NEJMicm1308354			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476452				2022-12-28	WOS:000330645400001
J	DeMeo, FE; Carry, B				DeMeo, F. E.; Carry, B.			Solar System evolution from compositional mapping of the asteroid belt	NATURE			English	Review							S-TYPE ASTEROIDS; SURFACE-COMPOSITION; TROJAN ASTEROIDS; SPECTROSCOPIC SURVEY; MAIN-BELT; WATER-ICE; WISE/NEOWISE OBSERVATIONS; PHOTOMETRIC SURVEY; JUPITER TROJANS; GIANT PLANETS	Advances in the discovery and characterization of asteroids over the past decade have revealed an unanticipated underlying structure that points to a dramatic early history of the inner Solar System. The asteroids in the main asteroid belt have been discovered to be more compositionally diverse with size and distance from the Sun than had previously been known. This implies substantial mixing through processes such as planetary migration and the subsequent dynamical processes.	[DeMeo, F. E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [DeMeo, F. E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Carry, B.] CNRS, UMR8028, Observ Paris, Inst Mecan Celeste & Calcul Ephemerides, F-75014 Paris, France; [Carry, B.] European Space Astron ESA Ctr, Madrid 28691, Spain	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite	DeMeo, FE (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,MS 16, Cambridge, MA 02138 USA.	fdemeo@cfa.harvard.edu		Carry, Benoit/0000-0001-5242-3089	ESAC faculty; National Science Foundation [0907766]; National Aeronautics and Space Administration (NASA) [NNX12AL26G, HST-HF-51319.01-A, NAS 5-26555]; Space Telescope Science Institute; Direct For Mathematical & Physical Scien [0907766] Funding Source: National Science Foundation	ESAC faculty; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to R. Binzel for help in shaping this review, and to K. Walsh, W. Bottke, N. Moskovitz, D. Polishook, T. Burbine, J. Wisdom and A. Morales for discussions. We thank C. Chapman for a review. We acknowledge support from the ESAC faculty for F.E.D.'s visit. This material is based upon work supported by the National Science Foundation under grant number 0907766 and by the National Aeronautics and Space Administration (NASA) under grant number NNX12AL26G. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or NASA. Support for this work was provided by NASA through the Hubble Fellowship grant HST-HF-51319.01-A, awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. F.E.D. is a Hubble Fellow.	Assandri MC, 2008, ASTRON ASTROPHYS, V488, P339, DOI 10.1051/0004-6361:200809553; Barucci MA, 2012, EXP ASTRON, V33, P645, DOI 10.1007/s10686-011-9231-8; BELL JF, 1989, ASTEROIDS II, P921; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2001, SCIENCE, V294, P1693, DOI 10.1126/science.1066760; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Brown P, 2011, METEORIT PLANET SCI, V46, P339, DOI 10.1111/j.1945-5100.2010.01167.x; Brunetto R, 2006, ICARUS, V180, P546, DOI 10.1016/j.icarus.2005.10.016; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Carry B, 2008, ASTRON ASTROPHYS, V478, P235, DOI 10.1051/0004-6361:20078166; Carry B, 2012, PLANET SPACE SCI, V73, P98, DOI 10.1016/j.pss.2012.03.009; Carvano JM, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913322; Carvano JM, 2001, ICARUS, V149, P173, DOI 10.1006/icar.2000.6512; Castillo-Rogez JC, 2011, ICARUS, V215, P599, DOI 10.1016/j.icarus.2011.08.007; Chapman C. R., 1971, P IAU C, P1; Chapman C. R., 1971, SP, V267, P1; CHAPMAN CR, 1975, ICARUS, V25, P104, DOI 10.1016/0019-1035(75)90191-8; Chapman CR, 2004, ANNU REV EARTH PL SC, V32, P539, DOI 10.1146/annurev.earth.32.101802.120453; Chapman CR, 1996, METEORIT PLANET SCI, V31, P699, DOI 10.1111/j.1945-5100.1996.tb02107.x; Chesley SR, 2003, SCIENCE, V302, P1739, DOI 10.1126/science.1091452; CLARK BE, 1995, ICARUS, V113, P387, DOI 10.1006/icar.1995.1029; DeMeo FE, 2013, ICARUS, V226, P723, DOI 10.1016/j.icarus.2013.06.027; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V305, P1, DOI 10.1016/j.epsl.2011.03.010; Emery JP, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/25; Emery JP, 2004, ICARUS, V170, P131, DOI 10.1016/j.icarus.2004.02.004; Emery JP, 2003, ICARUS, V164, P104, DOI 10.1016/S0019-1035(03)00143-X; Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; Fischer H., 1941, ASTRON NACHR, V272, P127; Fornasier S, 2007, ICARUS, V190, P622, DOI 10.1016/j.icarus.2007.03.033; Fornasier S, 2004, ICARUS, V172, P221, DOI 10.1016/j.icarus.2004.06.015; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; Gil-Hutton R, 2008, ICARUS, V193, P567, DOI 10.1016/j.icarus.2007.08.026; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GRADIE JC, 1989, ASTEROIDS II, P316; Grav T, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/49; Grav T, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/197; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; Ivezic Z, 2001, ASTRON J, V122, P2749, DOI 10.1086/323452; Jenniskens P, 2009, NATURE, V458, P485, DOI 10.1038/nature07920; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Jones RL, 2009, EARTH MOON PLANETS, V105, P101, DOI 10.1007/s11038-009-9305-z; Lauretta D. S., 2011, AGU FALL M; Lazzaro D, 2000, SCIENCE, V288, P2033, DOI 10.1126/science.288.5473.2033; Lazzaro D, 2004, ICARUS, V172, P179, DOI 10.1016/j.icarus.2004.06.006; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; Mainzer A, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/53; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; Masiero JR, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/7; Matthews M. S., 1989, ASTEROIDS, VII; MCCORD TB, 1974, SCIENCE, V186, P352, DOI 10.1126/science.186.4161.352; Meibom A, 1999, METEORIT PLANET SCI, V34, P7, DOI 10.1111/j.1945-5100.1999.tb01728.x; Mignard F, 2007, EARTH MOON PLANETS, V101, P97, DOI 10.1007/s11038-007-9221-z; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Moskovitz NA, 2008, ICARUS, V198, P77, DOI 10.1016/j.icarus.2008.07.006; Mothe-Diniz T, 2003, ICARUS, V162, P10, DOI 10.1016/S0019-1035(02)00066-0; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nesvorny D, 2008, ICARUS, V193, P85, DOI 10.1016/j.icarus.2007.08.034; O'Brien DP, 2007, ICARUS, V191, P434, DOI 10.1016/j.icarus.2007.05.005; Parker A, 2008, ICARUS, V198, P138, DOI 10.1016/j.icarus.2008.07.002; PETIT JM, 2002, ASTEROIDS, V3, P711; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Roig F, 2008, ASTRON ASTROPHYS, V483, P911, DOI 10.1051/0004-6361:20079177; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; RUZMAIKINA TV, 1989, ASTEROIDS II, P681; Sasaki S, 2001, NATURE, V410, P555, DOI 10.1038/35069013; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Warner BD, 2009, ICARUS, V204, P172, DOI 10.1016/j.icarus.2009.06.004; WETHERILL GW, 1979, ICARUS, V37, P96, DOI 10.1016/0019-1035(79)90118-0; WISDOM J, 1983, ICARUS, V56, P51, DOI 10.1016/0019-1035(83)90127-6; WOOD HJ, 1963, ASTROPHYS J, V137, P1279; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427; Yang B, 2007, ASTRON J, V134, P223, DOI 10.1086/518368; Yang B, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/95; Yano H., 2010, 38 COSPAR SCI ASS, P635; ZELLNER B, 1985, ICARUS, V61, P355, DOI 10.1016/0019-1035(85)90133-2	88	253	254	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					629	634		10.1038/nature12908	http://dx.doi.org/10.1038/nature12908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476886	Green Submitted			2022-12-28	WOS:000330321000030
J	Schiwon, M; Weisheit, C; Franken, L; Gutweiler, S; Dixit, A; Meyer-Schwesinger, C; Pohl, JM; Maurice, NJ; Thiebes, S; Lorenz, K; Quast, T; Fuhrmann, M; Baumgarten, G; Lohse, MJ; Opdenakker, G; Bernhagen, J; Bucala, R; Panzer, U; Kolanus, W; Grone, HJ; Garbi, N; Kastenmuller, W; Knolle, PA; Kurts, C; Engel, DR				Schiwon, Marzena; Weisheit, Christina; Franken, Lars; Gutweiler, Sebastian; Dixit, Akanksha; Meyer-Schwesinger, Catherine; Pohl, Judith-Mira; Maurice, Nicholas J.; Thiebes, Stephanie; Lorenz, Kristina; Quast, Thomas; Fuhrmann, Martin; Baumgarten, Georg; Lohse, Martin J.; Opdenakker, Ghislain; Bernhagen, Juergen; Bucala, Rick; Panzer, Ulf; Kolanus, Waldemar; Groene, Hermann-Josef; Garbi, Natalio; Kastenmueller, Wolfgang; Knolle, Percy A.; Kurts, Christian; Engel, Daniel R.			Crosstalk between Sentinel and Helper Macrophages Permits Neutrophil Migration into Infected Uroepithelium	CELL			English	Article							NECROSIS-FACTOR-ALPHA; URINARY-TRACT-INFECTION; DENDRITIC CELLS; MATRIX METALLOPROTEINASES; FACTOR THERAPY; IL-8 RECEPTOR; GELATINASE-B; BONE-MARROW; IN-VITRO; BACTERIAL	The phagocytes of the innate immune system, macrophages and neutrophils, contribute to antibacterial defense, but their functional specialization and cooperation is unclear. Here, we report that three distinct phagocyte subsets play highly coordinated roles in bacterial urinary tract infection. Ly6C(-) macrophages acted as tissue- resident sentinels that attracted circulating neutrophils and Ly6C(+) macrophages. Such Ly6C(+) macrophages played a previously undescribed helper role: once recruited to the site of infection, they produced the cytokine TNF, which caused Ly6C(-) macrophages to secrete CXCL2. This chemokine activated matrix metalloproteinase- 9 in neutrophils, allowing their entry into the uroepithelium to combat the bacteria. In summary, the sentinel macrophages elicit the powerful antibacterial functions of neutrophils only after confirmation by the helper macrophages, reminiscent of the licensing role of helper T cells in antiviral adaptive immunity. These findings identify helper macrophages and TNF as critical regulators in innate immunity against bacterial infections in epithelia.	[Schiwon, Marzena; Weisheit, Christina; Franken, Lars; Gutweiler, Sebastian; Dixit, Akanksha; Pohl, Judith-Mira; Maurice, Nicholas J.; Thiebes, Stephanie; Garbi, Natalio; Kastenmueller, Wolfgang; Knolle, Percy A.; Kurts, Christian; Engel, Daniel R.] Univ Clin Bonn, Inst Expt Immunol, D-53127 Bonn, Germany; [Weisheit, Christina; Baumgarten, Georg] Univ Clin Bonn, Anesthesiol Clin, D-53127 Bonn, Germany; [Meyer-Schwesinger, Catherine; Panzer, Ulf] Univ Clin Hamburg Eppendorf, Med Klin 3, D-20246 Hamburg, Germany; [Lorenz, Kristina; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Fuhrmann, Martin] German Ctr Neurodegenerat Dis DZNE, D-53125 Bonn, Germany; [Opdenakker, Ghislain] Univ Leuven, Rega Inst Med Res, Immunobiol Lab, B-3000 Louvain, Belgium; [Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, D-52062 Aachen, Germany; [Bucala, Rick] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Groene, Hermann-Josef] German Canc Res Ctr Heidelberg, D-69120 Heidelberg, Germany	University of Bonn; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); KU Leuven; RWTH Aachen University; Yale University; Helmholtz Association; German Cancer Research Center (DKFZ)	Kurts, C (corresponding author), Univ Clin Bonn, Inst Expt Immunol, D-53127 Bonn, Germany.	ckurts@web.de; daniel.robert.engel@gmail.com	Opdenakker, Ghislain/V-8562-2019; Garbi, Natalio/H-7666-2014; Weisheit, Christina/V-2507-2018; Opdenakker, Ghislain/Q-3130-2017; Fuhrmann, Martin/J-2707-2018; Lohse, Martin J/A-7160-2012; Engel, Daniel Robert/C-5945-2013; Lorenz, Kristina/F-3522-2016	Opdenakker, Ghislain/0000-0003-1714-2294; Weisheit, Christina/0000-0002-7647-1613; Opdenakker, Ghislain/0000-0003-1714-2294; Fuhrmann, Martin/0000-0001-7672-2913; Lohse, Martin J/0000-0002-0599-3510; Engel, Daniel Robert/0000-0001-7301-353X; Maurice, Nicholas/0000-0002-2667-472X; Lorenz, Kristina/0000-0002-5747-2207; Knolle, Percy A./0000-0003-2983-0414	Deutsche Forschungsgemeinschaft [En984/ 1-1, KFO228, SFB704, SFBTR57]; Excellence Cluster ImmunoSensation, Gottfried Wilhelm Leibniz-Price; European Union [261382]; NIH [AI042310]; Geconcerteerde Onderzoeksacties at the KU Leuven [2013/014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation, Gottfried Wilhelm Leibniz-Price; European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geconcerteerde Onderzoeksacties at the KU Leuven; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Simon Teteris and Katharina Hochheiser for helpful suggestions, Juliane Maurer, Christina Ohliger, Tanja To " pfer, Chrystel Llanto, Andreas Dolf, Peter Wurst, Greet Thijs, Manfred Dewor, and Hongqi Lue for technical assistance and H. Bluethmann for Tnfr<SUP>-/-</SUP> mice. We acknowledge support by the Central Animal Facilities of the Medical Faculty Bonn and the Flow-Cytometry Core Facility. This work was supported by intramural Bonfor fellowships to D. R. E and C. W., the Deutsche Forschungsgemeinschaft (Grants En984/ 1-1, KFO228, SFB704, SFBTR57, Excellence Cluster ImmunoSensation, Gottfried Wilhelm Leibniz-Price to C. K.), the European Union 7 th Framework Program (FP7/2007-2013) grant agreement no 261382 (INTRICATE), NIH AI042310 and the Geconcerteerde Onderzoeksacties (GOA 2013/014) at the KU Leuven.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERGER H, 1982, J BACTERIOL, V152, P1241; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Chen LL, 2013, AM J PHYSIOL-LUNG C, V305, pL702, DOI 10.1152/ajplung.00194.2013; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; Engel D, 2006, INFECT IMMUN, V74, P6100, DOI 10.1128/IAI.00881-06; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Foxman B, 2002, AM J MED, V113, p5S; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godaly G, 1997, INFECT IMMUN, V65, P3451, DOI 10.1128/IAI.65.8.3451-3456.1997; Hang L, 1999, J IMMUNOL, V162, P3037; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Kantari Chahrazade, 2008, V15, P118, DOI 10.1159/000136335; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kountouras J, 2005, GASTROENTEROLOGY, V129, P1138, DOI 10.1053/j.gastro.2005.07.047; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Luca M, 1997, AM J PATHOL, V151, P1105; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mpofu S, 2005, RHEUMATOLOGY, V44, P271, DOI 10.1093/rheumatology/keh483; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Parker AS, 2004, AM J EPIDEMIOL, V159, P42, DOI 10.1093/aje/kwh014; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Platt AM, 2008, IMMUNOL LETT, V119, P22, DOI 10.1016/j.imlet.2008.05.009; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Strangfeld A, 2006, BEST PRACT RES CL RH, V20, P1181, DOI 10.1016/j.berh.2006.08.010; Svensson M, 2011, KIDNEY INT, V80, P1064, DOI 10.1038/ki.2011.257; Szarvas T, 2011, NAT REV UROL, V8, P241, DOI 10.1038/nrurol.2011.44; Tan RJ, 2012, AM J PHYSIOL-RENAL, V302, pF1351, DOI 10.1152/ajprenal.00037.2012; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Winthrop KL, 2009, EMERG INFECT DIS, V15, P1556, DOI 10.3201/eid1510.090310; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	78	153	154	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					456	468		10.1016/j.cell.2014.01.006	http://dx.doi.org/10.1016/j.cell.2014.01.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485454	Green Accepted, Bronze			2022-12-28	WOS:000330580800013
J	Buxbaum, AR; Wu, B; Singer, RH				Buxbaum, Adina R.; Wu, Bin; Singer, Robert H.			Single beta-Actin mRNA Detection in Neurons Reveals a Mechanism for Regulating Its Translatability	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; GRANULES; TRANSLOCATION; LOCALIZATION; RECEPTORS	The physical manifestation of learning and memory formation in the brain can be expressed by strengthening or weakening of synaptic connections through morphological changes. Local actin remodeling underlies some forms of plasticity and may be facilitated by local beta-actin synthesis, but dynamic information is lacking. In this work, we use single-molecule in situ hybridization to demonstrate that dendritic beta-actin messenger RNA (mRNA) and ribosomes are in a masked, neuron-specific form. Chemically induced long-term potentiation prompts transient mRNA unmasking, which depends on factors active during synaptic activity. Ribosomes and single beta-actin mRNA motility increase after stimulation, indicative of release from complexes. Hence, the single-molecule assays we developed allow for the quantification of activity-induced unmasking and availability for active translation. Further, our work demonstrates that beta-actin mRNA and ribosomes are in a masked state that is alleviated by stimulation.	[Buxbaum, Adina R.; Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Buxbaum, Adina R.; Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Singer, Robert H.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Singer, Robert H.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu		buxbaum, adina/0000-0002-3452-5986	NIH [NS083085-19]; Weisman Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weisman Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. J. Bassell for the gift of the Dendra-actin 3'UTR construct, J. Du Hoffmann for invaluable programming help, D. R. Larson for Localize software, and Y. J. Yoon for cloning L10A and helpful discussions. We also thank T. Trcek and other past and present members of the Singer lab for their suggestions and support. This work was supported by NIH grant NS083085-19 (formerly GM84364) and the Weisman Family Foundation. Author notes: A. R. B., B. W., and R. H. S. designed the experiments; A. R. B. performed the experiments; A. R. B. and B. W. performed optical engineering and data analysis; and A. R. B. and R. H. S. wrote the manuscript. Data in this paper are in partial fulfillment of the Ph.D. degree to A.R.B.	Aschrafi A, 2005, P NATL ACAD SCI USA, V102, P2180, DOI 10.1073/pnas.0409803102; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klein ME, 2013, P NATL ACAD SCI USA, V110, P3125, DOI 10.1073/pnas.1209811110; Knowles RB, 1996, J NEUROSCI, V16, P7812; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	20	187	195	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					419	422		10.1126/science.1242939	http://dx.doi.org/10.1126/science.1242939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458642	Green Accepted			2022-12-28	WOS:000330039300049
J	Zaridze, D; Lewington, S; Boroda, A; Scelo, G; Karpov, R; Lazarev, A; Konobeevskaya, I; Igitov, V; Terechova, T; Boffetta, P; Sherliker, P; Kong, XL; Whitlock, G; Boreham, J; Brennan, P; Peto, R				Zaridze, David; Lewington, Sarah; Boroda, Alexander; Scelo, Ghislaine; Karpov, Rostislav; Lazarev, Alexander; Konobeevskaya, Irina; Igitov, Vladimir; Terechova, Tatiyana; Boffetta, Paolo; Sherliker, Paul; Kong, Xiangling; Whitlock, Gary; Boreham, Jillian; Brennan, Paul; Peto, Richard			Alcohol and mortality in Russia: prospective observational study of 151 000 adults	LANCET			English	Article							GLOBAL BURDEN; DISEASE; DRINKING; INJURY; TRENDS; 1980S; RISK	Background Russian adults have extraordinarily high rates of premature death. Retrospective enquiries to the families of about 50 000 deceased Russians had found excess vodka use among those dying from external causes (accident, suicide, violence) and eight particular disease groupings. We now seek prospective evidence of these associations. Methods In three Russian cities (Barnaul, Byisk, and Tomsk), we interviewed 200 000 adults during 1999-2008 (with 12 000 re-interviewed some years later) and followed them until 2010 for cause-specific mortality. In 151 000 with no previous disease and some follow-up at ages 35-74 years, Poisson regression (adjusted for age at risk, amount smoked, education, and city) was used to calculate the relative risks associating vodka consumption with mortality. We have combined these relative risks with age-specific death rates to get 20-year absolute risks. Findings Among 57 361 male smokers with no previous disease, the estimated 20-year risks of death at ages 35-54 years were 16% (95% CI 15-17) for those who reported consuming less than a bottle of vodka per week at baseline, 20% (18-22) for those consuming 1-2.9 bottles per week, and 35% (31-39) for those consuming three or more bottles per week; trend p<0.0001. The corresponding risks of death at ages 55-74 years were 50% (48-52) for those who reported consuming less than a bottle of vodka per week at baseline, 54% (51-57) for those consuming 1-2.9 bottles per week, and 64% (59-69) for those consuming three or more bottles per week; trend p<0.0001. In both age ranges most of the excess mortality in heavier drinkers was from external causes or the eight disease groupings strongly associated with alcohol in the retrospective enquiries. Self-reported drinking fluctuated; of the men who reported drinking three or more bottles of vodka per week who were reinterviewed a few years later, about half (185 of 321) then reported drinking less than one bottle per week. Such fluctuations must have substantially attenuated the apparent hazards of heavy drinking in this study, yet self-reported vodka use at baseline still strongly predicted risk. Among male non-smokers and among females, self-reported heavy drinking was uncommon, but seemed to involve similar absolute excess risks. Interpretation This large prospective study strongly reinforces other evidence that vodka is a major cause of the high risk of premature death in Russian adults.	[Zaridze, David; Boroda, Alexander] Russian Canc Res Ctr, Moscow, Russia; [Lewington, Sarah; Sherliker, Paul; Kong, Xiangling; Whitlock, Gary; Boreham, Jillian; Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Lewington, Sarah; Sherliker, Paul; Kong, Xiangling; Whitlock, Gary; Boreham, Jillian; Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England; [Scelo, Ghislaine; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Karpov, Rostislav; Konobeevskaya, Irina] Tomsk Res Ctr, Inst Cardiol, Tomsk, Russia; [Lazarev, Alexander; Igitov, Vladimir; Terechova, Tatiyana] Russian Canc Res Ctr, Altai Branch, Barnaul, Russia; [Boffetta, Paolo] Ichan Sch Med Mt Sinai, New York, NY USA	University of Oxford; University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC); Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; Icahn School of Medicine at Mount Sinai	Zaridze, D (corresponding author), NN Blokhin Russian Canc Res Ctr, Dept Epidemiol & Prevent, Kashirskoye Shosse 24, Moscow 115478, Russia.	dgzaridze@crc.umos.ru	Boffetta, Paolo/AAI-7767-2021; Karpov, Rostislav S./F-5406-2014; Zaridze, David/K-5605-2013; Scelo, Ghislaine/CAF-8077-2022; Boroda, Alexander/K-5129-2013; Konobeevskaya, Irina/J-4519-2017	Boffetta, Paolo/0000-0002-3811-2791; Karpov, Rostislav S./0000-0002-7011-4316; Konobeevskaya, Irina/0000-0002-4843-6642; Lewington, Sarah/0000-0002-4496-4771; Karpov, Rostislav S./0000-0001-8578-6636; Boroda, Alexander/0000-0002-4196-6042	UK Medical Research Council; British Heart Foundation; Cancer Research UK; European Union; WHO International Agency for Research on Cancer; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); European Union(European Commission); WHO International Agency for Research on Cancer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, British Heart Foundation, Cancer Research UK, European Union, WHO International Agency for Research on Cancer.	[Anonymous], WHO MORT DAT; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Nemtsov A. V., 2011, CONT HIST ALCOHOL RU; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Neufeld M, 2013, ALCOHOL ALCOHOLISM, V48, P222, DOI 10.1093/alcalc/ags134; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; World Health Organization, 1992, INT CLASS DIS REL HL; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	17	112	146	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1465	1473		10.1016/S0140-6736(13)62247-3	http://dx.doi.org/10.1016/S0140-6736(13)62247-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24486187	Green Published, hybrid			2022-12-28	WOS:000335325800027
J	Hautier, Y; Seabloom, EW; Borer, ET; Adler, PB; Harpole, WS; Hillebrand, H; Lind, EM; MacDougall, AS; Stevens, CJ; Bakker, JD; Buckley, YM; Chu, CJ; Collins, SL; Daleo, P; Damschen, EI; Davies, KF; Fay, PA; Firn, J; Gruner, DS; Jin, VL; Klein, JA; Knops, JMH; La Pierre, KJ; Li, W; McCulley, RL; Melbourne, BA; Moore, JL; O'Halloran, LR; Prober, SM; Risch, AC; Sankaran, M; Schuetz, M; Hector, A				Hautier, Yann; Seabloom, Eric W.; Borer, Elizabeth T.; Adler, Peter B.; Harpole, W. Stanley; Hillebrand, Helmut; Lind, Eric M.; MacDougall, Andrew S.; Stevens, Carly J.; Bakker, Jonathan D.; Buckley, Yvonne M.; Chu, Chengjin; Collins, Scott L.; Daleo, Pedro; Damschen, Ellen I.; Davies, Kendi F.; Fay, Philip A.; Firn, Jennifer; Gruner, Daniel S.; Jin, Virginia L.; Klein, Julia A.; Knops, Johannes M. H.; La Pierre, Kimberly J.; Li, Wei; McCulley, Rebecca L.; Melbourne, Brett A.; Moore, Joslin L.; O'Halloran, Lydia R.; Prober, Suzanne M.; Risch, Anita C.; Sankaran, Mahesh; Schuetz, Martin; Hector, Andy			Eutrophication weakens stabilizing effects of diversity in natural grasslands	NATURE			English	Article							ECOSYSTEM STABILITY; PLANT DIVERSITY; BIODIVERSITY LOSS; PRODUCTIVITY; ECOLOGY; LOSSES; POPULATION; RESISTANCE; IMPACT	Studies of experimental grassland communities(1-7) have demonstrated that plant diversity can stabilize productivity through species asynchrony, in which decreases in the biomass of some species are compensated for by increases in others(1,2). However, it remains unknown whether these findings are relevant to natural ecosystems, especially those for which species diversity is threatened by anthropogenic global change(8-11). Here we analyse diversity-stability relationships from 41 grasslands on five continents and examine how these relationships are affected by chronic fertilization, one of the strongest drivers of species loss globally(8). Unmanipulated communities with more species had greater species asynchrony, resulting in more stable biomass production, generalizing a result from biodiversity experiments to real-world grasslands. However, fertilization weakened the positive effect of diversity on stability. Contrary to expectations, this was not due to species loss after eutrophication but rather to an increase in the temporal variation of productivity in combination with a decrease in species asynchrony in diverse communities. Our results demonstrate separate and synergistic effects of diversity and eutrophication on stability, emphasizing the need to understand how drivers of global change interactively affect the reliable provisioning of ecosystem services in real-world systems.	[Hautier, Yann; Seabloom, Eric W.; Borer, Elizabeth T.; Lind, Eric M.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hautier, Yann] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Harpole, W. Stanley] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Buckley, Yvonne M.] Univ Queensland, Sch Biol Sci, Australian Res Council Ctr Excellence Environm De, Brisbane, Qld 4072, Australia; [Buckley, Yvonne M.] Trinity Coll Dublin, Dept Zool, Sch Nat Sci, Dublin 2, Ireland; [Chu, Chengjin] Lanzhou Univ, Sch Life Sci, Res Stn Alpine Meadow & Wetland Ecosyst, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China; [Collins, Scott L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Daleo, Pedro] UNMdP, CONICET, IIMyC, RA-7600 Mar Del Plata, Argentina; [Damschen, Ellen I.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Damschen, Ellen I.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Davies, Kendi F.; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fay, Philip A.] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Biol Sci, Brisbane, Qld 4000, Australia; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Jin, Virginia L.] USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA; [Klein, Julia A.] Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [La Pierre, Kimberly J.] Univ Calif Berkeley, Berkeley Initiat Global Change Biol, Berkeley, CA 94720 USA; [Li, Wei] Southwest Forestry Univ, Yunnan Acad Biodivers, Kunming 650224, Peoples R China; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Moore, Joslin L.] Univ Melbourne, Sch Bot, Australian Res Ctr Urban Ecol, Melbourne, Vic 3010, Australia; [Moore, Joslin L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [O'Halloran, Lydia R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Prober, Suzanne M.] CSIRO Ecosyst Sci, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, CH-8903 Birmensdorf, Switzerland; [Sankaran, Mahesh] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Sankaran, Mahesh] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Hector, Andy] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Minnesota System; University of Minnesota Twin Cities; University of Zurich; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Iowa State University; Carl von Ossietzky Universitat Oldenburg; University of Guelph; Lancaster University; University of Washington; University of Washington Seattle; University of Queensland; Trinity College Dublin; Lanzhou University; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; United States Department of Agriculture (USDA); Queensland University of Technology (QUT); University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); Colorado State University; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley; Southwest Forestry University - China; University of Kentucky; University of Melbourne; Monash University; Oregon State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Leeds; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Oxford	Hautier, Y (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	hauti001@umn.edu	Fay, Philip A./I-1853-2012; MacDougall, Andrew S/F-2037-2011; Chu, Chu/T-6038-2019; Knops, Johannes/AAA-8546-2020; Collins, Scott L/P-7742-2014; Risch, Anita C./A-9836-2012; Daleo, Pedro/A-4694-2008; Adler, Peter B./D-3781-2009; Prober, Suzanne/G-6465-2010; Hautier, Yann/D-5426-2015; Hautier, Yann/I-2526-2019; Harpole, William S/C-2814-2013; Moore, Joslin L/C-5270-2009; Hillebrand, Helmut/I-1717-2014; Moore, Joslin/AAE-3819-2020; Gruner, Daniel Stephen/A-5166-2010; Hector, Andrew/H-4199-2011; Bakker, Jonathan/I-6960-2013; Buckley, Yvonne/B-1281-2008	Fay, Philip A./0000-0002-8291-6316; Collins, Scott L/0000-0002-0193-2892; Risch, Anita C./0000-0003-0531-8336; Prober, Suzanne/0000-0002-6518-239X; Hautier, Yann/0000-0003-4347-7741; Hautier, Yann/0000-0003-4347-7741; Harpole, William S/0000-0002-3404-9174; Moore, Joslin L/0000-0001-9809-5092; Hillebrand, Helmut/0000-0001-7449-1613; Moore, Joslin/0000-0001-9809-5092; Gruner, Daniel Stephen/0000-0002-3153-4297; Hector, Andrew/0000-0002-1309-7716; Bakker, Jonathan/0000-0002-8973-2771; Buckley, Yvonne/0000-0001-7599-3201; Komatsu, Kimberly/0000-0001-7056-4547; Chu, Chengjin/0000-0002-0606-449X; Borer, Elizabeth/0000-0003-2259-5853; Stevens, Carly/0000-0002-2390-1763; Firn, Jennifer/0000-0001-6026-8912; Lind, Eric/0000-0003-3051-7724; MELBOURNE, BRETT/0000-0002-8843-4131; Daleo, Pedro/0000-0001-9759-1203; Seabloom, Eric/0000-0001-6780-9259	European Union [298935]; National Science Foundation Research Coordination Network [NSF-DEB-1042132]; Long Term Ecological Research (LTER) programme [NSF-DEB-1234162]; Institute on the Environment at the University of Minnesota [DG-0001-13]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	European Union(European Commission); National Science Foundation Research Coordination Network(National Science Foundation (NSF)); Long Term Ecological Research (LTER) programme; Institute on the Environment at the University of Minnesota(University of Minnesota System); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 298935 to Y.H. (with A. H. and E. W. S.). This work was generated using data from the Nutrient Network (http://www.nutnet.org) experiment, funded at the site-scale by individual researchers. Coordination and data management have been supported by funding to E. T. B. and E. W. S. from the National Science Foundation Research Coordination Network (NSF-DEB-1042132), the Long Term Ecological Research (LTER) programme (NSF-DEB-1234162 to Cedar Creek as well as other LTER sites), and the Institute on the Environment at the University of Minnesota (DG-0001-13). We also thank the Minnesota Supercomputer Institute for hosting project data, and the Institute on the Environment for hosting Network meetings. We thank R. S. L. Veiga, F. Isbell, R. K. Didham, H. McGinness and M. O'Brien for suggestions that improved the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; [Anonymous], 2012, LANG ENV STAT COMP; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bezemer TM, 2007, NATURE, V446, pE6, DOI 10.1038/nature05749; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; de Mazancourt C, 2013, ECOL LETT, V16, P617, DOI 10.1111/ele.12088; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; LAUENROTH WK, 1986, ECOL MODEL, V33, P297, DOI 10.1016/0304-3800(86)90045-1; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M., 2010, POPULATIONS ECOSYSTE; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; May R.M., 1973, STABILITY COMPLEXITY; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oesterheld M, 2000, METHODS IN ECOSYSTEM SCIENCE, P151; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pinheiro J, 2001, MIXED EFFECTS MODELS; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Selmants PC, 2012, J ECOL, V100, P723, DOI 10.1111/j.1365-2745.2011.01949.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang ZL, 2011, PLANT SOIL, V345, P315, DOI 10.1007/s11104-011-0784-0; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	42	297	312	39	756	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					521	+		10.1038/nature13014	http://dx.doi.org/10.1038/nature13014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24531763	Green Published			2022-12-28	WOS:000334741600036
J	Dupret, V; Sanchez, S; Goujet, D; Tafforeau, P; Ahlberg, PE				Dupret, Vincent; Sanchez, Sophie; Goujet, Daniel; Tafforeau, Paul; Ahlberg, Per E.			A primitive placoderm sheds light on the origin of the jawed vertebrate face	NATURE			English	Article							DEVELOPMENTAL MORPHOLOGY; EVOLUTION; EMBRYOLOGY; BRAINCASE; MESODERM; LAMPREY; SHARK; CHINA; FISH	Extant vertebrates form two clades, the jawless Cyclostomata (lampreys and hagfishes) and the jawed Gnathostomata (all other vertebrates), with contrasting facial architectures(1,2). These arise during development from just a few key differences in the growth patterns of the cranial primordia: notably, the nasal sacs and hypophysis originate from a single placode in cyclostomes but from separate placodes in gnathostomes, and infraoptic ectomesenchyme migrates forward either side of the single placode in cyclostomes but between the placodes in gnathostomes(3-8). Fossil stem gnathostomes preserve cranial anatomies rich in landmarks that provide proxies for developmental processes and allow the transition from jawless to jawed vertebrates to be broken down into evolutionary steps(7,9-12). Here we use propagation phase contrast synchrotron microtomography to image the cranial anatomy of the primitive placoderm (jawed stem gnathostome) Romundina(13), and show that itcombines jawed vertebrate architecture with cranial and cerebral proportions resembling those of cyclostomes and the galeaspid (jawless stem gnathostome) Shuyu(11). This combination seems to be primitive for jawed vertebrates, and suggests a decoupling between ectomesenchymal growth trajectory, ectomesenchymal proliferation, and cerebral shape change during the origin of gnathostomes.	[Dupret, Vincent; Sanchez, Sophie; Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, SE-75236 Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Goujet, Daniel] UPMC, MNHN, CNRS, UMR 7207,CR2P, F-75231 Paris 05, France	Uppsala University; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Dupret, V (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Norbyvagen 18A, SE-75236 Uppsala, Sweden.	vincent.dupret@ebc.uu.se; per.ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Dupret, Vincent/L-2306-2015	Tafforeau, Paul/0000-0002-5962-1683; Dupret, Vincent/0000-0002-6859-1041; Sanchez, Sophie/0000-0002-3611-6836; Ahlberg, Per/0000-0001-9054-2900	European Research Council [233111]; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation	We thank the European Synchrotron Radiation Facility for granting us beam time at ID19 (proposal EC-203). P. E. A., V. D. and S. S. acknowledge the support of European Research Council Advanced Investigator Grant 233111 and a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation, both awarded to P. E. A. We thank B. Ryll, M. Kundrat and H. Blom at Uppsala University for discussions. Specimen MNHN CPW 1 photographs were taken by P. Loubry (Centre National pour la Recherche Scientifique, Museum national d'Histoire naturelle, Paris).	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; COULY GF, 1993, DEVELOPMENT, V117, P409; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R. H, 1978, PLACODERMI; Dupret V, 2010, CR PALEVOL, V9, P369, DOI 10.1016/j.crpv.2010.07.005; Dupret V, 2010, GEODIVERSITAS, V32, P5, DOI 10.5252/g2010n1a1; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Goujet D, 1984, POISSONS PLACODERMES; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Janvier P, 1996, EARLY VERTEBRATES, V1; Kuratani S, 1999, DEV BIOL, V210, P381, DOI 10.1006/dbio.1999.9266; Kuratani S, 2000, ZOOL SCI, V17, P893, DOI 10.2108/zsj.17.893; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2004, J ANAT, V205, P335, DOI 10.1111/j.0021-8782.2004.00345.x; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; ORVIG T, 1975, PROBLEMES ACTUELS PA, P41; OsumiYamashita N, 1997, DEV GROWTH DIFFER, V39, P53; Ota KG, 2007, INTEGR COMP BIOL, V47, P329, DOI 10.1093/icb/icm022; Pulera D., 2007, DISSECTION VERTEBRAT; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Wada N, 2011, DEV BIOL, V356, P529, DOI 10.1016/j.ydbio.2011.06.008; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; YOUNG GC, 1984, PALAEONTOLOGY, V27, P635; Zhu M, 1996, J VERTEBR PALEONTOL, V16, P1, DOI 10.1080/02724634.1996.10011278; Zhu M., 2013, NATURE	30	94	97	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					500	+		10.1038/nature12980	http://dx.doi.org/10.1038/nature12980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24522530				2022-12-28	WOS:000333402000041
J	Sankararaman, S; Mallick, S; Dannemann, M; Prufer, K; Kelso, J; Paabo, S; Patterson, N; Reich, D				Sankararaman, Sriram; Mallick, Swapan; Dannemann, Michael; Pruefer, Kay; Kelso, Janet; Paeaebo, Svante; Patterson, Nick; Reich, David			The genomic landscape of Neanderthal ancestry in present-day humans	NATURE			English	Article							GENETIC-VARIATION; SEX-CHROMOSOMES; EAST ASIANS; SEQUENCE; EVOLUTION; EXPRESSION; EUROPEANS; HOTSPOTS; HISTORY; MICE	Genomic studies have shown that Neanderthals interbred with modern humans, and that non-Africans today are the products of this mixture(1,2). The antiquity of Neanderthal gene flow into modern humans means that genomic regions that derive from Neanderthals in any one human today are usually less than a hundred kilobases in size. However, Neanderthal haplotypes are also distinctive enough that several studies have been able to detect Neanderthal ancestry at specific loci(1,3-8). We systematically infer Neanderthal haplotypes in the genomes of 1,004 present-day humans(9). Regions that harbour a high frequency of Neanderthal alleles are enriched for genes affecting keratin filaments, suggesting that Neanderthal alleles may have helped modern humans to adapt to non-African environments. We identify multiple Neanderthal-derived alleles that confer risk for disease, suggesting that Neanderthal alleles continue to shape human biology. An unexpected finding is that regions with reduced Neanderthal ancestry are enriched in genes, implying selection to remove genetic material derived from Neanderthals. Genes that are more highly expressed in testes than in any other tissue are especially reduced in Neanderthal ancestry, and there is an approximately fivefold reduction of Neanderthal ancestry on the X chromosome, which is known from studies of diverse species to be especially dense in male hybrid sterility genes(10-12). These results suggest that part of the explanation for genomic regions of reduced Neanderthal ancestry is Neanderthal alleles that caused decreased fertility in males when moved to a modern human genetic background.	[Sankararaman, Sriram; Mallick, Swapan; Patterson, Nick; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sankararaman, Sriram; Mallick, Swapan; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Dannemann, Michael; Pruefer, Kay; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sankararaman, S (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sankararaman@genetics.med.harvard.edu; reich@genetics.med.harvard.edu	Reich, Daniel S./E-5701-2010; Kelso, Janet/N-1812-2019	Reich, Daniel S./0000-0002-2628-4334; Kelso, Janet/0000-0002-3618-322X	Presidential Innovation Fund of the Max Planck Society; NSF HOMINID [1032255]; NIH [GM100233]; Initiative for the Science of the Human Past at Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Presidential Innovation Fund of the Max Planck Society; NSF HOMINID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Initiative for the Science of the Human Past at Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Briggs, P. Moorjani, M. Przeworski, D. Presgraves and A. Williams for critical comments, and K. Kavanagh for help with Extended Data Fig. 2. We are grateful for support from the Presidential Innovation Fund of the Max Planck Society, NSF HOMINID grant 1032255 and NIH grant GM100233. S. S. was supported by a post-doctoral fellowship from the Initiative for the Science of the Human Past at Harvard University. D. R. is a Howard Hughes Medical Institute Investigator.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhatia G., 2013, PREPRINT; Coyne J.A., 1989, P180; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Durand E. Y., 2011, NEANDERTHAL ANCESTRY; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; McCallum A., 2007, INTRO STAT RELATIONA, P93; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Orr HA, 2001, EVOLUTION, V55, P1085; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; PERCIVAL D, 2005, WAVELET METHODS TIME; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; The SIGMA Type 2 Diabetes Consortium, 2014, NATURE; TUCKER PK, 1992, EVOLUTION, V46, P1146, DOI 10.1111/j.1558-5646.1992.tb00625.x; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024	39	526	544	23	527	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					354	+		10.1038/nature12961	http://dx.doi.org/10.1038/nature12961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24476815	Green Submitted, Green Accepted			2022-12-28	WOS:000333029000033
J	Denger, K; Weiss, M; Felux, AK; Schneider, A; Mayer, C; Spiteller, D; Huhn, T; Cook, AM; Schleheck, D				Denger, Karin; Weiss, Michael; Felux, Ann-Katrin; Schneider, Alexander; Mayer, Christoph; Spiteller, Dieter; Huhn, Thomas; Cook, Alasdair M.; Schleheck, David			Sulphoglycolysis in Escherichia coli K-12 closes a gap in the biogeochemical sulphur cycle	NATURE			English	Article							COMPLETE DEGRADATION; BACTERIA; SULFOQUINOVOSE; PATHWAY; ENZYMES; BIOSYNTHESIS; SYNTHASE; GROWTH	Sulphoquinovose (SQ, 6-deoxy-6-sulphoglucose) has been known for 50 years as the polar headgroup of the plant sulpholipid(1,2) in the photosynthetic membranes of all higher plants, mosses, ferns, algae and most photosynthetic bacteria(3). It is also found in some non-photosynthetic bacteria(4), and SQ is part of the surface layer of some Archaea(5). The estimated annual production of SQ(4) is 10,000,000,000 tonnes (10 petagrams), thus it comprises a major portion of the organo-sulphur in nature, where SQ is degraded by bacteria(6,7). However, despite evidence for at least three different degradative pathways in bacteria(6-8), no enzymic reaction or gene in any pathway has been defined, although a sulphoglycolytic pathway has been proposed(7). Here we show that Escherichia coli K-12, the most widely studied prokaryotic model organism, performs sulphoglycolysis, in addition to standard glycolysis. SQ is catabolised through four newly discovered reactions that we established using purified, heterologously expressed enzymes: SQ isomerase, 6-deoxy-6-sulphofructose (SF) kinase, 6-deoxy-6-sulphofructose-1-phosphate (SFP) aldolase, and 3-sulpholactaldehyde (SLA) reductase. The enzymes are encoded in a ten-gene cluster, which probably also encodes regulation, transport and degradation of the whole sulpholipid; the gene cluster is present in almost all (>91%) available E. coli genomes, and is wide-spread in Enterobacteriaceae. The pathway yields dihydroxyacetone phosphate (DHAP), which powers energy conservation and growth of E. coli, and the sulphonate product 2,3-dihydroxypropane-1-sulphonate (DHPS), which is excreted. DHPS is mineralized by other bacteria, thus closing the sulphur cycle within a bacterial community.	[Denger, Karin; Spiteller, Dieter; Cook, Alasdair M.; Schleheck, David] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Weiss, Michael; Felux, Ann-Katrin] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Schneider, Alexander; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Huhn, Thomas] Univ Konstanz, Dept Chem, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; Eberhard Karls University of Tubingen; University of Konstanz	Cook, AM (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	alasdair.cook@uni-konstanz.de; david.schleheck@uni-konstanz.de	Mayer, Christoph/S-8666-2017; Huhn, Thomas/A-2708-2009	Mayer, Christoph/0000-0003-4731-4851; Huhn, Thomas/0000-0001-6292-4215	Konstanz Research School Chemical Biology (KoRS-CB); German Research Foundation (DFG) [MA2436/4, SFB766/A15]; Baden-Wurttemberg Stiftung [P-BWS-Glyko11]; DFG [SCHL 1936/1-1]; University of Konstanz; Konstanz Young Scholar Fund	Konstanz Research School Chemical Biology (KoRS-CB); German Research Foundation (DFG)(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung; DFG(German Research Foundation (DFG)); University of Konstanz; Konstanz Young Scholar Fund	We thank E. Deuerling for substrain MG1655, J. Klebensberger for substrain BW25113 and its knockout mutants, and K. Leitner for help with growth experiments. The work of M.W. and A.-K.F. was supported by the Konstanz Research School Chemical Biology (KoRS-CB), the work of C.M. by German Research Foundation (DFG) grants (MA2436/4 and SFB766/A15) and by the Baden-Wurttemberg Stiftung (P-BWS-Glyko11), and the work of D.Sc. by a DFG grant (SCHL 1936/1-1) and by the University of Konstanz and the Konstanz Young Scholar Fund.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Benning C, 2007, PHOTOSYNTH RES, V92, P199, DOI 10.1007/s11120-007-9144-6; BENSON A. A., 1961, FED PROC, V20, P79; BENSON AA, 1963, ADV LIPID RES, V1, P387; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cook AM, 2002, ARCH MICROBIOL, V179, P1, DOI 10.1007/s00203-002-0497-0; COOK AM, 1987, FEMS MICROBIOL LETT, V46, P93, DOI 10.1016/0378-1097(87)90059-0; Cornish-Bowden A., 1981, BIOCHEM EDUC, V9, P133, DOI [10.1016/0307-4412(81)90102-3, DOI 10.1016/0307-4412(81)90102-3]; Denger K, 2012, FEMS MICROBIOL LETT, V328, P39, DOI 10.1111/j.1574-6968.2011.02477.x; Felux AK, 2013, J BACTERIOL, V195, P2921, DOI 10.1128/JB.00307-13; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; Harwood JL, 1979, BIOCHEM SOC T, V7, P440, DOI 10.1042/bst0070440; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mampel J, 2004, BIOCHEM J, V383, P91, DOI 10.1042/BJ20040652; MARTELLI HL, 1967, NATURE, V216, P1238, DOI 10.1038/2161238a0; Mayer J, 2010, MICROBIOL-SGM, V156, P1556, DOI 10.1099/mic.0.037580-0; Mayer J, 2009, J BACTERIOL, V191, P6052, DOI 10.1128/JB.00678-09; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Roy AB, 2003, APPL ENVIRON MICROB, V69, P6434, DOI 10.1128/AEM.69.11.6434-6441.2003; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Sato Y, 2006, INT J SYST EVOL MICR, V56, P973, DOI 10.1099/ijs.0.63922-0; Schmidt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056905; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; THURNHEER T, 1986, J GEN MICROBIOL, V132, P1215; Weiss M, 2012, APPL ENVIRON MICROB, V78, P8254, DOI 10.1128/AEM.02412-12	28	72	81	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					114	+		10.1038/nature12947	http://dx.doi.org/10.1038/nature12947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24463506	Green Submitted			2022-12-28	WOS:000332224400053
J	Kho, KA; Nezhat, CH				Kho, Kimberly A.; Nezhat, Ceana H.			Evaluating the Risks of Electric Uterine Morcellation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYSTERECTOMY; SERIES		[Kho, Kimberly A.] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Nezhat, Ceana H.] Atlanta Ctr Minimally Invas Surg & Reprod Med, Atlanta, GA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kho, KA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kimberly.kho@utsouthwestern.edu						Andy UU, 2014, J MINIM INVAS GYN, V21, P97, DOI 10.1016/j.jmig.2013.07.008; Frick AC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.077; Hagemann IS, 2011, INT J GYNECOL PATHOL, V30, P476, DOI 10.1097/PGP.0b013e3182107ecf; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Levitz J., THE WALL STREET JOUR; Milad MP, 2014, J MINIM INVAS GYN, V21, P486, DOI 10.1016/j.jmig.2013.12.003; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Ramm O, 2012, INT UROGYNECOL J, V23, P913, DOI 10.1007/s00192-012-1694-2; Seidman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050058; Uccella S, 2013, J MINIM INVAS GYN, V20, P583, DOI 10.1016/j.jmig.2013.02.022	10	87	94	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					905	906		10.1001/jama.2014.1093	http://dx.doi.org/10.1001/jama.2014.1093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24504415				2022-12-28	WOS:000332170800013
J	Jimenez, AJ; Maiuri, P; Lafaurie-Janvore, J; Divoux, S; Piel, M; Perez, F				Jimenez, Ana Joaquina; Maiuri, Paolo; Lafaurie-Janvore, Julie; Divoux, Severine; Piel, Matthieu; Perez, Franck			ESCRT Machinery Is Required for Plasma Membrane Repair	SCIENCE			English	Article							III COMPLEX; PROTEIN; ALIX; RELEASE; DOMAIN; CYTOKINESIS; ENDOSOMES; VESICLES; CELLS; HIV-1	Plasma membrane damage can be triggered by numerous phenomena, and efficient repair is essential for cell survival. Endocytosis, membrane patching, or extracellular budding can be used for plasma membrane repair. We found that endosomal sorting complex required for transport (ESCRT), involved previously in membrane budding and fission, plays a critical role in plasma membrane repair. ESCRT proteins were recruited within seconds to plasma membrane wounds. Quantitative analysis of wound closure kinetics coupled to mathematical modeling suggested that ESCRTs are involved in the repair of small wounds. Real-time imaging and correlative scanning electron microscopy (SEM) identified extracellular buds and shedding at the site of ESCRT recruitment. Thus, the repair of certain wounds is ensured by ESCRT-mediated extracellular shedding of wounded portions.	[Jimenez, Ana Joaquina; Maiuri, Paolo; Lafaurie-Janvore, Julie; Divoux, Severine; Piel, Matthieu; Perez, Franck] Inst Curie, F-75248 Paris 05, France; [Jimenez, Ana Joaquina; Maiuri, Paolo; Lafaurie-Janvore, Julie; Divoux, Severine; Piel, Matthieu; Perez, Franck] CNRS, UMR 144, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Perez, F (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris 05, France.	franck.perez@curie.fr	Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401; Jimenez Salazar, Ana Joaquina/0000-0003-4108-6632; Maiuri, Paolo/0000-0001-5079-445X	Institut Curie; CNRS; French Agence Nationale de la Recherche ("ANR"); Ligue Contre le Cancer grant; French ministerial fellowship; Fondation pour la Recherche Medicale fellowships; Institut Curie fellowship; LaBex CelTisPhyBio part of the IDEX PSL [ANR-10-LBX-0038, ANR-10-IDEX-0001-02]	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Agence Nationale de la Recherche ("ANR")(French National Research Agency (ANR)); Ligue Contre le Cancer grant; French ministerial fellowship; Fondation pour la Recherche Medicale fellowships(Fondation pour la Recherche Medicale); Institut Curie fellowship; LaBex CelTisPhyBio part of the IDEX PSL	This work was supported by the Institut Curie, CNRS, the French Agence Nationale de la Recherche ("ANR") (to F. P.), a Ligue Contre le Cancer grant (to M. P.), a French ministerial fellowship (to J.L.-J.), Fondation pour la Recherche Medicale fellowships (to J.L.-J. and P. M.), and an Institut Curie fellowship (to A.J.J.). F.P.'s team is supported by the LaBex CelTisPhyBio (ANR-10-LBX-0038 part of the IDEX PSL no. ANR-10-IDEX-0001-02).	Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Bodon G, 2011, J BIOL CHEM, V286, P40276, DOI 10.1074/jbc.M111.283671; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujita H, 2004, J CELL SCI, V117, P2997, DOI 10.1242/jcs.01170; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Romancino DP, 2013, FEBS LETT, V587, P1379, DOI 10.1016/j.febslet.2013.03.012; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319	38	355	362	7	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					986	+	1247136	10.1126/science.1247136	http://dx.doi.org/10.1126/science.1247136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24482116				2022-12-28	WOS:000332309600034
J	Nataneli, N; Chai, JSM				Nataneli, Nathaniel; Chai, Jean S. M.			Bilateral Corneal Perforation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nataneli, Nathaniel] Ophthalm Consultants Long Isl Rockville Ctr, New York, NY 11570 USA; [Chai, Jean S. M.] Singapore Natl Eye Ctr, Singapore, Singapore	Singapore National Eye Center	Nataneli, N (corresponding author), Ophthalm Consultants Long Isl Rockville Ctr, New York, NY 11570 USA.		Nataneli, Nathaniel/ABA-8808-2021						0	2	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					650	650		10.1056/NEJMicm1303823	http://dx.doi.org/10.1056/NEJMicm1303823			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521111				2022-12-28	WOS:000331187500011
J	Watson, E; MacNeil, LT; Ritter, AD; Yilmaz, LS; Rosebrock, AP; Caudy, AA; Walhout, AJM				Watson, Emma; MacNeil, Lesley T.; Ritter, Ashlyn D.; Yilmaz, L. Safak; Rosebrock, Adam P.; Caudy, Amy A.; Walhout, Albertha J. M.			Interspecies Systems Biology Uncovers Metabolites Affecting C. elegans Gene Expression and Life History Traits	CELL			English	Article							CAENORHABDITIS-ELEGANS; GUT MICROBIOTA; VITAMIN-B12; TRANSPORT; HOST; SPAN; INTEGRATION; PHYSIOLOGY; FERTILITY; GROWTH	Diet greatly influences gene expression and physiology. In mammals, elucidating the effects and mechanisms of individual nutrients is challenging due to the complexity of both the animal and its diet. Here, we used an interspecies systems biology approach with Caenorhabditis elegans and two of its bacterial diets, Escherichia coli and Comamonas aquatica, to identify metabolites that affect the animal's gene expression and physiology. We identify vitamin B12 as the major dilutable metabolite provided by Comamonas aq. that regulates gene expression, accelerates development, and reduces fertility but does not affect lifespan. We find that vitamin B12 has a dual role in the animal: it affects development and fertility via the methionine/S-Adenosylmethionine (SAM) cycle and breaks down the short-chain fatty acid propionic acid, preventing its toxic buildup. Our interspecies systems biology approach provides a paradigm for understanding complex interactions between diet and physiology.	[Watson, Emma; MacNeil, Lesley T.; Ritter, Ashlyn D.; Yilmaz, L. Safak; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Watson, Emma; MacNeil, Lesley T.; Ritter, Ashlyn D.; Yilmaz, L. Safak; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rosebrock, Adam P.; Caudy, Amy A.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Rosebrock, Adam P.; Caudy, Amy A.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University of Toronto	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu		Walhout, Marian/0000-0001-5587-3608; Caudy, Amy/0000-0001-6307-8137	National Institutes of Health [DK068429]; NIH [AG041605]; AHA Founders Affiliate Predoctoral Fellowship; Ontario Early Researcher Award; Canadian Foundation for Innovation; Ontario Leader's Opportunity Fund; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG041605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Founders Affiliate Predoctoral Fellowship; Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Leader's Opportunity Fund; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Walhout laboratory, Amy Walker, Victor Ambros, Job Dekker, and Chris Sassetti for helpful discussions. We thank Simon Dove and Bryan McGuffie for reagents and advice on transposon screening. This work was supported by the National Institutes of Health (grant DK068429 to A.J.M.W.). A. D. R. was supported by NIH predoctoral fellowship AG041605. E. W. was supported by an AHA Founders Affiliate Predoctoral Fellowship. A. A. C. is supported by the Ontario Early Researcher Award, by the Canadian Foundation for Innovation and the Ontario Leader's Opportunity Fund, by the Canadian Institutes for Health Research, and by the Natural Sciences and Engineering Research Council of Canada. Some nematode strains used in this work were provided by the CGC, which is funded by the NIH National Center for Research Resources (NCRR).	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; ALBERT MJ, 1980, NATURE, V283, P781, DOI 10.1038/283781a0; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; Bender D.A., 2003, NUTR BIOCH VITAMINS; Bito T, 2013, FEBS OPEN BIO, V3, P112, DOI 10.1016/j.fob.2013.01.008; BRENNER S, 1974, GENETICS, V77, P71; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gracida X, 2013, CURR BIOL, V23, P607, DOI 10.1016/j.cub.2013.02.034; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; ILLMAN RJ, 1986, J NUTR, V116, P1694, DOI 10.1093/jn/116.9.1694; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARASSEVA V, 1977, ZBL BAKT-INT J MED M, V239, P514; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Pepper MR, 2011, SEMIN CELL DEV BIOL, V22, P619, DOI 10.1016/j.semcdb.2011.05.005; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050	38	116	121	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					759	770		10.1016/j.cell.2014.01.047	http://dx.doi.org/10.1016/j.cell.2014.01.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529378	Green Accepted, Bronze			2022-12-28	WOS:000331379800014
J	Schwenk, TL				Schwenk, Thomas L.			The Moment of Truth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schwenk, Thomas L.] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Schwenk, Thomas L.] Univ Nevada, Sch Med, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Schwenk, TL (corresponding author), Univ Nevada, Sch Med, Reno, NV 89557 USA.	tschwenk@medicine.nevada.edu							0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					573	574		10.1001/jama.2013.286177	http://dx.doi.org/10.1001/jama.2013.286177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519294				2022-12-28	WOS:000330941000010
J	Tyzio, R; Nardou, R; Ferrari, DC; Tsintsadze, T; Shahrokhi, A; Eftekhari, S; Khalilov, I; Tsintsadze, V; Brouchoud, C; Chazal, G; Lemonnier, E; Lozovaya, N; Burnashev, N; Ben-Ari, Y				Tyzio, Roman; Nardou, Romain; Ferrari, Diana C.; Tsintsadze, Timur; Shahrokhi, Amene; Eftekhari, Sanaz; Khalilov, Ilgam; Tsintsadze, Vera; Brouchoud, Corinne; Chazal, Genevieve; Lemonnier, Eric; Lozovaya, Natalia; Burnashev, Nail; Ben-Ari, Yehezkel			Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring	SCIENCE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SPECTRUM DISORDERS; VASOPRESSIN; CHILDREN; NEURONS; BRAIN	We report that the oxytocin-mediated neuroprotective g-aminobutyric acid (GABA) excitatory-inhibitory shift during delivery is abolished in the valproate and fragile X rodent models of autism. During delivery and subsequently, hippocampal neurons in these models have elevated intracellular chloride levels, increased excitatory GABA, enhanced glutamatergic activity, and elevated gamma oscillations. Maternal pretreatment with bumetanide restored in offspring control electrophysiological and behavioral phenotypes. Conversely, blocking oxytocin signaling in naive mothers produced offspring having electrophysiological and behavioral autistic-like features. Our results suggest a chronic deficient chloride regulation in these rodent models of autism and stress the importance of oxytocin-mediated GABAergic inhibition during the delivery process. Our data validate the amelioration observed with bumetanide and oxytocin and point to common pathways in a drug-induced and a genetic rodent model of autism.	[Tyzio, Roman; Tsintsadze, Timur; Khalilov, Ilgam; Tsintsadze, Vera; Brouchoud, Corinne; Chazal, Genevieve; Lozovaya, Natalia; Burnashev, Nail; Ben-Ari, Yehezkel] INSERM, Mediterranean Inst Neurobiol INMED, U901, F-13258 Marseille, France; [Tyzio, Roman; Tsintsadze, Timur; Khalilov, Ilgam; Tsintsadze, Vera; Brouchoud, Corinne; Chazal, Genevieve; Lozovaya, Natalia; Burnashev, Nail; Ben-Ari, Yehezkel] Aix Marseille Univ, UMR 901, Marseille, France; [Nardou, Romain; Ferrari, Diana C.; Tsintsadze, Timur; Shahrokhi, Amene; Eftekhari, Sanaz; Ben-Ari, Yehezkel] Neurochlore, F-13273 Marseille 09, France; [Lemonnier, Eric] Lab Neurosci Brest EA4685, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Bretagne Occidentale	Ben-Ari, Y (corresponding author), INSERM, Mediterranean Inst Neurobiol INMED, U901, F-13258 Marseille, France.	yehezkel.ben-ari@inserm.fr	Romain, Nardou/AAI-6027-2020; lemonnier, eric/K-1084-2016; Burnashev, Nail/G-4056-2013; Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480	INSERM; Neurochlore; France's Agence Nationale de la Recherche [ANR-12-RPIB-0001-01]; Simons Foundation (SFARI) [230267]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Neurochlore; France's Agence Nationale de la Recherche(French National Research Agency (ANR)); Simons Foundation (SFARI)	We thank at INMED C. Rivera and C. Pellegrino for their assistance on the Western blot and for the panKCC2 antibody, R. Martinez for his technical help with the ultrasonic setup, and M. L. Scattoni and M. Wohr for their assistance with the vocalization experiments and analysis. This study was supported by INSERM (funds to INMED), Neurochlore, France's Agence Nationale de la Recherche (ANR-12-RPIB-0001-01), and the Simons Foundation (SFARI award #230267 to Y. B-A.). We also thank Sanofi-Syntelabo for the gift of SSR126768A. On 13 January 2011, Neurochlore filed a patent entitled "Compounds for the treatment of autism" (U.S. patent number 13/522372, worldwide PCT/EP2011/050394); Y. B-A. and E. L. are identified as inventors of this patent. Y. B-A. and E. L. are founders and shareholders of Neurochlore, a company focused on the treatment of developmental disorders. R.N. and D. C. F. own shares in Neurochlore.	Anagnostou E, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-16; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2008, TRENDS NEUROSCI, V31, P626, DOI 10.1016/j.tins.2008.09.002; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Cornew L, 2012, J AUTISM DEV DISORD, V42, P1884, DOI 10.1007/s10803-011-1431-6; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Inoue W, 2013, NAT NEUROSCI, V16, P605, DOI 10.1038/nn.3373; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kim JS, 2011, J NEUROSCI, V31, P13312, DOI 10.1523/JNEUROSCI.1440-11.2011; LAGERCRANTZ H, 1977, PEDIATR RES, V11, P889, DOI 10.1203/00006450-197708000-00007; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Lyall K, 2012, AUTISM RES, V5, P21, DOI 10.1002/aur.228; Marrosu F, 1987, Funct Neurol, V2, P355; Mazzuca M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00003; Nardou R, 2011, BRAIN, V134, P987, DOI 10.1093/brain/awr041; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Pobbe RLH, 2012, HORM BEHAV, V61, P436, DOI 10.1016/j.yhbeh.2011.10.010; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212	25	378	388	6	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					675	679		10.1126/science.1247190	http://dx.doi.org/10.1126/science.1247190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503856				2022-12-28	WOS:000330724000046
J	Youk, H; Lim, WA				Youk, Hyun; Lim, Wendell A.			Secreting and Sensing the Same Molecule Allows Cells to Achieve Versatile Social Behaviors	SCIENCE			English	Article							MAP KINASE PATHWAY; SIGNALING DYNAMICS; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; PARADOXICAL COMPONENTS; FEEDBACK-REGULATION; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PATTERN-FORMATION; ESCHERICHIA-COLI	Cells that secrete and sense the same signaling molecule are ubiquitous. To uncover the functional capabilities of the core "secrete-and-sense" circuit motif shared by these cells, we engineered yeast to secrete and sense the mating pheromone. Perturbing each circuit element revealed parameters that control the degree to which the cell communicated with itself versus with its neighbors. This tunable interplay of self-communication and neighbor communication enables cells to span a diverse repertoire of cellular behaviors. These include a cell being asocial by responding only to itself and social through quorum sensing, and an isogenic population of cells splitting into social and asocial subpopulations. A mathematical model explained these behaviors. The versatility of the secrete-and-sense circuit motif may explain its recurrence across	[Youk, Hyun; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Youk, Hyun; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Youk, Hyun/E-2661-2016	Youk, Hyun/0000-0003-1687-5760	NIH [R01 GM55040, R01 GM62583, PN2 EY016546, P50 GM081879]; NSF Synthetic Biology Engineering Research Center (SynBERC); Howard Hughes Medical Institute (HHMI); NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, P50GM081879, R01GM062583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Mitchell, S. Itzkovitz, T. Long, M. Thomson, E. Puchner, K. Roybal, L. Morsut, D. Sivak, A. Raj, and J. Gore for insightful discussions. This work was supported by NIH grants R01 GM55040, R01 GM62583, PN2 EY016546, and P50 GM081879, the NSF Synthetic Biology Engineering Research Center (SynBERC), and the Howard Hughes Medical Institute (HHMI) (to W.A.L.). H.Y. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2089-11).	Afek Y, 2011, SCIENCE, V331, P183, DOI 10.1126/science.1193210; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Barkai N, 1998, NATURE, V396, P422, DOI 10.1038/24760; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bischofs IB, 2009, P NATL ACAD SCI USA, V106, P6459, DOI 10.1073/pnas.0810878106; Bollenbach T, 2011, MOL CELL, V42, P413, DOI 10.1016/j.molcel.2011.04.016; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Cantrell D. A., 1984, SCIENCE, V224, P312, DOI 10.1126/science.6427923; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Chen SS, 2013, CURR OPIN BIOTECH, V24, P790, DOI 10.1016/j.copbio.2013.02.025; Coppey M, 2007, BIOPHYS J, V93, P1917, DOI 10.1529/biophysj.107.109736; Corson F, 2012, P NATL ACAD SCI USA, V109, P5568, DOI 10.1073/pnas.1201505109; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; de Ronde W, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048101; DeWitt AE, 2001, J CELL SCI, V114, P2301; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; Eldar A, 2011, P NATL ACAD SCI USA, V108, P13635, DOI 10.1073/pnas.1102923108; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Espinar L, 2013, P NATL ACAD SCI USA, V110, P7091, DOI 10.1073/pnas.1216091110; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Ferrell JE, 2008, CURR BIOL, V18, pR244, DOI 10.1016/j.cub.2008.02.035; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Goncalves-Sa J, 2011, CURR BIOL, V21, P1337, DOI 10.1016/j.cub.2011.06.054; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; Haskel-Ittah M, 2012, CELL, V150, P1016, DOI 10.1016/j.cell.2012.06.044; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; Hermsen R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000813; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Hoyos E, 2011, CURR BIOL, V21, P527, DOI 10.1016/j.cub.2011.02.040; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Jin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001763; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Liu F, 2013, P NATL ACAD SCI USA, V110, P6724, DOI 10.1073/pnas.1220912110; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Madhani H. D., 2006, YEAST MODEL CELLULAR; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; Mehta P, 2010, CURR OPIN GENET DEV, V20, P574, DOI 10.1016/j.gde.2010.09.004; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Perrimon N, 2011, CURR OPIN GENET DEV, V21, P681, DOI 10.1016/j.gde.2011.10.004; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rappaport N, 2012, J BIOL PHYS, V38, P267, DOI 10.1007/s10867-011-9240-x; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Savir Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-111; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schwab DJ, 2012, PHYSICA D, V241, P1782, DOI 10.1016/j.physd.2012.08.005; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Velenich A, 2012, CURR OPIN CHEM BIOL, V16, P323, DOI 10.1016/j.cbpa.2012.05.199; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Williams TC, 2013, ACS SYNTH BIOL, V2, P136, DOI 10.1021/sb300110b; Wong JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002491; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	99	125	126	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					628	+	1242782	10.1126/science.1242782	http://dx.doi.org/10.1126/science.1242782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VR	24503857	Green Accepted			2022-12-28	WOS:000349837100001
J	Hanson, J				Hanson, Jim			John Cornforth (1917-2013) OBITUARY	NATURE			English	Biographical-Item									Univ Sussex, Brighton, E Sussex, England	University of Sussex	Hanson, J (corresponding author), Univ Sussex, Brighton, E Sussex, England.	j.r.hanson@sussex.ac.uk							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					35	35		10.1038/506035a	http://dx.doi.org/10.1038/506035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499912	Bronze			2022-12-28	WOS:000330648100021
J	Allen, NB; Siddique, J; Wilkins, JT; Shay, C; Lewis, CE; Goff, DC; Jacobs, DR; Liu, K; Lloyd-Jones, D				Allen, Norrina B.; Siddique, Juned; Wilkins, John T.; Shay, Christina; Lewis, Cora E.; Goff, David C.; Jacobs, David R., Jr.; Liu, Kiang; Lloyd-Jones, Donald			Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ARTERY CALCIUM; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; CHOLESTEROL LEVEL; RISK DEVELOPMENT; STROKE; MORTALITY; CT; QUANTIFICATION	IMPORTANCE Single measures of blood pressure (BP) levels are associated with the development of atherosclerosis; however, long-term patterns in BP and their effect on cardiovascular disease risk are poorly characterized. OBJECTIVES To identify common BP trajectories throughout early adulthood and to determine their association with presence of coronary artery calcification (CAC) during middle age. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort data from 4681 participants in the CARDIA study, who were black and white men and women aged 18 to 30 years at baseline in 1985-1986 at 4 urban US sites, collected through 25 years of follow-up (2010-2011). We examined systolic BP, diastolic BP, and mid-BP (calculated as [SBP+DBP]/2, an important marker of coronary heart disease risk among younger populations) at baseline and years 2, 5, 7, 10, 15, 20, and 25. Latent mixture modeling was used to identify trajectories in systolic, diastolic, and mid-BP over time. MAIN OUTCOMES AND MEASURES Coronary artery calcification greater than or equal to Agatston score of 100 Hounsfield units (HU) at year 25. RESULTS We identified 5 distinct mid-BP trajectories: low-stable (21.8%; 95% CI, 19.9%-23.7%; n=987), moderate-stable (42.3%; 40.3%-44.3%; n=2085), moderate-increasing (12.2%; 10.4%-14.0%; n=489), elevated-stable (19.0%; 17.1%-20.0%; n=903), and elevated-increasing (4.8%; 4.0%-5.5%; n=217). Compared with the low-stable group, trajectories with elevated BP levels had greater odds of having a CAC score of 100 HU or greater. Adjusted odds ratios were 1.44 (95% CI, 0.83-2.49) for moderate-stable, 1.86 (95% CI, 0.91-3.82) for moderate-increasing, 2.28 (95% CI, 1.24-4.18), for elevated-stable, and 3.70 (95% CI, 1.66-8.20) for elevated-increasing groups. The adjusted prevalence of a CAC score of 100 HU or higher was 5.8% in the low-stable group. These odds ratios represent an absolute increase of 2.7%, 5%, 6.3%, and 12.9% for the prevalence of a CAC score of 100 HU or higher for the moderate-stable, moderate-increasing, elevated-stable and elevated-increasing groups, respectively, compared with the low-stable group. Associations were not altered after adjustment for baseline and year 25 BP. Findings were similar for trajectories of isolated systolic BP trajectories but were attenuated for diastolic BP trajectories. CONCLUSIONS AND RELEVANCE Blood pressure trajectories throughout young adulthood vary, and higher BP trajectories were associated with an increased risk of CAC in middle age. Long-term trajectories in BP may assist in more accurate identification of individuals with subclinical atherosclerosis.	[Allen, Norrina B.; Siddique, Juned; Wilkins, John T.; Liu, Kiang; Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Shay, Christina] Univ Oklahoma, Coll Publ Hlth, Oklahoma City, OK USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Goff, David C.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Northwestern University; Feinberg School of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities	Allen, NB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	norrina-allen@northwestern.edu		Jacobs, David/0000-0002-7232-0543; Lloyd-Jones, Donald/0000-0003-0847-6110; Shay, Christina/0000-0002-8310-7043; Allen, Norrina/0000-0002-6993-4384	National Heart, Lung, and Blood Institute (NHLBI); University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005]; NATIONAL CANCER INSTITUTE [K07CA154862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The CARDIA study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (grants HHSN268201300025C and HHSN268201300026C), Northwestern University (grant HHSN268201300027C), University of Minnesota (grant HHSN268201300028C), Kaiser Foundation Research Institute (grant HHSN268201300029C), and Johns Hopkins University School of Medicine (grant HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (grant AG0005).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allen N, 2012, CIRCULATION, V125, P37, DOI 10.1161/CIRCULATIONAHA.110.002774; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; Boshuizen HC, 2007, AM J EPIDEMIOL, V165, P398, DOI 10.1093/aje/kwk021; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Franklin SS, 2007, J AM SOC HYPERTENS, V1, P82, DOI 10.1016/j.jash.2006.11.004; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KANNEL WB, 1978, GERIATRICS, V33, P71; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LICHTENSTEIN MJ, 1985, BRIT MED J, V291, P243, DOI 10.1136/bmj.291.6490.243; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Mosley WJ, 2007, HYPERTENSION, V49, P1256, DOI 10.1161/HYPERTENSIONAHA.106.083592; Nagin DS, 2010, J QUANT CRIMINOL, V26, P445, DOI 10.1007/s10940-010-9113-7; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; Siddique J, 2012, J CONSULT CLIN PSYCH, V80, P995, DOI 10.1037/a0030452; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; TVERDAL A, 1987, BRIT MED J, V294, P671, DOI 10.1136/bmj.294.6573.671; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wills AK, 2012, EPIDEMIOLOGY, V23, P203, DOI 10.1097/EDE.0b013e3182456567; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	38	220	225	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					490	497		10.1001/jama.2013.285122	http://dx.doi.org/10.1001/jama.2013.285122			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	302GF	24496536	Bronze, Green Accepted			2022-12-28	WOS:000330589800022
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Too much information?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hand D., 2014, I MATH STAT B	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2014	348								g1319	10.1136/bmj.g1319	http://dx.doi.org/10.1136/bmj.g1319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4JK	24500360				2022-12-28	WOS:000331061700019
J	Pivetta, C; Esposito, MS; Sigrist, M; Arber, S				Pivetta, Chiara; Esposito, Maria Soledad; Sigrist, Markus; Arber, Silvia			Motor-Circuit Communication Matrix from Spinal Cord to Brainstem Neurons Revealed by Developmental Origin	CELL			English	Article							LATERAL RETICULAR NUCLEUS; SPINOCEREBELLAR TRACT NEURONS; C3-C4 PROPRIOSPINAL NEURONS; FUNCTIONAL-ORGANIZATION; CEREBELLAR CORTEX; MOSSY FIBERS; CAT; RAT; PROJECTION; PATHWAYS	Accurate motor-task execution relies on continuous comparison of planned and performed actions. Motor-output pathways establish internal circuit collaterals for this purpose. Here we focus on motor collateral organization between spinal cord and upstream neurons in the brainstem. We used a newly developed mouse genetic tool intersectionally with viruses to uncover the connectivity rules of these ascending pathways by capturing the transient expression of neuronal subpopulation determinants. We reveal a widespread and diverse network of spinal dual-axon neurons, with coincident input to forelimb motor neurons and the lateral reticular nucleus (LRN) in the brainstem. Spinal information to the LRN is not segregated by motor pool or neurotransmitter identity. Instead, it is organized according to the developmental domain origin of the progenitor cells. Thus, excerpts of most spinal information destined for action are relayed to supraspinal centers through exquisitely organized ascending connectivity modules, enabling precise communication between command and execution centers of movement.	[Pivetta, Chiara; Esposito, Maria Soledad; Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; [Pivetta, Chiara; Esposito, Maria Soledad; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch		Arber, Silvia/0000-0002-6261-250X; Esposito, Maria Soledad/0000-0003-0673-4219	ERC Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stad; Novartis Research Foundation; Human Frontier Science Foundation (HFSP) program	ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stad; Novartis Research Foundation; Human Frontier Science Foundation (HFSP) program	We are grateful to M. Mielich for technical support; E. Kremer for advice on production of Cav-Cre virus and material; A. Ponti, M. Kirschmann, M. Stadler, and R. Thierry for help and advice with image acquisition, processing, and statistical analysis; P. Kopp, J. F. Spetz, and B. Kuchemann for help with the generation of transgenic mice; M. Goulding for sharing unpublished data on Gata3 neurons; and P. Caroni and P. Scheiffele for discussions and comments on the manuscript. All authors were supported by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, and the Novartis Research Foundation. M. S. E. was supported by a long-term fellowship from the Human Frontier Science Foundation (HFSP) program.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; ALSTERMARK B, 1991, EXP BRAIN RES, V84, P561; ALSTERMARK B, 1985, J PHYSIOL-LONDON, V363, P287, DOI 10.1113/jphysiol.1985.sp015710; Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P279, DOI 10.1007/BF00236284; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; ARSHAVSKY YI, 1978, BRAIN RES, V151, P479, DOI 10.1016/0006-8993(78)91081-8; Arshavsky YI, 1986, CEREBELLUM RHYTHMICA; BRODAL A, 1949, J COMP NEUROL, V91, P259, DOI 10.1002/cne.900910206; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; CAMPBELL SK, 1974, BRAIN RES, V77, P1, DOI 10.1016/0006-8993(74)90801-4; CLENDENIN M, 1974, EXP BRAIN RES, V21, P487; CLENDENIN M, 1974, EXP BRAIN RES, V21, P473; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; EKEROT CF, 1990, EXP BRAIN RES, V79, P129, DOI 10.1007/BF00228881; Ezure K, 1997, EXP BRAIN RES, V113, P230, DOI 10.1007/BF02450321; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; HINMAN A, 1959, J COMP NEUROL, V113, P61, DOI 10.1002/cne.901130104; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jankowska E, 2010, J NEUROPHYSIOL, V104, P1872, DOI 10.1152/jn.00408.2010; Jankowska E, 2013, J PHYSIOL-LONDON, V591, P5445, DOI 10.1113/jphysiol.2012.248740; Jessell T. M., 2014, NATURE; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; KOEKKOEK SKE, 1995, NEUROSCI LETT, V200, P13, DOI 10.1016/0304-3940(95)12077-H; KUNZLE H, 1973, J COMP NEUROL, V149, P103, DOI 10.1002/cne.901490107; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Orlovsky G., 1999, NEURONAL CONTROL LOC; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; RAJAKUMAR N, 1992, ANAT EMBRYOL, V185, P25, DOI 10.1007/BF00213598; ROSEN I, 1969, BRAIN RES, V16, P55, DOI 10.1016/0006-8993(69)90085-7; SANTARCANGELO E, 1981, ARCH ITAL BIOL, V119, P324; Shinoda Y, 2000, PROG BRAIN RES, V124, P173; SHOKUNBI MT, 1985, J COMP NEUROL, V239, P216, DOI 10.1002/cne.902390208; Shrestha SS, 2012, NEUROSCIENCE, V226, P253, DOI 10.1016/j.neuroscience.2012.09.015; Shrestha SS, 2012, J PHYSIOL-LONDON, V590, P1737, DOI 10.1113/jphysiol.2011.226852; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; WALBERG F, 1958, J COMP NEUROL, V109, P363, DOI 10.1002/cne.901090304; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	50	75	75	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					537	548		10.1016/j.cell.2013.12.014	http://dx.doi.org/10.1016/j.cell.2013.12.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485459	Bronze			2022-12-28	WOS:000330580800019
J	Hodgkinson, S; Pollit, V; Sharpin, C; Lecky, F				Hodgkinson, Sarah; Pollit, Vicki; Sharpin, Carlos; Lecky, Fiona		Guideline Dev Grp	GUIDELINES Early management of head injury: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hodgkinson, Sarah; Pollit, Vicki; Sharpin, Carlos] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Lecky, Fiona] Univ Manchester, Univ Sheffield, Salford Royal Hosp NHS Fdn Trust, Sch Hlth & Related Res,EMRiS,Hlth Serv Res, Sheffield S1 4DA, S Yorkshire, England	Royal College of Physicians; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; University of Sheffield	Lecky, F (corresponding author), Univ Manchester, Univ Sheffield, Salford Royal Hosp NHS Fdn Trust, Sch Hlth & Related Res,EMRiS,Hlth Serv Res, Sheffield S1 4DA, S Yorkshire, England.	fiona.lecky@manchester.ac.uk		Lyttle, Mark/0000-0002-8634-7210	National Institute for Health Research [NIHR-RP-R3-12-013, 12/35/57, 13/15/02] Funding Source: researchfish; Department of Health [12/35/57, NIHR-RP-R3-12-013, HTA/13/15/02] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Dunning J, 2006, MULTICENTRE STUDY DE; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; National Institue for Health and Care Excellence, 2013, DEVELOPING NICE CLIN; National Institute for Health and Care Excellence, 2012, PATIENT EXPERIENCE I; National Institute for Health and Care Excellence, 2007, HEAD INJURY TRIAGE A; National Institute for Health and Care Excellence, 2003, HEAD INJURY TRIAGE A; National Institute for Health and Care Excellence, 2014, HEAD INJURY TRIAGE A; Osmond M. H., 2006, ACAD EMERG MED, V13, pS11, DOI DOI 10.1197/j.aem.2006.03.008; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	11	24	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2014	348								g104	10.1136/bmj.g104	http://dx.doi.org/10.1136/bmj.g104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AW	24452622	Green Published			2022-12-28	WOS:000330297300003
J	Cesaroni, G; Forastiere, F; Stafoggia, M; Andersen, ZJ; Badaloni, C; Beelen, R; Caracciolo, B; de Faire, U; Erbel, R; Eriksen, KT; Fratiglioni, L; Galassi, C; Hampel, R; Heier, M; Hennig, F; Hilding, A; Hoffmann, B; Houthuijs, D; Jockel, KH; Korek, M; Lanki, T; Leander, K; Magnusson, PKE; Migliore, E; Ostenson, CG; Overvad, K; Pedersen, NL; Pekkanen, JJ; Penell, J; Pershagen, G; Pyko, A; Raaschou-Nielsen, O; Ranzi, A; Ricceri, F; Sacerdote, C; Salomaa, V; Swart, W; Turunen, AW; Vineis, P; Weinmayr, G; Wolf, K; de Hoogh, K; Hoek, G; Brunekreef, B; Peters, A				Cesaroni, Giulia; Forastiere, Francesco; Stafoggia, Massimo; Andersen, Zorana J.; Badaloni, Chiara; Beelen, Rob; Caracciolo, Barbara; de Faire, Ulf; Erbel, Raimund; Eriksen, Kirsten T.; Fratiglioni, Laura; Galassi, Claudia; Hampel, Regina; Heier, Margit; Hennig, Frauke; Hilding, Agneta; Hoffmann, Barbara; Houthuijs, Danny; Joeckel, Karl-Heinz; Korek, Michal; Lanki, Timo; Leander, Karin; Magnusson, Patrik K. E.; Migliore, Enrica; Ostenson, Caes-Goeran; Overvad, Kim; Pedersen, Nancy L.; Pekkanen, Juha J.; Penell, Johanna; Pershagen, Goeran; Pyko, Andrei; Raaschou-Nielsen, Ole; Ranzi, Andrea; Ricceri, Fulvio; Sacerdote, Carlotta; Salomaa, Veikko; Swart, Wim; Turunen, Anu W.; Vineis, Paolo; Weinmayr, Gudrun; Wolf, Kathrin; de Hoogh, Kees; Hoek, Gerard; Brunekreef, Bert; Peters, Annette			Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project	BMJ-BRITISH MEDICAL JOURNAL			English	Article							USE REGRESSION-MODELS; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; HEART-DISEASE; PM2.5 ABSORBENCY; RISK-FACTORS; MORTALITY; HEALTH; AREAS; MEN	Objectives To study the effect of long term exposure to airborne pollutants on the incidence of acute coronary events in 11 cohorts participating in the European Study of Cohorts for Air Pollution Effects (ESCAPE). Design Prospective cohort studies and meta-analysis of the results. Setting Cohorts in Finland, Sweden, Denmark, Germany, and Italy. Participants 100 166 people were enrolled from 1997 to 2007 and followed for an average of 11.5 years. Participants were free from previous coronary events at baseline. Main outcome measures Modelled concentrations of particulate matter <2.5 mu m (PM2.5), 2.5-10 mu m (PMcoarse), and <10 mu m (PM10) in aerodynamic diameter, soot (PM2.5 absorbance), nitrogen oxides, and traffic exposure at the home address based on measurements of air pollution conducted in 2008-12. Cohort specific hazard ratios for incidence of acute coronary events (myocardial infarction and unstable angina) per fixed increments of the pollutants with adjustment for sociodemographic and lifestyle risk factors, and pooled random effects meta-analytic hazard ratios. Results 5157 participants experienced incident events. A 5 mu g/m(3) increase in estimated annual mean PM2.5 was associated with a 13% increased risk of coronary events (hazard ratio 1.13, 95% confidence interval 0.98 to 1.30), and a 10 mu g/m(3) increase in estimated annual mean PM10 was associated with a 12% increased risk of coronary events (1.12, 1.01 to 1.25) with no evidence of heterogeneity between cohorts. Positive associations were detected below the current annual European limit value of 25 mu g/m(3) for PM2.5 (1.18, 1.01 to 1.39, for 5 mu g/m(3) increase in PM2.5) and below 40 mu g/m(3) for PM10 (1.12, 1.00 to 1.27, for 10 mu g/m(3) increase in PM10). Positive but non-significant associations were found with other pollutants. Conclusions Long term exposure to particulate matter is associated with incidence of coronary events, and this association persists at levels of exposure below the current European limit values.	[Cesaroni, Giulia; Forastiere, Francesco; Stafoggia, Massimo; Badaloni, Chiara] Lazio Reg Hlth Serv, Dept Epidemiol, I-00198 Rome, Italy; [Andersen, Zorana J.; Eriksen, Kirsten T.; Raaschou-Nielsen, Ole] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Andersen, Zorana J.] Univ Copenhagen, Dept Publ Hlth, Ctr Epidemiol & Screening, DK-1014 Copenhagen, Denmark; [Beelen, Rob; Hoek, Gerard; Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Caracciolo, Barbara; Fratiglioni, Laura] Karolinska Inst, Aging Res Ctr, Dept Neurobiol, Care Sci & Soc, S-11330 Stockholm, Sweden; [Caracciolo, Barbara] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [de Faire, Ulf; Korek, Michal; Leander, Karin; Penell, Johanna; Pershagen, Goeran; Pyko, Andrei] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Erbel, Raimund] Univ Hosp Essen, West German Heart Ctr, D-45122 Essen, Germany; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, S-11330 Stockholm, Sweden; [Fratiglioni, Laura] Karolinska Univ Hosp, Div Clin Geriatr, SE-14186 Stockholm, Sweden; [Galassi, Claudia; Migliore, Enrica; Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Citta Salute Sci Hosp, I-10126 Turin, Italy; [Galassi, Claudia; Migliore, Enrica; Sacerdote, Carlotta] Ctr Canc Prevent Piemonte, I-10126 Turin, Italy; [Hampel, Regina; Heier, Margit; Wolf, Kathrin; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Heier, Margit] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, D-86156 Augsburg, Germany; [Hennig, Frauke; Hoffmann, Barbara; Weinmayr, Gudrun] IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Hilding, Agneta; Ostenson, Caes-Goeran] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, D-40225 Dusseldorf, Germany; [Houthuijs, Danny; Swart, Wim] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Joeckel, Karl-Heinz] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany; [Lanki, Timo; Pekkanen, Juha J.; Turunen, Anu W.] Natl Inst Hlth & Welf THL, Dept Environm Hlth, FI-70701 Kuopio, Finland; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostatist, SE-17177 Stockholm, Sweden; [Overvad, Kim] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, DK-8000 Aarhus, Denmark; [Overvad, Kim] Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, DK-9000 Aalborg, Denmark; [Ranzi, Andrea] Reg Agcy Environm Prevent Emilia Romagna, Environm Hlth Reference Centre, I-41121 Modena, Italy; [Ricceri, Fulvio; Vineis, Paolo] HuGeF, Mol & Genet Epidemiol Unit, I-10126 Turin, Italy; [Salomaa, Veikko] THL Natl Inst Hlth & Welfare, Dept Chron Dis Prevent, FI-00271 Helsinki, Finland; [Ricceri, Fulvio; de Hoogh, Kees] MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostatist, Imperial Coll London, London W2 1PG, England; [Weinmayr, Gudrun] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Danish Cancer Society; University of Copenhagen; Utrecht University; Karolinska Institutet; Stockholm University; Karolinska Institutet; University of Duisburg Essen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Karolinska Institutet; Karolinska University Hospital; Heinrich Heine University Dusseldorf; Netherlands National Institute for Public Health & the Environment; University of Duisburg Essen; Finland National Institute for Health & Welfare; Karolinska Institutet; Aarhus University; Aalborg University; Aalborg University Hospital; Finland National Institute for Health & Welfare; Imperial College London; Ulm University; Utrecht University; Utrecht University Medical Center	Cesaroni, G (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, I-00198 Rome, Italy.	g.cesaroni@deplazio.it	Andersen, Zorana Jovanovic/P-4983-2014; Penell, Johanna/HGE-9306-2022; Cesaroni, Giulia/K-1500-2016; Wolf, Kathrin/I-4461-2017; Magnusson, Patrik KE/C-4458-2017; Peters, Annette/A-6117-2011; Forastiere, Francesco/J-9067-2016; Ricceri, Fulvio/I-9910-2018; Stafoggia, Massimo/K-2261-2016; de Hoogh, Kees/ABE-1274-2021; Galassi, Claudia/K-3041-2016; Heier, Margit/AAT-5280-2020; Raaschou-Nielsen, Ole/GOK-0338-2022; Leander, Karin/C-7261-2017; Badaloni, Chiara/O-9750-2015; Badaloni, Chiara/AAM-7821-2020	Andersen, Zorana Jovanovic/0000-0003-4138-9828; Penell, Johanna/0000-0003-2083-4048; Cesaroni, Giulia/0000-0001-7361-9072; Wolf, Kathrin/0000-0002-4343-201X; Magnusson, Patrik KE/0000-0002-7315-7899; Peters, Annette/0000-0001-6645-0985; Forastiere, Francesco/0000-0002-9162-5684; Ricceri, Fulvio/0000-0001-8749-9737; Stafoggia, Massimo/0000-0003-2843-2908; Galassi, Claudia/0000-0003-1502-4390; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Leander, Karin/0000-0002-1404-9222; Badaloni, Chiara/0000-0003-3768-8841; Badaloni, Chiara/0000-0003-3768-8841; Pershagen, Goran/0000-0002-9701-1130; Korek, Michal/0000-0001-9326-3675; Sacerdote, Carlotta/0000-0002-8008-5096; Ranzi, Andrea/0000-0002-0037-9167; brunekreef, bert/0000-0001-9908-0060; Overvad, Kim/0000-0001-6429-7921; Pyko, Andrei/0000-0002-5170-9728	European Community [211250]; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement No 211250. The sources of funding had no role in study design, data collection, analyses, interpretation, and decision to submit the article for publication.	Atkinson RW, 2013, EPIDEMIOLOGY, V24, P44, DOI 10.1097/EDE.0b013e318276ccb8; Beelen R, EPIDEMIOLOG IN PRESS; Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cesaroni G, 2008, OCCUP ENVIRON MED, V65, P683, DOI 10.1136/oem.2007.037846; Cesaroni G, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-48; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; Crouse DL, 2012, ENVIRON HEALTH PERSP, V120, P708, DOI 10.1289/ehp.1104049; Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Eeftens M, 2011, OCCUP ENVIRON MED, V68, P765, DOI 10.1136/oem.2010.061135; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Gan WQ, 2011, ENVIRON HEALTH PERSP, V119, P501, DOI 10.1289/ehp.1002511; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; Meinow B, 2005, HEALTH SOC CARE COMM, V13, P366, DOI 10.1111/j.1365-2524.2005.00570.x; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Peters A, 2011, PROG CARDIOVASC DIS, V53, P327, DOI 10.1016/j.pcad.2011.02.002; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60; Roux AVD, 2003, AM J EPIDEMIOL, V157, P315, DOI 10.1093/aje/kwf207; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vineis P, 2006, INT J CANCER, V119, P169, DOI 10.1002/ijc.21801; Wandell PE, 2007, DIABETES METAB, V33, P30, DOI 10.1016/j.diabet.2006.07.001; Wang RR, 2013, ATMOS ENVIRON, V64, P312, DOI 10.1016/j.atmosenv.2012.09.056; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550	41	324	329	1	90	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2014	348								f7412	10.1136/bmj.f7412	http://dx.doi.org/10.1136/bmj.f7412			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AS	24452269	Green Published, hybrid			2022-12-28	WOS:000330296900002
J	Lin, RJ				Lin, Richard J.			The Role of Palliative Care in Medical Education	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lin, Richard J.] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Lin, RJ (corresponding author), Weill Cornell Med Coll, Dept Med, 525 East 68th St,Box 130, New York, NY 10065 USA.	ril9016@med.cornell.edu		Lin, Richard/0000-0002-0834-7880	NCATS NIH HHS [UL1 TR000457] Funding Source: Medline; NIA NIH HHS [P30 AG022845] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Case AA, 2013, J PALLIAT MED, V16, P230, DOI 10.1089/jpm.2012.0436; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Sanchez-Reilly Sandra, 2013, J Support Oncol, V11, P75; Swetz KM, 2012, ANN INTERN MED, V156; Thistlethwaite J, 2012, MED EDUC, V46, P58, DOI 10.1111/j.1365-2923.2011.04143.x; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	8	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					848	+		10.7326/0003-4819-159-12-201312170-00010	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24490267	Green Accepted			2022-12-28	WOS:000329735300017
J	Chatterjee, S; Riaz, H				Chatterjee, Subhankar; Riaz, Haris			ZOONOTIC DISEASE Rabies: beware of the dog	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ONE MEDICINE		[Chatterjee, Subhankar] RG Kar Med Coll & Hosp, Kolkata, India; [Riaz, Haris] Dow Univ Hlth Sci, Karachi, Pakistan	RG Kar Medical College & Hospital; Dow University of Health Sciences	Chatterjee, S (corresponding author), RG Kar Med Coll & Hosp, Kolkata, India.	chatterjeeaspiresubhankar.92@gmail.com						[Anonymous], 2012, SIKKIM HOPING TO BEC; Baxter Janie M, 2012, J Glob Health, V2, P010303, DOI 10.7189/jogh.02.010303; Dodet B, 2007, VACCINE, V25, P4123, DOI 10.1016/j.vaccine.2007.03.002; Government of India, 2006, REPORT OF WORKING GR; Kahn LH, 2008, AM J MED, V121, P169, DOI 10.1016/j.amjmed.2007.09.023; Kakkar M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001748; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Madhusudana SN, 2008, ANN INDIAN ACAD NEUR, V11, P3, DOI 10.4103/0972-2327.40219; Matibag GC, 2009, J INFECT DEV COUNTR, V3, P55; Menezes R, 2008, CAN MED ASSOC J, V178, P564, DOI 10.1503/cmaj.071488; Mudur Ganapati, 2005, BMJ, V331, P255, DOI 10.1136/bmj.331.7511.255; Reece JF, 2013, VET REC; Sajiman PS, 2013, TIMES OF INDIA; Singh A, 2013, MED J DY PATIL U, V6, P142, DOI DOI 10.4103/0975-2870.110298; Sudarshan MK., 2004, ASS PREV CONTROL RAB, V6, P44; Suraweera W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001847; Verma R, 2011, HUM VACCINES, V7, P792, DOI 10.4161/hv.7.7.15410; Vora P, 2013, HINDUSTAN TIMES; WHO, 2005, WHO TECH REP SER, V931, P1; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	20	1	2	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5912	10.1136/bmj.f5912	http://dx.doi.org/10.1136/bmj.f5912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473452				2022-12-28	WOS:000325426300013
J	Wumesh, KC; Satpathy, AT; Rapaport, AS; Briseno, CG; Wu, XD; Albring, JC; Russler-Germain, EV; Kretzer, NM; Durai, V; Persaud, SP; Edelson, BT; Loschko, J; Cella, M; Allen, PM; Nussenzweig, MC; Colonna, M; Sleckman, BP; Murphy, TL; Murphy, KM				Wumesh, K. C.; Satpathy, Ansuman T.; Rapaport, Aaron S.; Briseno, Carlos G.; Wu, Xiaodi; Albring, Joern C.; Russler-Germain, Emilie V.; Kretzer, Nicole M.; Durai, Vivek; Persaud, Stephen P.; Edelson, Brian T.; Loschko, Jakob; Cella, Marina; Allen, Paul M.; Nussenzweig, Michel C.; Colonna, Marco; Sleckman, Barry P.; Murphy, Theresa L.; Murphy, Kenneth M.			L-Myc expression by dendritic cells is required for optimal T-cell priming	NATURE			English	Article							COLONY-STIMULATING FACTOR; C-MYC; LISTERIA-MONOCYTOGENES; IN-VIVO; MOUSE; RECEPTOR; MICE; LYMPHOCYTE; ACTIVATION; MACROPHAGE	The transcription factors c-Myc and N-Myc-encoded by Myc and Mycn, respectively-regulate cellular growth(1) and are required for embryonic development(2,3). A third paralogue, Mycl1, is dispensable for normal embryonic development but its biological function has remained unclear(4). To examine the in vivo function of Mycl1 in mice, we generated an inactivating Mycl1(gfp) allele that also reports Mycl1 expression. We find that Mycl1 is selectively expressed in dendritic cells (DCs) of the immune system and controlled by IRF8, and that during DC development, Mycl1 expression is initiated in the common DC progenitor(5) concurrent with reduction in c-Myc expression. Mature DCs lack expression of c-Myc and N-Myc but maintain L-Myc expression even in the presence of inflammatory signals such as granulocyte-macrophage colony-stimulating factor. All DC subsets develop in Mycl1-deficient mice, but some subsets such as migratory CD103(+) conventional DCs in the lung and liver are greatly reduced at steady state. Importantly, loss of L-Myc by DCs causes a significant decrease in in vivo T-cell priming during infection by Listeria monocytogenes and vesicular stomatitis virus. The replacement of c-Myc by L-Myc in immature DCs may provide for Myc transcriptional activity in the setting of inflammation that is required for optimal T-cell priming(6).	[Wumesh, K. C.; Satpathy, Ansuman T.; Rapaport, Aaron S.; Briseno, Carlos G.; Wu, Xiaodi; Russler-Germain, Emilie V.; Kretzer, Nicole M.; Durai, Vivek; Persaud, Stephen P.; Edelson, Brian T.; Cella, Marina; Allen, Paul M.; Colonna, Marco; Sleckman, Barry P.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Albring, Joern C.] Univ Munster, Dept Med Hematol & Oncol A, D-48149 Munster, Germany; [Loschko, Jakob; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10065 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Munster; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Cella, Marina/ABA-8564-2020; Nussenzweig, Michel/AAE-7292-2019	Cella, Marina/0000-0003-1230-1313; Briseno, Carlos/0000-0002-4159-3864; Allen, Paul/0000-0003-3796-6047; Satpathy, Ansuman/0000-0002-5167-537X; Albring, Jorn/0000-0002-5534-7250; Persaud, Stephen/0000-0002-7733-5509; Colonna, Marco/0000-0001-5222-4987; Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; Siteman Cancer Center; American Heart Association [12PRE8610005, 12PRE12050419]; German Research Foundation [AL 1038/1-1]; American Society of Hematology Scholar Award; Burroughs Wellcome Fund Career Award; NCI Cancer Center Support Grant [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024157, T32AI007163, R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Siteman Cancer Center; American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); American Society of Hematology Scholar Award; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and the Siteman Cancer Center (K. M. M.), American Heart Association (12PRE8610005 to A. T. S. and 12PRE12050419 to W. K.), German Research Foundation (AL 1038/1-1; J.C.A.), American Society of Hematology Scholar Award and Burroughs Wellcome Fund Career Award for Medical Scientists (B. T. E.). We thank J. M. White for blastocyst injections and generation of mouse chimaeras, the Alvin J. Siteman Cancer Center for use of the Center for Biomedical Informatics and the Multiplexed Gene Analysis Core Facility. The Siteman Cancer Center is supported in part by the NCI Cancer Center Support Grant P30 CA91842.	Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Belz GT, 2010, METHODS MOL BIOL, V595, P351, DOI 10.1007/978-1-60761-421-0_23; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hatton KS, 1996, MOL CELL BIOL, V16, P1794; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lefrancois L., 2001, CURR PROTOC IMMUNOL, V3; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MAHFOUDI A, 1995, P NATL ACAD SCI USA, V92, P4206, DOI 10.1073/pnas.92.10.4206; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RESNITZKY D, 1991, CELL GROWTH DIFFER, V2, P33; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Scott CL, 1998, BLOOD, V92, P4119, DOI 10.1182/blood.V92.11.4119.423k40_4119_4127; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	55	55	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					243	+		10.1038/nature12967	http://dx.doi.org/10.1038/nature12967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24509714	Green Accepted			2022-12-28	WOS:000332651800041
J	Choudhuri, K; Llodra, J; Roth, EW; Tsai, J; Gordo, S; Wucherpfennig, KW; Kam, LC; Stokes, DL; Dustin, ML				Choudhuri, Kaushik; Llodra, Jaime; Roth, Eric W.; Tsai, Jones; Gordo, Susana; Wucherpfennig, Kai W.; Kam, Lance C.; Stokes, David L.; Dustin, Michael L.			Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse	NATURE			English	Article							CLASS-II; ACTIVATION; PROTEIN; PROLIFERATION; MICROSCOPY; MOLECULES; DYNAMICS; ADHESION; TSG101	The recognition events that mediate adaptive cellular immunity and regulate antibody responses depend on intercellular contacts between T cells and antigen-presenting cells (APCs)(1). T-cell signalling is initiated at these contacts when surface-expressed T-cell receptors (TCRs) recognize peptide fragments (antigens) of pathogens bound to major histocompatibility complex molecules (pMHC) on APCs. This, along with engagement of adhesion receptors, leads to the formation of a specialized junction between T cells and APCs, known as the immunological synapse(2), which mediates efficient delivery of effector molecules and intercellular signals across the synaptic cleft(3). T-cell recognition of pMHC and the adhesion ligand intercellular adhesion molecule-1 (ICAM-1) on supported planar bilayers recapitulates the domain organization of the immunological synapse(4,5), which is characterized by central accumulation of TCRs(5), adjacent to a secretory domain(2), both surrounded by an adhesive ring(4,5). Although accumulation of TCRs at the immunological synapse centre correlates with T-cell function(4), this domain is itself largely devoid of TCR signalling activity(5,6), and is characterized by an unexplained immobilization of TCR-pMHC complexes relative to the highly dynamic immunological synapse periphery(4,5). Here we show that centrally accumulated TCRs are located on the surface of extracellular microvesicles that bud at the immunological synapse centre. Tumour susceptibility gene 101 (TSG101)(6) sorts TCRs for inclusion in microvesicles, whereas vacuolar protein sorting 4 (VPS4)(7,8) mediates scission of microvesicles from the T-cell plasma membrane. The human immunodeficiency virus polyprotein Gag co-opts this process for budding of virus-like particles. B cells bearing cognate pMHC receive TCRs from T cells and initiate intracellular signals in response to isolated synaptic microvesicles. We conclude that the immunological synapse orchestrates TCR sorting and release in extracellular microvesicles. These microvesicles deliver transcellular signals across antigen-dependent synapses by engaging cognate pMHC on APCs.	[Choudhuri, Kaushik] Skirball Inst Biomol Med, Program Mol Pathogenesis, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Llodra, Jaime; Stokes, David L.] Skirball Inst Biomol Med, Program Struct Biol, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Roth, Eric W.] Northwestern Univ, Atom & Nanoscale Characterizat Expt Ctr, Evanston, IL 60208 USA; [Tsai, Jones; Kam, Lance C.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Gordo, Susana; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Gordo, Susana; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02215 USA; [Stokes, David L.] New York Struct Biol Ctr, New York, NY 10027 USA; [Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England	Northwestern University; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; New York University; University of Oxford	Dustin, ML (corresponding author), NYU, Sch Med, Dept Pathol, 540 First Ave, New York, NY 10016 USA.	stokes@nyu.edu; michael.dustin@kennedy.ox.ac.uk	Dustin, Michael/AAM-4611-2020	Choudhuri, Kaushik/0000-0002-3911-027X; Dustin, Michael/0000-0003-4983-6389	New York Structural Biology Center; Cancer Research Institute; NIH [K99AI093884, AI043542, AI045757, AI055037, AI088377, AI093884, EY016586]; Wellcome Trust; Kennedy Trust; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R21AI055037, R37AI043542, R01AI055037, R01AI043542, R00AI093884, R01AI088377, K99AI093884] Funding Source: NIH RePORTER	New York Structural Biology Center; Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Kennedy Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Schutz for suggesting the photoactivation experiment, H. Chen for microfabrication, W. Sundquist for providing Gag-GFP, VPS4-GFP and VPS4dn-GFP constructs, P. Bieniasz for Gag-mCherry, Gag Delta L-mCherry, ALIX-GFP and CHMP4B-GFP constructs, the New York Structural Biology Center for electron microscopy tomography, support and instrumentation and members of the Dustin laboratory for helpful discussions and contributions of reagents. We thank J. Nance for the gift of biotinylated duramycin-linked biotin. This work was supported in part by a Cancer Research Institute fellowship and NIH grant K99AI093884 (K.C.), a Wellcome Trust Principal Research Fellowship (M.L.D.), a Kennedy Trust Senior Research Fellowship (M.L.D.) and NIH grants AI043542, AI045757, AI055037, AI088377, AI093884 and EY016586 (Nanomedicine Development Center).	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; Dustin Michael L, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1813s76; Fleire Sebastian J., 2009, V462, P145, DOI 10.1007/978-1-60327-115-8_9; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He TP, 2007, BIOCHEM BIOPH RES CO, V359, P202, DOI 10.1016/j.bbrc.2007.05.099; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Keene DR, 2008, MICROSC MICROANAL, V14, P342, DOI 10.1017/S1431927608080306; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Sachse M, 2004, J CELL SCI, V117, P1699, DOI 10.1242/jcs.00998; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schubert DA, 2012, J EXP MED, V209, P335, DOI 10.1084/jem.20111485; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Tsai J, 2008, NANO LETT, V8, P425, DOI 10.1021/nl072304q; Vanherberghen B, 2004, P NATL ACAD SCI USA, V101, P16873, DOI 10.1073/pnas.0406240101; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	39	263	266	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					118	+		10.1038/nature12951	http://dx.doi.org/10.1038/nature12951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24487619	Green Accepted, Green Submitted			2022-12-28	WOS:000332224400054
J	Jiang, C; Brown, PJB; Ducret, A; Brun, YV				Jiang, Chao; Brown, Pamela J. B.; Ducret, Adrien; Brun, Yves V.			Sequential evolution of bacterial morphology by co-option of a developmental regulator	NATURE			English	Article							CAULOBACTER; ELONGATION; ADHESIVE; DIVISION; GROWTH; STALK; SHAPE	What mechanisms under lie the transitions responsible for the diverse shapes observed in the living world? Although bacteria exhibit a myriad of morphologies(1), the mechanisms responsible for the evolution of bacterial cell shape are not understood. We investigated morphological diversity in a group of bacteria that synthesize an appendage-like extension of the cell envelope called the stalk(2,3). The location and number of stalks varies among species, as exemplified by three distinct subcellular positions of stalks within a rod-shaped cell body: polar in the genus Caulobacter and subpolar or bilateral in the genus Asticcacaulis(4). Here we show that a developmental regulator of Caulobacter crescentus, SpmX(5), is co-opted in the genus Asticcacaulis to specify stalk synthesis either at the subpolar or bilateral positions. We also show that stepwise evolution of a specific region of SpmX led to the gain of a new function and localization of this protein, which drove the sequential transition in stalk positioning. Our results indicate that changes in protein function, co-option and modularity are key elements in the evolution of bacterial morphology. Therefore, similar evolutionary principles of morphological transitions apply to both single-celled prokaryotes and multicellular eukaryotes.	[Jiang, Chao; Brown, Pamela J. B.; Ducret, Adrien; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brun, YV (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ybrun@indiana.edu	Brown, Pamela/HGT-9595-2022	Brown, Pamela/0000-0002-7558-7155; Brun, Yves/0000-0002-9289-1909	National Institutes of Health [S10RR028697-01, GM051986]; National Science Foundation [MCB0731950]; Indiana University Metabolomics and Cytomics Initiative (METACyt) program; Lilly Foundation; National Institutes of Health National Research Service Award [AI072992]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI072992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Indiana University Metabolomics and Cytomics Initiative (METACyt) program; Lilly Foundation; National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Brun laboratory and C. Fuqua for comments on the manuscript. We thank D. Kysela, V. Hughes and V. Silvanose for help in environmental sampling and phylogenetic analysis, L. Zhuo and C. Huang for help in statistical analysis, S. Shaw for advice on quantitative image analysis, M. Hahn, M. Lynch and R. Raff for discussions on evolution, and the Center for Genomics and Bioinformatics at Indiana University for help in sequencing. We thank the Indiana University Light Microscopy Imaging Center for their help with OMX super-resolution microscopy, supported by National Institutes of Health grant S10RR028697-01, and the Indiana Molecular biology Institute electron microscopy facility at Indiana University for their help with electron microscopy. We thank M. Thanbichler, J. Poindexter, P. Caccamo and P. Viollier for providing us with Caulobacter strain and plasmids, J. Poindexter, J. Peterson, J. Lindquist and A. Quinones for help in locating the strain collection of the late Jack Pate from which we obtained some of the A. excentricus and A. biprosthecum strains used in this study, and M. Wortinger, S. Green, E. Quardokus and J. (Wagner) Herman for early work with Asticcacaulis that helped set the stage for this study. This work was supported by National Institutes of Health grant GM051986, National Science Foundation grant MCB0731950 and by a grant from the Indiana University Metabolomics and Cytomics Initiative (METACyt) program, which was financed, in part, by a major endowment from the Lilly Foundation. P. J. B. B. was supported by National Institutes of Health National Research Service Award AI072992.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Darwin, 1859, ORIGINS SPECIES MEAN; de Pedro MA, 2004, J BACTERIOL, V186, P2594, DOI 10.1128/JB.186.9.2594-2602.2004; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Loehlin DW, 2012, SCIENCE, V335, P943, DOI 10.1126/science.1215193; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; MERKER RI, 1988, APPL ENVIRON MICROB, V54, P2078, DOI 10.1128/AEM.54.8.2078-2085.1988; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OHTA N, 1992, P NATL ACAD SCI USA, V89, P10297, DOI 10.1073/pnas.89.21.10297; PATE JL, 1965, J CELL BIOL, V27, P133, DOI 10.1083/jcb.27.1.133; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; STOVEPOINDEXTER J L, 1964, J Cell Biol, V23, P587, DOI 10.1083/jcb.23.3.587; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Vasilyeva LV, 2006, INT J SYST EVOL MICR, V56, P2083, DOI 10.1099/ijs.0.64122-0; Wagner JK, 2007, MOL MICROBIOL, V64, P28, DOI 10.1111/j.1365-2958.2007.05633.x; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; Wan Z, 2013, MOL MICROBIOL, V88, P486, DOI 10.1111/mmi.12199; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	40	50	50	1	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					489	+		10.1038/nature12900	http://dx.doi.org/10.1038/nature12900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24463524	Green Accepted			2022-12-28	WOS:000332165100038
J	Ray, S; Naumann, R; Burgalossi, A; Tang, QS; Schmidt, H; Brecht, M				Ray, Saikat; Naumann, Robert; Burgalossi, Andrea; Tang, Qiusong; Schmidt, Helene; Brecht, Michael			Grid-Layout and Theta-Modulation of Layer 2 Pyramidal Neurons in Medial Entorhinal Cortex	SCIENCE			English	Article							STELLATE CELLS; SPATIAL PERIODICITY; RAT; ORGANIZATION; ACETYLCHOLINE; OSCILLATIONS; DYNAMICS; REPRESENTATION; HIPPOCAMPUS; NOVELTY	Little is known about how microcircuits are organized in layer 2 of the medial entorhinal cortex. We visualized principal cell microcircuits and determined cellular theta-rhythmicity in freely moving rats. Non-dentate-projecting, calbindin-positive pyramidal cells bundled dendrites together and formed patches arranged in a hexagonal grid aligned to layer 1 axons, parasubiculum, and cholinergic inputs. Calbindin-negative, dentate-gyrus-projecting stellate cells were distributed across layer 2 but avoided centers of calbindin-positive patches. Cholinergic drive sustained theta-rhythmicity, which was twofold stronger in pyramidal than in stellate neurons. Theta-rhythmicity was cell-type-specific but not distributed as expected from cell-intrinsic properties. Layer 2 divides into a weakly theta-locked stellate cell lattice and spatiotemporally highly organized pyramidal grid. It needs to be assessed how these two distinct principal cell networks contribute to grid cell activity.	[Ray, Saikat; Naumann, Robert; Burgalossi, Andrea; Tang, Qiusong; Schmidt, Helene; Brecht, Michael] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany	Humboldt University of Berlin	Brecht, M (corresponding author), Humboldt Univ, Bernstein Ctr Computat Neurosci, Philippstr 13,Haus 6, D-10115 Berlin, Germany.	michael.brecht@bccn-berlin.de	Tang, Qiusong/CAE-8888-2022; Naumann, Robert K./AAA-1924-2022	Naumann, Robert K./0000-0002-1295-9185; Ray, Saikat/0000-0002-2732-6612; Brecht, Michael/0000-0002-5387-0953; Schmidt, Helene/0000-0002-1622-6704	Humboldt Universitat zu Berlin; Bernstein Center for Computational Neuroscience Berlin [German Federal Ministry of Education and Research (BMBF)] [Forderkennzeichen 01GQ1001A]; NeuroCure; Neuro-Behavior European Research Council; Deutsche Forschungsgemeinschaft	Humboldt Universitat zu Berlin; Bernstein Center for Computational Neuroscience Berlin [German Federal Ministry of Education and Research (BMBF)]; NeuroCure; Neuro-Behavior European Research Council; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Humboldt Universitat zu Berlin, Bernstein Center for Computational Neuroscience Berlin [German Federal Ministry of Education and Research (BMBF), Forderkennzeichen 01GQ1001A], NeuroCure, the Neuro-Behavior European Research Council grant, and the Gottfried Wilhelm Leibniz Prize of the Deutsche Forschungsgemeinschaft. We thank C. Ebbesen, M. von Heimendahl, R. Rao, J. Steger, J. Tukker, U. Schneeweiss, P. Turko, and I. Vida.	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brecht M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0521; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; CATANIA KC, 1993, NATURE, V364, P493, DOI 10.1038/364493a0; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; GERMROTH P, 1989, NEUROSCIENCE, V30, P683, DOI 10.1016/0306-4522(89)90161-9; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Heys JG, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00032; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; LINGENHOHL K, 1991, EXP BRAIN RES, V84, P57; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Newman E. L., 2011, SOC NEUR ANN M; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Rowland DC, 2014, CURR OPIN NEUROBIOL, V24, P22, DOI 10.1016/j.conb.2013.08.012; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; Teles-Grilo Ruivo Leonor M, 2013, Front Synaptic Neurosci, V5, P2, DOI 10.3389/fnsyn.2013.00002; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	43	119	119	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					891	896		10.1126/science.1243028	http://dx.doi.org/10.1126/science.1243028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24457213				2022-12-28	WOS:000331552600048
J	Gopinathan, U; Cuadrado, C; Watts, N; Guinto, RR; Hougendobler, D; Wanjau, W; Lefebvre, A; Jorem, J; Jiang, XX; Habibullah, NK; Meganathan, S; Mushtaq, UA				Gopinathan, Unni; Cuadrado, Cristobal; Watts, Nick; Guinto, Renzo R.; Hougendobler, Daniel; Wanjau, Waruguru; Lefebvre, Alexandre; Jorem, Jacob; Jiang, Xiaoxiao; Habibullah, Nilofer Khan; Meganathan, Saveetha; Mushtaq, Usman Ahmad			The political origins of health inequity: the perspective of the Youth Commission on Global Governance for Health	LANCET			English	Editorial Material									[Gopinathan, Unni] Univ Oslo, Inst Hlth & Soc, N-0318 Oslo, Norway; [Cuadrado, Cristobal] Univ Chile, Sch Publ Hlth, Inst Populat Hlth, Santiago, Chile; [Watts, Nick] UCL, Inst Global Hlth, London, England; [Guinto, Renzo R.] Univ Philippines Manila, Natl Inst Hlth, Univ Hlth Care Study Grp, Manila, Philippines; [Hougendobler, Daniel] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Wanjau, Waruguru] Univ Nairobi, Kenyatta Natl Hosp, Sch Med, Coll Hlth Sci, Nairobi, Kenya; [Lefebvre, Alexandre] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Jorem, Jacob] Norwegian Univ Sci & Technol, Fac Med, N-7034 Trondheim, Norway; [Jorem, Jacob] Univ Oslo, Fac Law, N-0318 Oslo, Norway; [Jiang, Xiaoxiao] Harvard Sch Publ Hlth, Breast Canc Initiat, Beijing, Peoples R China; [Habibullah, Nilofer Khan] Amer Int Med Univ, Sch Med, St Lucia, St Lucia; [Meganathan, Saveetha] Univ Delhi, Delhi Sch Econ, Dept Social Work, Delhi 110007, India; [Mushtaq, Usman Ahmad] Univ Oslo, Fac Med, N-0318 Oslo, Norway	University of Oslo; Universidad de Chile; University of London; University College London; University of the Philippines System; University of the Philippines Manila; Georgetown University; Kenyatta National Hospital; University of Nairobi; Universite de Montreal; Norwegian University of Science & Technology (NTNU); University of Oslo; Delhi School of Economics; University of Delhi; University of Oslo	Gopinathan, U (corresponding author), Univ Oslo, Inst Hlth & Soc, N-0318 Oslo, Norway.	unni.gnathan@gmail.com	Cuadrado, Cristobal/J-2572-2014; Cuadrado, Cristobal/Q-3705-2019	Cuadrado, Cristobal/0000-0002-0174-5958; Cuadrado, Cristobal/0000-0002-0174-5958; Lefebvre, Alexandre/0000-0001-7461-5540; Guinto, Ramon Lorenzo Luis/0000-0002-3181-0423				[Anonymous], 1999, DEV FREEDOM; [Anonymous], 2013, NEW GLOB PARTN ER PO; Frenk J, 2014, LANCET, V383, P94, DOI 10.1016/S0140-6736(13)62561-1; Gopinathan U, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61247-1; Kickbusch I., 2013, HLTH POST 2015 DEV A; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; SEN A, 1992, INEQUALITY REEXAMINE, P207	7	4	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					E12	E13		10.1016/S0140-6736(14)60050-7	http://dx.doi.org/10.1016/S0140-6736(14)60050-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KP	24524783				2022-12-28	WOS:000331137700001
J	Korb, J				Korb, Judith			Robots Acting Locally and Building Globally	SCIENCE			English	Editorial Material									Univ Freiburg, D-79104 Freiburg, Germany	University of Freiburg	Korb, J (corresponding author), Univ Freiburg, D-79104 Freiburg, Germany.	judith.korb@biologie.uni-freiburg.de						Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Camazine S., 2001, SELF ORGANIZATION IN; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Korb J, 1999, OECOLOGIA, V118, P183, DOI 10.1007/s004420050717; Korb J, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P349, DOI 10.1007/978-90-481-3977-4_13; Smeathman H, 1781, PHILOS T ROY SOC LON, V71, P139, DOI [DOI 10.1098/RSTL.1781.0033, 10.1098/rstl.1781.0033]; Werfel J, 2014, SCIENCE, V343, P754, DOI 10.1126/science.1245842	7	3	3	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					742	743		10.1126/science.1250721	http://dx.doi.org/10.1126/science.1250721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531962				2022-12-28	WOS:000331557800029
J	Nishimura, J; Yamamoto, M; Hayashi, S; Ohyashiki, K; Ando, K; Brodsky, AL; Noji, H; Kitamura, K; Eto, T; Takahashi, T; Masuko, M; Matsumoto, T; Wano, Y; Shichishima, T; Shibayama, H; Hase, M; Li, L; Johnson, K; Lazarowski, A; Tamburini, P; Inazawa, J; Kinoshita, T; Kanakura, Y				Nishimura, Jun-ichi; Yamamoto, Masaki; Hayashi, Shin; Ohyashiki, Kazuma; Ando, Kiyoshi; Brodsky, Andres L.; Noji, Hideyoshi; Kitamura, Kunio; Eto, Tetsuya; Takahashi, Toru; Masuko, Masayoshi; Matsumoto, Takuro; Wano, Yuji; Shichishima, Tsutomu; Shibayama, Hirohiko; Hase, Masakazu; Li, Lan; Johnson, Krista; Lazarowski, Alberto; Tamburini, Paul; Inazawa, Johji; Kinoshita, Taroh; Kanakura, Yuzuru			Genetic Variants in C5 and Poor Response to Eculizumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A; POLYMORPHISM; MANAGEMENT; DISEASE; SAFETY	BackgroundEculizumab is a humanized monoclonal antibody that targets complement protein C5 and inhibits terminal complement-mediated hemolysis associated with paroxysmal nocturnal hemoglobinuria (PNH). The molecular basis for the poor response to eculizumab in a small population of Japanese patients is unclear. MethodsWe assessed the sequences of the gene encoding C5 in patients with PNH who had either a good or poor response to eculizumab. We also evaluated the functional properties of C5 as it was encoded in these patients. ResultsOf 345 Japanese patients with PNH who received eculizumab, 11 patients had a poor response. All 11 had a single missense C5 heterozygous mutation, c.2654GA, which predicts the polymorphism p.Arg885His. The prevalence of this mutation among the patients with PNH (3.2%) was similar to that among healthy Japanese persons (3.5%). This polymorphism was also identified in a Han Chinese population. A patient in Argentina of Asian ancestry who had a poor response had a very similar mutation, c.2653CT, which predicts p.Arg885Cys. Nonmutant and mutant C5 both caused hemolysis in vitro, but only nonmutant C5 bound to and was blocked by eculizumab. In vitro hemolysis due to nonmutant and mutant C5 was completely blocked with the use of N19-8, a monoclonal antibody that binds to a different site on C5 than does eculizumab. ConclusionsThe functional capacity of C5 variants with mutations at Arg885, together with their failure to undergo blockade by eculizumab, account for the poor response to this agent in patients who carry these mutations. (Funded by Alexion Pharmaceuticals and the Ministry of Health, Labor, and Welfare of Japan.)	[Nishimura, Jun-ichi; Yamamoto, Masaki; Shibayama, Hirohiko; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kinoshita, Taroh] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Hayashi, Shin; Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Hayashi, Shin; Inazawa, Johji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Ohyashiki, Kazuma] Tokyo Med Univ, Tokyo 1608402, Japan; [Hase, Masakazu] Alex Pharma, Tokyo, Japan; [Ando, Kiyoshi] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Noji, Hideyoshi; Shichishima, Tsutomu] Fukushima Med Univ, Fukushima, Japan; [Kitamura, Kunio] Ichinomiya Municipal Hosp, Ichinomiya, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Fukuoka, Japan; [Takahashi, Toru] Yamaguchi Grand Med Ctr, Hofu, Japan; [Masuko, Masayoshi] Niigata Univ, Med & Dent Hosp, Niigata, Japan; [Matsumoto, Takuro] Japanese Red Cross Takayama Hosp, Takayama, Japan; [Wano, Yuji] Iwate Prefectual Cent Hosp, Morioka, Iwate, Japan; [Brodsky, Andres L.; Lazarowski, Alberto] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Li, Lan; Johnson, Krista; Tamburini, Paul] Alex Pharmaceut, Cheshire, CT USA	Osaka University; Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical University; Tokai University; Fukushima Medical University; Niigata University; Iwate Prefectural Central Hospital; University of Buenos Aires	Nishimura, J (corresponding author), Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	junnishi@bldon.med.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009	Hayashi, Shin/0000-0002-0644-5890; Lazarowski, Alberto/0000-0001-8979-7631	Alexion Pharmaceuticals; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [22134002] Funding Source: KAKEN	Alexion Pharmaceuticals; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Alexion Pharmaceuticals and the Ministry of Health, Labor, and Welfare of Japan.	Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Brodsky RA, 2009, BLOOD, V113, P6522, DOI 10.1182/blood-2009-03-195966; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kanakura Y, 2011, INT J HEMATOL, V93, P36, DOI 10.1007/s12185-010-0748-9; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Luzzatto L, 2011, BRIT J HAEMATOL, V153, P709, DOI 10.1111/j.1365-2141.2011.08690.x; MIYATA T, 1994, NEW ENGL J MED, V330, P249, DOI 10.1056/NEJM199401273300404; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Risitano AM, 2009, BLOOD, V113, P4094, DOI 10.1182/blood-2008-11-189944; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Treon SP, 2005, J CLIN ONCOL, V23, P474, DOI 10.1200/JCO.2005.06.059; van den Berg C W, 2000, Methods Mol Biol, V150, P15; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; WURZNER R, 1991, COMPLEMENT INFLAMMAT, V8, P328; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	25	208	225	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					632	639		10.1056/NEJMoa1311084	http://dx.doi.org/10.1056/NEJMoa1311084			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521109				2022-12-28	WOS:000331187500009
J	Pontzen, A; Governato, F				Pontzen, Andrew; Governato, Fabio			Cold dark matter heats up	NATURE			English	Review							ADAPTIVE MESH REFINEMENT; DWARF GALAXIES; STAR-FORMATION; STELLAR FEEDBACK; ANGULAR-MOMENTUM; ULTRAVIOLET-SPECTRA; SATELLITE GALAXIES; MOLECULAR-HYDROGEN; DYNAMICAL FRICTION; MASS-DISTRIBUTION	A principal discovery in modern cosmology is that standard model particles comprise only 5 per cent of the mass-energy budget of the Universe. In the Lambda CDM paradigm, the remaining 95 per cent consists of dark energy (Lambda) and cold dark matter. Lambda CDM is being challenged by its apparent inability to explain the low-density 'cores' of dark matter measured at the centre of galaxies, where centrally concentrated high-density 'cusps' were predicted. But before drawing conclusions, it is necessary to include the effect of gas and stars, historically seen as passive components of galaxies. We now understand that these can inject heat energy into the cold dark matter through a coupling based on rapid gravitational potential fluctuations, explaining the observed low central densities.	[Pontzen, Andrew] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Pontzen, Andrew] Oxford Astrophys, Oxford OX1 3RH, England; [Pontzen, Andrew] Univ Oxford Balliol Coll, Oxford OX1 3BJ, England; [Governato, Fabio] Univ Washington, Dept Astron, Seattle, WA 98195 USA	University of London; University College London; University of Oxford; University of Oxford; University of Washington; University of Washington Seattle	Pontzen, A (corresponding author), UCL, Dept Phys & Astron, Mortimer St, London WC1E 6BT, England.	a.pontzen@ucl.ac.uk			Oxford Martin School; Royal Society; HST [GO-1125]; NSF [AST-0908499]; Division Of Astronomical Sciences [1108885] Funding Source: National Science Foundation	Oxford Martin School; Royal Society(Royal Society of London); HST; NSF(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S.-H. Oh, S. White, M. Pettini, C. Martin, M. Walker, J. Penarrubia, A. Brooks, T. Treu, R. Ellis, J. Wadsley and L. Randall for discussions and comments on an early draft. A. P. acknowledges support from the Oxford Martin School and Royal Society. F. G. acknowledges support from HST GO-1125 and NSF AST-0908499.	Arraki K. S., MON NOT R A IN PRESS; BARNES J, 1987, ASTROPHYS J, V319, P575, DOI 10.1086/165480; Bell EF, 2001, ASTROPHYS J, V550, P212, DOI 10.1086/319728; Binney J, 2001, MON NOT R ASTRON SOC, V321, P471, DOI 10.1046/j.1365-8711.2001.04024.x; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Boylan-Kolchin M, 2012, MON NOT R ASTRON SOC, V422, P1203, DOI 10.1111/j.1365-2966.2012.20695.x; Breddels MA, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321606; Brook CB, 2011, MON NOT R ASTRON SOC, V415, P1051, DOI 10.1111/j.1365-2966.2011.18545.x; Christensen C, 2012, MON NOT R ASTRON SOC, V425, P3058, DOI 10.1111/j.1365-2966.2012.21628.x; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Dalcanton JJ, 2001, ASTROPHYS J, V561, P35, DOI 10.1086/323207; de Blok WJG, 2008, ASTRON J, V136, P2648, DOI 10.1088/0004-6256/136/6/2648; de Naray RK, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/2/L29; Debattista VP, 1998, ASTROPHYS J, V493, pL5, DOI 10.1086/311118; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Di Cintio A, 2014, MON NOT R ASTRON SOC, V437, P415, DOI 10.1093/mnras/stt1891; DUBINSKI J, 1991, ASTROPHYS J, V378, P496, DOI 10.1086/170451; Dutton AA, 2013, MON NOT R ASTRON SOC, V432, P2496, DOI 10.1093/mnras/stt608; El-Zant A, 2001, ASTROPHYS J, V560, P636, DOI 10.1086/322516; El-Zant AA, 2004, ASTROPHYS J, V607, pL75, DOI 10.1086/421938; Ferrero I, 2012, MON NOT R ASTRON SOC, V425, P2817, DOI 10.1111/j.1365-2966.2012.21623.x; FLORES RA, 1994, ASTROPHYS J, V427, pL1, DOI 10.1086/187350; Gentile G, 2009, NATURE, V461, P627, DOI 10.1038/nature08437; Gnedin NY, 2009, ASTROPHYS J, V697, P55, DOI 10.1088/0004-637X/697/1/55; Gnedin OY, 2002, MON NOT R ASTRON SOC, V333, P299, DOI 10.1046/j.1365-8711.2002.05361.x; Goerdt T, 2006, MON NOT R ASTRON SOC, V368, P1073, DOI 10.1111/j.1365-2966.2006.10182.x; Governato F, 2012, MON NOT R ASTRON SOC, V422, P1231, DOI 10.1111/j.1365-2966.2012.20696.x; Governato F, 2010, NATURE, V463, P203, DOI 10.1038/nature08640; Heckman TM, 2000, ASTROPHYS J SUPPL S, V129, P493, DOI 10.1086/313421; Herpich J, 2014, MON NOT R ASTRON SOC, V437, P293, DOI 10.1093/mnras/stt1883; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Hunter DA, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/134; Kaplinghat M, 2000, PHYS REV LETT, V85, P3335, DOI 10.1103/PhysRevLett.85.3335; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Keres D, 2012, MON NOT R ASTRON SOC, V425, P2027, DOI 10.1111/j.1365-2966.2012.21548.x; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Knebe A, 2002, MON NOT R ASTRON SOC, V329, P813, DOI 10.1046/j.1365-8711.2002.05017.x; Kormendy J, 2010, ASTROPHYS J, V723, P54, DOI 10.1088/0004-637X/723/1/54; Kuhlen M, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/10; Mac Low MM, 1999, ASTROPHYS J, V513, P142, DOI 10.1086/306832; Maccio AV, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/1/L9; Maccio AV, 2007, MON NOT R ASTRON SOC, V378, P55, DOI 10.1111/j.1365-2966.2007.11720.x; Martin CL, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/127; Mashchenko S, 2008, SCIENCE, V319, P174, DOI 10.1126/science.1148666; Mashchenko S, 2006, NATURE, V442, P539, DOI 10.1038/nature04944; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; Maxwell AJ, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L35; Mayer L, 2001, ASTROPHYS J, V559, P754, DOI 10.1086/322356; McGaugh SS, 2007, ASTROPHYS J, V659, P149, DOI 10.1086/511807; McQuinn KBW, 2010, ASTROPHYS J, V721, P297, DOI 10.1088/0004-637X/721/1/297; Menci N, 2012, MON NOT R ASTRON SOC, V421, P2384, DOI 10.1111/j.1365-2966.2012.20470.x; Mo HJ, 2004, MON NOT R ASTRON SOC, V353, P829, DOI 10.1111/j.1365-2966.2004.08114.x; MOORE B, 1994, NATURE, V370, P629, DOI 10.1038/370629a0; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Munshi F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/56; Murray N, 2010, ASTROPHYS J, V709, P191, DOI 10.1088/0004-637X/709/1/191; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Navarro JF, 1996, MON NOT R ASTRON SOC, V283, pL72, DOI 10.1093/mnras/283.3.L72; Newman AB, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/25; Nierenberg AM, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/99; Oh SH, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/24; Oh SH, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/193; Papastergis E, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/38; Penarrubia J, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L42; Percival WJ, 2001, MON NOT R ASTRON SOC, V327, P1297, DOI 10.1046/j.1365-8711.2001.04827.x; Perez I, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118396; Peter AHG, 2013, MON NOT R ASTRON SOC, V430, P105, DOI 10.1093/mnras/sts535; Peter AHG, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.103501; Pontzen A, 2012, MON NOT R ASTRON SOC, V421, P3464, DOI 10.1111/j.1365-2966.2012.20571.x; Read JI, 2005, MON NOT R ASTRON SOC, V356, P107, DOI 10.1111/j.1365-2966.2004.08424.x; Robertson B, 2006, ASTROPHYS J, V645, P986, DOI 10.1086/504412; Rubin KHR, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L26; Rubin KHR, 2010, ASTROPHYS J, V719, P1503, DOI 10.1088/0004-637X/719/2/1503; Saitoh TR, 2008, PUBL ASTRON SOC JPN, V60, P667, DOI 10.1093/pasj/60.4.667; Shen S, 2010, MON NOT R ASTRON SOC, V407, P1581, DOI 10.1111/j.1365-2966.2010.17047.x; Simon JD, 2005, ASTROPHYS J, V621, P757, DOI 10.1086/427684; SIN SJ, 1994, PHYS REV D, V50, P3650, DOI 10.1103/PhysRevD.50.3650; Spergel DN, 2000, PHYS REV LETT, V84, P3760, DOI 10.1103/PhysRevLett.84.3760; Springel V, 2008, MON NOT R ASTRON SOC, V391, P1685, DOI 10.1111/j.1365-2966.2008.14066.x; Stadel J, 2009, MON NOT R ASTRON SOC, V398, pL21, DOI 10.1111/j.1745-3933.2009.00699.x; Stinson G, 2006, MON NOT R ASTRON SOC, V373, P1074, DOI 10.1111/j.1365-2966.2006.11097.x; Swaters RA, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/118; Swaters RA, 2003, ASTROPHYS J, V583, P732, DOI 10.1086/345426; Teyssier R, 2002, ASTRON ASTROPHYS, V385, P337, DOI 10.1051/0004-6361:20011817; Teyssier R, 2013, MON NOT R ASTRON SOC, V429, P3068, DOI 10.1093/mnras/sts563; The Planck Collaboration, ASTRON ASTR IN PRESS; Tonini C, 2006, ASTROPHYS J, V649, P591, DOI 10.1086/506431; Tulin S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.111301; van den Bosch FC, 2001, MON NOT R ASTRON SOC, V326, P1205, DOI 10.1046/j.1365-8711.2001.04656.x; van der Wel A, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/111; Viel M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043502; Walker MG, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/20; Weinberg MD, 2002, ASTROPHYS J, V580, P627, DOI 10.1086/343847; WHITE SDM, 1976, MON NOT R ASTRON SOC, V174, P19, DOI 10.1093/mnras/174.1.19; WHITE SDM, 1983, ASTROPHYS J, V274, pL1, DOI 10.1086/184139; Wise JH, 2011, MON NOT R ASTRON SOC, V414, P3458, DOI 10.1111/j.1365-2966.2011.18646.x; Wolf J, 2010, MON NOT R ASTRON SOC, V406, P1220, DOI 10.1111/j.1365-2966.2010.16753.x; Zolotov A, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/71	110	213	214	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					171	178		10.1038/nature12953	http://dx.doi.org/10.1038/nature12953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24522596	Green Accepted			2022-12-28	WOS:000331107700028
J	Waldherr, G; Wang, Y; Zaiser, S; Jamali, M; Schulte-Herbruggen, T; Abe, H; Ohshima, T; Isoya, J; Du, JF; Neumann, P; Wrachtrup, J				Waldherr, G.; Wang, Y.; Zaiser, S.; Jamali, M.; Schulte-Herbrueggen, T.; Abe, H.; Ohshima, T.; Isoya, J.; Du, J. F.; Neumann, P.; Wrachtrup, J.			Quantum error correction in a solid-state hybrid spin register	NATURE			English	Article							ENTANGLEMENT; QUBITS; READOUT; ION	Error correction is important in classical and quantum computation. Decoherence caused by the inevitable interaction of quantum bits with their environment leads to dephasing or even relaxation. Correction of the concomitant errors is therefore a fundamental requirement for scalable quantum computation(1-7). Although algorithms for error correction have been known for some time, experimental realizations are scarce(2-7). Here we show quantum error correction in a heterogeneous, solid-state spin system(8-21). We demonstrate that joint initialization, projective readout and fast local and non-local gate operations can all be achieved in diamond spin systems, even under ambient conditions. High-fidelity initialization of a whole spin register (99 per cent) and single-shot readout of multiple individual nuclear spins are achieved by using the ancillary electron spin of a nitrogen-vacancy defect. Implementation of a novel non-local gate generic to our electron-nuclear quantum register allows the preparation of entangled states of three nuclear spins, with fidelities exceeding 85 per cent. With these techniques, we demonstrate three-qubit phase-flip error correction. Using optimal control, all of the above operations achieve fidelities approaching those needed for fault-tolerant quantum operation, thus paving the way to large-scale quantum computation. Besides their use with diamond spin systems, our techniques can be used to improve scaling of quantum networks relying on phosphorus in silicon(19), quantum dots(22), silicon carbide(11) or rare-earth ions in solids(20,21).	[Waldherr, G.; Wang, Y.; Zaiser, S.; Jamali, M.; Neumann, P.; Wrachtrup, J.] Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany; [Waldherr, G.; Wang, Y.; Zaiser, S.; Jamali, M.; Neumann, P.; Wrachtrup, J.] Univ Stuttgart, Res Ctr SCOPE, D-70569 Stuttgart, Germany; [Schulte-Herbrueggen, T.] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; [Abe, H.; Ohshima, T.] Japan Atom Energy Agcy, Takasaki, Gunma 3701292, Japan; [Isoya, J.] Univ Tsukuba, Res Ctr Knowledge Communities, Tsukuba, Ibaraki 3058550, Japan; [Du, J. F.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Du, J. F.] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Wrachtrup, J.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	University of Stuttgart; University of Stuttgart; Technical University of Munich; Japan Atomic Energy Agency; University of Tsukuba; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Max Planck Society	Waldherr, G (corresponding author), Univ Stuttgart, Inst Phys 3, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	g.waldherr@physik.uni-stuttgart.de		Ohshima, Takeshi/0000-0002-7850-3164; Neumann, Philipp/0000-0003-2146-0412	Max Planck Society; ERC; DFG [SFB/TR21]; EU; JST-DFG [FOR1482, FOR1493]; Volkswagenstiftung	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); EU(European Commission); JST-DFG; Volkswagenstiftung(Volkswagen)	We thank F. Dolde, I. Jakobi, M. Kleinmann, F. Jelezko, J. Honert, A. Brunner and C. Walter for experimental help and discussions. We acknowledge financial support from the Max Planck Society, the ERC project SQUTEC, the DFG SFB/TR21, the EU projects DIAMANT, SIQS, QESSENCE and QINVC, the JST-DFG (FOR1482 and FOR1493), and the Volkswagenstiftung.	Aslam N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013064; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Boulant N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.130501; Chekhovich EA, 2013, NAT MATER, V12, P494, DOI [10.1038/NMAT3652, 10.1038/nmat3652]; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; Cramer J., 2013, PREPRINT; Dolde F, 2013, NAT PHYS, V9, P139, DOI 10.1038/nphys2545; Dreau A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.060502; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Filidou V, 2012, NAT PHYS, V8, P596, DOI [10.1038/NPHYS2353, 10.1038/nphys2353]; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Kolesov R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2034; Le Gall C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.057401; Machnes S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022305; Marseglia L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573870; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Mizuochi N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.041201; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Taminiau TH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137602; Waldherr G, 2012, NAT NANOTECHNOL, V7, P105, DOI [10.1038/NNANO.2011.224, 10.1038/nnano.2011.224]; Waldherr G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.090401; Waldherr G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.157601; Yin CM, 2013, NATURE, V497, P91, DOI 10.1038/nature12081	39	375	379	5	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					204	+		10.1038/nature12919	http://dx.doi.org/10.1038/nature12919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24476818	Green Submitted			2022-12-28	WOS:000331107700034
J	Dahms, K; Sharkova, Y; Heitland, P; Pankuweit, S; Schaefer, JR				Dahms, Kirsten; Sharkova, Yulia; Heitland, Peter; Pankuweit, Sabine; Schaefer, Juergen R.			Cobalt intoxication diagnosed with the help of Dr House	LANCET			English	Editorial Material									[Dahms, Kirsten; Sharkova, Yulia; Pankuweit, Sabine; Schaefer, Juergen R.] Univ Marburg, Univ Clin Marburg, D-35033 Marburg, Germany; [Dahms, Kirsten; Sharkova, Yulia; Pankuweit, Sabine; Schaefer, Juergen R.] Univ Marburg, Univ Clin Marburg, Ctr Undiagnosed Dis, D-35033 Marburg, Germany; [Heitland, Peter] Med Lab Bremen, Bremen, Germany	Philipps University Marburg; Philipps University Marburg	Schaefer, JR (corresponding author), Univ Marburg, Univ Clin Giessen & Marburg, Baldingerstr 1, D-35033 Marburg, Germany.	juergen.schaefer@uni-marburg.de						BONENFANT JL, 1967, CAN MED ASSOC J, V97, P910; Gilbert CJ, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2012.10.015; Jantzen C, 2013, ACTA ORTHOP, V84, P229, DOI 10.3109/17453674.2013.792034; Linna A, 2004, OCCUP ENVIRON MED, V61, P877, DOI 10.1136/oem.2003.009605	4	44	43	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					574	574		10.1016/S0140-6736(14)60037-4	http://dx.doi.org/10.1016/S0140-6736(14)60037-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24506908				2022-12-28	WOS:000331136400034
J	Glykys, J; Dzhala, V; Egawa, K; Balena, T; Saponjian, Y; Kuchibhotla, KV; Bacskai, BJ; Kahle, KT; Zeuthen, T; Staley, KJ				Glykys, J.; Dzhala, V.; Egawa, K.; Balena, T.; Saponjian, Y.; Kuchibhotla, K. V.; Bacskai, B. J.; Kahle, K. T.; Zeuthen, T.; Staley, K. J.			Local Impermeant Anions Establish the Neuronal Chloride Concentration	SCIENCE			English	Article							INTRACELLULAR CHLORIDE; BRAIN; GABA; COTRANSPORTER; INHIBITION; EXPRESSION; MECHANISM; PROTEOGLYCANS; POTASSIUM; TRANSPORT	Neuronal intracellular chloride concentration [Cl-](i) is an important determinant of gamma-aminobutyric acid type A (GABA(A)) receptor (GABA(A)R)-mediated inhibition and cytoplasmic volume regulation. Equilibrative cation-chloride cotransporters (CCCs) move Cl- across the membrane, but accumulating evidence suggests factors other than the bulk concentrations of transported ions determine [Cl-](i). Measurement of [Cl-](i) in murine brain slice preparations expressing the transgenic fluorophore Clomeleon demonstrated that cytoplasmic impermeant anions ([A](i)) and polyanionic extracellular matrix glycoproteins ([A](o)) constrain the local [Cl-]. CCC inhibition had modest effects on [Cl-] i and neuronal volume, but substantial changes were produced by alterations of the balance between [A](i) and [A](o). Therefore, CCCs are important elements of Cl- homeostasis, but local impermeant anions determine the homeostatic set point for [Cl-], and hence, neuronal volume and the polarity of local GABA(A)R signaling.	[Glykys, J.; Dzhala, V.; Egawa, K.; Balena, T.; Saponjian, Y.; Bacskai, B. J.; Staley, K. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Kuchibhotla, K. V.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Kahle, K. T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Zeuthen, T.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark	Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Copenhagen	Staley, KJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	staley.kevin@mgh.harvard.edu	Bacskai, Brian/AAE-9583-2021	Glykys, Joseph/0000-0002-1499-9172	National Institute of Neurological Disorders and Stroke, NIH [NS 40109-06]; American Epilepsy Society postdoctoral fellowship; NIH [R25]; Japan Foundation for Pediatric Research; Manton Center for Orphan Disease Research; NATIONAL CENTER FOR RESEARCH RESOURCES [U41RR019703, S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040109, R25NS065743, R01NS074772] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Epilepsy Society postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Foundation for Pediatric Research; Manton Center for Orphan Disease Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke, NIH, grant NS 40109-06 the Kennedy Endowment for Child Neurology and Mental Retardation. J.G. was supported by the American Epilepsy Society postdoctoral fellowship and NIH R25. K. E. was supported by The Japan Foundation for Pediatric Research. K. T. K. was supported by the Manton Center for Orphan Disease Research and NIH R25.	AlvarezLeefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P1; ALVAREZLEEFMANS FJ, 1992, J PHYSIOL-LONDON, V458, P603, DOI 10.1113/jphysiol.1992.sp019436; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Chahine NO, 2005, BIOPHYS J, V89, P1543, DOI 10.1529/biophysj.104.057315; CHAMBERLIN NL, 1988, BRAIN RES, V445, P12, DOI 10.1016/0006-8993(88)91068-2; DeFazio RA, 2000, J NEUROSCI, V20, P8069; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; GIANAZZA E, 1980, J CHROMATOGR, V193, P1, DOI 10.1016/S0021-9673(00)81438-7; Glass H. C., 2011, J PEDIAT, V159, pe1; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LEAF A, 1956, BIOCHEM J, V62, P241, DOI 10.1042/bj0620241; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Murakami T, 1996, ARCH HISTOL CYTOL, V59, P233, DOI 10.1679/aohc.59.233; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081; Ruusuvuori E, 2010, J NEUROSCI, V30, P15638, DOI 10.1523/JNEUROSCI.3355-10.2010; Song HM, 2009, J PROTEOME RES, V8, P346, DOI 10.1021/pr800631d; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y	41	127	127	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					670	675		10.1126/science.1245423	http://dx.doi.org/10.1126/science.1245423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503855	Green Accepted			2022-12-28	WOS:000330724000045
J	Reddy Munagala, VV; Tomar, V				Reddy Munagala, Vishnu V.; Tomar, Vaishali			Osteomalacia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 45-year-old woman presented with a 3-month history of generalized body pains that were nonresponsive to analgesic agents. Along with low back pain, she had progressive difficulty in getting up from sitting and supine positions and in walking. A 45-year-old woman presented with a 3-month history of generalized body pains that were nonresponsive to analgesic agents. Along with low back pain, she had progressive difficulty in getting up from sitting and supine positions and in walking. There was no history of trauma or any medication intake. She is an orthodox Muslim woman who wears a black veil outdoors and is completely covered, with little exposure to the sun, even in her courtyard. On examination, she had a waddling gait with painful movements of both thighs. The serum calcium level was 8.4 mg per deciliter (2.1 mmol per liter) ...	[Reddy Munagala, Vishnu V.] Vizag Rheumatol & Immunol Ctr, Visakhapatnam, Andhra Pradesh, India; [Tomar, Vaishali] Vijaya Med Ctr, Visakhapatnam, Andhra Pradesh, India		Reddy Munagala, VV (corresponding author), Vizag Rheumatol & Immunol Ctr, Visakhapatnam, Andhra Pradesh, India.								0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6							e10	10.1056/NEJMicm1308433	http://dx.doi.org/10.1056/NEJMicm1308433			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4NT	24499236				2022-12-28	WOS:000331073500002
J	Smith, JM				Smith, Jeanette M.			Top of the Ridge Albert Sheldon Pennoyer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					446	447		10.1001/jama.2013.279306	http://dx.doi.org/10.1001/jama.2013.279306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24496520				2022-12-28	WOS:000330589800001
J	Yuan, SY				Yuan, Sanying			China should reduce the overuse of intravenous infusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		Sichuan Univ, Dept Liver Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Yuan, SY (corresponding author), Sichuan Univ, Dept Liver Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	ysy404@126.com						An JG, 2013, LANCET, V382, P936, DOI 10.1016/S0140-6736(13)61928-5; [Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; [Anonymous], MOST 8 6 MILLION DOC; [Anonymous], 2013, CHINA NEWS      0910; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Harris DM, 2005, J LAW MED ETHICS, V33, P456, DOI 10.1111/j.1748-720X.2005.tb00512.x; Hesketh T, 2004, BRIT MED J, V329, P1427, DOI 10.1136/bmj.329.7480.1427; Hesketh T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5730; Hui L, 1997, PEDIATR INFECT DIS J, V16, P560, DOI 10.1097/00006454-199706000-00005; Li Z, 2011, BEIJING TODAY   0114; Liu T, 2006, BRIT MED J, V333, P365, DOI 10.1136/bmj.38943.408021.80; Ming Zhang, 2011, TIANJIN J NURSING, V19, P102; Shan J., 2012, CHINA DAILY; Sue DT, 2010, CHINESE RURAL HLTH S, V30, P296; Yan ZG, 1998, CHINA PHARM, V9, P246; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	16	14	15	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g1262	10.1136/bmj.g1262	http://dx.doi.org/10.1136/bmj.g1262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24495923				2022-12-28	WOS:000331060200005
J	Giacaman, R; Al-Ryami, A; Bashour, H; DeJong, J; Gaballah, N; Gherissi, A; Tekce, B; Zurayk, H				Giacaman, Rita; Al-Ryami, Asya; Bashour, Hyam; DeJong, Jocelyn; Gaballah, Noha; Gherissi, Atf; Tekce, Belgin; Zurayk, Huda			Importance of research networks: the Reproductive Health Working Group, Arab world and Turkey	LANCET			English	Editorial Material									[Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, Box 14, Ramallah, West Bank, Palestine; [Al-Ryami, Asya] Minist Hlth, Muscat, Oman; [Bashour, Hyam] Damascus Univ, Damascus, Syria; [Bashour, Hyam] Syrian Commiss Family Affair, Damascus, Syria; [DeJong, Jocelyn; Zurayk, Huda] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon; [Gaballah, Noha] Reprod Hlth Working Grp, Cairo, Egypt; [Gherissi, Atf] Tunis El Manar Univ, Tunis, Tunisia; [Tekce, Belgin] Bogazici Univ, Istanbul, Turkey	Birzeit University; American University of Beirut; Universite de Tunis-El-Manar; Bogazici University	Giacaman, R (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, Box 14, Ramallah, West Bank, Palestine.	rita@birzeit.edu						Al Riyami Asya, 2004, Reprod Health Matters, V12, P144, DOI 10.1016/S0968-8080(04)23113-5; Bashour HN, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002674; DeJong J, 2012, PUBLIC HEALTH IN THE ARABWORLD, P249; Erol M, 2011, SOC SCI MED, V73, P1490, DOI 10.1016/j.socscimed.2011.08.033; Fullerton JT, 2011, INT J CHILDBIRTH, V1, P4, DOI 10.1891/2156-5287.1.1.4; Giacaman R, 2005, HEALTH POLICY, V72, P129, DOI 10.1016/j.healthpol.2004.06.012; Khattab H.A.S., 1992, SILENT ENDURANCE SOC; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Tuysuz G, 2013, 100 TURKS EMULATE ST	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					483	485		10.1016/S0140-6736(13)62704-X	http://dx.doi.org/10.1016/S0140-6736(13)62704-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452048				2022-12-28	WOS:000330673700038
J	Gaffney, O				Gaffney, Owen			Quiet green revolution starts to make some noise	NATURE			English	Editorial Material									Int Geosphere Biosphere Programme, Stockholm, Sweden		Gaffney, O (corresponding author), Int Geosphere Biosphere Programme, Stockholm, Sweden.	owen.gaffney@igbp.kva.se		gaffney, owen/0000-0001-6244-991X					0	6	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					587	587		10.1038/505587a	http://dx.doi.org/10.1038/505587a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476852	Bronze			2022-12-28	WOS:000330321000004
J	McSweeney, S				McSweeney, Sean			Sophisticated synchrotrons	NATURE			English	Editorial Material									Brookhaven Natl Lab, Dept Photon Sci, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	McSweeney, S (corresponding author), Brookhaven Natl Lab, Dept Photon Sci, Upton, NY 11973 USA.	smcsweeney@bnl.gov			NIGMS NIH HHS [R01 GM095583] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					620	620		10.1038/505620a	http://dx.doi.org/10.1038/505620a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476881	Green Accepted			2022-12-28	WOS:000330321000023
J	Pitnick, S; Pfennig, DW				Pitnick, Scott; Pfennig, David W.			EVOLUTIONARY BIOLOGY Brotherly love benefits females	NATURE			English	Editorial Material							DROSOPHILA-MELANOGASTER; GENETICAL EVOLUTION; MATING STATUS; MALES		[Pitnick, Scott] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Pfennig, David W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Syracuse University; University of North Carolina; University of North Carolina Chapel Hill	Pitnick, S (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	sspitnic@syr.edu; dpfennig@unc.edu			Direct For Biological Sciences [1019479] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Arnqvist Goran, 2005, pUnpaginated; Carazo P, 2014, NATURE, V505, P672, DOI 10.1038/nature12949; Concannon MR, 2012, MOL ECOL, V21, P1477, DOI 10.1111/j.1365-294X.2012.05474.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; Morrow EH, 2003, BEHAV ECOL, V14, P802, DOI 10.1093/beheco/arg073; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Pizzari T, 2012, PHILOS T R SOC B, V367, P2314, DOI 10.1098/rstb.2011.0281; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Sirot LK, 2011, P NATL ACAD SCI USA, V108, P9922, DOI 10.1073/pnas.1100905108; Solomon NG., 2007, COOPERATIVE BREEDING	12	4	4	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					626	627		10.1038/nature12853	http://dx.doi.org/10.1038/nature12853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24463505				2022-12-28	WOS:000330321000028
J	Grotzinger, JP				Grotzinger, John P.			Habitability, Taphonomy, and the Search for Organic Carbon on Mars	SCIENCE			English	Editorial Material									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Grotzinger, JP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	grotz@gps.caltech.edu	Zorzano, María-Paz/F-2184-2015; Harri, Ari-Matti/C-7142-2012; Franz, Heather B/F-3508-2012; Glavin, Daniel P/D-6194-2012	Zorzano, María-Paz/0000-0002-4492-9650; Harri, Ari-Matti/0000-0001-8541-2802; Glavin, Daniel P/0000-0001-7779-7765				TYLER SA, 1954, SCIENCE, V119, P606, DOI 10.1126/science.119.3096.606	1	339	343	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					386	387		10.1126/science.1249944	http://dx.doi.org/10.1126/science.1249944			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458635				2022-12-28	WOS:000330039300039
J	Yount, KM				Yount, Kathryn M.			Worldwide prevalence of non-partner sexual violence	LANCET			English	Editorial Material									Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University	Yount, KM (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	kyount@emory.edu	Yount, Kathryn M/K-1239-2012; Yount, Kathryn Mary/W-2942-2019	Yount, Kathryn Mary/0000-0003-1917-1574				Abrahams N, 2014, LANCET; [Anonymous], 2013, LANCET, V318, P2; Dartnall E, 2013, BEST PRACT RES CL OB, V27, P3, DOI 10.1016/j.bpobgyn.2012.08.002; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2009, INT J GYNECOL OBSTET, V106, P144, DOI 10.1016/j.ijgo.2009.03.053; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Lawry L, 2011, AM J PUBLIC HEALTH, V101, P2004, DOI 10.2105/AJPH.2011.300347; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P2005, DOI 10.2105/AJPH.2011.300366; Vanwesenbeeck I, 2008, INT J SEX HEALTH, V20, P25, DOI 10.1080/19317610802157028; Watts CH, 2010, SEX TRANSM INFECT, V86, P93, DOI 10.1136/sti.2010.044610; Yount KM, 2013, J INTERPERS VIOLENCE, DOI 10.1177/0886260513511536	11	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1614	1616		10.1016/S0140-6736(13)62333-8	http://dx.doi.org/10.1016/S0140-6736(13)62333-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24529866				2022-12-28	WOS:000335670800006
J	Chung, SC; Gedeborg, R; Nicholas, O; James, S; Jeppsson, A; Wolfe, C; Heuschmann, P; Wallentin, L; Deanfield, J; Timmis, A; Jernberg, T; Hemingway, H				Chung, Sheng-Chia; Gedeborg, Rolf; Nicholas, Owen; James, Stefan; Jeppsson, Anders; Wolfe, Charles; Heuschmann, Peter; Wallentin, Lars; Deanfield, John; Timmis, Adam; Jernberg, Tomas; Hemingway, Harry			Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE; REPERFUSION THERAPY; ACC/AHA GUIDELINES; MORTALITY-RATES; FOCUSED UPDATE; MANAGEMENT; COUNTRIES; STRATEGY; DENMARK	Background International research for acute myocardial infarction lacks comparisons of whole health systems. We assessed time trends for care and outcomes in Sweden and the UK. Methods We used data from national registries on consecutive patients registered between 2004 and 2010 in all hospitals providing care for acute coronary syndrome in Sweden and the UK. The primary outcome was all-cause mortality 30 days after admission. We compared effectiveness of treatment by indirect casemix standardisation. This study is registered with ClinicalTrials.gov, number NCT01359033. Findings We assessed data for 119 786 patients in Sweden and 391 077 in the UK. 30-day mortality was 7.6% (95% CI 7.4-7.7) in Sweden and 10.5% (10.4-10.6) in the UK. Mortality was higher in the UK in clinically relevant subgroups defined by troponin concentration, ST-segment elevation, age, sex, heart rate, systolic blood pressure, diabetes mellitus status, and smoking status. In Sweden, compared with the UK, there was earlier and more extensive uptake of primary percutaneous coronary intervention (59% vs 22%) and more frequent use of beta blockers at discharge (89% vs 78%). After casemix standardisation the 30-day mortality ratio for UK versus Sweden was 1.37 (95% CI 1.30-1.45), which corresponds to 11 263 (95% CI 9620-12 827) excess deaths, but did decline over time (from 1.47, 95% CI 1.38-1.58 in 2004 to 1.20, 1.12-1.29 in 2010; p=0.01). Interpretation We found clinically important differences between countries in acute myocardial infarction care and outcomes. International comparisons research might help to improve health systems and prevent deaths.	[Chung, Sheng-Chia; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, UCL Partners, London NW1 2DA, England; [Nicholas, Owen] UCL, Natl Inst Clin Outcomes Res, London NW1 2DA, England; [Deanfield, John] UCL, Ctr Cardiovasc Prevent & Outcomes, London NW1 2DA, England; [Gedeborg, Rolf; James, Stefan; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [James, Stefan; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Jeppsson, Anders] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Jeppsson, Anders] Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden; [Wolfe, Charles] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Wolfe, Charles] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London, England; Kings Coll London, London WC2R 2LS, England; [Heuschmann, Peter] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Heuschmann, Peter] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Timmis, Adam] Barts Hlth London, Natl Inst Hlth Res, Biomed Res Unit, London, England; [Jernberg, Tomas] Karolinska Inst, Dept Med, Cardiol Sect, S-14186 Stockholm, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; Uppsala University; Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Wurzburg; University of Wurzburg; Barts Health NHS Trust; Karolinska Institutet	Jernberg, T (corresponding author), Karolinska Inst, Dept Cardiol, Karolinska Univ Hosp, S-14186 Stockholm, Sweden.	tomas.jernberg@karolinska.se; h.hemingway@ucl.ac.uk	Gedeborg, Rolf/AAV-6702-2020; James, Stefan K/J-4554-2014; Hemingway, Harry/C-1219-2009	Gedeborg, Rolf/0000-0002-8850-7863; Hemingway, Harry/0000-0003-2279-0624; Jernberg, Tomas/0000-0003-1695-379X; Chung, Sheng-Chia/0000-0001-6025-9207; Nicholas, Owen/0000-0002-0939-4283; Deanfield, John/0000-0001-8806-6052	European Union [223153]; National Institute for Health Research [NIHR] [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z]; Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; NIHR; National Institute for Social Care and Health Research; NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Barts and The London NIHR Cardiovascular Biomedical Research Unit; National Institute for Health Research; Swedish Heart and Lung Foundation; Wellcome Trust (UK); Swedish Association of Local Authorities and Regions; Swedish Heart-Lung Foundation; Seventh Framework Programme for Research; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10184, RP-PG-0407-10314, NF-SI-0510-10060] Funding Source: researchfish	European Union(European Commission); National Institute for Health Research [NIHR](National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Barts and The London NIHR Cardiovascular Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Wellcome Trust (UK)(Wellcome Trust); Swedish Association of Local Authorities and Regions; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Seventh Framework Programme for Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was done on behalf of the Swedish web-system for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies/The Swedish Register of Information and Knowledge about Swedish Health Intensive Care Admissions, the National Institute for Cardiovascular Outcomes Research/Myocardial Ischaemia National Audit Project, the Clinical Research Using Linked Bespoke Studies and Electronic Health Records programme, and the European Implementation Score project. This study was funded by the European Union Seventh Framework Programme for Research (CW, PH, and HH, grant 223153), National Institute for Health Research ([NIHR] AT and HH, grant RP-PG-0407-10314), Wellcome Trust (AT and HH, grant 086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (AT and HH, grant G0902393/99558), and by awards to establish the Farr Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, NIHR, National Institute for Social Care and Health Research, and Wellcome Trust. CW was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London, funded by the NIHR. AT was supported by Barts and The London NIHR Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. SJ, AJ, LW, and TJ were supported by the Swedish Heart and Lung Foundation. RG is employed at the Medical Products Agency in Sweden. The views expressed in this paper do not necessarily represent the views of the funding bodies.; Funding Seventh Framework Programme for Research, National Institute for Health Research, Wellcome Trust (UK), Swedish Association of Local Authorities and Regions, Swedish Heart-Lung Foundation.	Abildstrom SZ, 2003, HEART, V89, P507, DOI 10.1136/heart.89.5.507; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Antman Elliott M, 2004, Circulation, V110, pe82; Birkhead JS, 2004, HEART, V90, P1004, DOI 10.1136/hrt.2004.034470; Carlsson P, 2004, INT J TECHNOL ASSESS, V20, P44, DOI 10.1017/S0266462304000777; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Gavalova L, 2012, MYOCARDIAL ISCHAEMIA; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Improvement NHS, 2010, NAT ROLL OUT PRIM PC; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Julian DG, 1996, EUR HEART J, V17, P43; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kociol RD, 2012, JAMA-J AM MED ASSOC, V307, P66, DOI 10.1001/jama.2011.1926; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Laut KG, 2013, INT J CARDIOL, V168, P2745, DOI 10.1016/j.ijcard.2013.03.085; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Health Service, 2012, GROWTH PRIM PCI TREA; NICE, 2001, PROPH PAT WHO HAV EX; Packer C, 2006, INT J TECHNOL ASSESS, V22, P419, DOI 10.1017/S0266462306051336; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Schiele F, 2010, EUR HEART J, V31, P2614, DOI 10.1093/eurheartj/ehq305; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Sweden National Board of Health and Welfare, NAT GUID CARD CAR; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Thygesen K, 2007, EUR HEART J, V28, P2525; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X	37	209	221	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1305	1312		10.1016/S0140-6736(13)62070-X	http://dx.doi.org/10.1016/S0140-6736(13)62070-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24461715	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000334104900029
J	McCormack, RT; Armstrong, J; Leonard, D				McCormack, Robert T.; Armstrong, Joanne; Leonard, Debra			Codevelopment of Genome-Based Therapeutics and Companion Diagnostics Insights From an Institute of Medicine Roundtable	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McCormack, Robert T.] Janssen Diagnost Oncol Res & Dev, Raritan, NJ 08869 USA; [Armstrong, Joanne] Aetna, Sugar Land, TX USA; [Leonard, Debra] Univ Vermont, Coll Med, Burlington, VT 05405 USA	University of Vermont	McCormack, RT (corresponding author), Janssen Diagnost Oncol Res & Dev, 700 US Hwy 202, Raritan, NJ 08869 USA.	rmccorma@its.jnj.com						Centers for Medicare & Medicaid Services, CLINICAL LABORATORY; Goozner M, 2012, J NATL CANCER I, V104, P84, DOI 10.1093/jnci/djr552; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Institute of Medicine, 2014, REFINING PROCESSES F; The US Food and Drug Administration, 2011, DRAFT GUIDANCE FOR I; US Food and Drug Administration, PHARMACOGENOMIC BIOM	6	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1395	1396		10.1001/jama.2014.1508	http://dx.doi.org/10.1001/jama.2014.1508			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24522512				2022-12-28	WOS:000333935000011
J	Olfson, M; Marcus, SC; Bridge, JA				Olfson, Mark; Marcus, Steven C.; Bridge, Jeffrey A.			Focusing Suicide Prevention on Periods of High Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DELIBERATE SELF-HARM; CARE		[Olfson, Mark] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Olfson, Mark] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Marcus, Steven C.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Marcus, Steven C.] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA; [Bridge, Jeffrey A.] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA; [Bridge, Jeffrey A.] Ohio State Univ, Columbus, OH 43210 USA	Columbia University; New York State Psychiatry Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Olfson, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York State Psychiat Inst, 1051 Riverside Dr, New York, NY 10032 USA.	mo49@columbia.edu	Olfson, Mark/AAA-8547-2021; Bridge, Jeff/GQR-0436-2022		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021112] Funding Source: NIH RePORTER; AHRQ HHS [U19 HS021112] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], IMPROVING QUALITY AN; Appleby L, 1999, BRIT MED J, V318, P1235; Baker SP, 2013, AM J PREV MED, V44, P146, DOI 10.1016/j.amepre.2012.10.010; Betz ME, 2013, DEPRESS ANXIETY, V30, P1005, DOI 10.1002/da.22071; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Kuo CJ, 2012, BRIT J PSYCHIAT, V200, P405, DOI 10.1192/bjp.bp.111.099366; Marcus SC, 2012, AM J PUBLIC HEALTH, V102, P1145, DOI 10.2105/AJPH.2011.300598; Olfson M, 2013, AM J PSYCHIAT, V170, P1442, DOI 10.1176/appi.ajp.2013.12121506; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; While D, 2012, LANCET, V379, P1005, DOI 10.1016/S0140-6736(11)61712-1	10	67	68	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1107	1108		10.1001/jama.2014.501	http://dx.doi.org/10.1001/jama.2014.501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24515285				2022-12-28	WOS:000333010100011
J	Sakai, N; Sakai, T; Hirota, T; Watanabe, Y; Ceccarelli, C; Kahane, C; Bottinelli, S; Caux, E; Demyk, K; Vastel, C; Coutens, A; Taquet, V; Ohashi, N; Takakuwa, S; Yen, HW; Aikawa, Y; Yamamoto, S				Sakai, Nami; Sakai, Takeshi; Hirota, Tomoya; Watanabe, Yoshimasa; Ceccarelli, Cecilia; Kahane, Claudine; Bottinelli, Sandrine; Caux, Emmanuel; Demyk, Karine; Vastel, Charlotte; Coutens, Audrey; Taquet, Vianney; Ohashi, Nagayoshi; Takakuwa, Shigehisa; Yen, Hsi-Wei; Aikawa, Yuri; Yamamoto, Satoshi			Change in the chemical composition of infalling gas forming a disk around a protostar	NATURE			English	Article							CARBON-CHAIN MOLECULES; PRESTELLAR; MASS; EMISSION; SHOCKS; PHASE; CORE	IRAS 04368+2557 is a solar-type (low-mass) protostar embedded in a protostellar core (L1527) in the Taurus molecular cloud(1,2), which is only 140 parsecs away from Earth, making it the closest large star-forming region. The protostellar envelope has a flattened shape with a diameter of a thousand astronomical units (1 AU is the distance from Earth to the Sun), and is infalling and rotating(3-5). It also has a protostellar disk with a radius of 90 AU (ref. 6), from which a planetary system is expected to form(7,8). The interstellar gas, mainly consisting of hydrogen molecules, undergoes a change in density of about three orders of magnitude as it collapses from the envelope into the disk, while being heated from 10 kelvin to over 100 kelvin in the mid-plane, but it has hitherto not been possible to explore changes in chemical composition associated with this collapse. Here we report that the unsaturated hydrocarbon molecule cyclic-C3H2 resides in the infalling rotating envelope, whereas sulphur monoxide (SO) is enhanced in the transition zone at the radius of the centrifugal barrier (100 +/- 20 AU), which is the radius at which the kinetic energy of the infalling gas is converted to rotational energy. Such a drastic change in chemistry at the centrifugal barrier was not anticipated, but is probably caused by the discontinuous infalling motion at the centrifugal barrier and local heating processes there.	[Sakai, Nami; Watanabe, Yoshimasa; Yamamoto, Satoshi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Sakai, Takeshi] Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan; [Hirota, Tomoya] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Ceccarelli, Cecilia; Kahane, Claudine] Inst Planetol & Astrophys Grenoble, F-38041 Grenoble 9, France; [Bottinelli, Sandrine; Caux, Emmanuel; Demyk, Karine; Vastel, Charlotte] Univ Toulouse 3, Observ Midi Pyrenees, Univ Toulouse, IRAP, F-31062 Toulouse, France; [Bottinelli, Sandrine; Caux, Emmanuel; Demyk, Karine; Vastel, Charlotte] CNRS, IRAP, F-31028 Toulouse 4, France; [Coutens, Audrey] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Osterbro, Denmark; [Coutens, Audrey] Univ Copenhagen, Ctr Star & Planet Format, DK-1350 Copenhagen K, Denmark; [Coutens, Audrey] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark; [Taquet, Vianney] NASA, Goddard Space Flight Ctr, Astrochem Lab, Greenbelt, MD 20771 USA; [Ohashi, Nagayoshi; Yen, Hsi-Wei] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Ohashi, Nagayoshi] Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Takakuwa, Shigehisa; Yen, Hsi-Wei] Natl Taiwan Univ, Inst Astrophys, Taipei 10617, Taiwan; [Aikawa, Yuri] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan	University of Tokyo; University of Electro-Communications - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of Copenhagen; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Academia Sinica - Taiwan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Taiwan University; Kobe University	Sakai, N (corresponding author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	nami@taurus.phys.s.u-tokyo.ac.jp	Ceccarelli, Cecilia/ABB-8865-2020; 大橋永芳, Nagayoshi Ohashi/ABA-9767-2020; SAKAI, NAMI/G-4893-2014; 顏士韋, Hsi-Wei Yen/C-8307-2011; Coutens, Audrey/M-4533-2014; Sakai, Nami/N-7438-2015	Ceccarelli, Cecilia/0000-0001-9664-6292; 大橋永芳, Nagayoshi Ohashi/0000-0003-0998-5064; SAKAI, NAMI/0000-0002-3297-4497; 顏士韋, Hsi-Wei Yen/0000-0003-1412-893X; Coutens, Audrey/0000-0003-1805-3920; Sakai, Nami/0000-0002-3297-4497; Watanabe, Yoshimasa/0000-0002-9668-3592	Ministry of Education, Culture, Sports, Science and Technologies of Japan [21224002, 25400223, 25108005, 24684011]; JSPS; MAEE under the Japan-France integrated action programme (SAKURA); French Agence Nationale pour la Recherche (ANR) project FORCOMS [ANR-08-BLAN-0225]; Partenariats Hubert Curien (PHC) Programme SAKURA [25765VC]; Grants-in-Aid for Scientific Research [25108005, 21224002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technologies of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MAEE under the Japan-France integrated action programme (SAKURA); French Agence Nationale pour la Recherche (ANR) project FORCOMS(French National Research Agency (ANR)); Partenariats Hubert Curien (PHC) Programme SAKURA; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Hanawa and K. Furuya for discussions. This paper makes use of the ALMA dataset ADS/JAO.ALMA#2011.0.00604.S. ALMA is a partnership of the ESO (representing its member states), the NSF (USA) and NINS (Japan), together with the NRC (Canada) and the NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by the ESO, the AUI/NRAO and the NAOJ. We thank the ALMA staff for their support. N.S. and S.Y. acknowledge financial support from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technologies of Japan (21224002, 25400223 and 25108005), and by JSPS and MAEE under the Japan-France integrated action programme (SAKURA). T. H. acknowledges financial support from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan (21224002, 24684011 and 25108005). C. C. and C. K. acknowledge financial support from the French Agence Nationale pour la Recherche (ANR) project FORCOMS (contract ANR-08-BLAN-0225) and from the Partenariats Hubert Curien (PHC) Programme SAKURA 25765VC.	Aikawa Y, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/40; Aikawa Y, 2008, ASTROPHYS J, V674, P984, DOI 10.1086/524096; ANDRE P, 1993, ASTROPHYS J, V406, P122, DOI 10.1086/172425; Bachiller R, 2001, ASTRON ASTROPHYS, V372, P899, DOI 10.1051/0004-6361:20010519; Caselli P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0056-x; Ceccarelli C, 2003, ASTRON ASTROPHYS, V410, P587, DOI 10.1051/0004-6361:20031243; Chandra S, 2000, ASTRON ASTROPHYS SUP, V142, P113, DOI 10.1051/aas:2000142; Dubernet ML, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220630; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hincelin U, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/44; Hogerheijde MR, 2001, ASTROPHYS J, V553, P618, DOI 10.1086/320972; Lique F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2723733; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; McMullin JP, 2007, ASTR SOC P, V376, P127; NEUFELD DA, 1994, ASTROPHYS J, V428, P170, DOI 10.1086/174230; Ohashi N, 1997, ASTROPHYS J, V475, P211, DOI 10.1086/303533; Sakai N, 2008, ASTROPHYS J, V672, P371, DOI 10.1086/523635; Sakai N, 2010, ASTROPHYS J, V722, P1633, DOI 10.1088/0004-637X/722/2/1633; Shirley YL, 2002, ASTROPHYS J, V575, P337, DOI 10.1086/341286; Takakuwa S, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/52; Tobin JJ, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/48; Tobin JJ, 2012, NATURE, V492, P83, DOI 10.1038/nature11610; Torres RM, 2007, ASTROPHYS J, V671, P1813, DOI 10.1086/522924; Visser R, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117249; Wakelam V, 2005, ASTRON ASTROPHYS, V437, P149, DOI 10.1051/0004-6361:20042566; Wakelam V, 2004, ASTRON ASTROPHYS, V413, P609, DOI 10.1051/0004-6361:20031572; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548; Yen HW, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/22	28	157	157	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					78	+		10.1038/nature13000	http://dx.doi.org/10.1038/nature13000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24522533				2022-12-28	WOS:000332224400045
J	Horton, R; Lo, S				Horton, Richard; Lo, Selina			Protecting health: the global challenge for capitalism	LANCET			English	Editorial Material									[Horton, Richard; Lo, Selina] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; World Bank The, 2014, GLOB EC PROSP COP PO	2	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					577	578		10.1016/S0140-6736(13)62712-9	http://dx.doi.org/10.1016/S0140-6736(13)62712-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KP	24524780				2022-12-28	WOS:000331137700006
J	Jasechko, S; Sharp, ZD; Gibson, JJ; JeanBirks, S; Yi, Y; Fawcett, PJ				Jasechko, Scott; Sharp, Zachary D.; Gibson, John J.; JeanBirks, S.; Yi, Yi; Fawcett, Peter J.			Uncertainties in transpiration estimates Reply	NATURE			English	Letter							VARIABILITY		[Jasechko, Scott; Sharp, Zachary D.; Fawcett, Peter J.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Gibson, John J.; JeanBirks, S.; Yi, Yi] Alberta Innovates Technol Futures, Vancouver, BC V8Z 7X8, Canada; [Gibson, John J.; Yi, Yi] Univ Victoria, Dept Geog, Victoria, BC V8W 3R4, Canada; [JeanBirks, S.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of New Mexico; Alberta Innovates; University of Victoria; University of Waterloo	Jasechko, S (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	jasechko@unm.edu	yi, yi/HHY-7381-2022	Gibson, John/0000-0001-5952-0228				Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Coenders-Gerrits AMJ, 2014, NATURE, V506, pE1, DOI 10.1038/nature12925; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; FRIEDMAN I, 1953, GEOCHIM COSMOCHIM AC, V4, P89, DOI 10.1016/0016-7037(53)90066-0; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Miralles DG, 2011, HYDROL EARTH SYST SC, V15, P967, DOI 10.5194/hess-15-967-2011; Miralles DG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013530; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Syed TH, 2010, P NATL ACAD SCI USA, V107, P17916, DOI 10.1073/pnas.1003292107; Wang DG, 2007, J HYDROL, V347, P308, DOI 10.1016/j.jhydrol.2007.09.041	13	6	6	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					E2	E3		10.1038/nature12926	http://dx.doi.org/10.1038/nature12926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24522604				2022-12-28	WOS:000331107700002
J	Niu, YY; Shen, B; Cui, YQ; Chen, YC; Wang, JY; Wang, L; Kang, Y; Zhao, XY; Si, W; Li, W; Xiang, AP; Zhou, JK; Guo, XJ; Bi, Y; Si, CY; Hu, B; Dong, GY; Wang, H; Zhou, ZM; Li, TQ; Tan, T; Pu, XQ; Wang, F; Ji, SH; Zhou, Q; Huang, XX; Ji, WZ; Sha, JH				Niu, Yuyu; Shen, Bin; Cui, Yiqiang; Chen, Yongchang; Wang, Jianying; Wang, Lei; Kang, Yu; Zhao, Xiaoyang; Si, Wei; Li, Wei; Xiang, Andy Peng; Zhou, Jiankui; Guo, Xuejiang; Bi, Ye; Si, Chenyang; Hu, Bian; Dong, Guoying; Wang, Hong; Zhou, Zuomin; Li, Tianqing; Tan, Tao; Pu, Xiuqiong; Wang, Fang; Ji, Shaohui; Zhou, Qi; Huang, Xingxu; Ji, Weizhi; Sha, Jiahao			Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos	CELL			English	Article							ONE-STEP GENERATION; GERMLINE TRANSMISSION; TRANSGENIC MONKEYS; NONHUMAN PRIMATE; CAS9; MICE; SPECIFICITY; ENDONUCLEASE; CRISPR/CAS9; MUTATIONS	Monkeys serve as important model species for studying human diseases and developing therapeutic strategies, yet the application of monkeys in biomedical researches has been significantly hindered by the difficulties in producing animals genetically modified at the desired target sites. Here, we first applied the CRISPR/Cas9 system, a versatile tool for editing the genes of different organisms, to target monkey genomes. By coinjection of Cas9 mRNA and sgRNAs into one-cell-stage embryos, we successfully achieve precise gene targeting in cynomolgus monkeys. We also show that this system enables simultaneous disruption of two target genes (Ppar-gamma and Rag1) in one step, and no off-target mutagenesis was detected by comprehensive analysis. Thus, coinjection of one-cell-stage embryos with Cas9 mRNA and sgRNAs is an efficient and reliable approach for gene-modified cynomolgus monkey generation.	[Niu, Yuyu; Chen, Yongchang; Kang, Yu; Si, Wei; Si, Chenyang; Wang, Hong; Li, Tianqing; Tan, Tao; Pu, Xiuqiong; Wang, Fang; Ji, Shaohui; Ji, Weizhi] Yunnan Key Lab Primate Biomed Res, Kunming 650500, Peoples R China; [Shen, Bin; Wang, Jianying; Zhou, Jiankui; Hu, Bian; Huang, Xingxu] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Cui, Yiqiang; Wang, Lei; Guo, Xuejiang; Dong, Guoying; Zhou, Zuomin; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Xiaoyang; Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Niu, Yuyu; Chen, Yongchang; Kang, Yu; Si, Wei; Si, Chenyang; Wang, Hong; Li, Tianqing; Pu, Xiuqiong; Wang, Fang; Ji, Shaohui; Ji, Weizhi] Kunming Biomed Int & Natl Engn Res Ctr Biomed & A, Kunming 650500, Peoples R China; [Xiang, Andy Peng] Sun Yat Sen Univ, Key Lab Stem Cells & Tissue Engn, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510080, Guangdong, Peoples R China	Nanjing University; Nanjing Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Sun Yat Sen University	Sha, JH (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; wji@kbimed.com; shajh@njmu.edu.cn	Bi, Ye/A-6272-2017; Shen, Bin/ABD-5084-2021; Guo, Xuejiang/J-9600-2014	Shen, Bin/0000-0002-8946-8448; Guo, Xuejiang/0000-0002-0475-5705; Ji, Weizhi/0000-0003-2550-4224; Si, Wei/0000-0003-0861-0682; huang, xingxu/0000-0001-8934-1247	National Basic Research Program of China [2011CB944300, 2012CBA01300]; National High Technology Research and Development Program of China [2012AA020701]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	We thank Dr. Dangsheng Li from Shanghai Information Center for Life Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences for helpful discussions and insightful comments on this manuscript. We thank Dr. Xiujie Wang from Institutes of Genetics and Developmental Biology, Chinese Academy of Sciences for careful reading and editing of the manuscript. We also thank Lu Wang from CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences for help with the computational analysis of off-target sites. This study was supported by grants from the National Basic Research Program of China (2011CB944300 and 2012CBA01300), the National High Technology Research and Development Program of China (2012AA020701).	Chan AWS, 2013, ILAR J, V54, P211, DOI 10.1093/ilar/ilt035; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Chen Y, 2012, AM J PRIMATOL, V74, P165, DOI 10.1002/ajp.21017; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shen HL, 2013, NATURE, V503, P14, DOI 10.1038/503014a; Sun Q, 2008, P NATL ACAD SCI USA, V105, P12956, DOI 10.1073/pnas.0805639105; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	25	739	912	6	470	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					836	843		10.1016/j.cell.2014.01.027	http://dx.doi.org/10.1016/j.cell.2014.01.027			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24486104	Bronze			2022-12-28	WOS:000331379800020
J	Jack, A				Jack, Andrew			PHARMACEUTICALS Drug patents cause fresh spat between South Africa and industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				De Wit P., 2014, MAIL GUARDIAN   0117; Public Affairs Engagement, 2014, CAMP PREV DAM INN PR; South African Department of Science and Technology, 2013, BIOEC STRAT; South African Department of Trade and Industry, 2013, NAT POL INT IN PRESS	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2014	348								g1377	10.1136/bmj.g1377	http://dx.doi.org/10.1136/bmj.g1377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4KD	24511092				2022-12-28	WOS:000331063600003
J	Bloom, BJ; Nicholson, TL; Williams, JR; Campbell, SL; Bishof, M; Zhang, X; Zhang, W; Bromley, SL; Ye, J				Bloom, B. J.; Nicholson, T. L.; Williams, J. R.; Campbell, S. L.; Bishof, M.; Zhang, X.; Zhang, W.; Bromley, S. L.; Ye, J.			An optical lattice clock with accuracy and stability at the 10(-18) level	NATURE			English	Article							QUANTUM; FREQUENCY; METROLOGY; SHIFT	Progress in atomic, optical and quantum science(1,2) has led to rapid improvements in atomic clocks. At the same time, atomic clock research has helped to advance the frontiers of science, affecting both fundamental and applied research. The ability to control quantum states of individual atoms and photons is central to quantum information science and precision measurement, and optical clocks based on single ions have achieved the lowest systematic uncertainty of any frequency standard(3-5). Although many-atom lattice clocks have shown advantages in measurement precision over trapped-ion clocks(6,7), their accuracy has remained 16 times worse(8-10). Here we demonstrate a many-atom system that achieves an accuracy of 6.4x10(-18), which is not only better than a single-ion-based clock, but also reduces the required measurement time by two orders of magnitude. By systematically evaluating all known sources of uncertainty, including in situ monitoring of the blackbody radiation environment, we improve the accuracy of optical lattice clocks by a factor of 22. This single clock has simultaneously achieved the best known performance in the key characteristics necessary for consideration as a primary standard-stability and accuracy. More stable and accurate atomic clocks will benefit a wide range of fields, such as the realization and distribution of SI units(11), the search for time variation of fundamental constants(12), clock-based geodesy(13) and other precision tests of the fundamental laws of nature. This work also connects to the development of quantum sensors and many-body quantum state engineering(14) (such as spin squeezing) to advance measurement precision beyond the standard quantum limit.	[Bloom, B. J.; Nicholson, T. L.; Williams, J. R.; Campbell, S. L.; Bishof, M.; Zhang, X.; Zhang, W.; Bromley, S. L.; Ye, J.] NIST, JILA, Boulder, CO 80309 USA; [Bloom, B. J.; Nicholson, T. L.; Williams, J. R.; Campbell, S. L.; Bishof, M.; Zhang, X.; Zhang, W.; Bromley, S. L.; Ye, J.] Univ Colorado, Boulder, CO 80309 USA; [Bloom, B. J.; Nicholson, T. L.; Williams, J. R.; Campbell, S. L.; Bishof, M.; Zhang, X.; Zhang, W.; Bromley, S. L.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	ye@jila.colorado.edu	zhang, wei/N-1345-2019; Ye, Jun/C-3312-2011; Nicholson, Travis L/O-1573-2018; wei, zhang/G-4708-2012; Williams, Jason/B-8199-2015; Bloom, Benjamin/J-4799-2012	zhang, wei/0000-0003-2065-2535; Ye, Jun/0000-0003-0076-2112; Nicholson, Travis L/0000-0002-0503-7991; wei, zhang/0000-0003-2065-2535; Williams, Jason/0000-0002-3798-4424; Bloom, Benjamin/0000-0001-6831-0601; Bromley, Sarah/0000-0002-8130-6276; Campbell, Sara/0000-0002-7335-8391	National Institute of Standards and Technology; Defense Advanced Research Projects Agency's QuASAR Program; NSF PFC; National Defense Science and Engineering Graduate fellowship programme; NSF	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); Defense Advanced Research Projects Agency's QuASAR Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF PFC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Defense Science and Engineering Graduate fellowship programme; NSF(National Science Foundation (NSF))	We thank M. Martin, M. Swallows, E. Arimondo, J. L. Hall, T. Pfau, and W. D. Phillips for discussions and H. Green for technical assistance. This research is supported by the National Institute of Standards and Technology, the Defense Advanced Research Projects Agency's QuASAR Program, and the NSF PFC. M.B. acknowledges support from the National Defense Science and Engineering Graduate fellowship programme. S.L.C. and M.B. acknowledge support from the NSF Graduate Fellowship. Any mention of commercial products does not constitute an endorsement by NIST.	Bishof M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.093604; Borde CJ, 2005, PHILOS T R SOC A, V363, P2177, DOI 10.1098/rsta.2005.1635; Boyd MM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083002; Boyd MM, 2006, SCIENCE, V314, P1430, DOI 10.1126/science.1133732; Campbell GK, 2009, SCIENCE, V324, P360, DOI 10.1126/science.1169724; CHANDOS RJ, 1974, APPL OPTICS, V13, P2142, DOI 10.1364/AO.13.002142; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Cole GD, 2013, NAT PHOTONICS, V7, P644, DOI [10.1038/NPHOTON.2013.174, 10.1038/nphoton.2013.174]; Falke S, 2012, APPL PHYS B-LASERS O, V107, P301, DOI 10.1007/s00340-012-4952-6; Falke S., 2013, PREPRINT; Falke S, 2011, METROLOGIA, V48, P399, DOI 10.1088/0026-1394/48/5/022; Haroche S, 2013, REV MOD PHYS, V85, P1083, DOI 10.1103/RevModPhys.85.1083; Hinkley N, 2013, SCIENCE, V341, P1215, DOI 10.1126/science.1240420; Huntemann N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.090801; Kessler T, 2012, NAT PHOTONICS, V6, P687, DOI [10.1038/NPHOTON.2012.217, 10.1038/nphoton.2012.217]; Le Targat R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3109; Lemke ND, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103902; Lodewyck J, 2012, IEEE T ULTRASON FERR, V59, P411, DOI 10.1109/TUFFC.2012.2209; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Madej AA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203002; Martin MJ, 2013, SCIENCE, V341, P632, DOI 10.1126/science.1236929; MCNAMARA AG, 1962, REV SCI INSTRUM, V33, P330, DOI 10.1063/1.1717834; Middelmann T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263004; Middelmann T, 2011, IEEE T INSTRUM MEAS, V60, P2550, DOI 10.1109/TIM.2010.2088470; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Safronova MS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012509; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Takamoto M, 2005, NATURE, V435, P321, DOI 10.1038/nature03541; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	38	730	773	12	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					71	+		10.1038/nature12941	http://dx.doi.org/10.1038/nature12941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24463513	Green Submitted			2022-12-28	WOS:000330648100033
J	Kels, CG				Kels, Charles G.			Matchbox Cars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kels, Charles G.] Dept Homeland Secur, Off Hlth Affairs, Washington, DC USA; [Kels, Charles G.] US Air Force Reserve, Judge Advocate Gen Corps, Washington, DC USA		Kels, CG (corresponding author), Dept Homeland Secur, Off Hlth Affairs, Washington, DC USA.	charles.kels@hq.dhs.gov						Gunderman R., 2013, ATLANTIC; Kane CK., 2013, NEW DATA PHYS PRACTI; Kletke PR, 1996, JAMA-J AM MED ASSOC, V276, P555, DOI 10.1001/jama.276.7.555; Kocher R, 2011, NEW ENGL J MED, V364, P1790, DOI 10.1056/NEJMp1101959; Starr P, 1982, SOCIAL TRANSFORMATIO; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					467	468		10.1001/jama.2013.285727	http://dx.doi.org/10.1001/jama.2013.285727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24496533				2022-12-28	WOS:000330589800015
J	Cakir, I; Ozcan, U				Cakir, Isin; Ozcan, Umut			Mom's Milk Molds Neural Wiring for Metabolism	CELL			English	Editorial Material							LEPTIN	Vogt et al. demonstrate that, in mice, maternal high-fat feeding during lactation is sufficient to program the offspring for impaired energy and glucose homeostasis throughout their lifetime. They reveal that the resulting abnormal insulin signaling in the offspring interferes with the formation of hypothalamic neural circuits that contribute to metabolic status.	[Cakir, Isin; Ozcan, Umut] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009, R01DK098496] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK098496, R01 DK098496, R01DK081009] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; HADDEN DR, 1989, DIABETOLOGIA, V32, P625; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Sabin MA, 2008, FRONT HORM RES, V36, P85, DOI 10.1159/000115356; Steculorum SM, 2013, ENDOCRIN METAB CLIN, V42, P149, DOI 10.1016/j.ecl.2012.10.002; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008	10	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					396	397		10.1016/j.cell.2014.01.033	http://dx.doi.org/10.1016/j.cell.2014.01.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485448	Bronze			2022-12-28	WOS:000330580800006
J	Ekstrom, MP; Bornefalk-Hermansson, A; Abernethy, AP; Currow, DC				Ekstrom, Magnus P.; Bornefalk-Hermansson, Anna; Abernethy, Amy P.; Currow, David C.			Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SUSTAINED-RELEASE MORPHINE; PALLIATIVE CARE; DYSPNEA; MANAGEMENT; BREATHLESSNESS; PREVALENCE; MORTALITY; STATEMENT; SURVIVAL	Objective To evaluate the safety of benzodiazepines and opioids in patients with very severe chronic obstructive pulmonary disease (COPD). Design Population based longitudinal consecutive cohort study. Setting Centres prescribing long term oxygen therapy in Sweden. Patients 2249 patients starting long term oxygen therapy for COPD in Sweden between 2005 and 2009 in the national Swedevox Register. Main outcome measures Effects of benzodiazepines and opioids on rates of admission to hospital and mortality, adjusted for age, sex, arterial blood gases, body mass index (BMI), performance status, previous admissions, comorbidities, and concurrent drugs. Results 1681 (76%) patients were admitted to hospital, and 1129 (50%) died under observation. No patient was lost to follow-up. Benzodiazepines and opioids were not associated with increased admission: hazard ratio 0.98 (95% confidence interval, 0.87 to 1.10) and 0.98 (0.86 to 1.10), respectively. Benzodiazepines were associated with increased mortality (1.21, 1.05 to 1.39) with a dose response trend. Opioids also had a dose response relation with mortality: lower dose opioids (<= 30 mg oral morphine equivalents a day) were not associated with increased mortality (1.03, 0.84 to 1.26) in contrast with higher dose opioids (1.21, 1.02 to 1.44). Concurrent benzodiazepines and opioids in lower doses were not associated with increased admissions (0.86, 0.53 to 1.42) or mortality (1.25, 0.78 to 1.99). Associations were not modified by being naive to the drugs or by hypercapnia. Conclusions Lower dose opioids are not associated with increased admissions or deaths in patients with COPD and might be safe for symptom reduction in severe respiratory disease.	[Ekstrom, Magnus P.] Lund Univ, Div Resp Med & Allergol, Dept Clin Sci, SE-22100 Lund, Sweden; [Ekstrom, Magnus P.] Blekinge Hosp, Dept Med, SE-37185 Karlskrona, Sweden; [Bornefalk-Hermansson, Anna] Univ Uppsala Hosp, Uppsala Clin Res Ctr, SE-75237 Uppsala, Sweden; [Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27706 USA; [Abernethy, Amy P.; Currow, David C.] Flinders Univ S Australia, Discipline Serv, Adelaide, SA 5041, Australia; [Abernethy, Amy P.; Currow, David C.] Flinders Univ S Australia, Palliat Serv, Adelaide, SA 5041, Australia; [Abernethy, Amy P.; Currow, David C.] Flinders Univ S Australia, Support Serv, Adelaide, SA 5041, Australia	Lund University; Uppsala University; Uppsala University Hospital; Duke University; Flinders University South Australia; Flinders University South Australia; Flinders University South Australia	Ekstrom, MP (corresponding author), Blekinge Hosp, Dept Med, SE-37185 Karlskrona, Sweden.	pmekstrom@gmail.com		Ekstrom, Magnus/0000-0002-7227-5113; Currow, David/0000-0003-1988-1250; Bornefalk-Hermansson, Anna/0000-0001-9934-8485	Research Council of Blekinge; Swedish Heart-Lung Foundation	Research Council of Blekinge; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This study was funded by the Research Council of Blekinge and the Swedish Heart-Lung Foundation.	Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Allcroft P, 2013, J PALLIAT MED, V16, P741, DOI 10.1089/jpm.2012.0505; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Clemens KE, 2008, J PALLIAT MED, V11, P204, DOI 10.1089/jpm.2007.0131; Currow DC, 2013, J PALLIAT MED, V16, P881, DOI 10.1089/jpm.2012.0591; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Currow DC, 2009, J PAIN SYMPTOM MANAG, V38, P533, DOI 10.1016/j.jpainsymman.2009.01.006; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; Ekstrom MP, 2013, AM J RESP CRIT CARE, V187, P715, DOI 10.1164/rccm.201208-1565OC; Elkington H, 2005, PALLIATIVE MED, V19, P485, DOI 10.1191/0269216305pm1056oa; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goodridge Donna, 2010, Int J Chron Obstruct Pulmon Dis, V5, P99; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Johnson MJ, 2013, EUR RESPIR J, V42, P758, DOI 10.1183/09031936.00139812; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; McQuay H J, 1998, Health Technol Assess, V2, P1; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Rocker G, 2009, THORAX, V64, P910, DOI 10.1136/thx.2009.116699; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Stege G, 2010, RESP MED, V104, P518, DOI 10.1016/j.rmed.2009.10.022; STROM K, 1988, EUR RESPIR J, V1, P952; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Swedish National Board of Health and Welfare, 2008, QUAL CONT SWED HOSP; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO Collaborating Centre for Drug Statistics Methodology, 2010, GUID ATC CLASS DDD A; Young J, 2012, CAN FAM PHYSICIAN, V58, pE401	34	151	152	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2014	348								g445	10.1136/bmj.g445	http://dx.doi.org/10.1136/bmj.g445			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AY	24482539	Green Published, hybrid			2022-12-28	WOS:000330647900012
J	Heintz, C; Mair, W				Heintz, Caroline; Mair, William			You Are What You Host: Microbiome Modulation of the Aging Process	CELL			English	Review							LIFE-SPAN; C. ELEGANS; GUT MICROBIOME; GROWTH; EXTENDS; SIGNALS; FOLATE; DIET; TOR	The critical impact that microbiota have on health and disease makes the interaction between host and microbiome increasingly important as we evaluate therapeutics. Here, we highlight growing evidence that, beyond disease, microbes also affect the most fundamental of host physiological phenotypes, the rate of aging itself.	[Heintz, Caroline; Mair, William] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mair, W (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	wmair@hsph.harvard.edu	Heintz, Caroline/R-3272-2017	Mair, William/0000-0002-0661-1342	Ellison Medical Foundation; NIH/NIA [1R01AG044346]; NATIONAL INSTITUTE ON AGING [R01AG044346] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize to colleagues whose work was not cited due to space limitations. W.M. is funded by the Ellison Medical Foundation and the NIH/NIA 1R01AG044346.	Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Curran S. P., 2014, CELL METAB; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang R., 2013, ISRN MICROBIOL, V2013	24	141	151	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					408	411		10.1016/j.cell.2014.01.025	http://dx.doi.org/10.1016/j.cell.2014.01.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485451	Green Accepted, Bronze			2022-12-28	WOS:000330580800009
J	Denolle, MA; Dunham, EM; Prieto, GA; Beroza, GC				Denolle, M. A.; Dunham, E. M.; Prieto, G. A.; Beroza, G. C.			Strong Ground Motion Prediction Using Virtual Earthquakes	SCIENCE			English	Article							GREENS-FUNCTION; BASIN	Sedimentary basins increase the damaging effects of earthquakes by trapping and amplifying seismic waves. Simulations of seismic wave propagation in sedimentary basins capture this effect; however, there exists no method to validate these results for earthquakes that have not yet occurred. We present a new approach for ground motion prediction that uses the ambient seismic field. We apply our method to a suite of magnitude 7 scenario earthquakes on the southern San Andreas fault and compare our ground motion predictions with simulations. Both methods find strong amplification and coupling of source and structure effects, but they predict substantially different shaking patterns across the Los Angeles Basin. The virtual earthquake approach provides a new approach for predicting long-period strong ground motion.	[Denolle, M. A.; Dunham, E. M.; Beroza, G. C.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Denolle, M. A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Dunham, E. M.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Prieto, G. A.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Stanford University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Stanford University; Massachusetts Institute of Technology (MIT)	Denolle, MA (corresponding author), Stanford Univ, Dept Geophys, 397 Panama Mall, Stanford, CA 94305 USA.	mdenolle@stanford.edu	Prieto, German/B-8833-2008; Prieto, German/O-3025-2019	Prieto, German/0000-0001-8538-7379; Prieto, German/0000-0001-8538-7379; Dunham, Eric/0000-0003-0804-7746	NSF [EAR-0943885, EAR-0529922]; Southern California Earthquake Center (SCEC); U.S. Geological Survey [07HQAG0008]; Directorate For Geosciences [0943885] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Southern California Earthquake Center (SCEC); U.S. Geological Survey(United States Geological Survey); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank K. Olsen and anonymous reviewers for their comments and contributions to improve the manuscript. This work was supported by NSF grant EAR-0943885 and by the Southern California Earthquake Center (SCEC). SCEC is funded by NSF cooperative agreement EAR-0529922 and U.S. Geological Survey cooperative agreement 07HQAG0008. The SCEC contribution number for this paper is 1812. Data are available in the supplementary materials.	Aki K., 1957, B EARTHQ RES I TOKYO, V35, P415; Bard P.-Y., 1998, EARTHQ SPECTRA, V4, P609, DOI [10.1193/1.1585493, DOI 10.1193/1.1585493]; Burridge R., 1964, B SEISMOL SOC AM, V54, P1875, DOI [10.1785/BSSA05406A1875, DOI 10.1785/BSSA05406A1875]; Campbell KW, 2003, B SEISMOL SOC AM, V93, P314, DOI 10.1785/0120020029; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; CLAERBOUT JF, 1968, GEOPHYSICS, V33, P264, DOI 10.1190/1.1439927; Day SM, 2012, GEOPHYS J INT, V189, P1103, DOI 10.1111/j.1365-246X.2012.05416.x; Denolle MA, 2013, J GEOPHYS RES-SOL EA, V118, P2102, DOI 10.1029/2012JB009603; Denolle MA, 2012, B SEISMOL SOC AM, V102, P1214, DOI 10.1785/0120110183; Graves R, 2011, PURE APPL GEOPHYS, V168, P367, DOI 10.1007/s00024-010-0161-6; Guatteri M, 2004, B SEISMOL SOC AM, V94, P2051, DOI 10.1785/0120040037; Kohler MD, 2003, B SEISMOL SOC AM, V93, P757, DOI 10.1785/0120020017; Lobkis OI, 2001, J ACOUST SOC AM, V110, P3011, DOI 10.1121/1.1417528; Magistrale H, 2000, B SEISMOL SOC AM, V90, pS65, DOI 10.1785/0120000510; Nishida K, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005395; Olsen KB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036832; Olsen KB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025472; OLSEN KB, 1995, SCIENCE, V270, P1628, DOI 10.1126/science.270.5242.1628; Olsen KB, 2000, B SEISMOL SOC AM, V90, pS77, DOI 10.1785/0120000506; Prieto GA, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006067; Prieto GA, 2011, CR GEOSCI, V343, P600, DOI 10.1016/j.crte.2011.03.006; Prieto GA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034428; Roten D, 2012, B SEISMOL SOC AM, V102, P2008, DOI 10.1785/0120110286; Sabra KG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021862; Sanchez-Sesma FJ, 2006, B SEISMOL SOC AM, V96, P1182, DOI 10.1785/0120050181; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; Stehly L, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004237; Weaver RL, 2006, GEOPHYSICS, V71, pSI5, DOI 10.1190/1.2212247	29	76	81	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					399	403		10.1126/science.1245678	http://dx.doi.org/10.1126/science.1245678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458636				2022-12-28	WOS:000330039300043
J	Spencer, SP; Wilhelm, C; Yang, Q; Hall, JA; Bouladoux, N; Boyd, A; Nutman, TB; Urban, JF; Wang, J; Ramalingam, TR; Bhandoola, A; Wynn, TA; Belkaid, Y				Spencer, S. P.; Wilhelm, C.; Yang, Q.; Hall, J. A.; Bouladoux, N.; Boyd, A.; Nutman, T. B.; Urban, J. F., Jr.; Wang, J.; Ramalingam, T. R.; Bhandoola, A.; Wynn, T. A.; Belkaid, Y.			Adaptation of Innate Lymphoid Cells to a Micronutrient Deficiency Promotes Type 2 Barrier Immunity	SCIENCE			English	Article							RETINOIC ACID; T-CELLS; RESPONSES; CHILDREN; IL-13	How the immune system adapts to malnutrition to sustain immunity at barrier surfaces, such as the intestine, remains unclear. Vitamin A deficiency is one of the most common micronutrient deficiencies and is associated with profound defects in adaptive immunity. Here, we found that type 3 innate lymphoid cells (ILC3s) are severely diminished in vitamin A-deficient settings, which results in compromised immunity to acute bacterial infection. However, vitamin A deprivation paradoxically resulted in dramatic expansion of interleukin-13 (IL-13)-producing ILC2s and resistance to nematode infection in mice, which revealed that ILCs are primary sensors of dietary stress. Further, these data indicate that, during malnutrition, a switch to innate type 2 immunity may represent a powerful adaptation of the immune system to promote host survival in the face of ongoing barrier challenges.	[Spencer, S. P.; Wilhelm, C.; Hall, J. A.; Bouladoux, N.; Ramalingam, T. R.; Wynn, T. A.; Belkaid, Y.] NIAID, Immun Barrier Sites Initiat, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Spencer, S. P.; Wilhelm, C.; Hall, J. A.; Bouladoux, N.; Belkaid, Y.] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Spencer, S. P.; Yang, Q.; Bhandoola, A.] Univ Penn, Dept Pathol & Lab Med, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boyd, A.; Nutman, T. B.] NIAID, Helminth Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Urban, J. F., Jr.] USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Wang, J.] Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Ramalingam, T. R.; Wynn, T. A.] NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Immun Barrier Sites Initiat, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021; Wilhelm, Christoph/ABE-7176-2020	Wynn, Thomas A/0000-0002-7244-8731; Wilhelm, Christoph/0000-0002-9839-0291; Urban, Joseph/0000-0002-1590-8869; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X; Spencer, Sean/0000-0002-7328-5399	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; Office of Dietary Supplements, NIH; NIH [F30 DK094708]; Human Frontier Science Program; U.S. Department of Agriculture-Agricultural Research Service [1254-32000-094-00D]; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC011633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001133, ZIAAI001194, ZIAAI000829, ZIAAI000197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; Office of Dietary Supplements, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); U.S. Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; Office of Dietary Supplements, NIH; NIH grant F30 DK094708 (S.P.S.); Human Frontier Science Program (C.W.); U.S. Department of Agriculture-Agricultural Research Service project plan #1254-32000-094-00D (J.U.); and by the Damon Runyon Cancer Research Foundation (Dale F. and Betty Ann Frey Fellow, J.A.H.). We thank the NIAID animal facility staff; K. Holmes and the NIAID sorting facility, in particular, C. Eigsti and E. Stregevsky; and K. Beacht and the NIAID gnotobiotic facility, in particular, C. Avecedo and D. Trageser-Cesler for technical assistance. We thank D. Artis for providing C. rodentium, W. J. Leonard for providing TSLPR<SUP>-/-</SUP> mice, and W. Paul for providing IL33R<SUP>-/-</SUP> mice. We thank the Belkaid lab for critical discussions regarding the manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	[Anonymous], 2009, WHO GLOBAL DATABASE; Bancroft AJ, 1998, J IMMUNOL, V160, P3453; CARMAN JA, 1991, J IMMUNOL, V147, P1247; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hoag KA, 2002, J NUTR, V132, P3736, DOI 10.1093/jn/132.12.3736; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; LIMA AAM, 1992, EPIDEMIOL REV, V14, P222, DOI 10.1093/oxfordjournals.epirev.a036088; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; WHO, 2013, SOIL TRANSM HELM INF; WIEDERMANN U, 1993, IMMUNOLOGY, V80, P581; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039	33	299	320	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					432	437		10.1126/science.1247606	http://dx.doi.org/10.1126/science.1247606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458645	Green Accepted			2022-12-28	WOS:000330039300053
J	Walsh, T; Barr, PJ; Thompson, R; Ozanne, E; O'Neill, C; Elwyn, G				Walsh, Thom; Barr, Paul James; Thompson, Rachel; Ozanne, Elissa; O'Neill, Ciaran; Elwyn, Glyn			Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; AID; OUTCOMES; SURGERY; RATES	Objective To perform a systematic review of studies that assessed the potential of patient decision support interventions (decision aids) to generate savings. Design Systematic review. Data sources After registration with PROSPERO, we searched 12 databases, from inception to 15 March 2013, using relevant MeSH terms and text words. Included studies were assessed with Cochrane's risk of bias method and Drummond's quality checklist for economic studies. Per patient costs and projected savings associated with introducing patient decision support interventions were calculated, as well as absolute changes in treatment rates after implementation. Eligibility criteria Studies were included if they contained quantitative economic data, including savings, spending, costs, cost effectiveness analysis, cost benefit analysis, or resource utilization. We excluded studies that lacked quantitative data on savings, costs, monetary value, and/or resource utilization. Results After reviewing 1508 citations, we included seven studies with eight analyses. Of these seven studies, four analyses predicted system-wide savings, with two analyses from the same study. The predicted savings range from $8 (5 pound, (sic)6) to $3068 (1868 pound, (sic)2243) per patient. Larger savings accompanied reductions in treatment utilization rates. The impact on utilization rates was mixed. Authors used heterogeneous methods to allocate costs and calculate savings. Quality scores were low to moderate (median 4.5, range 0-8 out of 10), and risk of bias across the studies was moderate to high (3.5, range 3-6 out of 6), with studies predicting the most savings having the highest risk of bias. The range of issues identified in the studies included the relative absence of sensitivity analyses, the absence of incremental cost effectiveness ratios, and short time periods. Conclusion Although there is evidence to show that patients choose more conservative approaches when they become better informed, there is insufficient evidence, as yet, to be confident that the implementation of patient decision support interventions leads to system-wide savings. Further work-with sensitivity analyses, longer time horizons, and more contexts-is required to avoid premature or unrealistic expectations that could jeopardize implementation and lead to the loss of already proved benefits.	[Walsh, Thom; Barr, Paul James; Thompson, Rachel; Elwyn, Glyn] Dartmouth Coll, Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA; [Ozanne, Elissa; Elwyn, Glyn] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [O'Neill, Ciaran] Natl Univ Ireland, Sch Business & Econ, Galway, Ireland	Dartmouth College; Dartmouth College; Ollscoil na Gaillimhe-University of Galway	Elwyn, G (corresponding author), Dartmouth Coll, Dartmouth Ctr Hlth Care Delivery Sci, 37 Dewey Field Rd, Hanover, NH 03755 USA.	glynelwyn@gmail.com	Elwyn, Glyn/B-4798-2009; Elwyn, G./L-4292-2015	Elwyn, Glyn/0000-0002-0917-6286; Barr, Paul James/0000-0002-6868-7625; Thompson, Rachel/0000-0002-1009-0746	Dartmouth Center for Health Care Delivery Science; HRB Research Leaders Award [RL/2013/16]	Dartmouth Center for Health Care Delivery Science; HRB Research Leaders Award	This study was funded by the Dartmouth Center for Health Care Delivery Science. CO'N was supported by an HRB Research Leaders Award 2013 (RL/2013/16).	Agency for Healthcare Research and Quality, 2013, SERV DEL INN PROF; [Anonymous], 2013, NHS ENGL COMM SHAR D; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Cohen D, 2004, J EVAL CLIN PRACT, V10, P439, DOI 10.1111/j.1365-2753.2004.00503.x; Davies S, 2011, PAIN MED, V12, P59, DOI 10.1111/j.1526-4637.2010.01001.x; Drummond MF, 2015, METHODS EC EVALUATIO; Elwyn G, 2013, EUR J PERS CTR HEALT, V1, P129, DOI DOI 10.5750/EJPCH.V1I1.645; Elwyn G, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S14; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Frosch DL, 2008, ARCH INTERN MED, V168, P363, DOI 10.1001/archinternmed.2007.111; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Lewin Group, 2008, PATH HIGH PERF US HL; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Murray E, 2001, BMJ-BRIT MED J, V323, P493, DOI 10.1136/bmj.323.7311.493; Murray E, 2001, BMJ-BRIT MED J, V323, P490, DOI 10.1136/bmj.323.7311.490; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Shemilt A, 2011, COCHRANE HDB SYSTEMA, P1; van Peperstraten A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c2501; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Vuorma S, 2004, HEALTH EXPECT, V7, P327, DOI 10.1111/j.1369-7625.2004.00297.x; WAGNER EH, 1995, MED CARE, V33, P765, DOI 10.1097/00005650-199508000-00002; Weinstein JN, 2010, SPINE, V35, P1329, DOI 10.1097/BRS.0b013e3181e0f04d; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321	27	43	43	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g188	10.1136/bmj.g188	http://dx.doi.org/10.1136/bmj.g188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298BE	24458654	Green Published, hybrid			2022-12-28	WOS:000330298100006
J	Yach, D				Yach, Derek			The origins, development, effects, and future of the WHO Framework Convention on Tobacco Control: a personal perspective	LANCET			English	Editorial Material							GLOBAL BURDEN; MORTALITY	Worldwide, more than 1 billion people use tobacco, resulting in about 6 million deaths per year. The tobacco industry's documented history of subverting control efforts required innovative approaches by WHO-led by Gro Harlem Brundtland-including invocation of its constitutional authority to develop treaties. In 2003, WHO member states adopted the WHO Framework Convention on Tobacco Control (WHO FCTC). In the decade since, 177 countries have ratified and started to implement its full provisions. Success has been tempered by new challenges. Tobacco use has fallen in countries that are members of the Organisation for Economic Co-operation and Development but increased in low-income and middle-income countries, a result in no small part of illicit trade and cheap products from China and other unregulated state monopolies. This review of 50 years of policy development aimed at reducing the burden of disease attributable to tobacco reviews the origins and strategies used in forging the WHO FCTC, from the perspective of one who was there.	[Yach, Derek] Vital Inst, New York, NY 10011 USA		Yach, D (corresponding author), 3 Columbus Circle,Suite 1656, New York, NY 10019 USA.	dyach@thevitalitygroup.com						Allison R, 2002, GUARDIAN        0529; [Anonymous], 2002, SCRUTON MEDIA PLOT P; [Anonymous], 2000, ADV KNOWL REG TOB PR; [Anonymous], 1997, BBC NEWS; [Anonymous], 1998, GRO HARLEM BRUNDTLAN; [Anonymous], 1999, CURBING EPIDEMIC GOV; [Anonymous], 1993, ALL AFR C TOB CONTR; [Anonymous], 2008, MARKETERS ELECT CIGA; [Anonymous], 1996, NOTE SHABANJI OPUKAH; [Anonymous], 1993, 950149925 INT C PREV; Antezana Fernando S., 1998, World Health Statistics Quarterly, V51, P3; Augusta Jordan Rosan, 1996, COMMUNICATION; Bates C, COUNTERFACTUAL REASO; Bill & Melinda Gates Foundation, WHAT WE DO TOB CONTR; British American Tobacco, 2012, NCEA ANN REP; Castle S, 2013, NAMIBIAN        0112; CHAPMAN S, 1994, BRIT MED J, V308, P189, DOI 10.1136/bmj.308.6922.189; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; End Decade Review, 2000, NAT REP FOLL UP WORL; Fifa, FOOTB DEV GLOB SHOWP; Food and Agricultural Organization, 2003, PROJ TOB PROD CONS T; Framework Convention Alliance, BULLETIN; Framework Convention Alliance, 2004, BUILD SUPP GLOB TOB; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hajek P, 2013, LANCET RESP MED, V1, P429, DOI 10.1016/S2213-2600(13)70124-3; Hennessy Patrick, 2008, TELEGRAPH; Hu TW, 2006, TOB CONTROL, V15, pI37, DOI 10.1136/tc.2005.014621; Kahneman D., 2011, THINKING FAST SLOW; Kmietowicz Z, 2002, BRIT MED J, V324, P257, DOI 10.1136/bmj.324.7332.257; Levy DT, 2013, B WORLD HEALTH ORGAN, V91, P509, DOI 10.2471/BLT.12.113878; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Mamudu HM, 2009, GLOB PUBLIC HEALTH, V4, P150, DOI 10.1080/17441690802095355; Martin Broughton's remarks to the World Economic Forum, 1999, M BROUGHTONS REMARKS; Morris Philip, 1998, 51 WORLD HLTH ASS 10; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; National Institutes of Health Fogarty International Center, 2013, USENIX SEC S WASH DC; National Institutes of Health Fogarty International Center, 2013, USENIX SEC S WASH DC; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Opukah S, 1994, RE DATA COLLECTION T; Parliament of Australia, 2011, TOB PLAIN PACK BILL; Robert Wood Johnson Foundation, 2003, INT TOB CONTR C PACK; Royal College of Physicians, 1962, SMOK HLTH REP ROYAL; Samet J, 2001, WOMEN TOBACCO EPIDEM; Syed S, 1999, WHO TOBACCO RIGHTS C; Taylor ALRR, 1995, WHA4811 WHO TFI; Tobacco News and Information, 2000, DAIL DOC FRANK STAT; United Nations Economic and Social Council, 10 M ITS RES ORG SES; United States Surgeon General, 1964, SMOK HLTH REP ADV CO; Warren Charles W, 2009, Glob Health Promot, V16, P38, DOI 10.1177/1757975909342192; Warren CW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-S1-S1; Wellcome Trust Centre, WHO FRAM CONV TOB CO; WHO, 1997, HLTH FO ALL 21 CENT; WHO, 2012, 15 WORLD C TOB HLTH; WHO, 1999, WHO LAUNCH PARTN PHA; WHO, 2000, DIR GEN RESP TOB HEA; WHO, 2002, FIFA BAGS TOP HLTH A; WHO, 2006, B WORLD HLTH ORG BUS; WHO, 1989, TOHTAG8911 WHO; WHO, WORLD NO TOB DAY; WHO, 2013, 56 WHO; WHO Centre for Health Development Kobe. Japan, 1999, 4 M ADV COMM WHO HLT; WHO Framework Convention on Tobacco Control, 1996, PROC WHO FRAM CONV T; WHO Regional Offi ce for Europe, 1998, HLTH 21 HLTH ALL POL; WHO Tobacco Free Initiative (TFI), 2012, WHO REP GLOB TOB EP; WHO Tobacco Free Initiative (TFI), 1999, WHONCDTFI9912; WHO Tobacco Free Initiative (TFI), 2013, QUEST ANSW EL CIG EL; WHO Tobacco Free Initiative (TFI), 1999, NO WHER RUN NO WHER; WHO Tobacco Free Initiative (TFI), WHA2332 WHO TFI; WHO Tobacco Free Initiative (TFI), 2000, GLOB DIAL HLTH D YAC; WHO Tobacco Free Initiative (TFI), 1999, INT CONS TOB YOUTH W; WHO Tobacco Free Initiative (TFI), NGO CHANN OUTR PROJ; WHO Tobacco Free Initiative (TFI), BELL STAT; WHO. Tobacco Free Initiative (TFI), WHA5418 WHO TFI; WHO Tobacco Free Initiative (TFI), 2002, TOB FREE OL; WHO Tobacco Free Initiative (TFI), 2001, WHO CONS LIT PUBL IN; WHO Tobacco Free Initiative (TFI), 2013, TOB KILLS DONT BE DU; WHO Tobacco Free Initiative (TFI), WHO RES; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2000, TOB CO STRAT UND TOB; Yach D, 2006, ANN TROP MED PARASIT, V100, P465, DOI 10.1179/136485906X97462; Yach D, 2000, TOB CONTROL, V9, P206, DOI 10.1136/tc.9.2.206; Yach D, 2014, PUBLIC HLTH	83	32	32	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1771	1779		10.1016/S0140-6736(13)62155-8	http://dx.doi.org/10.1016/S0140-6736(13)62155-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6UO	24461287				2022-12-28	WOS:000336267300031
J	Lubans, D				Lubans, David			Obesity in men: are professional football clubs onside?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS; OVERWEIGHT		Univ Newcastle, Prior Res Ctr Phys Activ & Nutr, Newcastle, NSW 2308, Australia	University of Newcastle	Lubans, D (corresponding author), Univ Newcastle, Prior Res Ctr Phys Activ & Nutr, Newcastle, NSW 2308, Australia.	David.Lubans@newcastle.edu.au	Lubans, David Revalds/G-7436-2013	Lubans, David/0000-0002-0204-8257				Egger G., 2000, Australian Journal of Nutrition and Dietetics, V57, P46; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hunt K, 2014, LANCET; Morgan PJ, 2013, ANN BEHAV MED, V45, P139, DOI 10.1007/s12160-012-9424-z; Morgan PJ, 2011, OBES RES CLIN PRACT, V5, pE239, DOI 10.1016/j.orcp.2011.03.002; Morgan PJ, 2011, OBESITY, V19, P142, DOI 10.1038/oby.2010.119; Morgan PJ, 2009, OBESITY, V17, P2025, DOI 10.1038/oby.2009.85; Nowson CA, 2005, AM J CLIN NUTR, V81, P983; Pagoto SL, 2012, OBESITY, V20, P1234, DOI 10.1038/oby.2011.140; Resnicow Ken, 1999, Ethnicity and Disease, V9, P10; Sabinsky MS, 2007, EUR J CLIN NUTR, V61, P526, DOI 10.1038/sj.ejcn.1602537; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Young MD, 2012, OBES REV, V13, P393, DOI 10.1111/j.1467-789X.2011.00967.x	14	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1190	1191		10.1016/S0140-6736(13)62710-5	http://dx.doi.org/10.1016/S0140-6736(13)62710-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24457207	Green Submitted, hybrid			2022-12-28	WOS:000334104600005
J	Jinek, M; Jiang, FG; Taylor, DW; Sternberg, SH; Kaya, E; Ma, EB; Anders, C; Hauer, M; Zhou, KH; Lin, S; Kaplan, M; Iavarone, AT; Charpentier, E; Nogales, E; Doudna, JA				Jinek, Martin; Jiang, Fuguo; Taylor, David W.; Sternberg, Samuel H.; Kaya, Emine; Ma, Enbo; Anders, Carolin; Hauer, Michael; Zhou, Kaihong; Lin, Steven; Kaplan, Matias; Iavarone, Anthony T.; Charpentier, Emmanuelle; Nogales, Eva; Doudna, Jennifer A.			Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation	SCIENCE			English	Article							BACTERIAL IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; MACROMOLECULAR STRUCTURES; NEISSERIA-MENINGITIDIS; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; CRISPR IMMUNITY; NUCLEIC-ACIDS; DNA; COMPLEX	Type II CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems use an RNA-guided DNA endonuclease, Cas9, to generate double-strand breaks in invasive DNA during an adaptive bacterial immune response. Cas9 has been harnessed as a powerful tool for genome editing and gene regulation in many eukaryotic organisms. We report 2.6 and 2.2 angstrom resolution crystal structures of two major Cas9 enzyme subtypes, revealing the structural core shared by all Cas9 family members. The architectures of Cas9 enzymes define nucleic acid binding clefts, and single-particle electron microscopy reconstructions show that the two structural lobes harboring these clefts undergo guide RNA-induced reorientation to form a central channel where DNA substrates are bound. The observation that extensive structural rearrangements occur before target DNA duplex binding implicates guide RNA loading as a key step in Cas9 activation.	[Jinek, Martin; Anders, Carolin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Jiang, Fuguo; Kaya, Emine; Ma, Enbo; Hauer, Michael; Lin, Steven; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Taylor, David W.; Zhou, Kaihong; Lin, Steven; Kaplan, Matias; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Taylor, David W.; Iavarone, Anthony T.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Charpentier, Emmanuelle] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Charpentier, Emmanuelle] Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, D-38124 Braunschweig, Germany; [Charpentier, Emmanuelle] Hannover Med Sch, D-30625 Hannover, Germany; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Zurich; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Umea University; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jinek, M (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch; enogales@lbl.gov; doudna@berkeley.edu	Jinek, Martin/E-6621-2011; JIANG, FUGUO/G-6581-2012; Lin, Steven/ABD-7821-2021; Lin, Steven/G-6142-2019; Hauer, Michael/U-4800-2019	Jinek, Martin/0000-0002-7601-210X; JIANG, FUGUO/0000-0003-4469-1803; Lin, Steven/0000-0002-7542-4663; Lin, Steven/0000-0002-7542-4663; Hauer, Michael/0000-0001-7463-3191; Taylor, David/0000-0002-6198-1194; Sternberg, Samuel/0000-0001-8240-9114; Kaplan, Matias/0000-0003-3062-7026	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM066698] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Ivancic-Bace I, 2012, J MOL BIOL, V422, P607, DOI 10.1016/j.jmb.2012.06.024; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	61	663	843	67	476	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1215	+		10.1126/science.1247997	http://dx.doi.org/10.1126/science.1247997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7AE	24505130	Green Accepted			2022-12-28	WOS:000349777500001
J	Purcell, SM; Moran, JL; Fromer, M; Ruderfer, D; Solovieff, N; Roussos, P; O'Dushlaine, C; Chambert, K; Bergen, SE; Kahler, A; Duncan, L; Stahl, E; Genovese, G; Fernandez, E; Collins, MO; Komiyama, NH; Choudhary, JS; Magnusson, PKE; Banks, E; Shakir, K; Garimella, K; Fennell, T; DePristo, M; Grant, SGN; Haggarty, SJ; Gabriel, S; Scolnick, EM; Lander, ES; Hultman, CM; Sullivan, PF; McCarroll, SA; Sklar, P				Purcell, Shaun M.; Moran, Jennifer L.; Fromer, Menachem; Ruderfer, Douglas; Solovieff, Nadia; Roussos, Panos; O'Dushlaine, Colm; Chambert, Kimberly; Bergen, Sarah E.; Kahler, Anna; Duncan, Laramie; Stahl, Eli; Genovese, Giulio; Fernandez, Esperanza; Collins, Mark O.; Komiyama, Noboru H.; Choudhary, Jyoti S.; Magnusson, Patrik K. E.; Banks, Eric; Shakir, Khalid; Garimella, Kiran; Fennell, Tim; DePristo, Mark; Grant, Seth G. N.; Haggarty, Stephen J.; Gabriel, Stacey; Scolnick, Edward M.; Lander, Eric S.; Hultman, Christina M.; Sullivan, Patrick F.; McCarroll, Steven A.; Sklar, Pamela			A polygenic burden of rare disruptive mutations in schizophrenia	NATURE			English	Article							DE-NOVO MUTATIONS; MESSENGER-RNA; POSTSYNAPTIC DENSITY-95; INTELLECTUAL DISABILITY; ASSOCIATION ANALYSIS; PROTEIN; VARIANT; AUTISM; RISK; COMPLEX	Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.	[Purcell, Shaun M.; Moran, Jennifer L.; Fromer, Menachem; O'Dushlaine, Colm; Chambert, Kimberly; Bergen, Sarah E.; Duncan, Laramie; Genovese, Giulio; Haggarty, Stephen J.; Scolnick, Edward M.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Purcell, Shaun M.; Fromer, Menachem; Ruderfer, Douglas; Roussos, Panos; Stahl, Eli; Sklar, Pamela] Icahn Sch Med Mt Sinai, Div Psychiat Genom, Dept Psychiat, New York, NY 10029 USA; [Purcell, Shaun M.; Fromer, Menachem; Ruderfer, Douglas; Roussos, Panos; Stahl, Eli; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Purcell, Shaun M.; Fromer, Menachem; Solovieff, Nadia; Duncan, Laramie; Haggarty, Stephen J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun M.; Duncan, Laramie; Banks, Eric; Shakir, Khalid; Garimella, Kiran; Fennell, Tim; DePristo, Mark; Gabriel, Stacey; Lander, Eric S.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Bergen, Sarah E.; Kahler, Anna; Magnusson, Patrik K. E.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Fernandez, Esperanza] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Fernandez, Esperanza] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Collins, Mark O.; Komiyama, Noboru H.; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Prote Mass Spectrometry, Cambridge CB10 1SA, England; [Grant, Seth G. N.] Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland; [Grant, Seth G. N.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; KU Leuven; Flanders Institute for Biotechnology (VIB); Wellcome Trust Sanger Institute; University of Edinburgh; University of Edinburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Purcell, SM (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	shaun@broadinstitute.org	Magnusson, Patrik KE/C-4458-2017; Duncan, Laramie/AAW-5306-2021; Kähler, Anna K/J-2874-2012; Haggarty, Stephen J/M-9495-2016; Duncan, Laramie/AAG-6605-2019; Collins, Mark/AAB-7484-2021; Bergen, Sarah/I-8313-2012; Ruderfer, Douglas M/M-5795-2016; Choudhary, Jyoti/S-1232-2017	Magnusson, Patrik KE/0000-0002-7315-7899; Haggarty, Stephen J/0000-0002-7872-168X; Collins, Mark/0000-0002-7656-4975; Bergen, Sarah/0000-0002-5888-0034; Ruderfer, Douglas M/0000-0002-2365-386X; Choudhary, Jyoti/0000-0003-0881-5477; Duncan, Laramie/0000-0003-1131-661X; Moran, Jennifer/0000-0002-5664-4716; Garimella, Kiran/0000-0002-6212-5736; Grant, Seth/0000-0001-8732-8735; McCarroll, Steven/0000-0002-6954-8184	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) ARRA Grand Opportunity grant [NIMH RC2 MH089905]; Sylvan Herman Foundation; Stanley Center for Psychiatric Research; Stanley Medical Research Institute; NIH/National Human Genome Research Institute (NHGRI) [U54HG003067]; NIH/NIMH [R01 MH095088, R01 MH091115, R01 MH099126, R01 MH077139, R01 MH095034, T32 MH017119]; Tau Consortium; NIH/NHGRI [R01 HG005827]; Friedman Brain Institute at Mount Sinai School of Medicine; Karolinska Institutet, Karolinska University Hospital; Swedish Research Council; ALF from Swedish County Council; Soderstrom Konigska Foundation; Netherlands Scientific Organization [NWO 645-000-003]; Wellcome Trust; Genes to Cognition Program; Medical Research Council; European Union [241995, 242498, 242167]; Institute for Genomics and Multiscale Biology; Medical Research Council [G0802238] Funding Source: researchfish; MRC [G0802238] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG005827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099126, R01MH095088, RC2MH089905, T32MH017119, R01MH077139, R01MH095034, R01MH091115] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) ARRA Grand Opportunity grant; Sylvan Herman Foundation; Stanley Center for Psychiatric Research; Stanley Medical Research Institute; NIH/National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Tau Consortium; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Friedman Brain Institute at Mount Sinai School of Medicine; Karolinska Institutet, Karolinska University Hospital(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF from Swedish County Council; Soderstrom Konigska Foundation; Netherlands Scientific Organization; Wellcome Trust(Wellcome Trust); Genes to Cognition Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Institute for Genomics and Multiscale Biology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful for the participation of all subjects contributing to this research, and to the collection team that worked to recruit them: E. Flordal-Thelander, A.-B. Holmgren, M. Hallin, M. Lundin, A.-K. Sundberg, C. Pettersson, R. Satgunanthan-Dawoud, S. Hassellund, M. Radstrom, B. Ohlander, L. Nyren and I. Kizling. We acknowledge funding support from National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) ARRA Grand Opportunity grant NIMH RC2 MH089905 (S. M. P., P. S.), the Sylvan Herman Foundation, the Stanley Center for Psychiatric Research, the Stanley Medical Research Institute, NIH/National Human Genome Research Institute (NHGRI) grant U54HG003067 (E. S. L.), NIH/NIMH grant R01 MH095088 (S.J.H.), NIH/NIMH grant R01 MH091115 (S.J.H.), the Tau Consortium (S.J.H.), NIH/NIMH grant R01 MH099126 (S. M. P.), NIH/NHGRI grant R01 HG005827 (S. M. P.), NIH/NIMH grant R01 MH077139 (P. F. S.), NIH/NIMH grant R01 MH095034 (P. S.), NIH/NIMH grant T32 MH017119 (L. D.), the Friedman Brain Institute at Mount Sinai School of Medicine, the Karolinska Institutet, Karolinska University Hospital, the Swedish Research Council, an ALF grant from Swedish County Council, the Soderstrom Konigska Foundation, the Netherlands Scientific Organization (NWO 645-000-003), the Wellcome Trust, Genes to Cognition Program, The Medical Research Council and European Union projects GENCODYS no. 241995, EUROSPIN no. 242498 and SYNSYS no. 242167 (E. F., M.O.C., N.H.K., J.S.C., S.G.N.G.). Work at the Icahn School of Medicine at Mount Sinai was also supported by the Institute for Genomics and Multiscale Biology (including computational resources and staff expertise provided by the Department of Scientific Computing). The funders had no role in study design, execution, analysis or manuscript preparation.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745; Crowley JJ, 2013, MOL PSYCHIATR, V18, P138, DOI 10.1038/mp.2012.28; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Timms A. E., 2013, JAMA PSYCHIAT, V3, P1; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112	49	961	970	2	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					185	+		10.1038/nature12975	http://dx.doi.org/10.1038/nature12975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24463508	Green Accepted, Green Submitted			2022-12-28	WOS:000331107700030
J	Malone, R; McDaniel, P; Smith, E				Malone, Ruth; McDaniel, Patricia; Smith, Elizabeth			TOBACCO CONTROL It is time to plan the tobacco endgame	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SALE; BAN		[Malone, Ruth; McDaniel, Patricia; Smith, Elizabeth] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Malone, R (corresponding author), Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.	ruth.malone@ucsf.edu		Smith, Elizabeth/0000-0002-4712-513X				Connolly Gregory N, 2012, Am J Public Health, V102, pe1, DOI 10.2105/AJPH.2011.300583; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Hayes L, 2014, TOB CONTROL, V23, P183, DOI 10.1136/tobaccocontrol-2012-050777; Malone RE, 2010, TOB CONTROL, V19, P349, DOI 10.1136/tc.2010.039727; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Proctor RN, 2013, TOB CONTROL, V22, P27, DOI 10.1136/tobaccocontrol-2012-050811; Proctor RN, 2012, TOB CONTROL, V21, P87, DOI 10.1136/tobaccocontrol-2011-050338; Shahab L, 2010, TOB CONTROL, V19, P143, DOI 10.1136/tc.2009.033415; Smith EA, 2013, TOB CONTROL, V22, P1, DOI 10.1136/tobaccocontrol-2013-051066; Wang MP, 2015, TOB CONTROL, V24, P162, DOI 10.1136/tobaccocontrol-2013-051092; Warner KE, 2013, TOB CONTROL, V22, P3, DOI 10.1136/tobaccocontrol-2013-050989	11	10	10	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2014	348								g1453	10.1136/bmj.g1453	http://dx.doi.org/10.1136/bmj.g1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WS	24519766				2022-12-28	WOS:000331444300014
J	Win, TS; Henderson, J				Win, Thet Su; Henderson, James			Management of traumatic amputations of the upper limb	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIGITAL REPLANTATION; UPPER EXTREMITY; HAND; OUTCOMES; REVASCULARIZATION; EPIDEMIOLOGY; SELECTION; RECOVERY; CHILDREN; PATIENT		[Win, Thet Su] Broomfield Hosp, St Andrews Ctr Burns & Plast Surg, Chelmsford, Essex, England; [Henderson, James] Frenchay Hosp, North Bristol NHS Trust, Bristol BS16 1LE, Avon, England	Mid Essex Hospital Services NHS Trust; Broomfield Hospital; North Bristol NHS Trust	Henderson, J (corresponding author), Frenchay Hosp, North Bristol NHS Trust, Bristol BS16 1LE, Avon, England.	jh@jameshenderson.net						Andersson GBJ., 2001, GUIDES EVALUATION PE, VFifth ed.; Atkins SE, 2008, CURR ORTHOPAED, V22, P31, DOI 10.1016/j.cuor.2008.02.001; Atroshi I, 2001, HAND CLIN, V17, P343; Barmparas G, 2010, AM SURGEON, V76, P1214; Battiston B, 2007, J PLAST RECONSTR AES, V60, P849, DOI 10.1016/j.bjps.2007.02.017; BAUDET J, 1991, BLOOD COAGUL FIBRIN, V2, P193, DOI 10.1097/00001721-199102000-00030; CHEN ZW, 1981, ORTHOP CLIN N AM, V12, P849; Cheng GL, 1998, J HAND SURG-AM, V23A, P635, DOI 10.1016/S0363-5023(98)80049-X; Chung K.C., 2002, J HAND SURG, V2, P78, DOI [10.1053/jssh.2002.33319, DOI 10.1053/JSSH.2002.33319]; Dec Wojciech, 2006, Tech Hand Up Extrem Surg, V10, P124; Gelberman R H, 1978, J Hand Surg Am, V3, P313; GLICKMAN LT, 1990, MICROSURG, V11, P236, DOI 10.1002/micr.1920110311; GOLD AH, 1981, J TRAUMA, V21, P551, DOI 10.1097/00005373-198107000-00009; GOLDNER RD, 1987, J HAND SURG-AM, V12A, P961, DOI 10.1016/S0363-5023(87)80265-4; Graham B, 1998, J HAND SURG-AM, V23A, P783, DOI 10.1016/S0363-5023(98)80151-2; Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505; KLEINERT HE, 1977, ORTHOP CLIN N AM, V8, P309; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Lloyd MS, 2005, EMERG MED J, V22, P478, DOI 10.1136/emj.2003.008797; Lundborg G, 2001, LANCET, V358, P809, DOI 10.1016/S0140-6736(01)06001-9; Medling BD, 2007, CLIN PLAST SURG, V34, P177, DOI 10.1016/j.cps.2006.11.003; MORRISON WA, 1977, ORTHOP CLIN N AM, V8, P295; Ninkovic M, 2011, HAND CLIN, V27, P455, DOI 10.1016/j.hcl.2011.08.005; O'Brien B M, 1974, Clin Plast Surg, V1, P405; Ostlie K, 2011, DISABIL REHABIL, V33, P1636, DOI 10.3109/09638288.2010.541973; SAPEGA AA, 1988, J BONE JOINT SURG AM, V70A, P1500, DOI 10.2106/00004623-198870100-00010; SCOTT FA, 1981, J TRAUMA, V21, P204, DOI 10.1097/00005373-198103000-00003; Sebastin SJ, 2011, PLAST RECONSTR SURG, V128, P723, DOI 10.1097/PRS.0b013e318221dc83; Sorensen K, 2009, TRAUMA, V11, P209, DOI 10.1177/1460408609349889; SOUCACOS PN, 1994, MICROSURG, V15, P469, DOI 10.1002/micr.1920150707; Swearingen B, 2008, TRANSPLANTATION, V86, P627, DOI 10.1097/TP.0b013e318184ca6a; TARAS JS, 1991, MICROSURG, V12, P216, DOI 10.1002/micr.1920120311; TARK KC, 1989, J HAND SURG-AM, V14A, P17, DOI 10.1016/0363-5023(89)90054-3; URBANIAK JR, 1985, J BONE JOINT SURG AM, V67A, P611, DOI 10.2106/00004623-198567040-00017; WARD WA, 1991, CLIN ORTHOP RELAT R, P90; WEI FC, 1988, PLAST RECONSTR SURG, V82, P346, DOI 10.1097/00006534-198808000-00026; Wilhelmi BJ, 2003, HAND CLIN, V19, P89, DOI 10.1016/S0749-0712(02)00137-3	37	12	12	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2014	348								g255	10.1136/bmj.g255	http://dx.doi.org/10.1136/bmj.g255			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WO	24516069				2022-12-28	WOS:000331443900009
J	Zender, L				Zender, Lars			CANCER Interference identifies immune modulators	NATURE			English	Editorial Material							SCREEN		[Zender, Lars] Univ Tubingen, D-72076 Tubingen, Germany; [Zender, Lars] German Canc Res Ctr, German Ctr Translat Canc Res, Heidelberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Zender, L (corresponding author), Univ Tubingen, D-72076 Tubingen, Germany.	lars.zender@med.uni-tuebingen.de						Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Guo LY, 2013, P NATL ACAD SCI USA, V110, pE1849, DOI 10.1073/pnas.1305070110; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	10	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					39	40		10.1038/nature13050	http://dx.doi.org/10.1038/nature13050			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24476819				2022-12-28	WOS:000330648100023
J	Zweifel, DF; Pietramaggiori, G; Broome, M				Zweifel, Daniel F.; Pietramaggiori, Giorgio; Broome, Martin			Repositioning Dislocated Temporomandibular Joints	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zweifel, Daniel F.; Pietramaggiori, Giorgio; Broome, Martin] Univ Lausanne Hosp, Dept Maxillofacial Surg, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Zweifel, DF (corresponding author), Univ Lausanne Hosp, Dept Maxillofacial Surg, Lausanne, Switzerland.		Zweifel, Daniel/AAQ-6409-2020						0	1	1	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6							e9	10.1056/NEJMvcm1301200	http://dx.doi.org/10.1056/NEJMvcm1301200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4NT	24499237	Green Published			2022-12-28	WOS:000331073500001
J	Cohen, SP; Mao, JR				Cohen, Steven P.; Mao, Jianren			Neuropathic pain: mechanisms and their clinical implications	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; SPINAL GLUTAMATE TRANSPORTERS; PERIPHERAL-NERVE INJURY; QUALITY-OF-LIFE; GENERAL-POPULATION; NMDA RECEPTOR; PROINFLAMMATORY CYTOKINES; PHARMACOLOGICAL-TREATMENT; GABAERGIC INHIBITION	Neuropathic pain can develop after nerve injury, when deleterious changes occur in injured neurons and along nociceptive and descending modulatory pathways in the central nervous system. The myriad neurotransmitters and other substances involved in the development and maintenance of neuropathic pain also play a part in other neurobiological disorders. This might partly explain the high comorbidity rates for chronic pain, sleep disorders, and psychological conditions such as depression, and why drugs that are effective for one condition may benefit others. Neuropathic pain can be distinguished from non-neuropathic pain by two factors. Firstly, in neuropathic pain there is no transduction (conversion of a nociceptive stimulus into an electrical impulse). Secondly, the prognosis is worse: injury to major nerves is more likely than injury to non-nervous tissue to result in chronic pain. In addition, neuropathic pain tends to be more refractory than non-neuropathic pain to conventional analgesics, such as nonsteroidal anti-inflammatory drugs and opioids. However, because of the considerable overlap between neuropathic and nociceptive pain in terms of mechanisms and treatment modalities, it might be more constructive to view these entities as different points on the same continuum. This review focuses on the mechanisms of neuropathic pain, with special emphasis on clinical implications.	[Cohen, Steven P.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21029 USA; [Cohen, Steven P.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21029 USA; [Cohen, Steven P.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Mao, Jianren] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; Harvard University; Harvard Medical School; Massachusetts General Hospital	Cohen, SP (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21029 USA.	scohen40@jhmi.edu			Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences, Bethesda, MD, USA	Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences, Bethesda, MD, USA	Funded in part by the Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Bannister K, 2009, NEUROTHERAPEUTICS, V6, P703, DOI 10.1016/j.nurt.2009.07.009; Barkhudaryan N, 1999, NEUROCHEM RES, V24, P1169, DOI 10.1023/A:1020720722209; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Benedetti F, 1998, PAIN, V74, P205, DOI 10.1016/S0304-3959(97)00172-3; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.x; Clarke H, 2012, ANESTH ANALG, V115, P428, DOI 10.1213/ANE.0b013e318249d36e; COHEN KL, 1987, ARCH INTERN MED, V147, P1442, DOI 10.1001/archinte.147.8.1442; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Cohen SP, 2011, ADV PSYCHOSOM MED, V30, P139, DOI 10.1159/000324071; Cohen SP, 2009, ANESTHESIOLOGY, V111, P416, DOI 10.1097/ALN.0b013e3181ac1c47; DEVOR M, 1989, NEUROSCI LETT, V102, P149, DOI 10.1016/0304-3940(89)90070-0; DEVOR M, 1991, BRIT MED BULL, V47, P619, DOI 10.1093/oxfordjournals.bmb.a072496; Dieleman JP, 2008, PAIN, V137, P681, DOI 10.1016/j.pain.2008.03.002; DOUGHERTY PM, 1992, J NEUROSCI, V12, P883; Drew GM, 2004, PAIN, V109, P379, DOI 10.1016/j.pain.2004.02.007; Dubner Ronald, 2004, Suppl Clin Neurophysiol, V57, P3; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Field MJ, 1999, PAIN, V80, P391, DOI 10.1016/S0304-3959(98)00239-5; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; Goodsaid F, 2012, EXPERT OPIN DRUG DIS, V7, P457, DOI 10.1517/17460441.2012.679615; Guo W, 2002, J NEUROSCI, V22, P6208; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Jaggi AS, 2011, BRAIN RES, V1381, P187, DOI 10.1016/j.brainres.2011.01.002; Janssen SP, 2011, NEUROSCIENCE, V184, P183, DOI 10.1016/j.neuroscience.2011.03.060; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Koks S, 2008, BEHAV BRAIN RES, V188, P62, DOI 10.1016/j.bbr.2007.10.020; Korhonen T, 2006, SPINE, V31, P2759, DOI 10.1097/01.brs.0000245873.23876.1e; Landry RP, 2012, EXP NEUROL, V234, P340, DOI 10.1016/j.expneurol.2011.11.006; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lariviere WR, 2010, METHODS MOL BIOL, V617, P261, DOI 10.1007/978-1-60327-323-7_20; Leadley R M, 2012, J Pain Palliat Care Pharmacother, V26, P310, DOI 10.3109/15360288.2012.736933; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Levinson SR, 2012, MUSCLE NERVE, V46, P155, DOI 10.1002/mus.23314; Liu Y, 2012, MINERVA ANESTESIOL, V78, P653; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Lu G, 1997, NEUROCHEM INT, V30, P401, DOI 10.1016/S0197-0186(96)00075-7; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MAO J, 1992, BRAIN RES, V598, P271, DOI 10.1016/0006-8993(92)90193-D; Mao JR, 2002, J NEUROSCI, V22, P8312; McCleane G, 2008, CNS DRUGS, V22, P139, DOI 10.2165/00023210-200822020-00005; Mika J, 2010, NEUROSCIENCE, V165, P1420, DOI 10.1016/j.neuroscience.2009.11.064; Mika J, 2013, EUR J PHARM; Miller KE, 2011, PHARMACOL THERAPEUT, V130, P283, DOI 10.1016/j.pharmthera.2011.01.005; Miraucourt LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001116; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Nickel FT, 2012, EUR NEUROPSYCHOPHARM, V22, P81, DOI 10.1016/j.euroneuro.2011.05.005; Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Quintao NLM, 2006, NEUROPHARMACOLOGY, V50, P614, DOI 10.1016/j.neuropharm.2005.11.007; Quintero Gabriel C, 2011, J Pain Res, V4, P301, DOI 10.2147/JPR.S24703; Rasmussen PV, 2004, PAIN, V110, P461, DOI 10.1016/j.pain.2004.04.034; Rouwette T, 2012, EUR J PAIN, V16, P782, DOI 10.1002/j.1532-2149.2011.00071.x; Schuning J, 2009, CLIN J PAIN, V25, P683, DOI 10.1097/AJP.0b013e3181a1260e; Schulman E A, 2001, Curr Pain Headache Rep, V5, P454, DOI 10.1007/s11916-001-0057-3; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Shipton EA, 2011, ANAESTH INTENS CARE, V39, P824, DOI 10.1177/0310057X1103900506; Siu A, 2007, CNS DRUG REV, V13, P96, DOI 10.1111/j.1527-3458.2007.00006.x; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Song C, 2003, EUR J NEUROSCI, V18, P1739, DOI 10.1046/j.1460-9568.2003.02886.x; Sorkin LS, 2000, J PERIPHER NERV SYST, V5, P96, DOI 10.1046/j.1529-8027.2000.00012.x; Sung BK, 2003, J NEUROSCI, V23, P2899; Tang Y, 2009, CHINESE MED J-PEKING, V122, P2893, DOI 10.3760/cma.j.issn.0366-6999.2009.23.017; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Vo T, 2009, PAIN, V143, P169, DOI 10.1016/j.pain.2009.03.013; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; Walsh DA, 2012, CURR PAIN HEADACHE R, V16, P509, DOI 10.1007/s11916-012-0303-x; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Wehnert Y, 2002, ORTHOPADE, V31, P1076, DOI 10.1007/s00132-002-0361-6; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yoon MH, 1999, ANESTH ANALG, V89, P434, DOI 10.1097/00000539-199908000-00034; Zakrzewska JM, 2011, POSTGRAD MED J, V87, P410, DOI 10.1136/pgmj.2009.080473; Zeilhofer HU, 2012, ANNU REV PHARMACOL, V52, P111, DOI 10.1146/annurev-pharmtox-010611-134636; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746; Zhuo M, 2002, DRUG DISCOV TODAY, V7, P259, DOI 10.1016/S1359-6446(01)02138-9; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	105	277	282	11	154	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2014	348								f7656	10.1136/bmj.f7656	http://dx.doi.org/10.1136/bmj.f7656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4JK	24500412	Green Published			2022-12-28	WOS:000331061700001
J	Marrouche, NF; Wilber, D; Hindricks, G; Jais, P; Akoum, N; Marchlinski, F; Kholmovski, E; Burgon, N; Hu, N; Mont, L; Deneke, T; Duytschaever, M; Neumann, T; Mansour, M; Mahnkopf, C; Herweg, B; Daoud, E; Wissner, E; Bansmann, P; Brachmann, J				Marrouche, Nassir F.; Wilber, David; Hindricks, Gerhard; Jais, Pierre; Akoum, Nazem; Marchlinski, Francis; Kholmovski, Eugene; Burgon, Nathan; Hu, Nan; Mont, Lluis; Deneke, Thomas; Duytschaever, Mattias; Neumann, Thomas; Mansour, Moussa; Mahnkopf, Christian; Herweg, Bengt; Daoud, Emile; Wissner, Erik; Bansmann, Paul; Brachmann, Johannes			Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation The DECAAF Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS; IRREVERSIBLE INJURY; EUROPEAN-SOCIETY; PULMONARY VEIN; BLOOD-PRESSURE; TASK-FORCE; MECHANISMS; RISK; CONTRACTILE	IMPORTANCE Left atrial fibrosis is prominent in patients with atrial fibrillation (AF). Extensive atrial tissue fibrosis identified by delayed enhancement magnetic resonance imaging (MRI) has been associated with poor outcomes of AF catheter ablation. OBJECTIVE To characterize the feasibility of atrial tissue fibrosis estimation by delayed enhancement MRI and its association with subsequent AF ablation outcome. DESIGN, SETTING, AND PARTICIPANTS Multicenter, prospective, observational cohort study of patients diagnosed with paroxysmal and persistent AF (undergoing their first catheter ablation) conducted between August 2010 and August 2011 at 15 centers in the United States, Europe, and Australia. Delayed enhancement MRI images were obtained up to 30 days before ablation. MAIN OUTCOMES AND MEASURES Fibrosis quantificationwas performed at a core laboratory blinded to the participating center, ablation approach, and procedure outcome. Fibrosis blinded to the treating physicians was categorized as stage 1 (<10% of the atrial wall), 2 (>= 10%-<20%), 3 (>= 20%-<30%), and 4 (>= 30%). Patients were followed up for recurrent arrhythmia per current guidelines using electrocardiography or ambulatory monitor recording and results were analyzed at a core laboratory. Cumulative incidence of recurrence was estimated by stage at days 325 and 475 after a 90-day blanking period (standard time allowed for arrhythmias related to ablation-induced inflammation to subside) and the risk of recurrence was estimated (adjusting for 10 demographic and clinical covariates). RESULTS Atrial tissue fibrosis estimation by delayed enhancement MRI was successfully quantified in 272 of 329 enrolled patients (57 patients [17%] were excluded due to poor MRI quality). There were 260 patients who were followed up after the blanking period (mean [SD] age of 59.1 [10.7] years, 31.5% female, 64.6% with paroxysmal AF). For recurrent arrhythmia, the unadjusted overall hazard ratio per 1% increase in left atrial fibrosis was 1.06 (95% CI, 1.03-1.08; P<.001). Estimated unadjusted cumulative incidence of recurrent arrhythmia by day 325 for stage 1 fibrosis was 15.3%(95% CI, 7.6%-29.6%); stage 2, 32.6%(95% CI, 24.3%-42.9%); stage 3, 45.9%(95% CI, 35.5%-57.5%); and stage 4, 51.1% (95% CI, 32.8%-72.2%) and by day 475 was 15.3%(95% CI, 7.6%-29.6%), 35.8% (95% CI, 26.2%-47.6%), 45.9%(95% CI, 35.6%-57.5%), and 69.4%(95% CI, 48.6%-87.7%), respectively. Similar results were obtained after covariate adjustment. The addition of fibrosis to a recurrence prediction model that includes traditional clinical covariates resulted in an improved predictive accuracy with the C statistic increasing from 0.65 to 0.69 (risk difference of 0.05; 95% CI, 0.01-0.09). CONCLUSIONS AND RELEVANCE Among patients with AF undergoing catheter ablation, atrial tissue fibrosis estimated by delayed enhancement MRI was independently associated with likelihood of recurrent arrhythmia. The clinical implications of this association warrant further investigation.	[Marrouche, Nassir F.; Akoum, Nazem; Kholmovski, Eugene; Burgon, Nathan; Hu, Nan] Univ Utah, Sch Med, Comprehens Arrhythmia & Res Management Ctr, Salt Lake City, UT 84132 USA; [Wilber, David] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Hindricks, Gerhard] Univ Leipzig, D-04109 Leipzig, Germany; [Jais, Pierre] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Marchlinski, Francis] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Mont, Lluis] Univ Barcelona, Barcelona, Spain; [Deneke, Thomas] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Bochum, Germany; [Duytschaever, Mattias] Univ Hosp Ghent, Ghent, Belgium; [Neumann, Thomas] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Mansour, Moussa] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Mahnkopf, Christian; Brachmann, Johannes] Klinikum Coburg GmbH, Med Klin, Coburg, Germany; [Herweg, Bengt] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Daoud, Emile] Ohio State Univ, Columbus, OH 43210 USA; [Wissner, Erik] Asklepios Klin St Georg, Hamburg, Germany; [Bansmann, Paul] Med Ctr Porz Rhein, Cologne, Germany	Utah System of Higher Education; University of Utah; Loyola University Chicago; Leipzig University; CHU Bordeaux; University of Pennsylvania; Pennsylvania Medicine; University of Barcelona; Ruhr University Bochum; Ghent University; Ghent University Hospital; Kerckhoff Clinic; Harvard University; Massachusetts General Hospital; Klinikum Coburg; State University System of Florida; University of South Florida; University System of Ohio; Ohio State University; Asklepios Klinik St. Georg	Marrouche, NF (corresponding author), Univ Utah, Hlth Sci Ctr, 30 N 1900 E,Room 4A100, Salt Lake City, UT 84132 USA.	nassir.marrouche@hsc.utah.edu	Akoum, Nazem/ABA-7839-2020; Mont, Lluís/AAO-9518-2021; Duytschaever, Mattias/AAE-5353-2021; Brachmann, Johannes/AAD-1499-2021; Kholmovski, Eugene/AAM-6003-2021	Mont, Lluís/0000-0002-8115-5906; 	Comprehensive Arrhythmia and Research Management Center (CARMA) Center at the University of Utah; George S. and Dolores Dore Eccles Foundation	Comprehensive Arrhythmia and Research Management Center (CARMA) Center at the University of Utah; George S. and Dolores Dore Eccles Foundation	The Comprehensive Arrhythmia and Research Management Center (CARMA) Center at the University of Utah provided funding for the study. The George S. and Dolores Dore Eccles Foundation funded part of the DECAAF study.	Akoum N, 2011, J CARDIOVASC ELECTR, V22, P16, DOI 10.1111/j.1540-8167.2010.01876.x; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Allessie MA, 1998, J CARDIOVASC ELECTR, V9, P1378, DOI 10.1111/j.1540-8167.1998.tb00114.x; Badger TJ, 2010, CIRC-ARRHYTHMIA ELEC, V3, P249, DOI 10.1161/CIRCEP.109.868356; Bertaglia E, 2013, J CARDIOVASC ELECTR, V24, P1069, DOI 10.1111/jce.12194; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x; Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; FLAKER GC, 1995, AM J CARDIOL, V76, P355, DOI 10.1016/S0002-9149(99)80100-3; Gaita F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P269, DOI 10.1161/CIRCEP.108.774885; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x; Jais P, 2009, CIRCULATION, V120, pE83, DOI 10.1161/CIRCULATIONAHA.109.192636; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Kainuma S, 2011, EUR J CARDIO-THORAC, V40, P61, DOI 10.1016/j.ejcts.2010.11.008; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kobza R, 2004, HEART RHYTHM, V1, P676, DOI 10.1016/j.hrthm.2004.08.009; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; McGann CJ, 2008, J AM COLL CARDIOL, V52, P1263, DOI 10.1016/j.jacc.2008.05.062; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Perin EC, 2002, CIRCULATION, V106, P957, DOI 10.1161/01.CIR.0000026394.01888.18; Peters DC, 2007, RADIOLOGY, V243, P690, DOI 10.1148/radiol.2433060417; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Thomas MC, 2008, AM J HYPERTENS, V21, P1111, DOI 10.1038/ajh.2008.248; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	37	787	815	4	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					498	506		10.1001/jama.2014.3	http://dx.doi.org/10.1001/jama.2014.3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24496537	Green Published, Bronze			2022-12-28	WOS:000330589800023
J	Leblanc, LJ				Leblanc, Lindsay J.			ATOMIC PHYSICS Polar exploration	NATURE			English	Editorial Material							MONOPOLES; FIELD		Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	University of Alberta	Leblanc, LJ (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada.	lindsay.leblanc@ualberta.ca	LeBlanc, Lindsay/ABA-8511-2020	LeBlanc, Lindsay/0000-0002-9156-6100				Abbasi R, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.022001; Adrian-Martinez S, 2012, ASTROPART PHYS, V35, P634, DOI 10.1016/j.astropartphys.2012.02.007; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Fetter AL, 2009, REV MOD PHYS, V81, P647, DOI 10.1103/RevModPhys.81.647; Milton KA, 2006, REP PROG PHYS, V69, P1637, DOI 10.1088/0034-4885/69/6/R02; Mottonen M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250406; Pinfold JL, 2009, RADIAT MEAS, V44, P834, DOI 10.1016/j.radmeas.2009.10.062; Ray MW, 2014, NATURE, V505, P657, DOI 10.1038/nature12954; Roncaglia M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00043	11	0	0	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					627	628		10.1038/505627a	http://dx.doi.org/10.1038/505627a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476885				2022-12-28	WOS:000330321000029
J	Obokata, H; Sasai, Y; Niwa, H; Kadota, M; Andrabi, M; Takata, N; Tokoro, M; Terashita, Y; Yonemura, S; Vacanti, CA; Wakayama, T				Obokata, Haruko; Sasai, Yoshiki; Niwa, Hitoshi; Kadota, Mitsutaka; Andrabi, Munazah; Takata, Nozomu; Tokoro, Mikiko; Terashita, Yukari; Yonemura, Shigenobu; Vacanti, Charles A.; Wakayama, Teruhiko			RETRACTED: Bidirectional developmental potential in reprogrammed cells with acquired pluripotency (Retracted article. See vol. 511, pg. 112, 2014)	NATURE			English	Article; Retracted Publication							EMBRYONIC STEM-CELLS; GROUND-STATE; SELF-RENEWAL; EXPRESSION; GENES; MICE	We recently discovered an unexpected phenomenon of somatic cell reprogramming into pluripotent cells by exposure to sublethal stimuli, which we call stimulus-triggered acquisition of pluripotency (STAP)(1). This reprogramming does not require nuclear transfer(2,3) or genetic manipulation(4). Here we report that reprogrammed STAP cells, unlike embryonic stem (ES) cells, can contribute to both embryonic and placental tissues, as seen in a blastocyst injection assay. Mouse STAP cells lose the ability to contribute to the placenta as well as trophoblast marker expression on converting into ES-like stem cells by treatment with adrenocorticotropic hormone (ACTH) and leukaemia inhibitory factor (LIF). In contrast, when cultured with Fgf4, STAP cells give rise to proliferative stem cells with enhanced trophoblastic characteristics. Notably, unlike conventional trophoblast stem cells, the Fgf4-induced stem cells from STAP cells contribute to both embryonic and placental tissues in vivo and transform into ES-like cells when cultured with LIF-containing medium. Taken together, the developmental potential of STAP cells, shown by chimaera formation and in vitro cell conversion, indicates that they represent a unique state of pluripotency.	[Obokata, Haruko; Terashita, Yukari] RIKEN Ctr Dev Biol, Lab Cellular Reprogramming, Kobe, Hyogo 6500047, Japan; [Obokata, Haruko; Tokoro, Mikiko; Terashita, Yukari; Wakayama, Teruhiko] RIKEN Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo 6500047, Japan; [Obokata, Haruko; Vacanti, Charles A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Tissue Engn & Regenerat Med, Boston, MA 02115 USA; [Sasai, Yoshiki; Takata, Nozomu] RIKEN Ctr Dev Biol, Lab Organogenesis & Neurogenesis, Kobe, Hyogo 6500047, Japan; [Niwa, Hitoshi] RIKEN Ctr Dev Biol, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo 6500047, Japan; [Kadota, Mitsutaka; Andrabi, Munazah] RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo 6500047, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscopy Lab, Kobe, Hyogo 6500047, Japan; [Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi 4008510, Japan	RIKEN; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard Medical School; RIKEN; RIKEN; RIKEN; RIKEN; University of Yamanashi	Obokata, H (corresponding author), RIKEN Ctr Dev Biol, Lab Cellular Reprogramming, Kobe, Hyogo 6500047, Japan.	obokata@cdb.riken.jp; yoshikisasai@cdb.riken.jp; teru@cdb.riken.jp			RIKEN; Network Project for Realization of Regenerative Medicine; Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital;  [20062015]	RIKEN; Network Project for Realization of Regenerative Medicine; Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital; 	We thank S. Nishikawa and N. Love for discussion and M. Ohgushi, S. Kuraku, M. Eiraku, S. Ohtsuka and K. Kakiguchi for help with experimental planning, material preparation and analyses. Financial support for this research was provided by Intramural RIKEN Research Budget (H.O., T.W. and Y.S.), a Scientific Research in Priority Areas (20062015) to T.W., the Network Project for Realization of Regenerative Medicine to Y.S., and Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital to C.A.V.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968; Quinn J, 2006, METH MOLEC MED, V121, P125; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	23	82	97	3	401	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					676	+		10.1038/nature12969	http://dx.doi.org/10.1038/nature12969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24476891				2022-12-28	WOS:000330321000040
J	Ozkan, E; Chia, PH; Wang, RR; Goriatcheva, N; Borek, D; Otwinowski, Z; Walz, T; Shen, K; Garcia, KC				Oezkan, Engin; Chia, Poh Hui; Wang, Ruiqi Rachel; Goriatcheva, Natalia; Borek, Dominika; Otwinowski, Zbyszek; Walz, Thomas; Shen, Kang; Garcia, K. Christopher			Extracellular Architecture of the SYG-1/SYG-2 Adhesion Complex Instructs Synaptogenesis	CELL			English	Article							CHIASM-C-ROUGHEST; IMMUNOGLOBULIN SUPERFAMILY; AXONAL PROJECTIONS; CELL-ADHESION; NEPHRIN; PROTEIN; RECEPTOR; DROSOPHILA; ACTIN; SPECIFICITY	SYG-1 and SYG-2 are multipurpose cell adhesion molecules (CAMs) that have evolved across all major animal taxa to participate in diverse physiological functions, ranging from synapse formation to formation of the kidney filtration barrier. In the crystal structures of several SYG-1 and SYG-2 orthologs and their complexes, we find that SYG-1 orthologs homodimerize through a common, bispecific interface that similarly mediates an unusual orthogonal docking geometry in the heterophilic SYG-1/SYG-2 complex. C. elegans SYG-1's specification of proper synapse formation in vivo closely correlates with the heterophilic complex affinity, which appears to be tuned for optimal function. Furthermore, replacement of the interacting domains of SYG-1 and SYG-2 with those from CAM complexes that assume alternative docking geometries or the introduction of segmental flexibility compromised synaptic function. These results suggest that SYG extracellular complexes do not simply act as "molecular velcro'' and that their distinct structural features are important in instructing synaptogenesis.	[Oezkan, Engin; Goriatcheva, Natalia; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Goriatcheva, Natalia; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Oezkan, Engin; Goriatcheva, Natalia; Shen, Kang; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Chia, Poh Hui; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wang, Ruiqi Rachel; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Borek, Dominika; Otwinowski, Zbyszek] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Borek, Dominika; Otwinowski, Zbyszek] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Otwinowski, Zbyszek/0000-0003-3640-8545; Walz, Thomas/0000-0003-2606-2835; Wang, Ruiqi Rachel/0000-0002-5099-8177; Ozkan, Engin/0000-0002-0263-6729	 [5 R01 NS048392];  [5 R01 GM053163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Suzanne Fischer, Sec, ilcan Uyaniker, and Lauren Ely for helpful discussions, Georgios Skiniotis for preliminary EM imaging, Aaron Ring and Chia-Chi Ho for providing the amino acid sequence of Sirpa-FD6, and Demet Arac,, Michael E. Birnbaum, and Fernando Bazan for critical reading of the manuscript. This work is supported in part by 5 R01 NS048392 (K. S.) and by 5 R01 GM053163 (Z.O.). K. C. G., K. S., and T. W. are investigators of the Howard Hughes Medical Institute.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Mizuhara E, 2010, DEV BIOL, V338, P202, DOI 10.1016/j.ydbio.2009.11.032; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reddy GV, 1999, DEV GENES EVOL, V209, P581, DOI 10.1007/s004270050292; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; Volker LA, 2012, HISTOCHEM CELL BIOL, V137, P355, DOI 10.1007/s00418-011-0903-2; Wanner N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023598; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; WOLFF T, 1991, DEVELOPMENT, V113, P825; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	49	49	52	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					482	494		10.1016/j.cell.2014.01.004	http://dx.doi.org/10.1016/j.cell.2014.01.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485456	Green Accepted, Bronze			2022-12-28	WOS:000330580800015
J	Pallasch, CP; Leskov, I; Braun, CJ; Vorholt, D; Drake, A; Soto-Feliciano, YM; Bent, EH; Schwamb, J; Iliopoulou, B; Kutsch, N; van Rooijen, N; Frenzel, LP; Wendtner, CM; Heukamp, L; Kreuzer, KA; Hallek, M; Chen, JZ; Hemann, MT				Pallasch, Christian P.; Leskov, Ilya; Braun, Christian J.; Vorholt, Daniela; Drake, Adam; Soto-Feliciano, Yadira M.; Bent, Eric H.; Schwamb, Janine; Iliopoulou, Bettina; Kutsch, Nadine; van Rooijen, Nico; Frenzel, Lukas P.; Wendtner, Clemens M.; Heukamp, Lukas; Kreuzer, Karl Anton; Hallek, Michael; Chen, Jianzhu; Hemann, Michael T.			Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy	CELL			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; INITIAL THERAPY; RITUXIMAB; LYMPHOMA; CYCLOPHOSPHAMIDE; FLUDARABINE; CANCER; CELLS; CHEMOTHERAPY; MACROPHAGES	Therapy-resistant microenvironments represent a major barrier toward effective elimination of disseminated malignancies. Here, we show that select microenvironments can underlie resistance to antibody- based therapy. Using a humanized model of treatment refractory B cell leukemia, we find that infiltration of leukemia cells into the bone marrow rewires the tumor microenvironment to inhibit engulfment of antibody-targeted tumor cells. Resistance to macrophage-mediated killing can be overcome by combination regimens involving therapeutic antibodies and chemotherapy. Specifically, the nitrogen mustard cyclophosphamide induces an acute secretory activating phenotype (ASAP), releasing CCL4, IL8, VEGF, and TNFa from treated tumor cells. These factors induce macrophage infiltration and phagocytic activity in the bone marrow. Thus, the acute induction of stress-related cytokines can effectively target cancer cells for removal by the innate immune system. This synergistic chemoimmunotherapeutic regimen represents a potent strategy for using conventional anticancer agents to alter the tumor microenvironment and promote the efficacy of targeted therapeutics.	[Pallasch, Christian P.; Leskov, Ilya; Braun, Christian J.; Drake, Adam; Soto-Feliciano, Yadira M.; Bent, Eric H.; Iliopoulou, Bettina; Chen, Jianzhu; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pallasch, Christian P.; Leskov, Ilya; Braun, Christian J.; Drake, Adam; Soto-Feliciano, Yadira M.; Bent, Eric H.; Iliopoulou, Bettina; Chen, Jianzhu; Hemann, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pallasch, Christian P.; Vorholt, Daniela; Schwamb, Janine; Kutsch, Nadine; Frenzel, Lukas P.; Wendtner, Clemens M.; Kreuzer, Karl Anton; Hallek, Michael] Univ Cologne, Ctr Integrated Oncol, Dept Internal Med, D-50931 Cologne, Germany; [van Rooijen, Nico] VFM Amsterdam 1081, Amsterdam, Netherlands; [Heukamp, Lukas] Univ Hosp Cologne, Dept Pathol, D-50937 Cologne, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Cologne; University of Cologne	Chen, JZ (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	jchen@mit.edu; hemann@mit.edu	Van Rooijen, Nico/Z-1578-2019; Hallek, Michael/Y-3191-2019; Pallasch, Christian Philipp/T-3088-2018; Braun, Christian J/N-3755-2018; Heukamp, Lukas/G-9967-2012	Hallek, Michael/0000-0002-7425-4455; Braun, Christian J/0000-0003-1704-6219; Pallasch, Christian P./0000-0001-5675-6905; Heukamp, Lukas/0000-0002-3388-3482; Wendtner, Clemens-Martin/0000-0003-2866-2260	MIT Ludwig Center for Molecular Oncology; Marble Family Foundation; National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Interdisciplinary Research Group in Infectious Disease research program; German Research Foundation (DFG) [KFO286, CRC832]; German Research foundation; Koch Institute Support from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051, R01CA128803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	MIT Ludwig Center for Molecular Oncology; Marble Family Foundation; National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Interdisciplinary Research Group in Infectious Disease research program; German Research Foundation (DFG)(German Research Foundation (DFG)); German Research foundation(German Research Foundation (DFG)); Koch Institute Support from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Holly Criscione for expert technical assistance and Ryan Hayman for operational support. We also thank P. Bak, H. Eisen, and the entire Hemann lab for helpful discussions; the Swanson Biotechnology Center for excellent technical support; and J. Pritchard and L. Gilbert for critical reading of this manuscript. This work was partly supported by grants from the MIT Ludwig Center for Molecular Oncology (to M. T. H.), the Marble Family Foundation (to J. C. and M. T. H.), the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Interdisciplinary Research Group in Infectious Disease research program (to J. C.), and the German Research Foundation (DFG) as part of the KFO286 (to C. P. P., K. A. K., and M. H) and CRC832 (to L. H. and M. H). C. P. P. was supported by a research fellowship of the German Research foundation. This work was also supported in part by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute.	Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; FAN Z, 1993, CANCER RES, V53, P4637; Gokbuget N, 2004, Ann Hematol, V83 Suppl 1, pS129; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Meyer LH, 2011, CANCER CELL, V19, P206, DOI 10.1016/j.ccr.2010.11.014; Minard-Colin V, 2008, BLOOD, V112, P1205, DOI 10.1182/blood-2008-01-135160; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Moreton P, 2003, SEMIN ONCOL, V30, P493, DOI 10.1016/S0093-7754(03)00253-7; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Wendtner CM, 2004, LEUKEMIA, V18, P1093, DOI 10.1038/sj.leu.2403354; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621	31	129	137	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					590	602		10.1016/j.cell.2013.12.041	http://dx.doi.org/10.1016/j.cell.2013.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485462	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000330580800023
J	Kamphuis, EI; Bhattacharya, S; van der Veen, F; Mol, BWJ; Templeton, A				Kamphuis, Esme I.; Bhattacharya, S.; van der Veen, F.; Mol, B. W. J.; Templeton, A.		Evidence Based IVF Grp	Are we overusing IVF?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGIES; ONGOING PREGNANCY RATE; EMBRYO-TRANSFER; UNEXPLAINED SUBFERTILITY; SINGLETON PREGNANCIES; EXPECTANT MANAGEMENT; PERINATAL OUTCOMES; INCREASED RISK; CHILDREN BORN		[Kamphuis, Esme I.; van der Veen, F.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Bhattacharya, S.; Templeton, A.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB9 1FX, Scotland; [Mol, B. W. J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia	University of Amsterdam; Academic Medical Center Amsterdam; University of Aberdeen; Robinson Research Institute; University of Adelaide	Mol, BWJ (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia.	ben.mol@adelaide.edu.au	Sills, E Scott/AAQ-8463-2020	Sills, E Scott/0000-0001-7334-1031; Bhattacharya, Siladitya/0000-0002-4588-356X				Barnhart KT, 2013, FERTIL STERIL, V99, P299, DOI 10.1016/j.fertnstert.2012.12.032; Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Bhattacharya S, 2008, BMJ-BRIT MED J, V337, pa716; Brandes M, 2011, HUM REPROD, V26, P360, DOI 10.1093/humrep/deq349; Brandes M, 2010, HUM REPROD, V25, P118, DOI 10.1093/humrep/dep341; Brigham KB, 2013, HUM REPROD, V28, P666, DOI 10.1093/humrep/des418; Ceelen M, 2008, FERTIL STERIL, V90, P1662, DOI 10.1016/j.fertnstert.2007.09.005; Dar S, 2013, HUM REPROD, V28, P924, DOI 10.1093/humrep/des448; European Society of Human Reproduction and Embryology, ART ASS REPR TECHN F; Farquhar CM, 2011, HUM REPROD, V26, P3037, DOI 10.1093/humrep/der279; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870; Grace KS, 2009, SEMIN REPROD MED, V27, P409, DOI 10.1055/s-0029-1237429; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hughes EG, 2004, HUM REPROD, V19, P1105, DOI 10.1093/humrep/deh209; Human Fertilisation and Embryology Authority, HIST UK FERT TREATM; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kallen B, 2010, FERTIL STERIL, V94, P1680, DOI 10.1016/j.fertnstert.2009.12.027; Kalra SK, 2012, OBSTET GYNECOL, V120, P69, DOI 10.1097/AOG.0b013e31825b88fc; Kawwass JF, 2013, OBSTET GYNECOL, V121, P1263, DOI 10.1097/AOG.0b013e31829006d9; Mol BWJ, 2000, FERTIL STERIL, V73, P748, DOI 10.1016/S0015-0282(99)00610-X; NICE, 2013, ASS TREATM PEOPL FER; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pandian Z, 2012, COCHRANE DB SYST REV, V4; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Reindollar RH, 2010, FERTIL STERIL, V94, P888, DOI 10.1016/j.fertnstert.2009.04.022; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; STEPTOE PC, 1986, HUM REPROD, V1, P89, DOI 10.1093/oxfordjournals.humrep.a136366; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; Templeton A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7083; Troude P, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.058; van Dongen AJCM, 2010, FERTIL STERIL, V94, P1713, DOI 10.1016/j.fertnstert.2009.08.066; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141	36	94	97	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2014	348								g252	10.1136/bmj.g252	http://dx.doi.org/10.1136/bmj.g252			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AV	24472708	Green Submitted, Green Accepted			2022-12-28	WOS:000330647600010
J	Hu, JH; Srivastava, K; Wieland, M; Runge, A; Mogler, C; Besemfelder, E; Terhardt, D; Vogel, MJ; Cao, LJ; Korn, C; Bartels, S; Thomas, M; Augustin, HG				Hu, Junhao; Srivastava, Kshitij; Wieland, Matthias; Runge, Anja; Mogler, Carolin; Besemfelder, Eva; Terhardt, Dorothee; Vogel, Marion J.; Cao, Liji; Korn, Claudia; Bartels, Susanne; Thomas, Markus; Augustin, Hellmut G.			Endothelial Cell-Derived Angiopoietin-2 Controls Liver Regeneration as a Spatiotemporal Rheostat	SCIENCE			English	Article							GROWTH-FACTOR; HEPATOCYTE PROLIFERATION; ANGIOCRINE SIGNALS; EXPRESSION; INDUCTION; ANGIOGENESIS	Liver regeneration requires spatially and temporally precisely coordinated proliferation of the two major hepatic cell populations, hepatocytes and liver sinusoidal endothelial cells (LSECs), to reconstitute liver structure and function. The underlying mechanisms of this complex molecular cross-talk remain elusive. Here, we show that the expression of Angiopoietin-2 (Ang2) in LSECs is dynamically regulated after partial hepatectomy. During the early inductive phase of liver regeneration, Ang2 down-regulation leads to reduced LSEC transforming growth factor-beta 1 production, enabling hepatocyte proliferation by releasing an angiocrine proliferative brake. During the later angiogenic phase of liver regeneration, recovery of endothelial Ang2 expression enables regenerative angiogenesis by controlling LSEC vascular endothelial growth factor receptor 2 expression. The data establish LSECs as a dynamic rheostat of liver regeneration, spatiotemporally orchestrating hepatocyte and LSEC proliferation through angiocrine- and autocrine-acting Ang2, respectively.	[Hu, Junhao; Srivastava, Kshitij; Wieland, Matthias; Runge, Anja; Mogler, Carolin; Besemfelder, Eva; Terhardt, Dorothee; Vogel, Marion J.; Korn, Claudia; Bartels, Susanne; Thomas, Markus; Augustin, Hellmut G.] DKFZ Ctr Mol Biol Alliance, German Canc Res Ctr DKFZ, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany; [Srivastava, Kshitij; Wieland, Matthias; Runge, Anja; Thomas, Markus; Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis CBTM, D-69120 Heidelberg, Germany; [Mogler, Carolin] Heidelberg Univ, Med Fac Heidelberg, Dept Pathol, D-69120 Heidelberg, Germany; [Cao, Liji] German Canc Res Ctr, Div Med Phys Radiol, D-69120 Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Consortium, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Augustin, HG (corresponding author), DKFZ Ctr Mol Biol Alliance, German Canc Res Ctr DKFZ, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242; Cao, Liji/0000-0002-9010-9522	Deutsche Forschungsgemeinschaft [SFB-TR23, SFB-TR77, SFB873]; DKFZ-MOST Cancer Research Cooperation; EU; endowed chair from the Aventis Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DKFZ-MOST Cancer Research Cooperation; EU(European Commission); endowed chair from the Aventis Foundation	We thank G. Thurston (Regeneron, Tarrytown, NY) for providing Ang2-deficient mice and critical discussions. We also thank A. Budnik and S. Savant (DKFZ Heidelberg, Germany) for important discussions and comments on the manuscript. We gratefully acknowledge the excellent technical support of F. Bestvater and M. Brom of the Microscopy Facility, M. Bewerunge-Hudler of the Microarray Unit, and the DKFZ laboratory animal core facility. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB-TR23 "Vascular Differentiation," SFB-TR77 "HCC," and SFB873 "Stem Cell Biology"), the DKFZ-MOST Cancer Research Cooperation, and the EU FP7 "SYSTEMAGE" (all to H. G. A.). H. G. A. is supported by an endowed chair from the Aventis Foundation. Microarray data were deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE50046).	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; CHARI RS, 1995, AM J SURG, V169, P126, DOI 10.1016/S0002-9610(99)80120-2; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; JAKOWLEW SB, 1991, CELL REGUL, V2, P535, DOI 10.1091/mbc.2.7.535; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun R, 2005, BIOCHEM BIOPH RES CO, V338, P1943, DOI 10.1016/j.bbrc.2005.10.171; Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509	25	198	206	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					416	419		10.1126/science.1244880	http://dx.doi.org/10.1126/science.1244880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458641	Green Published			2022-12-28	WOS:000330039300048
J	Thoen, HH; How, MJ; Chiou, TH; Marshall, J				Thoen, Hanne H.; How, Martin J.; Chiou, Tsyr-Huei; Marshall, Justin			A Different Form of Color Vision in Mantis Shrimp	SCIENCE			English	Article							POLARIZATION VISION; STOMATOPOD; EYE; CRUSTACEA; SYSTEM	One of the most complex eyes in the animal kingdom can be found in species of stomatopod crustaceans (mantis shrimp), some of which have 12 different photoreceptor types, each sampling a narrow set of wavelengths ranging from deep ultraviolet to far red (300 to 720 nanometers) (1-3). Functionally, this chromatic complexity has presented a mystery (3-5). Why use 12 color channels when three or four are sufficient for fine color discrimination? Behavioral wavelength discrimination tests (Delta lambda functions) in stomatopods revealed a surprisingly poor performance, ruling out color vision that makes use of the conventional color-opponent coding system (6-8). Instead, our experiments suggest that stomatopods use a previously unknown color vision system based on temporal signaling combined with scanning eye movements, enabling a type of color recognition rather than discrimination.	[Thoen, Hanne H.; How, Martin J.; Marshall, Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Chiou, Tsyr-Huei] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	University of Queensland; National Cheng Kung University	Thoen, HH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	h.thoen@uq.edu.au	How, Martin J./G-1925-2010	How, Martin J./0000-0001-5135-8828; Chiou, Tsyr-Huei/0000-0003-3504-5113; Marshall, Justin/0000-0001-9006-6713; Thoen, Hanne Halkinrud/0000-0001-8695-9578	Asian Office of Aerospace Research and Development; Air Force Office of Scientific Research; Australian Research Council; Lizard Island Research Foundation; Lizard Island Research Station, a facility of the Australian Museum	Asian Office of Aerospace Research and Development; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Australian Research Council(Australian Research Council); Lizard Island Research Foundation; Lizard Island Research Station, a facility of the Australian Museum	This work was supported by grants from the Asian Office of Aerospace Research and Development, the Air Force Office of Scientific Research, the Australian Research Council, the Lizard Island Research Foundation, and a Doctoral Fellowship (2013) from the Lizard Island Research Station, a facility of the Australian Museum. We thank the reviewers for their great comments and W.-S. Chung, M. Bue, and R. Bedford for technical help. All data described in this manuscript are presented in either the main manuscript or the supplementary materials.	ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; BARLOW HB, 1982, VISION RES, V22, P635, DOI 10.1016/0042-6989(82)90099-2; CALDWELL RL, 1975, NATURWISSENSCHAFTEN, V62, P214, DOI 10.1007/BF00603166; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; CRONIN TW, 1989, J COMP PHYSIOL A, V166, P261; DINGLE H, 1969, BEHAVIOUR, V33, P115, DOI 10.1163/156853969X00341; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kleinlogel S, 2003, J COMP NEUROL, V467, P326, DOI 10.1002/cne.10922; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; LAND MF, 1990, J COMP PHYSIOL A, V167, P155; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; Marshall NJ, 1996, J COMP PHYSIOL A, V179, P473; MARSHALL NJ, 1991, PHILOS T ROY SOC B, V334, P57, DOI 10.1098/rstb.1991.0097; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Mollon J., 1986, COLOUR VISION DEFICI, P473; NEUMEYER C, 1991, EVOLUTION EYE VISUAL, V2, P284; Osorio D, 1997, VISION RES, V37, P3299, DOI 10.1016/S0042-6989(97)00136-3; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1997, SER BIOPHYS BIOCYBER, V1, P263; Wolpert HD, 2011, OPT PHOTONICS NEWS, V22, P16	25	112	115	48	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					411	413		10.1126/science.1245824	http://dx.doi.org/10.1126/science.1245824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458639				2022-12-28	WOS:000330039300046
J	Lamas, GA; Boineau, R; Goertz, C; Mark, DB; Rosenberg, Y; Stylianou, M; Rozema, T; Nahin, RL; Lindblad, L; Lewis, EF; Drisko, J; Lee, KL				Lamas, Gervasio A.; Boineau, Robin; Goertz, Christine; Mark, Daniel B.; Rosenberg, Yves; Stylianou, Mario; Rozema, Theodore; Nahin, Richard L.; Lindblad, Lauren; Lewis, Eldrin F.; Drisko, Jeanne; Lee, Kerry L.		TACT Trial Assess Chelation	Oral High-Dose Multivitamins and Minerals After Myocardial Infarction A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; ANTIOXIDANT VITAMINS; BETA-CAROTENE; PREVENTION; COMBINATION; MORTALITY; CANCER; RISK	Background: Whether high-dose multivitamins are effective for secondary prevention of atherosclerotic disease is unknown. Objective: To assess whether oral multivitamins reduce cardiovascular events and are safe. Design: Double-blind, placebo-controlled, 2 x 2 factorial, multi-center, randomized trial. (ClinicalTrials.gov: NCT00044213) Setting: 134 U.S. and Canadian academic and clinical sites. Patients: 1708 patients aged 50 years or older who had myocardial infarction (MI) at least 6 weeks earlier and had serum creatinine levels of 176.8 mu mol/L (2.0 mg/dL) or less. Intervention: Patients were randomly assigned to an oral, 28-component, high-dose multivitamin and multimineral mixture or placebo. Measurements: The primary end point was time to total death, recurrent MI, stroke, coronary revascularization, or hospitalization for angina. Results: The median age was 65 years, and 18% of patients were women. The qualifying MI occurred a median of 4.6 years (inter-quartile range [IQR], 1.6 to 9.2 years) before enrollment. Median follow-up was 55 months (IQR, 26 to 60 months). Patients received vitamins for a median of 31 months (IQR, 13 to 59 months) in the vitamin group and 35 months (IQR, 13 to 60 months) in the placebo group (P = 0.65). Totals of 645 (76%) and 646 (76%) patients in the vitamin and placebo groups, respectively, completed at least 1 year of oral therapy (P = 0.98), and 400 (47%) and 426 (50%) patients, respectively, completed at least 3 years (P = 0.23). Totals of 394 (46%) and 390 (46%) patients in the vitamin and placebo groups, respectively, discontinued the vitamin regimen (P = 0.67), and 17% of patients withdrew from the study. The primary end point occurred in 230 (27%) patients in the vitamin group and 253 (30%) in the placebo group (hazard ratio, 0.89 [95% CI, 0.75 to 1.07]; P = 0.21). No evidence suggested harm from vitamin therapy in any category of adverse events. Limitation: There was considerable nonadherence and withdrawal, limiting the ability to draw firm conclusions (particularly about safety). Conclusion: High-dose oral multivitamins and multiminerals did not statistically significantly reduce cardiovascular events in patients after MI who received standard medications. However, this conclusion is tempered by the nonadherence rate.	Mt Sinai Med Ctr, Miami Beach, FL 33140 USA; NHLBI, Bethesda, MD 20892 USA; Natl Ctr Complementary & Alternat Med, Bethesda, MD USA; Palmer Ctr Chiropract Res, Davenport, IA USA; Duke Clin Res Inst, Durham, NC USA; Biogenesis Med Ctr, Landrum, SC USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Mount Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Kansas; University of Kansas Medical Center	Lamas, GA (corresponding author), Columbia Univ, Div Cardiol, Mt Sinai Med Ctr, 4300 Alton Rd, Miami Beach, FL 33140 USA.	gervasio.lamas@msmc.com	Boineau, Robin/AAR-4452-2021	Mark, Daniel/0000-0001-6340-8087; Nahin, Richard/0000-0002-3682-4816	National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT001156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL092607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Institutes of Health.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blum S, 2010, PHARMACOGENOMICS, V11, P675, DOI [10.2217/pgs.10.17, 10.2217/PGS.10.17]; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COX DR, 1972, J R STAT SOC B, V34, P187; Gahche Jamie, 2011, NCHS Data Brief, P1; Galleano M, 2010, CURR PHARM BIOTECHNO, V11, P837, DOI 10.2174/138920110793262114; Joshipura KJ, 2009, PUBLIC HEALTH NUTR, V12, P115, DOI 10.1017/S1368980008002036; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lamas GA, 2013, JAMA-J AM MED ASSOC, V309, P1241, DOI 10.1001/jama.2013.2107; Lamas GA, 2012, AM HEART J, V163, P7, DOI 10.1016/j.ahj.2011.10.002; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levine GN, 1996, CIRCULATION, V93, P1107, DOI 10.1161/01.CIR.93.6.1107; Lonn EM, 2012, JAMA-J AM MED ASSOC, V308, P1802, DOI 10.1001/jama.2012.28259; National Institutes of Health, 2011, RFAAT01004 NIH; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; [No title captured]	25	38	38	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					797	+		10.7326/0003-4819-159-12-201312170-00004	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24490264	Green Accepted			2022-12-28	WOS:000329735300012
J	Marcus, DM				Marcus, Donald M.			PERSONAL VIEW Turning a blind eye to alternative medicine education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCIENCE		[Marcus, Donald M.] Baylor Coll Med, Texas Med Ctr, Dept Med, Houston, TX 77030 USA; [Marcus, Donald M.] Baylor Coll Med, Texas Med Ctr, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Marcus, DM (corresponding author), Baylor Coll Med, Texas Med Ctr, Dept Med, Houston, TX 77030 USA.	dmarcus@bcm.edu						Bevanger L, 2012, UK U DROP ALTERNATIV; Colquhoun D, 2007, NATURE, V446, P373, DOI 10.1038/446373a; Ernst E, 2008, J PAIN SYMPTOM MANAG, V35, P544, DOI 10.1016/j.jpainsymman.2007.07.004; Flexner A., 1910, MED ED US CANADA, V4, pxii xvii; Hamburg MA, COMMUNICATION; Harel Z, 2013, JAMA INTERN MED, V173, P926, DOI 10.1001/jamainternmed.2013.379; Long J., FDA GMP INSPECTORS C; Ludmerer KM, 2010, ACAD MED, V85, P193, DOI 10.1097/ACM.0b013e3181c8f1e7; MacLennan AH, 2012, MED J AUSTRALIA, V196, P225, DOI 10.5694/mja12.10128; Marcus DM, 2012, ARCH INTERN MED, V172, P1035, DOI 10.1001/archinternmed.2012.2687; Marcus DM, 2009, ACAD MED, V84, P1229, DOI 10.1097/ACM.0b013e3181b185f4; Nahin Richard L, 2009, Natl Health Stat Report, P1; Offit PA, 2013, DO YOU BELIEVE MAGIC, P94; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; United States Government Accountability Office, 2010, HERB DIET SUPPL EX D; US Government Accountability Office, 2009, DIET SUPPL FDA SHOUL	16	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5827	10.1136/bmj.f5827	http://dx.doi.org/10.1136/bmj.f5827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473448				2022-12-28	WOS:000325426300005
J	Naci, H; Ioannidis, JPA				Naci, Huseyin; Ioannidis, John P. A.			Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; MYOCARDIAL-INFARCTION; NETWORK METAANALYSIS; PRESCRIBING EXERCISE; COMPETING INTERVENTIONS; SECONDARY PREVENTION; HEART-FAILURE; DISEASE	Objective To determine the comparative effectiveness of exercise versus drug interventions on mortality outcomes. Design Metaepidemiological study. Eligibility criteria Meta-analyses of randomised controlled trials with mortality outcomes comparing the effectiveness of exercise and drug interventions with each other or with control (placebo or usual care). Data sources Medline and Cochrane Database of Systematic Reviews, May 2013. Main outcome measure Mortality. Data synthesis We combined study level death outcomes from exercise and drug trials using random effects network meta-analysis. Results We included 16 (four exercise and 12 drug) meta-analyses. Incorporating an additional three recent exercise trials, our review collectively included 305 randomised controlled trials with 339 274 participants. Across all four conditions with evidence on the effectiveness of exercise on mortality outcomes (secondary prevention of coronary heart disease, rehabilitation of stroke, treatment of heart failure, prevention of diabetes), 14 716 participants were randomised to physical activity interventions in 57 trials. No statistically detectable differences were evident between exercise and drug interventions in the secondary prevention of coronary heart disease and prediabetes. Physical activity interventions were more effective than drug treatment among patients with stroke (odds ratios, exercise v anticoagulants 0.09, 95% credible intervals 0.01 to 0.70 and exercise v antiplatelets 0.10, 0.01 to 0.62). Diuretics were more effective than exercise in heart failure (exercise v diuretics 4.11, 1.17 to 24.76). Inconsistency between direct and indirect comparisons was not significant. Conclusions Although limited in quantity, existing randomised trial evidence on exercise interventions suggests that exercise and many drug interventions are often potentially similar in terms of their mortality benefits in the secondary prevention of coronary heart disease, rehabilitation after stroke, treatment of heart failure, and prevention of diabetes.	[Naci, Huseyin] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England; [Naci, Huseyin] Harvard Univ, Sch Med, Dept Populat Med, Drug Policy Res Grp, Boston, MA USA; [Naci, Huseyin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	University of London; London School Economics & Political Science; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Stanford University	Naci, H (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	HNacih.naci@lse.ac.uk	Ioannidis, John P. A./G-9836-2011					Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barnes PM., 2012, NCHS DATA BRIE, V86, P8; Belardinelli R, 2012, J AM COLL CARDIOL, V60, P1521, DOI 10.1016/j.jacc.2012.06.036; Berge E, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003242; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Brazzelli M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub4; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Byberg L, 2009, BRIT J SPORT MED, V43, P482, DOI 10.1136/bmj.b688; Cartwright N., 2012, EVIDENCE BASED POLIC, DOI DOI 10.1093/ACPROF:OSOBL/9780199841608.001.0001; Chatterjee S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f55; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Davidson PM, 2010, EUR J CARDIOV PREV R, V17, P393, DOI 10.1097/HJR.0b013e328334ea56; Davies EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub3; Department of Health, 2011, UK PHYS ACT GUID; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S., 2011, NICE DSU TECHNICAL S; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3; Faris RF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003838.pub3; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Getz L, 2004, SCAND J PRIM HEALTH, V22, P202, DOI 10.1080/02813430410006693; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Heran BS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003040.pub2; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Khan KM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4141; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Kujala UM, 2009, BRIT J SPORT MED, V43, P550, DOI 10.1136/bjsm.2009.059808; Kujala UM, 2004, SCAND J MED SCI SPOR, V14, P339, DOI 10.1111/j.1600-0838.2004.413.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Naci H, 2013, EUR J PREV CARDIOL, V20, P641, DOI 10.1177/2047487313480435; Naci H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4261; NHS Information System, 2012, PRESCR DISP COMM ENG; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Pavey TG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6462; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Song FJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4909; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thompson PD, 2013, J AM COLL CARDIOL, V62, P715, DOI 10.1016/j.jacc.2013.03.030; Townsend N., 2012, PHYS ACTIVITY STAT 2; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; West RR, 2012, HEART, V98, P637, DOI 10.1136/heartjnl-2011-300302; Westin S, 2005, BRIT MED J, V330, P1461, DOI 10.1136/bmj.330.7506.1461; Williams Nefyn H, 2011, BMJ, V343, pd6615, DOI 10.1136/bmj.d6615	67	334	342	3	85	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5577	10.1136/bmj.f5577	http://dx.doi.org/10.1136/bmj.f5577			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473061	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000325426300002
J	Abrahams, N; Devries, K; Watts, C; Pallitto, C; Petzold, M; Shamu, S; Garcia-Moreno, C				Abrahams, Naeemah; Devries, Karen; Watts, Charlotte; Pallitto, Christina; Petzold, Max; Shamu, Simukai; Garcia-Moreno, Claudia			Worldwide prevalence of non-partner sexual violence: a systematic review	LANCET			English	Review							META-REGRESSION; ASSAULT; WOMEN; REVICTIMIZATION; PERPETRATOR; HEALTH	Background Several highly publicised rapes and murders of young women in India and South Africa have focused international attention on sexual violence. These cases are extremes of the wider phenomenon of sexual violence against women, but the true extent is poorly quantified. We did a systematic review to estimate prevalence. Methods We searched for articles published from Jan 1, 1998, to Dec 31, 2011, and manually search reference lists and contacted experts to identify population-based data on the prevalence of women's reported experiences of sexual violence from age 15 years onwards, by anyone except intimate partners. We used random effects meta-regression to calculate adjusted and unadjusted prevalence for regions, which we weighted by population size to calculate the worldwide estimate. Findings We identified 7231 studies from which we obtained 412 estimates covering 56 countries. In 2010 7.2% (95% CI 5.2-9.1) of women worldwide had ever experienced non-partner sexual violence. The highest estimates were in sub-Saharan Africa, central (21%, 95% CI 4.5-37.5) and sub-Saharan Africa, southern (17.4%, 11.4-23.3). The lowest prevalence was for Asia, south (3.3%, 0-8.3). Limited data were available from sub-Saharan Africa, central, North Africa/Middle East, Europe, eastern, and Asia Pacific, high income. Interpretation Sexual violence against women is common worldwide, with endemic levels seen in some areas, although large variations between settings need to be interpreted with caution because of differences in data availability and levels of disclosure. Nevertheless, our findings indicate a pressing health and human rights concern.	[Abrahams, Naeemah; Shamu, Simukai] South African Med Res Council, Gender & Hlth Res Unit, ZA-7405 Cape Town, Western Cape, South Africa; [Devries, Karen; Watts, Charlotte] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England; [Pallitto, Christina; Garcia-Moreno, Claudia] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Shamu, Simukai] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa	South African Medical Research Council; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Gothenburg; University of the Western Cape	Abrahams, N (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Francie van Zijl St, ZA-7405 Cape Town, Western Cape, South Africa.	nabraham@mrc.ac.za	Devries, Karen/K-1083-2016; Abrahams, Naeemah/AAF-1144-2020	Devries, Karen/0000-0001-8935-2181; Shamu, Simukai/0000-0002-2290-0515; Abrahams, Naeemah/0000-0002-6138-6256	South African Medical Research Council; Sigrid Rausing Trust; WHO	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sigrid Rausing Trust; WHO(World Health Organization)	South African Medical Research Council, Sigrid Rausing Trust, WHO.	Abrahams N, 2013, AFR J PSYCHIATRY, V16, P288, DOI [10.4314/ajpsy.v16i4.39, http://dx.doi.org/10.4314/ajpsy.v16i4.39]; Abrahams N, 2010, CULT HEALTH SEX, V12, P471, DOI 10.1080/13691050903556316; Ackard Diann M, 2003, J Child Sex Abus, V12, P17, DOI 10.1300/J070v12n01_02; BLOOM SS, 2008, VIOLENCE WOMEN GIRLS; Centre for Disease Control and Prevention, REPR HLTH SURV; Cohen Dara Kay, 2013, WARTIME SEXUAL VIOLE; Culbertson KA, 2001, J INTERPERS VIOLENCE, V16, P992, DOI 10.1177/088626001016010002; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Fergusson DM, 1997, CHILD ABUSE NEGLECT, V21, P789, DOI 10.1016/S0145-2134(97)00039-2; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gutner CA, 2006, J TRAUMA STRESS, V19, P813, DOI 10.1002/jts.20158; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Jewkes R, LANCET GLOB IN PRESS; Jewkes R., 2002, SEXUAL VIOLENCE; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Johnson H, 2008, VIOLENCE AGAINST WOMEN: AN INTERNATIONAL PERSPECTIVE, P1, DOI 10.1007/978-0-387-73204-6; Kelly L., 2005, GAP CHASM ATTRITION; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; M A Straus, 1983, DARK SIDE FAMILIES C, P119; MEASURE DHS, DEMOGRAPHIC HLTH SUR; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Pazzani LM, 2007, VIOLENCE AGAINST WOM, V13, P717, DOI 10.1177/1077801207302699; Temple JR, 2007, VIOLENCE AGAINST WOM, V13, P285, DOI 10.1177/1077801206297437; TJADEN P, 2000, VIOLENCE WOMEN, V0006; Ullman SE, 1999, AGGRESS VIOLENT BEH, V4, P343, DOI 10.1016/S1359-1789(98)00006-8; United Nations Interregional Crime and Justice Research Institute, INT VICT CRIM SURV; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization, 2021, VIOL WOM PREV EST 20	31	206	210	3	52	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1648	1654		10.1016/S0140-6736(13)62243-6	http://dx.doi.org/10.1016/S0140-6736(13)62243-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24529867				2022-12-28	WOS:000335670800027
J	Rice, ASC; Dworkin, RH; McCarthy, TD; Anand, P; Bountra, C; McCloud, PI; Hill, J; Cutter, G; Kitson, G; Desem, N; Raff, M				Rice, Andrew S. C.; Dworkin, Robert H.; McCarthy, Tom D.; Anand, Praveen; Bountra, Chas; McCloud, Philip I.; Hill, Julie; Cutter, Gary; Kitson, Geoff; Desem, Nuket; Raff, Milton		EMA401-003 Study Grp	EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial	LANCET			English	Article							NEUROPATHIC PAIN; HERPES-ZOSTER; DEFINITION; INVENTORY; RESPONSES; EFFICACY; VALIDITY; OUTCOMES; BINDING; COST	Background Existing treatments for postherpetic neuralgia, and for neuropathic pain in general, are limited by modest efficacy and unfavourable side-effects. The angiotensin II type 2 receptor (AT(2)R) is a new target for neuropathic pain. EMA401, a highly selective AT(2)R antagonist, is under development as a novel neuropathic pain therapeutic agent. We assessed the therapeutic potential of EMA401 in patients with postherpetic neuralgia. Methods In this multicentre, placebo-controlled, double-blind, randomised, phase 2 clinical trial, we enrolled patients (aged 22-89 years) with postherpetic neuralgia of at least 6 months' duration from 29 centres across six countries. We randomly allocated 183 participants to receive either oral EMA401 (100 mg twice daily) or placebo for 28 days. Randomisation was done according to a centralised randomisation schedule, blocked by study site, which was generated by an independent, unmasked statistician. Patients and staff at each site were masked to treatment assignment. We assessed the efficacy, safety, and pharmacokinetics of EMA401. The primary efficacy endpoint was change in mean pain intensity between baseline and the last week of dosing (days 22-28), measured on an 11-point numerical rating scale. The primary efficacy analysis was intention to treat. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12611000822987. Findings 92 patients were assigned to EMA401 and 91 were assigned to placebo. The patients given EMA401 reported significantly less pain compared with baseline values in the final week of treatment than did those given placebo (mean reductions in pain scores -2.29 [SD 1.75] vs -1.60 [1.66]; difference of adjusted least square means -0.69 [SE 0.25]; 95% CI -1.19 to -0.20; p=0.0066). No serious adverse events related to EMA401 occurred. Overall, 32 patients reported 56 treatment-emergent adverse events in the EMA401 group compared with 45 such events reported by 29 patients given placebo. Interpretation EMA401 (100 mg twice daily) provides superior relief of postherpetic neuralgia compared with placebo at the end of 28 days of treatment. EMA401 was well tolerated by patients.	[Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW10 9NH, England; [Anand, Praveen] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Peripheral Neuropathy Unit, London SW10 9NH, England; [Dworkin, Robert H.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [McCarthy, Tom D.; Kitson, Geoff; Desem, Nuket] Spinifex Pharmaceut, Melbourne, Vic, Australia; [Bountra, Chas] Univ Oxford, Struct Genom Consortium, Oxford, England; [Bountra, Chas] Univ Oxford, Dept Clin Med, Oxford, England; [McCloud, Philip I.; Hill, Julie] McCloud Consulting Grp, Sydney, NSW, Australia; [Cutter, Gary] Univ Alabama Birmingham, Birmingham, AL USA; [Cutter, Gary] Pythagoras, Birmingham, AL USA; [Raff, Milton] Christiaan Barnard Mem Hosp, Cape Town, South Africa; [Raff, Milton] Univ Cape Town, Dept Anaesthesia, ZA-7700 Rondebosch, South Africa	Imperial College London; Imperial College London; University of Rochester; University of Oxford; University of Oxford; University of Alabama System; University of Alabama Birmingham; University of Cape Town	Rice, ASC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Chelsea & Westminster Hosp Campus, London SW10 9NH, England.	a.rice@imperial.ac.uk	Rice, Andrew/I-7501-2012; Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X	Spinifex Pharmaceuticals	Spinifex Pharmaceuticals	Spinifex Pharmaceuticals.	Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Atkinson TM, 2010, PAIN MED, V11, P337, DOI 10.1111/j.1526-4637.2009.00774.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Brillante DG, 2008, DIABETES OBES METAB, V10, P143, DOI 10.1111/j.1463-1326.2006.00678.x; Chakrabarty A, 2013, J PAIN, V14, P1053, DOI 10.1016/j.jpain.2013.04.002; Daniel HC, 2008, EUR J PAIN, V12, P731, DOI 10.1016/j.ejpain.2007.11.006; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007393.pub3; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; Farrar JT, 2006, J PAIN SYMPTOM MANAG, V31, P369, DOI 10.1016/j.jpainsymman.2005.08.018; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gill D., 2011, COCHRANE DB SYST REV, V10; Hempenstall K, 2005, PLOS MED, V2, P628, DOI 10.1371/journal.pmed.0020164; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Moore A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2690; Moore RA, 2012, PAIN, V153, P265, DOI 10.1016/j.pain.2011.10.004; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Pincus T, 2004, PAIN, V109, P181, DOI 10.1016/j.pain.2004.02.004; Sang CN, 2013, CLIN J PAIN, V29, P281, DOI 10.1097/AJP.0b013e318258993e; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Smith MT, 2013, PAIN MED, V14, P1557, DOI 10.1111/pme.12157; Smith MT, 2013, PAIN MED, V14, P692, DOI 10.1111/pme.12063; Smith MT, BEHAV PHARM IN PRESS; Steckelings UM, 2012, EXPERT OPIN INV DRUG, V21, P763, DOI 10.1517/13543784.2012.681046; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; VANATTEN MK, 1993, J MED CHEM, V36, P3985, DOI 10.1021/jm00077a001; Wiffen PJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010567.pub2	32	126	134	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1637	1647		10.1016/S0140-6736(13)62337-5	http://dx.doi.org/10.1016/S0140-6736(13)62337-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24507377				2022-12-28	WOS:000335670800026
J	Swarts, DC; Jore, MM; Westra, ER; Zhu, YF; Janssen, JH; Snijders, AP; Wang, YL; Patel, DJ; Berenguer, J; Brouns, SJJ; van der Oost, J				Swarts, Daan C.; Jore, Matthijs M.; Westra, Edze R.; Zhu, Yifan; Janssen, Jorijn H.; Snijders, Ambrosius P.; Wang, Yanli; Patel, Dinshaw J.; Berenguer, Jose; Brouns, Stan J. J.; van der Oost, John			DNA-guided DNA interference by a prokaryotic Argonaute	NATURE			English	Article							THERMOPHILE THERMUS-THERMOPHILUS; STRUCTURAL BASIS; RNA; RECOGNITION; EUBACTERIA; SEQUENCE	RNA interference is widely distributed in eukaryotes and has a variety of functions, including antiviral defence and gene regulation(1,2). All RNA interference pathways use small single-stranded RNA(ssRNA) molecules that guide proteins of the Argonaute (Ago) family to complementary ssRNA targets: RNA-guided RNA interference(1,2). The role of prokaryotic Ago variants has remained elusive, although bioinformatics analysis has suggested their involvement in host defence(3). Here we demonstrate that Ago of the bacterium Thermus thermophilus (TtAgo) acts as a barrier for the uptake and propagation of foreign DNA. In vivo, TtAgo is loaded with 5'-phosphorylated DNA guides, 13-25 nucleotides in length, that are mostly plasmid derived and have a strong bias for a 5'-end deoxycytidine. These small interfering DNAs guide TtAgo to cleave complementary DNA strands. Hence, despite structural homology to its eukaryotic counterparts, TtAgo functions in host defence by DNA-guided DNA interference.	[Swarts, Daan C.; Jore, Matthijs M.; Westra, Edze R.; Zhu, Yifan; Janssen, Jorijn H.; Brouns, Stan J. J.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Snijders, Ambrosius P.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Wang, Yanli] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Berenguer, Jose] UAM CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Wageningen University & Research; Cancer Research UK; Chinese Academy of Sciences; Institute of Biophysics, CAS; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	van der Oost, J (corresponding author), Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands.	john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019; Berenguer, Jose/R-2507-2019; Jore, Matthijs/F-7852-2018; Swarts, Daan/Z-6262-2019	Berenguer, Jose/0000-0002-9689-6272; Jore, Matthijs/0000-0002-0686-370X; Swarts, Daan/0000-0003-4412-9191; Snijders, Bram/0000-0002-5416-8592; Brouns, Stan/0000-0002-9573-1724; Zhu, Yifan/0000-0002-8403-7833; Wang, Yanli/0000-0002-5969-1745; Janssen, Jorijn/0000-0002-9718-8630	Netherlands Organization of Scientific Research (NWO) ((NWO-TOP) [854.10.003]; Netherlands Organization of Scientific Research (NWO) (NWO Vidi) [864.11.005]; Spanish Ministry of Science and Innovation [BIO2010-18875]; Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER	Netherlands Organization of Scientific Research (NWO) ((NWO-TOP)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research (NWO) (NWO Vidi)(Netherlands Organization for Scientific Research (NWO)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We want to thank A. Hidalgo, C. E. Cesar, M. Davids and R. H. J. Staals for advice on experimental procedures. Furthermore, we would like to thank R. Engelhart, B. van Genugten, G. Goertz and R. Stolk for experimental contributions. This work was financially supported by grants from the Netherlands Organization of Scientific Research (NWO) to J.O. (NWO-TOP, 854.10.003), and to S. J. J. B. (NWO Vidi, 864.11.005), and by project BIO2010-18875 from the Spanish Ministry of Science and Innovation, and an Institutional Grant from the Fundacion Ramon Areces to CBMSO (J.B.).	Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Bates A. D., 2005, DNA TOPOLOGY; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Cava F, 2007, MOL MICROBIOL, V64, P630, DOI 10.1111/j.1365-2958.2007.05687.x; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; COLLIN RG, 1988, FEMS MICROBIOL LETT, V55, P235, DOI 10.1111/j.1574-6968.1988.tb13940.x; DUGUET M, 1993, NUCLEIC ACIDS RES, V21, P463, DOI 10.1093/nar/21.3.463; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Frank F, 2012, EMBO J, V31, P3588, DOI 10.1038/emboj.2012.204; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gregory ST, 2008, FEMS MICROBIOL LETT, V289, P187, DOI 10.1111/j.1574-6968.2008.01389.x; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Ketting RF, 2010, ADV EXP MED BIOL, V700, P1, DOI 10.1007/978-1-4419-7823-3_1; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	31	237	323	18	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					258	+		10.1038/nature12971	http://dx.doi.org/10.1038/nature12971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24531762	Green Accepted			2022-12-28	WOS:000332651800044
J	Martin, SS; Blumenthal, RS				Martin, Seth S.; Blumenthal, Roger S.			Concepts and Controversies: The 2013 American College of Cardiology/American Heart Association Risk Assessment and Cholesterol Treatment Guidelines	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION		[Martin, Seth S.; Blumenthal, Roger S.] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Blumenthal, RS (corresponding author), Johns Hopkins Univ Hosp, 1800 Orleans St,Blalock 524C, Baltimore, MD 21287 USA.	rblument@jhmi.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168; Martin, Seth/0000-0002-7021-7622				Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Goff Jr DC, 2013, CIRCULATION; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guyton JR, 2013, J AM COLL CARDIOL, V62, P1580, DOI 10.1016/j.jacc.2013.07.023; Martin SS, 2012, AM J CARDIOL, V110, P307, DOI 10.1016/j.amjcard.2012.03.023; Martin SS, 2013, CIRCULATION; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Stone NJ., 2014, J AM COLL CARDIOL, V63, P2889	10	42	42	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					356	+		10.7326/M13-2805	http://dx.doi.org/10.7326/M13-2805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24473832				2022-12-28	WOS:000332793900009
J	Rehman, A; Heng, EE; Cheema, FH				Rehman, Atiq; Heng, Elbert E.; Cheema, Faisal H.			Calcified amorphous tumour of right ventricle	LANCET			English	Editorial Material									[Cheema, Faisal H.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Rehman, Atiq] Columbia Univ, Coll Phys & Surg, New York Presbyterian Hosp, New York, NY USA; [Rehman, Atiq] Sarasota Mem Hosp, Sarasota, FL USA; [Heng, Elbert E.] Brown Univ, Providence, RI 02912 USA	University System of Maryland; University of Maryland Baltimore; Columbia University; NewYork-Presbyterian Hospital; Brown University	Cheema, FH (corresponding author), Univ Maryland, Sch Med, 110 S Paca St,7 N 106, Baltimore, MD 21201 USA.	faisal.cheema@me.com		Heng, Elbert/0000-0003-0061-1584					0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					815	815		10.1016/S0140-6736(13)60997-6	http://dx.doi.org/10.1016/S0140-6736(13)60997-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24529558				2022-12-28	WOS:000332398700028
J	Downing, NS; Ross, JS				Downing, Nicholas S.; Ross, Joseph S.			Innovation, Risk, and Patient Empowerment The FDA-Mandated Withdrawal of 23andMe's Personal Genome Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Downing, Nicholas S.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu		Ross, Joseph/0000-0002-9218-3320				American College of Medical Genetics and Genomics, ACMG RECOMMENDATIONS; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Government Accountability Office, DIRECT TO CONSUMER G; Lafata JE, 2004, CANCER EPIDEM BIOMAR, V13, P2126; US Food and Drug Administration, MEDICAL DEVICES PREM	6	13	15	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					793	794		10.1001/jama.2014.148	http://dx.doi.org/10.1001/jama.2014.148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24474248				2022-12-28	WOS:000331793700014
J	Brandt, AR; Heath, GA; Kort, EA; O'Sullivan, F; Petron, G; Jordaan, SM; Tans, P; Wilcox, J; Gopstein, AM; Arent, D; Wofsy, S; Brown, NJ; Bradley, R; Stucky, GD; Eardley, D; Harriss, R				Brandt, A. R.; Heath, G. A.; Kort, E. A.; O'Sullivan, F.; Petron, G.; Jordaan, S. M.; Tans, P.; Wilcox, J.; Gopstein, A. M.; Arent, D.; Wofsy, S.; Brown, N. J.; Bradley, R.; Stucky, G. D.; Eardley, D.; Harriss, R.			Methane Leaks from North American Natural Gas Systems	SCIENCE			English	Editorial Material							EMISSIONS		[Brandt, A. R.; Wilcox, J.] Stanford Univ, Stanford, CA 94305 USA; [Heath, G. A.; Arent, D.] Natl Renewable Energy Lab, Golden, CO USA; [Kort, E. A.] Univ Michigan, Ann Arbor, MI 48109 USA; [O'Sullivan, F.] MIT, Cambridge, MA 02139 USA; [Petron, G.; Tans, P.] NOAA, Boulder, CO USA; [Petron, G.] Univ Colorado, Boulder, CO 80309 USA; [Jordaan, S. M.] Univ Calgary, Calgary, AB, Canada; [Gopstein, A. M.] US Dept State, Washington, DC 20520 USA; [Arent, D.] Joint Inst Strateg Energy Anal, Golden, CO USA; [Wofsy, S.] Harvard Univ, Cambridge, MA 02138 USA; [Brown, N. J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Stucky, G. D.; Eardley, D.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Harriss, R.] Environm Def Fund, Boulder, CO USA	Stanford University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Calgary; Harvard University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; Environmental Defense Fund	Brandt, AR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	abrandt@stanford.edu	Jordaan, Sarah/C-5154-2018; Kort, Eric A/F-9942-2012; Tans, Pieter/AAG-8273-2019; Petron, Gabrielle/AAN-5133-2020	Jordaan, Sarah/0000-0002-1277-4746; Kort, Eric A/0000-0003-4940-7541; Tans, Pieter/0000-0002-9883-0787; Petron, Gabrielle/0000-0002-7458-5852; Heath, Garvin/0000-0001-6010-4475	Directorate For Engineering [1240584] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Allen DT, 2013, P NATL ACAD SCI USA, V110, P17768, DOI 10.1073/pnas.1304880110; Alvarez RA, 2012, P NATL ACAD SCI USA, V109, P6435, DOI 10.1073/pnas.1202407109; Chambers A., 2004, OPTICAL MEASUREMENT; Clearstone Engineering, 2002, ID EV OPP RED METH L; Environmental Defense Fund, 2013, NAT GAS EDF IS FIGHT; EPA, 2013, GREENH GAS REP PROGR; EPA, 2013, INV US GREENH GAS EM, P550; Harrison MR, 2011, NATURAL GAS IND METH; Hsu YK, 2010, ATMOS ENVIRON, V44, P1, DOI 10.1016/j.atmosenv.2009.10.002; Hummel K. E., 1996, METHANE EMISSIONS NA, V8; Innovative Environmental Solutions, 2009, FIELD MEAS PROGR IMP; Karion A, 2013, GEOPHYS RES LETT, V40, P4393, DOI 10.1002/grl.50811; Katzenstein AS, 2003, P NATL ACAD SCI USA, V100, P11975, DOI 10.1073/pnas.1635258100; Kort EA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034031; Levi M. A., 2012, J GEOPHYS RES, V117, P16; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; National Gas Machinery Laboratory; Clearston Engineering Ltd.; Innovative Environmental Solutions Inc, 2006, COST EFF DIR INSP MA; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Office of Inspector General, 2013, EPA NEEDS IMPR AIR E; Peischl J, 2013, J GEOPHYS RES-ATMOS, V118, P4974, DOI 10.1002/jgrd.50413; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Townsend-Small A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016826; US EPA, 2012, FED REGISTER, V77, P49490; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180; Weber CL, 2012, ENVIRON SCI TECHNOL, V46, P5688, DOI 10.1021/es300375n; Wennberg PO, 2012, ENVIRON SCI TECHNOL, V46, P9282, DOI 10.1021/es301138y; Williamson H. J., 1996, METHANE EMISSIONS NA, V4; Wunch D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039825; Xiao YP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009415	29	563	566	8	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					733	735		10.1126/science.1247045	http://dx.doi.org/10.1126/science.1247045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531957	Green Submitted			2022-12-28	WOS:000331557800024
J	Hellenthal, G; Busby, GBJ; Band, G; Wilson, JF; Capelli, C; Falush, D; Myers, S				Hellenthal, Garrett; Busby, George B. J.; Band, Gavin; Wilson, James F.; Capelli, Cristian; Falush, Daniel; Myers, Simon			A Genetic Atlas of Human Admixture History	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; HUMAN-POPULATIONS; GENOME SEQUENCES; INFERENCE; MONGOLS	Modern genetic data combined with appropriate statistical methods have the potential to contribute substantially to our understanding of human history. We have developed an approach that exploits the genomic structure of admixed populations to date and characterize historical mixture events at fine scales. We used this to produce an atlas of worldwide human admixture history, constructed by using genetic data alone and encompassing over 100 events occurring over the past 4000 years. We identified events whose dates and participants suggest they describe genetic impacts of the Mongol empire, Arab slave trade, Bantu expansion, first millennium CE migrations in Eastern Europe, and European colonialism, as well as unrecorded events, revealing admixture to be an almost universal force shaping human populations.	[Hellenthal, Garrett] UCL, UCL Genet Inst, London WC1E 6BT, England; [Busby, George B. J.; Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Band, Gavin; Myers, Simon] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Falush, Daniel] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Myers, Simon] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of London; University College London; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; Max Planck Society; University of Oxford	Myers, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	myers@stats.ox.ac.uk	Busby, George/K-9024-2014; Wilson, James F/A-5704-2009; Myers, Simon R/A-6792-2015	Busby, George/0000-0003-4148-6222; Wilson, James F/0000-0001-5751-9178; Myers, Simon R/0000-0002-2585-9626; Capelli, Cristian/0000-0001-9348-9084; Band, Gavin/0000-0002-1710-9024	John Fell Fund-University of Oxford; NIH; Wellcome Trust [098387/Z/12/Z]; Biotechnology and Biological Sciences Research Council; Royal Society/Wellcome Trust [098386/Z/12/Z]; Istituto Italiano di Antropologia	John Fell Fund-University of Oxford; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society/Wellcome Trust; Istituto Italiano di Antropologia	We are grateful for the John Fell Fund-University of Oxford, the NIH, the Wellcome Trust (S. M., grant 098387/Z/12/Z), the Biotechnology and Biological Sciences Research Council, the Royal Society/Wellcome Trust (G. H., grant 098386/Z/12/Z), and the Istituto Italiano di Antropologia for funding. J.F.W. is a director, stockholder, and employee of ScotlandsDNA (and formerly of EthnoAncestry). We thank S. Karachanak, D. Toncheva, P. Anagnostou, F. Cali, F. Brisighelli, V. Romano, G. LeFranc, C. Buresi, J. Ben Chibani, A. Haj-Khelil, S. Denden, R. Ploski, T. Hervig, T. Moen, P. Krajewski, and R. Herrera for providing samples for our genotyping and the blood donors and the staff of the Unita Operativa Complessa di Medicina Trasfusionale, Azienda Ospedaliera Umberto I, Siracusa (Italy). Data analyzed in this study may be downloaded via http://admixturemap.paintmychromosomes.com/. Raw genotype data are available at the Gene Expression Omnibus database online (www.ncbi.nlm.nih.gov/geo/), series accession number GSE53626.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Atwood Christopher P, 2004, ENCY MONGOLIA MONGOL; Bacon EE, 1951, SOUTHWEST J ANTHROP, V7, P230, DOI 10.1086/soutjanth.7.3.3628602; Baird SJE, 2006, HEREDITY, V97, P81, DOI 10.1038/sj.hdy.6800850; Beckwith C. I., 2006, EMPIRES SILK ROAD HI; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bodmer W. F., 1971, GENETICS HUMAN POPUL; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Chandler David, 2007, HIST CAMBODIA, V4th; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Falush D, 2003, GENETICS, V164, P1567; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gordon M., 1989, SLAVERY ARAB WORLD; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Heather P., 2009, EMPIRES BARBARIANS M; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINES M, 1999, KALASHA PEOPLE N W P; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pugach I, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r19; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	37	440	452	4	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					747	751		10.1126/science.1243518	http://dx.doi.org/10.1126/science.1243518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531965	Green Submitted, Green Accepted			2022-12-28	WOS:000331557800033
J	Feng, HM; Shih, CP				Feng, Hui-Ming; Shih, Cheng-Ping			An Unusual Auricular Foreign Body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feng, Hui-Ming; Shih, Cheng-Ping] Triserv Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital	Feng, HM (corresponding author), Triserv Gen Hosp, Taipei, Taiwan.	zhengping@mail.ndmctsgh.edu.tw							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					E11	E11		10.1056/NEJMicm1212769	http://dx.doi.org/10.1056/NEJMicm1212769			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521132				2022-12-28	WOS:000331187500001
J	Woodcock, J; Tainio, M; Cheshire, J; O'Brien, O; Goodman, A				Woodcock, James; Tainio, Marko; Cheshire, James; O'Brien, Oliver; Goodman, Anna			Health effects of the London bicycle sharing system: health impact modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ERECTILE DYSFUNCTION; PHYSICAL-ACTIVITY; RISK; MORTALITY; DISEASE; CYCLISTS; MONTREAL; PROGRAM; HAZARDS; DEATHS	Objective To model the impacts of the bicycle sharing system in London on the health of its users. Design Health impact modelling and evaluation, using a stochastic simulation model. Setting Central and inner London, England. Data sources Total population operational registration and usage data for the London cycle hire scheme (collected April 2011-March 2012), surveys of cycle hire users (collected 2011), and London data on travel, physical activity, road traffic collisions, and particulate air pollution (PM2.5, (collected 2005-12). Participants 578 607 users of the London cycle hire scheme, aged 14 years and over, with an estimated 78% of travel time accounted for by users younger than 45 years. Main outcome measures Change in lifelong disability adjusted life years (DALYs) based on one year impacts on incidence of disease and injury, modelled through medium term changes in physical activity, road traffic injuries, and exposure to air pollution. Results Over the year examined the users made 7.4 million cycle hire trips (estimated 71% of cycling time by men). These trips would mostly otherwise have been made on foot (31%) or by public transport (47%). To date there has been a trend towards fewer fatalities and injuries than expected on cycle hire bicycles. Using these observed injury rates, the population benefits from the cycle hire scheme substantially outweighed harms (net change -72 DALYs (95% credible interval -110 to -43) among men using cycle hire per accounting year; -15 (-42 to -6) among women; note that negative DALYs represent a health benefit). When we modelled cycle hire injury rates as being equal to background rates for all cycling in central London, these benefits were smaller and there was no evidence of a benefit among women (change -49 DALYs (-88 to -17) among men; -1 DALY (-27 to 12) among women). This sex difference largely reflected higher road collision fatality rates for female cyclists. At older ages the modelled benefits of cycling were much larger than the harms. Using background injury rates in the youngest age group (15 to 29 years), the medium term benefits and harms were both comparatively small and potentially negative. Conclusion London's bicycle sharing system has positive health impacts overall, but these benefits are clearer for men than for women and for older users than for younger users. The potential benefits of cycling may not currently apply to all groups in all settings.	[Woodcock, James; Tainio, Marko] Univ Cambridge, Sch Clin Med, Inst Metab Sci, UK CRC Ctr Diet & Act Res,MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Tainio, Marko] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland; [Cheshire, James; O'Brien, Oliver] UCL, Ctr Adv Spatial Anal, London, England; [Goodman, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of Cambridge; Polish Academy of Sciences; Systems Research Institute of the Polish Academy of Sciences; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Woodcock, J (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, UK CRC Ctr Diet & Act Res,MRC Epidemiol Unit, Cambridge CB2 0QQ, England.	jw745@medschl.cam.ac.uk	O'Brien, Oliver/I-6308-2019; Woodcock, James/AAH-6753-2021	Tainio, Marko/0000-0002-0973-2342; Woodcock, James/0000-0003-4769-5375; O'Brien, Oliver/0000-0002-3413-0853	MRC; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; National Institute for Health Research [PDF-2010-03-130]; ESRC [ES/G007462/1, ES/K009176/1] Funding Source: UKRI; MRC [MR/K023187/1, MR/K021796/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1, ES/K009176/1] Funding Source: researchfish; Medical Research Council [MR/K021796/1, MR/K023187/1] Funding Source: researchfish; National Institute for Health Research [PDF-2010-03-15] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JW's contribution to the work was supported by an MRC Population Health Scientist Fellowship and by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. This study was supported by the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research, and Wellcome Trust, under the auspices of the UK Clinical Research Collaboration. AG contributed to this paper while funded by a postdoctoral fellowship by the National Institute for Health Research (PDF-2010-03-130). The views presented in this paper are those of the authors, and do not necessarily reflect those of any of the study funders.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aldred R, 2013, MOBILITIES-UK, V8, P252, DOI 10.1080/17450101.2012.696342; Beecham R, 2013, TRANSPORTATION PLANN, P1; Census, 2011, 2011 CENS KEY STAT L; City of Westminster, 2010, DELEGATED AUTHORITY; Craig R, 2009, HLTH SURVEY ENGLAND; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; Dhondt S, 2012, INJURY PREV, V18, P413, DOI 10.1136/injuryprev-2011-040286; Fischer CM, 2012, ANN EMERG MED, V60, P228, DOI 10.1016/j.annemergmed.2012.03.018; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Fishman E, 2012, TRANSPORT RES F-TRAF, V15, P686, DOI 10.1016/j.trf.2012.08.002; Fuller D, 2013, PREV MED, V57, P920, DOI 10.1016/j.ypmed.2013.05.028; Fuller D, 2011, AM J PREV MED, V41, P80, DOI 10.1016/j.amepre.2011.03.002; GILBERT K, 1994, BRIT MED J, V308, P1534, DOI 10.1136/bmj.308.6943.1534; Goodman A, 2014, J TRANSPORT IN PRESS; Goodman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071790; Gosling W, 2010, GUARDIAN; Greater London Authority, 2013, MAYORS VIS CYCL LOND; Hanninen O., 2011, EUROPEAN PERSPECTIVE; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; London Atmospheric Emissions Inventory, 2008, LONDON ATMOSPHERIC E; London Cycling Campaign, 2012, SAF LORR SAF CYCL; Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939; Marceau L, 2001, INT J IMPOT RES, V13, P298, DOI 10.1038/sj.ijir.3900733; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meddin R, 2013, BIKE SHARING WORLD M; Mindell JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050606; Morgan AS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-699; Nieuwenhuijsen MJ, 2007, ATMOS ENVIRON, V41, P7995, DOI 10.1016/j.atmosenv.2007.08.002; O'Brien O, 2013, J TRANSPORT GEOGRAPH; Ogilvie F, 2012, PREV MED, V55, P40, DOI 10.1016/j.ypmed.2012.05.002; Ostro B, 2004, OUTDOOR AIR POLLUTIO; Panis LI, 2010, ATMOS ENVIRON, V44, P2263, DOI 10.1016/j.atmosenv.2010.04.028; Rofique J, 2011, NATL TRAVEL SURVEY 2; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Seaton A, 2005, OCCUP ENVIRON MED, V62, P355, DOI 10.1136/oem.2004.014332; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Sommer F, 2010, J SEX MED, V7, P2346, DOI 10.1111/j.1743-6109.2009.01664.x; STATS19, 2012, STATS19 HELP FIL COM; SWOV Institute for Road Safety Research, 2013, POW WEB TOOL; Teschke K, 2012, AM J PUBLIC HEALTH, V102, P2336, DOI 10.2105/AJPH.2012.300762; Transport for London, 2011, 4 TRANSP LOND; Transport for London, 2011, TRAV LOND REP LOND S; Transport for London, HLTH SAF ENV REP 201; Transport for London, 2012, ATT CYCL ANN REP 201; Transport of London, 2013, SAF STREETS LOND ROA; Ward H, 2002, REPORTING ROAD TRAFF; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Yana B, 2013, THESIS IMPERIAL COLL	55	238	240	5	97	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2014	348								g425	10.1136/bmj.g425	http://dx.doi.org/10.1136/bmj.g425			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WZ	24524928	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000331445000013
J	Williams, RP; Oakeshott, P				Williams, Rupert P.; Oakeshott, Pippa			Diagnosis and management of chronic heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Williams, Rupert P.] St Thomas Hosp, Kings Coll London British Heart Fdn Ctr Excellenc, Rayne Inst, London SE1 7EH, England; [Williams, Rupert P.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England; [Oakeshott, Pippa] Univ London, London WC1E 7HU, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London	Williams, RP (corresponding author), St Thomas Hosp, Kings Coll London British Heart Fdn Ctr Excellenc, Rayne Inst, London SE1 7EH, England.	rupert.williams@kcl.ac.uk		Oakeshott, Pippa/0000-0003-2568-8211					0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2014	348								g1429	10.1136/bmj.g1429	http://dx.doi.org/10.1136/bmj.g1429			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WT	24523371				2022-12-28	WOS:000331444400011
J	Hotchkiss, JW; Davies, CA; Dundas, R; Hawkins, N; Jhund, PS; Scholes, S; Bajekal, M; O'Flaherty, M; Critchley, J; Leyland, AH; Capewell, S				Hotchkiss, Joel W.; Davies, Carolyn A.; Dundas, Ruth; Hawkins, Nathaniel; Jhund, Pardeep S.; Scholes, Shaun; Bajekal, Madhavi; O'Flaherty, Martin; Critchley, Julia; Leyland, Alastair H.; Capewell, Simon			Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACT(SEC) model: retrospective analysis using routine data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECLINE; SCOTLAND; INEQUALITIES; RATES	Objective To quantify the contributions of prevention and treatment to the trends in mortality due to coronary heart disease in Scotland. Design Retrospective analysis using IMPACTSEC, a previously validated policy model, to apportion the recent decline in coronary heart disease mortality to changes in major cardiovascular risk factors and to increases in more than 40 treatments in nine non-overlapping groups of patients. Setting Scotland. Participants All adults aged 25 years or over, stratified by sex, age group, and fifths of Scottish Index of Multiple Deprivation. Main outcome measure Deaths prevented or postponed. Results 5770 fewer deaths from coronary heart disease occurred in 2010 than would be expected if the 2000 mortality rates had persisted (8042 rather than 13 813). This reflected a 43% fall in coronary heart disease mortality rates (from 262 to 148 deaths per 100 000). Improved treatments accounted for approximately 43% (95% confidence interval 33% to 61%) of the fall in mortality, and this benefit was evenly distributed across deprivation fifths. Notable treatment contributions came from primary prevention for hypercholesterolaemia (13%), secondary prevention drugs (11%), and chronic angina treatments (7%). Risk factor improvements accounted for approximately 39% (28% to 49%) of the fall in mortality (44% in the most deprived fifth compared with only 36% in the most affluent fifth). Reductions in systolic blood pressure contributed more than one third (37%) of the decline in mortality, with no socioeconomic patterning. Smaller contributions came from falls in total cholesterol (9%), smoking (4%), and inactivity (2%). However, increases in obesity and diabetes offset some of these benefits, potentially increasing mortality by 4% and 8% respectively. Diabetes showed strong socioeconomic patterning (12% increase in the most deprived fifth compared with 5% for the most affluent fifth). Conclusions Increases in medical treatments accounted for almost half of the large recent decline in mortality due to coronary heart disease in Scotland. Furthermore, the Scottish National Health Service seems to have delivered these benefits equitably. However, the substantial contributions from population falls in blood pressure and other risk factors were diminished by adverse trends in obesity and diabetes. Additional population-wide interventions are urgently needed to reduce coronary heart disease mortality and inequalities in future decades.	[Hotchkiss, Joel W.] Univ Glasgow, Sch Vet Med, Glasgow G61 1QH, Lanark, Scotland; [Davies, Carolyn A.; Dundas, Ruth; Leyland, Alastair H.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; [Hawkins, Nathaniel] Univ British Columbia, Div Cardiol, Vancouver, BC V5Z 1M9, Canada; [Jhund, Pardeep S.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Scholes, Shaun] UCL, Hlth & Social Surveys Res Grp, London WC1E 6BT, England; [Bajekal, Madhavi] UCL, Dept Appl Hlth Res, London WC1E 7HB, England; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, IPHS, Liverpool L69 3GL, Merseyside, England; [Critchley, Julia] St Georges Univ London, Populat Hlth Res Ctr, London SW17 0RE, England	University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of British Columbia; University of Glasgow; University of London; University College London; University of London; University College London; University of Liverpool; St Georges University London	Leyland, AH (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	alastair.leyland@glasgow.ac.uk	Shao, Ruitai/AAU-7642-2021; Jhund, Pardeep/GLS-9508-2022; Hawkins, Nathaniel Mark/AAW-5093-2020	Jhund, Pardeep/0000-0003-4306-5317; Hawkins, Nathaniel Mark/0000-0003-1286-2014; Leyland, Alastair/0000-0003-3741-7099; Critchley, Julia/0000-0002-5248-4188; Dundas, Ruth/0000-0002-3836-4286; O'Flaherty, Martin/0000-0001-8944-4131	EUROHEART II [A/100946]; Medical Research Council/Chief Scientist Office Social and Public Health Sciences Unit (MRC/CSO SPHSU), University of Glasgow [MC_US_A540_0001]; MRC [G0900847, MC_UU_12017/5] Funding Source: UKRI; Medical Research Council [MC_UU_12017/5, G0900847] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish	EUROHEART II; Medical Research Council/Chief Scientist Office Social and Public Health Sciences Unit (MRC/CSO SPHSU), University of Glasgow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Funding: This research was funded by EUROHEART II (predicting future CVD trends under different policy scenarios in the EU: impact CVD 2020, ADONIS code A/100946) and the Medical Research Council/Chief Scientist Office Social and Public Health Sciences Unit (MRC/CSO SPHSU), University of Glasgow, as part of the "Measuring health, variations in health and determinants of health" programme, MC_US_A540_0001.	[Anonymous], 2012, FOOD DRINK SCOTL KEY; ASH Scotland, 2010, ASH SCOTL STRAT PLAN; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barendregt JJ, 2010, VALUE HEALTH, V13, P388, DOI 10.1111/j.1524-4733.2009.00686.x; Bromley C, 2005, SCOTTISH HLTH SURVEY; Bromley C, 2009, SCOTTISH HLTH SURVEY; Bromley C, 2010, SCOTTISH HLTH SURVEY; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; COBBE SM, 1991, BRIT MED J, V302, P1517, DOI 10.1136/bmj.302.6791.1517; Davies CA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-134; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Hotchkiss JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000176; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; National Records of Scotland (formerly General Register Office for Scotland), AG STAND DEATH RAT C; NICE, 2010, PREV CARD DIS NICE P; NISRA, 2011, SMALL AR POP EST UK; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Scarborough P, 2013, CORONARY HEART DIS S; Scottish Governmen.t, 2013, DENMARK AIMING SMOKE; Scottish Government, 2009, SCOTT IND MULT DEPR; Scottish Intercollegiate Guidelines Network (SIGN), 2007, RISK EST PREV CARD D; Shaw A., 2000, SCOTTISH HLTH SURVEY; Tolonen H, 2005, EUR J EPIDEMIOL, V20, P887, DOI 10.1007/s10654-005-2672-5; UK Food Standards Agency, 2008, ASS DIET SOD LEV AD; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; UNAL B, 2007, IMPACT VALIDATED COM; Woodward M, 1996, J EPIDEMIOL COMMUN H, V50, P570, DOI 10.1136/jech.50.5.570	33	45	45	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2014	348								g1088	10.1136/bmj.g1088	http://dx.doi.org/10.1136/bmj.g1088			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4JW	24503058	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000331062900001
J	McSweeney, K; Nielsen, EA; Taylor, MJ; Wrathall, DJ; Pearson, Z; Wang, O; Plumb, ST				McSweeney, Kendra; Nielsen, Erik A.; Taylor, Matthew J.; Wrathall, David J.; Pearson, Zoe; Wang, Ophelia; Plumb, Spencer T.			Drug Policy as Conservation Policy: Narco-Deforestation	SCIENCE			English	Editorial Material									[McSweeney, Kendra; Pearson, Zoe] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Nielsen, Erik A.; Wang, Ophelia] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Taylor, Matthew J.] Univ Denver, Dept Geog & Environm, Denver, CO 80208 USA; [Wrathall, David J.] United Nations Univ, Inst Environm & Human Secur, D-53113 Bonn, Germany; [Plumb, Spencer T.] Univ Idaho, Coll Nat Resources, Moscow, ID 83844 USA	University System of Ohio; Ohio State University; Northern Arizona University; University of Denver; Idaho; University of Idaho	McSweeney, K (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.	mcsweeney.14@osu.edu		Nielsen, Erik/0000-0003-3862-5260				Allen W., 2012, YALE ENV 360    1008; [Anonymous], 2010, GLOBAL FOREST RESOUR; [Anonymous], 2011, WAR DRUGS REP GLOB C; Arnason C., 2011, ORG CRIME CENTRAL AM; Bradley AV, 2008, ECOL SOC, V13; Briones A., 2013, DRUG PROBLEM AM; Bunck J. M., 2012, BRIBES BULLETS INTIM; Cuellar Nelson Susan, 2011, TERRITORIAL DYNAMICS; Grandia L, 2013, DEV CHANGE, V44, P233, DOI 10.1111/dech.12020; Gruberg J., 2012, TIERRA IGUALDAD DESA; INCSR, 2013, 2013 INT NARC CONTR; InSight Crime, 2011, GRUPOS PODER PETEN T; McSweeney K., 2014, NACLA REPORT AM; Plumb ST, 2012, FORESTS, V3, P244, DOI 10.3390/f3020244; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Regalado O., 2012, MAPA COBERTURA FORES; Stone H., 2012, NICARAGUA COAST BECO; United Nations Office of Drugs and Crime, 2012, TRANSN ORG CRIM CENT	18	83	84	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					489	490		10.1126/science.1244082	http://dx.doi.org/10.1126/science.1244082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298SC	24482468				2022-12-28	WOS:000330343700027
J	Simoni, A; Wolfgang, W; Topping, MP; Kavlie, RG; Stanewsky, R; Albert, JT				Simoni, Alekos; Wolfgang, Werner; Topping, Matthew P.; Kavlie, Ryan G.; Stanewsky, Ralf; Albert, Joerg T.			A Mechanosensory Pathway to the Drosophila Circadian Clock	SCIENCE			English	Article							ENTRAINMENT; SYNCHRONIZATION; RHYTHMS; PHASE; LIGHT; MUTANTS; TISSUES; CYCLES	Circadian clocks attune the physiology of virtually all living organisms to the diurnal cycles of their environments. In metazoan animals, multiple sensory input pathways have been linked to clock synchronization with the environmental cycle (entrainment). Extrinsic entrainment cues include light and temperature. We show that (12-hour:12-hour) cycles of vibration and silence (VS) are sufficient to synchronize the daily locomotor activity of wild-type Drosophila melanogaster. Behavioral synchronization to VS cycles required a functional clock and functional chordotonal organs and was accompanied by phase-shifts of the daily oscillations of PERIOD protein concentrations in brain clock neurons. The feedback from mechanosensory-and particularly, proprioceptive-organs may help an animal to keep its circadian clock in sync with its own, stimulus-induced activities.	[Simoni, Alekos; Wolfgang, Werner; Stanewsky, Ralf] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Topping, Matthew P.; Albert, Joerg T.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Kavlie, Ryan G.; Albert, Joerg T.] UCL, Ear Inst, London WC1X 8EE, England; [Stanewsky, Ralf; Albert, Joerg T.] UCL, Dept Cell & Dev Biol, London WC1E 6DE, England	University of London; University of London; University College London; University of London; University College London; University of London; University College London	Stanewsky, R (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	r.stanewsky@ucl.ac.uk; joerg.albert@ucl.ac.uk	Stanewsky, Ralf/ABB-9193-2021	Simoni, Alekos/0000-0001-8629-721X; Stanewsky, Ralf/0000-0001-8238-6864; Su, Matthew/0000-0002-6186-211X	Biotechnology and Biological Sciences Research Council [BB/H001204/1, BB/G004455/1]; Human Frontier Science Program; European Union; Engineering and Physical Sciences Research Council [EP/F500351/1]; BBSRC [BB/J018589/2, BB/H001204/1, BB/G004455/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018589/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1206383] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Program(Human Frontier Science Program); European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/H001204/1 to R. S. and BB/G004455/1 to J.T.A.), the Human Frontier Science Program (to J.T.A.), and the European Union FP6 Integrated Project "EUCLOCK" (to R. S.). M. P. T. received funding from the Engineering and Physical Sciences Research Council (EP/F500351/1). Additional data, including raw data, are presented in the supplementary materials. The authors thank CoMPLEX students W. Ashworth and M. Ransley for their help, W. Potter for technical support, and P. Dayan from the Gatsby Computational Neuroscience Unit at University College London for valuable discussions.	CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; Gentile C, 2013, CURR BIOL, V23, P185, DOI 10.1016/j.cub.2012.12.023; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; MROSOVSKY N, 1990, CHRONOBIOL INT, V7, P35, DOI 10.3109/07420529009056952; MROSOVSKY N, 1987, NATURE, V330, P372, DOI 10.1038/330372a0; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; TUREK FW, 1986, NATURE, V321, P167, DOI 10.1038/321167a0; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	24	50	51	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					525	528		10.1126/science.1245710	http://dx.doi.org/10.1126/science.1245710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482478	Green Submitted			2022-12-28	WOS:000330343700043
J	Ramos, SBV; Laederach, A				Ramos, Silvia B. V.; Laederach, Alain			MOLECULAR BIOLOGY A second layer of information in RNA	NATURE			English	Editorial Material									[Ramos, Silvia B. V.; Laederach, Alain] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; [Ramos, Silvia B. V.; Laederach, Alain] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ramos, SBV (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA.	silvia_ramos@med.unc.edu; alain@unc.edu		Laederach, Alain/0000-0002-5088-9907	NHLBI NIH HHS [R01 HL111527] Funding Source: Medline; NICHD NIH HHS [K08 HD069597] Funding Source: Medline; NIGMS NIH HHS [R01 GM101237] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069597] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101237] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Shcherbakova I, 2008, CURR OPIN CHEM BIOL, V12, P655, DOI 10.1016/j.cbpa.2008.09.017; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Woodson SA, 2008, CURR OPIN CHEM BIOL, V12, P667, DOI 10.1016/j.cbpa.2008.09.024	12	9	10	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					621	622		10.1038/505621a	http://dx.doi.org/10.1038/505621a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476882	Green Accepted			2022-12-28	WOS:000330321000025
J	Bernays, S; Jarrett, P; Kranzer, K; Ferrand, RA				Bernays, Sarah; Jarrett, Prudence; Kranzer, Katharina; Ferrand, Rashida A.			Children growing up with HIV infection: the responsibility of success	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; ADOLESCENTS; DISCLOSURE; ADHERENCE; BARRIERS; AFRICA; CARE		[Bernays, Sarah; Kranzer, Katharina; Ferrand, Rashida A.] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Jarrett, Prudence] Univ Manchester, Sch Med, Manchester, Lancs, England; [Ferrand, Rashida A.] Biomed Res & Training Inst, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Biomedical Research Training Institute	Ferrand, RA (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	rashida.ferrand@lshtm.ac.uk	Bernays, Sarah/AFT-0369-2022; Kranzer, Katharina/O-8845-2014	Bernays, Sarah/0000-0001-7628-8408; Kranzer, Katharina/0000-0001-5691-7270; Jarrett, Prudence/0000-0002-8842-358X	Wellcome Trust [095878/Z/11/Z, 100714] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Calabrese SK, 2012, AIDS CARE, V24, P1092, DOI 10.1080/09540121.2012.699670; Cluver LD, 2012, J PEDIATR PSYCHOL, V37, P857, DOI 10.1093/jpepsy/jss004; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Le Doare K, 2012, PEDIATRICS, V130, pE1326, DOI 10.1542/peds.2012-0405; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Skovdal M, 2012, AJAR-AFR J AIDS RES, V11, P153, DOI 10.2989/16085906.2012.734975; Tadesse AW, 2012, AIDS CARE, V24, P1359, DOI 10.1080/09540121.2011.650677; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNICEF, 2013, GLOB UPD HIV TREATM	16	51	51	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1355	1357		10.1016/S0140-6736(13)62328-4	http://dx.doi.org/10.1016/S0140-6736(13)62328-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24529338				2022-12-28	WOS:000334104900033
J	Liu, XD; Chen, X; Zhong, B; Wang, AB; Wang, XH; Chu, FL; Nurieva, RI; Yan, XW; Chen, P; van der Flier, LG; Nakatsukasa, H; Neelapu, SS; Chen, WJ; Clevers, H; Tian, Q; Qi, H; Wei, L; Dong, C				Liu, Xindong; Chen, Xin; Zhong, Bo; Wang, Aibo; Wang, Xiaohu; Chu, Fuliang; Nurieva, Roza I.; Yan, Xiaowei; Chen, Ping; van der Flier, Laurens G.; Nakatsukasa, Hiroko; Neelapu, Sattva S.; Chen, Wanjun; Clevers, Hans; Tian, Qiang; Qi, Hai; Wei, Lai; Dong, Chen			Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development	NATURE			English	Article							B-CELLS; C-MAF; DIFFERENTIATION; EXPRESSION; BCL6; REGULATORS; STAT5; IL-21; FATE; GENE	In immune responses, activated T cells migrate to B-cell follicles and develop into follicular T-helper (T-FH) cells, a recently identified subset of CD4(+) T cells specialized in providing help to B lymphocytes in the induction of germinal centres(1,2). Although Bcl6 has been shown to be essential in T-FH-cell function, it may not regulate the initial migration of T cells(3) or the induction of the T-FH program, as exemplified by C-X-C chemokine receptor type 5 (CXCR5) upregulation(4). Here we show that expression of achaete-scute homologue 2 (Ascl2)-a basic helix-loop-helix (bHLH) transcription factor(5)-is ;selectively upregulated in T-FH cells. Ectopic expression of Ascl2 upregulates CXCR5 but not Bcl6, and downregulates C-C chemokine receptor 7 (CCR7) expression in T cells in vitro, as well as accelerating T-cell migration to the follicles and T-FH-cell development in vivo in mice. Genome-wide analysis indicates that Ascl2 directly regulates T-FH-related genes whereas it inhibits expression of T-helper cell 1 (T(H)1) and T(H)17 signature genes. Acute deletion of Ascl2, as well as blockade of its function with the Id3 protein in CD4(+) T cells, results in impaired T-FH-cell development and germinal centre response. Conversely, mutation of Id3, known to cause antibody-mediated autoimmunity, greatly enhances T-FH-cell generation. Thus, Ascl2 directly initiates T-FH-cell development.	[Liu, Xindong; Chen, Xin; Wang, Aibo; Wang, Xiaohu; Qi, Hai; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Liu, Xindong; Zhong, Bo; Wang, Aibo; Wang, Xiaohu; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Chu, Fuliang; Neelapu, Sattva S.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77054 USA; [Yan, Xiaowei; Tian, Qiang] Inst Syst Biol, Seattle, WA 98103 USA; [Chen, Ping] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [van der Flier, Laurens G.; Clevers, Hans] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van der Flier, Laurens G.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Nakatsukasa, Hiroko; Chen, Wanjun] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Wei, Lai] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Sun Yat Sen University	Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	xindongliu@hotmail.com; cdonglab@hotmail.com	Chen, Xin/GNH-1799-2022; dong, chen/B-3181-2009; liu, xindong/F-8422-2014	Chen, Xin/0000-0001-6212-2335; dong, chen/0000-0002-0084-9130; Qi, Hai/0000-0001-5475-3989; Liu, Xindong/0000-0002-2465-0337	National Institutes of Health (NIH) [AI106654]; NIDCR; NIH Lymphoma SPORE; MD Anderson Cancer Center; Chinese Ministry of Science and Technology '973' program [2014CB542501, 2012CB910402]; National Natural Science Foundation of China [81361120397]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772, RC2AR059010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH Lymphoma SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center; Chinese Ministry of Science and Technology '973' program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. A. Whitsett and J. P. Bridges at the University of Cincinnati for their provision of Ascl2 conditional knockout mice, D. Yi for help with ChIP-seq and microarray analysis, R. Dalla-Favera for Bcl6<SUP>-/-</SUP> mice, H. Hu for histochemistry staining, and the Dong laboratory members for their help. This work was supported in part by a grant from the National Institutes of Health (NIH; AI106654 to C. D.), an intramural research program (NIDCR to W. C. and H.N.), an NIH Lymphoma SPORE (to X. L.), an Odyssey fellowship from the MD Anderson Cancer Center (to X. L. and B.Z.), Chinese Ministry of Science and Technology '973' program grants (2014CB542501 and 2012CB910402), and a National Natural Science Foundation of China grant (81361120397 to H.Q.).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yoo JK, 2012, J EXP MED, V209, P1853, DOI 10.1084/jem.20112256; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472	30	237	250	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					513	+		10.1038/nature12910	http://dx.doi.org/10.1038/nature12910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24463518	Green Accepted			2022-12-28	WOS:000333402000044
J	Schwadron, NA; Adams, FC; Christian, ER; Desiati, P; Frisch, P; Funsten, HO; Jokipii, JR; McComas, DJ; Moebius, E; Zank, GP				Schwadron, N. A.; Adams, F. C.; Christian, E. R.; Desiati, P.; Frisch, P.; Funsten, H. O.; Jokipii, J. R.; McComas, D. J.; Moebius, E.; Zank, G. P.			Global Anisotropies in TeV Cosmic Rays Related to the Sun's Local Galactic Environment from IBEX	SCIENCE			English	Article							INTERSTELLAR-BOUNDARY-EXPLORER; MAGNETIC-FIELD; OUTER HELIOSPHERE; LO OBSERVATIONS; ENA FLUX; RIBBON; PARAMETERS; SPECTRUM; ORIGIN; ORIENTATION	Observations with the Interstellar Boundary Explorer (IBEX) have shown enhanced energetic neutral atom(ENA) emission from a narrow, circular ribbon likely centered on the direction of the local interstellar medium (LISM) magnetic field. Here, we show that recent determinations of the local interstellar velocity, based on interstellar atom measurements with IBEX, are consistent with the interstellar modulation of high-energy (tera-electron volts, TeV) cosmic rays and diffusive propagation from supernova sources revealed in global anisotropy maps of ground-based high-energy cosmic-ray observatories (Milagro, As gamma, and IceCube). Establishing a consistent local interstellar magnetic field direction using IBEX ENAs at hundreds to thousands of eV and galactic cosmic rays at tens of TeV has wide-ranging implications for the structure of our heliosphere and its interactions with the LISM, which is particularly important at the time when the Voyager spacecraft are leaving our heliosphere.	[Schwadron, N. A.; Moebius, E.] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; [Schwadron, N. A.; McComas, D. J.] SW Res Inst, San Antonio, TX 78228 USA; [Adams, F. C.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Christian, E. R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Desiati, P.] Univ Wisconsin, IceCube Observ, Madison, WI 53706 USA; [Desiati, P.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Frisch, P.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Jokipii, J. R.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Zank, G. P.] Univ Alabama, Huntsville, AL 35805 USA	University System Of New Hampshire; University of New Hampshire; Southwest Research Institute; University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Arizona; University of Texas System; University of Texas at San Antonio (UTSA); University of Alabama System; University of Alabama Huntsville	Schwadron, NA (corresponding author), Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA.	n.schwadron@unh.edu	Funsten, Herbert O/A-5702-2015	Funsten, Herbert O/0000-0002-6817-1039; Moebius, Eberhard/0000-0002-2745-6978; Desiati, Paolo/0000-0001-9768-1858	NASA's Explorers Program [NNG05EC85C]; Direct For Mathematical & Physical Scien [1229408] Funding Source: National Science Foundation	NASA's Explorers Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank all those who made IBEX possible. IBEX is primarily funded by NASA's Explorers Program (Contract no. NNG05EC85C). IBEX data are available at http://ibex.swri.edu/researchers/publicdata.shtml. IceCube cosmic ray data are available from http://icecube.wisc.edu/science/data.	Abbasi R, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/16; Abdo AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.221101; Abdo AA, 2009, ASTROPHYS J, V698, P2121, DOI 10.1088/0004-637X/698/2/2121; Amenomori M, 2010, AIP CONF PROC, V1302, P285, DOI 10.1063/1.3529985; Amenomori M., 2010, ASTROPHYS SPACE SCI, V6, P49; ARMSTRONG JW, 1995, ASTROPHYS J, V443, P209, DOI 10.1086/175515; Blasi P, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/01/011; Busching I, 2008, ADV SPACE RES, V42, P504, DOI 10.1016/j.asr.2007.05.051; Busching I, 2005, ASTROPHYS J, V619, P314, DOI 10.1086/426537; Busching I, 2001, ASTRON ASTROPHYS, V377, P1056, DOI 10.1051/0004-6361:20011125; Bzowski M, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/12; CHANDRASEKHAR S, 1952, ASTROPHYS J, V115, P103, DOI 10.1086/145518; Desiati P, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/44; Erlykin AD, 2006, ASTROPART PHYS, V25, P183, DOI 10.1016/j.astropartphys.2006.01.003; Evoli C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.211102; FORMAN MA, 1975, ASTROPHYS SPACE SCI, V32, P77, DOI 10.1007/BF00646218; Frisch PC, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/106; Funsten HO, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/30; Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Fuselier SA, 2009, SCIENCE, V326, P962, DOI 10.1126/science.1180981; Giacalone J, 1999, ASTROPHYS J, V520, P204, DOI 10.1086/307452; Giacinti G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.071101; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; Guillian G, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.062003; Hall DL, 1999, J GEOPHYS RES-SPACE, V104, P6737, DOI 10.1029/1998JA900107; Heerikhuisen J, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/29; Heerikhuisen J, 2010, ASTROPHYS J LETT, V708, pL126, DOI 10.1088/2041-8205/708/2/L126; Jokipii JR, 2007, SCIENCE, V316, P839, DOI 10.1126/science.1141628; Jokipii J. R., 1999, P 2 GUILL HAR C, P70; Jokipii JR, 2005, SCIENCE, V307, P1424, DOI 10.1126/science.1109701; JOKIPII JR, 1969, ASTROPHYS J, V155, P799, DOI 10.1086/149910; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; LEE LC, 1976, ASTROPHYS J, V206, P735, DOI 10.1086/154434; McComas DJ, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/77; McComas DJ, 2012, SCIENCE, V336, P1291, DOI 10.1126/science.1221054; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; Minter AH, 1996, ASTROPHYS J, V458, P194, DOI 10.1086/176803; Mobius E, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/11; Mobius E, 2009, SCIENCE, V326, P969, DOI 10.1126/science.1180971; Nagashima K, 1998, J GEOPHYS RES-SPACE, V103, P17429, DOI 10.1029/98JA01105; Opher M, 2007, SCIENCE, V316, P875, DOI 10.1126/science.1139480; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; Pogorelov N, 2009, SPACE SCI REV, V143, P31, DOI 10.1007/s11214-008-9429-x; Pogorelov NV, 2006, ASTROPHYS J, V636, pL161, DOI 10.1086/500087; Pohl M, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/4; Ptuskin VS, 2006, ASTROPHYS J, V642, P902, DOI 10.1086/501117; Ratkiewicz R, 1998, ASTRON ASTROPHYS, V335, P363; Schonrich R, 2010, MON NOT R ASTRON SOC, V403, P1829, DOI 10.1111/j.1365-2966.2010.16253.x; Schwadron NA, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/92; Schwadron NA, 2009, SCIENCE, V326, P966, DOI 10.1126/science.1180986; Schwadron N.A., 2011, EOS T AM GEOPHYS UN, V92, P297, DOI [10.1029/2011EO360001, DOI 10.1029/2011EO360001]; Shalchi A, 2010, ASTROPHYS J, V725, P2117, DOI 10.1088/0004-637X/725/2/2117; Witte M, 2004, ASTRON ASTROPHYS, V426, P835, DOI 10.1051/0004-6361:20035956; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277	54	76	77	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					988	990		10.1126/science.1245026	http://dx.doi.org/10.1126/science.1245026			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24526313	Green Published			2022-12-28	WOS:000332309600036
J	Kim, H; Abeysirigunawarden, SC; Chen, K; Mayerle, M; Ragunathan, K; Luthey-Schulten, Z; Ha, T; Woodson, SA				Kim, Hajin; Abeysirigunawarden, Sanjaya C.; Chen, Ke; Mayerle, Megan; Ragunathan, Kaushik; Luthey-Schulten, Zaida; Ha, Taekjip; Woodson, Sarah A.			Protein-guided RNA dynamics during early ribosome assembly	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOMES; SINGLE-MOLECULE; INDUCED FIT; STRUCTURAL DYNAMICS; BINDING-SITE; S4; SUBUNIT; RECOGNITION; RECONSTITUTION; FLEXIBILITY	The assembly of 30S ribosomes requires the precise addition of 20 proteins to the 16S ribosomal RNA. How early binding proteins change the ribosomal RNA structure so that later proteins may join the complex is poorly understood. Here we use single-molecule fluorescence resonance energy transfer (FRET) to observe real-time encounters between Escherichia coli ribosomal protein S4 and the 16S 5' domain RNA at an early stage of 30S assembly. Dynamic initial S4-RNA complexes pass through a stable non-native intermediate before converting to the native complex, showing that non-native structures can offer a low free-energy path to protein-RNA recognition. Three-colour FRET and molecular dynamics simulations reveal how S4 changes the frequency and direction of RNA helix motions, guiding a conformational switch that enforces the hierarchy of protein addition. These protein-guided dynamics offer an alternative explanation for induced fit in RNA-protein complexes.	[Kim, Hajin; Luthey-Schulten, Zaida; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Kim, Hajin; Luthey-Schulten, Zaida; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kim, Hajin; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Abeysirigunawarden, Sanjaya C.; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Chen, Ke; Ragunathan, Kaushik; Luthey-Schulten, Zaida; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Chen, Ke; Luthey-Schulten, Zaida; Ha, Taekjip] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Mayerle, Megan; Woodson, Sarah A.] Johns Hopkins Univ, CMDB Program, Baltimore, MD 21218 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Ha, T (corresponding author), Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu; swoodson@jhu.edu	Ha, Taekjip/B-9506-2009; Kim, Hajin/B-5166-2014	Ha, Taekjip/0000-0003-2195-6258; Mayerle, Megan/0000-0002-6237-920X; Luthey-Schulten, Zaida/0000-0001-9749-8367; Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health [R01 GM60819, R01 GM65367]; National Science Foundation (NSF) [PHY0822613, MCB12-44570]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM065367, R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01 GM60819 to S. A. W.; R01 GM65367 to T. H.) and from the National Science Foundation (NSF) (PHY0822613 to T. H. and MCB12-44570 to Z. L.-S.). Supercomputer computing time was provided by NSF XSEDE (TG-MCA03S027). T. H. is an investigator with the Howard Hughes Medical Institute.	Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Bellur DL, 2009, NUCLEIC ACIDS RES, V37, P1886, DOI 10.1093/nar/gkp036; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bokinsky G, 2006, J MOL BIOL, V361, P771, DOI 10.1016/j.jmb.2006.06.048; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Chen K, 2012, J PHYS CHEM B, V116, P6819, DOI 10.1021/jp212614b; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Gerstner RB, 2001, BIOCHEMISTRY-US, V40, P7165, DOI 10.1021/bi010026i; Grabow WW, 2012, J MOL BIOL, V424, P54, DOI 10.1016/j.jmb.2012.09.012; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Haller A, 2013, P NATL ACAD SCI USA, V110, P4188, DOI 10.1073/pnas.1218062110; HELD WA, 1974, J BIOL CHEM, V249, P3103; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hohng S, 2004, J MOL BIOL, V336, P69, DOI 10.1016/j.jmb.2003.12.014; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joo C., 2012, COLD SPRING HARB PRO, V2012, P1104, DOI [DOI 10.1101/PDB.PROT071530, DOI 10.1101/PDB.PR0T071530]; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Mayerle M, 2013, RNA, V19, P574, DOI 10.1261/rna.037028.112; Mayerle M, 2011, J MOL BIOL, V412, P453, DOI 10.1016/j.jmb.2011.07.048; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Munro JB, 2010, EMBO J, V29, P770, DOI 10.1038/emboj.2009.384; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; POWERS T, 1995, J BIOL CHEM, V270, P1238, DOI 10.1074/jbc.270.3.1238; Ramaswamy P, 2009, J MOL BIOL, V392, P666, DOI 10.1016/j.jmb.2009.07.032; Ramaswamy P, 2009, NAT STRUCT MOL BIOL, V16, P438, DOI 10.1038/nsmb.1585; Rau M, 2012, RNA, V18, P1984, DOI 10.1261/rna.035006.112; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Smith GJ, 2005, RNA, V11, P234, DOI 10.1261/rna.7180305; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Soper SFC, 2013, MOL CELL, V52, P506, DOI 10.1016/j.molcel.2013.09.020; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Weeks KM, 1996, SCIENCE, V271, P345, DOI 10.1126/science.271.5247.345; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Woodson SA, 2011, ACCOUNTS CHEM RES, V44, P1312, DOI 10.1021/ar2000474; Xie Z, 2004, P NATL ACAD SCI USA, V101, P534, DOI 10.1073/pnas.2636333100; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	61	107	110	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					334	+		10.1038/nature13039	http://dx.doi.org/10.1038/nature13039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522531	Green Accepted			2022-12-28	WOS:000331477800034
J	Eckel, S; Lee, JG; Jendrzejewski, F; Murray, N; Clark, CW; Lobb, CJ; Phillips, WD; Edwards, M; Campbell, GK				Eckel, Stephen; Lee, Jeffrey G.; Jendrzejewski, Fred; Murray, Noel; Clark, Charles W.; Lobb, Christopher J.; Phillips, William D.; Edwards, Mark; Campbell, Gretchen K.			Hysteresis in a quantized superfluid 'atomtronic' circuit	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; STATES; GAS; ROTATION	Atomtronics(1,2) is an emerging interdisciplinary field that seeks to develop new functional methods by creating devices and circuits where ultracold atoms, often superfluids, have a role analogous to that of electrons in electronics. Hysteresis is widely used in electronic circuits-it is routinely observed in superconducting circuits(3) and is essential in radio-frequency superconducting quantum interference devices(4). Furthermore, it is as fundamental to superfluidity(5) (and superconductivity) as quantized persistent currents(6-8), critical velocity(9-14) and Josephson effects(15,16). Nevertheless, despite multiple theoretical predictions(5,17-19), hysteresis has not been previously observed in any superfluid, atomic-gas Bose-Einstein condensate. Here we directly detect hysteresis between quantized circulation states in an atomtronic circuit formed from a ring of superfluid Bose-Einstein condensate obstructed by a rotating weak link (a region of low atomic density). This contrasts with previous experiments on superfluid liquid helium where hysteresis was observed directly in systems in which the quantization of flow could not be observed(20), and indirectly in systems that showed quantized flow(21,22). Our techniques allow us to tune the size of the hysteresis loop and to consider the fundamental excitations that accompany hysteresis. The results suggest that the relevant excitations involved in hysteresis are vortices, and indicate that dissipation has an important role in the dynamics. Controlled hysteresis in atomtronic circuits may prove to be a crucial feature for the development of practical devices, just as it has in electronic circuits such as memories, digital noise filters (for example Schmitt triggers) and magnetometers (for example superconducting quantum interference devices).	[Eckel, Stephen; Lee, Jeffrey G.; Jendrzejewski, Fred; Clark, Charles W.; Lobb, Christopher J.; Phillips, William D.; Campbell, Gretchen K.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Eckel, Stephen; Lee, Jeffrey G.; Jendrzejewski, Fred; Clark, Charles W.; Lobb, Christopher J.; Phillips, William D.; Campbell, Gretchen K.] Univ Maryland, Gaithersburg, MD 20899 USA; [Murray, Noel; Edwards, Mark] Georgia So Univ, Dept Phys, Statesboro, GA 30460 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia Southern University	Campbell, GK (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	gretchen.campbell@nist.gov	Eckel, Stephen/K-5215-2014; Clark, Charles W/A-8594-2009; Jendrzejewski, Fred/L-2998-2016; Edwards, Mark Andrew/Q-9662-2019; Campbell, Gretchen K/E-8338-2010	Eckel, Stephen/0000-0002-8887-0320; Clark, Charles W/0000-0001-8724-9885; Jendrzejewski, Fred/0000-0003-1488-7901; Edwards, Mark Andrew/0000-0002-3149-2402; Campbell, Gretchen K/0000-0003-2596-1919	ONR; ARO atomtronics MURI; NSF through the PFC at the JQI; National Research Council;  [PHY-1068761]; Direct For Mathematical & Physical Scien [0822671, 1068761] Funding Source: National Science Foundation	ONR(Office of Naval Research); ARO atomtronics MURI; NSF through the PFC at the JQI; National Research Council(Consiglio Nazionale delle Ricerche (CNR)); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by ONR, the ARO atomtronics MURI, and the NSF through the PFC at the JQI and grant PHY-1068761. S. E. is supported by a National Research Council postdoctoral fellowship. We wish to thank K. Wright, W. T. Hill III and A. Kumar for valuable discussions and experimental assistance.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Baharian S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013619; Beeler MC, 2013, NATURE, V498, P201, DOI 10.1038/nature12185; Cameron E, 2011, PUBL ASTRON SOC AUST, V28, P128, DOI 10.1071/AS10046; Choi S, 1998, PHYS REV A, V57, P4057, DOI 10.1103/PhysRevA.57.4057; Desbuquois R, 2012, NAT PHYS, V8, P645, DOI [10.1038/nphys2378, 10.1038/NPHYS2378]; Diakonov D, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013604; Engels P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160405; FETTER AL, 1967, PHYS REV, V153, P285, DOI 10.1103/PhysRev.153.285; Hoskinson E, 2006, NAT PHYS, V2, P23, DOI 10.1038/nphys190; Inouye S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080402; KOJIMA H, 1971, PHYS REV LETT, V27, P714, DOI 10.1103/PhysRevLett.27.714; Lamb H., 1932, HYDRODYNAMICS, P123; Levy S, 2007, NATURE, V449, P579, DOI 10.1038/nature06186; Madison KW, 2001, PHYS REV LETT, V86, P4443, DOI 10.1103/PhysRevLett.86.4443; Miller DE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070402; Morsch O, 2006, REV MOD PHYS, V78, P179, DOI 10.1103/RevModPhys.78.179; Moulder S, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013629; Mueller EJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.063603; Neely TW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160401; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Pepino RA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.140405; Plischke M., 2006, EQUILIBRIUM STAT PHY, P83; Ramanathan A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130401; Ramanathan A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4747163; Recati A, 2001, PHYS REV LETT, V86, P377, DOI 10.1103/PhysRevLett.86.377; Schwab K, 1998, J LOW TEMP PHYS, V110, P1043, DOI 10.1023/A:1022364200234; Schwab K, 1997, NATURE, V386, P585, DOI 10.1038/386585a0; SILVER AH, 1967, PHYS REV, V157, P317, DOI 10.1103/PhysRev.157.317; Watanabe G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.270404; Watanabe G, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.053602; Wright KC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025302; ZIMMERMAN JE, 1970, J APPL PHYS, V41, P1572, DOI 10.1063/1.1659074	33	245	246	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					200	+		10.1038/nature12958	http://dx.doi.org/10.1038/nature12958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24522597	Green Submitted			2022-12-28	WOS:000331107700033
J	Gadeyne, A; Sanchez-Rodriguez, C; Vanneste, S; Di Rubbo, S; Zauber, H; Vanneste, K; Van Leene, J; De Winne, N; Eeckhout, D; Persiau, G; De Slijke, EV; Cannoot, B; Vercruysse, L; Mayers, JR; Adamowski, M; Kania, U; Ehrlich, M; Schweighofer, A; Ketelaar, T; Maere, S; Bednarek, SY; Friml, J; Gevaert, K; Witters, E; Russinova, E; Persson, S; De Jaeger, G; Van Damme, D				Gadeyne, Astrid; Sanchez-Rodriguez, Clara; Vanneste, Steffen; Di Rubbo, Simone; Zauber, Henrik; Vanneste, Kevin; Van Leene, Jelle; De Winne, Nancy; Eeckhout, Dominique; Persiau, Geert; De Slijke, Eveline Van; Cannoot, Bernard; Vercruysse, Leen; Mayers, Jonathan R.; Adamowski, Maciek; Kania, Urszula; Ehrlich, Matthias; Schweighofer, Alois; Ketelaar, Tijs; Maere, Steven; Bednarek, Sebastian Y.; Friml, Jiri; Gevaert, Kris; Witters, Erwin; Russinova, Eugenia; Persson, Staffan; De Jaeger, Geert; Van Damme, Daniel			The TPLATE Adaptor Complex Drives Clathrin-Mediated Endocytosis in Plants	CELL			English	Article							DOMAIN-CONTAINING PROTEINS; PLASMA-MEMBRANE; AUXIN EFFLUX; DEPENDENT ENDOCYTOSIS; SOMATIC CYTOKINESIS; ORGAN DEVELOPMENT; ARABIDOPSIS; TRAFFICKING; DYNAMIN; YEAST	Clathrin-mediated endocytosis is the major mechanism for eukaryotic plasma membrane-based proteome turn-over. In plants, clathrin-mediated endocytosis is essential for physiology and development, but the identification and organization of the machinery operating this process remains largely obscure. Here, we identified an eight-core-component protein complex, the TPLATE complex, essential for plant growth via its role as major adaptor module for clathrin-mediated endocytosis. This complex consists of evolutionarily unique proteins that associate closely with core endocytic elements. The TPLATE complex is recruited as dynamic foci at the plasma membrane preceding recruitment of adaptor protein complex 2, clathrin, and dynamin-related proteins. Reduced function of different complex components severely impaired internalization of assorted endocytic cargoes, demonstrating its pivotal role in clathrin-mediated endocytosis. Taken together, the TPLATE complex is an early endocytic module representing a unique evolutionary plant adaptation of the canonical eukaryotic pathway for clathrin-mediated endocytosis.	[Gadeyne, Astrid; Vanneste, Steffen; Di Rubbo, Simone; Vanneste, Kevin; Van Leene, Jelle; De Winne, Nancy; Eeckhout, Dominique; Persiau, Geert; De Slijke, Eveline Van; Cannoot, Bernard; Vercruysse, Leen; Adamowski, Maciek; Kania, Urszula; Maere, Steven; Friml, Jiri; Russinova, Eugenia; De Jaeger, Geert; Van Damme, Daniel] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Gadeyne, Astrid; Vanneste, Steffen; Di Rubbo, Simone; Vanneste, Kevin; Van Leene, Jelle; De Winne, Nancy; Eeckhout, Dominique; Persiau, Geert; De Slijke, Eveline Van; Cannoot, Bernard; Vercruysse, Leen; Adamowski, Maciek; Kania, Urszula; Maere, Steven; Friml, Jiri; Russinova, Eugenia; De Jaeger, Geert; Van Damme, Daniel] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Sanchez-Rodriguez, Clara; Zauber, Henrik; Ehrlich, Matthias; Schweighofer, Alois; Persson, Staffan] Max Planck Inst Mol Planzenphysiol, D-14476 Potsdam, Germany; [Mayers, Jonathan R.; Bednarek, Sebastian Y.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Adamowski, Maciek; Kania, Urszula; Friml, Jiri] IST Austria, A-3400 Klosterneuburg, Austria; [Schweighofer, Alois] Vilnius State Univ, Inst Biotechnol IBT, LT-02242 Vilnius, Lithuania; [Ketelaar, Tijs] Wageningen Univ, Cell Biol Lab, NL-6708 PB Wageningen, Netherlands; [Gevaert, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Witters, Erwin] Univ Antwerp, Ctr Proteome Anal & Mass Spectrometry, Dept Biol, B-2020 Antwerp, Belgium; [Witters, Erwin] Flemish Inst Technol Res VITO, B-2400 Mol, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison; Institute of Science & Technology - Austria; Vilnius University; Wageningen University & Research; Flanders Institute for Biotechnology (VIB); Ghent University; University of Antwerp; VITO	Van Damme, D (corresponding author), VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	persson@mpimp-golm.mpg.de; daniel.vandamme@psb.vib-ugent.be	Gevaert, Kris/AAE-4212-2019; van damme, daniel/ABA-1397-2020; Maere, Steven G.G./P-5640-2014; Persson, Staffan/S-8399-2016; Adamowski, Maciek/HHZ-5725-2022; Friml, Jiri/D-9511-2012; van damme, daniel/F-6139-2014; Van Leene, Jelle/ABE-6697-2020; Gevaert, Kris/D-6489-2017; Vanneste, Steffen/K-8353-2013; Sanchez-Rodriguez, Clara/J-3235-2016; Sanchez-Rodriguez, Clara/J-5901-2014	Gevaert, Kris/0000-0002-4237-0283; van damme, daniel/0000-0002-9385-4851; Maere, Steven G.G./0000-0002-5341-136X; Persson, Staffan/0000-0002-6377-5132; Friml, Jiri/0000-0002-8302-7596; van damme, daniel/0000-0002-9385-4851; Van Leene, Jelle/0000-0002-4932-8192; Gevaert, Kris/0000-0002-4237-0283; Vanneste, Steffen/0000-0002-9948-9672; Sanchez-Rodriguez, Clara/0000-0003-0987-9317; Eeckhout, Dominique/0000-0001-5770-7670; Sanchez-Rodriguez, Clara/0000-0003-4451-5797; Kania, Urszula/0000-0001-5416-4287; Schweighofer, Alois/0000-0002-8466-0924; Gadeyne, Astrid/0000-0003-1867-1673; Russinova, Eugenia/0000-0002-0569-1977; Adamowski, Maciek/0000-0001-6463-5257; De Jaeger, Geert/0000-0001-6558-5669	Agency for Innovation by Science and Technology; Max-Planck Gesellschaft; Marie-Curie Initial Training Network BRAVISSIMO [PITN-GA-2008-215118]; National Science Foundation [1121998]; Ghent University; Hercules Foundation; Flemish Government-department EWI	Agency for Innovation by Science and Technology; Max-Planck Gesellschaft(Max Planck Society); Marie-Curie Initial Training Network BRAVISSIMO; National Science Foundation(National Science Foundation (NSF)); Ghent University(Ghent University); Hercules Foundation; Flemish Government-department EWI	The authors would like to thank Wim Grunewald (VIB/UGent, Belgium), Niko Geldner (University of Lausanne, Switzerland), Satoshi Naramoto and Masaru Fujimoto (University of Tokyo, Japan), Inhwan Hwang (Pohang University, Korea), Gerd Jurgens (Tubingen University, Germany), and Christian Luschnig (Vienna University, Austria) for sharing materials; Mansour Karimi and Riet De Rycke (VIB/University of Ghent, Belgium) for vector cloning and IEM attempts; and Luis Vidali (Worchester Polytechnic Institute, USA) for constructive discussions. A. G. was indebted to the Agency for Innovation by Science and Technology for a predoctoral fellowship. S. P. and C. S. R were funded through the Max-Planck Gesellschaft. K. V., S. V., J.V.L. and S. M. are fellows of the Research Foundation - Flanders (FWO). S. D. R. was funded by the Marie-Curie Initial Training Network BRAVISSIMO (PITN-GA-2008-215118). J.R.M and S.Y.B were supported by the National Science Foundation (1121998) (S.Y.B.). Part of this work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation, and the Flemish Government-department EWI. We apologize to colleagues whose work could not be cited due to space limitations.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Backues SK, 2010, PLANT CELL, V22, P3218, DOI 10.1105/tpc.110.077727; Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007973; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Barth M, 2004, J CELL SCI, V117, P2051, DOI 10.1242/jcs.01062; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boutte Y, 2010, EMBO J, V29, P546, DOI 10.1038/emboj.2009.363; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Collings DA, 2008, J EXP BOT, V59, P361, DOI 10.1093/jxb/erm324; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2010, CURR OPIN CELL BIOL, V22, P513, DOI 10.1016/j.ceb.2010.05.009; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Di Rubbo S, 2013, PLANT CELL, V25, P2986, DOI 10.1105/tpc.113.114058; Du YL, 2013, P NATL ACAD SCI USA, V110, P7946, DOI 10.1073/pnas.1220205110; Fan LS, 2013, DEVELOPMENT, V140, P3826, DOI 10.1242/dev.095711; Fujimoto M, 2010, P NATL ACAD SCI USA, V107, P6094, DOI 10.1073/pnas.0913562107; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irani NG, 2012, NAT CHEM BIOL, V8, P583, DOI [10.1038/NCHEMBIO.958, 10.1038/nchembio.958]; Kang BH, 2003, PLANT CELL, V15, P899, DOI 10.1105/tpc.009670; Kim SY, 2013, PLANT CELL, V25, P2970, DOI 10.1105/tpc.113.114264; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Lam BCH, 2001, PLANT CELL, V13, P2499, DOI 10.1105/tpc.13.11.2499; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Mayers JR, 2013, P NATL ACAD SCI USA, V110, P11857, DOI 10.1073/pnas.1302918110; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Song K, 2012, PLANT PHYSIOL, V159, P1013, DOI 10.1104/pp.112.199380; Sutter JU, 2007, CURR BIOL, V17, P1396, DOI 10.1016/j.cub.2007.07.020; Takano J., 2010, J BIOL CHEM; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Umasankar PK, 2012, NAT CELL BIOL, V14, P488, DOI 10.1038/ncb2473; van Damme D, 2006, PLANT CELL, V18, P3502, DOI 10.1105/tpc.106.040923; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; Van Leene J, 2011, METHODS MOL BIOL, V754, P195, DOI 10.1007/978-1-61779-154-3_11; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wang C, 2013, PLANT CELL, V25, P499, DOI 10.1105/tpc.112.108373; Yamaoka S, 2013, PLANT CELL, V25, P2958, DOI 10.1105/tpc.113.114082; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643	61	161	167	7	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					691	704		10.1016/j.cell.2014.01.039	http://dx.doi.org/10.1016/j.cell.2014.01.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529374	Bronze			2022-12-28	WOS:000331379800009
J	Herweijer, E; Leval, A; Ploner, A; Eloranta, S; Simard, JF; Dillner, J; Netterlid, E; Sparen, P; Arnheim-Dahlstrom, L				Herweijer, Eva; Leval, Amy; Ploner, Alexander; Eloranta, Sandra; Simard, Julia Fridman; Dillner, Joakim; Netterlid, Eva; Sparen, Par; Arnheim-Dahlstrom, Lisen			Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENITAL WARTS; ANOGENITAL WARTS; NATURAL-HISTORY; UNITED-STATES; YOUNG-WOMEN; HPV VACCINE; EFFICACY; IMMUNOGENICITY; INFECTIONS; PREVALENCE	IMPORTANCE Determining vaccine dose-level protection is essential to minimize program costs and increase mass vaccination program feasibility. Currently, a 3-dose vaccination schedule is recommended for both the quadrivalent and bivalent human papillomavirus (HPV) vaccines. Although the primary goal of HPV vaccination programs is to prevent cervical cancer, condyloma related to HPV types 6 and 11 is also prevented with the quadrivalent vaccine and represents the earliest measurable preventable disease outcome for the HPV vaccine. OBJECTIVE To examine the association between quadrivalent HPV vaccination and first occurrence of condyloma in relation to vaccine dose in a population-based setting. DESIGN, SETTING, AND PARTICIPANTS An open cohort of all females aged 10 to 24 years living in Sweden (n = 1 045 165) was followed up between 2006 and 2010 for HPV vaccination and first occurrence of condyloma using the Swedish nationwide population-based health data registers. MAIN OUTCOMES AND MEASURES Incidence rate ratios (IRRs) and incidence rate differences (IRDs) of condyloma were estimated using Poisson regression with vaccine dose as a time-dependent exposure, adjusting for attained age and parental education, and stratified on age at first vaccination. To account for prevalent infections, models included a buffer period of delayed case counting. RESULTS A total of 20 383 incident cases of condyloma were identified during follow-up, including 322 cases after receipt of at least 1 dose of the vaccine. For individuals aged 10 to 16 years at first vaccination, receipt of 3 doses was associated with an IRR of 0.18 (95% CI, 0.15-0.22) for condyloma, whereas receipt of 2 doses was associated with an IRR of 0.29 (95% CI, 0.21-0.40). One dose was associated with an IRR of 0.31 (95% CI, 0.20-0.49), which corresponds to an IRD of 384 cases (95% CI, 305-464) per 100 000 person-years, compared with no vaccination. The corresponding IRDs for 2 doses were 400 cases (95% CI, 346-454) and for 3 doses, 459 cases (95% CI, 437-482). The number of prevented cases between 3 and 2 doses was 59 (95% CI, 2-117) per 100 000 person-years. CONCLUSIONS AND RELEVANCE Although maximum reduction in condyloma risk was seen after receipt of 3 doses of quadrivalent HPV vaccine, receipt of 2 vaccine doses was also associated with a considerable reduction in condyloma risk. The implications of these findings for the relationship between number of vaccine doses and cervical cancer risk require further investigation.	[Herweijer, Eva; Ploner, Alexander; Eloranta, Sandra; Dillner, Joakim; Sparen, Par; Arnheim-Dahlstrom, Lisen] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Leval, Amy] Dept Communicable Dis Control & Prevent Stockholm, Stockholm, Sweden; [Leval, Amy] Karolinska Inst, Dept Med, Infect Dis Unit, SE-17177 Stockholm, Sweden; [Simard, Julia Fridman] Karolinska Inst, Clin Epidemiol Unit, Dept Med, SE-17177 Stockholm, Sweden; [Netterlid, Eva] Swedish Inst Communicable Dis Control, Stockholm, Sweden; [Netterlid, Eva] Lund Univ, Fac Med, Dept Clin Sci Malmo, Malmo, Sweden; [Netterlid, Eva] Skane Univ Hosp, Dept Occupat & Environm Dermatol, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Lund University; Lund University; Skane University Hospital	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Eloranta, Sandra/X-6661-2018	Sparen, Par/0000-0002-5184-8971; Simard, Julia/0000-0001-5735-9856; Ploner, Alexander/0000-0002-5042-8326	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by a grant from the Swedish Foundation for Strategic Research.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; Blomberg M, 2013, CLIN INFECT DIS, V57, P929, DOI 10.1093/cid/cit436; Castle PE, 2011, J INFECT DIS, V204, P335, DOI 10.1093/infdis/jir287; Cummings T, 2012, VACCINE, V30, P5496, DOI 10.1016/j.vaccine.2012.06.057; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Fagot JP, 2011, VACCINE, V29, P3610, DOI 10.1016/j.vaccine.2011.02.064; Flagg EW, 2013, AM J PUBLIC HEALTH, V103, P1428, DOI 10.2105/AJPH.2012.301182; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Harper DM, 2009, PUBLIC HEALTH GENOM, V12, P319, DOI 10.1159/000214922; Jensen KE, 2011, ACTA OBSTET GYN SCAN, V90, P459, DOI 10.1111/j.1600-0412.2010.01066.x; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Krajden M, 2011, CLIN VACCINE IMMUNOL, V18, P418, DOI 10.1128/CVI.00489-10; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Li RC, 2012, VACCINE, V30, P4284, DOI 10.1016/j.vaccine.2012.02.079; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Natunen Kari, 2011, Infect Dis Obstet Gynecol, V2011, P675858, DOI 10.1155/2011/675858; ORIEL JD, 1971, BRIT J VENER DIS, V47, P1; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Romanowski B, 2011, HUM VACCINES, V7, P1374, DOI 10.4161/hv.7.12.18322; Stanley M, 2007, BRIT J CANCER, V96, P1320, DOI 10.1038/sj.bjc.6603695; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Yoshikawa H, 2013, CANCER SCI, V104, P465, DOI 10.1111/cas.12106	31	69	70	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					597	603		10.1001/jama.2014.95	http://dx.doi.org/10.1001/jama.2014.95			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519299	Bronze			2022-12-28	WOS:000330941000015
J	Edwards, R				Edwards, Richard			PERSONAL VIEW Roll your own cigarettes are less natural and at least as harmful as factory rolled tobacco	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASIA SURVEY; SMOKING; PREVALENCE; THAILAND		Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Edwards, R (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	richard.edwards@otago.ac.nz	Edwards, Richard/O-4771-2017	Edwards, Richard/0000-0003-2264-9823				[Anonymous], GEN LIF SURV OV REP; Ayo-Yusuf OA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-597; Brennan K. A., 2013, ADDICT BIOL; DESTEFANI E, 1992, CANCER, V70, P679, DOI 10.1002/1097-0142(19920801)70:3&lt;679::AID-CNCR2820700323&gt;3.0.CO;2-Z; Health Sponsorship Council, 2009, 2008 HSC YEAR 10 IN; Leatherdale ST, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-557; New Zealand Ministry of Health. Tobacco returns 2012, 2012, TOB RET 2012 BRIT AM; Smokefree South West, WIS UP ROLL UPS; Wilson N, 2009, NEW ZEAL MED J, V122, P92; Yong HH, 2013, NICOTINE TOB RES, V15, P1339, DOI 10.1093/ntr/nts241; Young D, 2008, NICOTINE TOB RES, V10, P907, DOI 10.1080/14622200802027172; Young D, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/406283; Young D, 2010, NICOTINE TOB RES, V12, P1089, DOI 10.1093/ntr/ntq155	13	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2014	348								f7616	10.1136/bmj.f7616	http://dx.doi.org/10.1136/bmj.f7616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WS	24519762				2022-12-28	WOS:000331444300001
J	Shindo, A; Wallingford, JB				Shindo, Asako; Wallingford, John B.			PCP and Septins Compartmentalize Cortical Actomyosin to Direct Collective Cell Movement	SCIENCE			English	Article							CONVERGENT EXTENSION; TISSUE MORPHOGENESIS; POLARITY; GASTRULATION; INTERCALATION; DROSOPHILA; MIGRATION; ACTIN; DYNAMICS; MESODERM	Despite our understanding of actomyosin function in individual migrating cells, we know little about the mechanisms by which actomyosin drives collective cell movement in vertebrate embryos. The collective movements of convergent extension drive both global reorganization of the early embryo and local remodeling during organogenesis. We report here that planar cell polarity (PCP) proteins control convergent extension by exploiting an evolutionarily ancient function of the septin cytoskeleton. By directing septin-mediated compartmentalization of cortical actomyosin, PCP proteins coordinate the specific shortening of mesenchymal cell-cell contacts, which in turn powers cell interdigitation. These data illuminate the interface between developmental signaling systems and the fundamental machinery of cell behavior and should provide insights into the etiology of human birth defects, such as spina bifida and congenital kidney cysts.	[Wallingford, John B.] Howard Hughes Med Inst, Austin, TX 78712 USA; Univ Texas Austin, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Howard Hughes Med Inst, Austin, TX 78712 USA.	wallingford@austin.utexas.edu		Shindo, Asako/0000-0002-3314-7151	NIH/National Institute of General Medical Sciences; March of Dimes; Burroughs Wellcome Fund; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER	NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ewald, A. Wills, and M. Butler for critical reading and insightful comments on the manuscript. This work was supported by grants to J.B.W. from the NIH/National Institute of General Medical Sciences, the March of Dimes, and the Burroughs Wellcome Fund. A. S. was supported by fellowships from Uehara Memorial Foundation and Kanae Foundation for the Promotion of Medical Science. J.B.W. is an Early Career Scientist of the Howard Hughes Medical Institute.	Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Fernandez-Gonzalez R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045005; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kim HY, 2011, J CELL SCI, V124, P635, DOI 10.1242/jcs.067579; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Sawyer JK, 2011, MOL BIOL CELL, V22, P2491, DOI 10.1091/mbc.E11-05-0411; SHIH J, 1992, DEVELOPMENT, V116, P901; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vogt W., 1922, VERHANDL DTSCH ZOOL, V27, P49; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	31	120	121	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					649	652		10.1126/science.1243126	http://dx.doi.org/10.1126/science.1243126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503851	Green Accepted			2022-12-28	WOS:000330724000041
J	Kronenberg, M; Havran, WL				Kronenberg, Mitchell; Havran, Wendy L.			IMMUNOLOGY Oiling the wheels of autoimmunity	NATURE			English	Editorial Material							T-CELLS		[Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Havran, Wendy L.] Scripps Res Inst, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	mitch@liai.org; havran@scripps.edu	Kronenberg, Mitchell/AAT-6078-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI071922] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aljuffali IA, 2014, AAPS J, V16, P140, DOI 10.1208/s12248-013-9550-y; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Vera-Lastra O, 2013, EXPERT REV CLIN IMMU, V9, P361, DOI [10.1586/eci.13.2, 10.1586/ECI.13.2]; Witherden DA, 2013, J LEUKOCYTE BIOL, V94, P69, DOI 10.1189/jlb.0213101; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010	9	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					42	43		10.1038/506042a	http://dx.doi.org/10.1038/506042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499914				2022-12-28	WOS:000330648100025
J	Punukollu, M; Khan, S; Forsyth, D				Punukollu, Mallika; Khan, Saman; Forsyth, Dianne			Weight loss in an adolescent girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EATING-DISORDERS		[Punukollu, Mallika] Possilpk CAMHS, Glasgow G22 5DE, Lanark, Scotland; [Khan, Saman] Stobhill Hosp, Skye House In Patient Adolescent Unit, Glasgow, Lanark, Scotland; [Forsyth, Dianne] South CAMHS, Glasgow, Lanark, Scotland		Punukollu, M (corresponding author), Possilpk CAMHS, Glasgow G22 5DE, Lanark, Scotland.	mpunukollu@gmail.com						Birmingham C. L., 2010, MED MANAGEMENT EATIN; Casiero Deena, 2006, Cardiol Rev, V14, P227; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; HUMPHRIES LL, 1987, ANN INTERN MED, V106, P50, DOI 10.7326/0003-4819-106-1-50; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; National Institute for Health and Care Excellence, 2004, EATING DISORDERS; PUGLIESE MT, 1983, NEW ENGL J MED, V309, P513, DOI 10.1056/NEJM198309013090901; Royal College of Psychiatrists, 2011, JUN MARSIPAN MAN REA; Van den Eynde F, 2012, EUR EAT DISORD REV, V20, P94, DOI 10.1002/erv.1163	12	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2014	348								g1327	10.1136/bmj.g1327	http://dx.doi.org/10.1136/bmj.g1327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4JW	24502955				2022-12-28	WOS:000331062900003
J	Bolcun-Filas, E; Rinaldi, VD; White, ME; Schimenti, JC				Bolcun-Filas, Ewelina; Rinaldi, Vera D.; White, Michelle E.; Schimenti, John C.			Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway	SCIENCE			English	Article							MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; MOUSE MEIOSIS; P63; ATR; ACTIVATION; APOPTOSIS; RESPONSES; PROTECTS; HOMOLOG	Genetic errors in meiosis can lead to birth defects and spontaneous abortions. Checkpoint mechanisms of hitherto unknown nature eliminate oocytes with unrepaired DNA damage, causing recombination-defective mutant mice to be sterile. Here, we report that checkpoint kinase 2 (Chk2 or Chek2), is essential for culling mouse oocytes bearing unrepaired meiotic or induced DNA double-strand breaks (DSBs). Female infertility caused by a meiotic recombination mutation or irradiation was reversed by mutation of Chk2. Both meiotically programmed and induced DSBs trigger CHK2-dependent activation of TRP53 (p53) and TRP63 (p63), effecting oocyte elimination. These data establish CHK2 as essential for DNA damage surveillance in female meiosis and indicate that the oocyte DSB damage response primarily involves a pathway hierarchy in which ataxia telangiectasia and Rad3-related (ATR) signals to CHK2, which then activates p53 and p63.	[Bolcun-Filas, Ewelina; Rinaldi, Vera D.; White, Michelle E.; Schimenti, John C.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA	Cornell University	Schimenti, JC (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	jcs92@cornell.edu	Rinaldi, Vera/ABI-1422-2020	Rinaldi, Vera/0000-0002-0051-1754; White, Michelle E./0000-0002-9079-0880	NIH [GM45415]; NY State Stem Cell Program [CO26442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NY State Stem Cell Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM45415 to J.C.S. and contract CO26442 from the NY State Stem Cell Program. We thank A. Mills for providing p63 mutant mice and M. A. Handel for critical reading of the manuscript.	BAKER TG, 1971, MUTAT RES, V11, P9, DOI 10.1016/0027-5107(71)90028-5; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Reinholdt LG, 2005, CHROMOSOMA, V114, P127, DOI 10.1007/s00412-005-0346-4; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Wang XQ, 2006, J CELL PHYSIOL, V208, P613, DOI 10.1002/jcp.20700	24	164	168	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					533	536		10.1126/science.1247671	http://dx.doi.org/10.1126/science.1247671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482479	Green Accepted			2022-12-28	WOS:000330343700045
J	Novarino, G; Fenstermaker, AG; Zaki, MS; Hofree, M; Silhavy, JL; Heiberg, AD; Abdellateef, M; Rosti, B; Scott, E; Mansour, L; Masri, A; Kayserili, H; Al-Aama, JY; Abdel-Salam, GMH; Karminejad, A; Kara, M; Kara, B; Bozorgmehri, B; Ben-Omran, T; Mojahedi, F; Mahmoud, IGE; Bouslam, N; Bouhouche, A; Benomar, A; Hanein, S; Raymond, L; Forlani, S; Mascaro, M; Selim, L; Shehata, N; Al-Allawi, N; Bindu, PS; Azam, M; Gunel, M; Caglayan, A; Bilguvar, K; Tolun, A; Issa, MY; Schroth, J; Spencer, EG; Rosti, RO; Akizu, N; Vaux, KK; Johansen, A; Koh, AA; Megahed, H; Durr, A; Brice, A; Stevanin, G; Gabriel, SB; Ideker, T; Gleeson, JG				Novarino, Gaia; Fenstermaker, Ali G.; Zaki, Maha S.; Hofree, Matan; Silhavy, Jennifer L.; Heiberg, Andrew D.; Abdellateef, Mostafa; Rosti, Basak; Scott, Eric; Mansour, Lobna; Masri, Amira; Kayserili, Hulya; Al-Aama, Jumana Y.; Abdel-Salam, Ghada M. H.; Karminejad, Ariana; Kara, Majdi; Kara, Bulent; Bozorgmehri, Bita; Ben-Omran, Tawfeg; Mojahedi, Faezeh; Mahmoud, Iman Gamal El Din; Bouslam, Naima; Bouhouche, Ahmed; Benomar, Ali; Hanein, Sylvain; Raymond, Laure; Forlani, Sylvie; Mascaro, Massimo; Selim, Laila; Shehata, Nabil; Al-Allawi, Nasir; Bindu, P. S.; Azam, Matloob; Gunel, Murat; Caglayan, Ahmet; Bilguvar, Kaya; Tolun, Aslihan; Issa, Mahmoud Y.; Schroth, Jana; Spencer, Emily G.; Rosti, Rasim O.; Akizu, Naiara; Vaux, Keith K.; Johansen, Anide; Koh, Alice A.; Megahed, Hisham; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni; Gabriel, Stacy B.; Ideker, Trey; Gleeson, Joseph G.			Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders	SCIENCE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; PROTEIN; MUTATIONS; ARCHITECTURE; CYTOKINESIS; TRANSPORT; PATHWAYS; SUBUNIT	Hereditary spastic paraplegias (HSPs) are neurodegenerative motor neuron diseases characterized by progressive age-dependent loss of corticospinal motor tract function. Although the genetic basis is partly understood, only a fraction of cases can receive a genetic diagnosis, and a global view of HSP is lacking. By using whole-exome sequencing in combination with network analysis, we identified 18 previously unknown putative HSP genes and validated nearly all of these genes functionally or genetically. The pathways highlighted by these mutations link HSP to cellular transport, nucleotide metabolism, and synapse and axon development. Network analysis revealed a host of further candidate genes, of which three were mutated in our cohort. Our analysis links HSP to other neurodegenerative disorders and can facilitate gene discovery and mechanistic understanding of disease.	[Novarino, Gaia; Fenstermaker, Ali G.; Silhavy, Jennifer L.; Heiberg, Andrew D.; Abdellateef, Mostafa; Rosti, Basak; Scott, Eric; Mascaro, Massimo; Schroth, Jana; Spencer, Emily G.; Rosti, Rasim O.; Akizu, Naiara; Vaux, Keith K.; Johansen, Anide; Koh, Alice A.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92093 USA; [Hofree, Matan; Ideker, Trey] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Hofree, Matan; Ideker, Trey] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Zaki, Maha S.; Abdel-Salam, Ghada M. H.; Issa, Mahmoud Y.; Megahed, Hisham] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo 12311, Egypt; [Mansour, Lobna; Mahmoud, Iman Gamal El Din; Selim, Laila] Cairo Univ, Childrens Hosp, Neurometabol Unit, Dept Pediat Neurol, Cairo 406, Egypt; [Masri, Amira] Univ Jordan, Dept Pediat, Div Child Neurol, Amman 11942, Jordan; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Al-Aama, Jumana Y.] King Abdulaziz Univ, Dept Med Genet, Jeddah 21413, Saudi Arabia; [Karminejad, Ariana; Bozorgmehri, Bita] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran, Iran; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Kara, Bulent] Kocaeli Univ, Fac Med, Dept Pediat Neurol, TR-41380 Umuttepe, Kocaeli, Turkey; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha 3050, Qatar; [Mojahedi, Faezeh] Mashhad Med Genet Counseling Ctr, Mashhad 91767, Iran; [Bouslam, Naima; Bouhouche, Ahmed; Benomar, Ali] Univ Mohammed V Souissi, ERMN, Rabat 6402, Morocco; [Bouslam, Naima; Bouhouche, Ahmed; Benomar, Ali] Univ Mohammed V Souissi, CRECET, Rabat 6402, Morocco; [Hanein, Sylvain; Raymond, Laure; Forlani, Sylvie; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, INSERM U1127,CNRS UMR7225,UMR S975, F-75013 Paris, France; [Shehata, Nabil] Saudi German Hosp, Dept Pediat & Neonatol, Riyadh, Saudi Arabia; [Al-Allawi, Nasir] Univ Dohuk, Sch Med, Dept Pathol, Dohuk, Iraq; [Bindu, P. S.] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; [Azam, Matloob] Wah Med Coll, Dept Pediat & Child Neurol, Wah Cantt, Pakistan; [Gunel, Murat; Caglayan, Ahmet; Bilguvar, Kaya] Yale Univ, Sch Med, Dept Genet & Neurosurg, New Haven, CT 06510 USA; [Tolun, Aslihan] Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; [Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Brice, Alexis; Stevanin, Giovanni] Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Stevanin, Giovanni] Ecole Prat Hautes Etud, Inst Cerveau & Moelle Epiniere, Lab Neurogenet, F-75013 Paris, France; [Gabriel, Stacy B.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; University of Jordan; Istanbul University; King Abdulaziz University; Kocaeli University; Hamad Medical Corporation; Mohammed V University in Rabat; Mohammed V University in Rabat; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; National Institute of Mental Health & Neurosciences - India; Yale University; Bogazici University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92093 USA.	jogleeson@ucsd.edu	brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; Tolun, Aslihan/AAS-2250-2020; Vaux, Keith/R-2716-2019; masri, amira/C-4570-2015; Megahed, Hisham/AAP-4064-2020; Issa, Mahmoud/AAL-5118-2020; Zaki, Maha S/B-9361-2013; Caglayan, Ahmet O/D-1066-2012; Mahmoud, Iman Gamal El Din/Y-6497-2019; Wang, Guilin/G-8794-2018; Abdel-Salam, Ghada/W-1718-2017; hanein, sylvain/AAG-4933-2019; Al-aama, Jumana/AAA-8653-2021; Brice, Alexis/A-2170-2009; Kayserili, Hülya/AAA-5593-2021	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Tolun, Aslihan/0000-0002-0328-6046; Vaux, Keith/0000-0001-8738-5940; masri, amira/0000-0001-6103-8713; Issa, Mahmoud/0000-0002-3899-2821; Caglayan, Ahmet O/0000-0002-2332-322X; Mahmoud, Iman Gamal El Din/0000-0003-4853-1874; Abdel-Salam, Ghada/0000-0003-2893-8802; hanein, sylvain/0000-0001-5817-6330; Kayserili, Hülya/0000-0003-0376-499X; Ideker, Trey/0000-0002-1708-8454; Bozorgmehri, Babak/0000-0003-2400-6768; Zaki, Maha/0000-0001-7840-0002; Hofree, Matan/0000-0001-8368-0299; Lipton, Stuart/0000-0002-3490-1259; Spencer, Emily/0000-0003-2650-4357; Selim, laila/0000-0002-6548-6545; Bouhouche, Ahmed/0000-0001-5279-8649; Kariminejad, Ariana/0000-0002-8467-4728	Deutsche Forschungsgemeinschaft; Brain and Behavior Research Foundation; NIH [R01NS041537, R01NS048453, R01NS052455, P01HD070494, P30NS047101]; French National Agency for Research; Verum Foundation; European Union; Fondation Roger de Spoelberch; "Investissements d'avenir" [ANR-10-IAIHU-06]; Princess Al Jawhara Center of Excellence in Research of Hereditary Disorders; Inherited Disease Research [HHSN268200782096C, HHSN268201100011I, N01-CO-12400];  [P41GM103504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, R01NS041537, P30NS047101, R01NS048453] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Brain and Behavior Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Agency for Research(French National Research Agency (ANR)); Verum Foundation; European Union(European Commission); Fondation Roger de Spoelberch; "Investissements d'avenir"(French National Research Agency (ANR)); Princess Al Jawhara Center of Excellence in Research of Hereditary Disorders; Inherited Disease Research; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the participating families. Supported by the Deutsche Forschungsgemeinschaft (G.N.); the Brain and Behavior Research Foundation (A. G. F.); NIH R01NS041537, R01NS048453, R01NS052455, P01HD070494, and P30NS047101 (J.G.G.); French National Agency for Research (G. S., A. D.); the Verum Foundation (A. B.); the European Union (Omics call, "Neuromics" A. B.); Fondation Roger de Spoelberch (A. B.); P41GM103504 (T. I.); "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute, Paris); and Princess Al Jawhara Center of Excellence in Research of Hereditary Disorders. Genotyping services provided in part by Center for Inherited Disease Research contract numbers HHSN268200782096C, HHSN268201100011I, and N01-CO-12400. We thank the Broad Institute (U54HG003067 to E. Lander), the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M. Gunel), M. Liv for technical expertise, and E. N. Smith, N. Schork, M. Yahyaoui, F. Santorelli, and F. Darios for discussion. Data available at dbGaP (accession number phs000288). UCSD Institutional Review Board (070870) supervised the study. The authors declare no competing financial interests.	Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Bouslam N, 2007, HUM GENET, V121, P413, DOI 10.1007/s00439-007-0328-0; Cai Z, 2002, J PERIPHER NERV SYST, V7, P181, DOI 10.1046/j.1529-8027.2002.02023.x; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; D'Amico A, 2004, NEUROLOGY, V62, P2138, DOI 10.1212/01.WNL.0000127698.88895.85; DeLuca GC, 2004, NEUROPATH APPL NEURO, V30, P576, DOI 10.1111/j.1365-2990.2004.00587.x; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Dursun U, 2009, NEUROGENETICS, V10, P325, DOI 10.1007/s10048-009-0191-3; Esteves T, 2014, AM J HUM GENET, V94, P268, DOI 10.1016/j.ajhg.2013.12.005; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Jinnah HA, 2013, HAND CLINIC, V113, P1827, DOI 10.1016/B978-0-444-59565-2.00052-6; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee SM, 2012, J CELL BIOL, V199, P799, DOI 10.1083/jcb.201204137; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Meijer IA, 2004, ANN NEUROL, V56, P579, DOI 10.1002/ana.20239; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018; Park J, 2002, IMMUNITY, V17, P221, DOI 10.1016/S1074-7613(02)00368-0; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Thauerer B, 2012, J NEUROCHEM, V121, P329, DOI 10.1111/j.1471-4159.2012.07692.x; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070; Zivony-Elboum Y, 2012, J MED GENET, V49, P462, DOI 10.1136/jmedgenet-2012-100742; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	40	351	373	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					506	511		10.1126/science.1247363	http://dx.doi.org/10.1126/science.1247363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482476	Green Accepted			2022-12-28	WOS:000330343700038
J	Chiu, HY; Liao, YH				Chiu, Hsien-Yi; Liao, Yi-Hua			Occult Spinal Dysraphism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 3-year-old girl was referred for the removal of excess hair on the back, which had been present since birth, for cosmetic reasons. Physical examination revealed a tuft of coarse, dark hair in the midline of the back, just above the natal cleft. A 3-year-old girl was referred for the removal of excess hair on the back, which had been present since birth, for cosmetic reasons. The physical examination revealed a tuft of coarse, dark hair in the midline of the back just above the natal cleft (Panel A). Her history revealed leakage of clear fluid from the hypertrichotic region since birth. At that time, magnetic resonance imaging had shown syringomyelia at L1 (Panel B, arrowhead), diastematomyelia with bony spurs at L3 and L4 (Panel C, arrow), and tethered cord and low-lying conus medullaris at L5 (Panel B, arrow). At the age of ...	[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsinchu, Taiwan; [Liao, Yi-Hua] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiu, HY (corresponding author), Natl Taiwan Univ Hosp, Hsinchu, Taiwan.	yihualiao@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; LIAO, YI-HUA/0000-0002-4434-3780					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					466	466		10.1056/NEJMicm1308004	http://dx.doi.org/10.1056/NEJMicm1308004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476435				2022-12-28	WOS:000330645400011
J	Hiatt, WR; Smith, RJ				Hiatt, William R.; Smith, Robert J.			Assessing the Clinical Benefits of Lipid-Disorder Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CORONARY EVENTS; THERAPY	An FDA advisory committee voted against approval of a drug that reduces triglyceride levels, since several clinical trials revealed no cardiovascular benefit from other such drugs. This summary of panel deliberations highlights challenges in the development of lipid-disorder treatments. On October 16, 2013, the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) voted 9 to 2 against approval of Vascepa, a purified n-3 fatty acid formulation of ethyl eicosapentaenoic acid (EPA), for use as an adjunct to diet and in combination with a statin to reduce levels of triglycerides, non-high-density lipoprotein (non-HDL) cholesterol, apolipoprotein B, low-density lipoprotein (LDL) cholesterol, and very-low-density lipoprotein (VLDL) cholesterol in adult patients with mixed dyslipidemia and coronary heart disease or an equivalent risk of coronary heart disease. The sponsor and the FDA had previously agreed under a Special Protocol ...	[Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, Div Cardiol, Aurora, CO 80045 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, CPC Clin Res, Aurora, CO USA; [Smith, Robert J.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Smith, Robert J.] Providence Vet Affairs Med Ctr, Ocean State Res Inst, Providence, RI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Cardiol, Aurora, CO 80045 USA.							Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	5	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					396	399		10.1056/NEJMp1313866	http://dx.doi.org/10.1056/NEJMp1313866			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476429				2022-12-28	WOS:000330645400003
J	Broxterman, JT				Broxterman, Jane T.			Miracle on 39th Street	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Broxterman, Jane T.] Univ Kansas, Sch Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Broxterman, JT (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd,4035 Delp,MS 1027, Kansas City, KS 66160 USA.	jbroxterman@kumc.edu							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					854	855		10.7326/0003-4819-159-12-201312170-00013	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24490271				2022-12-28	WOS:000329735300021
J	Tsochatzis, EA; Bosch, J; Burroughs, AK				Tsochatzis, Emmanuel A.; Bosch, Jaime; Burroughs, Andrew K.			Liver cirrhosis	LANCET			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; CHRONIC HEPATITIS-B; RANDOMIZED CONTROLLED-TRIAL; VENOUS-PRESSURE GRADIENT; PORTAL-VEIN THROMBOSIS; INTRAHEPATIC ENDOTHELIAL DYSFUNCTION; ACUTE HEMODYNAMIC-RESPONSE; BETA-BLOCKERS; HEPATOCELLULAR-CARCINOMA; VARICEAL HEMORRHAGE	Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death worldwide but fourth in central Europe. Increasingly, cirrhosis has been seen to be not a single disease entity, but one that can be subclassified into distinct clinical prognostic stages, with 1-year mortality ranging from 1% to 57% depending on the stage. We review the current understanding of cirrhosis as a dynamic process and outline current therapeutic options for prevention and treatment of complications of cirrhosis, on the basis of the subclassification in clinical stages. The new concept in management of patients with cirrhosis should be prevention and early intervention to stabilise disease progression and to avoid or delay clinical decompensation and the need for liver transplantation. The challenge in the 21st century is to prevent the need for liver transplantation in as many patients with cirrhosis as possible.	[Tsochatzis, Emmanuel A.; Burroughs, Andrew K.] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England; [Tsochatzis, Emmanuel A.; Burroughs, Andrew K.] UCL Inst Liver & Digest Hlth, London NW3 2QG, England; [Bosch, Jaime] Univ Barcelona, Hosp Clin IDIBAPS, Hepat Hemodynam Lab, Barcelona, Spain; [Bosch, Jaime] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Burroughs, AK (corresponding author), Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, Pond St, London NW3 2QG, England.	andrew.burroughs@nhs.net	Bosch, Jaime/AFF-8344-2022; Tsochatzis, Emmanuel A/A-1651-2012; Burroughs, Andrew K/C-5645-2009; Bosch, Jaime/AAF-1006-2022	Tsochatzis, Emmanuel A/0000-0001-5069-2461; Burroughs, Andrew K/0000-0001-6527-457X; 				Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Abraldes JG, 2009, GASTROENTEROLOGY, V136, P1651, DOI 10.1053/j.gastro.2009.01.043; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Andreu V, 2002, J HEPATOL, V36, P356, DOI 10.1016/S0168-8278(01)00300-2; Angeli P, 2010, GUT, V59, P98, DOI 10.1136/gut.2008.176495; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Bai M, 2013, J GASTROEN HEPATOL, V28, P783, DOI 10.1111/jgh.12142; Bajaj JS, 2012, HEPATOLOGY, V55, P1164, DOI 10.1002/hep.25507; Bajaj JS, 2011, GASTROENTEROLOGY, V140, P478, DOI 10.1053/j.gastro.2010.08.061; Bajaj JS, 2010, AM J GASTROENTEROL, V105, P106, DOI 10.1038/ajg.2009.615; Bajaj JS, 2009, AM J GASTROENTEROL, V104, P1130, DOI 10.1038/ajg.2009.80; Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bellot P, 2013, J HEPATOL, V58, P922, DOI 10.1016/j.jhep.2012.12.020; Bellot P, 2010, HEPATOLOGY, V52, P2044, DOI 10.1002/hep.23918; Berzigotti A, 2011, HEPATOLOGY, V54, P555, DOI 10.1002/hep.24418; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; BOSCH J, 1984, HEPATOLOGY, V4, P1200, DOI 10.1002/hep.1840040617; Bosch J, 2010, HEPATOLOGY, V51, P2214, DOI 10.1002/hep.23689; Bureau C, 2011, J HEPATOL, V54, P901, DOI 10.1016/j.jhep.2010.08.025; Burroughs AK, 2010, J HEPATOL, V52, P946, DOI 10.1016/j.jhep.2010.02.015; Burroughs AK, 2010, HEPATOLOGY, V51, P1894, DOI 10.1002/hep.23710; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Charlton MR, 2006, HEPATOLOGY, V43, P1177, DOI 10.1002/hep.21239; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Cholongitas E, 2006, GUT, V55, P1789, DOI 10.1136/gut.2005.090415; Cholongitas E, 2012, ALIMENT PHARM THER, V35, P634, DOI 10.1111/j.1365-2036.2012.05000.x; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; De Gottardi A, 2012, AM J CLIN NUTR, V96, P584, DOI 10.3945/ajcn.112.040469; Dooley JS, 2011, SHERLOCK'S DISEASES OF THE LIVER AND BILIARY SYSTEM, 12TH EDITION, P1, DOI 10.1002/9781444341294; El-Serag HB, 2009, GASTROENTEROLOGY, V136, P1601, DOI 10.1053/j.gastro.2009.01.053; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Everson GT, 2013, HEPATOLOGY, V57, P1752, DOI 10.1002/hep.25976; Fede G, 2012, J HEPATOL, V56, P810, DOI 10.1016/j.jhep.2011.10.016; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Freedman ND, 2011, GASTROENTEROLOGY, V140, P1961, DOI 10.1053/j.gastro.2011.02.061; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Gluud LL, 2007, AM J GASTROENTEROL, V102, P2842, DOI 10.1111/j.1572-0241.2007.01564.x; Gonzalez R, 2008, ANN INTERN MED, V149, P109, DOI 10.7326/0003-4819-149-2-200807150-00007; Goulis J, 1999, LANCET, V353, P139, DOI 10.1016/S0140-6736(98)06020-6; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Guevara M, 2012, J HEPATOL, V57, P759, DOI 10.1016/j.jhep.2012.06.013; Hernandez-Gea V, 2012, AM J GASTROENTEROL, V107, P418, DOI 10.1038/ajg.2011.456; Hernandez-Guerra M, 2006, HEPATOLOGY, V43, P485, DOI 10.1002/hep.21080; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Hou MC, 2004, HEPATOLOGY, V39, P746, DOI 10.1002/hep.20126; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hytiroglou P, 2012, AM J CLIN PATHOL, V137, P5, DOI 10.1309/AJCP2T2OHTAPBTMP; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kalambokis GN, 2012, CLIN GASTROENTEROL H, V10, P815, DOI 10.1016/j.cgh.2012.02.025; Kim SU, 2012, J HEPATOL, V57, P556, DOI 10.1016/j.jhep.2012.04.029; La Mura V, 2009, J HEPATOL, V51, P279, DOI 10.1016/j.jhep.2009.04.015; Laleman W, 2013, HEPATOLOGY, V57, P2448, DOI 10.1002/hep.26314; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Leithead JA, 2008, LIVER TRANSPLANT, V14, P1159, DOI 10.1002/lt.21471; Lewis JH, 2013, ALIMENT PHARM THER, V37, P1132, DOI 10.1111/apt.12324; Lewis JH, 2007, HEPATOLOGY, V46, P1453, DOI 10.1002/hep.21848; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luca A, 1997, GASTROENTEROLOGY, V112, P1284, DOI 10.1016/S0016-5085(97)70142-2; Manolakopoulos S, 2009, J HEPATOL, V51, P468, DOI 10.1016/j.jhep.2009.05.031; Manousou P, 2011, LIVER TRANSPLANT, V17, P178, DOI 10.1002/lt.22209; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Merli M, 2003, J HEPATOL, V38, P266, DOI 10.1016/S0168-8278(02)00420-8; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Moriarty K, ALCOHOL RELATED DIS; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; Nkontchou G, 2011, J CLIN ENDOCR METAB, V96, P2601, DOI 10.1210/jc.2010-2415; Nkontchou G, 2010, J HEPATOL, V53, P827, DOI 10.1016/j.jhep.2010.04.035; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Parkes J, 2010, GUT, V59, P1245, DOI 10.1136/gut.2009.203166; Plank LD, 2008, HEPATOLOGY, V48, P557, DOI 10.1002/hep.22367; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; POYNARD T, 1991, NEW ENGL J MED, V324, P1532, DOI 10.1056/NEJM199105303242202; Rao GA, 2011, GASTROENTEROLOGY, V140, P144, DOI 10.1053/j.gastro.2010.08.055; Rasaratnam B, 2003, ANN INTERN MED, V139, P186, DOI 10.7326/0003-4819-139-3-200308050-00008; Reiberger T, 2013, J HEPATOL, V58, P911, DOI 10.1016/j.jhep.2012.12.011; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; RUNYON BA, 1991, GASTROENTEROLOGY, V100, P1737, DOI 10.1016/0016-5085(91)90677-D; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Senzolo M, 2011, HEPATOLOGY, V53, P2149, DOI 10.1002/hep.24176; Senzolo M, 2009, LIVER INT, V29, P1189, DOI 10.1111/j.1478-3231.2009.02038.x; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Sharma BC, 2009, GASTROENTEROLOGY, V137, P885, DOI 10.1053/j.gastro.2009.05.056; Sheron N, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654588; Sigal SH, 2007, GUT, V56, P597, DOI 10.1136/gut.2006.113050; Singh V, 2012, J HEPATOL, V56, P348, DOI 10.1016/j.jhep.2011.04.027; Soriano G, 2012, HEPATOLOGY, V55, P1922, DOI 10.1002/hep.25554; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553; Tandon P, 2010, AM J GASTROENTEROL, V105, P1917, DOI 10.1038/ajg.2010.196; Tandon P, 2010, J HEPATOL, V53, P273, DOI 10.1016/j.jhep.2010.03.013; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Torres DM, 2013, GASTROENTEROLOGY, V144, P670, DOI 10.1053/j.gastro.2013.02.015; Tripathi D, 2009, HEPATOLOGY, V50, P825, DOI 10.1002/hep.23045; Tritto G, 2011, J HEPATOL, V55, P574, DOI 10.1016/j.jhep.2010.11.034; Tsochatzis E, 2008, ALIMENT PHARM THER, V27, P80, DOI 10.1111/j.1365-2036.2007.03538.x; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Tsochatzis EA, 2010, ALIMENT PHARM THER, V31, P366, DOI 10.1111/j.1365-2036.2009.04182.x; Tsochatzis EA, 2012, HEPATOLOGY, V56, P1983, DOI 10.1002/hep.25915; Tsochatzis EA, 2010, GASTROENTEROLOGY, V139, P1813, DOI 10.1053/j.gastro.2010.10.031; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Villa E, 2012, GASTROENTEROLOGY, V143, P1253, DOI 10.1053/j.gastro.2012.07.018; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Villanueva C, 2009, GASTROENTEROLOGY, V137, P119, DOI 10.1053/j.gastro.2009.03.048; Vlachogiannakos J, 2009, ALIMENT PHARM THER, V29, P992, DOI 10.1111/j.1365-2036.2009.03958.x; Vlachogiannakos J, 2001, GUT, V49, P303, DOI 10.1136/gut.49.2.303; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Westin J, 2002, J VIRAL HEPATITIS, V9, P235, DOI 10.1046/j.1365-2893.2002.00356.x; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564; Zein CO, 2010, HEPATOLOGY, V51, P1487, DOI 10.1002/hep.23694	140	1057	1132	15	153	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1749	1761		10.1016/S0140-6736(14)60121-5	http://dx.doi.org/10.1016/S0140-6736(14)60121-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24480518				2022-12-28	WOS:000336267300029
J	Sternberg, SH; Redding, S; Jinek, M; Greene, EC; Doudna, JA				Sternberg, Samuel H.; Redding, Sy; Jinek, Martin; Greene, Eric C.; Doudna, Jennifer A.			DNA interrogation by the CRISPR RNA-guided endonuclease Cas9	NATURE			English	Article							IMMUNE-SYSTEM; TARGETED MUTAGENESIS; GENE-EXPRESSION; SEED SEQUENCE; SPECIFICITY; ACTIVATION; MECHANISM; TRANSCRIPTION; RECOGNITION; PROKARYOTES	The clustered regularly interspaced short palindromic repeats (CRISPR)-associated enzyme Cas9 is an RNA-guided endonuclease that uses RNA-DNA base-pairing to target foreign DNA in bacteria. Cas9-guide RNA complexes are also effective genome engineering agents in animals and plants. Here we use single-molecule and bulk biochemical experiments to determine how Cas9-RNA interrogates DNA to find specific cleavage sites. We show that both binding and cleavage of DNA by Cas9-RNA require recognition of a short trinucleotide protospacer adjacent motif (PAM). Non-target DNA binding affinity scales with PAM density, and sequences fully complementary to the guide RNA but lacking a nearby PAM are ignored by Cas9-RNA. Competition assays provide evidence that DNA strand separation and RNA-DNA heteroduplex formation initiate at the PAM and proceed directionally towards the distal end of the target sequence. Furthermore, PAM interactions trigger Cas9 catalytic activity. These results reveal how Cas9 uses PAM recognition to quickly identify potential target sites while scanning large DNA molecules, and to regulate scission of double-stranded DNA.	[Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Redding, Sy] Columbia Univ, Dept Chem, New York, NY 10032 USA; [Jinek, Martin; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	ecg2108@columbia.edu; doudna@berkeley.edu	Wilson, Matthew H/K-3193-2013; Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X; Sternberg, Samuel/0000-0001-8240-9114; Redding, Sy/0000-0003-3463-7985	National Science Foundation [MCB-1154511, MCB-1244557]; National Defense Science & Engineering Graduate Research Fellowship programs; National Institutes of Health [GM074739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073794, T32GM066698, R01GM074739] Funding Source: NIH RePORTER; Direct For Biological Sciences [1154511] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Research Fellowship programs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. Bhat, A. Smith and K. Zhou for technical assistance, and members of the Doudna and Greene laboratories and J. Cate for discussions and critical reading of the manuscript. S. H. S. acknowledges support from the National Science Foundation and National Defense Science & Engineering Graduate Research Fellowship programs. Funding was provided by the National Institutes of Health (GM074739 to E. C. G.) and the National Science Foundation (MCB-1154511 to E. C. G. and MCB-1244557 to J. A. D.). M. J. was a Research Specialist, E. C. G. is an Early Career Scientist, and J. A. D. is an Investigator of the Howard Hughes Medical Institute.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fazio T, 2008, LANGMUIR, V24, P10524, DOI 10.1021/la801762h; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gorman J, 2010, LANGMUIR, V26, P1372, DOI 10.1021/la902443e; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119	48	1073	1236	24	647	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					62	+		10.1038/nature13011	http://dx.doi.org/10.1038/nature13011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24476820	Green Accepted, Green Submitted			2022-12-28	WOS:000332224400042
J	Kocarnik, JM; Fullerton, SM				Kocarnik, Jonathan M.; Fullerton, Stephanie M.			Returning Pleiotropic Results From Genetic Testing to Patients and Research Participants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAITS; RISK		[Kocarnik, Jonathan M.; Fullerton, Stephanie M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Kocarnik, Jonathan M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Fullerton, Stephanie M.] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kocarnik, JM (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M4-B402,POB 19024, Seattle, WA 98109 USA.	jkocarni@fhcrc.org	Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048	NATIONAL CANCER INSTITUTE [T32CA009168, R25CA094880] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374, U01HG007307, U01HG004790, U01HG006507] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA094880, T32 CA009168, R25CA94880, T32CA09168] Funding Source: Medline; NHGRI NIH HHS [U01HG007307, U01 HG004790, P50HG003374, P50 HG003374, U01 HG006507, U01HG006507, U01HG004790, U01 HG007307] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Henrikson NB, 2008, PHARMACOGENOMICS J, V8, P85, DOI 10.1038/sj.tpj.6500457; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Pendergrass SA, 2011, GENET EPIDEMIOL, V35, P410, DOI 10.1002/gepi.20589; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949	9	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					795	796		10.1001/jama.2014.369	http://dx.doi.org/10.1001/jama.2014.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24481117	Green Accepted			2022-12-28	WOS:000331793700015
J	Li, M; Belmonte, JCI				Li, Mo; Belmonte, Juan Carlos Izpisua			AGEING Genetic rejuvenation of old muscle	NATURE			English	Editorial Material							CELLS; QUIESCENCE		[Li, Mo; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Li, M (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Li, Mo/J-2090-2014; Li, Mo/AAM-8266-2021	Li, Mo/0000-0003-0827-8907				Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cousin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063528; de Brito L. B. B., 2012, PREV CARDIOL; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Menendez S, 2012, AGING CELL, V11, P41, DOI 10.1111/j.1474-9726.2011.00754.x; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013	15	7	7	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					304	305		10.1038/nature13058	http://dx.doi.org/10.1038/nature13058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522526				2022-12-28	WOS:000331477800028
J	Rios, AC; Fu, NY; Lindeman, GJ; Visvader, JE				Rios, Anne C.; Fu, Nai Yang; Lindeman, Geoffrey J.; Visvader, Jane E.			In situ identification of bipotent stem cells in the mammary gland	NATURE			English	Article							LIFE-SPAN; MOUSE; BASAL; EXPRESSION; HIERARCHY; ADULT; GENE; CANDIDATE	The mammary epithelium undergoes profound morphogenetic changes during development. Architecturally, it comprises two primary lineages, the inner luminal and outer myoepithelial cell layers. Two opposing concepts on the nature of mammary stem cells (MaSCs) in the postnatal gland have emerged. One model, based on classical transplantation assays, postulates that bipotent MaSCs have a key role in coordinating ductal epithelial expansion and maintenance in the adult gland, whereas the second model proposes that only unipotent MaSCs identified by lineage tracing contribute to these processes. Through clonal cell-fate mapping studies using a stochastic multicolour cre reporter combined with a new three-dimensional imaging strategy, we provide evidence for the existence of bipotent MaSCs as well as distinct long-lived progenitor cells. The cellular dynamics at different developmental stages support a model in which both stem and progenitor cells drive morphogenesis during puberty, whereas bipotent MaSCs coordinate ductal homeostasis and remodelling of the mouse adult gland.	[Rios, Anne C.; Fu, Nai Yang; Lindeman, Geoffrey J.; Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Rios, Anne C.; Fu, Nai Yang; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia.	visvader@wehi.edu.au		FU, Naiyang/0000-0001-5457-4323; Rios, Anne/0000-0002-9082-8068; Lindeman, Geoffrey/0000-0001-9386-2416	Australian National Health and Medical Research Council (NHMRC); Victorian State Government through VCA funding of the Victorian Breast Cancer Research Consortium; Victorian State Government through Operational Infrastructure Support; Australian Cancer Research Foundation; Qualtrough Family Bequest; National Breast Cancer Foundation/Cure Cancer Australia Fellowship; NHMRC Research Fellowship; Australia Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government through VCA funding of the Victorian Breast Cancer Research Consortium; Victorian State Government through Operational Infrastructure Support; Australian Cancer Research Foundation; Qualtrough Family Bequest; National Breast Cancer Foundation/Cure Cancer Australia Fellowship; NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship	We are grateful to F. Jackling and K. Liu for genotyping, F. Vaillant for performing transplants, C. Nowell and K. Roger in the WEHI Imaging Facility for expert support, S. Firth at Monash MicroImaging, Leica and Zeiss for imaging support, D. Sieiro Mosti for help with quantification, J. Stanley for generation of transgenic strains, and the Animal, FACS and Histology facilities at WEHI. We also thank J. Adams for review of the manuscript, and H. Clevers, P. Chambon, M. Furtado, B. Hogan and M. Shen for the provision of mouse strains. This work was supported by the Australian National Health and Medical Research Council (NHMRC); the Victorian State Government through VCA funding of the Victorian Breast Cancer Research Consortium and Operational Infrastructure Support; the Australian Cancer Research Foundation; and the Qualtrough Family Bequest. A. C. R. and N.Y.F. were supported by a National Breast Cancer Foundation/Cure Cancer Australia Fellowship, G. J. L. by a NHMRC Research Fellowship and J. E. V. by an Australia Fellowship.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; HOSHINO K, 1967, NATURE, V213, P193, DOI 10.1038/213193a0; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Moumen M, 2012, STEM CELLS, V30, P1246, DOI 10.1002/stem.1090; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SMITH GH, 1988, J CELL SCI, V90, P173; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114	37	356	370	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					322	+		10.1038/nature12948	http://dx.doi.org/10.1038/nature12948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24463516				2022-12-28	WOS:000331477800032
J	Dotera, T; Oshiro, T; Ziherl, P				Dotera, T.; Oshiro, T.; Ziherl, P.			Mosaic two-lengthscale quasicrystals	NATURE			English	Article							PHASES; 12-FOLD; MODEL	Over the past decade, quasicrystalline order(1) has been observed in many soft-matter systems: in dendritic micelles(2), in star(3) and tetrablock(4) terpolymer melts and in diblock copolymer(5) and surfactant micelles(6). The formation of quasicrystals(7-9) from such a broad range of 'soft' macromolecular micelles suggests that they assemble by a generic mechanism rather than being dependent on the specific chemistry of each system. Indeed, micellar softness has been postulated(7) and shown to lead to quasicrystalline order(10). Here we theoretically explore this link by studying two-dimensional hard disks decorated with step-like square-shoulder repulsion that mimics, for example, the soft alkyl shell around the aromatic core in dendritic micelles(2). We find a family of quasicrystals with 10-, 12-, 18- and 24-fold bond orientational order which originate from mosaics of equilateral and isosceles triangles formed by particles arranged core-to-core and shoulder-to-shoulder. The pair interaction responsible for these phases highlights the role of local packing geometry in generating quasicrystallinity in soft matter, complementing the principles that lead to quasicrystal formation in hard tetrahedra(11,12). Based on simple interparticle potentials, quasicrystalline mosaics may well find use in diverse applications ranging from improved image reproduction(13) to advanced photonic materials(14).	[Dotera, T.; Oshiro, T.] Kinki Univ, Dept Phys, Higashiosaka, Osaka 5778502, Japan; [Ziherl, P.] Univ Ljubljana, Fac Math & Phys, SI-1000 Ljubljana, Slovenia; [Ziherl, P.] Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia	Kindai University (Kinki University); University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Dotera, T (corresponding author), Kinki Univ, Dept Phys, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	dotera@phys.kindai.ac.jp	Dotera, Tomonari/S-6553-2019	Dotera, Tomonari/0000-0001-9384-0399; Ziherl, Primoz/0000-0002-5989-6679	Japan Society for the Promotion of Science [22540375]; Slovenian Research Agency [P1-0055]; Marie-Curie Initial Training Network COMPLOIDS under FP7-PEOPLE-ITN [234810]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Marie-Curie Initial Training Network COMPLOIDS under FP7-PEOPLE-ITN	We thank J. Dolinsek, M. Engel, S. Forster, N. Fujita, M. A. Glaser, C. L. Henley, G. Kahl, R. D. Kamien, Y. Kimura, R. Lifshitz, C. N. Likos, T. C. Lubensky, Y. Sakamoto, M. Schmiedeberg, A. Siber and A. Takano for discussions. This work was supported by the Japan Society for the Promotion of Science through Grant-in-Aid for Scientific Research (C) (grant number 22540375), by the Slovenian Research Agency (grant number P1-0055) and by the Marie-Curie Initial Training Network COMPLOIDS under FP7-PEOPLE-ITN-2008 (grant number 234810).	ALDER BJ, 1957, J CHEM PHYS, V27, P1208, DOI 10.1063/1.1743957; Barkan K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.172201; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Engel M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225505; Fischer S, 2011, P NATL ACAD SCI USA, V108, P1810, DOI 10.1073/pnas.1008695108; Grunbaum B., 1986, TILINGS PATTERNS; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; HENLEY CL, 1991, PHYS REV B, V43, P993, DOI 10.1103/PhysRevB.43.993; Iacovella CR, 2011, P NATL ACAD SCI USA, V108, P20935, DOI 10.1073/pnas.1019763108; Jagla EA, 1998, PHYS REV E, V58, P1478, DOI 10.1103/PhysRevE.58.1478; KAWAMURA H, 1991, PHYSICA A, V177, P73, DOI 10.1016/0378-4371(91)90136-Z; LANCON F, 1986, EUROPHYS LETT, V2, P625, DOI 10.1209/0295-5075/2/8/009; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; Lifshitz R, 2007, PHILOS MAG, V87, P3021, DOI 10.1080/14786430701358673; Lifshitz R, 1997, PHYS REV LETT, V79, P1261, DOI 10.1103/PhysRevLett.79.1261; Malescio G, 2003, NAT MATER, V2, P97, DOI 10.1038/nmat820; Mikhael J, 2008, NATURE, V454, P501, DOI 10.1038/nature07074; Motornov M, 2010, PROG POLYM SCI, V35, P174, DOI 10.1016/j.progpolymsci.2009.10.004; Phillips CL, 2013, SOFT MATTER, V9, P8552, DOI 10.1039/c3sm51449h; POLIK WF, 1983, MACROMOLECULES, V16, P978, DOI 10.1021/ma00240a030; Skibinsky A, 1999, PHYS REV E, V60, P2664, DOI 10.1103/PhysRevE.60.2664; Steinhardt P. J., 1989, US Patent, Patent No. [4,894,726, 4894726]; Ungar G, 2005, SOFT MATTER, V1, P95, DOI 10.1039/b502443a; Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230; YOUNG DA, 1977, PHYS REV LETT, V38, P1213, DOI 10.1103/PhysRevLett.38.1213; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zhang JW, 2012, J AM CHEM SOC, V134, P7636, DOI 10.1021/ja301770v; Zoorob ME, 2000, NATURE, V404, P740, DOI 10.1038/35008023	30	153	156	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					208	211		10.1038/nature12938	http://dx.doi.org/10.1038/nature12938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24487618				2022-12-28	WOS:000331107700035
J	Kim, JH; Jeon, J; Shin, M; Won, Y; Lee, M; Kwak, JS; Lee, G; Rhee, J; Ryu, JH; Chun, CH; Chun, JS				Kim, Jin-Hong; Jeon, Jimin; Shin, Minhee; Won, Yoonkyung; Lee, Minju; Kwak, Ji-Sun; Lee, Gyuseok; Rhee, Jinseol; Ryu, Je-Hwang; Chun, Churl-Hong; Chun, Jang-Soo			Regulation of the Catabolic Cascade in Osteoarthritis by the Zinc-ZIP8-MTF1 Axis	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; FACTOR-I MTF-1; CARTILAGE DESTRUCTION; ZINC TRANSPORTER; MICE; MOUSE; IDENTIFICATION; EXPRESSION; LIVER; MODEL	Osteoarthritis (OA), primarily characterized by cartilage degeneration, is caused by an imbalance between anabolic and catabolic factors. Here, we investigated the role of zinc (Zn2+) homeostasis, Zn2+ transporters, and Zn2+-dependent transcription factors in OA pathogenesis. Among Zn2+ transporters, the Zn2+ importer ZIP8 was specifically upregulated in OA cartilage of humans and mice, resulting in increased levels of intracellular Zn2+ in chondrocytes. ZIP8-mediated Zn2+ influx upregulated the expression of matrix-degrading enzymes (MMP3, MMP9, MMP12, MMP13, and ADAMTS5) in chondrocytes. Ectopic expression of ZIP8 in mouse cartilage tissue caused OA cartilage destruction, whereas Zip8 knockout suppressed surgically induced OA pathogenesis, with concomitant modulation of Zn2+ influx and matrix-degrading enzymes. Furthermore, MTF1 was identified as an essential transcription factor in mediating Zn2+/ZIP8-induced catabolic factor expression, and genetic modulation of Mtf1 in mice altered OA pathogenesis. We propose that the zinc-ZIP8-MTF1 axis is an essential catabolic regulator of OA pathogenesis.	[Kim, Jin-Hong; Jeon, Jimin; Shin, Minhee; Won, Yoonkyung; Lee, Minju; Kwak, Ji-Sun; Lee, Gyuseok; Rhee, Jinseol; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Kim, Jin-Hong; Jeon, Jimin; Shin, Minhee; Won, Yoonkyung; Lee, Minju; Kwak, Ji-Sun; Lee, Gyuseok; Rhee, Jinseol; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Ryu, Je-Hwang] Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea; [Ryu, Je-Hwang] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Kwangju 500757, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Wonkwang University	Chun, JS (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea.	jschun@gist.ac.kr		Jeon, Jimin/0000-0003-1843-4555; Kim, Jin-Hong/0000-0002-6480-1929	National Research Foundation of Korea [2007-0056157, 2012M3A9B44028559, 2013R1A2A1A01009713, 2012-044384]; Korea Healthcare Technology RD Project [A110274]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology RD Project	This work was supported by grants from the National Research Foundation of Korea (2007-0056157, 2012M3A9B44028559, 2013R1A2A1A01009713, and 2012-044384) and the Korea Healthcare Technology R&D Project (A110274).	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bian Qin, 2012, Front Biosci (Elite Ed), V4, P74; Blindauer CA, 2010, NAT PROD REP, V27, P720, DOI 10.1039/b906685n; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Little CB, 2013, NAT REV RHEUMATOL, V9, P485, DOI 10.1038/nrrheum.2013.72; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Oh H, 2012, ARTHRITIS RHEUM-US, V64, P2568, DOI 10.1002/art.34481; Ovesen J, 2009, J TRACE ELEM MED BIO, V23, P1, DOI 10.1016/j.jtemb.2008.12.001; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; PRASAD AS, 1995, NUTRITION, V11, P93; Roschger A, 2013, OSTEOARTHR CARTILAGE, V21, P1707, DOI 10.1016/j.joca.2013.06.029; Ryu JH, 2012, CELL DEATH DIFFER, V19, P440, DOI 10.1038/cdd.2011.111; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	35	230	240	0	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					730	743		10.1016/j.cell.2014.01.007	http://dx.doi.org/10.1016/j.cell.2014.01.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529376	Bronze			2022-12-28	WOS:000331379800012
J	Rosenbaum, L				Rosenbaum, Lisa			"Misfearing" - Culture, Identity, and Our Perceptions of Health Risks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Lisa] Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania	Rosenbaum, L (corresponding author), Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.							Haidt J., 2012, RIGHTEOUS MIND WHY G; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Mosca L, 2013, CIRCULATION, V127, P1254, DOI 10.1161/CIR.0b013e318287cf2f; National Research Council; Institute of Medicine, 2013, US HLTH INT PERSP SH; Sunstein C. R., 2006, 274 U CHIC LAW EC OL	5	15	15	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					595	597		10.1056/NEJMp1314638	http://dx.doi.org/10.1056/NEJMp1314638			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA6CX	24521105				2022-12-28	WOS:000331187500005
J	Gatti, LV; Gloor, M; Miller, JB; Doughty, CE; Malhi, Y; Domingues, LG; Basso, LS; Martinewski, A; Correia, CSC; Borges, VF; Freitas, S; Braz, R; Anderson, LO; Rocha, H; Grace, J; Phillips, OL; Lloyd, J				Gatti, L. V.; Gloor, M.; Miller, J. B.; Doughty, C. E.; Malhi, Y.; Domingues, L. G.; Basso, L. S.; Martinewski, A.; Correia, C. S. C.; Borges, V. F.; Freitas, S.; Braz, R.; Anderson, L. O.; Rocha, H.; Grace, J.; Phillips, O. L.; Lloyd, J.			Drought sensitivity of Amazonian carbon balance revealed by atmospheric measurements	NATURE			English	Article							VERTICAL PROFILES; CO2; FORESTS; FLUXES; MODEL; CYCLE; EMISSIONS; DIOXIDE; TRENDS	Feedbacks between land carbon pools and climate provide one of the largest sources of uncertainty in our predictions of global climate(1,2). Estimates of the sensitivity of the terrestrial carbon budget to climate anomalies in the tropics and the identification of the mechanisms responsible for feedback effects remain uncertain(3,4). The Amazon basin stores a vast amount of carbon(5), and has experienced increasingly higher temperatures and more frequent floods and droughts over the past two decades(6). Here we report seasonal and annual carbon balances across the Amazon basin, based on carbon dioxide and carbon monoxide measurements for the anomalously dry and wet years 2010 and 2011, respectively. We find that the Amazon basin lost 0.48 +/- 0.18 petagrams of carbon per year (Pg C yr(-1)) during the dry year but was carbon neutral (0.06 +/- 0.1 Pg C yr(-1)) during the wet year. Taking into account carbon losses from fire by using carbon monoxide measurements, we derived the basin net biome exchange (that is, the carbon flux between the non-burned forest and the atmosphere) revealing that during the dry year, vegetation was carbon neutral. During the wet year, vegetation was a net carbon sink of 0.25 +/- 0.14 Pg C yr(-1), which is roughly consistent with the mean long-term intact-forest biomass sink of 0.39 +/- 0.10 Pg C yr(-1) previously estimated from forest censuses(7). Observations from Amazonian forest plots suggest the suppression of photosynthesis during drought as the primary cause for the 2010 sink neutralization. Overall, our results suggest that moisture has an important role in determining the Amazonian carbon balance. If the recent trend of increasing precipitation extremes persists(6), the Amazon may become an increasing carbon source as a result of both emissions from fires and the suppression of net biome exchange by drought.	[Gatti, L. V.; Domingues, L. G.; Basso, L. S.; Martinewski, A.; Correia, C. S. C.; Borges, V. F.] CNEN, IPEN, Atmospher Chem Lab, BR-05508000 Sao Paulo, Brazil; [Gloor, M.; Phillips, O. L.] Univ Leeds, Sch Geog, Leeds LS9 2JT, W Yorkshire, England; [Miller, J. B.] NOAA, Global Monitoring Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Miller, J. B.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Doughty, C. E.; Malhi, Y.; Anderson, L. O.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford OX1 3QY, England; [Freitas, S.; Braz, R.] INPE, Ctr Weather Forecasts & Climate Studies, BR-12630000 Cachoeira Paulista, Brazil; [Anderson, L. O.] INPE, Remote Sensing Div, BR-12227010 Sao Jose Dos Campos, Brazil; [Rocha, H.] Univ Sao Paulo, IAG, Dept Ciencias Atmosfer, BR-05508090 Sao Paulo, Brazil; [Lloyd, J.] James Cook Univ, Sch Trop & Marine Biol, Cairns, Qld 4870, Australia; [Lloyd, J.] James Cook Univ, Ctr Terr Environm & Sustainabil Sci, Cairns, Qld 4870, Australia; [Lloyd, J.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); University of Leeds; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Oxford; Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Sao Paulo; James Cook University; James Cook University; Imperial College London	Gatti, LV (corresponding author), CNEN, IPEN, Atmospher Chem Lab, 2242 Ave Prof Lineu Prestes,Cidade Univ, BR-05508000 Sao Paulo, Brazil.	lvgatti@gmail.com; eugloor@gmail.com; john.b.miller@noaa.gov	Miller, John B./AAE-7714-2019; Basso, Luana/E-3290-2014; Domingues, Lucas G/E-4730-2015; Freitas, Saulo/A-2279-2012; Gatti, Luciana Vanni/J-8569-2012; Anderson, Liana/G-8389-2012; Borges, Viviane/A-8613-2016; Freitas, Saulo R./AAN-6378-2020; Lloyd, Jonathan J/F-8893-2010; Phillips, Oliver/A-1523-2011	Miller, John B./0000-0001-8630-1610; Domingues, Lucas G/0000-0003-4868-917X; Freitas, Saulo/0000-0002-9879-646X; Gatti, Luciana Vanni/0000-0003-4908-8974; Anderson, Liana/0000-0001-9545-5136; Borges, Viviane/0000-0002-0336-5457; Freitas, Saulo R./0000-0002-9879-646X; Lloyd, Jonathan J/0000-0002-5458-9960; Phillips, Oliver/0000-0002-8993-6168; Doughty, Christopher/0000-0003-3985-7960; Braz, Rodrigo/0000-0003-3958-5563; Basso, Luana/0000-0002-4208-6039	UK Environmental Research Council (NERC) via the consortium grant 'AMAZONICA' NERC [NE/F005806/1]; State of Sao Paulo Science Foundation (FAPESP) [08/58120-3]; EU [283080]; NERC; Moore Foundation; CNPq; CAPES; Fapesp; IPEN; ERC; Natural Environment Research Council [NE/D005590/1, NE/I02982X/1, NE/F005776/1, NE/F005806/1, NE/F005040/1, NER/A/S/2003/00609] Funding Source: researchfish; NERC [NE/D005590/1, NE/F005040/1, NE/I02982X/1, NE/F005806/1, NE/F005776/1] Funding Source: UKRI	UK Environmental Research Council (NERC) via the consortium grant 'AMAZONICA' NERC; State of Sao Paulo Science Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Moore Foundation(Gordon and Betty Moore Foundation); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); IPEN; ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank P. Tans and P. Bakwin, who had the foresight to initiate a long-term high-precision greenhouse gas measurement laboratory in Sao Paulo, and D. Wickland, the NASA programme manager who initially supported this effort. This work has been financed primarily by the UK Environmental Research Council (NERC) via the consortium grant 'AMAZONICA' NERC (NE/F005806/1) and also by the State of Sao Paulo Science Foundation (FAPESP) via the 'Carbon Tracker' project (08/58120-3), and the EU via the 7th grant framework GEOCARBON project (grant number agreement 283080). NASA, NOAA and IPEN made large contributions to the construction and maintenance of the GHG laboratory in Brazil. Intensive plot measurements were supported by NERC and the Moore Foundation via grants given to RAINFOR. L.G.D., L.S.B., C.S.S.C., V.F.B. and A.M. were supported by CNPq, CAPES, Fapesp and IPEN, and O.L.P. by an ERC Advanced Grant. We thank measurement analysts and scientists at NOAA for providing data, and the pilots who collected the air samples. Numerous people at NOAA, especially A. Crotwell, D. Guenther, C. Sweeney and K. Thoning, provided advice and technical support for air sampling and measurements in Brazil. E. Dlugokencky provided data from Ascension Island and Ragged Point in Barbados. We also thank D. Galbraith for help with the comprehensive forest census plot data and R. Brienen for comments. Finally, we acknowledge S. Denning for reviews of the manuscript.	Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Araujo-Murakami A, 2014, PLANT ECOL DIVERS, V7, P55, DOI 10.1080/17550874.2013.798364; Arino O, 2012, REMOTE SENS ENVIRON, V116, P226, DOI 10.1016/j.rse.2011.05.025; Beck C, 2005, CLIMATE STATUS REPOR, V2004, P181; Center for International Earth Science Information Network (CIESIN), 2011, GRIDD POP WORLD VERS; Chou WW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001295; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; D'Amelio MTS, 2009, ATMOS CHEM PHYS, V9, P8785, DOI 10.5194/acp-9-8785-2009; da Costa ACL, 2014, PLANT ECOL DIVERS, V7, P7, DOI 10.1080/17550874.2013.798366; del Aguila-Pasquel J, 2014, PLANT ECOL DIVERS, V7, P71, DOI 10.1080/17550874.2013.798365; Doughty CE, 2014, PLANT ECOL DIVERS, V7, P41, DOI 10.1080/17550874.2013.798367; Draxler R., 2013, HYSPLIT HYBRID SINGL; Espinoza JC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047862; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Freitas SR, 2009, ATMOS CHEM PHYS, V9, P2843, DOI 10.5194/acp-9-2843-2009; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gatti LV, 2010, TELLUS B, V62, P581, DOI 10.1111/j.1600-0889.2010.00484.x; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P107, DOI 10.1080/17550874.2013.820222; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Gloor M, 2012, BIOGEOSCIENCES, V9, P5407, DOI 10.5194/bg-9-5407-2012; Greenberg JP, 2004, GLOBAL CHANGE BIOL, V10, P651, DOI 10.1111/j.1365-2486.2004.00758.x; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Huasco WH, 2014, PLANT ECOL DIVERS, V7, P125, DOI 10.1080/17550874.2013.819042; Huntingford C, 2009, TELLUS B, V61, P355, DOI 10.1111/j.1600-0889.2009.00414.x; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; INPE, 2011, PRODES PROJ DEFL AM; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Liu Z, 2012, B AM METEOROL SOC, V93, P1317, DOI 10.1175/BAMS-D-11-00152.1; Lloyd J, 2007, BIOGEOSCIENCES, V4, P759, DOI 10.5194/bg-4-759-2007; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Malhi Y, 2014, PLANT ECOL DIVERS, V7, P85, DOI 10.1080/17550874.2013.820805; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; National Institute for Environmental Studies (NIES), 2009, GLOB DRAIN BAS DAT G; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Rocha W, 2014, PLANT ECOL DIVERS, V7, P25, DOI 10.1080/17550874.2013.798368; Saleska S, 2009, GEOPHYS MONOGR SER, V186, P389, DOI 10.1029/2008GM000728; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; van der Werf GR, 2009, BIOGEOSCIENCES, V6, P235, DOI 10.5194/bg-6-235-2009; Zhou L. X., 2009, 14 WMO IAEA M EXP CA, P40	47	322	332	24	405	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					76	+		10.1038/nature12957	http://dx.doi.org/10.1038/nature12957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499918				2022-12-28	WOS:000330648100034
J	Tegtmeyer, LC; Rust, S; van Scherpenzeel, M; Ng, BG; Losfeld, ME; Timal, S; Raymond, K; He, P; Ichikawa, M; Veltman, J; Huijben, K; Shin, YS; Sharma, V; Adamowicz, M; Lammens, M; Reunert, J; Witten, A; Schrapers, E; Matthijs, G; Jaeken, J; Rymen, D; Stojkovic, T; Laforet, P; Petit, F; Aumaitre, O; Czarnowska, E; Piraud, M; Podskarbi, T; Stanley, CA; Matalon, R; Burda, P; Seyyedi, S; Debus, V; Socha, P; Sykut-Cegielska, J; van Spronsen, F; de Meirleir, L; Vajro, P; DeClue, T; Ficicioglu, C; Wada, Y; Wevers, RA; Vanderschaeghe, D; Callewaert, N; Fingerhut, R; van Schaftingen, E; Freeze, HH; Morava, E; Lefeber, DJ; Marquardt, T				Tegtmeyer, L. C.; Rust, S.; van Scherpenzeel, M.; Ng, B. G.; Losfeld, M. -E.; Timal, S.; Raymond, K.; He, P.; Ichikawa, M.; Veltman, J.; Huijben, K.; Shin, Y. S.; Sharma, V.; Adamowicz, M.; Lammens, M.; Reunert, J.; Witten, A.; Schrapers, E.; Matthijs, G.; Jaeken, J.; Rymen, D.; Stojkovic, T.; Laforet, P.; Petit, F.; Aumaitre, O.; Czarnowska, E.; Piraud, M.; Podskarbi, T.; Stanley, C. A.; Matalon, R.; Burda, P.; Seyyedi, S.; Debus, V.; Socha, P.; Sykut-Cegielska, J.; van Spronsen, F.; de Meirleir, L.; Vajro, P.; DeClue, T.; Ficicioglu, C.; Wada, Y.; Wevers, R. A.; Vanderschaeghe, D.; Callewaert, N.; Fingerhut, R.; van Schaftingen, E.; Freeze, H. H.; Morava, E.; Lefeber, D. J.; Marquardt, T.			Multiple Phenotypes in Phosphoglucomutase 1 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCOGEN-STORAGE-DISEASE; CONGENITAL DISORDERS; DILATED CARDIOMYOPATHY; MUSCLE GLYCOGENOSIS; NUCLEOTIDE SUGARS; GLYCOSYLATION; IDENTIFICATION; CHILDREN; THERAPY; GLUCOSE	BackgroundCongenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogonadism, growth retardation, hypoglycemia, myopathy, dilated cardiomyopathy, and cardiac arrest. MethodsHomozygosity mapping followed by whole-exome sequencing was used to identify a mutation in the gene for phosphoglucomutase 1 (PGM1) in two siblings. Sequencing identified additional mutations in 15 other families. Phosphoglucomutase 1 enzyme activity was assayed on cell extracts. Analyses of glycosylation efficiency and quantitative studies of sugar metabolites were performed. Galactose supplementation in fibroblast cultures and dietary supplementation in the patients were studied to determine the effect on glycosylation. ResultsPhosphoglucomutase 1 enzyme activity was markedly diminished in all patients. Mass spectrometry of transferrin showed a loss of complete N-glycans and the presence of truncated glycans lacking galactose. Fibroblasts supplemented with galactose showed restoration of protein glycosylation and no evidence of glycogen accumulation. Dietary supplementation with galactose in six patients resulted in changes suggestive of clinical improvement. A new screening test showed good discrimination between patients and controls. ConclusionsPhosphoglucomutase 1 deficiency, previously identified as a glycogenosis, is also a congenital disorder of glycosylation. Supplementation with galactose leads to biochemical improvement in indexes of glycosylation in cells and patients, and supplementation with complex carbohydrates stabilizes blood glucose. A new screening test has been developed but has not yet been validated. (Funded by the Netherlands Organization for Scientific Research and others.) Two brothers with an undefined congenital disorder of glycosylation were found to have phosphoglucomutase 1 deficiency, which has previously been described as a glycogen storage disorder. Supplementation with galactose improves protein glycosylation in this disease. Protein N-glycosylation is a ubiquitous process in all organ systems. During N-glycosylation, glycan precursors are assembled from monosaccharide units and then covalently attached to asparagine residues in the nascent peptide chain of a protein (Figure 1). The protein-bound glycans undergo further processing to generate mature glycoproteins. Genetic defects in protein N-glycosylation, designated as congenital disorders of glycosylation, lead to multisystem disorders. Mutations of genes involved in N-glycosylation may affect either the biosynthesis of the glycan precursor (congenital disorder of glycosylation type I [CDG-I]) or the processing of the glycan after its attachment to the protein (congenital disorder of glycosylation type ...	[Tegtmeyer, L. C.; Reunert, J.; Schrapers, E.; Marquardt, T.] Univ Childrens Hosp Munster, Dept Gen Pediat, Munster, Germany; [Debus, V.] Univ Childrens Hosp Munster, Dept Pediat Cardiol, Munster, Germany; [Rust, S.; Witten, A.] Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Shin, Y. S.; Podskarbi, T.] Mol Genet & Metab Lab, Munich, Germany; [Seyyedi, S.] City Med Ctr, Wiesbaden, Germany; [van Scherpenzeel, M.; Timal, S.; Huijben, K.; Wevers, R. A.; Lefeber, D. J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Timal, S.; Lefeber, D. J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Lammens, M.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Veltman, J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van Spronsen, F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Ng, B. G.; Losfeld, M. -E.; He, P.; Ichikawa, M.; Sharma, V.; Freeze, H. H.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Raymond, K.] Mayo Clin, Coll Med, Biochem Genet Lab, Rochester, MN USA; [Adamowicz, M.] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, Warsaw, Poland; [Czarnowska, E.] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Socha, P.] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Sykut-Cegielska, J.] Childrens Mem Hlth Inst, Dept Metab Dis, Warsaw, Poland; [Matthijs, G.; Jaeken, J.; Rymen, D.] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Vanderschaeghe, D.; Callewaert, N.] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Vanderschaeghe, D.; Callewaert, N.] Univ Ghent VIB, Unit Med Biotechnol, Dept Mol Biomed Res, Ghent, Belgium; [de Meirleir, L.] Univ Brussels, Brussels, Belgium; [van Schaftingen, E.] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Stojkovic, T.; Laforet, P.] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Pathol Neuromusculaire Paris Est, Inst Myol, F-75634 Paris, France; [Petit, F.] Hop Antoine Beclere, Lab Genet Mol Malad Metab, Clamart, France; [Aumaitre, O.] Ctr Hosp Univ CHU Gabriel Montpied, Serv Med Interne, Clermont Ferrand, France; [Piraud, M.] CHU Lyon, Serv Malad Hereditaires Metab, Bron, France; [Stanley, C. A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Ficicioglu, C.] Childrens Hosp Philadelphia, Div Pediat, Philadelphia, PA 19104 USA; [Matalon, R.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Burda, P.] Univ Childrens Hosp, Div Metab, Childrens Res Ctr, Zurich, Switzerland; [Fingerhut, R.] Univ Childrens Hosp, Swiss Newborn Screening Lab, Childrens Res Ctr, Zurich, Switzerland; [Vajro, P.] Univ Salerno, Dept Med & Surg, Div Pediat, I-84081 Baronissi, Italy; [DeClue, T.] Univ S Florida, Dept Pediat, Morsani Coll Med, Tampa, FL 33620 USA; [Wada, Y.] Osaka Med Ctr, Osaka, Japan; [Wada, Y.] Res Inst Maternal & Child Hlth, Osaka, Japan; [Morava, E.] Tulane Univ, Sch Med, Dept Pediat, Hayward Genet Ctr, New Orleans, LA 70112 USA	University of Munster; University of Munster; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; KU Leuven; University Hospital Leuven; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Clermont Ferrand; CHU Lyon; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Medical Branch Galveston; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Salerno; State University System of Florida; University of South Florida; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tulane University	Marquardt, T (corresponding author), Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, Albert Schweitzer Campus 1,Gebaude A13, D-48149 Munster, Germany.	d.lefeber@neuro.umcn.nl; thorsten.marquardt@ukmuenster.de	Ficicioglu, Can/AAQ-8002-2020; Sykut-Cegielska, Jolanta/V-4253-2019; Morava, E./L-4529-2015; Vajro, Pietro/H-5179-2019; De Meirleir, Linda/D-6591-2016; Lefeber, Dirk DJ/A-2146-2014; Veltman, Joris A/F-5128-2010; Fingerhut, Ralph/AAY-5061-2021; STOJKOVIC, Tanya/AAA-3967-2021; Van+Schaftingen, Emile/AAF-5532-2020; Lammens, Martin/H-1503-2011; Lammens, Martin/AAI-9343-2021; Wevers, Ron A./H-8116-2014; Witten, Anika/C-5297-2019; van Scherpenzeel, Monique/N-7008-2015	Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Veltman, Joris A/0000-0002-3218-8250; Fingerhut, Ralph/0000-0002-9674-8931; Lammens, Martin/0000-0002-3881-6692; Wevers, Ron A./0000-0003-2278-9746; van Scherpenzeel, Monique/0000-0002-9696-4562; Czarnowska, Elzbieta/0000-0002-1785-1405; Callewaert, Nico/0000-0003-2069-6917; STANLEY, CHARLES/0000-0003-4881-9392; Freeze, Hudson/0000-0001-6316-0501; Petit, Francois/0000-0002-6506-8060; Ficicioglu, Can/0000-0002-8331-9804; VAJRO, PIetro/0000-0002-9418-5880; Van Schaftingen, Emile/0000-0002-6199-7647; Socha, Piotr/0000-0002-1621-464X; Matthijs, Gert/0000-0001-6710-1912	Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Netherlands Organization for Scientific Research and others	Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Biffi S, 2007, CLIN BIOCHEM, V40, P1431, DOI 10.1016/j.clinbiochem.2007.08.015; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; Gehrmann J, 2003, CARDIOL YOUNG, V13, P345, DOI 10.1017/S1047951103000702; He P, 2012, J BIOL CHEM, V287, P18210, DOI 10.1074/jbc.M112.355677; Huhtaniemi IT, 2000, ASIAN J ANDROL, V2, P241; Illingworth B, 1964, CONTROL GLYCOGEN MET, P336; Illingworth Brown B, 1968, CARBOHYD METABOL, P144; Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656; Mandato C, 2006, PEDIATR RES, V59, P293, DOI 10.1203/01.pdr.0000196378.30165.26; Miller BS, 2009, CLIN ENDOCRINOL, V70, P892, DOI 10.1111/j.1365-2265.2009.03531.x; Mohamed M, 2011, BBA-MOL BASIS DIS, V1812, P691, DOI 10.1016/j.bbadis.2011.02.011; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Nakashima H, 1992, Rinsho Shinkeigaku, V32, P42; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; QUICK CB, 1974, EUR J BIOCHEM, V42, P511, DOI 10.1111/j.1432-1033.1974.tb03366.x; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Shin YS, 1991, TECHNIQUES DIAGNOSTI, P267; Sickmann HM, 2005, NEUROCHEM RES, V30, P1295, DOI 10.1007/s11064-005-8801-4; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; SUGIE H, 1988, NEUROLOGY, V38, P602, DOI 10.1212/WNL.38.4.602; THOMSON WHS, 1963, J NEUROL NEUROSUR PS, V26, P60, DOI 10.1136/jnnp.26.1.60; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Weinstein DA, 2002, EUR J PEDIATR, V161, pS35, DOI 10.1007/s00431-002-1000-2	27	180	186	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					533	542		10.1056/NEJMoa1206605	http://dx.doi.org/10.1056/NEJMoa1206605			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499211	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000331073500009
J	Echard, A; Burgess, D				Echard, Arnaud; Burgess, David			The Changing Lipidome during Cell Division	CELL			English	Editorial Material							CYTOKINESIS; DOMAINS	Cell division entails dramatic membrane rearrangements, but what is the role of lipids in the process? Eggert et al. explore the dynamics of the lipidome during cell division and provide new insights on the functions of specific lipids in cytokinesis.	[Echard, Arnaud] Inst Pasteur, Membrane Traff & Cell Div Lab, F-75015 Paris, France; [Echard, Arnaud] CNRS, URA2582, F-75015 Paris, France; [Burgess, David] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Boston College	Echard, A (corresponding author), Inst Pasteur, Membrane Traff & Cell Div Lab, 25-28 Rue Dr Roux, F-75015 Paris, France.	arnaud.echard@pasteur.fr; david.burgess@bc.edu		Echard, Arnaud/0000-0001-7402-1398				Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Echard A, 2012, CYTOSKELETON, V69, P893, DOI 10.1002/cm.21067; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Gudejko HFM, 2012, CYTOSKELETON, V69, P1000, DOI 10.1002/cm.21078; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642	10	9	9	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					394	395		10.1016/j.cell.2014.01.018	http://dx.doi.org/10.1016/j.cell.2014.01.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485447	Bronze			2022-12-28	WOS:000330580800005
J	Hunt, DP; Muse, VV; Ly, A				Hunt, Daniel P.; Muse, Victorine V.; Ly, Amy			Case 4-2014: A 39-Year-Old Man with Night Sweats and Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHEMA-NODOSUM; SARCOIDOSIS; MANIFESTATIONS; PSORIASIS; LYMPHOMA; COHORT	A 39-year-old man with a history of psoriasis was admitted to the hospital because of night sweats and abdominal pain. Imaging studies showed numerous ill-defined, hypoattenuating lesions in the spleen and mediastinal and hilar lymphadenopathy. Presentation of CaseDr. Jordan B. Strom (Medicine): A 39-year-old man was admitted to this hospital because of night sweats and abdominal pain. The patient had been well until 1 week before admission, when night sweats developed, which he attributed to the summer heat. Three days before admission, episodes of sharp abdominal pain developed; the pain was greatest at the costal margin on the right side, and the patient rated it at up to 7 on a scale of 0 to 10 (with 10 indicating the most severe pain). The pain lasted up to 2.5 hours, increased with deep breaths, ...	[Hunt, Daniel P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ly, Amy] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hunt, Daniel P.] Harvard Med Sch, Dept Med, Boston, MA USA; [Muse, Victorine V.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Ly, Amy] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hunt, DP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Hunt, Dan/AAL-3807-2021					Cribier B, 1998, INT J DERMATOL, V37, P667, DOI 10.1046/j.1365-4362.1998.00316.x; De Smet D, 2010, AM J CLIN PATHOL, V134, P939, DOI 10.1309/AJCPNC7STHG0FWMP; Ebert EC, 2008, AM J GASTROENTEROL, V103, P3184, DOI 10.1111/j.1572-0241.2008.02202.x; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2006, J INVEST DERMATOL, V126, P2194, DOI 10.1038/sj.jid.5700410; Hannuksela-Svahn A, 2000, J INVEST DERMATOL, V114, P587, DOI 10.1046/j.1523-1747.2000.00898.x; Koyama T, 2004, RADIOGRAPHICS, V24, P87, DOI 10.1148/rg.241035076; Mana J, 1999, AM J MED, V107, P240, DOI 10.1016/S0002-9343(99)00223-5; Mukhopadhyay S, 2010, ARCH PATHOL LAB MED, V134, P667, DOI 10.1043/1543-2165-134.5.667; Penna C, 2003, NEW ENGL J MED, V349, pE16, DOI 10.1056/ENEJMicm020110; Psychos DN, 2000, CLIN RHEUMATOL, V19, P212, DOI 10.1007/s100670050159; Richardson Stephen K, 2008, Adv Dermatol, V24, P171, DOI 10.1016/j.yadr.2008.09.006; Vardhanabhuti V, 2012, CLIN RADIOL, V67, P263, DOI 10.1016/j.crad.2011.04.018	13	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					467	473		10.1056/NEJMcpc1305990	http://dx.doi.org/10.1056/NEJMcpc1305990			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476436				2022-12-28	WOS:000330645400012
J	Obri, A; Ouararhni, K; Papin, C; Diebold, ML; Padmanabhan, K; Marek, M; Stoll, I; Roy, L; Reilly, PT; Mak, TW; Dimitrov, S; Romier, C; Hamiche, A				Obri, Arnaud; Ouararhni, Khalid; Papin, Christophe; Diebold, Marie-Laure; Padmanabhan, Kiran; Marek, Martin; Stoll, Isabelle; Roy, Ludovic; Reilly, Patrick T.; Mak, Tak W.; Dimitrov, Stefan; Romier, Christophe; Hamiche, Ali			ANP32E is a histone chaperone that removes H2A.Z from chromatin	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; VARIANT H2A.Z; CRYSTAL-STRUCTURE; DNA METHYLATION; COMPLEX; PROTEIN; MODEL; ACETYLTRANSFERASE; PURIFICATION; DEPOSITION	H2A.Z is an essential histone variant implicated in the regulation of key nuclear events. However, the metazoan chaperones responsible for H2A.Z deposition and its removal from chromatin remain unknown. Here we report the identification and characterization of the human protein ANP32E as a specific H2A.Z chaperone. We show that ANP32E is a member of the presumed H2A.Z histone-exchange complex p400/TIP60. ANP32E interacts with a short region of the docking domain of H2A.Z through a new motif termed H2A.Z interacting domain (ZID). The 1.48 angstrom resolution crystal structure of the complex formed between the ANP32E-ZID and the H2A.Z/H2B dimer and biochemical data support an underlying molecular mechanism for H2A.Z/H2B eviction from the nucleosome and its stabilization by ANP32E through a specific extension of the H2A.Z carboxy-terminal alpha-helix. Finally, analysis of H2A.Z localization in ANP32E(-/-) cells by chromatin immunoprecipitation followed by sequencing shows genome-wide enrichment, redistribution and accumulation of H2A.Z at specific chromatin control regions, in particular at enhancers and insulators.	[Obri, Arnaud; Ouararhni, Khalid; Papin, Christophe; Stoll, Isabelle; Roy, Ludovic; Hamiche, Ali] Univ Strasbourg, CNRS, INSERM, Dept Genom Fonct & Canc,IGBMC, F-67404 Illkirch Graffenstaden, France; [Diebold, Marie-Laure; Marek, Martin; Romier, Christophe] Univ Strasbourg, CNRS, INSERM, Dept Biol Struct Integrat,IGBMC, F-67404 Illkirch Graffenstaden, France; [Padmanabhan, Kiran; Dimitrov, Stefan] Univ Grenoble 1, INSERM, U823, Equipe Labelisee Ligue Canc,Inst Albert Bonniot, F-38042 Grenoble 9, France; [Reilly, Patrick T.; Mak, Tak W.] Natl Canc Ctr, Div Cellular & Mol Res, Lab Inflammat Biol, Singapore, Singapore; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Cancer Centre Singapore (NCCS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hamiche, A (corresponding author), Univ Strasbourg, CNRS, INSERM, Dept Genom Fonct & Canc,IGBMC, 1 Rue Laurent Fries,bp 10142, F-67404 Illkirch Graffenstaden, France.	dimitrov@ujf-grenoble.fr; romier@igbmc.fr; hamiche@igbmc.fr	Obri, Arnaud/B-4691-2019; Marek, Martin/N-3204-2017; Padmanabhan, Kiran/N-2953-2013; Marek, Martin/P-5702-2016; Marek, Martin/M-6162-2019; dimitrov, stefan/M-7697-2013	Obri, Arnaud/0000-0002-0779-1082; Marek, Martin/0000-0001-7220-5644; Padmanabhan, Kiran/0000-0001-7020-1682; Marek, Martin/0000-0003-0394-7382; Marek, Martin/0000-0001-7220-5644; dimitrov, stefan/0000-0002-1326-3630; Romier, Christophe/0000-0002-3680-935X; Roy, Ludovic/0000-0001-6940-874X; Diebold-Durand, Marie-Laure/0000-0002-2061-9260; Papin, Christophe/0000-0001-8124-5883	CNRS; INSERM; Universite de Strasbourg; INCa [INCa_4496, INCa_4454]; ANR (VariZome) [ANR-12-BSV8-0018-01]; ANR (Nucleoplat) [NT09_476241]; Association pour la Recherche sur le Cancer; La Fondation pour la Recherche Medicale; La Ligue Nationale contre le Cancer (Equipe labellisee); French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct (ESFRI); Ligue Nationale contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; INCa(Institut National du Cancer (INCA) France); ANR (VariZome)(French National Research Agency (ANR)); ANR (Nucleoplat)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La Ligue Nationale contre le Cancer (Equipe labellisee); French Infrastructure for Integrated Structural Biology (FRISBI); Instruct (ESFRI); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank I. Davidson, P. Antony, J. Cavarelli and D. Moras for reading the manuscript, and V. Cura and A. McEwen for help during data collection. This work was supported by CNRS, INSERM, Universite de Strasbourg, and by grants from INCa (INCa_4496 and INCa_4454), ANR (VariZome, ANR-12-BSV8-0018-01; Nucleoplat, NT09_476241), the Association pour la Recherche sur le Cancer, La Fondation pour la Recherche Medicale, La Ligue Nationale contre le Cancer (Equipe labellisee, to A.H. and S.D.), the French Infrastructure for Integrated Structural Biology (FRISBI; ANR-10-INSB-05-01) and by Instruct (ESFRI). A.O. acknowledges the Association pour la Recherche sur le Cancer for Financial support. K.P. was supported by la Ligue Nationale contre le Cancer.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Billon P, 2012, BBA-GENE REGUL MECH, V1819, P290, DOI 10.1016/j.bbagrm.2011.10.004; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Choi J, 2009, NUCLEIC ACIDS RES, V37, P5993, DOI 10.1093/nar/gkp660; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hamiche A, 1999, METHODS, V19, P457, DOI 10.1006/meth.1999.0882; Hamiche A, 2012, BBA-GENE REGUL MECH, V1819, P230, DOI 10.1016/j.bbagrm.2011.08.009; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iouzalen N, 1996, NUCLEIC ACIDS RES, V24, P3947, DOI 10.1093/nar/24.20.3947; Jensen K, 2011, MOL GENET GENOMICS, V285, P287, DOI 10.1007/s00438-011-0604-5; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Kular RK, 2009, J BIOL CHEM, V284, P7783, DOI 10.1074/jbc.M806150200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Reilly PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013597; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tochio N, 2010, J MOL BIOL, V401, P97, DOI 10.1016/j.jmb.2010.06.005; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	64	159	172	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					648	+		10.1038/nature12922	http://dx.doi.org/10.1038/nature12922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24463511				2022-12-28	WOS:000330321000033
J	Reade, MC; Finfer, S				Reade, Michael C.; Finfer, Simon			Sedation and Delirium in the Intensive Care Unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CRITICALLY-ILL PATIENTS; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; HALOPERIDOL PROPHYLAXIS; POSTOPERATIVE DELIRIUM; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; DOUBLE-BLIND; NO-SEDATION; OPEN-LABEL	Patients in ICUs often require pain relief and sedation to treat both the underlying medical condition and the unpleasantness associated with being in an ICU. This review provides guidance on the identification and treatment of delirium and sedation. Patients in intensive care units (ICUs) are treated with many interventions (most notably endotracheal intubation and invasive mechanical ventilation) that are observed or perceived to be distressing. Pain is the most common memory patients have of their ICU stay.(1) Agitation can precipitate accidental removal of endotracheal tubes or of intravascular catheters used for monitoring or administration of life-sustaining medications. Consequently, sedatives and analgesics are among the most commonly administered drugs in ICUs. Early intensive care practice evolved from intraoperative anesthetic care at a time when mechanical ventilation was delivered by rudimentary machines that were not capable of synchronizing with patients' ...	[Reade, Michael C.] Univ Queensland, Trauma & Crit Care Res Ctr, Brisbane, Qld 4029, Australia; [Reade, Michael C.] Australian Def Force Acad, Joint Hlth Command, Brisbane, Qld, Australia; [Finfer, Simon] George Inst Global Hlth, Sydney, NSW, Australia; [Finfer, Simon] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia	University of Queensland; Australian Defense Force Academy; George Institute for Global Health; University of Sydney; Royal North Shore Hospital; University of Sydney	Reade, MC (corresponding author), Univ Queensland, Royal Brisbane & Womens Hosp, Level 9,Hlth Sci Bldg, Brisbane, Qld 4029, Australia.	m.reade@uq.edu.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707; Finfer, Simon/0000-0002-2785-5864				American Psychiatric Association, 2011, DIAGN STAT MAN MENT; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Breen D, 2005, CRIT CARE, V9, pR200, DOI 10.1186/cc3495; Dahaba AA, 2004, ANESTHESIOLOGY, V101, P640, DOI 10.1097/00000542-200409000-00012; De Jonghe B, 2005, CRIT CARE MED, V33, P120, DOI 10.1097/01.CCM.0000150268.04228.68; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Gamberini M, 2009, CRIT CARE MED, V37, P1762, DOI 10.1097/CCM.0b013e31819da780; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas Celine, 2011, Intensive Crit Care Nurs, V27, P46, DOI 10.1016/j.iccn.2010.11.002; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Ho KM, 2008, INTENS CARE MED, V34, P1969, DOI 10.1007/s00134-008-1186-5; Hudetz JA, 2009, J CARDIOTHOR VASC AN, V23, P651, DOI 10.1053/j.jvca.2008.12.021; Jackson DL, 2009, CRIT CARE, V13, DOI 10.1186/cc8212; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Muellejans B, 2006, CRIT CARE, V10, DOI 10.1186/cc4939; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Prakanrattana U, 2007, ANAESTH INTENS CARE, V35, P714, DOI 10.1177/0310057X0703500509; Pun BT, 2007, AM J NURS, V107, P40; Reade MC, 2011, CRIT CARE RESUSC, V13, P217; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Roberts DJ, 2012, DRUGS, V72, P1881, DOI 10.2165/11636220-000000000-00000; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Skrobik YK, 2004, INTENS CARE MED, V30, P444, DOI 10.1007/s00134-003-2117-0; Soliman HM, 2001, BRIT J ANAESTH, V87, P186, DOI 10.1093/bja/87.2.186; Spies C, 2011, INTENS CARE MED, V37, P469, DOI 10.1007/s00134-010-2100-5; Stein-Parbury J, 2000, Am J Crit Care, V9, P20; Strom T, 2011, CRIT CARE, V15, DOI 10.1186/cc10586; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; SWINAMER DL, 1988, CHEST, V93, P4, DOI 10.1378/chest.93.1.4; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; van den Boogaard M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e420; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; Vasilevskis EE, 2011, J AM GERIATR SOC, V59, pS249, DOI 10.1111/j.1532-5415.2011.03673.x; Vasilevskis EE, 2010, CRIT CARE MED, V38, pS683, DOI 10.1097/CCM.0b013e3181f245d3; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f	56	310	328	3	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					444	454		10.1056/NEJMra1208705	http://dx.doi.org/10.1056/NEJMra1208705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476433	Bronze			2022-12-28	WOS:000330645400009
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Beware the lies of patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com						BURGOON M, 1994, J LANG SOC PSYCHOL, V13, P443, DOI 10.1177/0261927X94134005; Jones W, 1998, HIPPOCRATES, VII, P297; Kanaan R, 2012, ADV CLIN NEUROSCI RE, V12, P15	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2014	348								g382	10.1136/bmj.g382	http://dx.doi.org/10.1136/bmj.g382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AW	24452623				2022-12-28	WOS:000330297300007
J	Esposito, MS; Capelli, P; Arber, S				Esposito, Maria Soledad; Capelli, Paolo; Arber, Silvia			Brainstem nucleus MdV mediates skilled forelimb motor tasks	NATURE			English	Article						Translating the behavioural output of the nervous system into movement involves interaction between brain and spinal; cord. The brainstem provides an essential bridge between the two structures; but circuit-level organization and function; of this intermediary system remain poorly understood. Here we use intersectional virus tracing and genetic strategies in; mice to reveal a selective synaptic connectivity matrix between brainstem substructures and functionally distinct spinal; motor neurons that regulate limb movement. The brainstem nucleus medullary reticular formation ventral part (MdV); stands out as specifically targeting subpopulations of forelimb-innervating motor neurons. Its glutamatergic premotor; neurons receive synaptic input from key upper motor centres and are recruited during motor tasks. Selective neuronal; ablation or silencing experiments reveal that MdV is critically important specifically for skilled motor behaviour; including; accelerating rotarod and single-food-pellet reaching tasks. Our results indicate that distinct premotor brainstem; nuclei access spinal subcircuits to mediate task-specific aspects of motor programs.	MESENCEPHALIC LOCOMOTOR REGION; SPINAL-CORD; GABAERGIC NEURONS; ORGANIZATION; ACTIVATION; MOVEMENTS; CIRCUITS; SPECIFICITY; RECOVERY; SINGLE		[Esposito, Maria Soledad; Capelli, Paolo; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland; [Esposito, Maria Soledad; Capelli, Paolo; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland.	silvia.arber@unibas.ch		Esposito, Maria Soledad/0000-0003-0673-4219; Arber, Silvia/0000-0002-6261-250X	Human Frontier Science Program; European Research Council Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stadt; Novartis Research Foundation	Human Frontier Science Program(Human Frontier Science Program); European Research Council Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; Novartis Research Foundation	We are grateful to M. Mielich, B. Rapp, D. Salvador and M. Sigrist for expert technical help, L. Gelman, A. Ponti, N. Ehrenfeuchter, M. Kirschmann and R. Thierry for help and advice with image acquisition and analysis, and to P. Caroni for discussions and comments on the manuscript. We thank F. Donato, Y. Zuo, A. Takeoka, P. Tovote and P. Botta for advice on design of behavioral experiments, and S. Sternson for providing PSEM<SUP>308</SUP> and advice for neuronal silencing experiments. M.S.E. was supported by a long-term fellowship of the Human Frontier Science Program, and all authors by a European Research Council Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt and the Novartis Research Foundation.	Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Blanco JE, 2007, EXP NEUROL, V203, P333, DOI 10.1016/j.expneurol.2006.08.017; Bretzner F, 2013, J NEUROSCI, V33, P14681, DOI 10.1523/JNEUROSCI.5231-12.2013; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; GARCIARILL E, 1987, BRAIN RES, V411, P1, DOI 10.1016/0006-8993(87)90675-5; Gorski JA, 2002, J NEUROSCI, V22, P6309; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Greene E.C., 1935, T AM PHILOS SOC, V27, P1; Grillner S, 1972, Prog Brain Res, V37, P243, DOI 10.1016/S0079-6123(08)63906-0; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59; HOLMQVIST B, 1961, Acta Physiol Scand Suppl, V186, P1; Hyland BI, 1997, BEHAV BRAIN RES, V85, P175, DOI 10.1016/S0166-4328(97)87582-1; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jankowska E, 2003, J NEUROSCI, V23, P1867; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kuypers HGJM., HDB PHYSL NERVOUS SY, P56; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9; Noga BR, 2003, J NEUROPHYSIOL, V90, P1464, DOI 10.1152/jn.00034.2003; Orlovsky G., 1999, NEURONAL CONTROL LOC; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Roh J, 2011, J NEUROPHYSIOL, V106, P1363, DOI 10.1152/jn.00842.2010; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	49	156	157	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					351	+		10.1038/nature13023	http://dx.doi.org/10.1038/nature13023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24487621				2022-12-28	WOS:000334403000043
J	Li, QG; Clarke, JA; Gao, KQ; Zhou, CF; Meng, QJ; Li, DL; D'Alba, L; Shawkey, MD				Li, Quanguo; Clarke, Julia A.; Gao, Ke-Qin; Zhou, Chang-Fu; Meng, Qingjin; Li, Daliang; D'Alba, Liliana; Shawkey, Matthew D.			Melanosome evolution indicates a key physiological shift within feathered dinosaurs	NATURE			English	Article							INTEGUMENTARY STRUCTURES; MELANOCORTIN SYSTEM; COLOR PATTERNS; PHEOMELANIN; PLUMAGE; AGOUTI; PLEIOTROPY; BOETTGERI; BIRDS	Inference of colour patterning in extinct dinosaurs(1-3) has been based on the relationship between the morphology of melanin-containing organelles (melanosomes) and colour in extant bird feathers. When this relationship evolved relative to the origin of feathers and other novel integumentary structures, such as hair and filamentous body covering in extinct archosaurs, has not been evaluated. Here we sample melanosomes from the integument of 181 extant amniote taxa and 13 lizard, turtle, dinosaur and pterosaur fossils from the Upper-Jurassic and Lower-Cretaceous of China. We find that in the lineage leading to birds, the observed increase in the diversity of melanosome morphologies appears abruptly, near the origin of pinnate feathers in maniraptoran dinosaurs. Similarly, mammals show an increased diversity of melanosome form compared to all ectothermic amniotes. In these two clades, mammals and maniraptoran dinosaurs including birds, melanosome form and colour are linked and colour reconstruction may be possible. By contrast, melanosomes in lizard, turtle and crocodilian skin, as well as the archosaurian filamentous body coverings (dinosaur 'protofeathers' and pterosaur 'pycnofibres'), show a limited diversity of form that is uncorrelated with colour in extant taxa. These patterns may be explained by convergent changes in the key melanocortin system of mammals and birds, which is known to affect pleiotropically both melanin-based colouration and energetic processes such as metabolic rate in vertebrates(4), and may therefore support a significant physiological shift in maniraptoran dinosaurs.	[Li, Quanguo] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing 100083, Peoples R China; [Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Zhou, Chang-Fu] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Meng, Qingjin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Li, Daliang] Museum China Univ Geosci Beijing, Beijing 100083, Peoples R China; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA	China University of Geosciences; University of Texas System; University of Texas Austin; Peking University; Shenyang Normal University; China University of Geosciences; University System of Ohio; University of Akron; University System of Ohio; University of Akron	Clarke, JA (corresponding author), Univ Texas Austin, Dept Geol Sci, 1 Univ Stn C1100, Austin, TX 78712 USA.	Julia_Clarke@jsg.utexas.edu; shawkey@uakron.edu	D'Alba, Liliana/AAC-4969-2022; Li, Quanguo/ABE-9756-2021; Meng, Q./GSI-6185-2022	D'Alba, Liliana/0000-0002-2478-3455; Shawkey, Matthew/0000-0002-5131-8209; Zhou, Chang-Fu/0000-0002-3744-7573	National Natural Science Foundation of China (NSFC) [41272031]; Fundamental Research Funds for Central Universities; Beijing Municipal Bureau of Human Resources; NSF [EAR-1251895, 1251922]; Human Frontier Science Program (HFSP) [RGY-0083]; Air Force Office of Scientific Research (AFOSR) [FA9550-13-1-0222]; Jurassic Foundation; Division Of Earth Sciences [1251922, 1251895] Funding Source: National Science Foundation	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Beijing Municipal Bureau of Human Resources; NSF(National Science Foundation (NSF)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Jurassic Foundation; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Natural Science Foundation of China (NSFC) grant 41272031, Fundamental Research Funds for Central Universities, Beijing Municipal Bureau of Human Resources, NSF grants EAR-1251895 and 1251922, Human Frontier Science Program (HFSP) grant RGY-0083, Air Force Office of Scientific Research (AFOSR) grant FA9550-13-1-0222, and the Jurassic Foundation. The Smithsonian Institution (J. F. Jacobs and A. Wynn) and San Diego Museum of Natural History (P. Unitt) provided extant samples. BMNHC PH000911 was photographed by M. Ellison.	Bagnara JT, 1973, CHROMATOPHORES COLOR; Calder III W. A., 1978, BIOCH PHYSL A, V60, P479; Carney RM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1642; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Emaresi G, 2013, MOL ECOL, V22, P4915, DOI 10.1111/mec.12438; Greenwold MJ, 2011, J EXP ZOOL PART B, V316B, P609, DOI 10.1002/jez.b.21436; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; McGraw KJ., 2006, BIRD COLORATION, P243; McNamara M. E., BIOL LETT, V9; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Roulin A, 2013, J HERPETOL, V47, P258, DOI 10.1670/12-028; Snyder HK, 2012, BIOL LETTERS, V8, P393, DOI 10.1098/rsbl.2011.1168; Spearman R. I. C., 1973, INTEGUMENT; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Team RC., 2022, LANG ENV STAT COMP; Wolnicka-Glubisz A, 2012, EXP DERMATOL, V21, P537, DOI 10.1111/j.1600-0625.2012.01511.x; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Yabuuchi M, 2010, J POULT SCI, V47, P176, DOI 10.2141/jpsa.009110; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	30	80	81	0	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					350	+		10.1038/nature12973	http://dx.doi.org/10.1038/nature12973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24522537				2022-12-28	WOS:000333029000032
J	Nasca, TJ; Weiss, KB; Bagian, JP				Nasca, Thomas J.; Weiss, Kevin B.; Bagian, James P.			Improving Clinical Learning Environments for Tomorrow's Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								On the basis of site visits that it has conducted for its Clinical Learning Environment Review program, the Accreditation Council for Graduate Medical Education reports finding a generalized lack of resident engagement in systems-based practice.Approximately 2 months ago, I had a patient where I accidently administered a wrong dose of fentanyl during a procedure. The patient developed severe hypotension, and the procedure had to be temporarily halted until we could get her blood pressure back up. My attending was close by. He responded quickly. Ultimately, no harm was done.The reason I believe this happened is that during a procedure I'm sometimes required to administer fentanyl and must dilute it during the procedure. There are two dilutions, either to directly administer by syringe, or for use as an intravenous drip. We do this ...	[Nasca, Thomas J.; Weiss, Kevin B.; Bagian, James P.] Accreditat Council Grad Med Educ, Chicago, IL USA; [Bagian, James P.] Univ Michigan, Ctr Healthcare Engn & Patient Safety, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Nasca, TJ (corresponding author), Accreditat Council Grad Med Educ, Chicago, IL USA.			Bagian, James/0000-0003-1792-6099				[Anonymous], 2014, CLER PATHW EXC FRAM; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Weiss Kevin B, 2012, J Grad Med Educ, V4, P396, DOI 10.4300/JGME-04-03-31	5	61	62	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					991	993		10.1056/NEJMp1314628	http://dx.doi.org/10.1056/NEJMp1314628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC7ED	24467307				2022-12-28	WOS:000332689100005
J	Welbourn, A				Welbourn, Alice			PERSONAL VIEW WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Salamander Trust, London, England		Welbourn, A (corresponding author), Salamander Trust, London, England.	alice@salamandertrust.net						[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2020, HIGH POSS COST COVID; BMJ podcast, 2013, COMMUNICATION; Chitembo Amina, 2012, Reprod Health Matters, V20, P5, DOI 10.1016/S0968-8080(12)39638-9; Coalition of Women living with HIV/AIDS (COWHLA) in Malawi Salamander Trust, SEEK SAF SLEEP STON; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; International Community of Women Living with HIV/AIDS (ICW) Global Global Network of Women Living with HIV (GNP+) Coalition of Women Living with HIV/ AIDS (COWALHA) ICW Eastern Africa, UND PERSP EXP WOM LI; Malyuta R, 2013, PAEDIAT HIV CARE LOW; Sophia Forum, 2013, REP REF SOPH FOR FIN; Van de Perre P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3763; World Health Organization, 2012, VOL MED MAL CIRC HIV; World Health Organization, 2021, VIOL WOM PREV EST 20	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2014	348								f7601	10.1136/bmj.f7601	http://dx.doi.org/10.1136/bmj.f7601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4KD	24508753				2022-12-28	WOS:000331063600001
J	Montori, VM; Brito, JP; Ting, HH				Montori, Victor M.; Brito, Juan P.; Ting, Henry H.			Patient-Centered and Practical Application of New High Cholesterol Guidelines to Prevent Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Montori, Victor M.; Brito, Juan P.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Montori, Victor M.; Brito, Juan P.] Mayo Clin, Knowledge & Evaluat Res Unit, Div Endocrinol, Rochester, MN 55905 USA; [Ting, Henry H.] Mayo Clin, Knowledge & Evaluat Res Unit, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Mayo Clinic, STAT ASP CHOIC DEC A; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076	5	52	52	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					465	466		10.1001/jama.2014.110	http://dx.doi.org/10.1001/jama.2014.110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24496532				2022-12-28	WOS:000330589800014
J	Sachan, D				Sachan, Dinsa			How market based pricing is failing Indian patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dinsasachan@gmail.com						[Anonymous], 2004, WORLD MED SIT; Deutsche Bank Research, 2008, IND PHARM IND COURS; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Government of India. Department of Pharmaceuticals, 2013, DRUG PRIC CONTR ORD; Government of India Ministry of Health and Family Welfare, 2011, NAT LIST ESS MED; Srinivasan S., 2013, EC POLITICAL WEEKLY	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2014	348								g278	10.1136/bmj.g278	http://dx.doi.org/10.1136/bmj.g278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AV	24474222	Bronze			2022-12-28	WOS:000330647600011
J	Howes, O				Howes, Oliver			Cognitive therapy: at last an alternative to antipsychotics?	LANCET			English	Editorial Material							SCHIZOPHRENIA; DRUGS; EFFICACY		[Howes, Oliver] Ctr Clin Sci, London SE5 8AF, England; [Howes, Oliver] Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Howes, O (corresponding author), Ctr Clin Sci, London SE5 8AF, England.	oliver.howes@csc.mrc.ac.uk	Howes, Oliver/E-7156-2010	Howes, Oliver/0000-0002-2928-1972	Medical Research Council [G0700995, MC_U120097115] Funding Source: Medline; Medical Research Council [1116129] Funding Source: researchfish; MRC [G0700995] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Howes OD, 2009, CURR PHARM DESIGN, V15, P2550, DOI 10.2174/138161209788957528; Howes OD, 2005, J CLIN PSYCHOPHARM, V25, P259, DOI 10.1097/01.jcp.0000162798.87249.4d; Howes OD, 2007, J CLIN PSYCHIAT, V68, P361, DOI 10.4088/JCP.v68n0302; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Khin NA, 2012, J CLIN PSYCHIAT, V73, P856, DOI 10.4088/JCP.11r07539; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Morrison A.P., 2014, LANCET; Ogasa M, 2013, PSYCHOPHARMACOLOGY, V225, P519, DOI 10.1007/s00213-012-2838-2; Taylor D, 2009, BRIT J PSYCHIAT, V195, pS13, DOI 10.1192/bjp.195.52.s13; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	16	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1364	1366		10.1016/S0140-6736(13)62569-6	http://dx.doi.org/10.1016/S0140-6736(13)62569-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24508319				2022-12-28	WOS:000335318400006
J	Gale, CP; Fox, KAA				Gale, Chris P.; Fox, Keith A. A.			International comparisons of acute myocardial infarction	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION		[Gale, Chris P.] Univ Leeds, Div Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England; [Gale, Chris P.] York Teaching Hosp, Dept Cardiol, York, N Yorkshire, England; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Leeds; University of Edinburgh	Gale, CP (corresponding author), Univ Leeds, Div Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England.	c.p.gale@leeds.ac.uk	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Gale, Chris/0000-0003-4732-382X	Department of Health [NIHR/CS/009/004] Funding Source: Medline; National Institute for Health Research [NIHR/CS/009/004] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Chung SC, 2014, LANCET; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Laut KG, 2013, EUROINTERVENTION, V9, P469, DOI 10.4244/EIJV9I4A76; Laut KG, 2013, INT J CARDIOL, V168, P2745, DOI 10.1016/j.ijcard.2013.03.085; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0	7	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1274	1276		10.1016/S0140-6736(13)62367-3	http://dx.doi.org/10.1016/S0140-6736(13)62367-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24461716	hybrid, Green Submitted			2022-12-28	WOS:000334104900006
J	Garcia-Sastre, A; Schmolke, M				Garcia-Sastre, Adolfo; Schmolke, Mirco			Avian influenza A H10N8-a virus on the verge?	LANCET			English	Editorial Material							TRANSMISSION; FERRETS		[Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Schmolke, Mirco] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Schmolke, Mirco/AAI-9081-2020	Schmolke, Mirco/0000-0002-2491-3029; Garcia-Sastre, Adolfo/0000-0002-6551-1827				Center for Infectious Disease Research and Policy, 2014, CHIN 2 H7N9 WAV TOPS; Center for Infectious Disease Research and Policy, 2013, AV INFL BIRD FLU IMP; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiao PR, 2012, J VIROL, V86, P7716, DOI 10.1128/JVI.00959-12; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Peng F, 2014, XINHUANET       0126; Rivers C, 2013, PLOS CURR, DOI [10.1371/currents.outbreaks.264e737b489bef383fbcbaba60daf928, DOI 10.1371/CURRENTS.0UTBREAKS.264E737B489BEF383FB]; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; World Health Organization, CUM NUMB CONF HUM CA	14	55	56	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					676	677		10.1016/S0140-6736(14)60163-X	http://dx.doi.org/10.1016/S0140-6736(14)60163-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24508318	Green Published			2022-12-28	WOS:000331653300007
J	Guo, SQ; Zi, XY; Schulz, VP; Cheng, JJ; Zhong, M; Koochaki, SHJ; Megyola, CM; Pan, XH; Heydari, K; Weissman, SM; Gallagher, PG; Krause, DS; Fan, R; Lu, J				Guo, Shangqin; Zi, Xiaoyuan; Schulz, Vincent P.; Cheng, Jijun; Zhong, Mei; Koochaki, Sebastian H. J.; Megyola, Cynthia M.; Pan, Xinghua; Heydari, Kartoosh; Weissman, Sherman M.; Gallagher, Patrick G.; Krause, Diane S.; Fan, Rong; Lu, Jun			Nonstochastic Reprogramming from a Privileged Somatic Cell State	CELL			English	Article							PLURIPOTENT STEM-CELLS; MICE LACKING; E-CADHERIN; EXPRESSION; GENERATION; FIBROBLASTS; QUIESCENCE; INDUCTION; P57(KIP2); EFFICIENT	Reprogramming somatic cells to induced pluripotency by Yamanaka factors is usually slow and inefficient and is thought to be a stochastic process. We identified a privileged somatic cell state, from which acquisition of pluripotency could occur in a nonstochastic manner. Subsets of murine hematopoietic progenitors are privileged whose progeny cells predominantly adopt the pluripotent fate with activation of endogenous Oct4 locus after four to five divisions in reprogramming conditions. Privileged cells display an ultrafast cell cycle of similar to 8 hr. In fibroblasts, a sub-population cycling at a similar ultrafast speed is observed after 6 days of factor expression and is increased by p53 knockdown. This ultrafast cycling population accounts for >99% of the bulk reprogramming activity in wild-type or p53 knockdown fibroblasts. Our data demonstrate that the stochastic nature of reprogramming can be overcome in a privileged somatic cell state and suggest that cell-cycle acceleration toward a critical threshold is an important bottleneck for reprogramming.	[Guo, Shangqin; Zhong, Mei; Koochaki, Sebastian H. J.; Megyola, Cynthia M.; Krause, Diane S.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Guo, Shangqin; Cheng, Jijun; Zhong, Mei; Koochaki, Sebastian H. J.; Megyola, Cynthia M.; Pan, Xinghua; Weissman, Sherman M.; Krause, Diane S.; Fan, Rong; Lu, Jun] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Zi, Xiaoyuan; Fan, Rong] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Schulz, Vincent P.; Gallagher, Patrick G.] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Cheng, Jijun; Pan, Xinghua; Weissman, Sherman M.; Gallagher, Patrick G.; Lu, Jun] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Heydari, Kartoosh] Yale Univ, Dept Immunobiol, Yale Flow Cytometry Core Facil, New Haven, CT 06520 USA; [Weissman, Sherman M.; Fan, Rong; Lu, Jun] Yale Univ, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Krause, Diane S.] Yale Univ, Dept Lab Med, New Haven, CT 06520 USA; [Zi, Xiaoyuan] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Naval Medical University	Guo, SQ (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA.	shangqin.guo@yale.edu	Guo, Shangqin/AAL-7580-2020; Guo, Shangqin/Q-4088-2019	Guo, Shangqin/0000-0003-1157-0423; Pan, Xinghua (Victor)/0000-0002-7421-8155; Schulz, Vincent/0000-0001-6333-4284	NIH [K01 DK082982, R01CA149109, P30 DK0724429, R01 DK086267, R01HL106184, U54 CA143798, P01GM099130]; State of Connecticut; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [R01CA149109, U54CA143798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK086267, K01DK082982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants K01 DK082982 (to S. G.), R01CA149109 (to J.L.), P30 DK0724429 and R01 DK086267 (to D. S. K.), R01HL106184 (to P. G. G.), U54 CA143798 (to R. F.), P01GM099130 (to S. M. W.), the State of Connecticut (to J.L., R. F., and S. M. W.), and the Packard Fellowship for Science and Engineering (R.F.).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lodish H., 2000, MOL CELL BIOL CELL C; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Megyola CM, 2013, STEM CELLS, V31, P895, DOI 10.1002/stem.1323; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	54	123	125	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					649	662		10.1016/j.cell.2014.01.020	http://dx.doi.org/10.1016/j.cell.2014.01.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24486105	Green Accepted, Bronze			2022-12-28	WOS:000331379800006
J	Grover, RK; Zhu, XY; Nieusma, T; Jones, T; Boero, I; MacLeod, AS; Mark, A; Niessen, S; Kim, HJ; Kong, L; Assad-Garcia, N; Kwon, K; Chesi, M; Smider, VV; Salomon, DR; Jelinek, DF; Kyle, RA; Pyles, RB; Glass, JI; Ward, AB; Wilson, IA; Lerner, RA				Grover, Rajesh K.; Zhu, Xueyong; Nieusma, Travis; Jones, Teresa; Boero, Isabel; MacLeod, Amanda S.; Mark, Adam; Niessen, Sherry; Kim, Helen J.; Kong, Leopold; Assad-Garcia, Nacyra; Kwon, Keehwan; Chesi, Marta; Smider, Vaughn V.; Salomon, Daniel R.; Jelinek, Diane F.; Kyle, Robert A.; Pyles, Richard B.; Glass, John I.; Ward, Andrew B.; Wilson, Ian A.; Lerner, Richard A.			A Structurally Distinct Human Mycoplasma Protein that Generically Blocks Antigen-Antibody Union	SCIENCE			English	Article							MULTIPLE-MYELOMA; BINDING DOMAIN; EBOLA-VIRUS; FAB; RECOGNITION; EPITOPES; COMPLEX	We report the discovery of a broadly reactive antibody-binding protein (Protein M) from human mycoplasma. The crystal structure of the ectodomain of transmembrane Protein M differs from other known protein structures, as does its mechanism of antibody binding. Protein M binds with high affinity to all types of human and nonhuman immunoglobulin G, predominantly through attachment to the conserved portions of the variable region of the kappa and lambda light chains. Protein M blocks antibody-antigen union, likely because of its large C-terminal domain extending over the antibody-combining site, blocking entry to large antigens. Similar to the other immunoglobulin-binding proteins such as Protein A, Protein M as well as its orthologs in other Mycoplasma species could become invaluable reagents in the antibody field.	[Grover, Rajesh K.; Jones, Teresa; Boero, Isabel; Smider, Vaughn V.; Lerner, Richard A.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Grover, Rajesh K.; Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Zhu, Xueyong; Nieusma, Travis; Kim, Helen J.; Kong, Leopold; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [MacLeod, Amanda S.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Mark, Adam; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Assad-Garcia, Nacyra; Kwon, Keehwan; Glass, John I.] J Craig Venter Res Inst, Synthet Biol & Bioenergy Grp, Rockville, MD 20850 USA; [Chesi, Marta] Mayo Clin Arizona, Comprehens Canc Ctr, Scottsdale, AZ 85259 USA; [Jelinek, Diane F.; Kyle, Robert A.] Mayo Clin, Div Hematol, Dept Internal Med, Coll Med, Rochester, MN 55905 USA; [Jelinek, Diane F.; Kyle, Robert A.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Pyles, Richard B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; J. Craig Venter Institute; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute	Lerner, RA (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA.	rlerner@scripps.edu	Ward, Andrew/ABD-7728-2021; Zhu, Xueyong/ABE-3068-2021; Ward, Andrew B/F-9203-2014; Glass, John/A-6572-2015	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Smider, Vaughn/0000-0003-3488-6383; Kong, Leopold/0000-0001-7456-1773; Glass, John/0000-0002-3784-5301; Kim, Helen/0000-0003-0096-7740	Scripps Research Institute; NIH through the National Center for Research Resources' P41 program [RR017573]; NIH [RO1 AI042266, 5 R21 AI098057-02, R01 AG020686, U19 AI06360, K08 AR063729-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098057, R01AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	Scripps Research Institute; NIH through the National Center for Research Resources' P41 program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Cravatt and G. Siuzdak for mass spectroscopy studies, M. Lee and C. Locke for assistance in Western blot and ELISA studies, W. Yu for protein purification, and H. Tien of the Robotics Core at the Joint Center for Structural Genomics (www.jcsg.org) for automated crystal screening. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource beamlines 11-1 and 12-2. The b12 IgG and PGT135 IgG were kindly provided by B. Moldt in the laboratory of D. Burton, and the other anti-HIV antibody Fabs were provided by J.-P. Julien and Y. Hua. The Lupus mouse serum and mouse chromatin were kindly provided by R. Baccala. The plasmapheresis fluid from a patient with Goodpasture's disease and human recombinant COL4A3 antigen were provided by V. Pedchenko. The KZ52 IgG, 13C6 IgG, and Ebola GP were kindly provided by E. Saphire. The electron microscopy studies were supported by startup funds from The Scripps Research Institute (to A. B. W.) and conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). We also thank NIH RO1 AI042266 (I. A. W.), NIH 5 R21 AI098057-02 (J.I.G.), NIH R01 AG020686 (M. C.), NIH U19 AI06360 (D.R.S.), and NIH K08 AR063729-01 (A. M.) for support. Coordinates and structure factors are deposited in PDB under accession codes 4NZR for Protein M TD/PGT135 Fab complex, 4NZT for Protein M TD/CR9114 Fab complex, and 4NZU for 13PL Fab'. The electron microscopy reconstructions are deposited in the Electron Microscopy Data Bank under accession codes EMD-5834 for Fab of human mAb b12 in complex with Protein M, EMD-5835 for Fab of multiple Myeloma patient human mAb 13PL in complex with Protein M TD, and EMD-5836 Fab of human mAb b12 in complex with Protein M TD. A patent covering this work (official application PCT 13/050656) entitled "Immunoglobulin-binding of human mycoplasma antigens and methods of use thereof" has been filed. This is publication 25063 from The Scripps Research Institute.	Bertoni F, 2006, J CLIN INVEST, V116, P22, DOI 10.1172/JCI27476; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Doxey AC, 2013, VIRULENCE, V4, P453, DOI 10.4161/viru.25180; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Grover RK, 2012, P NATL ACAD SCI USA, V109, P6036, DOI 10.1073/pnas.1202214109; GUNWAR S, 1991, J BIOL CHEM, V266, P15318; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Minguet S, 2008, EUR J IMMUNOL, V38, P2475, DOI 10.1002/eji.200738094; Panfilio Sara, 2013, Leuk Res Rep, V2, P39, DOI 10.1016/j.lrr.2013.01.002; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937	23	59	63	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					656	661		10.1126/science.1246135	http://dx.doi.org/10.1126/science.1246135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7QC	24503852	Green Accepted			2022-12-28	WOS:000349821400002
J	Cantalupo, S; Arrigoni-Battaia, F; Prochaska, JX; Hennawi, JF; Madau, P				Cantalupo, Sebastiano; Arrigoni-Battaia, Fabrizio; Prochaska, J. Xavier; Hennawi, Joseph F.; Madau, Piero			A cosmic web filament revealed in Lyman-alpha emission around a luminous high-redshift quasar	NATURE			English	Article							ADAPTIVE MESH REFINEMENT; EMITTING GALAXIES; X-RAY; RADIO; EMITTERS; SPECTROSCOPY; EVOLUTION; DISCOVERY; NEBULA; FOREST	Simulations of structure formation in the Universe predict that galaxies are embedded in a 'cosmic web'(1), where most baryons reside as rarefied and highly ionized gas(2). This material has been studied for decades in absorption against background sources(3), but the sparseness of these inherently one-dimensional probes preclude direct constraints on the three-dimensional morphology of the underlying web. Here we report observations of a cosmic web filament in Lyman-alpha emission, discovered during a survey for cosmic gas fluorescently illuminated by bright quasars(4,5) at redshift z approximate to 2.3. With a linear projected size of approximately 460 physical kiloparsecs, the Lyman-alpha emission surrounding the radio-quiet quasar UM287 extends well beyond the virial radius of any plausible associated dark-matter halo and therefore traces intergalactic gas. The estimated cold gas mass of the filament from the observed emission-about 10(12.0 +/- 0.5)/C-1/2 solar masses, where C is the gas clumping factor-is more than ten times larger than what is typically found in cosmological simulations(5,6), suggesting that a population of intergalactic gas clumps with subkiloparsec sizes may be missing in current numerical models.	[Cantalupo, Sebastiano; Prochaska, J. Xavier; Madau, Piero] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Cantalupo, Sebastiano; Prochaska, J. Xavier] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Arrigoni-Battaia, Fabrizio; Prochaska, J. Xavier; Hennawi, Joseph F.] Max Planck Inst Astron, D-69117 Heidelberg, Germany	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Max Planck Society	Cantalupo, S (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, 1156 High St, Santa Cruz, CA 95064 USA.	cantal@ucolick.org		Arrigoni Battaia, Fabrizio/0000-0002-4770-6137; Cantalupo, Sebastiano/0000-0001-5804-1428	National Science Foundation (NSF) [AST-1010004, OIA-1124453]; NASA [NNX12AF87G]; W.M. Keck Foundation; Division Of Astronomical Sciences [1229745] Funding Source: National Science Foundation; Office Of The Director [1124453] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); W.M. Keck Foundation(W.M. Keck Foundation); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank the staff of the W.M. Keck Observatory for their support during the installation and testing of our custom-built narrow-band filter. S.C. thanks M. Haehnelt for comments on an earlier version of the letter and J. Primack for useful conversations. S.C. and J.X.P. acknowledge support from the National Science Foundation (NSF) grant AST-1010004. P.M. acknowledges support from the NSF through grant OIA-1124453, and from NASA through grant NNX12AF87G. The data presented here were obtained at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The Observatory was made possible by the financial support of the W.M. Keck Foundation. We acknowledge the cultural role that the summit of Mauna Kea has within the indigenous Hawaiian community.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321529; BARNES JE, 1992, ANNU REV ASTRON ASTR, V30, P705, DOI 10.1146/annurev.aa.30.090192.003421; BECKER RH, 1994, ASTR SOC P, V61, P165; Bergeron J, 1999, ASTRON ASTROPHYS, V343, pL40; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bertin E, 2002, ASTR SOC P, V281, P228; Bertin E., 2006, ASP C SER, V351, P112; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; Cantalupo S, 2005, ASTROPHYS J, V628, P61, DOI 10.1086/430758; Cantalupo S, 2007, ASTROPHYS J, V657, P135, DOI 10.1086/510883; Cantalupo S, 2012, MON NOT R ASTRON SOC, V425, P1992, DOI 10.1111/j.1365-2966.2012.21529.x; Cantalupo S, 2011, MON NOT R ASTRON SOC, V411, P1678, DOI 10.1111/j.1365-2966.2010.17799.x; Carilli CL, 2002, ASTROPHYS J, V567, P781, DOI 10.1086/338669; CEN RY, 1994, ASTROPHYS J, V437, pL9, DOI 10.1086/187670; Christensen L, 2006, ASTRON ASTROPHYS, V459, P717, DOI 10.1051/0004-6361:20065318; Ciardullo R, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/110; da Angela J, 2008, MON NOT R ASTRON SOC, V383, P565, DOI 10.1111/j.1365-2966.2007.12552.x; Dey A, 2005, ASTROPHYS J, V629, P654, DOI 10.1086/430775; Fumagalli M., 2013, PREPRINT; Geach JE, 2009, ASTROPHYS J, V700, P1, DOI 10.1088/0004-637X/700/1/1; Gould A, 1996, ASTROPHYS J, V468, P462, DOI 10.1086/177707; Guaita L, 2010, ASTROPHYS J, V714, P255, DOI 10.1088/0004-637X/714/1/255; HECKMAN TM, 1991, ASTROPHYS J, V370, P78, DOI 10.1086/169794; Hennawi JF, 2006, ASTROPHYS J, V651, P61, DOI 10.1086/507069; Hickox RC, 2009, ASTROPHYS J, V696, P891, DOI 10.1088/0004-637X/696/1/891; Ivezic Z, 2002, ASTRON J, V124, P2364, DOI 10.1086/344069; Kollmeier JA, 2010, ASTROPHYS J, V708, P1048, DOI 10.1088/0004-637X/708/2/1048; Kurk JD, 2000, ASTRON ASTROPHYS, V358, pL1; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; Matsuda Y, 2011, MON NOT R ASTRON SOC, V410, pL13, DOI 10.1111/j.1745-3933.2010.00969.x; MCCARTHY PJ, 1993, ANNU REV ASTRON ASTR, V31, P639; McIntosh DH, 1999, ASTROPHYS J, V514, P40, DOI 10.1086/306936; North PL, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201015153; Polletta M, 2008, ASTROPHYS J, V675, P960, DOI 10.1086/524343; Prescott MKM, 2009, ASTROPHYS J, V702, P554, DOI 10.1088/0004-637X/702/1/554; Prochaska JX, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/136; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; Reuland M, 2003, ASTROPHYS J, V592, P755, DOI 10.1086/375619; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Teyssier R, 2002, ASTRON ASTROPHYS, V385, P337, DOI 10.1051/0004-6361:20011817; Trainor R, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L3; Trainor RF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/39; Venemans BP, 2007, ASTRON ASTROPHYS, V461, P823, DOI 10.1051/0004-6361:20053941; Villar-Martin M, 2007, MON NOT R ASTRON SOC, V378, P416, DOI 10.1111/j.1365-2966.2007.11811.x; Yang YJ, 2010, ASTROPHYS J, V719, P1654, DOI 10.1088/0004-637X/719/2/1654	46	239	240	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					63	+		10.1038/nature12898	http://dx.doi.org/10.1038/nature12898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24463517	Green Submitted			2022-12-28	WOS:000330648100031
J	Wunderink, RG; Waterer, GW				Wunderink, Richard G.; Waterer, Grant W.			Community-Acquired Pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-ASSOCIATED PNEUMONIA; ANTIMICROBIAL THERAPY; STAPHYLOCOCCUS-AUREUS; CLINICAL-OUTCOMES; ELDERLY-PATIENTS; PREDICTION RULE; SEVERE SEPSIS; OF-CARE; EPIDEMIOLOGY; ANTIBIOTICS	A 67-year-old woman with mild Alzheimer's disease who has a 2-day history of productive cough, fever, and increased confusion is transferred from a nursing home to the emergency department. According to the transfer records, she has had no recent hospitalizations or recent use of antibiotic agents. Her temperature is 38.4 degrees C (101 degrees F), the blood pressure is 145/85 mm Hg, the respiratory rate is 30 breaths per minute, the heart rate is 120 beats per minute, and the oxygen saturation is 91% while she is breathing ambient air. Crackles are heard in both lower lung fields. She is oriented to person only. The white-cell count is 4000 per cubic millimeter, the serum sodium level is 130 mmol per liter, and the blood urea nitrogen is 25 mg per deciliter (9.0 mmol per liter). A radiograph of the chest shows infiltrates in both lower lobes. How and where should this patient be treated? Community-Acquired Pneumonia Community-acquired pneumonia remains a leading cause of death in the United States and around the world. Although the diagnosis of community-acquired pneumonia is straightforward in most cases, underlying cardiopulmonary disease and atypical presentation in elderly persons can delay recognition. The majority of hospitalized patients with community-acquired pneumonia can be treated with either a respiratory fluoroquinolone or a combination of cephalosporin and a macrolide. Alternative antibiotic treatment should be based on the presence of multiple risk factors for health care-associated pneumonia, specific risks (e.g., structural lung disease), or uniquely characteristic syndromes (e.g., the toxin-mediated, community-acquired, methicillin-resistant Staphylococcus aureus syndrome). The current criteria for health care-associated pneumonia result in excessive use of broad-spectrum antibiotic agents. The presence of multiple pneumonia-specific alternative risk factors may allow focused diagnostic testing and treatment. Patients with three or more minor criteria for severe community-acquired pneumonia (e.g., elevated blood urea nitrogen, confusion, and a high respiratory rate) should receive extensive intervention in the emergency department and be considered for admission to the intensive care unit.	[Wunderink, Richard G.; Waterer, Grant W.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Waterer, Grant W.] Univ Western Australia, Perth, WA 6009, Australia	Northwestern University; Feinberg School of Medicine; University of Western Australia	Wunderink, RG (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	r-wunderink@northwestern.edu	Waterer, Grant/AAG-2385-2021	Wunderink, Richard/0000-0002-8527-4195	Pfizer; AstraZeneca; Achaogen; Crucell (Johnson Johnson); Accelerate Diagnostics; Bayer Healthcare; Sanofi; GlaxoSmithKline; bioMerieux	Pfizer(Pfizer); AstraZeneca(AstraZeneca); Achaogen; Crucell (Johnson Johnson); Accelerate Diagnostics; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Sanofi; GlaxoSmithKline(GlaxoSmithKline); bioMerieux	Dr. Wunderink reports receiving fees for board membership from Pfizer, AstraZeneca, and Achaogen; consulting fees from Crucell (Johnson & Johnson), Accelerate Diagnostics, Bayer Healthcare, Sanofi, and GlaxoSmithKline; and grant support through his institution from bioMerieux and Pfizer. He was cochair of the last Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) community-acquired pneumonia guidelines committee and participated in the hospital-acquired, ventilator-acquired, and health care-associated pneumonia guidelines committee. Dr. Waterer has been selected as co-chair of the next ATS-IDSA community-acquired pneumonia guidelines committee and is a member of the current IDSA hospital-acquired and ventilator-associated pneumonia guidelines committee. No other potential conflict of interest relevant to this article was reported.	Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Attridge RT, 2011, EUR RESPIR J, V38, P878, DOI 10.1183/09031936.00141110; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; Brown RB, 2003, CHEST, V123, P1503, DOI 10.1378/chest.123.5.1503; Capelastegui A, 2004, CLIN INFECT DIS, V39, P955, DOI 10.1086/423960; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Dean NC, 2001, AM J MED, V110, P451, DOI 10.1016/S0002-9343(00)00744-0; El Solh AA, 2004, CLIN INFECT DIS, V39, P474, DOI 10.1086/422317; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Kett DH, 2011, LANCET INFECT DIS, V11, P181, DOI 10.1016/S1473-3099(10)70314-5; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Kollef MH, 2006, CHEST, V129, P1210, DOI 10.1378/chest.129.5.1210; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Labelle AJ, 2010, CHEST, V137, P1130, DOI 10.1378/chest.09-1652; Lim HF, 2013, EUR RESP J; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Pines JM, 2009, J EMERG MED, V37, P335, DOI 10.1016/j.jemermed.2009.06.127; Polgreen PM, 2007, INFECT CONT HOSP EP, V28, P212, DOI 10.1086/512174; Renaud B, 2009, CRIT CARE MED, V37, P2867, DOI 10.1097/CCM.0b013e3181b02dbb; Renaud B, 2009, CRIT CARE, V13, DOI 10.1186/cc7781; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Sicot N, 2013, CLIN MICROBIOL INFEC, V19, pE142, DOI 10.1111/1469-0691.12022; Sligl WI, 2013, CRIT CARE MED; Vanderkooi OG, 2005, CLIN INFECT DIS, V40, P1288, DOI 10.1086/429242; Waterer GW, 2006, CHEST, V130, P11, DOI 10.1378/chest.130.1.11; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Wilson KC, 2011, AM J RESP CRIT CARE, V183, P1454, DOI 10.1164/rccm.201009-1451PP; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03602.x; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH; Yealy DM, 2005, ANN INTERN MED, V143, P881, DOI 10.7326/0003-4819-143-12-200512200-00006; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x	49	151	171	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					543	551		10.1056/NEJMcp1214869	http://dx.doi.org/10.1056/NEJMcp1214869			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499212				2022-12-28	WOS:000331073500010
J	Macartney, K				Macartney, Kristine			Prevention of varicella: time for two-dose vaccination	LANCET			English	Editorial Material							EFFICACY; PROGRAM; RUBELLA; MEASLES; MUMPS		Childrens Hosp Westmead, Kids Res Inst, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia	University of Sydney	Macartney, K (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia.	kristine.macartney@health.nsw.gov.au						ATAGI committee. Varicella, 2013, AUSTR IMM HDB, P423; Bayer O, 2007, VACCINE, V25, P6655, DOI 10.1016/j.vaccine.2007.07.010; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; Marin Mona, 2010, Morbidity and Mortality Weekly Report, V59, P1; Pharmaceutical Benefits Advisory Committee, 2020, NUSINERSEN; Prymula R, 2014, LANCET; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; Shapiro ED, 2011, J INFECT DIS, V203, P312, DOI 10.1093/infdis/jiq052; Spackova M, 2010, VACCINE, V28, P686, DOI 10.1016/j.vaccine.2009.10.086; Varis T, 1996, J INFECT DIS, V174, pS330, DOI 10.1093/infdis/174.Supplement_3.S330; Ward K, 2013, VACCINE, V31, P1413, DOI 10.1016/j.vaccine.2012.12.052; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201	14	7	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1276	1277		10.1016/S0140-6736(14)60078-7	http://dx.doi.org/10.1016/S0140-6736(14)60078-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24485547				2022-12-28	WOS:000334104900007
J	Annas, GJ; Elias, S				Annas, George J.; Elias, Sherman			23andMe and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Because of a warning from the FDA, 23andMe has stopped marketing its personal genome service. Now, a dialogue about key issues in genomic testing could result in clear standards for the industry, including requirements for informed consent and disclosure of results. In August 2013, the genetic-testing company 23andMe began running a compelling national television commercial, in which attractive young people said that for $99 you could learn hundreds of things about your health, including that you might have an increased risk of heart disease, arthritis, gallstones, [or] hemochromatosis (www.ispot.tv/ad/7qoF/23-and-me). It was the centerpiece of the company's campaign to sign up 1 million consumers. On November 22, the Food and Drug Administration (FDA) sent 23andMe a warning letter ordering it to immediately discontinue marketing the PGS [Saliva Collection Kit and Personal Genome Service] until such time as it receives FDA marketing authorization ...	[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; [Elias, Sherman] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Boston University; Northwestern University; Feinberg School of Medicine	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							[Anonymous], 2013, PV WAY PERS MED FDAS; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Glantz L, 2008, NEW ENGL J MED, V358, P298, DOI 10.1056/NEJMhle074597; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	5	82	84	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					985	988		10.1056/NEJMp1316367	http://dx.doi.org/10.1056/NEJMp1316367			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC7ED	24520936	Bronze			2022-12-28	WOS:000332689100003
J	LeBrun, EG; Jones, NT; Gilbert, LE				LeBrun, Edward G.; Jones, Nathan T.; Gilbert, Lawrence E.			Chemical Warfare Among Invaders: A Detoxification Interaction Facilitates an Ant Invasion	SCIENCE			English	Article							IMPORTED FIRE ANTS; HYMENOPTERA-FORMICIDAE; ARGENTINE ANTS; VENOM; COMMUNITIES	As tawny crazy ants (Nylanderia fulva) invade the southern United States, they often displace imported fire ants (Solenopsis invicta). After exposure to S. invicta venom, N. fulva applies abdominal exocrine gland secretions to its cuticle. Bioassays reveal that these secretions detoxify S. invicta venom. Further, formic acid from N. fulva venom is the detoxifying agent. N. fulva exhibits this detoxification behavior after conflict with a variety of ant species; however, it expresses it most intensely after interactions with S. invicta. This behavior may have evolved in their shared South American native range. The capacity to detoxify a major competitor's venom probably contributes substantially to its ability to displace S. invicta populations, making this behavior a causative agent in the ecological transformation of regional arthropod assemblages.	[LeBrun, Edward G.; Jones, Nathan T.; Gilbert, Lawrence E.] Univ Texas Austin, Brackenridge Field Lab, Dept Integrat Biol, Austin, TX 78703 USA	University of Texas System; University of Texas Austin	LeBrun, EG (corresponding author), Univ Texas Austin, Brackenridge Field Lab, Dept Integrat Biol, 2907 Lake Austin Blvd, Austin, TX 78703 USA.	edwardlebrun@austin.utexas.edu		LeBrun, Edward/0000-0002-7262-6585	Helen C. Kleberg and Robert J. Kleberg Foundation; Lee and Ramona Bass Foundation	Helen C. Kleberg and Robert J. Kleberg Foundation; Lee and Ramona Bass Foundation	We thank M. Marischen and P. Diebold for technical assistance and N. Youssef and J. Oliver for providing S. richteri. E. Sarnat provided a technical drawing, and S. Stokes assisted in formulating the formic acid solution. R. Plowes provided useful discussion. Funding was provided by the Helen C. Kleberg and Robert J. Kleberg Foundation and the Lee and Ramona Bass Foundation. Data are archived at the Dryad Digital Repository, doi: 10.5061/dryad.5t110.	ANDERSEN AN, 1991, OECOLOGIA, V88, P157, DOI 10.1007/BF00320805; BLUM MS, 1958, SCIENCE, V128, P306, DOI 10.1126/science.128.3319.306-a; BLUM MS, 1992, J TOXICOL-TOXIN REV, V11, P115, DOI 10.3109/15569549209033107; BUREN WF, 1974, J NEW YORK ENTOMOL S, V82, P113; Buschinger A., 1984, P95; Calcaterra LA, 2010, ANN ENTOMOL SOC AM, V103, P71, DOI 10.1603/008.103.0110; Chen J, 2013, TOXICON, V76, P160, DOI 10.1016/j.toxicon.2013.09.018; dos Santos LD, 2010, J PROTEOME RES, V9, P3867, DOI 10.1021/pr1000829; Emery C, 1906, B SOC ENTOMOLOGICA I, V37, P107; Feener DH, 2008, ECOLOGY, V89, P1824, DOI 10.1890/07-0659.1; Greenberg L, 2008, ANN ENTOMOL SOC AM, V101, P1162, DOI 10.1603/0013-8746-101.6.1162; Jackson Brian D., 1993, Chemoecology, V4, P125, DOI 10.1007/BF01256548; LeBrun EG, 2007, ECOLOGY, V88, P63, DOI 10.1890/0012-9658(2007)88[63:AESOCB]2.0.CO;2; LeBrun EG, 2013, BIOL INVASIONS, V15, P2429, DOI 10.1007/s10530-013-0463-6; Mayr G, 1862, VERHANDLUNGEN KAISER, V12, P649, DOI DOI 10.5281/ZENODO.25912; Pitts J.P., 2002, THESIS U GEORGIA ATH; Sorrells TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018717; Tschinkel WR, 2006, FIRE ANTS; VERMEIJ GJ, 1991, SCIENCE, V253, P1099, DOI 10.1126/science.253.5024.1099; Wild AL, 2007, ZOOTAXA, P1	20	32	35	9	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1014	1017		10.1126/science.1245833	http://dx.doi.org/10.1126/science.1245833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24526314				2022-12-28	WOS:000332309600043
J	Baringhaus, J; Ruan, M; Edler, F; Tejeda, A; Sicot, M; Taleb-Ibrahimi, A; Li, AP; Jiang, ZG; Conrad, EH; Berger, C; Tegenkamp, C; de Heer, WA				Baringhaus, Jens; Ruan, Ming; Edler, Frederik; Tejeda, Antonio; Sicot, Muriel; Taleb-Ibrahimi, Amina; Li, An-Ping; Jiang, Zhigang; Conrad, Edward H.; Berger, Claire; Tegenkamp, Christoph; de Heer, Walt A.			Exceptional ballistic transport in epitaxial graphene nanoribbons	NATURE			English	Article							QUANTUM; CONFINEMENT; CONDUCTANCE	Graphene nanoribbons will be essential components in future graphene nanoelectronics(1). However, in typical nanoribbons produced from lithographically patterned exfoliated graphene, the charge carriers travel only about ten nanometres between scattering events, resulting in minimum sheet resistances of about one kilohm per square(2-5). Here we show that 40-nanometre-wide graphene nanoribbons epitaxially grown on silicon carbide(6,7) are single-channel room-temperature ballistic conductors on a length scale greater than ten micrometres, which is similar to the performance of metallic carbon nanotubes. This is equivalent to sheet resistances below 1 ohm per square, surpassing theoretical predictions for perfect graphene(8) by at least an order of magnitude. In neutral graphene ribbons, we show that transport is dominated by two modes. One is ballistic and temperature independent; the other is thermally activated. Transport is protected from back-scattering, possibly reflecting ground-state properties of neutral graphene. At room temperature, the resistance of both modes is found to increase abruptly at a particular length-the ballistic mode at 16 micrometres and the other at 160 nanometres. Our epitaxial graphene nanoribbons will be important not only in fundamental science, but also-because they can be readily produced in thousands-in advanced nanoelectronics, which can make use of their room-temperature ballistic transport properties.	[Baringhaus, Jens; Edler, Frederik; Tegenkamp, Christoph] Leibniz Univ Hannover, Inst Festkorperphys, D-30167 Hannover, Germany; [Ruan, Ming; Jiang, Zhigang; Conrad, Edward H.; Berger, Claire; de Heer, Walt A.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Tejeda, Antonio; Sicot, Muriel] Univ Lorraine, UMR CNRS 7198, Inst Jean Lamour, F-54506 Vandoeuvre Les Nancy, France; [Tejeda, Antonio; Taleb-Ibrahimi, Amina] UR1 CNRS Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Li, An-Ping] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Berger, Claire] CNRS UJF INP, Inst Neel, F-38042 Grenoble 6, France	Leibniz University Hannover; University System of Georgia; Georgia Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	de Heer, WA (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	walt.deheer@physics.gatech.edu	Edler, Frederik/K-3842-2018; Li, An-Ping/B-3191-2012; Tegenkamp, Christoph/ABC-9726-2021; Tegenkamp, Christoph/I-1639-2013; Tejeda, A./C-4711-2014	Edler, Frederik/0000-0003-4825-4504; Li, An-Ping/0000-0003-4400-7493; Tegenkamp, Christoph/0000-0003-0453-0765; Tegenkamp, Christoph/0000-0003-0453-0765; Tejeda, A./0000-0003-0125-4603	German Research Foundation [1459]; AFOSR; NSF [MRSEC - DMR 0820382]; W. M. Keck Foundation; Partner University Fund; Scientific User Facilities Division, BES of the DOE	German Research Foundation(German Research Foundation (DFG)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Partner University Fund; Scientific User Facilities Division, BES of the DOE	C.T. thanks the German Research Foundation Priority Program 1459 'Graphene' for financial support. C. B., E. H. C. and W.A.d.H. thank R. Dong, P. Goldbart, Z. Guo, J. Hankinson, J. Hicks, Y. Hu, J. Kunc, M. Kindermann, D. Mayou, M. Nevius, J. Palmer, A. Sidorov and P. de Heer for assistance and comments. C. B., E. H. C. and W.A.d.H. thank the AFOSR, NSF (MRSEC - DMR 0820382), W. M. Keck Foundation and Partner University Fund for financial support. Work at ORNL was supported by the Scientific User Facilities Division, BES of the DOE.	Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen JH, 2008, NAT NANOTECHNOL, V3, P206, DOI 10.1038/nnano.2008.58; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; Datta S., 1997, ELECT TRANSPORT MESO; de Heer WA, 2011, P NATL ACAD SCI USA, V108, P16900, DOI 10.1073/pnas.1105113108; de Picciotto R, 2001, NATURE, V411, P51, DOI 10.1038/35075009; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801; Hicks J, 2013, NAT PHYS, V9, P49, DOI [10.1038/nphys2487, 10.1038/NPHYS2487]; Hu YK, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/15/154010; Huard B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236803; Huard B, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.121402; Lemme MC, 2007, IEEE ELECTR DEVICE L, V28, P282, DOI 10.1109/LED.2007.891668; Lin YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161409; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Norimatsu W, 2010, PHYSICA E, V42, P691, DOI 10.1016/j.physe.2009.11.151; Ruan M., 2012, THESIS GEORGIA I TEC; Schonenberger C, 1999, APPL PHYS A-MATER, V69, P283, DOI 10.1007/s003390051003; Sprinkle M, 2010, NAT NANOTECHNOL, V5, P727, DOI 10.1038/nnano.2010.192; Todd K, 2009, NANO LETT, V9, P416, DOI 10.1021/nl803291b; Tombros N, 2011, NAT PHYS, V7, P697, DOI [10.1038/NPHYS2009, 10.1038/nphys2009]; Wakabayashi K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.036601; Wang XR, 2011, NAT NANOTECHNOL, V6, P563, DOI [10.1038/nnano.2011.138, 10.1038/NNANO.2011.138]	30	430	438	14	561	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					349	354		10.1038/nature12952	http://dx.doi.org/10.1038/nature12952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24499819	Green Submitted			2022-12-28	WOS:000331477800037
J	Joshi, RK; Carbone, P; Wang, FC; Kravets, VG; Su, Y; Grigorieva, IV; Wu, HA; Geim, AK; Nair, RR				Joshi, R. K.; Carbone, P.; Wang, F. C.; Kravets, V. G.; Su, Y.; Grigorieva, I. V.; Wu, H. A.; Geim, A. K.; Nair, R. R.			Precise and Ultrafast Molecular Sieving Through Graphene Oxide Membranes	SCIENCE			English	Article							CARBON NANOTUBE; SEPARATION MEMBRANES; GRAPHITE OXIDE; WATER; TRANSPORT; PERMEATION	Graphene-based materials can have well-defined nanometer pores and can exhibit low frictional water flow inside them, making their properties of interest for filtration and separation. We investigate permeation through micrometer-thick laminates prepared by means of vacuum filtration of graphene oxide suspensions. The laminates are vacuum-tight in the dry state but, if immersed in water, act as molecular sieves, blocking all solutes with hydrated radii larger than 4.5 angstroms. Smaller ions permeate through the membranes at rates thousands of times faster than what is expected for simple diffusion. We believe that this behavior is caused by a network of nanocapillaries that open up in the hydrated state and accept only species that fit in. The anomalously fast permeation is attributed to a capillary-like high pressure acting on ions inside graphene capillaries.	[Joshi, R. K.; Kravets, V. G.; Su, Y.; Grigorieva, I. V.; Geim, A. K.; Nair, R. R.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Carbone, P.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England; [Wang, F. C.; Wu, H. A.] Univ Sci & Technol China, Dept Modern Mech, Chinese Acad Sci, Key Lab Mech Behav & Design Mat, Hefei 230027, Anhui, Peoples R China	University of Manchester; University of Manchester; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Geim, AK (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	geim@man.ac.uk; rahul.raveendran-nair@manchester.ac.uk	Raveendran Nair, Rahul/G-5839-2010; Carbone, Paola/P-5607-2015; Nair, Rahul Raveendran/Z-1566-2019; Geim, Andre K/J-7888-2012; Wang, Fengchao/G-1708-2012; Carbone, Paola/AAJ-4977-2021; Joshi, Rakesh/F-3134-2011; Joshi, Rakesh/ABC-3387-2020; Wu, Hengan/A-3646-2009	Carbone, Paola/0000-0001-9927-8376; Geim, Andre K/0000-0003-2861-8331; Wang, Fengchao/0000-0002-5954-3881; Carbone, Paola/0000-0001-9927-8376; Joshi, Rakesh/0000-0002-7497-9499; Wu, Hengan/0000-0003-0288-1617; SU, YANG/0000-0002-7042-0524	European Research Council; Royal Society; Engineering and Physical Research Council (UK); National Natural Science Foundation (China); Marie Curie Fellowship; Leverhulme Trust; Bluestone Global Tech; EPSRC [EP/K016946/1, EP/K005014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K016946/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Engineering and Physical Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); Marie Curie Fellowship(European Commission); Leverhulme Trust(Leverhulme Trust); Bluestone Global Tech; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Research Council, the Royal Society, Engineering and Physical Research Council (UK), and the National Natural Science Foundation (China). We thank A. Mishchenko and J. Waters for help. R. K. J. also acknowledges support by the Marie Curie Fellowship, and R.R.N. acknowledges support by the Leverhulme Trust and Bluestone Global Tech.	Boukhvalov DW, 2013, NANO LETT, V13, P3930, DOI 10.1021/nl4020292; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Eda G, 2010, ADV MATER, V22, P2392, DOI 10.1002/adma.200903689; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Gin DL, 2011, SCIENCE, V332, P674, DOI 10.1126/science.1203771; Han Y, 2013, ADV FUNCT MATER, V23, P3693, DOI 10.1002/adfm.201202601; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hu M, 2013, ENVIRON SCI TECHNOL, V47, P3715, DOI 10.1021/es400571g; Huang HB, 2013, CHEM COMMUN, V49, P5963, DOI 10.1039/c3cc41953c; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Lerf A, 2006, J PHYS CHEM SOLIDS, V67, P1106, DOI 10.1016/j.jpcs.2006.01.031; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Majumder M, 2005, J AM CHEM SOC, V127, P9062, DOI 10.1021/ja043013b; McKeown NB, 2006, CHEM SOC REV, V35, P675, DOI 10.1039/b600349d; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Pacile D, 2011, CARBON, V49, P966, DOI 10.1016/j.carbon.2010.09.063; Qiu L, 2011, CHEM COMMUN, V47, P5810, DOI 10.1039/c1cc10720h; Raidongia K, 2012, J AM CHEM SOC, V134, P16528, DOI 10.1021/ja308167f; Sun PZ, 2013, ACS NANO, V7, P428, DOI 10.1021/nn304471w; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Van der Bruggen B, 1999, J MEMBRANE SCI, V156, P29, DOI 10.1016/S0376-7388(98)00326-3; Wang SB, 2013, CHEM ENG J, V226, P336, DOI 10.1016/j.cej.2013.04.070; Wei N., ARXIV13085367; Wilson NR, 2009, ACS NANO, V3, P2547, DOI 10.1021/nn900694t; You SJ, 2013, CARBON, V52, P171, DOI 10.1016/j.carbon.2012.09.018	28	1712	1795	125	2671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					752	754		10.1126/science.1245711	http://dx.doi.org/10.1126/science.1245711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531966	Green Submitted			2022-12-28	WOS:000331557800034
J	Edgar, GJ; Stuart-Smith, RD; Willis, TJ; Kininmonth, S; Baker, SC; Banks, S; Barrett, NS; Becerro, MA; Bernard, ATF; Berkhout, J; Buxton, CD; Campbell, SJ; Cooper, AT; Davey, M; Edgar, SC; Forsterra, G; Galvan, DE; Irigoyen, AJ; Kushner, DJ; Moura, R; Parnell, PE; Shears, NT; Soler, G; Strain, EMA; Thomson, RJ				Edgar, Graham J.; Stuart-Smith, Rick D.; Willis, Trevor J.; Kininmonth, Stuart; Baker, Susan C.; Banks, Stuart; Barrett, Neville S.; Becerro, Mikel A.; Bernard, Anthony T. F.; Berkhout, Just; Buxton, Colin D.; Campbell, Stuart J.; Cooper, Antonia T.; Davey, Marlene; Edgar, Sophie C.; Foersterra, Guenter; Galvan, David E.; Irigoyen, Alejo J.; Kushner, David J.; Moura, Rodrigo; Parnell, P. Ed; Shears, Nick T.; Soler, German; Strain, Elisabeth M. A.; Thomson, Russell J.			Global conservation outcomes depend on marine protected areas with five key features	NATURE			English	Article							SIZE-STRUCTURE; RESERVES; ABUNDANCE; HOTSPOTS; NETWORK; FISHES; REEFS	In line with global targets agreed under the Convention on Biological Diversity, the number of marine protected areas (MPAs) is increasing rapidly, yet socio-economic benefits generated by MPAs remain difficult to predict and under debate(1,2). MPAs often fail to reach their full potential as a consequence of factors such as illegal harvesting, regulations that legally allow detrimental harvesting, or emigration of animals outside boundaries because of continuous habitat or inadequate size of reserve(3-5). Here we show that the conservation benefits of 87 MPAs investigated worldwide increase exponentially with the accumulation of five key features: no take, well enforced, old (>10 years), large (>100 km(2)), and isolated by deep water or sand. Using effective MPAs with four or five key features as an unfished standard, comparisons of underwater survey data from effective MPAs with predictions based on survey data from fished coasts indicate that total fish biomass has declined about two-thirds from historical baselines as a result of fishing. Effective MPAs also had twice as many large (>250 mm total length) fish species per transect, five times more large fish biomass, and fourteen times more shark biomass than fished areas. Most (59%) of the MPAs studied had only one or two key features and were not ecologically distinguishable from fished sites. Our results show that global conservation targets based on area alone will not optimize protection of marine biodiversity. More emphasis is needed on better MPA design, durable management and compliance to ensure that MPAs achieve their desired conservation value.	[Edgar, Graham J.; Stuart-Smith, Rick D.; Kininmonth, Stuart; Barrett, Neville S.; Berkhout, Just; Buxton, Colin D.; Cooper, Antonia T.; Davey, Marlene; Soler, German; Thomson, Russell J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Willis, Trevor J.] Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth PO4 9LY, Hants, England; [Kininmonth, Stuart] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; [Baker, Susan C.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Banks, Stuart] Charles Darwin Fdn, Puerto Ayora, Galapagos, Ecuador; [Becerro, Mikel A.] Nat Prod & Agrobiol Inst IPNA CSIC, Bites Lab, San Cristobal la Laguna 38206, Tenerife, Spain; [Bernard, Anthony T. F.] South African Environm Observat Network, Elwandle Node, ZA-6140 Grahamstown, South Africa; [Campbell, Stuart J.] Indonesia Marine Program, Wildlife Conservat Soc, Bogor 16151, Indonesia; [Edgar, Sophie C.] Dept Water, Perth, WA 6000, Australia; [Foersterra, Guenter] Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Fac Recursos Nat, Valparaiso, Chile; [Galvan, David E.; Irigoyen, Alejo J.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, RA-9120 Puerto Madryn, Argentina; [Kushner, David J.] Natl Pk Serv, Ventura, CA 93001 USA; [Moura, Rodrigo] Univ Fed Rio de Janeiro, Inst Biol, BR-21941902 Rio De Janeiro, Brazil; [Parnell, P. Ed] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Shears, Nick T.] Univ Auckland, Leigh Marine Lab, Leigh 0985, New Zealand; [Strain, Elisabeth M. A.] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, I-16348123 Ravenna, Italy	University of Tasmania; University of Portsmouth; Stockholm University; University of Tasmania; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); Wildlife Conservation Society - Indonesia; Pontificia Universidad Catolica de Valparaiso; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); United States Department of the Interior; Universidade Federal do Rio de Janeiro; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Auckland; University of Bologna	Edgar, GJ (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, GPO Box 252-49, Hobart, Tas 7001, Australia.	g.edgar@utas.edu.au	Edgar, Graham/C-8341-2013; Baker, Susan C/F-9307-2011; Strain, Elisabeth/U-3520-2017; de Moura, Rodrigo Leao/AAL-5781-2020; Buxton, Colin/AAV-3489-2021; Becerro, Mikel/ABC-9478-2021; Kininmonth, Stuart/N-9299-2013; Stuart-Smith, Rick D/M-1829-2013; Barrett, Neville S/J-7593-2014; Thomson, Russell J/H-5653-2012; Stuart-Smith, Rick/I-5214-2019; Edgar, Graham/AAY-3797-2020; Baker, Susan/O-8482-2019; Bernard, Anthony/M-8292-2019; Willis, Trevor/F-5337-2012	Edgar, Graham/0000-0003-0833-9001; Baker, Susan C/0000-0002-7593-0267; Strain, Elisabeth/0000-0003-2165-9544; de Moura, Rodrigo Leao/0000-0002-5597-6196; Becerro, Mikel/0000-0002-6047-350X; Kininmonth, Stuart/0000-0001-9198-3396; Stuart-Smith, Rick D/0000-0002-8874-0083; Barrett, Neville S/0000-0002-6167-1356; Thomson, Russell J/0000-0003-4949-4120; Stuart-Smith, Rick/0000-0002-8874-0083; Edgar, Graham/0000-0003-0833-9001; Baker, Susan/0000-0002-7593-0267; Bernard, Anthony/0000-0003-0482-6283; Willis, Trevor/0000-0002-0357-1189; Buxton, Colin/0000-0002-3256-5220; Galvan, David/0000-0001-8132-6069; Campbell, Stuart/0000-0002-1158-3200; Berkhout, Just/0000-0002-1656-4535	Australian Research Council; Fulbright Visiting Scholarship; Institute for Marine and Antarctic Studies; Marine Biodiversity Hub; Australian Government's National Environmental Research Program; National Geographic Society; Conservation International; Wildlife Conservation Society; Winifred Violet Scott Trust; Tasmanian Parks and Wildlife Service; Winston Churchill Memorial Trust; University of Tasmania; ASSEMBLE Marine	Australian Research Council(Australian Research Council); Fulbright Visiting Scholarship; Institute for Marine and Antarctic Studies; Marine Biodiversity Hub; Australian Government's National Environmental Research Program(Australian Government); National Geographic Society(National Geographic Society); Conservation International; Wildlife Conservation Society; Winifred Violet Scott Trust; Tasmanian Parks and Wildlife Service; Winston Churchill Memorial Trust; University of Tasmania; ASSEMBLE Marine	We thank the many Reef Life Survey (RLS) divers who contributed to data collection. Development of the RLS data set was supported by the former Commonwealth Environment Research Facilities Program, whereas analyses were supported by the Australian Research Council, a Fulbright Visiting Scholarship (to G.J.E.), the Institute for Marine and Antarctic Studies, and the Marine Biodiversity Hub, a collaborative partnership funded under the Australian Government's National Environmental Research Program. Surveys were assisted by grants from the National Geographic Society, Conservation International, Wildlife Conservation Society, Winifred Violet Scott Trust, Tasmanian Parks and Wildlife Service, the Winston Churchill Memorial Trust, University of Tasmania, and ASSEMBLE Marine. We are grateful to the many park officers who assisted the study by providing permits and assisting with field activities, and to numerous marine institutions worldwide for hosting survey trips.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; [CIAT CIESIN], 2005, GRIDD POP WORLD VERS; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2011, AQUAT CONSERV, V21, P313, DOI 10.1002/aqc.1187; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Forcada A, 2008, MAR ENVIRON RES, V66, P536, DOI 10.1016/j.marenvres.2008.08.003; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2003, ECOL APPL, V13, pS117; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; IUCN Standards and Petitions Working Group, 2008, GUID US IUCN RED LIS; Kaufmann D., 2010, 5431 WORLD BANK; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P132, DOI 10.1093/icesjms/fsn201; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pala C, 2013, SCIENCE, V339, P640, DOI 10.1126/science.339.6120.640; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Silverman B.W., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	35	1059	1085	21	992	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					216	+		10.1038/nature13022	http://dx.doi.org/10.1038/nature13022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24499817	Green Submitted			2022-12-28	WOS:000331107700037
J	Fialkov, A; Barkana, R; Visbal, E				Fialkov, Anastasia; Barkana, Rennan; Visbal, Eli			The observable signature of late heating of the Universe during cosmic reionization	NATURE			English	Article							X-RAY-EMISSION; 1ST STARS; BLACK-HOLES; INTERGALACTIC MEDIUM; DARK-MATTER; LY-ALPHA; GALAXIES; HYDROGEN; GROWTH; FLUCTUATIONS	Models and simulations(1-4) of the epoch of reionization predict that spectra of the 21-centimetre transition of atomic hydrogen will show a clear fluctuation peak, at a redshift and scale, respectively, that mark the central stage of reionization and the characteristic size of ionized bubbles. This is based on the assumption(5-7) that the cosmic gas was heated by stellar remnants-particularly X-ray binaries-to temperatures well above the cosmic microwave background at that time (about 30 kelvin). Here we show instead that the hard spectra (that is, spectra with more high-energy photons than low-energy photons) of X-ray binaries(8,9) make such heating ineffective, resulting in a delayed and spatially uniform heating that modifies the 21-centimetre signature of reionization. Rather than looking for a simple rise and fall of the large-scale fluctuations (peaking at several millikelvin), we must expect a more complex signal also featuring a distinct minimum (at less than a millikelvin) that marks the rise of the cosmic mean gas temperature above the microwave background. Observing this signal, possibly with radio telescopes in operation today, will demonstrate the presence of a cosmic background of hard X-rays at that early time.	[Fialkov, Anastasia; Barkana, Rennan] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Fialkov, Anastasia] Ecole Normale Super, CNRS, Dept Phys, F-75005 Paris, France; [Visbal, Eli] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Visbal, Eli] Harvard Univ, Jefferson Lab Phys, Cambridge, MA 02138 USA; [Visbal, Eli] Harvard Univ, Inst Theory & Computat, Cambridge, MA 02138 USA	Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Columbia University; Harvard University; Harvard University	Fialkov, A (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	anastasia.fialkov@gmail.com; barkana@wise.tau.ac.il	Fialkov, Anastasia/AAI-6731-2021		Israel Science Foundation [823/09]; LabEx ENS-ICFP [ANR-10-LABX-0010, ANR-10-IDEX-0001-02 PSL*]	Israel Science Foundation(Israel Science Foundation); LabEx ENS-ICFP	We are grateful to S. Naoz for drawing our attention to the work of T. Fragos, who provided us with detailed model spectra of X-ray binaries, which helped motivate this study. This work was supported by Israel Science Foundation grant number823/09, and by the LabEx ENS-ICFP (grant numbers ANR-10-LABX-0010and ANR-10-IDEX-0001-02 PSL*).	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321529; Ahn K, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/1/L16; Barkana R, 2005, ASTROPHYS J, V626, P1, DOI 10.1086/429954; Barkana R, 2004, ASTROPHYS J, V609, P474, DOI 10.1086/421079; Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Basu-Zych AR, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/152; Basu-Zych AR, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/45; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Bromm V., 2013, PREPRINT; Chen XL, 2004, ASTROPHYS J, V602, P1, DOI 10.1086/380829; Christian P, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/09/014; Chuzhoy L, 2007, ASTROPHYS J, V655, P843, DOI 10.1086/510146; Chuzhoy L, 2006, ASTROPHYS J, V651, P1, DOI 10.1086/507670; Ciardi B, 2010, MON NOT R ASTRON SOC, V401, P2635, DOI 10.1111/j.1365-2966.2009.15843.x; Fialkov A, 2014, MON NOT R ASTRON SOC, V437, pL36, DOI 10.1093/mnrasl/slt135; Fialkov A, 2013, MON NOT R ASTRON SOC, V432, P2909, DOI 10.1093/mnras/stt650; Fialkov A, 2012, MON NOT R ASTRON SOC, V424, P1335, DOI 10.1111/j.1365-2966.2012.21318.x; Fragos T, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L31; Fragos T, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/41; Furlanetto SR, 2004, ASTROPHYS J, V613, P1, DOI 10.1086/423025; Furlanetto SR, 2004, ASTROPHYS J, V611, P642, DOI 10.1086/422242; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; Furlanetto SR, 2006, MON NOT R ASTRON SOC, V371, P867, DOI 10.1111/j.1365-2966.2006.10725.x; Furlanetto SR, 2010, MON NOT R ASTRON SOC, V404, P1869, DOI 10.1111/j.1365-2966.2010.16401.x; Gilfanov M, 2004, MON NOT R ASTRON SOC, V347, pL57, DOI 10.1111/j.1365-2966.2004.07450.x; Haiman Z, 1997, ASTROPHYS J, V484, P985, DOI 10.1086/304386; Hirata CM, 2006, MON NOT R ASTRON SOC, V367, P259, DOI 10.1111/j.1365-2966.2005.09949.x; Lutzgendorf N, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321183; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; McClintock J. E., 2006, CAMBRIDGE ASTROPHYS, V157, P157; McConnell NJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/184; McQuinn M, 2006, ASTROPHYS J, V653, P815, DOI 10.1086/505167; Mellema G, 2006, MON NOT R ASTRON SOC, V372, P679, DOI 10.1111/j.1365-2966.2006.10919.x; Mesinger A, 2013, MON NOT R ASTRON SOC, V431, P621, DOI 10.1093/mnras/stt198; Mesinger A, 2011, MON NOT R ASTRON SOC, V411, P955, DOI 10.1111/j.1365-2966.2010.17731.x; Mineo S, 2012, MON NOT R ASTRON SOC, V426, P1870, DOI 10.1111/j.1365-2966.2012.21831.x; Mirabel IF, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016357; Naoz S, 2006, MON NOT R ASTRON SOC, V373, pL98, DOI 10.1111/j.1745-3933.2006.00251.x; Oh SP, 2001, ASTROPHYS J, V553, P499, DOI 10.1086/320957; PARSONS AR, 2013, PREPRINT; Pritchard JR, 2007, MON NOT R ASTRON SOC, V376, P1680, DOI 10.1111/j.1365-2966.2007.11519.x; Sazonov SY, 2004, MON NOT R ASTRON SOC, V347, P144, DOI 10.1111/j.1365-2966.2004.07184.x; Schroeder J, 2013, MON NOT R ASTRON SOC, V428, P3058, DOI 10.1093/mnras/sts253; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Tamura M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/65; Tanaka T, 2012, MON NOT R ASTRON SOC, V425, P2974, DOI 10.1111/j.1365-2966.2012.21539.x; Vasudevan RV, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L37; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Volonteri M, 2009, ASTROPHYS J, V703, P2113, DOI 10.1088/0004-637X/703/2/2113; Wise JH, 2012, MON NOT R ASTRON SOC, V427, P311, DOI 10.1111/j.1365-2966.2012.21809.x; Wyithe JSB, 2013, MON NOT R ASTRON SOC, V428, P2741, DOI 10.1093/mnras/sts242; Wyithe JSB, 2003, ASTROPHYS J, V595, P614, DOI 10.1086/377475; Wyithe JSB, 2004, NATURE, V432, P194, DOI 10.1038/nature03033; Zahn O, 2007, ASTROPHYS J, V654, P12, DOI 10.1086/509597	57	131	131	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					197	+		10.1038/nature12999	http://dx.doi.org/10.1038/nature12999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24499820	Green Submitted			2022-12-28	WOS:000331107700032
J	Selby, JV; Lipstein, SH				Selby, Joseph V.; Lipstein, Steven H.			PCORI at 3 Years - Progress, Lessons, and Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Selby, Joseph V.; Lipstein, Steven H.] PCORI, Washington, DC 20036 USA		Selby, JV (corresponding author), PCORI, Washington, DC 20036 USA.							[Anonymous], 2013, PROM PRACT MEAN ENG; Beal AC, 2013, PCORIS ENGAGEMENT AW; Beal AC, 2013, PCORIS 1 ADVISORY PA; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407	5	83	83	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					592	595		10.1056/NEJMp1313061	http://dx.doi.org/10.1056/NEJMp1313061			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA6CX	24521104				2022-12-28	WOS:000331187500004
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Ending AIDS - Is an HIV Vaccine Necessary?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION	The numbers of AIDS-related deaths and new HIV infections have decreased dramatically, thanks to prevention and treatment tools. But to control the pandemic more quickly and sustain the success, a safe and at least moderately effective vaccine is essential. In the past decade, according to the 2013 Global Report of the Joint United Nations Program on HIV/AIDS (UNAIDS), the numbers of AIDS-related deaths and new human immunodeficiency virus (HIV) infections have fallen by about one third from their peaks accomplishments made possible by the accelerated implementation of effective prevention and treatment tools. Of particular note, the scale-up of antiretroviral therapy (ART) averted 5.4 million deaths in low- and middle-income countries between 1995 and 2012. HIV prevention efforts have expanded from a narrow agenda of providing condoms and clean needles to use of a comprehensive toolkit of preventive interventions ...	[Fauci, Anthony S.; Marston, Hilary D.] NIAID, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, Off Director, 9000 Rockville Pike, Bethesda, MD 20892 USA.							COHEN J, 2013, SCIENCE, V342, P546; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	5	68	70	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					495	498		10.1056/NEJMp1313771	http://dx.doi.org/10.1056/NEJMp1313771			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA4NT	24499210				2022-12-28	WOS:000331073500004
J	Willerslev, E; Davison, J; Moora, M; Zobel, M; Coissac, E; Edwards, ME; Lorenzen, ED; Vestergard, M; Gussarova, G; Haile, J; Craine, J; Gielly, L; Boessenkool, S; Epp, LS; Pearman, PB; Cheddadi, R; Murray, D; Brathen, KA; Yoccoz, N; Binney, H; Cruaud, C; Wincker, P; Goslar, T; Alsos, IG; Bellemain, E; Brysting, AK; Elven, R; Sonstebo, JH; Murton, J; Sher, A; Rasmussen, M; Ronn, R; Mourier, T; Cooper, A; Austin, J; Moller, P; Froese, D; Zazula, G; Pompanon, F; Rioux, D; Niderkorn, V; Tikhonov, A; Savvinov, G; Roberts, RG; MacPhee, RDE; Gilbert, MTP; Kjaer, KH; Orlando, L; Brochmann, C; Taberlet, P				Willerslev, Eske; Davison, John; Moora, Mari; Zobel, Martin; Coissac, Eric; Edwards, Mary E.; Lorenzen, Eline D.; Vestergard, Mette; Gussarova, Galina; Haile, James; Craine, Joseph; Gielly, Ludovic; Boessenkool, Sanne; Epp, Laura S.; Pearman, Peter B.; Cheddadi, Rachid; Murray, David; Brathen, Kari Anne; Yoccoz, Nigel; Binney, Heather; Cruaud, Corinne; Wincker, Patrick; Goslar, Tomasz; Alsos, Inger Greve; Bellemain, Eva; Brysting, Anne Krag; Elven, Reidar; Sonstebo, Jorn Henrik; Murton, Julian; Sher, Andrei; Rasmussen, Morten; Ronn, Regin; Mourier, Tobias; Cooper, Alan; Austin, Jeremy; Moller, Per; Froese, Duane; Zazula, Grant; Pompanon, Franois; Rioux, Delphine; Niderkorn, Vincent; Tikhonov, Alexei; Savvinov, Grigoriy; Roberts, Richard G.; MacPhee, Ross D. E.; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Orlando, Ludovic; Brochmann, Christian; Taberlet, Pierre			Fifty thousand years of Arctic vegetation and megafaunal diet	NATURE			English	Article							SPECIES RICHNESS ESTIMATORS; PERENNIALLY FROZEN LOESS; ST-MICHAEL ISLAND; YUKON-TERRITORY; RADIOCARBON CHRONOLOGIES; MAMMOTH-STEPPE; DNA-SEQUENCES; PLANT; SOIL; CLIMATE	Although it is generally agreed that the Arctic flora is among the youngest and least diverse on Earth, the processes that shaped it are poorly understood. Here we present 50 thousand years (kyr) of Arctic vegetation history, derived from the first large-scale ancient DNA metabarcoding study of circumpolar plant diversity. For this interval we also explore nematode diversity as a proxy for modelling vegetation cover and soil quality, and diets of herbivorous megafaunal mammals, many of which became extinct around 10 kyr BP (before present). For much of the period investigated, Arctic vegetation consisted of dry steppe-tundra dominated by forbs (non-graminoid herbaceous vascular plants). During the Last Glacial Maximum (25-15 kyr BP), diversity declined markedly, although forbs remained dominant. Much changed after 10 kyr BP, with the appearance of moist tundra dominated by woody plants and graminoids. Our analyses indicate that both graminoids and forbs would have featured in megafaunal diets. As such, our findings question the predominance of a Late Quaternary graminoid-dominated Arctic mammoth steppe.	[Willerslev, Eske; Lorenzen, Eline D.; Vestergard, Mette; Haile, James; Rasmussen, Morten; Mourier, Tobias; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Davison, John; Moora, Mari; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-51005 Tartu, Estonia; [Coissac, Eric; Gielly, Ludovic; Pompanon, Franois; Rioux, Delphine; Taberlet, Pierre] Univ Grenoble 1, UMR 5553, Lab Ecol Alpine LECA, CNRS, F-38041 Grenoble 9, France; [Edwards, Mary E.; Binney, Heather] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Lorenzen, Eline D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Gussarova, Galina; Boessenkool, Sanne; Epp, Laura S.; Bellemain, Eva; Elven, Reidar; Sonstebo, Jorn Henrik; Brochmann, Christian] Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, NO-0318 Oslo, Norway; [Gussarova, Galina] St Petersburg State Univ, Dept Bot, St Petersburg 199034, Russia; [Haile, James] Murdoch Univ, Vet & Life Sci Sch, Ancient DNA Lab, Perth, WA 6150, Australia; [Craine, Joseph] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Pearman, Peter B.] Swiss Fed Res Inst WSL, Landscape Dynam Unit, CH-8903 Birmensdorf, Switzerland; [Cheddadi, Rachid] Univ Montpellier 2, Inst Sci Evolut Montpellier, UMR 5554, F-34095 Montpellier 5, France; [Murray, David] Univ Alaska Museum North, Fairbanks, AK 99775 USA; [Brathen, Kari Anne; Yoccoz, Nigel] Arctic Univ Norway, Dept Arctic & Marine Biol, NO-9037 Tromso, Norway; [Cruaud, Corinne; Wincker, Patrick] CEA, Inst Genom, Genoscope, F-91000 Evry, France; [Goslar, Tomasz] Adam Mickiewicz Univ, Fac Phys, PL-61614 Poznan, Poland; [Goslar, Tomasz] Poznan Radiocarbon Lab, PL-61612 Poznan, Poland; [Alsos, Inger Greve] Tromso Univ Museum, NO-9037 Tromso, Norway; [Brysting, Anne Krag] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, NO-0316 Oslo, Norway; [Murton, Julian] Univ Sussex, Dept Geog, Permafrost Lab, Brighton BN1 9QJ, E Sussex, England; [Sher, Andrei] Russian Acad Sci, Inst Ecol & Evolut, Moscow 119071, Russia; [Ronn, Regin] Terr Ecol, Dept Biol, DK-2100 Copenhagen O, Denmark; [Cooper, Alan; Austin, Jeremy] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Moller, Per] Lund Univ, Dept Geol Quaternary Sci, SE-22362 Lund, Sweden; [Froese, Duane] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Zazula, Grant] Govt Yukon, Dept Tourism & Culture, Yukon Palaeontol Program, Whitehorse, YT Y1A 2C6, Canada; [Niderkorn, Vincent] INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France; [Tikhonov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Savvinov, Grigoriy] North Eastern Fed Univ, Inst Appl Ecol North, Yakutsk 677000, Russia; [Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [MacPhee, Ross D. E.] Amer Museum Nat Hist, Div Vertebrate Zool Mammal, New York, NY 10024 USA	University of Copenhagen; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Southampton; University of California System; University of California Berkeley; University of Oslo; Saint Petersburg State University; Murdoch University; Kansas State University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UiT The Arctic University of Tromso; CEA; Adam Mickiewicz University; UiT The Arctic University of Tromso; University of Oslo; University of Sussex; Russian Academy of Sciences; University of Adelaide; Lund University; University of Alberta; INRAE; VetAgro Sup; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; North-Eastern Federal University in Yakutsk; University of Wollongong; American Museum of Natural History (AMNH)	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	ewillerslev@snm.ku.dk	Bråthen, Kari Anne/AAN-4666-2020; Niderkorn, Vincent/O-7290-2019; Sønstebø, Jørn Henrik/Q-1144-2019; Coissac, Éric/AAE-8735-2019; Orlando, Ludovic/A-8932-2013; Möller, Per/AAJ-7963-2020; Brysting, Anne Krag/G-5032-2017; Epp, Laura Saskia/J-5301-2016; Roberts, Richard Graham/B-8245-2013; Yoccoz, Nigel/C-8561-2014; Epp, Laura/AFS-1695-2022; Willerslev, Eske/AAA-5686-2019; Grigoriy, Savvinov/T-7914-2017; Boessenkool, Sanne/K-4274-2017; Willerslev, Eske/A-9619-2011; Moora, Mari/D-1961-2009; Austin, Jeremy J/F-8729-2010; Tikhonov, Alexei/G-7478-2016; Gilbert, Marcus TP/A-8936-2013; Brochmann, Christian/A-4105-2009; Craine, Joseph/D-4569-2009; Sønstebø, Jørn Henrik/H-9177-2016; Alsos, Inger Greve/O-8154-2019; Gielly, Ludovic/ADQ-6036-2022; Rønn, Regin/K-4460-2014; Cheddadi, Rachid/GXM-6391-2022; Vestergård, Mette/J-4181-2014; Kjaer, Kurt/A-4199-2013; Gussarova, Galina/E-4758-2015; Mourier, Tobias/C-1164-2015; Alsos, Inger G/A-9507-2016; Zobel, Martin/H-1336-2015; Gussarova, Galina/ABC-8696-2021; Pompanon, François/D-3459-2009; Pearman, Peter B/C-6298-2011; TABERLET, Pierre/D-1178-2010; Nielsen, Rasmus/D-4405-2009; Lorenzen, Eline/D-1442-2012	Bråthen, Kari Anne/0000-0003-0942-1074; Niderkorn, Vincent/0000-0002-4631-7623; Coissac, Éric/0000-0001-7507-6729; Orlando, Ludovic/0000-0003-3936-1850; Möller, Per/0000-0001-5365-2668; Brysting, Anne Krag/0000-0003-0388-4406; Epp, Laura Saskia/0000-0002-2230-9477; Roberts, Richard Graham/0000-0002-0128-4119; Yoccoz, Nigel/0000-0003-2192-1039; Boessenkool, Sanne/0000-0001-8033-1165; Willerslev, Eske/0000-0002-7081-6748; Moora, Mari/0000-0002-4819-7506; Austin, Jeremy J/0000-0003-4244-2942; Gilbert, Marcus TP/0000-0002-5805-7195; Craine, Joseph/0000-0001-6561-3244; Alsos, Inger Greve/0000-0002-8610-1085; Rønn, Regin/0000-0002-7486-1191; Vestergård, Mette/0000-0002-0054-4855; Kjaer, Kurt/0000-0002-8871-5179; Gussarova, Galina/0000-0001-5388-7491; Mourier, Tobias/0000-0003-2727-1903; Alsos, Inger G/0000-0002-8610-1085; Zobel, Martin/0000-0001-7957-6704; Gussarova, Galina/0000-0001-5388-7491; Pompanon, François/0000-0003-4600-0172; Pearman, Peter B/0000-0002-0794-101X; TABERLET, Pierre/0000-0002-3554-5954; Elven, Reidar/0000-0003-3375-7408; Nielsen, Rasmus/0000-0003-0513-6591; Cooper, Alan/0000-0002-7738-7851; Murton, Julian/0000-0002-9469-5856; Sonstebo, Jorn Henrik/0000-0002-3204-1283; Lorenzen, Eline/0000-0002-6353-2819; Goslar, Tomasz/0000-0002-1346-3122; Cruaud, Corinne/0000-0002-4752-7278; Tikhonov, Alexei/0000-0002-7227-5797	European Union [GOCE-2006-036866]; Danish National Research Foundation (Centre of Excellence); European Regional Development Fund (Centre of Excellence FIBIR); European Regional Development Fund [IUT 20-28]; Research Council of Norway [191627/V40]; Australian Research Council [DP0558446]; Marie Curie International Outgoing Fellowship [PIOF-GA-2009-253376]; Carlsberg Foundation	European Union(European Commission); Danish National Research Foundation (Centre of Excellence); European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); European Regional Development Fund(European Commission); Research Council of Norway(Research Council of Norway); Australian Research Council(Australian Research Council); Marie Curie International Outgoing Fellowship(European Commission); Carlsberg Foundation(Carlsberg Foundation)	We thank A. Lister, R. D. Guthrie, M. Hofreiter and L. Parducci for thoughts and discussions on our findings and K. Andersen for help identifying possible contamination. We thank T. B. Brand, P. S. Olsen, V. Mirre, L. J. Gillespie, J. M. Saarela, J. Doubt, M. Lomonosova, D. Shaulo, J. E. Eriksen, S. Ickert-Bond, T. Ager, D. Bielman, M. Hajibabaei, A. Telka and S. Zimov for help and providing samples. We thank the Danish National Sequencing Centre. This work was supported by the European Union 6th framework project ECOCHANGE (GOCE-2006-036866, coordinated by P.T.), the Danish National Research Foundation (Centre of Excellence to E.W.), the European Regional Development Fund (Centre of Excellence FIBIR and IUT 20-28 to J.D., M.M. and M.Z.), the Research Council of Norway (191627/V40 to C.B.), the Australian Research Council (DP0558446 to R.G.R.), a Marie Curie International Outgoing Fellowship (PIOF-GA-2009-253376 to E.D.L.) and a Carlsberg Foundation Fellowship (to M.V.).	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Ager TA, 2003, QUATERNARY RES, V60, P19, DOI 10.1016/S0033-5894(03)00068-1; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson PM, 2004, DEV QUA SCI, V1, P427; [Anonymous], 2007, LABDSV ORDINATION MU; Arnold LJ, 2011, BOREAS, V40, P417, DOI 10.1111/j.1502-3885.2010.00181.x; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Austrheim G, 2003, CAN J BOT, V81, P171, DOI [10.1139/B03-010, 10.1139/b03-010]; Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; Beilman D. W., 2011, SVALB GEOL WORKSH TR; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Birks H. J. B., 2004, QUATERNARY PALAEOECO; Boeskorov GG, 2011, QUATERNARY SCI REV, V30, P2262, DOI 10.1016/j.quascirev.2011.02.010; Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coissac Eric, 2012, Methods Mol Biol, V888, P13, DOI 10.1007/978-1-61779-870-2_2; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Demuro M, 2008, QUAT GEOCHRONOL, V3, P346, DOI 10.1016/j.quageo.2007.12.003; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunn P. K., 2011, TWEEDIE TWEEDIE EXPO; Elven R., 2011, ANNOTATED CHECKLIST; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Froese DG, 2006, QUATERNARY SCI REV, V25, P1542, DOI 10.1016/j.quascirev.2006.01.028; Goslar T, 2009, J QUATERNARY SCI, V24, P481, DOI 10.1002/jqs.1283; Gotelli Nicholas J., 2011, P39; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Haile J., 2012, METHODS MOL BIOL ANC, P57; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Harington C.R., 1996, Current Research in the Pleistocene, V13, P105; Hebsgaard MB, 2009, ANTIQUITY, V83, P430, DOI 10.1017/S0003598X00098537; Hofle C, 1996, GEODERMA, V71, P219, DOI 10.1016/0016-7061(96)00007-9; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hopkins D.M., 1982, PALEOECOLOGY BERINGI, P3, DOI DOI 10.1016/B978-0-12-355860-2.50008-9; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hoschitz M, 2004, NEMATOLOGY, V6, P737, DOI 10.1163/1568541042843531; Hua Q, 2004, RADIOCARBON, V46, P1273, DOI 10.1017/S0033822200033142; Jackson ST, 2012, QUATERNARY SCI REV, V49, P1, DOI 10.1016/j.quascirev.2012.05.020; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Kholodov A. L., 2011, REPORTS POLAR MARINE, V636, P43; Kienast F, 2005, QUATERNARY RES, V63, P283, DOI 10.1016/j.yqres.2005.01.003; Klotz S., 2002, BIOLFLOR; Kosintsev PA, 2012, QUATERN INT, V276, P253, DOI 10.1016/j.quaint.2011.11.004; Kosintsev PA, 2012, QUATERN INT, V255, P231, DOI 10.1016/j.quaint.2011.03.027; Kuhn I, 2004, DIVERS DISTRIB, V10, P363, DOI 10.1111/j.1366-9516.2004.00106.x; Kuzmina SA, 2011, QUATERNARY SCI REV, V30, P2091, DOI 10.1016/j.quascirev.2010.03.019; LAMB HF, 1988, HDB VEGETATION SCI, V7, P519; Lazarev P. A., 1998, MLEKOPITAYUSHIE ANTR, P55; Legendre P., 2012, NUMERICAL ECOLOGY; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLauchlan KK, 2013, NATURE, V495, P352, DOI 10.1038/nature11916; Moller P, 1999, BOREAS, V28, P92; Muhs DR, 2003, QUATERNARY RES, V60, P110, DOI 10.1016/S0033-5894(03)00062-0; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; MURRAY DF, 1995, ECOL STU AN, V113, P21; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NGRIP dating group, 2008, IGBP PAGES WORLD DAT, V2008-034; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Palymsky B.F., 1989, FORMING RELIEF CORRE, P117; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Popovici I, 2000, APPL SOIL ECOL, V14, P27, DOI 10.1016/S0929-1393(99)00048-7; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ritchie J. C., 1982, PALEOECOLOGY BERINGI, P113; Ruess L, 1999, NEMATOLOGY, V1, P513, DOI 10.1163/156854199508513; Sanborn PT, 2006, QUATERNARY RES, V66, P147, DOI 10.1016/j.yqres.2006.02.008; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shehzad W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032104; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Sher A. V., 1979, 14 PAC SCI C TOUR GU, P1; SOHLENIUS B, 1985, OIKOS, V44, P430, DOI 10.2307/3565784; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Sulerzhitsky L.D., 1997, KRIOSFERA ZEMLI, V1, P12; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taylor PG, 1996, MOL BIOL EVOL, V13, P283, DOI 10.1093/oxfordjournals.molbev.a025566; Tomasovych A, 2010, PALEOBIOLOGY, V36, P672, DOI 10.1666/08092.1; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van der Wal R, 2006, OIKOS, V114, P177, DOI 10.1111/j.2006.0030-1299.14264.x; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Vestergard M, 2004, PEDOBIOLOGIA, V48, P257, DOI 10.1016/j.pedobi.2004.01.003; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; Yeates GW, 1996, NEW ZEAL J ZOOL, V23, P401, DOI 10.1080/03014223.1996.9518099; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zanina OG, 2011, QUATERNARY SCI REV, V30, P2107, DOI 10.1016/j.quascirev.2011.01.021; Zazula GD, 2007, QUATERNARY SCI REV, V26, P979, DOI 10.1016/j.quascirev.2006.12.006; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005	108	343	357	15	459	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					47	+		10.1038/nature12921	http://dx.doi.org/10.1038/nature12921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499916	Green Accepted			2022-12-28	WOS:000330648100028
J	Mohamed, M; Hayes, R; Mosetlhi, T				Mohamed, Muhajir; Hayes, Robert; Mosetlhi, Tefo			A man with acute venous thromboembolism and thrombocytopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEPARIN-INDUCED THROMBOCYTOPENIA; PATHOGENESIS; DIAGNOSIS		[Mohamed, Muhajir; Mosetlhi, Tefo] Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia; [Mohamed, Muhajir] Univ Tasmania, Launceston Clin Sch, Launceston, Tas 7250, Australia; [Hayes, Robert] Launceston Gen Hosp, Dept Pathol, Launceston, Tas, Australia	University of Tasmania	Mohamed, M (corresponding author), Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia.	muhajirbm@yahoo.com						Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Cuker A, 2012, BLOOD, V119, P2209, DOI 10.1182/blood-2011-11-376293; Deitcher SR, 2001, VASC MED, V6, P113, DOI 10.1177/1358836X0100600208; Krauel K, 2012, BLOOD, V119, P1248, DOI 10.1182/blood-2011-05-353391; Levy JH, 2007, HEMATOL ONCOL CLIN N, V21, P65, DOI 10.1016/j.hoc.2006.11.003; Linkins LA, 2012, CHEST, V141, pE495S, DOI 10.1378/chest.11-2303; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Ortel Thomas L, 2009, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2009.1.225; Refaai MA, 2010, J THROMB HAEMOST, V8, P1419, DOI 10.1111/j.1538-7836.2010.03861.x; Stasi R, 2012, HEMATOL-AM SOC HEMAT, P191, DOI 10.1182/asheducation-2012.1.191; Warkentin TE, 2005, CHEST, V127, P1857, DOI 10.1378/chest.127.5.1857; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Warkentin TE, 2003, BRIT J HAEMATOL, V121, P535, DOI 10.1046/j.1365-2141.2003.04334.x; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6	16	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2014	348								g1164	10.1136/bmj.g1164	http://dx.doi.org/10.1136/bmj.g1164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IR	24493671				2022-12-28	WOS:000331059800001
J	Tell, T				Tell, Tariq			State formation and underdevelopment in the Arab world	LANCET			English	Editorial Material									Amer Univ Beirut, Ctr Arab & Middle East Studies CAMES, Beirut, Lebanon	American University of Beirut	Tell, T (corresponding author), Amer Univ Beirut, Ctr Arab & Middle East Studies CAMES, Bliss St, Beirut, Lebanon.	tt09@aub.edu.lb						Amin G, 1981, AL MASHRIQ AL ARABI; Anderson L., 1986, STATE SOCIAL TRANSFO; [Anonymous], 1971, ARAB COLD WAR GAMAL; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Beinin Joel, 2001, WORKERS PEASANTS MOD; Bromley Simon, 1994, RETHINKING MIDDLE E; Brown L. C., 1984, INT POLITICS MIDDLE; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; Fieldhouse D.K., 2006, W IMPERIALISM MIDDLE; Gelvin J. L., 2012, ARAB UPRISING WHAT E; Gelvin James L., 2007, ISRAEL PALESTINE CON; Gerber Haim, 1987, SOCIAL ORIGINS MODER; Hanieh A, 2011, CAPITALISM AND CLASS IN THE GULF ARAB STATES, P1, DOI 10.1057/9780230119604; Hinnebusch R, 2010, MIDDLE EAST CRIT, V19, P201, DOI 10.1080/19436149.2010.514470; ISSAWI Charles, 1982, EC HIST MIDDLE E N A; Owen R., 1998, HIST MIDDLE E EC 20; Owen R, 1985, ARAB SOC CONTINUITY, P16; Richards Alan, 2008, POLITICAL EC MIDDLE; Rivlin P, 2011, ARAB EC 21 CENTURY; Rogan E, 2010, ARABS; Schatkowski Schilcher Linda, 1992, PROBLEMS MODERN MIDD, P229; SEDDON D, 1994, FREE MARKETS FOOD RI; Thompson E, COLONIAL CITIZENS RE; WATERBURY J, 1991, INT J MIDDLE E STUD, V23, P1	24	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					480	482		10.1016/S0140-6736(13)62548-9	http://dx.doi.org/10.1016/S0140-6736(13)62548-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452049				2022-12-28	WOS:000330673700037
J	Coaker, G				Coaker, Gitta			Pathogen Specialization	SCIENCE			English	Editorial Material							PLANT-PATHOGENS		Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Coaker, G (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	glcoaker@ucdavis.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092772] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1054298] Funding Source: National Science Foundation; NIGMS NIH HHS [R01 GM092772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106	8	1	1	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					496	497		10.1126/science.1250171	http://dx.doi.org/10.1126/science.1250171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482473	Green Accepted			2022-12-28	WOS:000330343700032
J	Nisbet, EG; Dlugokencky, EJ; Bousquet, P				Nisbet, Euan G.; Dlugokencky, Edward J.; Bousquet, Philippe			Methane on the Rise-Again	SCIENCE			English	Editorial Material							ATMOSPHERIC METHANE; EMISSIONS		[Nisbet, Euan G.] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Dlugokencky, Edward J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Bousquet, Philippe] CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France	University of London; Royal Holloway University London; National Oceanic Atmospheric Admin (NOAA) - USA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Nisbet, EG (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	e.nisbet@es.rhul.ac.uk	Dlugokencky, Edward/AAN-8746-2020	Dlugokencky, Edward/0000-0003-0612-6985; Bousquet, Philippe/0000-0002-4444-2703	NERC [NE/F006160/1, NE/K006045/1, NE/F020937/1, NE/I014683/1, NE/M005836/1, NE/I028874/1] Funding Source: UKRI; Natural Environment Research Council [NE/M005836/1, NE/I028874/1, NE/I014683/1, NE/F006160/1, NE/K006045/1, NE/F020937/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bergamaschi P, 2013, J GEOPHYS RES-ATMOS, V118, P7350, DOI 10.1002/jgrd.50480; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; BP, 2013, BP STAT REV WORLD EN; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Fisher RE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049319; Karion A, 2013, GEOPHYS RES LETT, V40, P4393, DOI 10.1002/grl.50811; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Pison I, 2013, ATMOS CHEM PHYS, V13, P11609, DOI 10.5194/acp-13-11609-2013; Shakhova N, 2014, NAT GEOSCI, V7, P64, DOI [10.1038/NGEO2007, 10.1038/ngeo2007]; Whiteman G, 2013, NATURE, V499, P401, DOI 10.1038/499401a	12	347	361	4	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					493	495		10.1126/science.1247828	http://dx.doi.org/10.1126/science.1247828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482471				2022-12-28	WOS:000330343700030
J	Jones, DS				Jones, David S.			Still Delirious after All These Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OPEN-HEART SURGERY; PSYCHIATRIC COMPLICATIONS	With the emergence of intensive care in the 1950s and 1960s, delirium became more prominent. Doctors quickly set out to understand and prevent it, but delirium results from so many sources that decisive understanding remains elusive. Doctors have recognized delirium for centuries. Transient alterations in consciousness, attention, orientation, perception, or behavior were well known with malaria and alcohol withdrawal or after surgery. Delirium became more prominent in the 1950s and 1960s with the emergence of intensive care. Intensive care units (ICUs) made it possible for patients to survive more severe illnesses and for doctors to attempt more aggressive interventions that required physiological monitoring, respiratory support, and intensive nursing. Delirium, the `new madness of medical progress,'(1) became more prevalent and more visible. Doctors set out to understand and prevent it, but, as the Critical Care Medicine article ...	[Jones, David S.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							HACKETT TP, 1968, NEW ENGL J MED, V279, P1365, DOI 10.1056/NEJM196812192792504; HELLER SS, 1970, NEW ENGL J MED, V283, P1015, DOI 10.1056/NEJM197011052831903; KORNFELD DS, 1965, NEW ENGL J MED, V273, P287, DOI 10.1056/NEJM196508052730601; KORNFELD DS, 1974, ARCH GEN PSYCHIAT, V31, P249; LAZARUS HR, 1968, AM J PSYCHIAT, V124, P1190, DOI 10.1176/ajp.124.9.1190	5	4	4	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					399	401		10.1056/NEJMp1400062	http://dx.doi.org/10.1056/NEJMp1400062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303AA	24476430	Green Published			2022-12-28	WOS:000330645400004
J	Murchison, EP; Wedge, DC; Alexandrov, LB; Fu, BY; Martincorena, I; Ning, ZM; Tubio, JMC; Werner, EI; Allen, J; De Nardi, AB; Donelan, EM; Marino, G; Fassati, A; Campbell, PJ; Yang, FT; Burt, A; Weiss, RA; Stratton, MR				Murchison, Elizabeth P.; Wedge, David C.; Alexandrov, Ludmil B.; Fu, Beiyuan; Martincorena, Inigo; Ning, Zemin; Tubio, Jose M. C.; Werner, Emma I.; Allen, Jan; De Nardi, Andrigo Barboza; Donelan, Edward M.; Marino, Gabriele; Fassati, Ariberto; Campbell, Peter J.; Yang, Fengtang; Burt, Austin; Weiss, Robin A.; Stratton, Michael R.			Transmissable Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage	SCIENCE			English	Article							MUTATIONAL PROCESSES; COAT COLOR; EVOLUTION; DOMESTICATION; INSERTION; GENES; SIZE	Canine transmissible venereal tumor (CTVT) is the oldest known somatic cell lineage. It is a transmissible cancer that propagates naturally in dogs. We sequenced the genomes of two CTVT tumors and found that CTVT has acquired 1.9 million somatic substitution mutations and bears evidence of exposure to ultraviolet light. CTVT is remarkably stable and lacks subclonal heterogeneity despite thousands of rearrangements, copy-number changes, and retrotransposon insertions. More than 10,000 genes carry nonsynonymous variants, and 646 genes have been lost. CTVT first arose in a dog with low genomic heterozygosity that may have lived about 11,000 years ago. The cancer spawned by this individual dispersed across continents about 500 years ago. Our results provide a genetic identikit of an ancient dog and demonstrate the robustness of mammalian somatic cells to survive for millennia despite a massive mutation burden.	[Murchison, Elizabeth P.; Wedge, David C.; Alexandrov, Ludmil B.; Fu, Beiyuan; Martincorena, Inigo; Ning, Zemin; Tubio, Jose M. C.; Werner, Emma I.; Campbell, Peter J.; Yang, Fengtang; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Murchison, Elizabeth P.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Allen, Jan; Donelan, Edward M.] AMRRIC, Nightcliff, NT 0814, Australia; [De Nardi, Andrigo Barboza] Sao Paulo State Univ UNESP, Dept Clin & Vet Surg, BR-14884900 Sao Paulo, Brazil; [Marino, Gabriele] Univ Messina, Dept Vet Sci, I-98168 Messina, Italy; [Fassati, Ariberto; Weiss, Robin A.] UCL, Wohl Vir Ctr, London WC1E 6BT, England; [Fassati, Ariberto; Weiss, Robin A.] UCL, Med Res Council Ctr Med & Mol Virol, Div Infect & Immun, London WC1E 6BT, England; [Burt, Austin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Wellcome Trust Sanger Institute; University of Cambridge; Universidade Estadual Paulista; University of Messina; University of London; University College London; University of London; University College London; Imperial College London	Murchison, EP (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	epm27@cam.ac.uk; mrs@sanger.ac.uk	Tubio, Jose M.C./H-5076-2015; Yang, Fan/GYU-4249-2022; Tubio, Jose/AAG-7345-2019; Wedge, David/AAC-4977-2021; Ning, Zemin/D-2411-2013; Alexandrov, Ludmil/AAS-1454-2021	Tubio, Jose M.C./0000-0003-3540-2459; Tubio, Jose/0000-0003-3540-2459; Alexandrov, Ludmil/0000-0003-3596-4515; Murchison, Elizabeth Proby/0000-0001-7462-8907; MARINO, Gabriele/0000-0001-6519-406X; Wedge, David/0000-0002-7572-3196; Fassati, Ariberto/0000-0003-1934-5327; Ning, Zemin/0000-0003-4359-776X; Burt, Austin/0000-0001-5146-9640; Martincorena, Inigo/0000-0003-1122-4416; Yang, Fengtang/0000-0002-3573-2354	Wellcome Trust [098051]; Kadoorie Charitable Foundation; L'Oreal-United Nations Educational, Scientific, and Cultural Organization for Women in Science Fellowship; European Molecular Biology Organization [Lt-456-2010, ALTF-1287-2012]; Marie Curie Intra-European Fellowship grant; MRC [G0501446, G0900950, G9721629] Funding Source: UKRI; Medical Research Council [G0900950, G0501446, G0900950B, G9721629, G9721629B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Kadoorie Charitable Foundation; L'Oreal-United Nations Educational, Scientific, and Cultural Organization for Women in Science Fellowship(L'Oreal Group); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant reference 098051), the Kadoorie Charitable Foundation, and a L'Oreal-United Nations Educational, Scientific, and Cultural Organization for Women in Science Fellowship (E.P.M.). We are grateful to A. King, S. Cooke, A. Strakova, M. Peleteiro, C. Semedo, T. M. Morata Raposo, R. R. Huppes, C. Marchiori Bueno, and the people of Maningrida. We thank members of the Wellcome Trust Sanger Institute Cancer Genome Project IT group and the Wellcome Trust Sanger Institute Core Sequencing and IT facilities. Additional sources of support included European Molecular Biology Organization Long Term fellowships [Lt-456-2010 (E.P.M.) and ALTF-1287-2012 (I.M.)] and a Marie Curie Intra-European Fellowship grant (J.M.C.T.). Genome sequence data reported in this study are available with accession number PRJEB5068 in the European Nucleotide Archive.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Blaine D. P., 1810, DOMESTIC TREATISE DI, P161; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Ganguly B, 2016, VET COMP ONCOL, V14, P1, DOI 10.1111/vco.12060; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; KATZIR N, 1985, P NATL ACAD SCI USA, V82, P1054, DOI 10.1073/pnas.82.4.1054; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Takeuchi Y, 2009, ANIM GENET, V40, P616, DOI 10.1111/j.1365-2052.2009.01888.x; Thomas R, 2009, CHROMOSOME RES, V17, P927, DOI 10.1007/s10577-009-9080-8; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837	27	103	108	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					437	440		10.1126/science.1247167	http://dx.doi.org/10.1126/science.1247167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458646	Green Accepted			2022-12-28	WOS:000330039300054
J	Azim, E; Jiang, J; Alstermark, B; Jessell, TM				Azim, Eiman; Jiang, Juan; Alstermark, Bror; Jessell, Thomas M.			Skilled reaching relies on a V2a propriospinal internal copy circuit	NATURE			English	Article							LATERAL RETICULAR NUCLEUS; VENTRAL SPINOCEREBELLAR TRACT; OPTIMAL FEEDBACK-CONTROL; MOUSE SPINAL-CORD; MOTOR CONTROL; FUNCTIONAL ORGANIZATION; V2-DERIVED INTERNEURONS; LIMB MOVEMENTS; MUS-MUSCULUS; PATHWAYS	The precision of skilled forelimb movement has long been presumed to rely on rapid feedback corrections triggered by internally directed copies of outgoing motor commands, but the functional relevance of inferred internal copy circuits has remained unclear. One class of spinal interneurons implicated in the control of mammalian forelimb movement, cervical propriospinal neurons (PNs), has the potential to convey an internal copy of premotor signals through dual innervation of forelimb-innervating motor neurons and precerebellar neurons of the lateral reticular nucleus. Here we examine whether the PNinternal copy pathway functions in the control of goal-directed reaching. In mice, PNs include a genetically accessible subpopulation of cervical V2a interneurons, and their targeted ablation perturbs reaching while leaving intact other elements of forelimb movement. Moreover, optogenetic activation of the PN internal copy branch recruits a rapid cerebellar feedback loop that modulates forelimb motor neuron activity and severely disrupts reaching kinematics. Our findings implicate V2a PNs as the focus of an internal copy pathway assigned to the rapid updating of motor output during reaching behaviour.	[Azim, Eiman; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Mortimer B Zuckerman Mind Brain Behav Inst,Dept N, New York, NY 10032 USA; [Azim, Eiman; Jessell, Thomas M.] Columbia Univ, Dept Mol Biophys, New York, NY 10032 USA; [Jiang, Juan; Alstermark, Bror] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Umea University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Mortimer B Zuckerman Mind Brain Behav Inst,Dept N, New York, NY 10032 USA.	ea2471@columbia.edu; bror.alstermark@umu.se; tmj1@columbia.edu		Azim, Eiman/0000-0002-1015-1772	Umea University; Swedish Research Council; National Institutes of Health [NS033245]; Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R01NS080932, R37NS033245] Funding Source: NIH RePORTER	Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Zagoraiou, S. Crone and K. Sharma for the Chx10-cre mouse; T. Buch for the DTR-GFP construct; K. Deisseroth for the AAV-FLEX-hChR2-YFP plasmid; and M. Churchland for providing a low-pass filter. We are grateful to J. Krakauer for discussion of concepts in mammalian motor control and debate about terminology and text, and T. Isa for comments and continuing discussion on primate forelimb movement. R. Axel, M. Churchland, D. Jabaudon, A. Karpova, A. Miri, N. Sawtell and C. Zuker also provided discussion and comments on the manuscript. We are grateful to K. Miao for technical assistance; S. Fageiry for work on retrograde CTB labeling; T. Akay for assistance with the horizontal ladder task; D. Ng for the Cre-expressing plasmid; M. Mendelsohn, N. Zabello and S. Patruni for animal care; E. Danielsson and P. Utsi for engineering support; and B. Han, K. MacArthur, S. Morton and I. Schieren for technical assistance. E.A. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation; J.J. was supported by grants to B.A. from Umea University; B.A. was supported by grants from the Swedish Research Council; T.M.J. was supported by National Institutes of Health grant NS033245, the Harold and Leila Y. Mathers Foundation and Project A.L.S., and is an investigator of the Howard Hughes Medical Institute.	Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x; ALSTERMARK B, 1981, EXP BRAIN RES, V42, P282, DOI 10.1007/BF00237495; ALSTERMARK B, 1990, EXP BRAIN RES, V81, P447, DOI 10.1007/BF02423494; Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; ALSTERMARK B, 1981, EXP BRAIN RES, V42, P299, DOI 10.1007/BF00237496; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P96, DOI 10.1007/BF00228851; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P279, DOI 10.1007/BF00236284; ALSTERMARK B, 1992, IBRO SER, P327; Alstermark B, 2013, J PHYSIOL-LONDON, V591, P5453, DOI 10.1113/jphysiol.2013.256669; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; ARSHAVSKY YI, 1978, BRAIN RES, V151, P479, DOI 10.1016/0006-8993(78)91081-8; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; BRODAL A, 1949, J COMP NEUROL, V91, P259, DOI 10.1002/cne.900910206; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; CARPENTER MB, 1960, J COMP NEUROL, V114, P295, DOI 10.1002/cne.901140307; CORVAJA N, 1977, NEUROSCIENCE, V2, P537, DOI 10.1016/0306-4522(77)90050-1; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Fink A. J. P., 2013, SPINAL PRESYNAPTIC I; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; ILLERT M, 1981, EXP BRAIN RES, V42, P269; ILLERT M, 1977, EXP BRAIN RES, V29, P323; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Ito M, 1984, CEREBELLUM NEURAL CO; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; SCHULTZ W, 1979, BRAIN, V102, P127, DOI 10.1093/brain/102.1.127; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Whishaw IQ, 1996, BEHAV BRAIN RES, V78, P101, DOI 10.1016/0166-4328(95)00236-7; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Zhan XP, 2007, J COMP NEUROL, V504, P583, DOI 10.1002/cne.21463; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	52	186	187	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					357	+		10.1038/nature13021	http://dx.doi.org/10.1038/nature13021			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24487617	Green Accepted			2022-12-28	WOS:000334403000044
J	Prymula, R; Bergsaker, MR; Esposito, S; Gothefors, L; Man, S; Snegova, N; Stefkovicova, M; Usonis, V; Wysocki, J; Douha, M; Vassilev, V; Nicholson, O; Innis, BL; Willems, P				Prymula, Roman; Bergsaker, Marianne Riise; Esposito, Susanna; Gothefors, Leif; Man, Sorin; Snegova, Nadezhda; Stefkovicova, Maria; Usonis, Vytautas; Wysocki, Jacek; Douha, Martine; Vassilev, Ventzislav; Nicholson, Ouzama; Innis, Bruce L.; Willems, Paul			Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial	LANCET			English	Article							HEALTHY-CHILDREN; UNITED-STATES; MMRV VACCINE; IMMUNOGENICITY; SAFETY; PERSISTENCE; PREVENTION; ANTIBODY; QUADRIVALENT; DURATION	Background Rates of varicella have decreased substantially in countries implementing routine varicella vaccination. Immunisation is possible with monovalent varicella vaccine or a combined measles-mumps-rubella-varicella vaccine (MMRV). We assessed protection against varicella in naive children administered one dose of varicella vaccine or two doses of MMRV. Methods This study was done in ten European countries with endemic varicella. Healthy children aged 12-22 months were randomised (3: 3: 1 ratio, by computer-generated randomisation list, with block size seven) to receive 42 days apart (1) two doses of MMRV (MMRV group), or (2) MMR at dose one and monovalent varicella vaccine at dose two (MMR+V group), or (3) two doses of MMR (MMR group; control). Participants and their parents or guardians, individuals involved in assessment of any outcome, and sponsor staff involved in review or analysis of data were masked to treatment assignment. The primary efficacy endpoint was occurrence of confirmed varicella (by detection of varicella zoster virus DNA or epidemiological link) from 42 days after the second vaccine dose to the end of the first phase of the trial. Cases were graded for severity. Efficacy analyses were per protocol. Safety analyses included all participants who received at least one vaccine dose. This trial is registered with ClinicalTrials.gov, number NCT00226499. Findings Between Sept 1, 2005, and May 10, 2006, 5803 children (mean age 14.2 months, SD 2.5) were vaccinated. In the efficacy cohort of 5285 children, the mean duration of follow-up in the MMRV group was 36 months (SD 8.8), in the MMR+V group was 36 months (8.5) and in the MMR group was 35 months (8.9). Varicella cases were confirmed for 37 participants in the MMRV group (two moderate to severe), 243 in the MMR+V group, and 201 in the MMR group. Second cases occurred for three participants (all in the MMR+V group). Varicella cases were moderate to severe for two participants in the MMRV group, 37 in the MMR+V group (one being a second case that followed a mild first case); and 117 in the MMR group. Efficacy of two-dose MMRV against all varicella was 94.9% (97.5% CI 92.4-96.6), and against moderate to severe varicella was 99.5% (97.5-99.9). Efficacy of one-dose varicella vaccine against all varicella was 65.4% (57.2-72.1), and against moderate to severe varicella (post hoc) was 90.7% (85.9-93.9). The most common adverse event in all groups was injection-site redness (up to 25% of participants). Within 15 days after dose one, 57.4% (95% CI 53.9-60.9) of participants in the MMRV group reported fever of 38 degrees C or more, by contrast with 44.5% (41.0-48.1) with MMR+V, and 39.8% (33.8-46.1) with MMR. Eight serious adverse events were deemed related to vaccination (three MMRV, four MMR+V, one MMR). All resolved within the study period. Interpretation These results support the implementation of two-dose varicella vaccination on a short course, to ensure optimum protection from all forms of varicella disease.	[Prymula, Roman] Univ Hosp, Hradec Kralove, Czech Republic; [Bergsaker, Marianne Riise] Norwegian Inst Publ Hlth, Dept Vaccines, Oslo, Norway; [Esposito, Susanna] Univ Milan, Pediat Highly Intens Care Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Gothefors, Leif] Swedish Inst Communicable Dis Control, Stockholm, Sweden; [Gothefors, Leif] Umea Univ, Dept Clin Sci Pediat, Umea, Sweden; [Man, Sorin] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania; [Snegova, Nadezhda] Inst Immunol, Moscow, Russia; [Stefkovicova, Maria] Reg Off Publ Hlth, Dept Epidemiol, Trencin, Slovakia; [Usonis, Vytautas] Vilnius State Univ, Clin Paediat, Vilnius, Lithuania; [Wysocki, Jacek] Univ Sch Med Sci, Poznan, Poland; [Wysocki, Jacek] Reg Med Ctr Mother & Child, Poznan, Poland; [Nicholson, Ouzama; Innis, Bruce L.] GlaxoSmithKline Vaccines, King Of Prussia, PA 19406 USA; [Douha, Martine; Vassilev, Ventzislav; Willems, Paul] GlaxoSmithKline Vaccines, Wavre, Belgium	University Hospital Hradec Kralove; Norwegian Institute of Public Health (NIPH); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Swedish Institute for Infectious Disease Control; Umea University; Iuliu Hatieganu University of Medicine & Pharmacy; NRC Institute of Immunology FMBA of Russia; Vilnius University; GlaxoSmithKline; GlaxoSmithKline	Nicholson, O (corresponding author), GlaxoSmithKline Vaccines, King Of Prussia, PA 19406 USA.	ouzama.n.henry@gsk.com	Prymula, Roman/AEG-7401-2022; Usonis, Vytautas/R-6471-2019; Man, Sorin/AAB-4700-2021; Esposito, Susanna/K-3475-2016; Štefkovičová, Mária/AAD-8185-2019	Esposito, Susanna/0000-0003-4103-2837; Prymula, Roman/0000-0003-1567-2259; Innis, Bruce/0000-0002-1753-7248; Stefkovicova, Maria/0000-0002-1296-7417	GSK; GlaxoSmithKline Vaccines	GSK(GlaxoSmithKline); GlaxoSmithKline Vaccines	Writing assistance was provided by Matthew Morgan (4Clinics, Waterloo, Belgium), was funded by GSK, and was used in all stages of the report's development. Veronique Duquenne (Cromsource, Kraainem, Belgium) and Luise Kalbe (GlaxoSmtihKline) coordinated the report's development.; Funding GlaxoSmithKline Vaccines.	Atkinson W, 2002, PINK BOOK; Bayer O, 2007, VACCINE, V25, P6655, DOI 10.1016/j.vaccine.2007.07.010; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dhillon Sohita, 2008, Paediatr Drugs, V10, P337, DOI 10.2165/00148581-200810050-00007; Fu CX, 2010, PEDIATR INFECT DIS J, V29, P690, DOI 10.1097/INF.0b013e3181d7380e; Gillet Y, 2009, VACCINE, V27, P446, DOI 10.1016/j.vaccine.2008.10.064; Goh P, 2007, INFECTION, V35, P326, DOI 10.1007/s15010-007-6337-z; Halperin SA, 2009, VACCINE, V27, P2701, DOI 10.1016/j.vaccine.2009.02.044; Hanna C, 2009, VACCINE, V27, P6504, DOI 10.1016/j.vaccine.2009.07.076; Jumaan A, 2002, VARICELLA VACCINE PR, P1; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Knuf M, 2006, PEDIATR INFECT DIS J, V25, P12, DOI 10.1097/01.inf.0000195626.35239.58; Kreth HW, 2008, BIODRUGS, V22, P387, DOI 10.2165/0063030-200822060-00005; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Lee BR, 2004, J INFECT DIS, V190, P477, DOI 10.1086/422041; Li S, 2002, PEDIATR INFECT DIS J, V21, P337, DOI 10.1097/00006454-200204000-00014; Lieberman JM, 2006, PEDIATR INFECT DIS J, V25, P615, DOI 10.1097/01.inf.0000220209.35074.0b; Lopez AS, 2011, PEDIATRICS, V127, P238, DOI 10.1542/peds.2010-0962; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; MedDRA, 2009, MED DICT REG ACT VER; Nolan T, 2002, VACCINE, V21, P281, DOI 10.1016/S0264-410X(02)00459-0; Quian J, 2008, ARCH DIS CHILD, V93, P845, DOI 10.1136/adc.2007.126243; Quian J, REDUCTION HOSP AMBUL; Rumke HC, 2011, VACCINE, V29, P3842, DOI 10.1016/j.vaccine.2011.02.067; Schuster V, 2008, PEDIATR INFECT DIS J, V27, P724, DOI 10.1097/INF.0b013e318170bb22; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; Seward JF, 2004, JAMA-J AM MED ASSOC, V292, P704, DOI 10.1001/jama.292.6.704; Shapiro ED, 2011, J INFECT DIS, V203, P312, DOI 10.1093/infdis/jiq052; Sheffer R, 2005, PEDIATR INFECT DIS J, V24, P434, DOI 10.1097/01.inf.0000160947.89942.30; Shinefield H, 2005, PEDIATR INFECT DIS J, V24, P665, DOI 10.1097/01.inf.0000172902.25009.a1; Shinefield HR, 2002, PEDIATR INFECT DIS J, V21, P555, DOI 10.1097/00006454-200206000-00014; Spackova M, 2010, VACCINE, V28, P686, DOI 10.1016/j.vaccine.2009.10.086; Varis T, 1996, J INFECT DIS, V174, pS330, DOI 10.1093/infdis/174.Supplement_3.S330; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Vessey SJR, 2001, J PEDIATR-US, V139, P297, DOI 10.1067/mpd.2001.116051; Wutzler P, 2008, DTSCH ARZTEBL INT, V105, P567, DOI 10.3238/arztebl.2008.0567	39	64	73	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1313	1324		10.1016/S0140-6736(12)61461-5	http://dx.doi.org/10.1016/S0140-6736(12)61461-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24485548				2022-12-28	WOS:000334104900030
J	Desai, TJ; Brownfield, DG; Krasnow, MA				Desai, Tushar J.; Brownfield, Douglas G.; Krasnow, Mark A.			Alveolar progenitor and stem cells in lung development, renewal and cancer	NATURE			English	Article							FETAL-RAT LUNG; DISTAL LUNG; MOUSE LUNG; II CELLS; K-RAS; MICE; EPITHELIUM; MAINTENANCE; EXPRESSION; ADENOCARCINOMA	Alveoli are gas-exchange sacs lined by squamous alveolar type (AT) 1 cells and cuboidal, surfactant-secreting AT2 cells. Classical studies suggested that AT1 arise from AT2 cells, but recent studies propose other sources. Here we use molecular markers, lineage tracing and clonal analysis to map alveolar progenitors throughout the mouse lifespan. We show that, during development, AT1 and AT2 cells arise directly from a bipotent progenitor, whereas after birth new AT1 cells derive from rare, self-renewing, long-lived, mature AT2 cells that produce slowly expanding clonal foci of alveolar renewal. This stem-cell function is broadly activated by AT1 injury, and AT2 self-renewal is selectively induced by EGFR (epidermal growth factor receptor) ligands in vitro and oncogenic Kras(G12D) in vivo, efficiently generating multifocal, clonal adenomas. Thus, there is a switch after birth, when AT2 cells function as stem cells that contribute to alveolar renewal, repair and cancer. We propose that local signals regulate AT2 stem-cell activity: a signal transduced by EGFR-KRAS controls self-renewal and is hijacked during oncogenesis, whereas another signal controls reprogramming to AT1 fate.	[Desai, Tushar J.; Brownfield, Douglas G.; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Desai, Tushar J.; Brownfield, Douglas G.; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Desai, Tushar J.] Stanford Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	tdesai@stanford.edu; krasnow@stanford.edu		Brownfield, Doug/0000-0003-4769-1518	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL084095, U01HL099999, U01HL099995] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL084095, U01 HL099999, U01 HL099995] Funding Source: Medline; NICHD NIH HHS [T32 HD007249] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1974, LAB INVEST, V30, P35; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bertalanffy F. D., 1955, LANCET, V266, P1365; BOWDEN DH, 1968, ARCH PATHOL, V86, P671; BRODY JS, 1978, AM REV RESPIR DIS, V117, P307; BUCKINGHAM S, 1964, SCIENCE, V145, P1192, DOI 10.1126/science.145.3637.1192; BURRI PH, 1992, ANAT REC, V234, P399, DOI 10.1002/ar.1092340310; Burri PH, 2011, COMPREHENSIVE PHYSL, P1; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; DOBBS LG, 1985, BIOCHIM BIOPHYS ACTA, V846, P155, DOI 10.1016/0167-4889(85)90121-1; EVANS MJ, 1969, AM REV RESPIR DIS, V100, P372, DOI 10.1164/arrd.1969.100.3.372; EVANS MJ, 1973, AM J PATHOL, V70, P175; Faust N, 2000, BLOOD, V96, P719; Fujino N, 2012, AM J RESP CELL MOL, V46, P422, DOI 10.1165/rcmb.2011-0172OC; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HUGHES G M, 1973, Folia Morphologica (Prague), V21, P155; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053817; Lynch P. J., 2006, BRONCHIAL ANATOMY DE; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Messier EM, 2012, EXP LUNG RES, V38, P363, DOI 10.3109/01902148.2012.713077; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miller LAD, 2001, J HISTOCHEM CYTOCHEM, V49, P1593, DOI 10.1177/002215540104901213; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SPENCER H, 1962, NATURE, V194, P880, DOI 10.1038/194880a0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugahara K, 1998, CELL TISSUE RES, V291, P295, DOI 10.1007/s004410050999; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WILLIAMS MC, 1990, AM J RESP CELL MOL, V2, P533, DOI 10.1165/ajrcmb/2.6.533; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109	52	542	574	7	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					190	+		10.1038/nature12930	http://dx.doi.org/10.1038/nature12930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24499815	Green Accepted			2022-12-28	WOS:000332651800030
J	Krashes, MJ; Shah, BP; Madara, JC; Olson, DP; Strochlic, DE; Garfield, AS; Vong, L; Pei, HJ; Watabe-Uchida, M; Uchida, N; Liberles, SD; Lowell, BB				Krashes, Michael J.; Shah, Bhavik P.; Madara, Joseph C.; Olson, David P.; Strochlic, David E.; Garfield, Alastair S.; Linh Vong; Pei, Hongjuan; Watabe-Uchida, Mitsuko; Uchida, Naoshige; Liberles, Stephen D.; Lowell, Bradford B.			An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger	NATURE			English	Article							ENERGY-EXPENDITURE; FEEDING-BEHAVIOR; POMC NEURONS; FOOD-INTAKE; CELL-TYPES; NPY; PROTEIN; LEPTIN; HYPOTHALAMUS; RECEPTORS	Hunger is a hard-wired motivational state essential for survival. Agouti-related peptide (AgRP)-expressing neurons in the arcuate nucleus (ARC) at the base of the hypothalamus are crucial to the control of hunger. They are activated by caloric deficiency and, when naturally or artificially stimulated, they potently induce intense hunger and subsequent food intake(1-5). Consistent with their obligatory role in regulating appetite, genetic ablation or chemogenetic inhibition of AgRP neurons decreases feeding(3,6,7). Excitatory input to AgRP neurons is important in caloric-deficiency-induced activation, and is notable for its remarkable degree of caloric-state-dependent synaptic plasticity(8-10). Despite the important role of excitatory input, its source(s) has been unknown. Here, through the use of Cre-recombinase-enabled, cell-specific neuron mapping techniques in mice, we have discovered strong excitatory drive that, unexpectedly, emanates from the hypothalamic paraventricular nucleus, specifically from subsets of neurons expressing thyrotropin-releasing hormone (TRH) and pituitary adenylate cyclase-activating polypeptide (PACAP, also known as ADCYAP1). Chemogenetic stimulation of these afferent neurons in sated mice markedly activates AgRP neurons and induces intense feeding. Conversely, acute inhibition in mice with caloric-deficiency-induced hunger decreases feeding. Discovery of these afferent neurons capable of triggering hunger advances understanding of how this intense motivational state is regulated.	[Krashes, Michael J.; Shah, Bhavik P.; Madara, Joseph C.; Olson, David P.; Garfield, Alastair S.; Linh Vong; Lowell, Bradford B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA; [Strochlic, David E.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Strochlic, David E.; Uchida, Naoshige; Liberles, Stephen D.; Lowell, Bradford B.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Garfield, Alastair S.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Pei, Hongjuan] Univ Michigan, Div Pediat Endocrinol, Dept Pediat, Ann Arbor, MI 48105 USA; [Watabe-Uchida, Mitsuko; Uchida, Naoshige] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Edinburgh; University of Michigan System; University of Michigan; Harvard University	Lowell, BB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA.	blowell@bidmc.harvard.edu	Krashes, Michael/P-7677-2019	Liberles, Stephen/0000-0002-2177-9741; Garfield, Alastair/0000-0002-9628-6140; Uchida, Naoshige/0000-0002-5755-9409; Olson, David/0000-0001-9249-7760	NIH [R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, P30 DK046200, P30 DK57521, F32 DK089710, K08 DK071561, F32 DK078478, R01 MH095953]; ADA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089044, R01DK096010, F32DK078478, F32DK089710, R01DK071051, K08DK071561, P30DK046200, R37DK053477, P30DK057521, R01DK075632, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101207, R01MH095953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the following NIH grants to B. B. L.: R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, BNORC Transgenic Core P30 DK046200 and BADERC Transgenic Core P30 DK57521; to M.J.K.: F32 DK089710; to D.P.O.: K08 DK071561; to L. V.: F32 DK078478; to N.U.: R01 MH095953; and an ADA Mentor-Based Fellowship to B. P. S. and B. B. L. We thank D. Cusher and Y. Li for mouse genotyping, J. Carroll and Y. Guo for perfusions and tissue removal, B. L. Roth and S. C. Rogan for generating the AAV-DIO-hM3Dq-mCherry plasmid, K. Deisseroth for generating the AAV-DIO-ChR2-mCherry plasmid and A. N. Hollenberg for the TRH riboprobe.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Fukushima Y, 2001, AM J PHYSIOL-REG I, V281, pR1562, DOI 10.1152/ajpregu.2001.281.5.R1562; GOLD RM, 1977, PHYSIOL BEHAV, V18, P1111, DOI 10.1016/0031-9384(77)90019-1; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; SATOH T, 1992, MOL BRAIN RES, V14, P131, DOI 10.1016/0169-328X(92)90020-C; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013	33	363	368	6	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					238	+		10.1038/nature12956	http://dx.doi.org/10.1038/nature12956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24487620	Green Accepted, Green Published			2022-12-28	WOS:000332651800040
J	Weymouth, AJ; Hofmann, T; Giessibl, FJ				Weymouth, Alfred John; Hofmann, Thomas; Giessibl, Franz J.			Quantifying Molecular Stiffness and Interaction with Lateral Force Microscopy	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; REAL-SPACE; ATOM; IDENTIFICATION; SPECTROSCOPY; RESOLUTION; SURFACES	The spatial resolution of atomic force microscopy (AFM) can be drastically increased by terminating the tip with a single carbon monoxide (CO) molecule. However, the CO molecule is not stiff, and lateral forces, such as those around the sides of molecules, distort images. This issue begs a larger question of how AFM can probe structures that are laterally weak. Lateral force microscopy (LFM) can probe lateral stiffnesses that are not accessible to normal-force AFM, resulting in higher spatial resolution. With LFM, we determined the torsional spring constant of a CO-terminated tip molecule to be 0.24 newtons per meter. This value is less than that of a surface molecule and an example of a system whose stiffness is a product not only of bonding partners but also local environment.	[Weymouth, Alfred John; Hofmann, Thomas; Giessibl, Franz J.] Univ Regensburg, D-93053 Regensburg, Germany	University of Regensburg	Weymouth, AJ (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	jay.weymouth@ur.de	Giessibl, Franz J/K-8022-2013; Weymouth, Alfred John/F-4038-2016	Giessibl, Franz J/0000-0002-5585-1326; Weymouth, Alfred John/0000-0001-8793-9368	Deutsche Forschungsgemeinschaft [GRK 1570]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank D. Meuer for the LFM sensor construction, A.-K. Greitner for COMSOL modeling of the LFM sensor, and the Deutsche Forschungsgemeinschaft (GRK 1570) for financial support.	Albers BJ, 2009, NAT NANOTECHNOL, V4, P307, DOI [10.1038/nnano.2009.57, 10.1038/NNANO.2009.57]; Albrecht F, 2013, J AM CHEM SOC, V135, P9200, DOI 10.1021/ja404084p; Bartels L, 1997, APPL PHYS LETT, V71, P213, DOI 10.1063/1.119503; Boneschanscher MP, 2012, ACS NANO, V6, P10216, DOI 10.1021/nn3040155; Braun J, 1996, J CHEM PHYS, V105, P3258, DOI 10.1063/1.471841; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; Gajdos M, 2005, SURF SCI, V590, P117, DOI 10.1016/j.susc.2005.04.047; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Giessibl FJ, 2002, P NATL ACAD SCI USA, V99, P12006, DOI 10.1073/pnas.182160599; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Mohn F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793200; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Morse PM, 1929, PHYS REV, V34, P57, DOI 10.1103/PhysRev.34.57; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Pfeiffer O, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161403; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Sun ZX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046104; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Ternes M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.016802; Welker J, 2013, ACS NANO, V7, P7377, DOI 10.1021/nn403106v; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850; Welker J, 2012, BEILSTEIN J NANOTECH, V3, P238, DOI 10.3762/bjnano.3.27; Weymouth AJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.126103; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603	26	94	96	2	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1120	1122		10.1126/science.1249502	http://dx.doi.org/10.1126/science.1249502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24505131	Green Published			2022-12-28	WOS:000332331500043
J	Sousa-Victor, P; Gutarra, S; Garcia-Prat, L; Rodriguez-Ubreva, J; Ortet, L; Ruiz-Bonilla, V; Jardi, M; Ballestar, E; Gonzalez, S; Serrano, AL; Perdiguero, E; Munoz-Canoves, P				Sousa-Victor, Pedro; Gutarra, Susana; Garcia-Prat, Laura; Rodriguez-Ubreva, Javier; Ortet, Laura; Ruiz-Bonilla, Vanessa; Jardi, Merce; Ballestar, Esteban; Gonzalez, Susana; Serrano, Antonio L.; Perdiguero, Eusebio; Munoz-Canoves, Pura			Geriatric muscle stem cells switch reversible quiescence into senescence	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CELLULAR SENESCENCE; SATELLITE CELLS; P16(INK4A); MECHANISMS; MYOGENESIS; SARCOPENIA; CHROMATIN; BMI-1	Regeneration of skeletal muscle depends on a population of adult stem cells (satellite cells) that remain quiescent throughout life. Satellite cell regenerative functions decline with ageing. Here we report that geriatric satellite cells are incapable of maintaining their normal quiescent state in muscle homeostatic conditions, and that this irreversibly affects their intrinsic regenerative and self-renewal capacities. In geriatric mice, resting satellite cells lose reversible quiescence by switching to an irreversible pre-senescence state, caused by derepression of p16(INK4a) (also called Cdkn2a). On injury, these cells fail to activate and expand, undergoing accelerated entry into a full senescence state (geroconversion), even in a youthful environment. p16(INK4a) silencing in geriatric satellite cells restores quiescence and muscle regenerative functions. Our results demonstrate that maintenance of quiescence in adult life depends on the active repression of senescence pathways. As p16(INK4a) is dysregulated in human geriatric satellite cells, these findings provide the basis for stem-cell rejuvenation in sarcopenic muscles.	[Sousa-Victor, Pedro; Gutarra, Susana; Garcia-Prat, Laura; Ortet, Laura; Ruiz-Bonilla, Vanessa; Jardi, Merce; Serrano, Antonio L.; Perdiguero, Eusebio; Munoz-Canoves, Pura] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Cell Biol Grp, CIBER Neurodegenerat Dis, E-08003 Barcelona, Spain; [Rodriguez-Ubreva, Javier; Ballestar, Esteban] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Programme, Chromatin & Dis Grp, E-08907 Barcelona, Spain; [Gonzalez, Susana] Ctr Nacl Invest Cardiovasc, Stem Cell Aging Grp, E-28029 Madrid, Spain; [Munoz-Canoves, Pura] Inst Catalana Recerca & Estudis Avancats, E-08010 Barcelona, Spain	Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro Nacional de Investigaciones Cardiovasculares (CNIC); ICREA	Munoz-Canoves, P (corresponding author), Pompeu Fabra Univ, Dept Expt & Hlth Sci, Cell Biol Grp, CIBER Neurodegenerat Dis, E-08003 Barcelona, Spain.	eusebio.perdiguero@upf.edu; pura.munoz@upf.edu	Gonzalez, Susana/I-3154-2015; Ballestar, Esteban/ABG-8561-2020; Perdiguero, Eusebio/F-3178-2013; M, Jardi/I-1201-2015; Munoz-Canoves, Pura/B-3889-2015; Sousa-Victor, Pedro/AER-5744-2022; Serrano, A/I-9198-2014; Ruiz Bonilla, Vanessa/I-1026-2015; Cortada, Laura Ortet/I-1204-2015	Gonzalez, Susana/0000-0002-7443-6195; Perdiguero, Eusebio/0000-0003-3529-8989; M, Jardi/0000-0002-2058-6606; Ruiz Bonilla, Vanessa/0000-0001-6345-2264; Cortada, Laura Ortet/0000-0002-3774-1844; Garcia-Prat, Laura/0000-0002-3786-4852; RODRIGUEZ-UBREVA, JAVIER/0000-0003-4707-4536; Ballestar, Esteban/0000-0002-1400-2440	MINECO-Spain [SAF2012-38547, FIS-PS09/01267, FIS-PI13/025, PLE2009-0124]; AFM; MDA; E-Rare; Fundacio Marato TV3; DuchennePP-NL; EU; Fundacao para a Ciencia e a Tecnologia (Portugal); Programa de Formacion de Personal Investigador (Spain); ICREA Funding Source: Custom	MINECO-Spain; AFM(Association Francaise contre les Myopathies); MDA(Muscular Dystrophy Association); E-Rare; Fundacio Marato TV3; DuchennePP-NL; EU(European Commission); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Programa de Formacion de Personal Investigador (Spain); ICREA(ICREA)	We are indebted to M. Raya and V. Lukesova for their contributions to this study; J. Martin-Caballero (PRBB Animal Facility), O. Fornas (UPF/CRG FACS Facility) and CRG/UPF Genomic Facility for technical help; A. Consiglio for help in lentivirus obtention; E. Rebollo for advice on imaging; M. van Lohuizen for Bmi1-deficient mice; M. Blasco's laboratory for help with ageing mice; T. Kawamura and M. Serrano for p16<SUP>INK4a</SUP> constructs; A. Sacco, S. Tajbakhsh, B. Gayraud-Morel, D. Montarras, J. Morgan and F. S. Tedesco for advice on cell transplantation; A. Brack and P. Zammit for advice on reserve cells; and Myoage network and tissue bank for support. The authors acknowledge funding from MINECO-Spain (SAF2012-38547, FIS-PS09/01267, FIS-PI13/025, PLE2009-0124), AFM, MDA, E-Rare, Fundacio Marato TV3, DuchennePP-NL and EU-FP7 (Myoage, Optistem and Endostem). P.S.-V. and L.G.-P. were supported by predoctoral fellowships from Fundacao para a Ciencia e a Tecnologia (Portugal) and Programa de Formacion de Personal Investigador (Spain), respectively.	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Blagosklonny MV, 2013, CANCER BIOL THER, V14, P1092, DOI 10.4161/cbt.27350; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Derave W, 2005, AM J PHYSIOL-ENDOC M, V289, pE272, DOI 10.1152/ajpendo.00039.2005; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vidal B, 2012, HUM MOL GENET, V21, P1989, DOI 10.1093/hmg/dds012; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yoshida N, 1998, J CELL SCI, V111, P769	50	574	590	5	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					316	+		10.1038/nature13013	http://dx.doi.org/10.1038/nature13013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522534				2022-12-28	WOS:000331477800031
J	Demetriades, C; Doumpas, N; Teleman, AA				Demetriades, Constantinos; Doumpas, Nikolaos; Teleman, Aurelio A.			Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2	CELL			English	Article							ACTIVATING PROTEIN COMPLEX; RAG GTPASES; TSC1-TSC2 COMPLEX; GAP ACTIVITY; MTOR; KINASE; TUBERIN; RHEB; DEPRIVATION; SUFFICIENCY	TOR complex 1 (TORC1) is a potent anabolic regulator of cellular growth and metabolism. When cells have sufficient amino acids, TORC1 is active due to its lysosomal localization mediated via the Rag GTPases. Upon amino acid removal, the Rag GTPases release TORC1, causing it to become cytoplasmic and inactive. We show here that, upon amino acid removal, the Rag GTPases also recruit TSC2 to the lysosome, where it can act on Rheb. Only when both the Rag GTPases and Rheb are inactive is TORC1 fully released from the lysosome. Upon amino acid withdrawal, cells lacking TSC2 fail to completely release TORC1 from the lysosome, fail to completely inactivate TORC1, and fail to adjust physiologically to amino acid starvation. These data suggest that regulation of TSC2 subcellular localization may be a general mechanism to control its activity and place TSC2 in the amino-acid-sensing pathway to TORC1.	[Demetriades, Constantinos; Doumpas, Nikolaos; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Demetriades, C (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	k.dimitriadis@dkfz.de; a.teleman@dkfz.de	Demetriades, Constantinos/E-7444-2015; Teleman, Aurelio A/E-6864-2013; Demetriades, Constantinos/AAD-3600-2021; Teleman, Aurelio/V-8470-2019	Demetriades, Constantinos/0000-0001-7813-7726; Teleman, Aurelio A/0000-0002-4237-9368; Demetriades, Constantinos/0000-0001-7813-7726; Teleman, Aurelio/0000-0002-4237-9368	NICHD; Metabolomics Core Technology Platform of the Excellence cluster "CellNet-works'' (University of Heidelberg); Deutsche Forschungsgemeinschaft [ZUK 40/2010-3009262]; European Research Council under the European Union (ERC) [260602]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Metabolomics Core Technology Platform of the Excellence cluster "CellNet-works'' (University of Heidelberg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council under the European Union (ERC)(European Research Council (ERC))	A.T. would like to dedicate this paper to Rich Losick and Steve Cohen, who taught him how to do research. We thank David Kwiatkowski and Michael Hall for the TSC2 mutant MEFs, Lukas Huber for the p14<SUP>-/-</SUP> MEFs, and Hong Wu for the PTEN mutant MEFs. We would also like to acknowledge David Sabatini for supplying the pRK5-HA-GST-Rag plasmids (Adgene 19298, 19301, 19304, and 19307), Kun-Liang Guan for the pcDNA3-HA-RagA and RagC point mutants, Brendan Manning for the pcDNA3-FLAG-TSC2 and pRK7-FLAG-TSC1 expression vectors, and Duojia Pan for the pAc5.1-Tsc2-V5-His expression vector. Several antibodies were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa. We thank the Metabolomics Core Technology Platform of the Excellence cluster "CellNet-works'' (University of Heidelberg) and the Deutsche Forschungsgemeinschaft (grant ZUK 40/2010-3009262) for support with the HPLC-based intracellular amino acid measurements, the DKFZ Mass Spectrometry core facility for protein identifications, Androniki Kolovou and Jacomine Krijnse Locker and the University of Heidelberg EM Core Facility for support with electron microscopy experiments, and Sibylle Schleich and Katrine Weischenfeldt for technical support. This work was supported by the European Research Council under the European Union's Seventh Framework Programme (ERC starting grant 260602).	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Proud CG, 2011, BIOCHEM SOC T, V39, P431, DOI 10.1042/BST0390431; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	35	271	272	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					786	799		10.1016/j.cell.2014.01.024	http://dx.doi.org/10.1016/j.cell.2014.01.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529380	Green Accepted, Bronze			2022-12-28	WOS:000331379800016
J	Rasmussen, M; Anzick, SL; Waters, MR; Skoglund, P; DeGiorgio, M; Stafford, TW; Rasmussen, S; Moltke, I; Albrechtsen, A; Doyle, SM; Poznik, GD; Gudmundsdottir, V; Yadav, R; Malaspinas, AS; White, SS; Allentoft, ME; Cornejo, OE; Tambets, K; Eriksson, A; Heintzman, PD; Karmin, M; Korneliussen, TS; Meltzer, DJ; Pierre, TL; Stenderup, J; Saag, L; Warmuth, VM; Lopes, MC; Malhi, RS; Brunak, S; Sicheritz-Ponten, T; Barnes, I; Collins, M; Orlando, L; Balloux, F; Manica, A; Gupta, R; Metspalu, M; Bustamante, CD; Jakobsson, M; Nielsen, R; Willerslev, E				Rasmussen, Morten; Anzick, Sarah L.; Waters, Michael R.; Skoglund, Pontus; DeGiorgio, Michael; Stafford, Thomas W., Jr.; Rasmussen, Simon; Moltke, Ida; Albrechtsen, Anders; Doyle, Shane M.; Poznik, G. David; Gudmundsdottir, Valborg; Yadav, Rachita; Malaspinas, Anna-Sapfo; White, Samuel Stockton; Allentoft, Morten E.; Cornejo, Omar E.; Tambets, Kristiina; Eriksson, Anders; Heintzman, Peter D.; Karmin, Monika; Korneliussen, Thorfinn Sand; Meltzer, David J.; Pierre, Tracey L.; Stenderup, Jesper; Saag, Lauri; Warmuth, Vera M.; Lopes, Margarida C.; Malhi, Ripan S.; Brunak, Soren; Sicheritz-Ponten, Thomas; Barnes, Ian; Collins, Matthew; Orlando, Ludovic; Balloux, Francois; Manica, Andrea; Gupta, Ramneek; Metspalu, Mait; Bustamante, Carlos D.; Jakobsson, Mattias; Nielsen, Rasmus; Willerslev, Eske			The genome of a Late Pleistocene human from a Clovis burial site in western Montana	NATURE			English	Article							DNA; TREE; AGE	Clovis, with its distinctive biface, blade and osseous technologies, is the oldest widespread archaeological complex defined in North America, dating from 11,100 to 10,700 C-14 years before present (BP) (13,000 to 12,600 calendar years BP)(1,2). Nearly 50 years of archaeological research point to the Clovis complex as having developed south of the North American ice sheets from an ancestral technology(3). However, both the origins and the genetic legacy of the people who manufactured Clovis tools remain under debate. It is generally believed that these people ultimately derived from Asia and were directly related to contemporary Native Americans(2). An alternative, Solutrean, hypothesis posits that the Clovis predecessors emigrated from southwestern Europe during the Last Glacial Maximum(4). Here we report the genome sequence of a male infant (Anzick-1) recovered from the Anzick burial site in western Montana. The human bones date to 10,705 +/- 35 C-14 years BP (approximately 12,707-12,556 calendar years BP) and were directly associated with Clovis tools. We sequenced the genome to an average depth of 14.4x and show that the gene flow from the Siberian Upper Palaeolithic Mal'ta population(5) into Native American ancestors is also shared by the Anzick-1 individual and thus happened before 12,600 years BP. We also show that the Anzick-1 individual is more closely related to all indigenous American populations than to any other group. Our data are compatible with the hypothesis that Anzick-1 belonged to a population directly ancestral to many contemporary Native Americans. Finally, we find evidence of a deep divergence in Native American populations that predates the Anzick-1 individual.	[Rasmussen, Morten; Stafford, Thomas W., Jr.; Malaspinas, Anna-Sapfo; Allentoft, Morten E.; Korneliussen, Thorfinn Sand; Pierre, Tracey L.; Stenderup, Jesper; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Anzick, Sarah L.] Anzick Family, Livingston, MT 59047 USA; [Waters, Michael R.] Texas A&M Univ, Dept Anthropol, Ctr Study Amer 1, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Dept Geog, Ctr Study Amer 1, College Stn, TX 77843 USA; [Skoglund, Pontus; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [DeGiorgio, Michael; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Stafford, Thomas W., Jr.] Univ Aarhus, Dept Phys & Astron, AMS Dating Ctr 14C, DK-8000 Aarhus C, Denmark; [Rasmussen, Simon; Gudmundsdottir, Valborg; Yadav, Rachita; Brunak, Soren; Sicheritz-Ponten, Thomas; Gupta, Ramneek] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen N, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Doyle, Shane M.] Montana State Univ, Dept Educ, Bozeman, MT 59717 USA; [Poznik, G. David] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Poznik, G. David] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [White, Samuel Stockton] Univ Montana, PhD Program, Anthropol Dept, Missoula, MT 59808 USA; [Cornejo, Omar E.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Tambets, Kristiina; Karmin, Monika; Saag, Lauri; Metspalu, Mait] Estonian Bioctr, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Tambets, Kristiina; Karmin, Monika; Saag, Lauri; Metspalu, Mait] Univ Tartu, EE-51010 Tartu, Estonia; [Eriksson, Anders; Warmuth, Vera M.; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Eriksson, Anders] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal 239556900, Saudi Arabia; [Heintzman, Peter D.; Barnes, Ian] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Meltzer, David J.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Lopes, Margarida C.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Collins, Matthew] Univ York, BioArCh, Dept Biol, York YO10 5DD, N Yorkshire, England; [Collins, Matthew] Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Collins, Matthew] Univ York, BioArCh, Dept Chem, York YO10 5DD, N Yorkshire, England; [Balloux, Francois] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Bustamante, Carlos D.] Stanford Univ, Littlefield Ctr, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bustamante, Carlos D.] Stanford Univ, Littlefield Ctr, Ctr Evolutionary & Human Genom, Stanford, CA 94305 USA; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	University of Copenhagen; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Uppsala University; University of California System; University of California Berkeley; Aarhus University; Technical University of Denmark; University of Copenhagen; University of Chicago; Montana State University System; Montana State University Bozeman; Stanford University; Stanford University; University of Montana System; University of Montana; Washington State University; Estonian Biocentre; University of Tartu; University of Cambridge; King Abdullah University of Science & Technology; University of London; Royal Holloway University London; Southern Methodist University; University of London; University College London; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of York - UK; University of York - UK; University of York - UK; Imperial College London; Stanford University; Stanford University; Uppsala University	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	ewillerslev@snm.ku.dk	Barnes, Ian C/B-8081-2008; Saag, Lauri/H-3312-2012; Orlando, Ludovic/A-8932-2013; Waters, Michael/ABI-2377-2020; Albrechtsen, Anders/K-4281-2013; Korneliussen, Thorfinn Sand/ABB-7656-2021; Metspalu, Mait/G-8671-2015; Collins, Matthew J/A-7534-2008; Moltke, Ida/C-6158-2011; Jakobsson, Mattias/A-6116-2011; Rasmussen, Simon/G-6258-2016; Manica, Andrea/B-5497-2008; Eriksson, Anders/C-9767-2010; Tambets, Kristiina/M-2568-2019; Manica, Andrea/N-9013-2019; Waters, Michael R/A-9430-2009; Gupta, Ramneek/G-7278-2012; Willerslev, Eske/A-9619-2011; Collins, Matthew James/O-1095-2019; Balloux, Francois/D-4783-2009; Korneliussen, Thorfinn Sand/F-6421-2014; Balloux, Francois/X-7856-2019; Willerslev, Eske/AAA-5686-2019; Heintzman, Peter D./I-6768-2013; Rasmussen, Simon/AAA-2308-2020; Nielsen, Rasmus/D-4405-2009; Brunak, Soren/O-6621-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Barnes, Ian C/0000-0001-8322-6918; Saag, Lauri/0000-0002-0978-7415; Orlando, Ludovic/0000-0003-3936-1850; Waters, Michael/0000-0003-2660-3355; Albrechtsen, Anders/0000-0001-7306-031X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Metspalu, Mait/0000-0003-3099-9161; Collins, Matthew J/0000-0003-4226-5501; Moltke, Ida/0000-0001-7052-8554; Jakobsson, Mattias/0000-0001-7840-7853; Rasmussen, Simon/0000-0001-6323-9041; Manica, Andrea/0000-0003-1895-450X; Eriksson, Anders/0000-0003-3436-3726; Tambets, Kristiina/0000-0002-8173-6380; Manica, Andrea/0000-0003-1895-450X; Gupta, Ramneek/0000-0001-6841-6676; Willerslev, Eske/0000-0002-7081-6748; Collins, Matthew James/0000-0003-4226-5501; Balloux, Francois/0000-0003-1978-7715; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Balloux, Francois/0000-0003-1978-7715; Heintzman, Peter D./0000-0002-6449-0219; Rasmussen, Simon/0000-0001-6323-9041; Bustamante, Carlos D./0000-0002-4187-7920; Nielsen, Rasmus/0000-0003-0513-6591; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Allentoft, Morten/0000-0003-4424-3568; Gudmundsdottir, Valborg/0000-0002-7459-1603; Brunak, Soren/0000-0003-0316-5866; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Meltzer, David/0000-0001-8084-9802; Skoglund, Pontus/0000-0002-3021-5913; Karmin, Monika/0000-0001-9827-5579; Malhi, Ripan/0000-0002-1484-0292	Lundbeck Foundation; Danish National Research Foundation [DNRF94]; US National Science Foundation [DBI-1103639]; Swiss National Science foundation; National Science Foundation (NSF) [DGE-1147470]; European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Basic Research [SF0270177As08]; Estonian Science Foundation [8973]; SNIC-UPPMAX [b2012063]; Biotechnology and Biological Sciences Research Council [P25032, BB/H005854/1]; North Star Archaeological Research Program, Center for the Study of the First Americans, Texas AM University; E. Hill; Stafford Research, Inc.; BBSRC [BB/H005854/1, BB/H008802/2, BB/H008802/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008802/1, BB/H008802/2] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); US National Science Foundation(National Science Foundation (NSF)); Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)); European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Basic Research; Estonian Science Foundation; SNIC-UPPMAX; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); North Star Archaeological Research Program, Center for the Study of the First Americans, Texas AM University; E. Hill; Stafford Research, Inc.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Villum Fonden(Villum Fonden); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank the Danish National High-throughput DNA Sequencing Centre for help with sequencing, B. Henn and J. Kidd for assistance with Human Genome Diversity Project data, J. Keene for help with illustrations, M. Li, P. L. F. Johnson and M. Stoneking for help with the mtDNA analysis, L. A. Lahren for input to the site description and for establishing contact with the Native American groups, and J. E. Morrow, S. Fiedel and E. Lorenzen for comments on the manuscript. GeoGenetics were supported by the Lundbeck Foundation and the Danish National Research Foundation (DNRF94). M. D. was supported by the US National Science Foundation (grant DBI-1103639). A.-S.M. was supported by the Swiss National Science foundation. G. D. P. was supported by National Science Foundation (NSF) graduate research fellowship DGE-1147470. M. M., M. K., K. T. and L. S. were supported by the European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu, Estonian Basic Research (grant SF0270177As08) and Estonian Science Foundation (grant 8973). Computations in Uppsala were performed on resources provided by SNIC-UPPMAX (project b2012063) and in Tartu using the High Performance Computing Centre of the University of Tartu. A. E., V. M. W., M. C. L., F. B. and A. M. were supported by the Biotechnology and Biological Sciences Research Council (grant P25032 and BB/H005854/1). We thank the North Star Archaeological Research Program, Center for the Study of the First Americans, Texas A&M University, E. Hill, and Stafford Research, Inc. for funding some of the project.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Hemmings, 2010, CLOVIS TECHNOLOGY; Jantz RL, 2001, AM J PHYS ANTHROPOL, V114, P146, DOI 10.1002/1096-8644(200102)114:2<146::AID-AJPA1014>3.0.CO;2-E; Kemp B. M., 2010, HUMAN VARIATION AM I, P12; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; LAHREN L, 1974, SCIENCE, V186, P147, DOI 10.1126/science.186.4159.147; Lahren L. A., 2006, HOMELAND; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Morrow JE., 2006, PALEOINDIAN ARCHAEOL, P123; Owsley DW, 2001, PLAINS ANTHROPOL, V46, P115, DOI 10.1080/2052546.2001.11932062; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Stanford DJ, 2012, ACROSS ATLANTIC ICE: THE ORIGIN OF AMERICA'S CLOVIS CULTURE, P1; Steele DG, 1999, WHO WERE THE FIRST AMERICANS?, P97; Straus LG, 2005, WORLD ARCHAEOL, V37, P507, DOI 10.1080/00438240500395797; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166	29	299	313	0	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					225	+		10.1038/nature13025	http://dx.doi.org/10.1038/nature13025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24522598	Green Accepted, Green Submitted			2022-12-28	WOS:000331107700039
J	Tarlo, SM; Lemiere, C				Tarlo, Susan M.; Lemiere, Catherine			Occupational Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WORK-RELATED ASTHMA; AIRWAYS DYSFUNCTION SYNDROME; RESPIRATORY SYMPTOMS; PREDICTION MODEL; UNITED-STATES; RISK-FACTORS; PREVENTION; EXPOSURE; IMMUNOTHERAPY; ALLERGY		[Tarlo, Susan M.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Tarlo, Susan M.] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lemiere, Catherine] Univ Montreal, Hop Sacre Coeur Montreal, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Universite de Montreal	Tarlo, SM (corresponding author), Toronto Western Hosp EW7 449, 399 Bathurst St, Toronto, ON M9A 4S9, Canada.	susan.tarlo@utoronto.ca		Tarlo, Susan/0000-0002-4746-5310; Lemiere, Catherine/0000-0003-3667-9628	SOMA Medical Assessments; Graydon Sheppard Professional Corporation; Barrick Gold; AllerGen; AstraZeneca; Merck; GlaxoSmithKline	SOMA Medical Assessments; Graydon Sheppard Professional Corporation; Barrick Gold; AllerGen; AstraZeneca(AstraZeneca); Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline)	Dr. Tarlo reports receiving consulting fees for worker assessments, expert testimony, or both from SOMA Medical Assessments, Graydon Sheppard Professional Corporation, and Barrick Gold and grant support through her institution from AllerGen. Dr. Lemiere reports receiving consulting fees, lecture fees, and payment for the development of educational presentations from AstraZeneca; consulting fees and lecture fees from Merck; and lecture fees, as well as grant support through her institution, from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Adisesh A, 2011, OCCUP MED-OXFORD, V61, P62, DOI 10.1093/occmed/kqq171; Akinbami Lara J, 2012, NCHS Data Brief, P1; Allan KM, 2010, OCCUP MED-OXFORD, V60, P458, DOI 10.1093/occmed/kqq055; Arif AA, 2003, AM J IND MED, V44, P368, DOI 10.1002/ajim.10291; Arif AA, 2012, OCCUP ENVIRON MED, V69, P35, DOI 10.1136/oem.2011.064865; ARMENTIA A, 1990, ANN ALLERGY, V65, P265; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch Gisela I, 2005, Crit Care Med, V33, pS102, DOI 10.1097/01.CCM.0000151138.10586.3A; Baur X, 2012, EUR RESPIR J, V39, P529, DOI 10.1183/09031936.00096111; Beach J, 2005, Evid Rep Technol Assess (Summ), P1; Beach J, 2007, CHEST, V131, P569, DOI 10.1378/chest.06-0492; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Blomqvist A, 2005, INT ARCH OCC ENV HEA, V78, P123, DOI 10.1007/s00420-004-0573-7; Brooks SM, 1998, CHEST, V113, P42, DOI 10.1378/chest.113.1.42; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Buyantseva LV, 2011, J OCCUP ENVIRON MED, V53, P420, DOI 10.1097/JOM.0b013e3182122376; de Groene GJ, 2011, COCHRANE DATABASE SY, V5; Eisner MD, 2006, AM J MED, V119, P884, DOI 10.1016/j.amjmed.2006.01.016; Fishwick D, 2011, OCCUP MED-OXFORD, V61, P321, DOI 10.1093/occmed/kqr116; Gautrin D, 2000, AM J RESP CRIT CARE, V162, P1222, DOI 10.1164/ajrccm.162.4.2001023; Gordon S, 2003, OCCUP MED-OXFORD, V53, P371, DOI 10.1093/occmed/kqg117; Guidotti TL, 2011, AM J IND MED, V54, P649, DOI 10.1002/ajim.20987; Hansen I, 2004, LARYNGO RHINO OTOL, V83, P512, DOI 10.1055/s-2004-814505; Heederik D, 2012, EUR RESPIR REV, V21, P112, DOI 10.1183/09059180.00005111; Henneberger PK, 2011, AM J RESP CRIT CARE, V184, P368, DOI 10.1164/rccm.812011ST; Hoy RF, 2010, OCCUP MED-OXFORD, V60, P546, DOI 10.1093/occmed/kqq117; Jaakkola MS, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-22; Jarvis J, 2005, OCCUP ENVIRON MED, V62, P243, DOI 10.1136/oem.2004.016402; JYO T, 1989, J ALLERGY CLIN IMMUN, V83, P386, DOI 10.1016/0091-6749(89)90123-1; KERN DG, 1991, AM REV RESPIR DIS, V144, P1058, DOI 10.1164/ajrccm/144.5.1058; KIPEN HM, 1994, J OCCUP ENVIRON MED, V36, P1133, DOI 10.1097/00043764-199410000-00017; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Latza U, 2005, INT ARCH OCC ENV HEA, V78, P394, DOI 10.1007/s00420-004-0594-2; Lavaud F, 2013, ALLERGY, V68, P813, DOI 10.1111/all.12149; Lemiere C, 2012, OCCUP ENVIRON MED, V69, P901, DOI 10.1136/oemed-2012-100663; Malo JL, 2011, IMMUNOL ALLERGY CLIN, V31, P645, DOI 10.1016/j.iac.2011.07.003; MALO JL, 1991, AM REV RESPIR DIS, V143, P528, DOI 10.1164/ajrccm/143.3.528; Mazurek JM, 2013, J ASTHMA, V50, P390, DOI 10.3109/02770903.2013.769267; Meijer E, 2010, EUR RESPIR J, V36, P735, DOI 10.1183/09031936.00171609; Merget R, 2001, J ALLERGY CLIN IMMUN, V107, P707; Merget R, 2010, AM J IND MED, V53, P42, DOI 10.1002/ajim.20786; Moscato G, 2012, ALLERGY, V67, P491, DOI 10.1111/j.1398-9995.2011.02784.x; NILSSON R, 1993, BRIT J IND MED, V50, P65; Obadia M, 2009, AM J IND MED, V52, P716, DOI 10.1002/ajim.20730; Pralong JA, 2013, OCCUP ENVIRON MED, V70, P70, DOI 10.1136/oemed-2012-101189; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Quirce S, 2011, IMMUNOL ALLERGY CLIN, V31, P677, DOI 10.1016/j.iac.2011.07.001; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; Sarlo K, 2003, ANN ALLERG ASTHMA IM, V90, P32, DOI 10.1016/S1081-1206(10)61646-8; Sastre J, 2003, J ALLERGY CLIN IMMUN, V111, P985, DOI 10.1067/mai.2003.1390; Sastre J, 2006, CURR OPIN ALLERGY CL, V6, P96, DOI 10.1097/01.all.0000216851.10571.64; Soo J, 2012, CHEST, V142, P1244, DOI 10.1378/chest.11-2210; Stave GM, 2012, J OCCUP ENVIRON MED, V54, P558, DOI 10.1097/JOM.0b013e318247a44a; Suarthana E, 2010, J CLIN EPIDEMIOL, V63, P1011, DOI 10.1016/j.jclinepi.2009.10.008; Tarlo SM, 1997, AM J IND MED, V32, P517, DOI 10.1002/(SICI)1097-0274(199711)32:5<517::AID-AJIM12>3.0.CO;2-5; Tarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201; Tarlo SM, 2010, CURR ALLERGY ASTHM R, V10, P278, DOI 10.1007/s11882-010-0118-y; Thanasias E, 2013, ADV EXP MED BIOL, V755, P47, DOI 10.1007/978-94-007-4546-9_6; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Toren Kjell, 2009, BMC Pulm Med, V9, P7, DOI 10.1186/1471-2466-9-7; Vandenplas O, 2012, EUR RESPIR REV, V21, P97, DOI 10.1183/09059180.00004911; Wilken D, 2012, EUR RESPIR REV, V21, P105, DOI 10.1183/09059180.00005011; Wittczak T, 2012, INT J OCCUP MED ENV, V25, P242, DOI 10.2478/S13382-012-0031-9; Yucesoy B, 2012, TOXICOL SCI, V129, P166, DOI 10.1093/toxsci/kfs183; Zock JP, 2010, CURR OPIN ALLERGY CL, V10, P114, DOI 10.1097/ACI.0b013e32833733fe	65	219	228	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					640	649		10.1056/NEJMra1301758	http://dx.doi.org/10.1056/NEJMra1301758			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521110				2022-12-28	WOS:000331187500010
J	Cohen, D; Raftery, J				Cohen, Deborah; Raftery, James			Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cohen, Deborah] BMJ, London WC1H 9JR, England; [Raftery, James] Univ Southampton, Southampton, Hants, England	University of Southampton	Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						[Anonymous], 2012, TELEGRAPH; [Anonymous], 2012, COMMUNICATION; [Anonymous], 2007, CENTERWATCH MONTHLY, V14; [Anonymous], 2012, CYSTIC FIBROSIS QUES; BBC News, 2013, BBC NEWS; Centre for Drug Evaluation and Review, 2012, SUMM REV REG ACT; Cystic Fibrosis Foundation, ANN REP 2012; FiercePharma, 2013, KAL VERT PHARM; Institute of Medicine, 2009, VENT PHIL STRAT SUPP; Ivacaftor, 2013, PRESCRIRE INT, V22, P229; McGrory B, 2012, BOSTON GLOBE; NHS Commissioning Board, 2012, CLIN COMM POL IV CYS; O'Sullivan BP, 2013, JAMA-J AM MED ASSOC, V310, P1343, DOI 10.1001/jama.2013.278129; Scottish Government, 2013, CONS NEW PET PE1462; Scottish Parliament, PEO1462 NEW TREATM C; Werth B., 2013, MIT TECHNOLOGY REV	16	22	22	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2014	348								g1445	10.1136/bmj.g1445	http://dx.doi.org/10.1136/bmj.g1445			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WT	24523379				2022-12-28	WOS:000331444400020
J	Kuipers, E; Yesufu-Udechuku, A; Taylor, C; Kendall, T				Kuipers, Elizabeth; Yesufu-Udechuku, Amina; Taylor, Clare; Kendall, Tim			Management of psychosis and schizophrenia in adults: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; ILLNESS; HEALTH		[Kuipers, Elizabeth] Kings Coll London, Inst Psychiat, Dept Psychol, London SE5 8AF, England; [Kuipers, Elizabeth] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr, London SE5 8AF, England; [Yesufu-Udechuku, Amina] Univ Coll London Clin Educ & Hlth Psychol, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Taylor, Clare; Kendall, Tim] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8BB, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Kendall, Tim] Univ Coll London Clin Educ & Hlth Psychol, London WC1E 7HB, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; University College London; University of London; University College London; University of London; University College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8BB, England.	TKendall@rcpsych.ac.uk	Kuipers, Elizabeth A/A-3683-2009		National Institute for Health Research [NF-SI-0611-10103] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Department of Health, 2008, REF CAR PROGR APPR; Harwood RH, 2004, B WORLD HEALTH ORGAN, V82, P251; Jobe TH, 2005, CAN J PSYCHIAT, V50, P892, DOI 10.1177/070674370505001403; Kendall T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5782; Lawrence D, 2010, J PSYCHOPHARMACOL, V24, P61, DOI 10.1177/1359786810382058; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; National Institute for Health and Care Excellence, 2009, DEPR TREATM MAN DEPR; National Institute for Health and Care Excellence, 2013, PHYS ACT BRIEF ADV A; National Institute for Health and Care Excellence, 2007, DRUG MIS PSYCH INT C, V51; National Institute for Health and Care Excellence, 2009, ANT PERS DIS TREATM; National Institute for Health and Care Excellence, 2006, OB GUID PREV ID ASS; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; National Institute for Health and Care Excellence, 2009, DEPR CHRON PHYS HLTH; National Institute for Health and Care Excellence, 2009, SCHIZ COR INT TREATM; National Institute for Health and Care Excellence, 2005, POSTTR STRESS DIS MA; National Institute for Health and Care Excellence, 2007, DRUG MIS OP DET CLIN, V52; National Institute for Health and Care Excellence, 2008, LIP MOD CARD RISK AS; National Institute for Health and Care Excellence, 2009, BORD PERS DIS TREATM; National Institute for Health and Care Excellence, 2011, PREV TYP 2 DIAB POP; National Institute for Health and Care Excellence, 2011, CLIN GUID; National Institute for Health and Care Excellence, 2013, SOC ANX DIS REC ASS; National Institute for Health and Care Excellence, 2010, PREV CARD DIS PUBL H; National Institute for Health and Care Excellence, 2011, ALC US DIS DIAGN ASS; National Institute of Health and Care Excellence, 2014, PSYCH SCHIZ TREATM M; NHS Commissioning Board, 2013, COMM QUAL INN CQUIN; NHS Employers, 2013, 2013 14 GEN MED SERV; Reilly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036468; Royal College of Psychiatrists, 2012, REP NAT AUD SCHIZ NA; Royal College of Psychiatrists, POMH UK PRESCR OBS M; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schizophrenia Commission, 2012, AB ILLN REP SCHIZ CO; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Work Foundation, 2013, WORK SCHIZ PATHW EMP; World Health Organization, 2013, MENT HLTH SCHIZ	36	79	80	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2014	348								g1173	10.1136/bmj.g1173	http://dx.doi.org/10.1136/bmj.g1173			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WT	24523363	Green Published			2022-12-28	WOS:000331444400003
J	Rothschild, E				Rothschild, Emma			The Art of Medicine Histories of family health	LANCET			English	Editorial Material									Harvard Univ, Ctr Hist & Econ, Cambridge, MA 02138 USA	Harvard University	Rothschild, E (corresponding author), Harvard Univ, Ctr Hist & Econ, Cambridge, MA 02138 USA.	rothsch@fas.harvard.edu						Amrith SS, 2006, CAMB IMP POST-COL ST, P1, DOI 10.1057/9780230627369; Harper Tim, 2014, HIST HLTH SE ASIA PE; Rosenberg C, 2013, LANCET, V382, P851, DOI 10.1016/S0140-6736(13)61852-8; ROTHSCHILD Emma, 2012, INNER LIFE EMPIRES 1; The Cullen Project, CONS LETT W CULL 171	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					506	507		10.1016/S0140-6736(14)60173-2	http://dx.doi.org/10.1016/S0140-6736(14)60173-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AA5KH	24516883	Green Submitted			2022-12-28	WOS:000331136400014
J	Moss-Racusin, CA; van der Toorn, J; Dovidio, JF; Brescoll, VL; Graham, MJ; Handelsman, J				Moss-Racusin, Corinne A.; van der Toorn, Jojanneke; Dovidio, John F.; Brescoll, Victoria L.; Graham, Mark J.; Handelsman, Jo			Scientific Diversity Interventions	SCIENCE			English	Editorial Material							PREJUDICE; SCIENCE; BIAS; REDUCTION; RACE		[Moss-Racusin, Corinne A.] Skidmore Coll, Saratoga Springs, NY 12866 USA; [van der Toorn, Jojanneke] Leiden Univ, NL-233 AK Leiden, Netherlands; [Dovidio, John F.; Brescoll, Victoria L.; Graham, Mark J.; Handelsman, Jo] Yale Univ, New Haven, CT 06520 USA	Skidmore College; Leiden University; Leiden University - Excl LUMC; Yale University	Moss-Racusin, CA (corresponding author), Skidmore Coll, Saratoga Springs, NY 12866 USA.	cmossrac@skidmore.edu		Dovidio, John/0000-0002-6110-8344; van der Toorn, Jojanneke/0000-0003-0476-772X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM090574] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [1R13GM090574-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carnes M, 2012, J DIVERS HIGH EDUC, V5, P63, DOI 10.1037/a0028128; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; Dobbin F., 2013, OXFORD HDB DIVERSITY, P253; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Handelsman J, 2007, SCI TEACHING; Lai CK, 2013, SOC PERSONAL PSYCHOL, V7, P315, DOI 10.1111/spc3.12023; Legault L, 2011, PSYCHOL SCI, V22, P1472, DOI 10.1177/0956797611427918; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Pfund C, 2009, SCIENCE, V324, P470, DOI 10.1126/science.1170015; Racusin, 2012, CALLING ALL WHITE ME; Rudman L, 2012, ADV EXPT SOCIAL PSYC, P167; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Shields SA, 2011, J DIVERS HIGH EDUC, V4, P120, DOI 10.1037/a0022953; Steneck NH, 2007, ACAD MED, V82, P829, DOI 10.1097/ACM.0b013e31812f7d4d; Stephan C. W., 2001, IMPROVING INTERGROUP	17	98	99	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					615	616		10.1126/science.1245936	http://dx.doi.org/10.1126/science.1245936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	304CP	24503840				2022-12-28	WOS:000330724000027
J	Balch, JK				Balch, Jennifer K.			ATMOSPHERIC SCIENCE Drought and fire change sink to source	NATURE			English	Editorial Material							CARBON-DIOXIDE; AMAZON; DEFORESTATION; FOREST		Penn State Univ, Dept Geog, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Balch, JK (corresponding author), Penn State Univ, Dept Geog, University Pk, PA 16802 USA.	jkbalch@psu.edu						Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Balch JK, 2010, SCIENCE, V330, DOI 10.1126/science.1194032; Barlow Jos, 2006, P225; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Wang X, 2014, NATURE	12	10	10	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					41	42		10.1038/506041a	http://dx.doi.org/10.1038/506041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499913				2022-12-28	WOS:000330648100024
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Privacy is theft-sharing is caring	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Eggers D., 2013, CIRCLE; Hutcheon S, 2013, SYDNEY MORNING HERAL; Lupton D, 2013, CROAKEY BLOG    1223; Lupton D., 2013, IEEE EXPLORE    1209; Macaskill E., 2013, GUARDIAN; McKinsey and Company, 2013, BIG DAT REV HEALTHC; Moynihan R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5160; Ramesh R., 2014, GUARDIAN	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2014	348								g1320	10.1136/bmj.g1320	http://dx.doi.org/10.1136/bmj.g1320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4JK	24501253				2022-12-28	WOS:000331061700020
J	Sun, B; Looi, LS; Guo, SY; He, ZM; Gan, ES; Huang, JB; Xu, YF; Wee, WY; Ito, T				Sun, Bo; Looi, Liang-Sheng; Guo, Siyi; He, Zemiao; Gan, Eng-Seng; Huang, Jiangbo; Xu, Yifeng; Wee, Wan-Yi; Ito, Toshiro			Timing Mechanism Dependent on Cell Division Is Invoked by Polycomb Eviction in Plant Stem Cells	SCIENCE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; FUNCTIONAL GENOMICS; FLOWER DEVELOPMENT; HISTONE H3; DROSOPHILA; PROTEIN; CHROMATIN	Plant floral stem cells divide a limited number of times before they stop and terminally differentiate, but the mechanisms that control this timing remain unclear. The precise temporal induction of the Arabidopsis zinc finger repressor KNUCKLES (KNU) is essential for the coordinated growth and differentiation of floral stem cells. We identify an epigenetic mechanism in which the floral homeotic protein AGAMOUS (AG) induces KNU at similar to 2 days of delay. AG binding sites colocalize with a Polycomb response element in the KNU upstream region. AG binding to the KNU promoter causes the eviction of the Polycomb group proteins from the locus, leading to cell division-dependent induction. These analyses demonstrate that floral stem cells measure developmental timing by a division-dependent epigenetic timer triggered by Polycomb eviction.	[Sun, Bo; Looi, Liang-Sheng; Guo, Siyi; He, Zemiao; Gan, Eng-Seng; Huang, Jiangbo; Xu, Yifeng; Wee, Wan-Yi; Ito, Toshiro] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Looi, Liang-Sheng; He, Zemiao; Gan, Eng-Seng; Huang, Jiangbo; Ito, Toshiro] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Ito, T (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	itot@tll.org.sg	Guo, Siyi/AAT-4247-2020	Guo, Siyi/0000-0003-2013-1772; Ito, Toshiro/0000-0002-8206-2787; Gan, Eng Seng/0000-0001-9753-4524	Temasek Life Sciences Laboratory (TLL); PRESTO (Japan Science and Technology Agency, 4-1-8 Honcho Kawaguchi, Saitama, Japan); National Research Foundation Singapore under its Competitive Research Programme (CRP) [NRFCRP001-108]	Temasek Life Sciences Laboratory (TLL); PRESTO (Japan Science and Technology Agency, 4-1-8 Honcho Kawaguchi, Saitama, Japan); National Research Foundation Singapore under its Competitive Research Programme (CRP)	We thank H. Li and K. Kanehara for their experimental help, G. C. Angenent for the pAG::GFP seeds, D. Voytas for Golden Gate TAL effector kit (through Addgene), and RIKEN BRC for the Arabidopsis T87 culture cells. We thank H. Yu and F. Berger for their comments on the manuscript. This work was supported by a research grant to T. I. from Temasek Life Sciences Laboratory (TLL), PRESTO (Japan Science and Technology Agency, 4-1-8 Honcho Kawaguchi, Saitama, Japan), and the National Research Foundation Singapore under its Competitive Research Programme (CRP Award NRFCRP001-108). All the constructs made in this work are available from T. I. under a material transfer agreement with TLL.	Berger N, 2011, PLANT CELL, V23, P4065, DOI 10.1105/tpc.111.087866; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beuchle D, 2001, DEVELOPMENT, V128, P993; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Ito T, 1997, PLANT CELL PHYSIOL, V38, P248, DOI 10.1093/oxfordjournals.pcp.a029160; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Ito T, 2003, CURR BIOL, V13, P1524, DOI 10.1016/S0960-9822(03)00612-2; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ogawa Y, 2008, PLANT CELL PHYSIOL, V49, P242, DOI 10.1093/pcp/pcm181; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stals H, 2001, TRENDS PLANT SCI, V6, P359, DOI 10.1016/S1360-1385(01)02016-7; STEEVES T.A, 1989, PATTERNS IN PLANT DE; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Urbanus SL, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-5; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471	39	142	145	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					505	+	1248559	10.1126/science.1248559	http://dx.doi.org/10.1126/science.1248559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482483				2022-12-28	WOS:000330343700037
J	Collins, FS; Tabak, LA				Collins, Francis S.; Tabak, Lawrence A.			NIH plans to enhance reproducibility	NATURE			English	Editorial Material									[Collins, Francis S.; Tabak, Lawrence A.] US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), US Natl Inst Hlth, Bethesda, MD 20892 USA.	lawrence.tabak@nih.gov		Subramoni, Hari/0000-0002-1200-2754	Intramural NIH HHS [Z99 OD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; [Anonymous], 2013, ECONOMIST; Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; US Department of Health and Human Services, 2011, OFF RES INT ANN REP; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148	10	818	825	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					612	613		10.1038/505612a	http://dx.doi.org/10.1038/505612a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24482835	Green Accepted, Bronze			2022-12-28	WOS:000330321000016
J	Radaelli, PG				Radaelli, Paolo G.			Crystallography needs a governing body	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Radaelli, PG (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	p.g.radaelli@physics.ox.ac.uk	Radaelli, Paolo G/C-2952-2011	Radaelli, Paolo G/0000-0002-6717-035X				Banks M., 2011, PHYS WORLD; Cavalleri A, 2007, NATURE, V448, P651, DOI 10.1038/448651a; European Commission, 2010, ESFRI ROADM RES INFR; European Commission, 2008, ESFRI ROADM RES INFR; European Commission, 2006, ESFRI ROADM RES INFR; Lockyer N, 2013, NATURE, V504, P367, DOI 10.1038/504367a; Steigenberger U., 1997, ESS NEXT GENERATION	7	2	2	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					607	609		10.1038/505607a	http://dx.doi.org/10.1038/505607a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24482833	Bronze			2022-12-28	WOS:000330321000014
J	Halfwerk, W; Jones, PL; Taylor, RC; Ryan, MJ; Page, RA				Halfwerk, W.; Jones, P. L.; Taylor, R. C.; Ryan, M. J.; Page, R. A.			Risky Ripples Allow Bats and Frogs to Eavesdrop on a Multisensory Sexual Display	SCIENCE			English	Article							WATER-SURFACE-WAVES; MATING SIGNALS; COMMUNICATION; BEHAVIOR; CUES; PREDATION; EVOLUTION	Animal displays are often perceived by intended and unintended receivers in more than one sensory system. In addition, cues that are an incidental consequence of signal production can also be perceived by different receivers, even when the receivers use different sensory systems to perceive them. Here we show that the vocal responses of male tungara frogs (Physalaemus pustulosus) increase twofold when call-induced water ripples are added to the acoustic component of a rival's call. Hunting bats (Trachops cirrhosus) can echolocate this signal by-product and prefer to attack model frogs when ripples are added to the acoustic component of the call. This study illustrates how the perception of a signal by-product by intended and unintended receivers through different sensory systems generates both costs and benefits for the signaler.	[Halfwerk, W.; Jones, P. L.; Ryan, M. J.; Page, R. A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Halfwerk, W.] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; [Jones, P. L.; Ryan, M. J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Taylor, R. C.] Salisbury Univ, Dept Biol, Salisbury, MD 21801 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Leiden University; Leiden University - Excl LUMC; University of Texas System; University of Texas Austin; University System of Maryland; Salisbury University	Halfwerk, W (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.	w.halfwerk@biology.leidenuniv.nl	Page, Rachel A/GQQ-2818-2022; Page, Rachel/AAE-4816-2021	Page, Rachel A/0000-0001-7072-0669; Halfwerk, Wouter/0000-0002-4111-0930	Netherlands Organization for Scientific Research [825.11.026]; NSF [IOS 1120031]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF))	We are grateful to M. Dixon, A. Lea, K. Ottens, J. Jacobitz, J. Finley, F. Rhebergen, and M. Shuman-Goodier for valuable help during the experiments. Comments from D. Blumstein, H. Slabbekoorn, J. Ratcliffe, and one anonymous reviewer substantially improved the manuscript, and J. Touchon and S. Dennis provided statistical advice. We thank the late Stan Rand for illuminating discussions about ripples in communication. We thank B. Klein, P. Clements, and Moey Inc. for fabricating the pneumatic robotic frog system. The research was funded through a Rubicon grant (825.11.026) to W. H. from the Netherlands Organization for Scientific Research; an NSF grant (IOS 1120031) to R. C. T., M. J. R., and R. A. P.; and resources made available to R. A. P. from the Smithsonian Tropical Research Institute (STRI). All research reported here complied with STRI Institutional Animal Care and Use Committee protocols. We obtained all required permits from the government of Panama. The authors report no conflict of interest. Raw data will be made available at the Dryad Data Repository (10.5061/dryad.82t1k).	Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Bernal XE, 2007, ETHOLOGY, V113, P755, DOI 10.1111/j.1439-0310.2007.01374.x; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; ELEPFANDT A, 1985, BIOL BEHAV, V10, P333; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hobel G, 2013, BEHAVIOUR, V150, P471, DOI 10.1163/1568539X-00003062; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; LEWIS ER, 1985, SCIENCE, V227, P187, DOI 10.1126/science.227.4683.187; Markl H., 1983, NEUROETHOLOGY BEHAV, P333; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Page RA, 2008, ANIM BEHAV, V76, P761, DOI 10.1016/j.anbehav.2008.05.006; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Preininger D, 2013, BEHAV ECOL SOCIOBIOL, V67, P1449, DOI 10.1007/s00265-013-1489-6; Roberts JA, 2007, BEHAV ECOL, V18, P236, DOI 10.1093/beheco/arl079; Ryan M. J., 1985, TUNGARA FROG STUDY S; Siemers BM, 2001, J EXP BIOL, V204, P3843; SUTHERS RA, 1965, J EXP ZOOL, V158, P319, DOI 10.1002/jez.1401580307; Taylor RC, 2013, SCIENCE, V341, P273, DOI 10.1126/science.1237113; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Ubernickel K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00096; Uetz GW, 2002, BRAIN BEHAV EVOLUT, V59, P222, DOI 10.1159/000064909; WALKOWIAK W, 1985, NATURWISSENSCHAFTEN, V72, P49, DOI 10.1007/BF00405335; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	27	87	88	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					413	416		10.1126/science.1244812	http://dx.doi.org/10.1126/science.1244812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458640				2022-12-28	WOS:000330039300047
J	Lamy, F; Gersonde, R; Winckler, G; Esper, O; Jaeschke, A; Kuhn, G; Ullermann, J; Martinez-Garcia, A; Lambert, F; Kilian, R				Lamy, F.; Gersonde, R.; Winckler, G.; Esper, O.; Jaeschke, A.; Kuhn, G.; Ullermann, J.; Martinez-Garcia, A.; Lambert, F.; Kilian, R.			Increased Dust Deposition in the Pacific Southern Ocean During Glacial Periods	SCIENCE			English	Article							WESTERLY WIND CHANGES; DOME-C; HEMISPHERE; MAXIMUM; VARIABILITY; TRANSPORT; AUSTRALIA; SECTOR	Dust deposition in the Southern Ocean constitutes a critical modulator of past global climate variability, but how it has varied temporally and geographically is underdetermined. Here, we present data sets of glacial-interglacial dust-supply cycles from the largest Southern Ocean sector, the polar South Pacific, indicating three times higher dust deposition during glacial periods than during interglacials for the past million years. Although the most likely dust source for the South Pacific is Australia and New Zealand, the glacial-interglacial pattern and timing of lithogenic sediment deposition is similar to dust records from Antarctica and the South Atlantic dominated by Patagonian sources. These similarities imply large-scale common climate forcings, such as latitudinal shifts of the southern westerlies and regionally enhanced glaciogenic dust mobilization in New Zealand and Patagonia.	[Lamy, F.; Gersonde, R.; Esper, O.; Jaeschke, A.; Kuhn, G.; Ullermann, J.] Alfred Wegener Inst AWI Helmholtz Zentrum Polar &, Bremerhaven, Germany; [Lamy, F.; Gersonde, R.; Jaeschke, A.] MARUM Ctr Marine Environm Sci, Bremen, Germany; [Winckler, G.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Winckler, G.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Martinez-Garcia, A.] Swiss Fed Inst Technol, Inst Geol, Zurich, Switzerland; [Lambert, F.] Univ Chile, Ctr Climate & Resilience Res, Santiago, Chile; [Kilian, R.] Univ Trier, Fachbereich Raum & Umweltwissensch, Trier, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Columbia University; Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidad de Chile; Universitat Trier	Lamy, F (corresponding author), Alfred Wegener Inst AWI Helmholtz Zentrum Polar &, Bremerhaven, Germany.	frank.lamy@awi.de	Jaeschke, Andrea/B-8799-2017; Martínez-García, Alfredo/A-6244-2010; Lambert, Fabrice/M-2003-2014; Lamy, Frank/H-3611-2014	Jaeschke, Andrea/0000-0003-2518-2739; Martínez-García, Alfredo/0000-0002-7206-5079; Lambert, Fabrice/0000-0002-2192-024X; Kuhn, Gerhard/0000-0001-6069-7485; Esper, Oliver/0000-0002-4342-3471; Lamy, Frank/0000-0001-5952-1765	R/V Polarstern; AWI Helmholtz-Zentrum fur Polar- und Meeresforschung; MARUM-Center for Marine Environmental Sciences; University of Bremen; European Union;  [CONICYT/FONDAP/15110009]	R/V Polarstern; AWI Helmholtz-Zentrum fur Polar- und Meeresforschung; MARUM-Center for Marine Environmental Sciences; University of Bremen; European Union(European Commission); 	We thank the captain, crew, and scientific party of R/V Polarstern for their support during cruise ANT-XXVI-2. J. Collins, R. Tiedemann, H. W. Arz, and three anonymous reviewers provided comments and suggestions that substantially improved the paper. We acknowledge data contributions by P. Kohler and S. Steph and thank S. Albani and N. Mahowald for making their model output available. U. Bock, J. Hefter, R. Frohlking, and S. Wiebe provided technical support at AWI. G. W. thanks R. Schwarz and M. Q. Fleisher for excellent laboratory support at Lamont-Doherty Earth Observatory. We acknowledge financial support for this work through the AWI Helmholtz-Zentrum fur Polar- und Meeresforschung, the MARUM-Center for Marine Environmental Sciences, the University of Bremen, and the European Union project Past4future. F. Lambert acknowledges support by Project CONICYT/FONDAP/15110009. Data are available at www.pangaea.de.	Abelmann A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001199; Albani S, 2012, CLIM DYNAM, V38, P1731, DOI 10.1007/s00382-011-1139-5; Alloway BV, 2007, J QUATERNARY SCI, V22, P9, DOI 10.1002/jqs.1079; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; Bradtmiller LI, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001693; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Gaiero DM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030520; Gersonde R., 2011, EXPEDITION RES VESSE; Hesse PP, 2003, QUATERNARY SCI REV, V22, P2007, DOI 10.1016/S0277-3791(03)00164-1; Hesse PP, 1999, QUATERNARY RES, V52, P343, DOI 10.1006/qres.1999.2084; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Kohfeld KE, 2013, QUATERNARY SCI REV, V68, P76, DOI 10.1016/j.quascirev.2013.01.017; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Lambert F, 2012, CLIM PAST, V8, P609, DOI 10.5194/cp-8-609-2012; Li F, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009190; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Marx SK, 2009, GEOCHIM COSMOCHIM AC, V73, pA843; Mcgee D, 2010, QUATERNARY SCI REV, V29, P2340, DOI 10.1016/j.quascirev.2010.06.009; McGowan H, 2008, ATMOS ENVIRON, V42, P6915, DOI 10.1016/j.atmosenv.2008.05.053; Measures CI, 2000, GLOBAL BIOGEOCHEM CY, V14, P317, DOI 10.1029/1999GB001188; Noble TL, 2012, EARTH PLANET SC LETT, V317, P374, DOI 10.1016/j.epsl.2011.10.007; Sayles FL, 2001, DEEP-SEA RES PT II, V48, P4323, DOI 10.1016/S0967-0645(01)00091-1; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sime LC, 2013, QUATERNARY SCI REV, V64, P104, DOI 10.1016/j.quascirev.2012.12.008; Sugden DE, 2009, NAT GEOSCI, V2, P281, DOI 10.1038/NGEO474; THIEDE J, 1979, GEOLOGY, V7, P259, DOI 10.1130/0091-7613(1979)7<259:WROTLQ>2.0.CO;2; Tournadre J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007441; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595	32	148	155	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					403	407		10.1126/science.1245424	http://dx.doi.org/10.1126/science.1245424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458637	Green Published			2022-12-28	WOS:000330039300044
J	Mol, F; van Mello, NM; Strandell, A; Strandell, K; Jurkovic, D; Ross, J; Barnhart, KT; Yalcinkaya, TM; Verhoeve, HR; Graziosi, GCM; Koks, CAM; Klinte, I; Hogstrom, L; Janssen, ICAH; Kragt, H; Hoek, A; Trimbos-Kemper, TCM; Broekmans, FJM; Willemsen, WNP; Ankum, WM; Mol, BW; van Wely, M; van der Veen, F; Hajenius, PJ				Mol, Femke; van Mello, Norah M.; Strandell, Annika; Strandell, Karin; Jurkovic, Davor; Ross, Jackie; Barnhart, Kurt T.; Yalcinkaya, Tamer M.; Verhoeve, Harold R.; Graziosi, Giuseppe C. M.; Koks, Carolien A. M.; Klinte, Ingmar; Hogstrom, Lars; Janssen, Ineke C. A. H.; Kragt, Harry; Hoek, Annemieke; Trimbos-Kemper, Trudy C. M.; Broekmans, Frank J. M.; Willemsen, Wim N. P.; Ankum, Willem M.; Mol, Ben W.; van Wely, Madelon; van der Veen, Fulco; Hajenius, Petra J.			Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled trial	LANCET			English	Article							ECTOPIC PREGNANCY; FERTILITY	Background Tubal ectopic pregnancy can be surgically treated by salpingectomy, in which the affected Fallopian tube is removed, or salpingotomy, in which the tube is preserved. Despite potentially increased risks of persistent trophoblast and repeat ectopic pregnancy, salpingotomy is often preferred over salpingectomy because the preservation of both tubes is assumed to off er favourable fertility prospects, although little evidence exists to support this assumption. We aimed to assess whether salpingotomy would improve rates of ongoing pregnancy by natural conception compared with salpingectomy. Methods In this open-label, multicentre, international, randomised controlled trial, women aged 18 years and older with a laparoscopically confirmed tubal pregnancy and a healthy contralateral tube were randomly assigned via a central internet-based randomisation program to receive salpingotomy or salpingectomy. The primary outcome was ongoing pregnancy by natural conception. Differences in cumulative ongoing pregnancy rates were expressed as a fecundity rate ratio with 95% CI, calculated by Cox proportional-hazards analysis with a time horizon of 36 months. Secondary outcomes were persistent trophoblast and repeat ectopic pregnancy (expressed as relative risks [RRs] with 95% CIs) and ongoing pregnancy after ovulation induction, intrauterine insemination, or IVF. The researchers who collected data for fertility outcomes were masked to the assigned intervention, but patients and the investigators who analysed the data were not. All endpoints were analysed by intention to treat. We also did a (non-prespecified) meta-analysis that included the findings from the present trial. This trial is registered, number ISRCTN37002267. Findings 446 women were randomly assigned between Sept 24, 2004, and Nov 29, 2011, with 215 allocated to salpingotomy and 231 to salpingectomy. Follow-up was discontinued on Feb 1, 2013. The cumulative ongoing pregnancy rate was 60.7% after salpingotomy and 56.2% after salpingectomy (fecundity rate ratio 1.06, 95% CI 0.81-1.38; log-rank p=0.678). Persistent trophoblast occurred more frequently in the salpingotomy group than in the salpingectomy group (14 [7%] vs 1 [<1%]; RR 15.0, 2.0-113.4). Repeat ectopic pregnancy occurred in 18 women (8%) in the salpingotomy group and 12 (5%) women in the salpingectomy group (RR 1.6, 0.8-3.3). The number of ongoing pregnancies after ovulation induction, intrauterine insemination, or IVF did not differ significantly between the groups. 43 (20%) women in the salpingotomy group were converted to salpingectomy during the initial surgery because of persistent tubal bleeding. Our meta-analysis, which included our own results and those of one other study, substantiated the results of the trial. Interpretation In women with a tubal pregnancy and a healthy contralateral tube, salpingotomy does not significantly improve fertility prospects compared with salpingectomy.	[Mol, Femke; van Wely, Madelon; van der Veen, Fulco] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [van Mello, Norah M.; Ankum, Willem M.; Mol, Ben W.; Hajenius, Petra J.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Willemsen, Wim N. P.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Trimbos-Kemper, Trudy C. M.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Broekmans, Frank J. M.] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Verhoeve, Harold R.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Koks, Carolien A. M.] Maxima Med Ctr, Veldhoven, Netherlands; [Kragt, Harry] Reinier de Graaf Hosp, Delft, Netherlands; [Graziosi, Giuseppe C. M.] St Antonius Hosp, Nieuwegein, Netherlands; [Janssen, Ineke C. A. H.] Groene Hart Hosp, Gouda, Netherlands; [Strandell, Annika; Strandell, Karin] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; [Hogstrom, Lars] Skaraborg Hosp, Skovde, Sweden; [Klinte, Ingmar] NU Hosp Grp, Trollhattan, Sweden; [Jurkovic, Davor; Ross, Jackie] Kings Coll Hosp London, Kings Early Pregnancy Unit, London, England; [Yalcinkaya, Tamer M.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Barnhart, Kurt T.] Univ Penn, Penn Fertil Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jurkovic, Davor] Univ Coll London Hosp, Dept Obstet & Gynaecol, London, England; [Mol, Ben W.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Onze Lieve Vrouwe Gasthuis Hospital; Maxima Medical Center; Reinier de Graaf Hospital; St. Antonius Hospital Utrecht; Sahlgrenska University Hospital; NU Hospital Group; King's College Hospital NHS Foundation Trust; King's College Hospital; Wake Forest University; Wake Forest Baptist Medical Center; University of Pennsylvania; Pennsylvania Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Adelaide	Mol, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.mol@amc.nl	Ross, Jackie A/H-2113-2013; van Wely, Madelon/GXV-1757-2022	Ross, Jackie A/0000-0003-4168-6910; van Wely, Madelon/0000-0001-8263-213X; Mol, Femke/0000-0002-6892-5574; Van Mello, Norah Melina/0000-0002-0805-2994	Netherlands Organisation for Health Research and Development (ZonMW); Region Vastra Gotaland Health & Medical Care Committee	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Region Vastra Gotaland Health & Medical Care Committee	Netherlands Organisation for Health Research and Development (ZonMW), Region Vastra Gotaland Health & Medical Care Committee.	American College of Obstetricians and Gynecologists, 2008, OBSTET GYNECOL, V111, P1476; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; de Bennetot M, 2012, FERTIL STERIL, V98, P1271, DOI 10.1016/j.fertnstert.2012.06.041; Fernandez H, 2013, HUM REPROD, V28, P1247, DOI 10.1093/humrep/det037; Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists, 2004, GREEN TOP GUID 21 MA; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; HAJENIUS PJ, 1995, HUM REPROD, V10, P683, DOI 10.1093/oxfordjournals.humrep.a136012; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; MILLER NF, 1957, AM J OBSTET GYNECOL, V74, P699, DOI 10.1016/0002-9378(57)90049-2; Mol BWJ, 1998, HUM REPROD, V13, P1804, DOI 10.1093/humrep/13.7.1804; Mol Femke, 2008, BMC Womens Health, V8, P11, DOI 10.1186/1472-6874-8-11; Nederlandse Vereniging voor Obstetrie en Gynaecologie, 2001, RICHTL TUB EUG DIAGN; Newbatt E, 2012, BMJ-BRIT MED J, V345, P8136; RICHARDS BC, 1984, AM J OBSTET GYNECOL, V150, P100, DOI 10.1016/S0002-9378(84)80118-0; ROSENBLUM JM, 1960, AM J OBSTET GYNECOL, V80, P274; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; van Mello NM, 2010, REPROD BIOMED ONLINE, V21, P687, DOI 10.1016/j.rbmo.2010.06.034; Whitehouse B, 1922, Proc R Soc Med, V15, P17	19	78	98	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1483	1489		10.1016/S0140-6736(14)60123-9	http://dx.doi.org/10.1016/S0140-6736(14)60123-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24499812				2022-12-28	WOS:000335325800029
J	Constantinides, MG; McDonald, BD; Verhoef, PA; Bendelac, A				Constantinides, Michael G.; McDonald, Benjamin D.; Verhoef, Philip A.; Bendelac, Albert			A committed precursor to innate lymphoid cells	NATURE			English	Article							ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; LEUKEMIA ZINC-FINGER; TYPE-2 IMMUNITY; NKP46(+) CELLS; INFLAMMATION; LINEAGE; FETAL; NK; DIFFERENTIATION	Innate lymphoid cells (ILCs) specialize in the rapid secretion of polarized sets of cytokines and chemokines to combat infection and promote tissue repair at mucosal barriers(1-9). Their diversity and similarities with previously characterized natural killer (NK) cells and lymphoid tissue inducers (LTi) have prompted a provisional classification of all innate lymphocytes into groups 1, 2 and 3 solely on the basis of cytokine properties(10), but their developmental pathways and lineage relationships remain elusive. Here we identify and characterize a novel subset of lymphoid precursors in mouse fetal liver and adult bone marrow that transiently express high amounts of PLZF, a transcription factor previously associated with NK T cell development(11,12), by using lineage tracing and transfer studies. PLZF(high) cells were committed ILC progenitors with multiple ILC1, ILC2 and ILC3 potential at the clonal level. They excluded classical LTi and NK cells, but included a peculiar subset of NK1.1(+)DX5(-) 'NK-like' cells residing in the liver. Deletion of PLZF markedly altered the development of several ILC subsets, but not LTi or NK cells. PLZF(high) precursors also expressed high amounts of ID2 and GATA3, as well as TOX, a known regulator of PLZF-independent NK and LTi lineages(13). These findings establish novel lineage relationships between ILC, NK and LTi cells, and identify the common precursor to ILCs, termed ILCP. They also reveal the broad, defining role of PLZF in the differentiation of innate lymphocytes.	[Constantinides, Michael G.; McDonald, Benjamin D.; Verhoef, Philip A.; Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Constantinides, Michael/0000-0003-4770-7751	NIH [R01HL118092, R01AI038339, P30DK42086]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118092, T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108643, T32AI007090, R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Yokoyama for discussion; F. Gounari and R. de Pooter for advice on OP9 cultures; H. Gudjonson for statistical advice; D. Leclerc, J. Cao, M. Olsen and R. Duggan for help with cell sorting; V. Bindokas and R. Mathew for help with fluorescence microscopy. This work was supported by NIH grants R01HL118092, R01AI038339 and P30DK42086 and by The Howard Hughes Medical Institute (A.B.).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Constantinides MG, 2011, J IMMUNOL, V187, P309, DOI 10.4049/jimmunol.1100761; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gleimer M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00374; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	29	545	567	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					397	+		10.1038/nature13047	http://dx.doi.org/10.1038/nature13047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24509713	Green Accepted			2022-12-28	WOS:000334403000052
J	Kamel, H; Navi, BB; Sriram, N; Hovsepian, DA; Devereux, RB; Elkind, MSV				Kamel, Hooman; Navi, Babak B.; Sriram, Nandita; Hovsepian, Dominic A.; Devereux, Richard B.; Elkind, Mitchell S. V.			Risk of a Thrombotic Event after the 6-Week Postpartum Period	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; CASE-CROSSOVER; TOTAL HIP; PREGNANCY; STROKE; MANAGEMENT; PROPHYLAXIS; GUIDELINES; DESIGN	Background The postpartum state is associated with a substantially increased risk of thrombosis. It is uncertain to what extent this heightened risk persists beyond the conventionally defined 6-week postpartum period. Methods Using claims data on all discharges from nonfederal emergency departments and acute care hospitals in California, we identified women who were hospitalized for labor and delivery between January 1, 2005, and June 30, 2010. We used validated diagnosis codes to identify a composite primary outcome of ischemic stroke, acute myocardial infarction, or venous thromboembolism. We then used conditional logistic regression to assess each patient's likelihood of a first thrombotic event during sequential 6-week periods after delivery, as compared with the corresponding 6-week period 1 year later. Results Among the 1,687,930 women with a first recorded delivery, 1015 had a thrombotic event (248 cases of stroke, 47 cases of myocardial infarction, and 720 cases of venous thromboembolism) in the period of 1 year plus up to 24 weeks after delivery. The risk of primary thrombotic events was markedly higher within 6 weeks after delivery than in the same period 1 year later, with 411 events versus 38 events, for an absolute risk difference of 22.1 events (95% confidence interval [CI], 19.6 to 24.6) per 100,000 deliveries and an odds ratio of 10.8 (95% CI, 7.8 to 15.1). There was also a modest but significant increase in risk during the period of 7 to 12 weeks after delivery as compared with the same period 1 year later, with 95 versus 44 events, for an absolute risk difference of 3.0 events (95% CI, 1.6 to 4.5) per 100,000 deliveries and an odds ratio of 2.2 (95% CI, 1.5 to 3.1). Risks of thrombotic events were not significantly increased beyond the first 12 weeks after delivery. Conclusions Among patients in our study, an elevated risk of thrombosis persisted until at least 12 weeks after delivery. However, the absolute increase in risk beyond 6 weeks after delivery was low. (Funded by the National Institute of Neurological Disorders and Stroke.)	[Kamel, Hooman; Navi, Babak B.; Sriram, Nandita; Hovsepian, Dominic A.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Kamel, Hooman; Navi, Babak B.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Devereux, Richard B.] Weill Cornell Med Coll, Div Cardiol, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Coll Phys & Surg, Dept Neurol, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Cornell University; Cornell University; Cornell University; Columbia University; Columbia University	Kamel, H (corresponding author), 407 E 61st St,5th Fl, New York, NY 10065 USA.	hok9010@med.cornell.edu	Kamel, Hooman/AGG-9071-2022	Navi, Babak/0000-0001-8424-6128	National Institute of Neurological Disorders and Stroke of the NIH [K23NS082367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS082367] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the National Institute of Neurological Disorders and Stroke of the NIH (K23NS082367, to Dr. Kamel).	American Hospital Association, ANN SURV FAST FACTS; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Bushnell CD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b664; DAHLMAN T, 1985, GYNECOL OBSTET INVES, V20, P37, DOI 10.1159/000298969; Delaney JA, 2009, STAT METHODS MED RES, V18, P53, DOI 10.1177/0962280208092346; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Guyatt GH, 2012, CHEST, V142, P1698; Guyatt GH, 2012, CHEST, V141, P1129; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Henriksson P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8632; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Jaigobin C, 2000, STROKE, V31, P2948, DOI 10.1161/01.STR.31.12.2948; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kittner SJ, 1996, NEW ENGL J MED, V335, P768, DOI 10.1056/NEJM199609123351102; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kjellberg U, 1999, THROMB HAEMOSTASIS, V81, P527; LOUDEN KA, 1990, BRIT J OBSTET GYNAEC, V97, P1108, DOI 10.1111/j.1471-0528.1990.tb02498.x; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Middeldorp S, 2013, J THROMB HAEMOST, V11, P180, DOI 10.1111/jth.12266; Nazziola E, 2003, ANN EMERG MED, V42, P592, DOI 10.1067/S0196-0644(03)00389-5; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Res HS, 2001, EPIDEMIOLOGY, V12, P456, DOI 10.1097/00001648-200107000-00016; Scott CA, 2012, OBSTET GYNECOL, V120, P318, DOI 10.1097/AOG.0b013e31825f287c; Suissa S, 1998, EPIDEMIOLOGY, V9, P441, DOI 10.1097/00001648-199807000-00016; Sultan AA, 2012, BRIT J HAEMATOL, V156, P366, DOI 10.1111/j.1365-2141.2011.08956.x; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; U.S. Census Bureau, CAL STAT COUNT QUICK; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403	36	252	272	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1307	1315		10.1056/NEJMoa1311485	http://dx.doi.org/10.1056/NEJMoa1311485			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24524551	Green Accepted			2022-12-28	WOS:000333830000009
J	Ritsma, L; Ellenbroek, SIJ; Zomer, A; Snippert, HJ; de Sauvage, FJ; Simons, BD; Clevers, H; van Rheenen, J				Ritsma, Laila; Ellenbroek, Saskia I. J.; Zomer, Anoek; Snippert, Hugo J.; de Sauvage, Frederic J.; Simons, Benjamin D.; Clevers, Hans; van Rheenen, Jacco			Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging	NATURE			English	Article							SELF-RENEWAL; BMI1; DIFFERENTIATION; COMPETITION; MECHANISMS; MARKER; NICHE; LRIG1; LGR5	The rapid turnover of the mammalian intestinal epithelium is supported by stem cells located around the base of the crypt(1). In addition to the Lgr5 marker, intestinal stem cells have been associated with other markers that are expressed heterogeneously within the crypt base region(1-6). Previous quantitative clonal fate analyses have led to the proposal that homeostasis occurs as the consequence of neutral competition between dividing stem cells(7-9). However, the short-term behaviour of individual Lgr5(+) cells positioned at different locations within the crypt base compartment has not been resolved. Here we establish the short-term dynamics of intestinal stem cells using the novel approach of continuous intravital imaging of Lgr5-Confetti mice. Wefind that Lgr5(+) cells in the upper part of the niche (termed 'border cells') can be passively displaced into the transit-amplifying domain, after the division of proximate cells, implying that the determination of stem-cell fate can be uncoupled from division. Through quantitative analysis of individual clonal lineages, we show that stem cells at the crypt base, termed 'central cells', experience a survival advantage over border stem cells. However, through the transfer of stem cells between the border and central regions, all Lgr5(+) cells are endowed with long-term self-renewal potential. These findings establish a novel paradigm for stem-cell maintenance in which a dynamically heterogeneous cell population is able to function long term as a single stem-cell pool.	[Ritsma, Laila; Ellenbroek, Saskia I. J.; Zomer, Anoek; Clevers, Hans; van Rheenen, Jacco] Hubrecht Inst KNAW, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Ritsma, Laila; Ellenbroek, Saskia I. J.; Zomer, Anoek; Clevers, Hans; van Rheenen, Jacco] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.] Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands; [de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Simons, Benjamin D.] Univ Cambridge, Dept Phys, Cavevdish Lab, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QN, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Roche Holding; Genentech; University of Cambridge; University of Cambridge; University of Cambridge	van Rheenen, J (corresponding author), Hubrecht Inst KNAW, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu; j.vanrheenen@hubrecht.eu	Ritsma, Laila/AAZ-6620-2020; van Rheenen, Jacco/G-3655-2014; Simons, Benjamin/AAY-8920-2020; de Sauvage, Frederic/ABE-8400-2020	Ritsma, Laila/0000-0002-0214-2008; Simons, Benjamin/0000-0002-3875-7071; de Sauvage, Frederic/0000-0002-5275-2584; Ellenbroek, Saskia/0000-0001-8007-2634; Zomer, Anoek/0000-0001-7209-6476	Dutch Organization of Scientific Research (NWO) [91710330, 175.010.2007.00, 834.11.002]; Dutch Cancer Society (KWF) [HUBR 2009-4621]; Association for International Cancer Research (AICR) [13-0297]; Wellcome Trust [098357/Z/12/Z]; Worldwide Cancer Research [13-0297] Funding Source: researchfish	Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Association for International Cancer Research (AICR); Wellcome Trust(Wellcome TrustEuropean Commission); Worldwide Cancer Research	The authors would like to thank A. de Graaff from the Hubrecht Imaging Center for imaging support, all members of the van Rheenen group for useful discussions and the Hubrecht Institute animal caretakers for animal support. This work was supported by a Vidi fellowship (91710330; J.v.R.) and equipment grants (175.010.2007.00 and 834.11.002; J.v.R.) from the Dutch Organization of Scientific Research (NWO), a grant from the Dutch Cancer Society (KWF; HUBR 2009-4621; J.v.R.), a grant from the Association for International Cancer Research (AICR; 13-0297; J.v.R.), and the Wellcome Trust (grant number 098357/Z/12/Z; B.D.S.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stine RR, 2013, TRENDS CELL BIOL, V23, P357, DOI 10.1016/j.tcb.2013.03.001; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	30	330	332	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					362	+		10.1038/nature12972	http://dx.doi.org/10.1038/nature12972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24531760	Green Accepted			2022-12-28	WOS:000333029000035
J	Larsbrink, J; Rogers, TE; Hemsworth, GR; McKee, LS; Tauzin, AS; Spadiut, O; Klinter, S; Pudlo, NA; Urs, K; Koropatkin, NM; Creagh, AL; Haynes, CA; Kelly, AG; Cederholm, SN; Davies, GJ; Martens, EC; Brumer, H				Larsbrink, Johan; Rogers, Theresa E.; Hemsworth, Glyn R.; McKee, Lauren S.; Tauzin, Alexandra S.; Spadiut, Oliver; Klinter, Stefan; Pudlo, Nicholas A.; Urs, Karthik; Koropatkin, Nicole M.; Creagh, A. Louise; Haynes, Charles A.; Kelly, Amelia G.; Cederholm, Stefan Nilsson; Davies, Gideon J.; Martens, Eric C.; Brumer, Harry			A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes	NATURE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; MAXIMUM-LIKELIHOOD; CELL WALLS; MICROBIOME; PROTEINS; BACTERIA; METAGENOMICS; DEGRADATION; SPECIFICITY; RECOGNITION	A well-balanced human diet includes a significant intake of non-starch polysaccharides, collectively termed 'dietary fibre', from the cell walls of diverse fruits and vegetables(1). Owing to the paucity of alimentary enzymes encoded by the human genome(2), our ability to derive energy from dietary fibre depends on the saccharification and fermentation of complex carbohydrates by the massive microbial community residing in our distal gut(3,4). The xyloglucans (XyGs) are a ubiquitous family of highly branched plant cell wall polysaccharides(5,6) whose mechanism(s) of degradation in the human gut and consequent importance in nutrition have been unclear(1,7,8). Here we demonstrate that a single, complex gene locus in Bacteroides ovatus confers XyG catabolism in this common colonic symbiont. Through targeted gene disruption, biochemical analysis of all predicted glycoside hydrolases and carbohydrate-binding proteins, and three-dimensional structural determination of the vanguard endo-xyloglucanase, we reveal the molecular mechanisms through which XyGs are hydrolysed to component monosaccharides for further metabolism. We also observe that orthologous XyG utilization loci (XyGULs) serve as genetic markers of XyG catabolism in Bacteroidetes, that XyGULs are restricted to a limited number of phylogenetically diverse strains, and that XyGULs are ubiquitous in surveyed human metagenomes. Our findings reveal that the metabolism of even highly abundant components of dietary fibre may be mediated by niche species, which has immediate fundamental and practical implications for gut symbiont population ecology in the context of human diet, nutrition and health(9-12).	[Larsbrink, Johan; McKee, Lauren S.; Spadiut, Oliver; Klinter, Stefan; Cederholm, Stefan Nilsson; Brumer, Harry] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Div Glycosci, S-10691 Stockholm, Sweden; [Rogers, Theresa E.; Pudlo, Nicholas A.; Urs, Karthik; Koropatkin, Nicole M.; Kelly, Amelia G.; Martens, Eric C.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Hemsworth, Glyn R.; Davies, Gideon J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [McKee, Lauren S.; Spadiut, Oliver] Royal Inst Technol KTH, Wallenberg Wood Sci Ctr, S-10044 Stockholm, Sweden; [Tauzin, Alexandra S.; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Tauzin, Alexandra S.; Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada; [Creagh, A. Louise; Haynes, Charles A.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Creagh, A. Louise; Haynes, Charles A.] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V6T 1Z4, Canada	Royal Institute of Technology; University of Michigan System; University of Michigan; University of York - UK; Royal Institute of Technology; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Div Glycosci, S-10691 Stockholm, Sweden.	gideon.davies@york.ac.uk; emartens@umich.edu; brumer@msl.ubc.ca	Larsbrink, Johan/A-3053-2013; McKee, Lauren/A-2782-2013; Davies, Gideon J/A-9042-2011; Hemsworth, Glyn/AAS-5473-2021	Larsbrink, Johan/0000-0001-8386-2914; McKee, Lauren/0000-0002-3372-8773; Davies, Gideon J/0000-0002-7343-776X; Hemsworth, Glyn/0000-0002-8226-1380; Rogers, Theresa/0000-0002-9741-5768; Klinter, Stefan/0000-0003-2536-7151; Kelly, Amelia/0000-0002-0311-4885	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via CarboMat-the KTH Advanced Carbohydrate Materials Centre); Swedish Research Council (Vetenskapsradet); Wallenberg Wood Science Centre; Michael Smith Laboratories, University of British Columbia; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Biotechnology and Biological Sciences Research Council [BB/I014802/1]; National Institutes of Health [DK084214, GM099513]; Global Probiotics Council Young Investigator Grant for Probiotics Research; BBSRC [BB/I014802/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099513] Funding Source: NIH RePORTER	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via CarboMat-the KTH Advanced Carbohydrate Materials Centre)(Swedish Research Council Formas); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Wallenberg Wood Science Centre; Michael Smith Laboratories, University of British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Probiotics Council Young Investigator Grant for Probiotics Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the following colleagues for providing materials or experimental assistance: F. Vilaplana (neutral sugar analysis of XyG preparations), G. Sundqvist (protein mass spectrometry), F. Ibatullin (aryl glycoside syntheses), S. Prexler (protein production and purification), S. Tuomivaara and W. York (provision of acetylated tomato XyG samples), the staff at the University of Michigan Germfree Laboratory (technical assistance with gnotobiotic mouse experiments) and the staff at the Diamond Light Source (provision of data collection facilities). Work in Stockholm was supported by the Mizutani Foundation for Glycoscience, The Swedish Research Council Formas (via CarboMat-the KTH Advanced Carbohydrate Materials Centre), The Swedish Research Council (Vetenskapsradet; salary support to H. B.), and the Wallenberg Wood Science Centre (salary support to O.S. and L. S. M.). Work in Vancouver was supported by faculty funding from the Michael Smith Laboratories, University of British Columbia; the Natural Sciences and Engineering Research Council of Canada (Discovery Grant); the Canada Foundation for Innovation and the British Columbia Knowledge Development Fund. Work in York was supported by the Biotechnology and Biological Sciences Research Council under reference BB/I014802/1. Work in Ann Arbor was supported by National Institutes of Health grants DK084214 and GM099513; T. E. R. was supported in part by the Global Probiotics Council Young Investigator Grant for Probiotics Research awarded to E.C.M.	[Anonymous], 2003, Current Trends in Polymer Science, V8, P27; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cameron EA, 2012, J BIOL CHEM, V287, P34614, DOI 10.1074/jbc.M112.397380; Cartmell Alan, 2011, J Biol Chem, V286, P15483, DOI 10.1074/jbc.M110.215962; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cummings JH, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80252-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Greffe L, 2005, GLYCOBIOLOGY, V15, P437, DOI 10.1093/glycob/cwi013; Hartemink R, 1996, ANAEROBE, V2, P223, DOI 10.1006/anae.1996.0031; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Hsieh YSY, 2009, MOL PLANT, V2, P943, DOI 10.1093/mp/ssp061; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Ibatullin FM, 2008, BIOCHEMISTRY-US, V47, P7762, DOI 10.1021/bi8009168; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDougall GJ, 1996, J SCI FOOD AGR, V70, P133, DOI [10.1002/(SICI)1097-0010(199602)70:2&lt;133::AID-JSFA495&gt;3.0.CO;2-4, 10.1002/(SICI)1097-0010(199602)70:2<133::AID-JSFA495>3.3.CO;2-W]; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; von Schantz L, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-92; Wegmann U., 2013, ENV MICROBIOL; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	59	297	318	8	265	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					498	+		10.1038/nature12907	http://dx.doi.org/10.1038/nature12907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24463512	Green Accepted			2022-12-28	WOS:000332165100040
J	Kitamura, T; Pignatelli, M; Suh, J; Kohara, K; Yoshiki, A; Abe, K; Tonegawa, S				Kitamura, Takashi; Pignatelli, Michele; Suh, Junghyup; Kohara, Keigo; Yoshiki, Atsushi; Abe, Kuniya; Tonegawa, Susumu			Island Cells Control Temporal Association Memory	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; LAYER-II; DISCONTIGUOUS EVENTS; PERSISTENT ACTIVITY; NMDA RECEPTORS; NEURONS; RAT; HIPPOCAMPUS; CA1; PROJECTION	Episodic memory requires associations of temporally discontiguous events. In the entorhinal-hippocampal network, temporal associations are driven by a direct pathway from layer III of the medial entorhinal cortex (MECIII) to the hippocampal CA1 region. However, the identification of neural circuits that regulate this association has remained unknown. In layer II of entorhinal cortex (ECII), we report clusters of excitatory neurons called island cells, which appear in a curvilinear matrix of bulblike structures, directly project to CA1, and activate interneurons that target the distal dendrites of CA1 pyramidal neurons. Island cells suppress the excitatory MECIII input through the feed-forward inhibition to control the strength and duration of temporal association in trace fear memory. Together, the two EC inputs compose a control circuit for temporal association memory.	[Kitamura, Takashi; Pignatelli, Michele; Suh, Junghyup; Kohara, Keigo; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Cambridge, MA 02139 USA; [Kitamura, Takashi; Pignatelli, Michele; Suh, Junghyup; Kohara, Keigo; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Yoshiki, Atsushi; Abe, Kuniya] RIKEN BioResource Ctr, Ibaraki 3050074, Japan; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020; Yoshiki, Atsushi/O-6162-2019; Kitamura, Takashi/AAR-7837-2021	Yoshiki, Atsushi/0000-0002-9450-5151; Kitamura, Takashi/0000-0001-5597-859X; Pignatelli, Michele/0000-0002-4918-2066	RIKEN Brain Science Institute	RIKEN Brain Science Institute	We thank K. Deisseroth (ChR2 and eArch3.0 construct) and E. Boyden (ArchT construct) for providing the plasmids; R. Neve for generating the AAV-DIO-synaptophysin-mCherry; J. Martin, C. Ragion, N. Nayyar, M. Serock, L. Sultzman, M. Ragion, L. Smith, and A. Rivest for experimental help; J. Young, C. Yokoyama, T. Ryan, R. Redondo, X. Liu, and K. Mulroy for comments; and the members of Tonegawa lab for support. This work was supported by the RIKEN Brain Science Institute.	ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Andersen P., 2007, HIPPOCAMPUS BOOK; Bertrand S, 2001, J PHYSIOL-LONDON, V532, P369, DOI 10.1111/j.1469-7793.2001.0369f.x; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310; HJORTHSIMONSEN A, 1975, J COMP NEUROL, V161, P57, DOI 10.1002/cne.901610106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kawano J, 2009, NEUROSCI RES, V64, P213, DOI 10.1016/j.neures.2009.03.005; Klink R, 1997, HIPPOCAMPUS, V7, P571; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OTTERSEN OP, 1982, J COMP NEUROL, V205, P30, DOI 10.1002/cne.902050104; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	37	197	199	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					896	901		10.1126/science.1244634	http://dx.doi.org/10.1126/science.1244634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24457215	Green Submitted, Green Accepted			2022-12-28	WOS:000331552600049
J	Hall, KB				Hall, Kathleen B.			MOLECULAR BIOLOGY Protein binding cannot subdue a lively RNA	NATURE			English	Editorial Material							CONFORMATIONAL CAPTURE; INDUCED FIT; RECOGNITION; SPECIFICITY		Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Hall, KB (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	kathleenhal@gmail.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096444] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM096444] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Haller A, 2011, NAT CHEM BIOL, V7, P393, DOI [10.1038/NCHEMBIO.562, 10.1038/nchembio.562]; HELD WA, 1974, J BIOL CHEM, V249, P3103; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575	9	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					303	304		10.1038/nature13055	http://dx.doi.org/10.1038/nature13055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522527	Green Accepted			2022-12-28	WOS:000331477800027
J	Potter, NE; Greaves, M				Potter, Nicola E.; Greaves, Mel			CANCER Persistence of leukaemic ancestors	NATURE			English	Editorial Material							STEM-CELLS; CLONAL EVOLUTION; MUTATIONS		[Potter, Nicola E.; Greaves, Mel] Inst Canc Res, Ctr Evolut & Canc, London SM2 5NG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Potter, NE (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London SM2 5NG, England.	nicola.potter@icr.ac.uk; mel.greaves@icr.ac.uk						Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	14	7	8	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					300	301		10.1038/nature13056	http://dx.doi.org/10.1038/nature13056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522525				2022-12-28	WOS:000331477800025
J	Baconguis, I; Bohlen, CJ; Goehring, A; Julius, D; Gouaux, E				Baconguis, Isabelle; Bohlen, Christopher J.; Goehring, April; Julius, David; Gouaux, Eric			X-Ray Structure of Acid-Sensing Ion Channel 1-Snake Toxin Complex Reveals Open State of a Na+-Selective Channel	CELL			English	Article							EPITHELIAL SODIUM-CHANNEL; SENSORY NEURONS; TRYPSIN-INHIBITOR; PARADOXICAL STIMULATION; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; AMILORIDE BLOCK; P2X RECEPTORS; PORE REGION; PAIN	Acid-sensing ion channels (ASICs) detect extracellular protons produced during inflammation or ischemic injury and belong to the superfamily of degenerin/epithelial sodium channels. Here, we determine the cocrystal structure of chicken ASIC1a with MitTx, a pain-inducing toxin from the Texas coral snake, to define the structure of the open state of ASIC1a. In the MitTx-bound open state and in the previously determined low-pH desensitized state, TM2 is a discontinuous alpha helix in which the Gly-Ala-Ser selectivity filter adopts an extended, belt-like conformation, swapping the cytoplasmic one-third of TM2 with an adjacent subunit. Gly 443 residues of the selectivity filter provide a ring of three carbonyl oxygen atoms with a radius of similar to 3.6 angstrom, presenting an energetic barrier for hydrated ions. The ASIC1a-MitTx complex illuminates the mechanism of MitTx action, defines the structure of the selectivity filter of voltage-independent, sodium-selective ion channels, and captures the open state of an ASIC.	[Baconguis, Isabelle; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Bohlen, Christopher J.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Baconguis, Isabelle/AAH-3790-2021	Gouaux, Eric/0000-0002-8549-2360; Baconguis, Isabelle/0000-0002-5440-2289	National Research Service Awards from the National Institute of Neurological Disorders and Stroke; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065597, F31NS070597, R01NS081115, R37NS038631, R01NS065071] Funding Source: NIH RePORTER	National Research Service Awards from the National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Gouaux lab and C. Jahr for helpful discussions, W. Lu for data processing, L. Vaskalis for figures, and H. Owen and J. Dieter for manuscript preparation. This work was supported by National Research Service Awards from the National Institute of Neurological Disorders and Stroke (I. B. and C. J. B.) and grants from the NIH (E. G. and D. J.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Carattino MD, 2012, J BIOL CHEM, V287, P12927, DOI 10.1074/jbc.M111.329284; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUBER R, 1970, NATURWISSENSCHAFTEN, V57, P389, DOI 10.1007/BF00599976; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Kellenberger S, 2003, MOL PHARMACOL, V64, P848, DOI 10.1124/mol.64.4.848; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Qadri YJ, 2010, J BIOL CHEM, V285, P9627, DOI 10.1074/jbc.M109.082735; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	64	204	214	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					717	729		10.1016/j.cell.2014.01.011	http://dx.doi.org/10.1016/j.cell.2014.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24507937	Green Accepted, Bronze			2022-12-28	WOS:000331379800011
J	Savioli, L				Savioli, Lorenzo			Preventive Anthelmintic Chemotherapy - Expanding the Armamentarium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEBENDAZOLE; ALBENDAZOLE; INFECTIONS; TRICHURIS		World Hlth Org, Dept Control Neglected Trop Dis, Geneva, Switzerland	World Health Organization	Savioli, L (corresponding author), World Hlth Org, Dept Control Neglected Trop Dis, Geneva, Switzerland.				World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Albonico M, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P109; Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; ALBONICO M, 1994, T ROY SOC TROP MED H, V88, P585, DOI 10.1016/0035-9203(94)90174-0; [Anonymous], 2013, 2012 POP HOUS CENS; [Anonymous], 2006, PREV CHEM HUM HELM C; Geerts S, 1997, PARASITOL TODAY, V13, P149, DOI 10.1016/S0169-4758(97)01024-7; Mackenzie CD, 2011, EXPERT REV ANTI-INFE, V9, P497, DOI [10.1586/eri.11.30, 10.1586/ERI.11.30]; Speich B, 2014, NEW ENGL J MED, V370, P610, DOI 10.1056/NEJMoa1301956; Taylor MJ, 2013, PARASITOLOGY    0718; WHO, 2013, ASS EFF ANTH DRUG SC; WHO, 2013, PCT DAT	11	10	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					665	666		10.1056/NEJMe1312403	http://dx.doi.org/10.1056/NEJMe1312403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521114				2022-12-28	WOS:000331187500015
J	Taylor, G; McNeill, A; Girling, A; Farley, A; Lindson-Hawley, N; Aveyard, P				Taylor, Gemma; McNeill, Ann; Girling, Alan; Farley, Amanda; Lindson-Hawley, Nicola; Aveyard, Paul			Change in mental health after smoking cessation: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; DEPRESSION; ABSTINENCE; MECHANISMS; CIGARETTE; ATTITUDES; TOBACCO; SMOKERS; POLICY	Objective To investigate change in mental health after smoking cessation compared with continuing to smoke. Design Systematic review and meta-analysis of observational studies. Data sources Web of Science, Cochrane Central Register of Controlled Trials, Medline, Embase, and PsycINFO for relevant studies from inception to April 2012. Reference lists of included studies were hand searched, and authors were contacted when insufficient data were reported. Eligibility criteria for selecting studies Longitudinal studies of adults that assessed mental health before smoking cessation and at least six weeks after cessation or baseline in healthy and clinical populations. Results 26 studies that assessed mental health with questionnaires designed to measure anxiety, depression, mixed anxiety and depression, psychological quality of life, positive affect, and stress were included. Follow-up mental health scores were measured between seven weeks and nine years after baseline. Anxiety, depression, mixed anxiety and depression, and stress significantly decreased between baseline and follow-up in quitters compared with continuing smokers: the standardised mean differences (95% confidence intervals) were anxiety -0.37 (95% confidence interval -0.70 to -0.03); depression -0.25 (-0.37 to -0.12); mixed anxiety and depression -0.31 (-0.47 to -0.14); stress -0.27 (-0.40 to -0.13). Both psychological quality of life and positive affect significantly increased between baseline and follow-up in quitters compared with continuing smokers 0.22 (0.09 to 0.36) and 0.40 (0.09 to 0.71), respectively). There was no evidence that the effect size differed between the general population and populations with physical or psychiatric disorders. Conclusions Smoking cessation is associated with reduced depression, anxiety, and stress and improved positive mood and quality of life compared with continuing to smoke. The effect size seems as large for those with psychiatric disorders as those without. The effect sizes are equal or larger than those of antidepressant treatment for mood and anxiety disorders.	[Taylor, Gemma; Girling, Alan; Farley, Amanda] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Taylor, Gemma; McNeill, Ann; Farley, Amanda; Lindson-Hawley, Nicola; Aveyard, Paul] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies Epidemiol & Publ, Nottingham NG5 1PB, England; [McNeill, Ann] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Lindson-Hawley, Nicola; Aveyard, Paul] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England	University of Birmingham; University of Nottingham; University of London; King's College London; University of Oxford	Taylor, G (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	GMT181@bham.ac.uk; paul.aveyard@phc.ox.ac.uk	Naughton, Felix/B-4177-2011	Naughton, Felix/0000-0001-9790-2796; Lindson, Nicola/0000-0003-2539-9268; McNeill, Ann/0000-0002-6223-4000; Girling, Alan/0000-0003-2022-045X; Aveyard, Paul/0000-0002-1802-4217; Taylor, Gemma/0000-0003-2185-0162	National Coordinating Centre for Research; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Department of Health; UK Clinical Research Collaboration; National Coordinating Centre for Research Capacity Development scholarship; National Institute for Health Research Health Technology Assessment HTA programme [09/110/01]; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	National Coordinating Centre for Research; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; UK Clinical Research Collaboration; National Coordinating Centre for Research Capacity Development scholarship; National Institute for Health Research Health Technology Assessment HTA programme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a National Coordinating Centre for Research Capacity Development scholarship. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the Department of Health, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. GT is funded by a National Coordinating Centre for Research Capacity Development scholarship. NL-H is funded by a research grant awarded by the National Institute for Health Research Health Technology Assessment HTA programme (09/110/01).	[Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Banham L, 2010, ADDICTION, V105, P1176, DOI 10.1111/j.1360-0443.2010.02946.x; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Bjorngaard JH, 2013, PSYCHOL MED, V43, P711, DOI 10.1017/S0033291712001274; Bower P, 2013, BMJ-BRIT MED J, V346, pf450; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Clancy N, 2013, FAM PRACT, V30, P587, DOI 10.1093/fampra/cmt032; Coulthard M, 2002, TOBACCO ALCOHOL DRUG; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Fidler JA, 2009, NICOTINE TOB RES, V11, P1182, DOI 10.1093/ntr/ntp120; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Guthrie SK, 2004, PROG NEURO-PSYCHOPH, V28, P617, DOI 10.1016/j.pnpbp.2004.01.005; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hughes JR, 2010, NICOTINE TOB RES, V12, P756, DOI 10.1093/ntr/ntq078; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Hunot V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001848; Johnson JL, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-23; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kerr S, 2006, HEALTH SOC CARE COMM, V14, P572, DOI 10.1111/j.1365-2524.2006.00659.x; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Lawn SJ, 2002, SOC SCI MED, V54, P93, DOI 10.1016/S0277-9536(01)00008-9; Lerman C, 1996, ADDICT BEHAV, V21, P9, DOI 10.1016/0306-4603(95)00032-1; Lightwood J, 2000, TOBACCO CONTROL DEV, P63; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mamedel M, 2007, J NUCL MED, V48, P1829, DOI 10.2967/jnumed.107.043471; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; McEwen A, 2008, NICOTINE TOB RES, V10, P843, DOI 10.1080/14622200802027248; McNally L, 2006, J PUBLIC HEALTH-UK, V28, P192, DOI 10.1093/pubmed/fdl029; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; National Institute for Health and Clinical Excellence, 2011, GEN ANX DIS AD MAN P; Parrott AC, 1999, AM PSYCHOL, V54, P817, DOI 10.1037/0003-066X.54.10.817; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Prochaska J, 2013, AM J PUBLIC HLTH; Royal College of Physicians Royal College of Psychiatrists, 2013, SMOK MENT HLTH; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson B, 2003, NICOTINE TOB RES, V5, P923, DOI 10.1080/14622200310001615277; U.S. Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; *US DEP HHS, 1990, HLTH BEN SMOK CESS; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; West R, 2001, ADDICTION, V96, P891, DOI 10.1046/j.1360-0443.2001.96689110.x; World Health Organization, 2019, WHO REPORT GLOBAL TO; Zhou XL, 2009, ADDICT BEHAV, V34, P365, DOI 10.1016/j.addbeh.2008.11.013	46	531	536	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2014	348								g1151	10.1136/bmj.g1151	http://dx.doi.org/10.1136/bmj.g1151			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA9WZ	24524926	Green Published, hybrid			2022-12-28	WOS:000331445000002
J	Verma, AA; Razak, F; Detsky, AS				Verma, Amol A.; Razak, Fahad; Detsky, Allan S.			Understanding Choice Why Physicians Should Learn Prospect Theory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL LUNG-CANCER; CARE; CHEMOTHERAPY; PREFERENCES; DECISIONS; SURVIVAL; HEALTH		[Verma, Amol A.; Razak, Fahad; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Razak, Fahad] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Razak, Fahad] Harvard Ctr Populat & Dev Studies, Boston, MA USA; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca		Verma, Amol/0000-0001-6857-931X				Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Klastersky J, 2001, LUNG CANCER-J IASLC, V34, pS95; Latimer AE, 2008, BRIT J HEALTH PSYCH, V13, P659, DOI 10.1348/135910707X246186; Rivers SE, 2005, J HEALTH PSYCHOL, V10, P65, DOI 10.1177/1359105305048556; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Winter L, 2007, SOC SCI MED, V65, P1695, DOI 10.1016/j.socscimed.2007.06.012	9	31	31	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					571	572		10.1001/jama.2013.285245	http://dx.doi.org/10.1001/jama.2013.285245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519293				2022-12-28	WOS:000330941000009
J	Laroche, D; Gervais, G; Lilly, MP; Reno, JL				Laroche, D.; Gervais, G.; Lilly, M. P.; Reno, J. L.			1D-1D Coulomb Drag Signature of a Luttinger Liquid	SCIENCE			English	Article							SPIN-CHARGE SEPARATION; QUANTUM WIRES; CARBON NANOTUBES; SYSTEMS	One-dimensional (1D) interacting electronic systems exhibit distinct properties when compared to their counterparts in higher dimensions. We report Coulomb drag measurements between vertically integrated quantum wires separated by a barrier only 15 nanometers wide. The temperature dependence of the drag resistance is measured in the true 1D regime where both wires have less than one 1D subband occupied. As a function of temperature, an upturn in the drag resistance is observed below a temperature T* similar to 1.6 kelvin. This crossover in Coulomb drag behavior is consistent with Tomonaga-Luttinger liquid models for the 1D-1D drag between quantum wires.	[Laroche, D.; Gervais, G.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Laroche, D.; Lilly, M. P.; Reno, J. L.] Sandia Natl Labs, Ctr Integrated Nanotechnol, Albuquerque, NM 87185 USA	McGill University; United States Department of Energy (DOE); Sandia National Laboratories	Gervais, G (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	gervais@physics.mcgill.ca		Laroche, Dominique/0000-0003-1121-3821	Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy (DOE); U.S. DOE's National Nuclear Security Administration [DE-AC04-94AL85000]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute For Advanced Research (CIFAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. DOE's National Nuclear Security Administration(National Nuclear Security Administration); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute For Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	We acknowledge the technical assistance of D. Tibbetts and J. Hedberg and we thank I. Affleck for illuminating discussions. This work has been supported by the Division of Materials Sciences and Engineering, Office of Basic Energy Sciences, U.S. Department of Energy (DOE). This work was performed, in part, at the Center for Integrated Nanotechnologies, a U.S. DOE, Office of Basic Energy Sciences, user facility. Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. DOE's National Nuclear Security Administration under contract DE-AC04-94AL85000. We also acknowledge the financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Institute For Advanced Research (CIFAR), and the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). All data and fabrication recipes presented in this work are available upon request to G.G.	Auslaender OM, 2005, SCIENCE, V308, P88, DOI 10.1126/science.1107821; Auslaender OM, 2000, PHYS REV LETT, V84, P1764, DOI 10.1103/PhysRevLett.84.1764; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Braunecker B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165119; Debray P, 2001, J PHYS-CONDENS MAT, V13, P3389, DOI 10.1088/0953-8984/13/14/312; Dmitriev AP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245402; Fiete GA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165104; Flensberg K, 1998, PHYS REV LETT, V81, P184, DOI 10.1103/PhysRevLett.81.184; Fuchs T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045321; GRAMILA TJ, 1991, PHYS REV LETT, V66, P1216, DOI 10.1103/PhysRevLett.66.1216; HALDANE FDM, 1981, PHYS REV LETT, V47, P1840, DOI 10.1103/PhysRevLett.47.1840; Ishii H, 2003, NATURE, V426, P540, DOI 10.1038/nature02074; Klesse R, 2000, PHYS REV B, V62, P16912, DOI 10.1103/PhysRevB.62.16912; Laroche D, 2011, NAT NANOTECHNOL, V6, P793, DOI [10.1038/NNANO.2011.182, 10.1038/nnano.2011.182]; Levchenko A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.216806; Mortensen NA, 2001, PHYS REV LETT, V86, P1841, DOI 10.1103/PhysRevLett.86.1841; Narozhny BN, 2000, PHYS REV LETT, V84, P5383, DOI 10.1103/PhysRevLett.84.5383; Nazarov YV, 1998, PHYS REV LETT, V81, P653, DOI 10.1103/PhysRevLett.81.653; Peguiron J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086404; Ponomarenko VV, 2000, PHYS REV LETT, V85, P4928, DOI 10.1103/PhysRevLett.85.4928; Pustilnik M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126805; Sanchez R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076801; Steinberg H, 2008, NAT PHYS, V4, P116, DOI 10.1038/nphys810; Yamamoto M, 2006, SCIENCE, V313, P204, DOI 10.1126/science.1126601	27	54	54	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					631	634		10.1126/science.1244152	http://dx.doi.org/10.1126/science.1244152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24457214	Green Published, Green Submitted			2022-12-28	WOS:000330724000036
J	Meng, GN; Paulose, J; Nelson, DR; Manoharan, VN				Meng, Guangnan; Paulose, Jayson; Nelson, David R.; Manoharan, Vinothan N.			Elastic Instability of a Crystal Growing on a Curved Surface	SCIENCE			English	Article							GRAIN-BOUNDARY SCARS; LIPID VESICLES; SOLID DOMAINS; VISUALIZATION; STABILITY; GROWTH; PHASES	Although the effects of kinetics on crystal growth are well understood, the role of substrate curvature is not yet established. We studied rigid, two-dimensional colloidal crystals growing on spherical droplets to understand how the elastic stress induced by Gaussian curvature affects the growth pathway. In contrast to crystals grown on flat surfaces or compliant crystals on droplets, these crystals formed branched, ribbon-like domains with large voids and no topological defects. We show that this morphology minimizes the curvature-induced elastic energy. Our results illustrate the effects of curvature on the ubiquitous process of crystallization, with practical implications for nanoscale disorder-order transitions on curved manifolds, including the assembly of viral capsids, phase separation on vesicles, and crystallization of tetrahedra in three dimensions.	[Meng, Guangnan; Nelson, David R.; Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Paulose, Jayson; Nelson, David R.; Manoharan, Vinothan N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Manoharan, VN (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	vnm@seas.harvard.edu	Manoharan, Vinothan N/C-1292-2008	Manoharan, Vinothan N/0000-0003-0370-6095; Paulose, Jayson/0000-0002-4014-9817	Harvard Materials Research Science and Engineering Center through NSF [DMR-0820484]	Harvard Materials Research Science and Engineering Center through NSF	We thank F. Spaepen for helpful discussions. Supported by the Harvard Materials Research Science and Engineering Center through NSF grant DMR-0820484.	ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Bandekar A, 2012, LANGMUIR, V28, P4113, DOI 10.1021/la204765r; Bao HX, 2011, ADV MATER, V23, P2644, DOI 10.1002/adma.201100698; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; BERNAL JD, 1964, PROC R SOC LON SER-A, V280, P299, DOI 10.1098/rspa.1964.0147; Bruss IR, 2012, P NATL ACAD SCI USA, V109, P10781, DOI 10.1073/pnas.1205606109; Chushak Y, 2005, EUROPHYS LETT, V72, P767, DOI 10.1209/epl/i2005-10307-8; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; Klug WS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168104; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; LANGER JS, 1980, REV MOD PHYS, V52, P1, DOI 10.1103/RevModPhys.52.1; Libbrecht KG, 2005, REP PROG PHYS, V68, P855, DOI 10.1088/0034-4885/68/4/R03; Lipowsky P, 2005, NAT MATER, V4, P407, DOI 10.1038/nmat1376; LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0; Luque A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4712304; Majidi C, 2008, P R SOC A, V464, P1309, DOI 10.1098/rspa.2007.0341; Morozov AY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041925; MULLINS WW, 1964, J APPL PHYS, V35, P444, DOI 10.1063/1.1713333; MULLINS WW, 1963, J APPL PHYS, V34, P323, DOI 10.1063/1.1702607; Nelson D., 2002, DEFECTS AND GEOMETRY; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797; Roth R, 1999, PHYS REV LETT, V83, P448, DOI 10.1103/PhysRevLett.83.448; Schneider S, 2005, EUROPHYS LETT, V70, P136, DOI 10.1209/epl/i2004-10464-2; SKJELTORP AT, 1987, PHYS REV LETT, V58, P1444, DOI 10.1103/PhysRevLett.58.1444; Steno N., 1916, THE PRODROMUS OF NIC; Sunagawa I., 2005, CRYSTALS GROWTH MORP	30	168	169	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					634	637		10.1126/science.1244827	http://dx.doi.org/10.1126/science.1244827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503849	Green Submitted			2022-12-28	WOS:000330724000037
J	Vyleta, NP; Jonas, P				Vyleta, Nicholas P.; Jonas, Peter			Loose Coupling Between Ca2+ Channels and Release Sensors at a Plastic Hippocampal Synapse	SCIENCE			English	Article							SHORT-TERM PLASTICITY; MOSSY FIBER SYNAPSES; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; RAT HIPPOCAMPUS; BUFFER SATURATION; PYRAMIDAL CELLS; CALCIUM INFLUX; ACTIVE ZONE; FACILITATION	The distance between Ca2+ channels and release sensors determines the speed and efficacy of synaptic transmission. Tight "nanodomain" channel-sensor coupling initiates transmitter release at synapses in the mature brain, whereas loose "microdomain" coupling appears restricted to early developmental stages. To probe the coupling configuration at a plastic synapse in the mature central nervous system, we performed paired recordings between mossy fiber terminals and CA3 pyramidal neurons in rat hippocampus. Millimolar concentrations of both the fast Ca2+ chelator BAPTA [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] and the slow chelator EGTA efficiently suppressed transmitter release, indicating loose coupling between Ca2+ channels and release sensors. Loose coupling enabled the control of initial release probability by fast endogenous Ca2+ buffers and the generation of facilitation by buffer saturation. Thus, loose coupling provides the molecular framework for presynaptic plasticity.	[Vyleta, Nicholas P.; Jonas, Peter] IST Austria Inst Sci & Technol Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Jonas, P (corresponding author), IST Austria Inst Sci & Technol Austria, Campus 1, A-3400 Klosterneuburg, Austria.	peter.jonas@ist.ac.at		Jonas, Peter/0000-0001-5001-4804	Fond zur Forderung der Wissenschaftlichen Forschung [P 24909-B24]; European Union (European Research Council) [268548]	Fond zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); European Union (European Research Council)(European Research Council (ERC)European Commission)	We thank E. Neher and R. Shigemoto for critically reading the manuscript, F. Marr and M. Duggan for technical assistance, A. Solymosi for manuscript editing, and the scientific service units of IST Austria for efficient help. Supported by the Fond zur Forderung der Wissenschaftlichen Forschung (P 24909-B24) and the European Union (European Research Council Advanced Grant 268548 to P.J.).	ADLER EM, 1991, J NEUROSCI, V11, P1496; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Eggermann E, 2012, NAT NEUROSCI, V15, P20, DOI 10.1038/nn.3002; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 2002, J NEUROSCI, V22, P10524; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nadkarni S, 2012, P NATL ACAD SCI USA, V109, P14657, DOI 10.1073/pnas.1211971109; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmidt H, 2013, CURR BIOL, V23, P244, DOI 10.1016/j.cub.2012.12.007; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Scimemi A, 2012, J NEUROSCI, V32, P18157, DOI 10.1523/JNEUROSCI.3827-12.2012; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; Thanawala MS, 2013, J NEUROSCI, V33, P4625, DOI 10.1523/JNEUROSCI.4031-12.2013; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	43	119	119	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					665	670		10.1126/science.1244811	http://dx.doi.org/10.1126/science.1244811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503854				2022-12-28	WOS:000330724000044
J	Mills, A				Mills, Anne			Health Care Systems in Low- and Middle-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NATIONAL INCENTIVE PROGRAM; PROMOTE SAFE DELIVERY; PAYMENT; IMPACT; POLICY	Health care systems need organizational direction, physical plants, and fiscal resources to deliver services to their constituents. This article addresses how or whether these needs are being met in low- and middle-income countries. Over the past 10 years, debates on global health have paid increasing attention to the importance of health care systems, which encompass the institutions, organizations, and resources (physical, financial, and human) assembled to deliver health care services that meet population needs. It has become especially important to emphasize health care systems in low- and middle-income countries because of the substantial external funding provided for disease-specific programs, especially for drugs and medical supplies, and the relative underfunding of the broader health care infrastructures in these countries.(1) A functioning health care system is fundamental to the achievement of universal coverage for health ...	[Mills, Anne] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Mills, A (corresponding author), Keppel St, London WC1E 7HT, England.	anne.mills@lshtm.ac.uk		Mills, Anne/0000-0001-9863-9950				Abiiro GA, 2013, HEALTH POLICY PLANN, V28, P263, DOI 10.1093/heapol/czs059; [Anonymous], 2009, CONSTR SCAL COSTS; [Anonymous], 2013, COUNTD 2015 ACC MAT; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bosch-Capblanch X, 2011, COCHRANE DB SYST REV, V9; Broomberg J, 1997, PRIVATE HLTH PROVIDE; Gilson L, 2011, HLTH SYSTEMS LOW MID; Gilson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001079; Hanson K, 2003, J INT DEV, V15, P1, DOI DOI 10.1002/JID.963; High Level Expert Group, 2011, REP UN HLTH COV IND; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008133; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; McMaster University, HLTH SYST EV; Mills A, 2011, GLOBAL HLTH DIS PROG, P615; Mills A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P87; National Department of Health, 2011, GREEN PAP NAT HLTH I; Oxman Andrew D, 2009, J Evid Based Med, V2, P70, DOI 10.1111/j.1756-5391.2009.01020.x; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Powell-Jackson T, 2009, ADV HEALTH ECON HEAL, V21, P221, DOI 10.1108/S0731-2199(2009)0000021012; Powell-Jackson T., 2011, FINANCIAL INCENTIVES; Powell-Jackson T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-97; Savedoff WD, 2011, INCENTIVE PROLIFERAT; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Unger JP, 2009, REPROD HEALTH MATTER, V17, P91, DOI 10.1016/S0968-8080(09)33460-6; WHO, 2010, WOR HEALT REP, P1; WHO, GLOB HLTH EXP DAT; World Health Organization, UN HLTH COV	32	275	278	7	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					552	557		10.1056/NEJMra1110897	http://dx.doi.org/10.1056/NEJMra1110897			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499213	Green Accepted			2022-12-28	WOS:000331073500011
J	Wang, D; Pan, K; Subedi, R; Deng, X; Ahmed, Z; Allada, K; Aniol, KA; Armstrong, DS; Arrington, J; Bellini, V; Beminiwattha, R; Benesch, J; Benmokhtar, F; Bertozzi, W; Camsonne, A; Canan, M; Cates, GD; Chen, JP; Chudakov, E; Cisbani, E; Dalton, MM; de Jager, CW; De Leo, R; Deconinck, W; Deur, A; Dutta, C; El Fassi, L; Erler, J; Flay, D; Franklin, GB; Friend, M; Frullani, S; Garibaldi, F; Gilad, S; Giusa, A; Glamazdin, A; Golge, S; Grimm, K; Hafidi, K; Hansen, JO; Higinbotham, DW; Holmes, R; Holmstrom, T; Holt, RJ; Huang, J; Hyde, CE; Jen, CM; Jones, D; Kang, H; King, PM; Kowalski, S; Kumar, KS; Lee, JH; LeRose, JJ; Liyanage, N; Long, E; McNulty, D; Margaziotis, DJ; Meddi, F; Meekins, DG; Mercado, L; Meziani, ZE; Michaels, R; Mihovilovic, M; Muangma, N; Myers, KE; Nanda, S; Narayan, A; Nelyubin, V; Nuruzzaman; Oh, Y; Parno, D; Paschke, KD; Phillips, SK; Qian, X; Qiang, Y; Quinn, B; Rakhman, A; Reimer, PE; Rider, K; Riordan, S; Roche, J; Rubin, J; Russo, G; Saenboonruang, K; Saha, A; Sawatzky, B; Shahinyan, A; Silwal, R; Sirca, S; Souder, PA; Suleiman, R; Sulkosky, V; Sutera, CM; Tobias, WA; Urciuoli, GM; Waidyawansa, B; Wojtsekhowski, B; Ye, L; Zhao, B; Zheng, X				Wang, D.; Pan, K.; Subedi, R.; Deng, X.; Ahmed, Z.; Allada, K.; Aniol, K. A.; Armstrong, D. S.; Arrington, J.; Bellini, V.; Beminiwattha, R.; Benesch, J.; Benmokhtar, F.; Bertozzi, W.; Camsonne, A.; Canan, M.; Cates, G. D.; Chen, J. -P.; Chudakov, E.; Cisbani, E.; Dalton, M. M.; de Jager, C. W.; De Leo, R.; Deconinck, W.; Deur, A.; Dutta, C.; El Fassi, L.; Erler, J.; Flay, D.; Franklin, G. B.; Friend, M.; Frullani, S.; Garibaldi, F.; Gilad, S.; Giusa, A.; Glamazdin, A.; Golge, S.; Grimm, K.; Hafidi, K. D.; Hansen, J. O.; Higinbotham, D. W.; Holmes, R.; Holmstrom, T.; Holt, R. J.; Huang, J.; Hyde, C. E.; Jen, C. M.; Jones, D.; Kang, Hoyoung; King, P. M.; Kowalski, S.; Kumar, K. S.; Lee, J. H.; LeRose, J. J.; Liyanage, N.; Long, E.; McNulty, D.; Margaziotis, D. J.; Meddi, F.; Meekins, D. G.; Mercado, L.; Meziani, Z. -E.; Michaels, R.; Mihovilovic, M.; Muangma, N.; Myers, K. E.; Nanda, S.; Narayan, A.; Nelyubin, V.; Nuruzzaman; Oh, Y.; Parno, D.; Paschke, K. D.; Phillips, S. K.; Qian, X.; Qiang, Y.; Quinn, B.; Rakhman, A.; Reimer, P. E.; Rider, K.; Riordan, S.; Roche, J.; Rubin, J.; Russo, G.; Saenboonruang, K.; Saha, A.; Sawatzky, B.; Shahinyan, A.; Silwal, R.; Sirca, S.; Souder, P. A.; Suleiman, R.; Sulkosky, V.; Sutera, C. M.; Tobias, W. A.; Urciuoli, G. M.; Waidyawansa, B.; Wojtsekhowski, B.; Ye, L.; Zhao, B.; Zheng, X.		Jefferson Lab PVDIS Collaboration	Measurement of parity violation in electron-quark scattering	NATURE			English	Article							CONTACT INTERACTIONS; WEAK; CONSERVATION; COLLISIONS; NONCONSERVATION; SYMMETRIES; SEARCH; TESTS	Symmetry permeates nature and is fundamental to all laws of physics. One example is parity (mirror) symmetry, which implies that flipping left and right does not change the laws of physics. Laws for electromagnetism, gravity and the subatomic strong force respect parity symmetry, but the subatomic weak force does not(1,2). Historically, parity violation in electron scattering has been important in establishing (and now testing) the standard model of particle physics. One particular set of quantities accessible through measurements of parity-violating electron scattering are the effective weak couplings C-2q, sensitive to the quarks' chirality preference when participating in the weak force, which have been measured directly(3,4) only once in the past 40 years. Here we report a measurement of the parity-violating asymmetry in electron-quark scattering, which yields a determination of 2C(2u)-C-2d (where u and d denote up and down quarks, respectively) with a precision increased by a factor of five relative to the earlier result. These results provide evidence with greater than 95 per cent confidence that the C-2q couplings are non-zero, as predicted by the electroweak theory. They lead to constraints on new parity-violating interactions beyond the standard model, particularly those due to quark chirality. Whereas contemporary particle physics research is focused on high-energy colliders such as the Large Hadron Collider, our results provide specific chirality information on electroweak theory that is difficult to obtain at high energies. Our measurement is relatively free of ambiguity in its interpretation, and opens the door to even more precise measurements in the future.	[Wang, D.; Subedi, R.; Deng, X.; Cates, G. D.; Dalton, M. M.; de Jager, C. W.; Jones, D.; Liyanage, N.; Nelyubin, V.; Paschke, K. D.; Riordan, S.; Saenboonruang, K.; Silwal, R.; Tobias, W. A.; Zheng, X.] Univ Virginia, Charlottesville, VA 22904 USA; [Pan, K.; Bertozzi, W.; Deconinck, W.; Gilad, S.; Huang, J.; Kowalski, S.; Muangma, N.; Sulkosky, V.] MIT, Cambridge, MA 02139 USA; [Ahmed, Z.; Holmes, R.; Jen, C. M.; Rakhman, A.; Souder, P. A.] Syracuse Univ, Syracuse, NY 13244 USA; [Allada, K.; Dutta, C.] Univ Kentucky, Lexington, KY 40506 USA; [Aniol, K. A.; Margaziotis, D. J.] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA; [Armstrong, D. S.; Lee, J. H.; Zhao, B.] Coll William & Mary, Williamsburg, VA 23187 USA; [Arrington, J.; Holt, R. J.; Reimer, P. E.; Rubin, J.] Argonne Natl Lab, Div Phys, Argonne, IL 60439 USA; [Bellini, V.; Giusa, A.; Russo, G.; Sutera, C. M.] Univ Catania, Ist Nazl Fis Nucl, Dipt Fis, I-95123 Catania, Italy; [Beminiwattha, R.; King, P. M.; Lee, J. H.; Roche, J.; Waidyawansa, B.] Ohio Univ, Athens, OH 45701 USA; [Benesch, J.; Camsonne, A.; Chen, J. -P.; Chudakov, E.; de Jager, C. W.; Deur, A.; Hansen, J. O.; Higinbotham, D. W.; LeRose, J. J.; Meekins, D. G.; Michaels, R.; Nanda, S.; Saha, A.; Sawatzky, B.; Suleiman, R.; Wojtsekhowski, B.] Thomas Jefferson Natl Accelerator Facil, Newport News, VA 23606 USA; [Benmokhtar, F.; Franklin, G. B.; Friend, M.; Parno, D.; Quinn, B.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Canan, M.; Golge, S.; Hyde, C. E.] Old Dominion Univ, Norfolk, VA 23529 USA; [Cisbani, E.; Frullani, S.; Garibaldi, F.] Ist Nazl Fis Nucl, Sez Roma, Grp Sanita, I-00161 Rome, Italy; [Cisbani, E.; Frullani, S.; Garibaldi, F.] Ist Super Sanita, I-00161 Rome, Italy; [De Leo, R.] Univ Bari, I-70126 Bari, Italy; [El Fassi, L.] Rutgers State Univ, Newark, NJ 07102 USA; [Erler, J.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico; [Flay, D.; Meziani, Z. -E.] Temple Univ, Philadelphia, PA 19122 USA; [Glamazdin, A.] Kharkov Phys & Technol Inst, UA-61108 Kharkov, Ukraine; [Grimm, K.] Louisiana Tech Univ, Ruston, LA 71272 USA; [Holmstrom, T.; Rider, K.] Longwood Univ, Farmville, VA 23909 USA; [Hyde, C. E.] Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire, FR-63000 Clermont Ferrand, France; [Kang, Hoyoung; Oh, Y.] Seoul Natl Univ, Seoul 151742, South Korea; [Kumar, K. S.; McNulty, D.; Mercado, L.] Univ Massachusetts, Amherst, MA 01003 USA; [Long, E.] Kent State Univ, Kent, OH 44242 USA; [Meddi, F.; Urciuoli, G. M.] Ist Nazl Fis Nucl, Sez Roma, I-00161 Rome, Italy; [Meddi, F.; Urciuoli, G. M.] Univ Roma La Sapienza, I-00161 Rome, Italy; [Mihovilovic, M.; Sirca, S.] Jozef Stefan Inst, SI-1001 Ljubljana, Slovenia; [Myers, K. E.] George Washington Univ, Washington, DC 20052 USA; [Narayan, A.; Nuruzzaman] Mississippi State Univ, Starkeville, MS 39762 USA; [Phillips, S. K.] Univ New Hampshire, Durham, NH 03824 USA; [Qian, X.; Qiang, Y.] Duke Univ, Durham, NC 27708 USA; [Shahinyan, A.] Yerevan Phys Inst, Yerevan 0036, Armenia; [Ye, L.] China Inst Atom Energy, Beijing 102413, Peoples R China	University of Virginia; Massachusetts Institute of Technology (MIT); Syracuse University; University of Kentucky; California State University System; California State University Los Angeles; William & Mary; United States Department of Energy (DOE); Argonne National Laboratory; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; University System of Ohio; Ohio University; United States Department of Energy (DOE); Jefferson National Accelerator; Carnegie Mellon University; Old Dominion University; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Superiore di Sanita (ISS); Universita degli Studi di Bari Aldo Moro; Rutgers State University Newark; Rutgers State University New Brunswick; Universidad Nacional Autonoma de Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Kharkov Institute of Physics & Technology; University of Louisiana System; Louisiana Technical University; Longwood University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Seoul National University (SNU); University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; George Washington University; Mississippi State University; University System Of New Hampshire; University of New Hampshire; Duke University; Yerevan Physics Institute; China Institute of Atomic Energy	Zheng, X (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.	xz5y@virginia.edu	Arrington, John R/D-1116-2012; Reimer, Paul E/E-2223-2013; Hyde, Charles E/W-9190-2018; Higinbotham, Douglas W./J-9394-2014; Giusa, Antonio/G-5508-2012; Wang, Diancheng/W-4600-2018; Suleiman, Riad/AAG-3389-2019; Narayan, Amrendra/GWV-6315-2022; Cisbani, Evaristo/C-9249-2011; Franklin, Gregg B/N-7743-2014; Long, Elena Amanda/HCH-3587-2022; Paschke, Kent/AAJ-8801-2020; BELLINI, Vincenzo/B-1239-2012; Quinn, Brian P/N-7343-2014; Dalton, Mark/B-5380-2016; Deur, Alexandre/H-9778-2019; Deconinck, Wouter/F-4054-2012; Pan, Kai/D-4241-2016; Rakhman, Adurahim/K-8146-2012; Mesick, Katherine/M-3495-2014; Narayan, Amrendra/Q-3243-2016; Parno, Diana/B-7546-2017; Beminiwattha, Rakitha/K-5685-2013	Arrington, John R/0000-0002-0702-1328; Reimer, Paul E/0000-0002-0301-2176; Hyde, Charles E/0000-0001-7282-8120; Higinbotham, Douglas W./0000-0003-2758-6526; Giusa, Antonio/0000-0002-5142-0043; Cisbani, Evaristo/0000-0002-6774-8473; Franklin, Gregg B/0000-0003-4176-1378; Long, Elena Amanda/0000-0001-9272-7183; BELLINI, Vincenzo/0000-0001-6906-7463; Quinn, Brian P/0000-0003-2800-986X; Dalton, Mark/0000-0001-9204-7559; Deur, Alexandre/0000-0002-2203-7723; Deconinck, Wouter/0000-0003-4033-6716; Pan, Kai/0000-0001-9930-5063; Rakhman, Adurahim/0000-0002-9880-6074; Mesick, Katherine/0000-0001-6138-1474; Narayan, Amrendra/0000-0003-3814-9559; Parno, Diana/0000-0002-9363-0401; Glamazdin, Alexander/0000-0002-4172-7324; Saenboonruang, Kiadtisak/0000-0001-7401-3654; King, Paul/0000-0002-3448-2306; Meziani, Zein-Eddine/0000-0001-9450-2914; Lee, Jeong Han/0000-0002-1699-2660; Beminiwattha, Rakitha/0000-0002-1473-1651; Kang, Hoyoung/0000-0001-7074-7220; Qian, Xin/0000-0002-7903-7935; Roche, Julie/0000-0003-1913-3308; Erler, Jens/0000-0002-8311-6644; Qiang, Yi/0000-0001-7026-7841; Jen, Chun-Min/0000-0003-4070-8866; Hansen, Jens-Ole/0000-0002-7908-3886; Huang, Jin/0000-0002-6261-6172; Benmokhtar, Fatiha/0000-0003-3670-4045	Medium Energy Physics Group at the Argonne National Laboratory; PAPIIT (DGAPAUNAM) [IN106913]; CONACyT (Mexico) [151234]; Mainz Institute for Theoretical Physics (MITP); Jeffress Memorial Trust [J-836]; US NSF [0653347]; US DOE [DE-SC0003885, DE-AC02-06CH11357, DE-AC05-06OR23177]; Direct For Mathematical & Physical Scien [1306376] Funding Source: National Science Foundation; Division Of Physics [1068667, 1206082, 1206053] Funding Source: National Science Foundation	Medium Energy Physics Group at the Argonne National Laboratory; PAPIIT (DGAPAUNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mainz Institute for Theoretical Physics (MITP); Jeffress Memorial Trust; US NSF(National Science Foundation (NSF)); US DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the personnel of Jefferson Lab for their efforts which resulted in the successful completion of the experiment, and A. Accardi, P. Blunden, W. Melnitchouk and their collaborators for carrying out the calculations necessary for the completion of the data analysis. X.Z. thanks the Medium Energy Physics Group at the Argonne National Laboratory for support during the initial work on this experiment. J.E. was supported by PAPIIT (DGAPAUNAM) project IN106913 and CONACyT (Mexico) project 151234, and acknowledges the hospitality and support by the Mainz Institute for Theoretical Physics (MITP) where part of his work was completed. This work was supported in part by the Jeffress Memorial Trust (award no. J-836), the US NSF (award no. 0653347), and the US DOE (award nos DE-SC0003885 and DE-AC02-06CH11357). This work was authored by Jefferson Science Associates, LLC under US DOE contract no. DE-AC05-06OR23177. The US Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce this manuscript for US Government purposes.	Aad G, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.015010; Aaron FD, 2011, PHYS LETT B, V705, P52, DOI 10.1016/j.physletb.2011.09.109; Abrahamyan S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.112502; Alcorn J, 2004, NUCL INSTRUM METH A, V522, P294, DOI 10.1016/j.nima.2003.11.415; Androic D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.141803; Anthony PL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.081601; Armstrong DS, 2012, ANNU REV NUCL PART S, V62, P337, DOI 10.1146/annurev-nucl-102010-130419; Beise E, 2004, PROG PART NUCL PHYS, V54, P289, DOI 10.1016/j.ppnp.2004.07.002; Bennett SC, 1999, PHYS REV LETT, V83, P889, DOI 10.1103/PhysRevLett.83.889; CAHN RN, 1978, PHYS REV D, V17, P1313, DOI 10.1103/PhysRevD.17.1313; Chekanov S, 2004, PHYS LETT B, V591, P23, DOI 10.1016/j.physletb.2004.03.081; Czarnecki A, 2005, NATURE, V435, P437, DOI 10.1038/435437a; Dzuba VA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203003; EICHTEN EJ, 1983, PHYS REV LETT, V50, P811, DOI 10.1103/PhysRevLett.50.811; Erler J, 2013, PROG PART NUCL PHYS, V71, P119, DOI 10.1016/j.ppnp.2013.03.004; Ginges JSM, 2004, PHYS REP, V397, P63, DOI 10.1016/j.physrep.2004.03.005; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; LEE TD, 1956, PHYS REV, V104, P254, DOI 10.1103/PhysRev.104.254; Martin AD, 2009, EUR PHYS J C, V63, P189, DOI 10.1140/epjc/s10052-009-1072-5; PRESCOTT CY, 1978, PHYS LETT B, V77, P347, DOI 10.1016/0370-2693(78)90722-0; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; Schael S, 2013, PHYS REP, V532, P119, DOI 10.1016/j.physrep.2013.07.004; Subedi R, 2013, NUCL INSTRUM METH A, V724, P90, DOI 10.1016/j.nima.2013.05.040; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264; Wood CS, 1997, SCIENCE, V275, P1759, DOI 10.1126/science.275.5307.1759; WU CS, 1957, PHYS REV, V105, P1413, DOI 10.1103/PhysRev.105.1413	27	66	67	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					67	70		10.1038/nature12964	http://dx.doi.org/10.1038/nature12964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499917				2022-12-28	WOS:000330648100032
J	Tatham, KC; Patel, KP				Tatham, Kate C.; Patel, Kinesh P.			Suitability of common drugs for patients who avoid animal products	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICATION		[Tatham, Kate C.] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, London, England; [Patel, Kinesh P.] St Marks Hosp, Wolfson Unit Endoscopy, Harrow HA1 3UJ, Middx, England	Imperial College London; Imperial College London	Patel, KP (corresponding author), St Marks Hosp, Wolfson Unit Endoscopy, Harrow HA1 3UJ, Middx, England.	kinesh.patel@gmail.com	Tatham, Kate/AAB-5839-2020	Tatham, Kate/0000-0003-3080-8011				Al-Tabakha MM, 2010, J PHARM PHARM SCI, V13, P428, DOI 10.18433/J3K881; BBC News, 2013, BBC NEWS; Bendelstein Y, 2005, GELATIN REVISITED; Clery E, 2010, FOOD TECHNOLOGIES FI; National Institute for Health and Care Excellence, 2009, MED ADH CG76 NICE; RICHARDSON NJ, 1994, ECOL FOOD NUTR, V33, P1, DOI 10.1080/03670244.1994.9991412; Sattar SP, 2004, ANN PHARMACOTHER, V38, P621, DOI 10.1345/aph.1D324; Vegetarian Society, WHAT IS VEG; Vissamsetti B, 2012, POSTGRAD MED J, V88, P499, DOI 10.1136/postgradmedj-2011-130306; World Health Organization (WHO), 2001, US UNL JUR UNCL SUBS	10	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g401	10.1136/bmj.g401	http://dx.doi.org/10.1136/bmj.g401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496281				2022-12-28	WOS:000331060200015
J	Nakkash, R; Afifi, R; Maziak, W				Nakkash, Rima; Afifi, Rima; Maziak, Wasim			Research and activism for tobacco control in the Arab world	LANCET			English	Editorial Material							LEBANON; ADVOCACY; POLICY		[Nakkash, Rima; Afifi, Rima] Amer Univ Beirut, Fac Hlth Sci, WHO Collaborating Ctr Hlth Promot & Behav Sci, Dept Hlth Promot & Community Hlth, Beirut 11072020, Lebanon; [Maziak, Wasim] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA; [Maziak, Wasim] Syrian Ctr Tobacco Studies, Aleppo, Syria	American University of Beirut; State University System of Florida; Florida International University	Nakkash, R (corresponding author), Amer Univ Beirut, Fac Hlth Sci, WHO Collaborating Ctr Hlth Promot & Behav Sci, Dept Hlth Promot & Community Hlth, Beirut 11072020, Lebanon.	rn06@aub.edu.lb	Afifi, Rima A/M-5615-2016; Maziak, Wasim/V-7567-2017	Afifi, Rima A/0000-0003-3154-3617; Nakkash, Rima/0000-0001-8800-5591				Chapman S, 2001, HEALTH EDUC BEHAV, V28, P274, DOI 10.1177/109019810102800303; Mackay J, 2013, LANCET, V381, P1581, DOI 10.1016/S0140-6736(13)60854-5; Mackay J, 2013, NICOTINE TOB RES, V15, P757, DOI 10.1093/ntr/nts197; Champagne BM, 2010, SALUD PUBLICA MEXICO, V52, pS330, DOI 10.1590/S0036-36342010000800031; Maziak W, 2014, HEALTH POLICY PLANN, V29, P784, DOI 10.1093/heapol/czt055; Nakkash R, 2008, TOB CONTROL, V17, P324, DOI 10.1136/tc.2008.025254; Nakkash R, 2009, TOB CONTROL, V18, P310, DOI 10.1136/tc.2008.029405; Nakkash RT, 2010, ASIA-PAC J PUBLIC HE, V22, p168S, DOI 10.1177/1010539510373020; Novotny TE, 2008, HLTH NUTR POPULATION; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Salti N, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2012-050703, DOI 10.1136/T0BACC0C0NTR0L-2012-050703]; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					392	393		10.1016/S0140-6736(13)62381-8	http://dx.doi.org/10.1016/S0140-6736(13)62381-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24452050				2022-12-28	WOS:000330673700009
J	Carter, M				Carter, Meg			Last gasp for e-cigarette ads that glamorise the habit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com							0	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2014	348								g475	10.1136/bmj.g475	http://dx.doi.org/10.1136/bmj.g475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AT	24470628				2022-12-28	WOS:000330647400018
J	Arvidson, RE; Squyres, SW; Bell, JF; Catalano, JG; Clark, BC; Crumpler, LS; de Souza, PA; Fairen, AG; Farrand, WH; Fox, VK; Gellert, R; Ghosh, A; Golombek, MP; Grotzinger, JP; Guinness, EA; Herkenhoff, KE; Jolliff, BL; Knoll, AH; Li, R; McLennan, SM; Ming, DW; Mittlefehldt, DW; Moore, JM; Morris, RV; Murchie, SL; Parker, TJ; Paulsen, G; Rice, JW; Ruff, SW; Smith, MD; Wolff, MJ				Arvidson, R. E.; Squyres, S. W.; Bell, J. F., III; Catalano, J. G.; Clark, B. C.; Crumpler, L. S.; de Souza, P. A., Jr.; Fairen, A. G.; Farrand, W. H.; Fox, V. K.; Gellert, R.; Ghosh, A.; Golombek, M. P.; Grotzinger, J. P.; Guinness, E. A.; Herkenhoff, K. E.; Jolliff, B. L.; Knoll, A. H.; Li, R.; McLennan, S. M.; Ming, D. W.; Mittlefehldt, D. W.; Moore, J. M.; Morris, R. V.; Murchie, S. L.; Parker, T. J.; Paulsen, G.; Rice, J. W.; Ruff, S. W.; Smith, M. D.; Wolff, M. J.			Ancient Aqueous Environments at Endeavour Crater, Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; RIES CRATER; SUEVITE	Opportunity has investigated in detail rocks on the rim of the Noachian age Endeavour crater, where orbital spectral reflectance signatures indicate the presence of Fe+3-rich smectites. The signatures are associated with fine-grained, layered rocks containing spherules of diagenetic or impact origin. The layered rocks are overlain by breccias, and both units are cut by calcium sulfate veins precipitated from fluids that circulated after the Endeavour impact. Compositional data for fractures in the layered rocks suggest formation of Al-rich smectites by aqueous leaching. Evidence is thus preserved for water-rock interactions before and after the impact, with aqueous environments of slightly acidic to circum-neutral pH that would have been more favorable for prebiotic chemistry and microorganisms than those recorded by younger sulfate-rich rocks at Meridiani Planum.	[Arvidson, R. E.; Catalano, J. G.; Fox, V. K.; Guinness, E. A.; Jolliff, B. L.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Squyres, S. W.; Fairen, A. G.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Bell, J. F., III; Ruff, S. W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Clark, B. C.; Farrand, W. H.; Wolff, M. J.] Space Sci Inst, Boulder, CO 80301 USA; [Crumpler, L. S.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [de Souza, P. A., Jr.] Commonwealth Sci & Ind Res Org CSIRO Computat Inf, Hobart, Tas 7001, Australia; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Ghosh, A.] Tharsis Inc, Gaithersburg, MD 20877 USA; [Golombek, M. P.; Parker, T. J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Grotzinger, J. P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Knoll, A. H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Li, R.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D. W.; Mittlefehldt, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Moore, J. M.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Murchie, S. L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Paulsen, G.] Honeybee Robot Spacecraft Mech Corp, Pasadena, CA 91103 USA; [Rice, J. W.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Smith, M. D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Washington University (WUSTL); Cornell University; Arizona State University; Arizona State University-Tempe; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Guelph; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; United States Department of the Interior; United States Geological Survey; Harvard University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	arvidson@wunder.wustl.edu	de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008; Catalano, Jeffrey/A-8322-2013; Murchie, Scott L/E-8030-2015	de Souza, Paulo/0000-0002-0091-8925; de Souza, Paulo A/0000-0002-0091-8925; Catalano, Jeffrey/0000-0001-9311-977X; Murchie, Scott L/0000-0002-1616-8751; McLennan, Scott/0000-0003-4259-7178	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA. The CRISM operations team at the Applied Physics Laboratory, Johns Hopkins University, and the Opportunity operations team at the Jet Propulsion Laboratory, California Institute of Technology were responsible for planning and acquiring the relevant data. The NASA Planetary Data System through the Geosciences Node (http://pds-geosciences.wustl.edu/) provides access to the CRISM and Opportunity data used in this paper.	Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; Catalano JG, 2013, J GEOPHYS RES-PLANET, V118, P2124, DOI 10.1002/jgre.20161; Chan MA, 2007, GEOFLUIDS, V7, P356, DOI 10.1111/j.1468-8123.2007.00187.x; Dobrea EZN, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053180; Ehlmann BL, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004156; Ehlmann B. L., 2010, 1 MOSC SOL SYST S 1H; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Emmerich K, 2009, CLAY CLAY MINER, V57, P104, DOI 10.1346/CCMN.2009.0570110; Fralick P., 2011, SOC SEDIMENTARY GEOL, V11, P211; GRAUP G, 1981, EARTH PLANET SC LETT, V55, P407, DOI 10.1016/0012-821X(81)90168-0; Jirsa M.A., 2011, GSA FIELD GUIDE, V24, P147, DOI [10.1130/2011.0024(08), DOI 10.1130/2011.0024(08)]; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; Loope DB, 2012, SEDIMENTOLOGY, V59, P1769, DOI 10.1111/j.1365-3091.2012.01325.x; Mermut AR, 2001, CLAY CLAY MINER, V49, P381, DOI 10.1346/CCMN.2001.0490504; Morris R. V., 2011, 42 LUN PLAN SCI C WO, P1608; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; NESBITT HW, 1992, AM J SCI, V292, P740, DOI 10.2475/ajs.292.10.740; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Rice MS, 2010, ICARUS, V205, P375, DOI 10.1016/j.icarus.2009.03.035; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stoffler D, 2013, METEORIT PLANET SCI, V48, P515, DOI 10.1111/maps.12086; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Wilson JH, 2012, CHEM GEOL, V312, P195, DOI 10.1016/j.chemgeo.2012.04.013; Wolters F, 2009, CLAY CLAY MINER, V57, P115, DOI 10.1346/CCMN.2009.0570111; Wray JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040734; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	30	152	154	0	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1248097	10.1126/science.1248097	http://dx.doi.org/10.1126/science.1248097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458648	Green Submitted, Green Accepted			2022-12-28	WOS:000330039300008
J	Spence, D				Spence, Des			FROM THE FRONTLINE Middle aged medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Gotzsche, 2013, DEADLY MED ORG CRIM; Mayor Susan, 2013, BMJ, V347, pf7678, DOI 10.1136/bmj.f7678; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Rees K, 2013, COCHRANE SUMMAR 1206; Rees K, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD009825.PUB2; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2014	348								g395	10.1136/bmj.g395	http://dx.doi.org/10.1136/bmj.g395			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BI	24464282				2022-12-28	WOS:000330298500011
J	Ludman, H				Ludman, Harold			ABC of Ear, Nose and Throat, 6th Edition Vertigo and Imbalance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ludman, Harold] Kings Coll Hosp London, London, England; [Ludman, Harold] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Ludman, H (corresponding author), Kings Coll Hosp London, London, England.							Ludman H, 1998, DIS EAR; Luxon LM, 2003, TXB AUDIOLOGICAL MED	2	4	7	4	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2014	348								g283	10.1136/bmj.g283	http://dx.doi.org/10.1136/bmj.g283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298AW	24452766				2022-12-28	WOS:000330297300004
J	Grodstein, F; O'Brien, J; Kang, JH; Dushkes, R; Cook, NR; Okereke, O; Manson, JE; Glynn, RJ; Buring, JE; Gaziano, JM; Sesso, HD				Grodstein, Francine; O'Brien, Jacqueline; Kang, Jae Hee; Dushkes, Rimma; Cook, Nancy R.; Okereke, Olivia; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.; Gaziano, J. Michael; Sesso, Howard D.			Long-Term Multivitamin Supplementation and Cognitive Function in Men A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS HEALTH; ALZHEIMERS-DISEASE; B-VITAMINS; CARDIOVASCULAR-DISEASE; BETA-CAROTENE; FOLIC-ACID; DECLINE; FOLATE; PREVENTION; WOMEN	Background: Despite widespread use of multivitamin supplements, their effect on cognitive health-a critical issue with aging-remains inconclusive. To date, no long-term clinical trials have studied multivitamin use and cognitive decline in older persons. Objective: To evaluate whether long-term multivitamin supplementation affects cognitive health in later life. Design: Randomized, double-blind, placebo-controlled trial of a multivitamin from 1997 to 1 June 2011. The cognitive function substudy began in 1998. Up to 4 repeated cognitive assessments by telephone interview were completed over 12 years. (ClinicalTrials.gov: NCT00270647) Setting: The Physicians' Health Study II. Patients: 5947 male physicians aged 65 years or older. Intervention: Daily multivitamin or placebo. Measurements: A global composite score averaging 5 tests of global cognition, verbal memory, and category fluency. The secondary end point was a verbal memory score combining 4 tests of verbal memory, which is a strong predictor of Alzheimer disease. Results: No difference was found in mean cognitive change over time between the multivitamin and placebo groups or in the mean level of cognition at any of the 4 assessments. Specifically, for the global composite score, the mean difference in cognitive change over follow-up was -0.01 SU (95% CI, -0.04 to 0.02 SU) when treatment was compared with placebo. Similarly, cognitive performance did not differ between the multivitamin and placebo groups on the secondary outcome, verbal memory (mean difference in cognitive change over follow-up, -0.005 SU [CI, -0.04 to 0.03 SU]). Limitation: Doses of vitamins may be too low or the population may be too well-nourished to benefit from a multivitamin. Conclusion: In male physicians aged 65 years or older, long-term use of a daily multivitamin did not provide cognitive benefits.	Harvard Univ, Sch Publ Hlth, Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Grodstein, F (corresponding author), Brigham & Womens Hosp, 181 Longwood Ave, Boston, MA 02115 USA.	phfrg@channing.harvard.edu	Okereke, Olivia I/R-9934-2016; Okereke, Olivia/AAF-7031-2021		National Institutes of Health; BASF; Pfizer; DSM Nutritional Products; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG015933, T32AG000158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); Pfizer(Pfizer); DSM Nutritional Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: National Institutes of Health, BASF, Pfizer, and DSM Nutritional Products.	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Balk EM, 2007, ARCH INTERN MED, V167, P21, DOI 10.1001/archinte.167.1.21; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Devore EE, 2010, AM J CLIN NUTR, V92, P1157, DOI 10.3945/ajcn.2010.29634; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Evans DA, 2011, ALZHEIMERS DEMENT, V7, P110, DOI 10.1016/j.jalz.2010.11.008; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN, P103; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia AA, 2004, J AM GERIATR SOC, V52, P66, DOI 10.1111/j.1532-5415.2004.52012.x; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Gillette-Guyonnet S, 2007, J NUTR HEALTH AGING, V11, P132; Grima NA, 2012, J ALZHEIMERS DIS, V29, P561, DOI 10.3233/JAD-2011-111751; Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184; Haller J, 1999, INT J VITAM NUTR RES, V69, P160, DOI 10.1024/0300-9831.69.3.160; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kado DM, 2005, AM J MED, V118, P161, DOI 10.1016/j.amjmed.2004.08.019; Kang JH, 2006, EPIDEMIOLOGY, V17, P650, DOI 10.1097/01.ede.0000239727.59575.da; Kang JH, 2008, AM J CLIN NUTR, V88, P1602, DOI 10.3945/ajcn.2008.26404; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kang JH, 2003, NEUROLOGY, V60, P1591; Kennedy DO, 2011, DRUGS, V71, P1957, DOI 10.2165/11594130-000000000-00000; Kesse-Guyot E, 2011, AM J CLIN NUTR, V94, P892, DOI 10.3945/ajcn.110.007815; Kim JM, 2008, PSYCHIAT INVEST, V5, P36, DOI 10.4306/pi.2008.5.1.36; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Macpherson H, 2012, PSYCHOPHARMACOLOGY, V220, P351, DOI 10.1007/s00213-011-2481-3; Malouf R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004514.pub2; McNeill G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-10; Mecocci P, 2012, BBA-MOL BASIS DIS, V1822, P631, DOI 10.1016/j.bbadis.2011.10.006; Morris MC, 2012, P NUTR SOC, V71, P1, DOI 10.1017/S0029665111003296; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P641, DOI 10.1001/archneur.62.4.641; Morris MC, 2002, ARCH NEUROL-CHICAGO, V59, P1125, DOI 10.1001/archneur.59.7.1125; Nachum-Biala Y, 2012, BIOFACTORS, V38, P145, DOI 10.1002/biof.1006; Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Raman G, 2007, J NUTR, V137, P1789, DOI 10.1093/jn/137.7.1789; Rosenberg IH, 2007, AM J CLIN NUTR, V85, p325S, DOI 10.1093/ajcn/85.1.325S; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sardesai V M, 1995, Nutr Clin Pract, V10, P19, DOI 10.1177/011542659501000119; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Selhub J, 2000, AM J CLIN NUTR, V71, p614S; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Summers WK, 2010, J ALZHEIMERS DIS, V19, P429, DOI 10.3233/JAD-2010-1229; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tangney CC, 2009, NEUROLOGY, V72, P361, DOI 10.1212/01.wnl.0000341272.48617.b0; Teunissen C E, 2003, J Nutr Health Aging, V7, P153; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Wald DS, 2010, AM J MED, V123, P522, DOI 10.1016/j.amjmed.2010.01.017; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Wengreen HJ, 2007, J NUTR HEALTH AGING, V11, P230; Wilson RS, 2010, ARCH NEUROL-CHICAGO, V67, P855, DOI 10.1001/archneurol.2010.129; Wolters M, 2005, PREV MED, V41, P253, DOI 10.1016/j.ypmed.2004.11.007; Yaffe K, 2004, NEUROLOGY, V63, P1705, DOI 10.1212/01.WNL.0000142969.19465.8F	63	75	78	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					806	+		10.7326/0003-4819-159-12-201312170-00006	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24490265	Green Accepted			2022-12-28	WOS:000329735300013
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Does NHS England have a slow puncture?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH SECRETARY; HOSPITALS; CHIEF					nigel.hawkes1@btinternet.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2030; Hawkes N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3364; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5633; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5639; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5545; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4951; Wise J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5727	7	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2013	347								f5812	10.1136/bmj.f5812	http://dx.doi.org/10.1136/bmj.f5812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OK	24473447				2022-12-28	WOS:000325426300004
J	Holmes, J; Meng, Y; Meier, PS; Brennan, A; Angus, C; Campbell-Burton, A; Guo, YL; Hill-McManus, D; Purshouse, RC				Holmes, John; Meng, Yang; Meier, Petra S.; Brennan, Alan; Angus, Colin; Campbell-Burton, Alexia; Guo, Yelan; Hill-McManus, Daniel; Purshouse, Robin C.			Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study	LANCET			English	Article							TAX; DRINKING; METAANALYSIS; MORTALITY; POLICIES; HEALTH	Background Several countries are considering a minimum price policy for alcohol, but concerns exist about the potential effects on drinkers with low incomes. We aimed to assess the effect of a 0.45 pound minimum unit price (1 unit is 8 g/10 mL ethanol) in England across the income and socioeconomic distributions. Methods We used the Sheffield Alcohol Policy Model (SAPM) version 2.6, a causal, deterministic, epidemiological model, to assess effects of a minimum unit price policy. SAPM accounts for alcohol purchasing and consumption preferences for population subgroups including income and socioeconomic groups. Purchasing preferences are regarded as the types and volumes of alcohol beverages, prices paid, and the balance between on-trade (eg, bars) and off-trade (eg, shops). We estimated price elasticities from 9 years of survey data and did sensitivity analyses with alternative elasticities. We assessed effects of the policy on moderate, hazardous, and harmful drinkers, split into three socioeconomic groups (living in routine or manual households, intermediate households, and managerial or professional households). We examined policy effects on alcohol consumption, spending, rates of alcohol-related health harm, and opportunity costs associated with that harm. Rates of harm and costs were estimated for a 10 year period after policy implementation. We adjusted baseline rates of mortality and morbidity to account for differential risk between socioeconomic groups. Findings Overall, a minimum unit price of 0.45 pound led to an immediate reduction in consumption of 1.6% (-11.7 units per drinker per year) in our model. Moderate drinkers were least affected in terms of consumption (-3.8 units per drinker per year for the lowest income quintile vs 0.8 units increase for the highest income quintile) and spending (increase in spending of 0.04 pound vs 1.86 pound per year). The greatest behavioural changes occurred in harmful drinkers (change in consumption of -3.7% or -138.2 units per drinker per year, with a decrease in spending of 4.01) pound, especially in the lowest income quintile (-7.6% or -299.8 units per drinker per year, with a decrease in spending of 34.63) pound compared with the highest income quintile (-1.0% or -34.3 units, with an increase in spending of 16.35) pound. Estimated health benefits from the policy were also unequally distributed. Individuals in the lowest socioeconomic group (living in routine or manual worker households and comprising 41.7% of the sample population) would accrue 81.8% of reductions in premature deaths and 87.1% of gains in terms of quality-adjusted life-years. Interpretation Irrespective of income, moderate drinkers were little affected by a minimum unit price of 0.45 pound in our model, with the greatest effects noted for harmful drinkers. Because harmful drinkers on low incomes purchase more alcohol at less than the minimum unit price threshold compared with other groups, they would be affected most by this policy. Large reductions in consumption in this group would however coincide with substantial health gains in terms of morbidity and mortality related to reduced alcohol consumption.	[Holmes, John; Meng, Yang; Meier, Petra S.; Brennan, Alan; Angus, Colin; Campbell-Burton, Alexia; Guo, Yelan; Hill-McManus, Daniel] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; [Purshouse, Robin C.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	Holmes, J (corresponding author), Univ Sheffield, Sect Publ Hlth, ScHARR, Sheffield S1 4DA, S Yorkshire, England.	john.holmes@sheffield.ac.uk	Meier, Petra S/L-7387-2017; Angus, Colin/AAT-2786-2020; Meier, Petra/P-7504-2019; Hill-McManus, Daniel/AAA-9305-2022	Meier, Petra S/0000-0001-5354-1933; Angus, Colin/0000-0003-0529-4135; Meier, Petra/0000-0001-5354-1933; Hill-McManus, Daniel/0000-0002-1936-3907; Holmes, John/0000-0001-9283-2151; Purshouse, Robin/0000-0001-5880-1925; Brennan, Alan/0000-0002-1025-312X	UK Medical Research Council; Economic and Social Research Council [G1000043]; Medical Research Council [G1000043, MR/K023195/1, MR/K023195/1B] Funding Source: researchfish; MRC [G1000043] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council and Economic and Social Research Council (grant G1000043).	[Anonymous], 2013, HANSARD, V560, P451; Anyaegbu G., 2010, EC LABOUR MARKET REV, V4, P49, DOI DOI 10.1057/elmr.2010.9; Australian National Preventive Health Agency, 2012, EXPLORING THE PUBLIC; Booth A, 2008, INDEPENDENT REVIEW O; Brennan A, 2013, PUBLIC RESPONSE A SM; Canadian Public Health Association, 2013, TOO HIGH A COST A PU; Centre for Economics and Business Research, 2012, MINIMUM UNIT PRICING; Centre for Economics and Business Research, 2013, ALCOHOL CONSUMPTION; Daley JI, 2012, AM J PREV MED, V42, P382, DOI 10.1016/j.amepre.2011.12.008; Dargay JM, 1999, J TRANSP ECON POLICY, V33, P287; Department of Health (DoH), 2012, STEERING GROUP REPOR; Duffy JC, 2012, THE MINIMAL EVIDENCE; Griffith R, 2013, PRICE BASED MEASURES; GUNNINGSCHEPERS L, 1989, HEALTH POLICY, V12, P1; Hill-MacManus D, 2012, MODEL BASED APPRAISA; Holmes J, 2012, DRUG ALCOHOL DEPEN, V123, P7, DOI 10.1016/j.drugalcdep.2011.12.005; Home Office, 2013, NEXT STEPS FOLLOWING; Huang C-D, 2003, ECONOMETRIC MODELS O; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Ludbrook A, 2012, APPL HEALTH ECON HEA, V10, P51, DOI 10.2165/11594840-000000000-00000; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Meng Y, 2013, MODELLED INCOME GROU; Meng Y, J HEALTH ECON IN PRE; Office for National Statistics, 2009, LIVING COSTS AND FOO; Office for National Statistics, 2011, GENERAL LIFESTYLE SU; Purshouse RC, 2009, MODELLING TO ASSESS; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Remler DK, 2004, AM J PUBLIC HEALTH, V94, P225, DOI 10.2105/AJPH.94.2.225; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; Stockwell T, 2013, AM J PUBLIC HEALTH, V103, P2014, DOI 10.2105/AJPH.2013.301289; SUTTON M, 1995, HEALTH ECON, V4, P237, DOI 10.1002/hec.4730040308; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	35	196	195	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1655	1664		10.1016/S0140-6736(13)62417-4	http://dx.doi.org/10.1016/S0140-6736(13)62417-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24522180	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000335670800028
J	Lundgren, JD; Phillips, A				Lundgren, Jens D.; Phillips, Andrew			Antiretroviral dose reduction: good for patients and rollout	LANCET			English	Editorial Material							TRIALS		[Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Phillips, Andrew] UCL, Res Dept Infect & Populat Hlth, London, England	Rigshospitalet; University of Copenhagen; University of London; University College London	Lundgren, JD (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	jens.lundgren@regionh.dk	Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850				[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2013, UNAIDS REP GLOB AIDS; ENCORE1 Study Group, 2014, LANCET; Haas D, 2008, INT C AIDS 1998 GEN, P698; Hill A, 2010, OPEN INFECT DIS J, V4, P85; Medecins Sans Frontieres, 2013, UNT WEB ANT PRIC RED; Molina JM, 2014, HIV MED, V15, P57, DOI 10.1111/hiv.12071; Venter WDF, 2012, S AFR J HIV MED, P20; Warmsley SL, 2013, NEW ENGL J MED, V369, P1807	9	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1442	1443		10.1016/S0140-6736(13)62556-8	http://dx.doi.org/10.1016/S0140-6736(13)62556-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24522177				2022-12-28	WOS:000335325800006
J	Rehm, J				Rehm, Juergen			Russia: lessons for alcohol epidemiology and alcohol policy	LANCET			English	Editorial Material							MORTALITY; CONSUMPTION; DISEASE; BURDEN		[Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, D-01062 Dresden, Germany	University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Technische Universitat Dresden	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada.	jtrehm@gmail.com						Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Gmel G., 2003, SUCHT, V49, P105, DOI [https://doi.org/10.1024/suc.2003.49.2.105, DOI 10.1024/SUC.2003.49.2.105]; Gmel G, 2011, ADDICTION, V106, P1037, DOI 10.1111/j.1360-0443.2010.03167.x; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Nemtsov A. V., 2011, CONT HIST ALCOHOL RU; Neufeld M, 2013, ALCOHOL ALCOHOLISM, V48, P222, DOI 10.1093/alcalc/ags134; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P509, DOI 10.1093/alcalc/agt021; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Zaridze D, 2014, LANCET; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	12	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1440	1442		10.1016/S0140-6736(14)60038-6	http://dx.doi.org/10.1016/S0140-6736(14)60038-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24486186	hybrid			2022-12-28	WOS:000335325800005
J	Anagnostou, K; Islam, S; King, Y; Foley, L; Pasea, L; Bond, S; Palmer, C; Deighton, J; Ewan, P; Clark, A				Anagnostou, Katherine; Islam, Sabita; King, Yvonne; Foley, Loraine; Pasea, Laura; Bond, Simon; Palmer, Chris; Deighton, John; Ewan, Pamela; Clark, Andrew			Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; TOLERANCE INDUCTION; FOOD ALLERGY; CLINICAL-FEATURES; NUT ALLERGY; PREVALENCE	Background Small studies suggest peanut oral immunotherapy (OIT) might be effective in the treatment of peanut allergy. We aimed to establish the efficacy of OIT for the desensitisation of children with allergy to peanuts. Methods We did a randomised controlled crossover trial to compare the efficacy of active OIT (using characterised peanut flour; protein doses of 2-800 mg/day) with control (peanut avoidance, the present standard of care) at the NIHR/Wellcome Trust Cambridge Clinical Research Facility (Cambridge, UK). Randomisation (1: 1) was by use of an audited online system; group allocation was not masked. Eligible participants were aged 7-16 years with an immediate hypersensitivity reaction after peanut ingestion, positive skin prick test to peanuts, and positive by double-blind placebo-controlled food challenge (DBPCFC). We excluded participants if they had a major chronic illness, if the care provider or a present household member had suspected or diagnosed allergy to peanuts, or if there was an unwillingness or inability to comply with study procedures. Our primary outcome was desensitisation, defined as negative peanut challenge (1400 mg protein in DBPCFC) at 6 months (first phase). Control participants underwent OIT during the second phase, with subsequent DBPCFC. Immunological parameters and disease-specific quality-of-life scores were measured. Analysis was by intention to treat. Fisher's exact test was used to compare the proportion of those with desensitisation to peanut after 6 months between the active and control group at the end of the first phase. This trial is registered with Current Controlled Trials, number ISRCTN62416244. Findings The primary outcome, desensitisation, was recorded for 62% (24 of 39 participants; 95% CI 45-78) in the active group and none of the control group after the first phase (0 of 46; 95% CI 0-9; p<0.001). 84% (95% CI 70-93) of the active group tolerated daily ingestion of 800 mg protein (equivalent to roughly five peanuts). Median increase in peanut threshold after OIT was 1345 mg (range 45-1400; p<0.001) or 25.5 times (range 1.82-280; p<0.001). After the second phase, 54% (95% CI 35-72) tolerated 1400 mg challenge (equivalent to roughly ten peanuts) and 91% (79-98) tolerated daily ingestion of 800 mg protein. Quality-of-life scores improved (decreased) after OIT (median change -1.61; p<0.001). Side-effects were mild in most participants. Gastrointestinal symptoms were, collectively, most common (31 participants with nausea, 31 with vomiting, and one with diarrhoea), then oral pruritus after 6.3% of doses (76 participants) and wheeze after 0.41% of doses (21 participants). Intramuscular adrenaline was used after 0.01% of doses (one participant). Interpretation OIT successfully induced desensitisation in most children within the study population with peanut allergy of any severity, with a clinically meaningful increase in peanut threshold. Quality of life improved after intervention and there was a good safety profile. Immunological changes corresponded with clinical desensitisation. Further studies in wider populations are recommended; peanut OIT should not be done in non-specialist settings, but it is effective and well tolerated in the studied age group.	[Anagnostou, Katherine; Islam, Sabita; Ewan, Pamela; Clark, Andrew] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Med, Cambridge, England; [King, Yvonne; Foley, Loraine; Deighton, John; Ewan, Pamela; Clark, Andrew] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Allergy, Cambridge, England; [Bond, Simon] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Clin Trials Unit, Cambridge, England; [Pasea, Laura; Palmer, Chris] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge CB2 0QQ, England; [Bond, Simon] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Clark, A (corresponding author), Univ Cambridge, Dept Med, Addenbrookes Hosp, Box 157, Cambridge CB2 0QQ, England.	andrew.clark@addenbrookes.nhs.uk	Anagnostou, Katherine/U-6073-2019; Bond, Simon/AAB-9077-2020	Bond, Simon/0000-0003-2528-1040; Anagnostou, Aikaterini/0000-0001-6240-7437	Efficacy and Mechanism Evaluation Programme [08/99/18]; Medical Research Council (MRC); University of Cambridge; NIHR/Wellcome Trust Cambridge Clinical Research Facility on the Cambridge Biomedical Campus; Addenbrooke's Hospital (Cambridge University Hospital Foundation Trust); MRC-NIHR; Medical Research Council [MC_G1002461, MC_UP_1302/2] Funding Source: researchfish; MRC [MC_G1002461, MC_UP_1302/2] Funding Source: UKRI	Efficacy and Mechanism Evaluation Programme; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cambridge(University of Cambridge); NIHR/Wellcome Trust Cambridge Clinical Research Facility on the Cambridge Biomedical Campus; Addenbrooke's Hospital (Cambridge University Hospital Foundation Trust); MRC-NIHR(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding MRC-NIHR partnership.; This project was awarded by the Efficacy and Mechanism Evaluation Programme (08/99/18), and is funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership, and jointly sponsored by the University of Cambridge and Addenbrooke's Hospital (Cambridge University Hospital Foundation Trust). The NIHR/Wellcome Trust Cambridge Clinical Research Facility on the Cambridge Biomedical Campus supported the research. We thank Gareth Jones, headteacher at The Perse Prep School in Cambridge, and the Perse Prep Parents for fundraising to buy equipment used during this work. We thank our data monitoring committee (Nicola Brathwaite [chair], Ken Ong, Carlo Acerini), and members of our Trial Steering Committee (Robert Boyle [Chair], Chris Palmer, Hazel Gowland). We thank the Anaphylaxis Campaign who reviewed the study protocol, funding application, and patient information sheets, and provided a patient representative (Hazel Gowland) as a member of the Trial Steering Committee.	Anagnostou K, 2011, CLIN EXP ALLERGY, V41, P1273, DOI 10.1111/j.1365-2222.2011.03699.x; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Barnett J, 2011, ALLERGY, V66, P969, DOI 10.1111/j.1398-9995.2011.02563.x; Blumchen K, 2010, J ALLERGY CLIN IMMUN, V126, P83, DOI 10.1016/j.jaci.2010.04.030; Boyle RJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008838.pub2; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Clark AT, 2009, ALLERGY, V64, P1218, DOI 10.1111/j.1398-9995.2009.01982.x; Clark AT, 2008, J ALLERGY CLIN IMMUN, V122, P286, DOI 10.1016/j.jaci.2008.05.015; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Factor JM, 2012, ANN ALLERG ASTHMA IM, V109, P348, DOI 10.1016/j.anai.2012.08.015; Flokstra-de Blok BMJ, 2009, CLIN EXP ALLERGY, V39, P127, DOI [10.1111/j.1365-2222.2008.03120.x, 10.1111/j.1365-2222.2009.03376.x]; Ho MHK, 2008, J ALLERGY CLIN IMMUN, V121, P731, DOI 10.1016/j.jaci.2007.11.024; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Kapoor S, 2004, ALLERGY, V59, P185, DOI 10.1046/j.1398-9995.2003.00365.x; Keil T, 2010, ALLERGY, V65, P482, DOI 10.1111/j.1398-9995.2009.02171.x; Leitch IS, 2005, INT J ENVIRON HEAL R, V15, P79, DOI 10.1080/09603120500062052; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Niggemann B, 2010, ALLERGY, V65, P2, DOI 10.1111/j.1398-9995.2009.02170.x; Nurmatov U, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009014.pub2; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; Rimbaud L, 2010, RISK ANAL, V30, P7, DOI 10.1111/j.1539-6924.2009.01322.x; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x	29	281	285	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1297	1304		10.1016/S0140-6736(13)62301-6	http://dx.doi.org/10.1016/S0140-6736(13)62301-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24485709	Green Published, hybrid			2022-12-28	WOS:000334104900028
J	Chung, H; Loehlin, DW; Dufour, HD; Vaccarro, K; Millar, JG; Carroll, SB				Chung, Henry; Loehlin, David W.; Dufour, Heloise D.; Vaccarro, Kathy; Millar, Jocelyn G.; Carroll, Sean B.			A Single Gene Affects Both Ecological Divergence and Mate Choice in Drosophila	SCIENCE			English	Article							CUTICULAR HYDROCARBONS; SEXUAL SELECTION; SERRATA; TRAITS	Evolutionary changes in traits involved in both ecological divergence and mate choice may produce reproductive isolation and speciation. However, there are few examples of such dual traits, and the genetic and molecular bases of their evolution have not been identified. We show that methyl-branched cuticular hydrocarbons (mbCHCs) are a dual trait that affects both desiccation resistance and mate choice in Drosophila serrata. We identify a fatty acid synthase mFAS (CG3524) responsible for mbCHC production in Drosophila and find that expression of mFAS is undetectable in oenocytes (cells that produce CHCs) of a closely related, desiccation-sensitive species, D. birchii, due in part to multiple changes in cis-regulatory sequences of mFAS. We suggest that ecologically influenced changes in the production of mbCHCs have contributed to reproductive isolation between the two species.	[Chung, Henry; Loehlin, David W.; Dufour, Heloise D.; Vaccarro, Kathy; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Chung, Henry; Loehlin, David W.; Dufour, Heloise D.; Vaccarro, Kathy; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Riverside	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Chung, Henry/C-9374-2014	Chung, Henry/0000-0001-5056-2755; Dufour, Heloise/0000-0001-7934-7549	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Hercus MJ, 1999, GENETICS, V151, P1493; Higgie M, 2008, EVOLUTION, V62, P1192, DOI 10.1111/j.1558-5646.2008.00357.x; Howard RW, 2003, J CHEM ECOL, V29, P961, DOI 10.1023/A:1022992002239; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Spikes AE, 2010, J CHEM ECOL, V36, P943, DOI 10.1007/s10886-010-9837-8; van Heerwaarden B, 2009, P ROY SOC B-BIOL SCI, V276, P1517, DOI 10.1098/rspb.2008.1288; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003	19	123	124	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1148	1151		10.1126/science.1249998	http://dx.doi.org/10.1126/science.1249998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24526311				2022-12-28	WOS:000332331500051
J	Li, Y				Li, Yan			China's misuse of antibiotics should be curbed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nottingham Trent Univ, Sch Arts & Humanities, Nottingham, England	Nottingham Trent University	Li, Y (corresponding author), Nottingham Trent Univ, Sch Arts & Humanities, Nottingham, England.	yan.li@ntu.ac.uk						[Anonymous], 2011, ANT HEAV OV CHIN; Chen Z., 2012, REPORT MANAGEMENT CL; Currie J, 2011, J HEALTH ECON, V30, P933, DOI 10.1016/j.jhealeco.2011.05.009; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Hueston WJ, 1997, J FAM PRACTICE, V44, P261; Jiang C, 2012, TIME; Little P, 1997, BRIT MED J, V315, P350; Sun XY, 2009, SOC SCI MED, V68, P1775, DOI 10.1016/j.socscimed.2009.02.043; Xiao Y., 2010, CHINESE HLTH EC, V29, P94, DOI [10.3969/j.issn.1003-0743.2010.05.034, DOI 10.3969/J.ISSN.1003-0743.2010.05.034]	9	51	58	6	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2014	348								g1083	10.1136/bmj.g1083	http://dx.doi.org/10.1136/bmj.g1083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA9WT	24523392				2022-12-28	WOS:000331444400002
J	Greaves, M				Greaves, Mel			RETROSPECTIVE Janet Rowley (1925-2013)	SCIENCE			English	Biographical-Item									Inst Canc Res, London SM2 5NG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Greaves, M (corresponding author), Inst Canc Res, London SM2 5NG, England.	mel.greaves@icr.ac.uk						ROWLEY JD, PUBLICATION LIST	1	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					626	626		10.1126/science.1251005	http://dx.doi.org/10.1126/science.1251005			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503847				2022-12-28	WOS:000330724000034
J	Cagney, H				Cagney, Hannah			Intimate partner violence and HIV: unwelcome accomplices	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; WOMEN; PREVENTION; DIAPHRAGM; AFRICA		The Lancet, London NW1 7BY, England		Cagney, H (corresponding author), The Lancet, London NW1 7BY, England.	hannah.cagney@lancet.com						Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Kacanek D, 2013, JAIDS-J ACQ IMM DEF, V64, P400, DOI 10.1097/QAI.0b013e3182a6b0be; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Roman NV, 2013, FAM PRACT, V30, P256, DOI 10.1093/fampra/cms084; World Health Organization UNAIDS, 2004, INF B SER, P1	5	7	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					395	395		10.1016/S0140-6736(14)60055-6	http://dx.doi.org/10.1016/S0140-6736(14)60055-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24485573				2022-12-28	WOS:000330673700011
J	Dong, SM; Stam, R; Cano, LM; Song, J; Sklenar, J; Yoshida, K; Bozkurt, TO; Oliva, R; Liu, ZY; Tian, MY; Win, J; Banfield, MJ; Jones, AME; van der Hoorn, RAL; Kamoun, S				Dong, Suomeng; Stam, Remco; Cano, Liliana M.; Song, Jing; Sklenar, Jan; Yoshida, Kentaro; Bozkurt, Tolga O.; Oliva, Ricardo; Liu, Zhenyu; Tian, Miaoying; Win, Joe; Banfield, Mark J.; Jones, Alexandra M. E.; van der Hoorn, Renier A. L.; Kamoun, Sophien			Effector Specialization in a Lineage of the Irish Potato Famine Pathogen	SCIENCE			English	Article							PHYTOPHTHORA-INFESTANS; PLANT-PATHOGENS; CYSTEINE PROTEASES; GENOME EVOLUTION; HOST JUMPS; DEFENSE; TOMATO; SELECTION; TARGETS	Accelerated gene evolution is a hallmark of pathogen adaptation following a host jump. Here, we describe the biochemical basis of adaptation and specialization of a plant pathogen effector after its colonization of a new host. Orthologous protease inhibitor effectors from the Irish potato famine pathogen, Phytophthora infestans, and its sister species, Phytophthora mirabilis, which is responsible for infection of Mirabilis jalapa, are adapted to protease targets unique to their respective host plants. Amino acid polymorphisms in both the inhibitors and their target proteases underpin this biochemical specialization. Our results link effector specialization to diversification and speciation of this plant pathogen.	[Dong, Suomeng; Stam, Remco; Cano, Liliana M.; Sklenar, Jan; Yoshida, Kentaro; Bozkurt, Tolga O.; Oliva, Ricardo; Win, Joe; Jones, Alexandra M. E.; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Song, Jing; Liu, Zhenyu; Tian, Miaoying] Ohio State Univ, Dept Plant Pathol, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA; [Banfield, Mark J.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [van der Hoorn, Renier A. L.] Univ Oxford, Plant Chemet Lab, Dept Plant Sci, Oxford OX1 3RB, England; [van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Plant Chemet Lab, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University System of Ohio; Ohio State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford; Max Planck Society	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Jones, Alexandra/B-5227-2009; Banfield, Mark/C-7453-2013; Cano, Liliana M/O-7041-2016; Liu, Zhenyu/C-1369-2014; Song, Jing/F-7567-2014; Stam, Remco/AAK-1881-2021; Kamoun, Sophien/B-3529-2009; Bozkurt, Tolga Osman/AAA-8014-2019; van der Hoorn, Renier/AAU-1005-2020; Win, Joe/H-2557-2014; Liu, Zhenyu/O-2337-2018; Bozkurt, Tolga O/C-9764-2014; Liu, Zhenyu/C-9814-2012	Jones, Alexandra/0000-0003-2571-8708; Banfield, Mark/0000-0001-8921-3835; Cano, Liliana M/0000-0002-7996-4181; Stam, Remco/0000-0002-3444-6954; Kamoun, Sophien/0000-0002-0290-0315; Bozkurt, Tolga Osman/0000-0003-0507-6875; van der Hoorn, Renier/0000-0002-3692-7487; Win, Joe/0000-0002-9851-2404; Liu, Zhenyu/0000-0002-8320-7845; Bozkurt, Tolga O/0000-0003-0507-6875; Dong, Suomeng/0000-0002-9623-6776; Tian, Miaoying/0000-0001-8900-6414; Yoshida, Kentaro/0000-0002-3614-1759	Gatsby Charitable Foundation; U.K. Biotechnology and Biological Sciences Research Council; Ohio Agricultural Research and Development Center at The Ohio State University; National Research Initiative of the U.S. Department of Agriculture [OHO00963-SS]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0624] Funding Source: researchfish; BBSRC [BBS/E/J/000C0624] Funding Source: UKRI	Gatsby Charitable Foundation; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ohio Agricultural Research and Development Center at The Ohio State University; National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. G. O. Saunders for comments on drafts of the manuscript and C. Taylor, M. D. Coffey, and V. Vleeshouwers for providing biomaterial. This project was funded by the Gatsby Charitable Foundation, the U.K. Biotechnology and Biological Sciences Research Council, the Ohio Agricultural Research and Development Center at The Ohio State University, and a National Research Initiative of the U.S. Department of Agriculture grant OHO00963-SS. Sequences are deposited in GenBank under the submission accession numbers provided in (9).	Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Richau KH, 2012, PLANT PHYSIOL, V158, P1583, DOI 10.1104/pp.112.194001; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Stukenbrock EH, 2013, NEW PHYTOL, V199, P895, DOI 10.1111/nph.12374; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	14	141	148	9	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					552	555		10.1126/science.1246300	http://dx.doi.org/10.1126/science.1246300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482481				2022-12-28	WOS:000330343700050
J	Carazo, P; Tan, CKW; Allen, F; Wigby, S; Pizzari, T				Carazo, Pau; Tan, Cedric K. W.; Allen, Felicity; Wigby, Stuart; Pizzari, Tommaso			Within-group male relatedness reduces harm to females in Drosophila	NATURE			English	Article							SEXUAL CONFLICT; KIN SELECTION; COMPETITION; PEPTIDE; MELANOGASTER; AGGRESSION; RESPONSES; EVOLUTION; EXPOSURE; FITNESS	To resolve the mechanisms that switch competition to cooperation is key to understanding biological organization(1). This is particularly relevant for intrasexual competition, which often leads to males harming females(2). Recent theory proposes that kin selection may modulate female harm by relaxing competition among male relatives(3-5). Here we experimentally manipulate the relatedness of groups of male Drosophila melanogaster competing over females to demonstrate that, as expected, within-group relatedness inhibits male competition and female harm. Females exposed to groups of three brothers unrelated to the female had higher lifetime reproductive success and slower reproductive ageing compared to females exposed to groups of three males unrelated to each other. Triplets of brothers also fought less with each other, courted females less intensively and lived longer than triplets of unrelated males. However, associations among brothers may be vulnerable to invasion by minorities of unrelated males: when two brothers were matched with an unrelated male, the unrelated male sired on average twice as many offspring as either brother. These results demonstrate that relatedness can profoundly affect fitness through its modulation of intrasexual competition, as flies plastically adjust sexual behaviour in a manner consistent with kin-selection theory.	[Carazo, Pau; Tan, Cedric K. W.; Allen, Felicity; Wigby, Stuart; Pizzari, Tommaso] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Pizzari, T (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tommaso.pizzari@zoo.ox.ac.uk	Carazo, Pau/B-3311-2011; Wigby, Stuart/A-3916-2017	Carazo, Pau/0000-0002-1525-6522; Wigby, Stuart/0000-0002-2260-2948; Tan, Cedric/0000-0001-6505-2467	Marie Curie fellowship [PIEF-GA-2010-273010]; Wellcome Trust VIP award; NERC; Leverhulme Trust; BBSRC [BB/K014544/1] Funding Source: UKRI; NERC [NE/H008047/1, NE/D002788/1, NE/J018937/1, NE/D003865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014544/1] Funding Source: researchfish; Natural Environment Research Council [NE/J018937/1, NE/H008047/1, NE/D003865/1, NE/C507196/1, NE/D002788/1] Funding Source: researchfish	Marie Curie fellowship(European Commission); Wellcome Trust VIP award(Wellcome Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following funding agencies: Marie Curie fellowship (PIEF-GA-2010-273010 to P.C.), the Wellcome Trust VIP award and NERC fellowship (to S.W.), NERC research grant and the Leverhulme Trust (to T.P.). We thank C. Garroway, J. Perry and S. Michaelides for technical help; and M. Bonsall, A. Buckling, G. McDonald, D. Noble, J. Perry, P. Pizzari, R. Snook and S. West for helpful discussions.	ANXOLABEHERE D, 1976, EVOLUTION, V30, P523, DOI 10.1111/j.1558-5646.1976.tb00930.x; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; CHARLESWORTH B, 1970, Theoretical Population Biology, V1, P352, DOI 10.1016/0040-5809(70)90051-1; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Clancy David J., 2001, Drosophila Information Service, V84, P168; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; Edward DA, 2011, EVOLUTION, V65, P564, DOI 10.1111/j.1558-5646.2010.01151.x; Eldakar OT, 2009, SCIENCE, V326, P816, DOI 10.1126/science.1180183; Fedorka KM, 2005, J EVOLUTION BIOL, V18, P1515, DOI 10.1111/j.1420-9101.2005.00942.x; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Krakauer AH, 2005, NATURE, V434, P69, DOI 10.1038/nature03325; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Liggett RE, 2005, J SENS STUD, V20, P48, DOI 10.1111/j.1745-459X.2005.00003.x; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; MCINNIS DO, 1982, AM NAT, V119, P319, DOI 10.1086/283912; Moore AJ, 2005, AM NAT, V165, pS88, DOI 10.1086/429354; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; Pizzari T, 2012, PHILOS T R SOC B, V367, P2314, DOI 10.1098/rstb.2011.0281; PROUT T, 1985, AM NAT, V126, P521, DOI 10.1086/284436; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rankin DJ, 2011, J EVOLUTION BIOL, V24, P71, DOI 10.1111/j.1420-9101.2010.02143.x; Rankin DJ, 2006, TRENDS ECOL EVOL, V21, P225, DOI 10.1016/j.tree.2006.02.013; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Robinson SP, 2012, ANIM BEHAV, V84, P1169, DOI 10.1016/j.anbehav.2012.08.020; Tan CKW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1691; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wild G, 2011, THEOR POPUL BIOL, V80, P298, DOI 10.1016/j.tpb.2011.09.002	43	59	59	1	94	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					672	+		10.1038/nature12949	http://dx.doi.org/10.1038/nature12949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24463521	Green Submitted, Green Accepted			2022-12-28	WOS:000330321000039
J	Chapman, S				Chapman, Simon			When will the tobacco industry apologise for its monstrous harms?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					McCarthy M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g266	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2014	348								g437	10.1136/bmj.g437	http://dx.doi.org/10.1136/bmj.g437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AW	24477025				2022-12-28	WOS:000330647700024
J	Frisch, S				Frisch, Suzy			PUBLIC HEALTH Taking the temperature of Detroit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Center for Healthcare Research and Transformation, 2013, ACC MENT HLTH CAR MI; Henry Ford Health System, COMM HLTH NEEDS ASS; Reeves J., 2013, US TODAY	3	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2014	348								g485	10.1136/bmj.g485	http://dx.doi.org/10.1136/bmj.g485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BI	24464390				2022-12-28	WOS:000330298500012
J	Morrison, AP; Turkington, D; Pyle, M; Spencer, H; Brabban, A; Dunn, G; Christodoulides, T; Dudley, R; Chapman, N; Callcott, P; Grace, T; Lumley, V; Drage, L; Tully, S; Irving, K; Cummings, A; Byrne, R; Davies, LM; Hutton, P				Morrison, Anthony P.; Turkington, Douglas; Pyle, Melissa; Spencer, Helen; Brabban, Alison; Dunn, Graham; Christodoulides, Tom; Dudley, Rob; Chapman, Nicola; Callcott, Pauline; Grace, Tim; Lumley, Victoria; Drage, Laura; Tully, Sarah; Irving, Kerry; Cummings, Anna; Byrne, Rory; Davies, Linda M.; Hutton, Paul			Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial	LANCET			English	Article							SCALE; MEDICATION; HALLUCINATIONS; RELIABILITY; EXPERIENCE; PANSS; RISK	Background Antipsychotic drugs are usually the first line of treatment for schizophrenia; however, many patients refuse or discontinue their pharmacological treatment. We aimed to establish whether cognitive therapy was effective in reducing psychiatric symptoms in people with schizophrenia spectrum disorders who had chosen not to take antipsychotic drugs. Methods We did a single-blind randomised controlled trial at two UK centres between Feb 15, 2010, and May 30, 2013. Participants aged 16-65 years with schizophrenia spectrum disorders, who had chosen not to take antipsychotic drugs for psychosis, were randomly assigned (1:1), by a computerised system with permuted block sizes of four or six, to receive cognitive therapy plus treatment as usual, or treatment as usual alone. Randomisation was stratified by study site. Outcome assessors were masked to group allocation. Our primary outcome was total score on the positive and negative syndrome scale (PANSS), which we assessed at baseline, and at months 3, 6, 9, 12, 15, and 18. Analysis was by intention to treat, with an ANCOVA model adjusted for site, age, sex, and baseline symptons.This study is registered as an International Standard Randomised Controlled Trial, number 29607432. Findings 74 individuals were randomly assigned to receive either cognitive therapy plus treatment as usual (n=37), or treatment as usual alone (n=37). Mean PANSS total scores were consistently lower in the cognitive therapy group than in the treatment as usual group, with an estimated between-group effect size of -6.52 (95% CI -10.79 to -2.25; p=0.003). We recorded eight serious adverse events: two in patients in the cognitive therapy group (one attempted overdose and one patient presenting risk to others, both after therapy), and six in those in the treatment as usual group (two deaths, both of which were deemed unrelated to trial participation or mental health; three compulsory admissions to hospital for treatment under the mental health act; and one attempted overdose). Interpretation Cognitive therapy significantly reduced psychiatric symptoms and seems to be a safe and acceptable alternative for people with schizophrenia spectrum disorders who have chosen not to take antipsychotic drugs. Evidence-based treatments should be available to these individuals. A larger, definitive trial is needed.	[Morrison, Anthony P.; Pyle, Melissa; Chapman, Nicola; Tully, Sarah; Hutton, Paul] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Dunn, Graham] Univ Manchester, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Davies, Linda M.] Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Morrison, Anthony P.; Pyle, Melissa; Chapman, Nicola; Drage, Laura; Tully, Sarah; Irving, Kerry; Byrne, Rory; Hutton, Paul] Greater Manchester West Mental Hlth NHS Fdn Trust, Manchester, Lancs, England; [Turkington, Douglas; Spencer, Helen; Dudley, Rob; Cummings, Anna] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Turkington, Douglas; Spencer, Helen; Christodoulides, Tom; Dudley, Rob; Callcott, Pauline; Cummings, Anna] Northumberland Tyne & Wear NHS Mental Hlth Fdn Tr, Newcastle Upon Tyne, Tyne & Wear, England; [Brabban, Alison] Univ Durham, Durham, England; [Brabban, Alison; Grace, Tim; Lumley, Victoria] Tees Esk & Wear Valley NHS Mental Hlth Fdn Trust, Durham, England	University of Manchester; University of Manchester; University of Manchester; Newcastle University - UK; Durham University	Morrison, AP (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England.	tony.morrison@manchester.ac.uk		Davies, Linda/0000-0001-8801-3559; Morrison, Anthony/0000-0002-4389-2091; Dudley, Robert/0000-0002-3765-9998; Tully, Sarah/0000-0002-8107-3994	National Institute for Health Research; National Institute for Health Research [PB-PG-1208-18053] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research.	Ainsworth J, 2007, INT J HEALTHC INF SY, V2, P1, DOI 10.4018/jhisi.2007040101; Alvarez-Jimenez M, 2008, BRIT J PSYCHIAT, V193, P101, DOI 10.1192/bjp.bp.107.042853; [Anonymous], 2012, PROG NEUROL PSYCHIAT, V16, P35, DOI 10.1002/14651858.CD008712.pub2; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Blackburn IM, 2001, BEHAV COGN PSYCHOTH, V29, P431, DOI 10.1017/S1352465801004040; Correll CU, 2013, LANCET, V382, P919, DOI 10.1016/S0140-6736(13)61032-6; Day JC, 2005, ARCH GEN PSYCHIAT, V62, P717, DOI 10.1001/archpsyc.62.7.717; Haddock G, 1999, PSYCHOL MED, V29, P879, DOI 10.1017/S0033291799008661; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kingdon D. G., 2005, COGNITIVE THERAPY SC; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Lepping P, 2011, BRIT J PSYCHIAT, V198, P341, DOI 10.1192/bjp.bp.109.075366; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Leucht S, 2007, NEUROPSYCHOPHARMACOL, V32, P1903, DOI 10.1038/sj.npp.1301325; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2010, SCHIZOPHRENIA BULL, V36, P461, DOI 10.1093/schbul/sbq016; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Little R.J.A., 2002, STAT ANAL MISSING DA; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Moncrieff J, 2009, ACTA PSYCHIAT SCAND, V120, P102, DOI 10.1111/j.1600-0447.2009.01356.x; Morosini PL, 2000, ACTA PSYCHIAT SCAND, V101, P323, DOI 10.1111/j.1600-0447.2000.tb10933.x; Morrison A, 2004, COGNITIVE THERAPY PS; Morrison AP, 2012, PSYCHOL MED, V42, P1049, DOI 10.1017/S0033291711001899; Morrison AP, 2013, PSYCHOSIS, V5, P82, DOI 10.1080/17522439.2012.756539; Morrison AP, 2012, BRIT J PSYCHIAT, V201, P83, DOI 10.1192/bjp.bp.112.112110; Morrison AP, 2001, BEHAV COGN PSYCHOTH, V29, P257, DOI 10.1017/S1352465801003010; National Collaborating Centre for Mental Health (UK), 2009, SCHIZ COR INT TREATM; National Institute for Clinical Excellence, 2013, PSYCH SCHIZ CHILDR Y; Neil ST, 2009, PSYCHOSIS, V1, P145, DOI 10.1080/17522430902913450; Owen GS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39580.546597.BE; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Subotnik KL, 2011, AM J PSYCHIAT, V168, P286, DOI 10.1176/appi.ajp.2010.09010087; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Warner L, 2006, REV LIT CONSULTATION; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	38	156	160	1	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1395	1403		10.1016/S0140-6736(13)62246-1	http://dx.doi.org/10.1016/S0140-6736(13)62246-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24508320	Green Published, Green Accepted			2022-12-28	WOS:000335318400025
J	Johnson, LM; Du, JM; Hale, CJ; Bischof, S; Feng, SH; Chodavarapu, RK; Zhong, XH; Marson, G; Pellegrini, M; Segal, DJ; Patel, DJ; Jacobsen, SE				Johnson, Lianna M.; Du, Jiamu; Hale, Christopher J.; Bischof, Sylvain; Feng, Suhua; Chodavarapu, Ramakrishna K.; Zhong, Xuehua; Marson, Giuseppe; Pellegrini, Matteo; Segal, David J.; Patel, Dinshaw J.; Jacobsen, Steven E.			SRA- and SET-domain-containing proteins link RNA polymerase V occupancy to DNA methylation	NATURE			English	Article							STRUCTURAL BASIS; RECOGNITION; IV; TRANSCRIPTION; ASSOCIATION; PATTERNS; REQUIRES; MUTANTS; UHRF1	RNA-directed DNA methylation in Arabidopsis thaliana depends on the upstream synthesis of 24-nucleotide small interfering RNAs (siRNAs) by RNA POLYMERASE IV (Pol IV) 1,2 and downstream synthesis of non-coding transcripts by Pol V. Pol V transcripts are thought to interact with siRNAs which then recruit DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2) to methylate DNA(3-7). The SU(VAR) 3-9 homologues SUVH2 and SUVH9 act in this downstream step but the mechanism of their action is unknown(8,9). Here we show that genome-wide Pol V association with chromatin redundantly requires SUVH2 and SUVH9. Although SUVH2 and SUVH9 resemble histone methyltransferases, a crystal structure reveals that SUVH9 lacks a peptide-substrate binding cleft and lacks a properly formed S-adenosyl methionine (SAM)-binding pocket necessary for normal catalysis, consistent with a lack of methyltransferase activity for these proteins(8). SUVH2 and SUVH9 both contain SRA (SET- and RING-ASSOCIATED) domains capable of binding methylated DNA(8), suggesting that they function to recruit Pol V through DNA methylation. Consistent with this model, mutation of DNA METHYLTRANSFERASE 1 (MET1) causes loss of DNA methylation, a nearly complete loss of Pol V at its normal locations, and redistribution of Pol V to sites that become hypermethylated. Furthermore, tethering SUVH2 with a zinc finger to an unmethylated site is sufficient to recruit Pol V and establish DNA methylation and gene silencing. These results indicate that Pol V is recruited to DNA methylation through the methyl-DNA binding SUVH2 and SUVH9 proteins, and our mechanistic findings suggest a means for selectively targeting regions of plant genomes for epigenetic silencing.	[Johnson, Lianna M.; Hale, Christopher J.; Bischof, Sylvain; Feng, Suhua; Chodavarapu, Ramakrishna K.; Zhong, Xuehua; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Du, Jiamu; Marson, Giuseppe; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Davis	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Segal, David/V-9126-2019	Du, Jiamu/0000-0002-1337-0786; Segal, David/0000-0001-8962-3105; Pellegrini, Matteo/0000-0001-9355-9564	Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM60398]; Damon Runyon post-doctoral fellowship; Swiss National Science Foundation; Ruth L. Kirschstein National Research Service [F32GM096483-01]; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, F32GM096483, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon post-doctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to W. Shi at the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory (BNL) for support in diffraction data collection. We thank C. Pikaard for the NRPE1 antibodies and M. Akhavan for technical assistance. High-throughput sequencing was performed in the UCLA BSCRC BioSequencing Core Facility. This work was supported by the Abby Rockefeller Mauze Trust and the Maloris and STARR foundations to D.J.P., and NIH grant GM60398 to S.E.J. C.J.H. is supported by the Damon Runyon post-doctoral fellowship, S.B. is supported by a post-doctoral fellowship of the Swiss National Science Foundation, S.F. is a Special Fellow of the Leukemia & Lymphoma Society, and X.Z. is supported by Ruth L. Kirschstein National Research Service grant F32GM096483-01. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Aufsatz W, 2004, PLANT MOL BIOL, V54, P793, DOI 10.1007/s11103-004-0179-1; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenberg MVC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003946; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kolb AF, 2005, TRENDS BIOTECHNOL, V23, P399, DOI 10.1016/j.tibtech.2005.06.005; Kuhlmann M, 2012, PLANT MOL BIOL, V79, P623, DOI 10.1007/s11103-012-9934-x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelissier T, 2000, RNA, V6, P55, DOI 10.1017/S135583820099201X; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Zhang H, 2013, P NATL ACAD SCI USA, V110, P8290, DOI 10.1073/pnas.1300585110; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354	41	195	206	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					124	+		10.1038/nature12931	http://dx.doi.org/10.1038/nature12931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24463519	Green Accepted, Green Submitted			2022-12-28	WOS:000332224400055
J	Magnus, DC; Wilfond, BS; Caplan, AL				Magnus, David C.; Wilfond, Benjamin S.; Caplan, Arthur L.			Accepting Brain Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DONOR RULE	The cases of Jahi McMath and Marlise Munoz have reopened public debate about brain death. But the law and ethics have long recognized that deferring to medical expertise regarding the diagnosis of brain death is the most reasonable way to manage the process of dying. Two cases in which patients have been determined to be dead according to neurologic criteria (brain death) have recently garnered national headlines. In Oakland, California, Jahi McMath's death was determined by means of multiple independent neurologic examinations, including one ordered by a court. Her family refused to accept that she had died and went to court to prevent physicians at Children's Hospital and Research Center in Oakland from discontinuing ventilator support. Per a court-supervised agreement, the body was given to the family 3 weeks after the initial determination. The family's attorney stated that ventilatory support was continued and nutritional support ...	[Magnus, David C.] Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Wilfond, Benjamin S.] Seattle Childrens Hosp, Treuman Katz Ctr Pediat Eth, Seattle, WA USA; [Caplan, Arthur L.] NYU, Div Med Eth, New York, NY USA	Stanford University; Seattle Children's Hospital	Magnus, DC (corresponding author), Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA.							[Anonymous], 1968, JAMA, V205, P337; Bernat JL, 2013, NEW ENGL J MED, V369, P1289, DOI 10.1056/NEJMp1308078; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1981, DEFINING DEATH A REP; Truog RD, 2013, NEW ENGL J MED, V369, P1287, DOI 10.1056/NEJMp1307220	4	51	52	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					891	894		10.1056/NEJMp1400930	http://dx.doi.org/10.1056/NEJMp1400930			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24499177				2022-12-28	WOS:000332309800004
J	Nishimasu, H; Ran, FA; Hsu, PD; Konermann, S; Shehata, SI; Dohmae, N; Ishitani, R; Zhang, F; Nureki, O				Nishimasu, Hiroshi; Ran, F. Ann; Hsu, Patrick D.; Konermann, Silvana; Shehata, Soraya I.; Dohmae, Naoshi; Ishitani, Ryuichiro; Zhang, Feng; Nureki, Osamu			Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA	CELL			English	Article							BACTERIAL IMMUNE-SYSTEM; ONE-STEP GENERATION; HOLLIDAY JUNCTION; CRISPR/CAS SYSTEM; HUMAN-CELLS; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; RUVC RESOLVASE; SPECIFICITY; TRANSCRIPTION	The CRISPR-associated endonuclease Cas9 can be targeted to specific genomic loci by single guide RNAs (sgRNAs). Here, we report the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 angstrom resolution. The structure revealed a bilobed architecture composed of target recognition and nuclease lobes, accommodating the sgRNA: DNA heteroduplex in a positively charged groove at their interface. Whereas the recognition lobe is essential for binding sgRNA and DNA, the nuclease lobe contains the HNH and RuvC nuclease domains, which are properly positioned for cleavage of the complementary and noncomplementary strands of the target DNA, respectively. The nuclease lobe also contains a carboxyl-terminal domain responsible for the interaction with the protospacer adjacent motif (PAM). This high-resolution structure and accompanying functional analyses have revealed the molecular mechanism of RNA-guided DNA targeting by Cas9, thus paving the way for the rational design of new, versatile genome-editing technologies.	[Nishimasu, Hiroshi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, Tokyo 1130032, Japan; [Ran, F. Ann; Hsu, Patrick D.; Konermann, Silvana; Shehata, Soraya I.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Ran, F. Ann; Hsu, Patrick D.; Konermann, Silvana; Shehata, Soraya I.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Konermann, Silvana; Shehata, Soraya I.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Konermann, Silvana; Shehata, Soraya I.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, CREST JST, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; RIKEN; Japan Science & Technology Agency (JST); RIKEN	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.	zhang@broadinstitute.org; nureki@biochem.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Hsu, Patrick/ABD-5749-2021; Macrae, Rhiannon/AAX-1536-2020; Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410; Hsu, Patrick/0000-0002-9380-2648	PRESTO from the Japan Science and Technology (JST) Agency and Platform for Drug Discovery and Informatics; Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Core Research for Evolutional Science and Technology (CREST) Program, The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation of Japan Science and Technology Agency (JST); NIH Director's Pioneer Award [5DP1-MH100706]; Keck Foundation; McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	PRESTO from the Japan Science and Technology (JST) Agency and Platform for Drug Discovery and Informatics(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program, The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by PRESTO from the Japan Science and Technology (JST) Agency and Platform for Drug Discovery and Informatics (to H.N.); by a grant from the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) (to O.N.); and by the Core Research for Evolutional Science and Technology (CREST) Program, The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation of Japan Science and Technology Agency (JST), (to O.N.). F.Z. is supported by an NIH Director's Pioneer Award (5DP1-MH100706); by the Keck, McKnight, Poitras, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations; and by Bob Metcalfe and Jane Pauley. A patent application has been filed related to this work, and the authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab Web site (http://www.genome-engineering.org).	ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen L, 2013, NUCLEIC ACIDS RES, V41, P648, DOI 10.1093/nar/gks1015; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	40	1080	1412	39	495	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					935	949		10.1016/j.cell.2014.02.001	http://dx.doi.org/10.1016/j.cell.2014.02.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24529477	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000332083900012
J	Baggett, MV; Turbett, SE; Schwartzenberg, SS; Stone, JR				Baggett, Meridale V.; Turbett, Sarah E.; Schwartzenberg, Shmuel S.; Stone, James R.			Case 5-2014: A 59-Year-Old Man with Fever, Confusion, Thrombocytopenia, Rash, and Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOUNTAIN SPOTTED-FEVER; INFECTIVE ENDOCARDITIS; SURGICAL PATHOLOGY; PATHOGENESIS; SPECIMENS; DIAGNOSIS; LESIONS		[Baggett, Meridale V.; Turbett, Sarah E.; Schwartzenberg, Shmuel S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Baggett, Meridale V.; Turbett, Sarah E.; Schwartzenberg, Shmuel S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Baggett, MV (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				GlaxoSmithKline; Merck	GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company)	Dr. Stone reports receiving consulting fees from GlaxoSmithKline and Merck, and providing expert testimony for GlaxoSmithKline regarding rosiglitazone. No other potential conflict of interest relevant to this article was reported.	Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097/00005792-200111000-00002; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Castonguay MC, 2013, CARDIOVASC PATHOL, V22, P19, DOI 10.1016/j.carpath.2012.05.007; Centers for Disease Control and Prevention, ROCK MOUNT SPOTT FEV; Chirinos JA, 2007, CLIN RHEUMATOL, V26, P590, DOI 10.1007/s10067-005-0176-z; Delgado-Jimenez Y, 2013, INT J DERMATOL, V52, P1071, DOI 10.1111/j.1365-4632.2012.05468.x; FARRIOR JB, 1976, CHEST, V70, P239, DOI 10.1378/chest.70.2.239; Gunson TH, 2007, AUSTRALAS J DERMATOL, V48, P251, DOI 10.1111/j.1440-0960.2007.00397.x; HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5; Miller DV, 2004, HUM PATHOL, V35, P1112, DOI 10.1016/j.humpath.2004.05.013; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; MURRAY HW, 1977, ARCH INTERN MED, V137, P844, DOI 10.1001/archinte.137.7.844; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; RAO AK, 1988, NEW ENGL J MED, V318, P1021, DOI 10.1056/NEJM198804213181603; Roberson J C 2nd, 1995, J Clin Rheumatol, V1, P118, DOI 10.1097/00124743-199504000-00011; Siddiquee Z, 2012, CARDIOVASC PATHOL, V21, P470, DOI 10.1016/j.carpath.2012.02.001; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; Thiene G, 2006, CARDIOVASC PATHOL, V15, P256, DOI 10.1016/j.carpath.2006.05.009	20	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					651	660		10.1056/NEJMcpc1310004	http://dx.doi.org/10.1056/NEJMcpc1310004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521112				2022-12-28	WOS:000331187500012
J	Coenders-Gerrits, AMJ; van der Ent, RJ; Bogaard, TA; Wang-Erlandsson, L; Hrachowitz, M; Savenije, HHG				Coenders-Gerrits, A. M. J.; van der Ent, R. J.; Bogaard, T. A.; Wang-Erlandsson, L.; Hrachowitz, M.; Savenije, H. H. G.			Uncertainties in transpiration estimates	NATURE			English	Letter							FRESH-WATER DISCHARGE; INTERANNUAL VARIABILITY; INTERCEPTION; SURFACE; CANOPY; FOREST		[Coenders-Gerrits, A. M. J.; van der Ent, R. J.; Bogaard, T. A.; Wang-Erlandsson, L.; Hrachowitz, M.; Savenije, H. H. G.] Delft Univ Technol, Water Resources Sect, NL-2628 CN Delft, Netherlands; [Wang-Erlandsson, L.] Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden	Delft University of Technology; Stockholm University	Coenders-Gerrits, AMJ (corresponding author), Delft Univ Technol, Water Resources Sect, Stevinweg 1, NL-2628 CN Delft, Netherlands.	a.m.j.coenders@tudelft.nl	Wang-Erlandsson, Lan/V-5999-2019; Coenders, Miriam/C-8713-2011; van der Ent, Ruud J/K-8593-2016; Savenije, H/AAS-1883-2020	Wang-Erlandsson, Lan/0000-0002-7739-5069; Coenders, Miriam/0000-0002-7340-4685; van der Ent, Ruud J/0000-0001-5450-4333; Hrachowitz, Markus/0000-0003-0508-1017; Bogaard, Thom/0000-0002-1325-024X				Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; Gerrits AMJ, 2010, HYDROL PROCESS, V24, P3011, DOI 10.1002/hyp.7712; Hrachowitz M, 2013, HYDROL EARTH SYST SC, V17, P533, DOI 10.5194/hess-17-533-2013; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kendall C., 1998, ISOTOPE TRACERS CATC, DOI [10.1016/c2009-0-10239-8, DOI 10.1016/C2009-0-10239-8, 10.1016/C2009-0-10239-8]; Miralles DG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013530; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Syed TH, 2010, P NATL ACAD SCI USA, V107, P17916, DOI 10.1073/pnas.1003292107; Wang DG, 2007, J HYDROL, V347, P308, DOI 10.1016/j.jhydrol.2007.09.041; Welp LR, 2011, NATURE, V477, P579, DOI 10.1038/nature10421; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Zhang S., 2010, ACTA ECOL SIN, V30, P201, DOI [10.1016/j.chnaes.2010.06.003, DOI 10.1016/J.CHNAES.2010.06.003]	15	126	130	4	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					E1	E2		10.1038/nature12925	http://dx.doi.org/10.1038/nature12925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24522603				2022-12-28	WOS:000331107700001
J	Young, MJ; Lehmann, LS				Young, Michael J.; Lehmann, Lisa Soleymani			Undocumented Injustice? Medical Repatriation and the Ends of Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENTAL-HEALTH; SAFETY-NET; TRANSFERS; IMMIGRATION; REFUGEES		[Young, Michael J.; Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Young, MJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 1936, CHICAGO TRIBUNE; [Anonymous], 2013, 900863 ICN CTR MED M; [Anonymous], 2013, 1699 UCLA CTR HLTH P; Appel JM, 2012, AM J BIOETHICS, V12, P9, DOI 10.1080/15265161.2012.692436; Banatvala N, 1998, PREHOSP DISASTER MED, V13, P17; Breen JO, 2012, NEW ENGL J MED, V366, P2045, DOI 10.1056/NEJMp1202039; Coast J, 2001, Health Expect, V4, P243, DOI 10.1046/j.1369-6513.2001.00147.x; Daniels N, ROUTLEDGE C IN PRESS; HIMMELSTEIN DU, 1984, AM J PUBLIC HEALTH, V74, P494, DOI 10.2105/AJPH.74.5.494; Kane C., 2003, IMPACT EMTALA PHYS P; KELLERMANN AL, 1988, AM J PUBLIC HEALTH, V78, P1287, DOI 10.2105/AJPH.78.10.1287; Kuczewski M, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2012.692433; McNamara RM, 2013, J EMERG MED, V45, P111, DOI 10.1016/j.jemermed.2012.12.019; Monger R., 2009, FOREIGN BORN COMPONE; New York Lawyers for the Public Interest Center for Social Justice at Seton Hall Law School, 2012, DISCH DEP DANG JOURN; Parmet WE, 2013, NEW ENGL J MED, V369, P596, DOI 10.1056/NEJMp1306637; Passel J.S., 2013, POPULATION DECLINE U; Pfeffer N, 1991, IS QUALITY GOOD YOU, P45; Pitt D., 2013, ASS PRESS       0424; Ramji-Nogales J, 2007, STANFORD LAW REV, V60, P295; Rumbaut R.G., 2006, IMMIGRANT AM PORTRAI; Sabin M, 2006, REV PANAM SALUD PUBL, V19, P163, DOI 10.1590/S1020-49892006000300004; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; Shah JP, 2012, J GEN INTERN MED, V27, P1142, DOI 10.1007/s11606-012-2040-6; Sommers BD, 2013, NEW ENGL J MED, V369, P593, DOI 10.1056/NEJMp1306636; Tienda M, 2013, DAEDALUS-US, V142, P48, DOI 10.1162/DAED_a_00218; von Lersner U, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-88; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d; Zallman L, 2013, HEALTH AFFAIR, V32, P1153, DOI 10.1377/hlthaff.2012.1223	29	9	10	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					669	673		10.1056/NEJMhle1311198	http://dx.doi.org/10.1056/NEJMhle1311198			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA6CX	24521116				2022-12-28	WOS:000331187500017
J	Omer, SB; Peterson, D; Curran, EA; Hinman, A; Orenstein, WA				Omer, Saad B.; Peterson, Diane; Curran, Eileen A.; Hinman, Alan; Orenstein, Walter A.			Legislative Challenges to School Immunization Mandates, 2009-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							POLICIES		[Omer, Saad B.; Curran, Eileen A.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Peterson, Diane] Immunizat Act Coalit, St Paul, MN USA; [Hinman, Alan] Task Force Global Hlth, Decatur, GA USA; [Orenstein, Walter A.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	Omer, SB (corresponding author), Emory Univ, 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA.	somer@emory.edu						Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037	2	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					620	621		10.1001/jama.2013.282869	http://dx.doi.org/10.1001/jama.2013.282869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519303	Bronze			2022-12-28	WOS:000330941000019
J	Heimsath, AM				Heimsath, Arjun M.			Limits of Soil Production?	SCIENCE			English	Editorial Material							EROSION; CLIMATE		Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Heimsath, AM (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	arjun.heimsath@asu.edu	Heimsath, Arjun M/D-9214-2013					DiBiase RA, 2012, EARTH SURF PROC LAND, V37, P855, DOI 10.1002/esp.3205; Dixon JL, 2012, CR GEOSCI, V344, P597, DOI 10.1016/j.crte.2012.10.012; Ferrier KL, 2008, EARTH PLANET SC LETT, V272, P591, DOI 10.1016/j.epsl.2008.05.024; Heimsath AM, 2012, NAT GEOSCI, V5, P210, DOI [10.1038/NGEO1380, 10.1038/ngeo1380]; Larsen IJ, 2014, SCIENCE, V343, P637, DOI 10.1126/science.1244908; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Montgomery D., 2007, SPELLING HANDWRITING; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Willenbring JK, 2013, GEOLOGY, V41, P343, DOI 10.1130/G33918.1	12	7	7	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					617	618		10.1126/science.1250173	http://dx.doi.org/10.1126/science.1250173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503841				2022-12-28	WOS:000330724000028
J	Wang, C; Potter, AC; Senthil, T				Wang, Chong; Potter, Andrew C.; Senthil, T.			Classification of Interacting Electronic Topological Insulators in Three Dimensions	SCIENCE			English	Article								A fundamental open problem in condensed-matter physics is how the dichotomy between conventional and topological band insulators is modified in the presence of strong electron interactions. We show that there are six interacting electronic topological insulators that have no noninteracting counterpart. Combined with the previously known band insulators, these produce a total of eight topologically distinct phases. Two of the six interacting topological insulators can be described as Mott insulators in which the electron spins form spin analogs of the topological band insulator. The remaining phases are obtained as combinations of these two "topological paramagnets" and the topological band insulator. We prove that these eight phases form a complete list of all possible interacting topological insulators and discuss their experimental signatures.	[Wang, Chong; Potter, Andrew C.; Senthil, T.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Potter, Andrew C.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Senthil, T (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	senthil@mit.edu	Potter, Andrew/AAM-1480-2020; Todadri, Senthil/ABG-1337-2021	Potter, Andrew/0000-0001-5048-1269	U.S. Department of Energy [DESC-8739-ER46872]; NSF [DGE-0801525]; Simons Foundation [229736]	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Simons Foundation	We thank X. Chen, C.-M. Jian, and particularly A. Vishwanath for useful discussions and B. Swingle and P. A. Lee for comments on our manuscript. This work was supported by U.S. Department of Energy DESC-8739-ER46872 (T. S. and C. W.), by NSF grant DGE-0801525 (A. C. P.), and partially by the Simons Foundation by award no. 229736 (T. S.). T. S. also thanks the hospitality of Harvard University, where this work was partially done. After this work was completed, we learned of (40), which also pointed out the relation between Kramers fermion and theta = pi TI.	Balents L, 1999, PHYS REV B, V60, P1654, DOI 10.1103/PhysRevB.60.1654; Chen X, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155114; Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; Fidkowski L, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041016; Fidkowski L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075103; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Gu Z-C., EFFECT INTERATIONS 2; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hasan MZ, 2011, ANNU REV CONDEN MA P, V2, P55, DOI 10.1146/annurev-conmatphys-062910-140432; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; Levin M., 2012, PHYS REV B, V86; Liu ZX, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067205; Lu YM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125119; Metlitski MA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035131; Pesin D, 2010, NAT PHYS, V6, P376, DOI 10.1038/NPHYS1606; Qi XL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/065002; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Ryu S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245132; Ryu S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065010; Schuch N, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165139; Senthil T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046801; Senthil T, 2000, PHYS REV B, V62, P7850, DOI 10.1103/PhysRevB.62.7850; Tang E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.096403; Turner AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075102; Wang C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235122; Wen X.G., 2004, QUANTUM FIELD THEORY; Xu CK, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174412	30	183	184	9	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					629	631		10.1126/science.1243326	http://dx.doi.org/10.1126/science.1243326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503848	Green Submitted			2022-12-28	WOS:000330724000035
J	Bagchi, R; Gallery, RE; Gripenberg, S; Gurr, SJ; Narayan, L; Addis, CE; Freckleton, RP; Lewis, OT				Bagchi, Robert; Gallery, Rachel E.; Gripenberg, Sofia; Gurr, Sarah J.; Narayan, Lakshmi; Addis, Claire E.; Freckleton, Robert P.; Lewis, Owen T.			Pathogens and insect herbivores drive rainforest plant diversity and composition	NATURE			English	Article							DEPENDENT SEEDLING MORTALITY; SPECIES SHADE TOLERANCE; DENSITY-DEPENDENCE; RECRUITMENT; COEXISTENCE; PREDATION; FEEDBACK	Tropical forests are important reservoirs of biodiversity(1), but the processes that maintain this diversity remain poorly understood(2). The Janzen-Connell hypothesis(3,4) suggests that specialized natural enemies such as insect herbivores and fungal pathogens maintain high diversity by elevating mortality when plant species occur at high density (negative density dependence; NDD). NDD has been detected widely in tropical forests(5-9), but the prediction that NDD caused by insects and pathogens has a community-wide role in maintaining tropical plant diversity remains untested. We show experimentally that changes in plant diversity and species composition are caused by fungal pathogens and insect herbivores. Effective plant species richness increased across the seed-to-seedling transition, corresponding to large changes in species composition(5). Treating seeds and young seedlings with fungicides significantly reduced the diversity of the seedling assemblage, consistent with the Janzen-Connell hypothesis. Although suppressing insect herbivores using insecticides did not alter species diversity, it greatly increased seedling recruitment and caused a marked shift in seedling species composition. Overall, seedling recruitment was significantly reduced at high con-specific seed densities and this NDD was greatest for the species that were most abundant as seeds. Suppressing fungi reduced the negative effects of density on recruitment, confirming that the diversity enhancing effect of fungi is mediated by NDD. Our study provides an overall test of the Janzen-Connell hypothesis and demonstrates the crucial role that insects and pathogens have both in structuring tropical plant communities and in maintaining their remarkable diversity.	[Bagchi, Robert; Gallery, Rachel E.; Gripenberg, Sofia; Narayan, Lakshmi; Addis, Claire E.; Lewis, Owen T.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bagchi, Robert] ETH, Inst Terr Ecosyst, Ecosyst Management Grp, CH-8092 Zurich, Switzerland; [Gallery, Rachel E.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Gripenberg, Sofia] Univ Turku, Dept Biol, Sect Biodivers & Environm Res, Turku 20014, Finland; [Gurr, Sarah J.] Univ Exeter, Dept Biosci, Exeter EX4 4QD, Devon, England; [Gurr, Sarah J.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Arizona; University of Turku; University of Exeter; University of Oxford; University of Sheffield	Lewis, OT (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	owen.lewis@zoo.ox.ac.uk	Bagchi, Robert/F-1732-2011; Gripenberg, Sofia/AAA-3410-2022; Gallery, Rachel E/I-2169-2014; Lewis, Owen T/B-9531-2011; Freckleton, Rob P/B-6455-2013	Bagchi, Robert/0000-0003-4035-4105; Gripenberg, Sofia/0000-0002-8788-2258; Lewis, Owen/0000-0001-7935-6111; Freckleton, Robert/0000-0002-8338-864X; Gallery, Rachel/0000-0002-9159-8778	Natural Environment Research Council (NERC) [NE/DO10721/1]; Academy of Finland [126296]; BBSRC [BB/J008923/1, BB/J008923/2, BB/G00207X/1] Funding Source: UKRI; NERC [NE/D010721/1] Funding Source: UKRI; Direct For Biological Sciences [1257139] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/G00207X/1, BB/J008923/2, BB/J008923/1] Funding Source: researchfish; Natural Environment Research Council [NE/D010721/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Permission to undertake research in the Chiquibul Forest Reserve was granted by the Ministry of Natural Resources, Belize under Scientific Collection/Research Permit CD/60/3/07(20). We thank the staff at the Las Cuevas Research Station (the late N. Bol, C. Bol, M. Bol and J. Boucher) for their help; and R. Cocomb, E. Miles, C. Rasell, M. Senior, T. Swinfield and O. Theisinger provided field assistance. H. Rue provided advice on implementing measurement error models in INLA. This research was funded by the Natural Environment Research Council (NERC; standard grant NE/DO10721/1) and S.G. was funded by grant 126296 from the Academy of Finland.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bagchi R, 2010, ECOL LETT, V13, P1262, DOI 10.1111/j.1461-0248.2010.01520.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bridgewater S., 2012, NATURAL HIST BELIZE, V1st; Bridgewater S. G. M., 2006, Edinburgh Journal of Botany, V63, P269, DOI 10.1017/S0960428606000618; Carroll RJ, 2006, MEASUREMENT ERROR NO, V2nd ed., DOI DOI 10.1201/9781420010138; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONNELL J H, 1971, P298; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Norghauer JM, 2006, OECOLOGIA, V148, P437, DOI 10.1007/s00442-006-0395-2; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Pinheiro JC, 2000, MIXED EFFECTS MODELS; R Development Core Team, 2009, R LANG ENV STAT COMP; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Theimer TC, 2011, ECOLOGY, V92, P1637, DOI 10.1890/10-2231.1; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	37	413	436	37	708	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					85	+		10.1038/nature12911	http://dx.doi.org/10.1038/nature12911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24463522	Green Submitted			2022-12-28	WOS:000330648100036
J	Jacob, JA				Jacob, Julie A.			"Vaccine hesitant" parents affect vaccination rates in some communities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												julieajacob@aol.com						Children's Hospital of Philadelphia Vaccine Education Center, 2013, FACTS CHILDH VACC; Seither R, 2013, MMWR-MORBID MORTAL W, V62, P607	2	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g1211	10.1136/bmj.g1211	http://dx.doi.org/10.1136/bmj.g1211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496468				2022-12-28	WOS:000331060200003
J	Dewachi, O; Skelton, M; Nguyen, VK; Fouad, FM; Abu Sitta, G; Maasri, Z; Giacaman, R				Dewachi, Omar; Skelton, Mac; Vinh-Kim Nguyen; Fouad, Fouad M.; Abu Sitta, Ghassan; Maasri, Zeina; Giacaman, Rita			Changing therapeutic geographies of the Iraqi and Syrian wars	LANCET			English	Article							HEALTH; POLITICS; CARE	The health consequences of the ongoing US-led war on terror and civil armed conflicts in the Arab world are much more than the collateral damage inflicted on civilians, infrastructure, environment, and health systems. Protracted war and armed conflicts have displaced populations and led to lasting transformations in health and health care. In this report, we analyse the effects of conflicts in Iraq and Syria to show bow wars and conflicts have resulted in both the militarisation and regionalisation of health care, conditions that complicate the rebuilding of previously robust national health-care systems. Moreover, we show how historical and transnational frameworks can be used to show the longtei III consequences of war and conflict on health and health care. We introduce the concept of therapeutic geographies-defined as the geographic reorganisation of health care within and across borders under conditions of war.	[Dewachi, Omar; Fouad, Fouad M.] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon; [Maasri, Zeina] Amer Univ Beirut, Dept Architecture & Design, Beirut, Lebanon; [Skelton, Mac] Johns Hopkins Univ, Dept Anthropol, Baltimore, MD USA; [Vinh-Kim Nguyen] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Fouad, Fouad M.] Syrian Ctr Tobacco Studies, Aleppo, Syria; [Abu Sitta, Ghassan] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Giacaman, Rita] Birzeit Univ, Inst Community Hlth, Ramallah, West Bank, Palestine	American University of Beirut; American University of Beirut; Johns Hopkins University; Universite de Montreal; American University of Beirut; Birzeit University	Dewachi, O (corresponding author), Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon.	oa02@aub.edu.lb	Abu-Sittah, Ghassan/AAE-3169-2020	Maasri, Zeina/0000-0002-4395-7406				Abu-Rish Ziad, 2013, JADALIYYA; Al Hilfi TK, 2013, LANCET, V381, P939, DOI 10.1016/S0140-6736(13)60320-7; Al Mosawi AJ, 2008, J CONTIN EDUC HEALTH, V28, P103, DOI 10.1002/chp.166; Amnesty International, 2011, CLIM FEAR SYR HOSP P; [Anonymous], 2012, LANCET, V380, P537, DOI 10.1016/S0140-6736(12)61309-9; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2013, MIS WAR ZON LIF SYR; [Anonymous], 2008, LANCET, V371, P2008; Assessment Working Group for Northern Syria, 2013, JOINT RAP ASS NO SYR; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Brodney M, 2013, MED TREATMENT FIRE E; Burkle FM, 2004, LANCET, V364, P1371, DOI 10.1016/S0140-6736(04)17196-1; Burnham G, 2012, INT J HEALTH PLAN M, V27, pe51, DOI 10.1002/hpm.1091; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; Chatelard G., 2010, DISPOSSESSION DISPLA; Coupland R, 2011, HLTH CARE DANGER 16; Coupland R, 2007, B WORLD HEALTH ORGAN, V85, P181, DOI 10.2471/BLT.06.037135; Coutts A, 2013, LANCET, V381, pE6, DOI 10.1016/S0140-6736(13)60053-7; Dewachi O, 2013, WAR COSTS MED TRAVEL; Donaldson RI, 2012, PREHOSP DISASTER MED, V27, P153, DOI 10.1017/S1049023X12000519; Duffield M, 2007, DEV SECURITY UNENDIN; Fieldhouse D.K., 2006, W IMPERIALISM MIDDLE; Furber AS, 2004, J EPIDEMIOL COMMUN H, V58, P890, DOI 10.1136/jech.2003.019216; Gregory D, 2011, GEOGR J, V177, P238, DOI 10.1111/j.1475-4959.2011.00426.x; Hassan H, 2013, EUROPEAN COUNCI 0613; Haysom S., 2013, SANCTUARY CITY URBAN; Hoskins E, 1993, WAR PUBLIC HLTH; International Crisis Group, 2013, CLOS COMF SYR LEB; Jolly D, 2013, NEW YORK TIME U 0613; Kelly PF, 1999, PROG HUM GEOG, V23, P379, DOI 10.1177/030913259902300303; Koechler H, 2002, WAR TERROR ITS IMPAC; LARISSA FAST, 2013, SECURITY FACTS HUMAN; Longuenesse, 2012, PUBLIC HLTH ARAB WOR; MacFarquhar N, 2013, NEW YORK TIME U 0323; Manson, 2013, FINANC TIMES; Marlowe JM, 2010, J REFUG STUD, V23, P183, DOI 10.1093/jrs/feq013; Maziak W, 2009, INT J PUBLIC HEALTH, V54, P349, DOI 10.1007/s00038-009-0061-7; Medecins Sans Frontieres, 2012, FLEEING VIOL SYR SYR; Medecins Sans Frontieres, 2011, HLTH SERV PAR BAHR M; Merill S, 2010, WAR MACHINE GLOBAL H; Monsutti A, 2010, DISPOSSESSION DISPLA, V14; Mowafi H, 2011, GLOB PUBLIC HEALTH, V6, P1; Newman E, 2004, SECUR DIALOGUE, V35, P173, DOI 10.1177/0967010604044975; Paley AR, 2006, WASHINGTON POST 0830; Pantuliano S, 2011, CITY LIMITS URBANIS; Pollack Ken, 2013, FALL RISE FALL IRAQ; Reif K, 2006, CONFLICT FUELS IRAQI; Rubenstein LS, 2010, LANCET, V375, P329, DOI 10.1016/S0140-6736(09)61926-7; Ryan C., 2012, NEW ARAB COLD WAR ST; Skelton M, 2013, DECLINES HLTH HLTH C; Sollom R, 2012, GUN ONGOING ASSAULTS; Sollom R, 2011, WITNESS WAR CRIMES E; Sullivan R, 2011, J ROY SOC MED, V104, P490, DOI 10.1258/jrsm.2011.110230; Tell T, 2014, LANCET, V383, P480, DOI 10.1016/S0140-6736(13)62548-9; Ulutas U, 2013, MIDDLE E MONITO 0829; UN Assistance Mission for Iraq, 2008, HUM RIGHTS REP JAN J; United Nations General Assembly, 2013, REP IND INT COMM INQ; United Nations High Commissioner for Refugees, 2012, DISPL NEW 21 CENT CH; Wakabi W, 2011, LANCET, V377, P2167, DOI 10.1016/S0140-6736(11)60946-X; WHO, 2013, WHO HLTH SYST FRAM; WHO, 2013, JORD SAYS HLTH SERV; WHO, 2008, SOC DET HLTH COUNTR, V32; WHO Regional Office for the Eastern Mediterranean, 2012, SYR AR REP JORD LEB; Williamson JA, 2011, INT REV RED CROSS, V93, P1035, DOI 10.1017/S1816383112000380; World Health Organization (WHO), 2013, DON UPD SYR AR REP; Zetter R, 2012, FORCED MIGRATION CHA	66	69	69	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					449	457		10.1016/S0140-6736(13)62299-0	http://dx.doi.org/10.1016/S0140-6736(13)62299-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24452046				2022-12-28	WOS:000330673700034
J	Zhang, XY				Zhang, Xiaoyu			Delayed Gratification-Waiting to Terminate Stem Cell Identity	SCIENCE			English	Editorial Material							POLYCOMB GROUP PROTEINS; HISTONE H3; ARABIDOPSIS; MAINTENANCE; MOTIFS; GENES; LEAFY; LINK		Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Zhang, XY (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	xiaoyu@plantbio.uga.edu	Zhang, xiaoyu/GXA-3206-2022					Berger N, 2011, PLANT CELL, V23, P4065, DOI 10.1105/tpc.111.087866; Deng WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-593; He CS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00454; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	12	7	9	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					498	499		10.1126/science.1249343	http://dx.doi.org/10.1126/science.1249343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482475				2022-12-28	WOS:000330343700034
J	Liu, HP; Moynihan, KD; Zheng, YR; Szeto, GL; Li, AV; Huang, B; Van Egeren, DS; Park, C; Irvine, DJ				Liu, Haipeng; Moynihan, Kelly D.; Zheng, Yiran; Szeto, Gregory L.; Li, Adrienne V.; Huang, Bonnie; Van Egeren, Debra S.; Park, Clara; Irvine, Darrell J.			Structure-based programming of lymph-node targeting in molecular vaccines	NATURE			English	Article							DELIVERY; OLIGONUCLEOTIDES; VACCINATION; ANTIGEN; CELLS	In cancer patients, visual identification of sentinel lymph nodes (LNs) is achieved by the injection of dyes that bind avidly to endogenous albumin, targeting these compounds to LNs, where they are efficiently filtered by resident phagocytes(1,2). Here we translate this 'albumin hitchhiking' approach to molecular vaccines, through the synthesis of amphiphiles (amph-vaccines) comprising an antigen or adjuvant cargo linked to a lipophilic albumin-binding tail by a solubility-promoting polar polymer chain. Administration of structurally optimized CpG-DNA/peptide amph-vaccines in mice resulted in marked increases in LN accumulation and decreased systemic dissemination relative to their parent compounds, leading to 30-fold increases in T-cell priming and enhanced anti-tumour efficacy while greatly reducing systemic toxicity. Amph-vaccines provide a simple, broadly applicable strategy to simultaneously increase the potency and safety of subunit vaccines.	[Liu, Haipeng; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Liu, Haipeng; Moynihan, Kelly D.; Zheng, Yiran; Szeto, Gregory L.; Li, Adrienne V.; Huang, Bonnie; Park, Clara; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Liu, Haipeng; Moynihan, Kelly D.; Zheng, Yiran; Szeto, Gregory L.; Li, Adrienne V.; Huang, Bonnie; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Van Egeren, Debra S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	djirvine@mit.edu	Szeto, Gregory/N-9648-2019; Zheng, Yiran/U-6049-2017	Szeto, Gregory/0000-0001-7604-1333; Van Egeren, Debra/0000-0002-4017-0413; Moynihan, Kelly/0000-0001-6200-7863; Zheng, Yiran/0000-0002-6545-7867	Koch Institute from the National Cancer Institute [P30-CA14051]; National Institutes of Health [AI091693, AI104715, AI095109]; Department of Defense [W911NF-13-D-0001, W911NF-07-D-0004, T.O. 8]; Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology and Harvard; NATIONAL CANCER INSTITUTE [P30CA014051, F32CA180586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095109, U19AI091693, P01AI104715] Funding Source: NIH RePORTER	Koch Institute from the National Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology and Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the National Institutes of Health (grants AI091693, AI104715 and AI095109), the Department of Defense (W911NF-13-D-0001 and W911NF-07-D-0004, T.O. 8) and the Ragon Institute of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard. D.J.I. is an investigator of the Howard Hughes Medical Institute. We thank T. C. Wu for kindly providing the TC-1 tumour cells. We thank the Koch Institute Swanson Biotechnology Center for technical support, specifically the applied therapeutics and whole animal imaging core facility, histology and flow cytometry core facility. The authors acknowledge the service to the MIT community of the late Sean Collier.	Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Faries MB, 2000, ANN SURG ONCOL, V7, P98, DOI 10.1007/s10434-000-0098-6; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Johansen P, 2010, J CONTROL RELEASE, V148, P56, DOI 10.1016/j.jconrel.2010.05.019; John ALS, 2012, NAT MATER, V11, P250, DOI [10.1038/NMAT3222, 10.1038/nmat3222]; Kastantin M, 2010, J PHYS CHEM B, V114, P12632, DOI 10.1021/jp1001786; Keler T, 2007, ONCOGENE, V26, P3758, DOI 10.1038/sj.onc.1210375; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; KRIEG AM, 1995, ANTISENSE RES DEV, V5, P241, DOI 10.1089/ard.1995.5.241; Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266; Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446; Pal I, 2011, ADV DRUG DELIVER REV, V63, P909, DOI 10.1016/j.addr.2011.05.018; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Salhab M, 2011, SURG ONCOL, V20, pE195, DOI 10.1016/j.suronc.2011.06.006; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Schreurs MWJ, 2000, CANCER RES, V60, P6995; Tenbusch M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039038; TRUBETSKOY VS, 1995, ADV DRUG DELIVER REV, V16, P311, DOI 10.1016/0169-409X(95)00032-3; Tsopelas C, 2002, J NUCL MED, V43, P1377; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905	28	582	603	26	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					519	+		10.1038/nature12978	http://dx.doi.org/10.1038/nature12978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24531764	Green Submitted, Green Accepted			2022-12-28	WOS:000333402000045
J	Arabi, YM; Arifi, AA; Balkhy, HH; Najm, H; Aldawood, AS; Ghabashi, A; Hawa, H; Alothman, A; Khaldi, A; Al Raiy, B				Arabi, Yaseen M.; Arifi, Ahmed A.; Balkhy, Hanan H.; Najm, Hani; Aldawood, Abdulaziz S.; Ghabashi, Alaa; Hawa, Hassan; Alothman, Adel; Khaldi, Abdulaziz; Al Raiy, Basel			Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-FREQUENCY OSCILLATION; ACUTE LUNG INJURY; DISTRESS-SYNDROME; NITRIC-OXIDE; MERS-COV; SARS; CORTICOSTEROIDS; REPLICATION	Background: Since September 2012, 170 confirmed infections with Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization, including 72 deaths. Data on critically ill patients with MERS-CoV infection are limited. Objective: To describe the critical illness associated with MERS-CoV. Design: Case series. Setting: 3 intensive care units (ICUs) at 2 tertiary care hospitals in Saudi Arabia. Patients: 12 patients with confirmed or probable MERS-CoV infection. Measurements: Presenting symptoms, comorbid conditions, pulmonary and extrapulmonary manifestations, measures of severity of illness and organ failure, ICU course, and outcome are described, as are the results of surveillance of health care workers (HCWs) and patients with potential exposure. Results: Between December 2012 and August 2013, 114 patients were tested for suspected MERS-CoV; of these, 11 ICU patients (10%) met the definition of confirmed or probable cases. Three of these patients were part of a health care-associated cluster that also included 3 HCWs. One HCW became critically ill and was the 12th patient in this case series. Median Acute Physiology and Chronic Health Evaluation II score was 28 (range, 16 to 36). All 12 patients had underlying comorbid conditions and presented with acute severe hypoxemic respiratory failure. Most patients (92%) had extrapulmonary manifestations, including shock, acute kidney injury, and thrombocytopenia. Five (42%) were alive at day 90. Of the 520 exposed HCWs, only 4 (1%) were positive. Limitation: The sample size was small. Conclusion: MERS-CoV causes severe acute hypoxemic respiratory failure and considerable extrapulmonary organ dysfunction and is associated with high mortality. Community-acquired and health care-associated MERS-CoV infection occurs in patients with chronic comorbid conditions. The health care-associated cluster suggests that human-to-human transmission does occur with unprotected exposure.	King Saud bin Abdulaziz Univ Hlth Sci, Riyadh 11426, Saudi Arabia; King Abdulaziz Hosp, Al Hasa 31982, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Hospital - Al Ahsa	Arabi, YM (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Intens Care, Mail Code 1425,POB 22490, Riyadh 11426, Saudi Arabia.	arabi@ngha.med.sa	Arifi, Ahmed/AAM-8591-2021; Arabi, Yaseen/ABF-3316-2020	Arabi, Yaseen/0000-0001-5735-6241				Afshari A, 2011, ANESTH ANALG, V112, P1411, DOI 10.1213/ANE.0b013e31820bd185; Akerstrom S, 2009, VIROLOGY, V395, P1, DOI 10.1016/j.virol.2009.09.007; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Auyeung TW, 2005, J INFECTION, V51, P98, DOI 10.1016/j.jinf.2004.09.008; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Gomersall CD, 2004, CRIT CARE, V8, P105, DOI 10.1186/cc2452; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Kuri T, 2010, VIRULENCE, V1, P273, DOI 10.4161/viru.1.4.11465; Lu L, 2013, MICROBES INFECT, V15, P625, DOI 10.1016/j.micinf.2013.06.003; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Mer M, 1998, CHEST, V114, P426, DOI 10.1378/chest.114.2.426; Momattin H, 2013, INT J INFECT DIS, V17, pE792, DOI 10.1016/j.ijid.2013.07.002; Morgenstern B, 2005, BIOCHEM BIOPH RES CO, V326, P905, DOI 10.1016/j.bbrc.2004.11.128; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Paragas J, 2005, ANTIVIR RES, V66, P99, DOI 10.1016/j.antiviral.2005.01.002; Perlman S, 2013, MBIO, V4; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Sweeney AM, 2005, CRIT CARE MED, V33, P204; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Tran K, 2013, CADTH Technol Overv, V3, pe3201; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; World Health Organization, 2013, GLOB AL RESP REV INT; World Health Organization, 2013, GLOB AL RESP MODDL E; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	35	408	431	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					389	+		10.7326/M13-2486	http://dx.doi.org/10.7326/M13-2486			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24474051				2022-12-28	WOS:000333521300015
J	Gluck, AR				Gluck, Abbe R.			A Legal Victory for Insurance Exchanges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A federal judge has rejected a challenge to the new health insurance exchanges that could have crippled the Affordable Care Act by denying tax subsidies to the 73% of Americans who are expected to purchase their health insurance through a federally run exchange. Health care reform won a big victory in court on January 15, when a federal judge in Washington, D.C., rejected a challenge to the new health insurance marketplaces, or exchanges, created under the Affordable Care Act (ACA). Had this challenge succeeded, it could have crippled the ACA by denying its generous tax subsidies to the more than 12.5 million Americans expected to use this financial assistance to buy their health insurance through a federally run exchange. The exchanges' technical difficulties have received much attention, but this legal challenge is arguably more important, because it goes to the heart of one ...	Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Gluck, AR (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							[Anonymous], 2014, CIV NO 13 0623	1	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					896	899		10.1056/NEJMp1400707	http://dx.doi.org/10.1056/NEJMp1400707			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC2EB	24499178				2022-12-28	WOS:000332309800006
J	Ottersen, OP; Dasgupta, J; Blouin, C; Buss, P; Chongsuvivatwong, V; Frenk, J; Fukuda-Parr, S; Gawanas, BP; Giacaman, R; Gyapong, J; Leaning, J; Marmot, M; McNeill, D; Mongella, GI; Moyo, N; Mogedal, S; Ntsaluba, A; Ooms, G; Bjertness, E; Lie, AL; Moon, S; Roalkvam, S; Sandberg, KI; Scheel, IB				Ottersen, Ole Petter; Dasgupta, Jashodhara; Blouin, Chantal; Buss, Paulo; Chongsuvivatwong, Virasakdi; Frenk, Julio; Fukuda-Parr, Sakiko; Gawanas, Bience P.; Giacaman, Rita; Gyapong, John; Leaning, Jennifer; Marmot, Michael; McNeill, Desmond; Mongella, Gertrude I.; Moyo, Nkosana; Mogedal, Sigrun; Ntsaluba, Ayanda; Ooms, Gorik; Bjertness, Espen; Lie, Ann Louise; Moon, Suerie; Roalkvam, Sidsel; Sandberg, Kristin I.; Scheel, Inger B.			The political origins of health inequity: prospects for change	LANCET			English	Review							GLOBAL FINANCIAL CRISIS; SOCIAL DETERMINANTS; GOVERNANCE; POLICY; TRADE; TOBACCO; EQUITY; ACCESS; FRAMEWORK; DYNAMICS		[Ottersen, Ole Petter] Univ Oslo, Univ Presidents Offi, Oslo, Norway; [McNeill, Desmond; Roalkvam, Sidsel; Sandberg, Kristin I.] Univ Oslo, Ctr Dev & Environm, Oslo, Norway; [Bjertness, Espen; Lie, Ann Louise; Scheel, Inger B.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Dasgupta, Jashodhara] SAHAYOG, Lucknow, Uttar Pradesh, India; [Blouin, Chantal] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Buss, Paulo] Fundacao Oswaldo Cruz, Ctr Global Hlth, Rio De Janeiro, Brazil; [Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand; [Leaning, Jennifer] Harvard Univ, FXB Ctr Hlth & Human Rights, Boston, MA USA; [Frenk, Julio] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA USA; [Fukuda-Parr, Sakiko] New Sch Social Res, Grad Program Int Aff airs, New York, NY 10011 USA; [Gawanas, Bience P.] Minist Hlth & Social, Windhoek, Namibia; [Giacaman, Rita] Birzeit Univ, West Bank, Occupied Palestinian Terr, Inst Community & Publ Hlth, Birzeit, Israel; [Gyapong, John] Univ Ghana, Accra, Ghana; UCL, Dept Epidemiol & Publ Hlth, London, England; [Mongella, Gertrude I.] Advocacy Women Africa, Dar Es Salaam, Tanzania; [Moyo, Nkosana] Mandela Inst Dev Studies, Johannesburg, South Africa; [Mogedal, Sigrun] Norwegian Knowledge Ctr Hlth Serv, Global Hlth Unit, Oslo, Norway; [Ntsaluba, Ayanda] Discovery Holdings, Johannesburg, South Africa; [Ooms, Gorik] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Moon, Suerie] Harvard Univ, Harvard Global Hlth Inst, Cambridge, MA 02138 USA	University of Oslo; University of Oslo; University of Oslo; Institut national de sante publique du Quebec (INSPQ); Fundacao Oswaldo Cruz; Prince of Songkla University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; The New School; Birzeit University; University of Ghana; University of London; University College London; Norwegian Knowledge Centre for Health Services; Institute of Tropical Medicine (ITM); Harvard University	Ottersen, OP (corresponding author), POB 1072, N-0316 Oslo, Norway.	rektor@uio.no	Ooms, Gorik/A-2537-2015; Marmot, M G/Y-3920-2019	Ooms, Gorik/0000-0002-9804-0128; Marmot, M G/0000-0002-2431-6419; mcneill, desmond/0000-0002-8948-3197; Moon, Suerie/0000-0001-8504-1212; Gyapong, John/0000-0002-8415-1468	Norwegian Agency for Development Cooperation (NORAD); Norwegian Ministry of Foreign Affairs; Norwegian Ministry of Education and Research; Board of the University of Oslo (Oslo, Norway); Institute of Health and Society at the University of Oslo; Centre for Development and the Environment at the University of Oslo; Harvard Global Health Institute (Harvard University, Cambridge, MA, USA); British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0100222, G8802774, G0601647, G19/35, G0701830, G0902037, G1000616] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0601647, G1000616, G0902037, G0701830] Funding Source: UKRI	Norwegian Agency for Development Cooperation (NORAD)(CGIAR); Norwegian Ministry of Foreign Affairs; Norwegian Ministry of Education and Research; Board of the University of Oslo (Oslo, Norway); Institute of Health and Society at the University of Oslo; Centre for Development and the Environment at the University of Oslo; Harvard Global Health Institute (Harvard University, Cambridge, MA, USA); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of the Commission was made possible by unrestricted grants from the Norwegian Agency for Development Cooperation (NORAD), the Norwegian Ministry of Foreign Affairs, the Norwegian Ministry of Education and Research, the Board of the University of Oslo (Oslo, Norway), and by financial and in-kind support from the Institute of Health and Society and the Centre for Development and the Environment (both at the University of Oslo), and the Harvard Global Health Institute (Harvard University, Cambridge, MA, USA). The funding bodies had no influence on the direction, progress, writing, or publication of the report. Finances were administered in accordance with Norwegian law, and with full public disclosure. In addition to constructive advice and input, Jeanette H Magnus provided the administrative base and infrastructure for the Commission at the Institute for Health and Society at the University of Oslo. We are grateful to Harald Siem, who played an important part in establishing the Commission and led the Commission's Secretariat through the project's first phase, until summer, 2012. Valuable research assistance was provided by Emmanuella Asabor, Lotte Danielsen, Unni Gopinathan, Just Haffeld, Sverre O Lie, Diego Solares, Larissa Stendie, Elina Suzuki, Rosemary Wyber, and Alyssa Yamamoto. We also thank Maren O Kloster for her technical assistance, and Svein Hullstein for his administrative support. We are very thankful for Ron Labonte's insightful and constructive comments about, and input to, the draft report at various stages. We off er a special thanks to the People's Health Movement, which contributed with six background papers via an editorial group consisting of Bridget Lloyd, David Sanders, Amit Sengupta, and Hani Serag. The authors of these backgrond papers were Susana Barria, Alexis Benos, Anne-Emanuelle Birn, Chiara Bodini, Eugene Cairncross, Sharon Friel, Sophia Kisting, Elias Kondilis, David Legge, Mariette Liefferink, Baijayanta Mukhopadhyay, Lexi Bambas Nolen, Jagjit Plahe, Farah M Shroff, Angelo Stefanini, Anne-Marie Thow, Pol De Vos, David van Wyk, and Aed Yaghi. Three additional highly useful background papers were developed by David Woodward; Bjorn Skogmo and Sigrun Mogedal; and the Oslo Church City Mission (led by Per Kristian Hilden, with coauthors Christina Marie Brux Mburu, Arnhild Taksdal, Frode Eick, Kari Gran, Hanne Haagenrud, Olav Laegdene, Linnea Nasholm, Anna Olofsson). We also thank Bruce Ross-Larson for his excellent editorial advice; John-Arne Rottingen, who had an important role in the initiation of the project; and Tim Cadman for fruitful discussions. Our special thanks are extended to the Youth Commission on Global Governance for Health, chaired by Unni Gopinathan, for continuous feedback on the Commission's work, and to the Rockefeller Foundation for hosting the Commission at its centre in Bellagio, Italy. We are also very grateful to Jashodhara Dasgupta and Gertrude I Mongella for hosting Commission meetings in New Delhi, India, and Arusha, Tanzania, which involved invaluable contributions from local civil society actors and national authorities.	Abella MI, 2002, MIGRATIONS AVENIR, V14, P181; African Union, 2012, ROADM SHAR RESP GLOB; Al-Tuwaijri S, 2004, 10 90 REPORT HLTH RE; Alter KJ, 2009, PERSPECT POLIT, V7, P13, DOI 10.1017/S1537592709090033; Amnesty International and Greenpeace Netherlands, 2012, TOX TRUTH CO CALL TR; Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; Anand S., 2000, J HUMAN DEV, V1, P83, DOI [10.1080/14649880050008782, DOI 10.1080/14649880050008782]; [Anonymous], 2013, STATE FOOD INSECURIT; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 2009, FORCED MIGRATION REV, DOI DOI 10.1016/B978-0-7020-3008-6.50008-9; [Anonymous], 2009, EUROPEAN RES MIGRATI; [Anonymous], 2005, NW J INT LAW BUS, V26; [Anonymous], 2012, 5 WAYS TACKLE DIS DI; [Anonymous], 1982, POVERTY FAMINES ESSA; [Anonymous], 2012, BLOOMBERG; [Anonymous], 2011, BASEL CONVENTION CON; [Anonymous], 2003, INT MIGR HLTH HUM RI; [Anonymous], 12 PREC; [Anonymous], 2012, GLOBAL HLTH WATCH 3, V3, P165; Bambas-Nolen L, 2013, CASE STUDY EXTRACTIV; Bambra C, 2005, HEALTH PROMOT INT, V20, P187, DOI 10.1093/heapro/dah608; Beall R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001154; Benatar S, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P1, DOI 10.1017/CBO9780511984792; Benatar SR, 2009, INT AFF, V85, P347, DOI 10.1111/j.1468-2346.2009.00797.x; Bench Marks Foundation, 2012, WHAT GOV NEEDS PREV; Bernauer T, 2013, GLOBAL ENVIRON CHANG, V23, P439, DOI 10.1016/j.gloenvcha.2013.01.001; Betts A, 2010, INT J REFUG LAW, V22, P209, DOI 10.1093/ijrl/eeq018; Beuchelt TD, 2012, AGR HUM VALUES, V29, P259, DOI 10.1007/s10460-012-9355-0; Bill & Melinda Gates Foundation, WHO WE AR FDN FACT S; Birn A-E, 2009, SOCIAL MED, V4, P166; Biswas D, 2012, HEALTH HUM RIGHTS, V14, P49; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Blyth M., 2013, AUSTERITY HIST DANGE; Boas M., 2004, GLOBAL I DEV FRAMING, P1; Borras S., 2010, BROADER VIEW POLITIC, V001; Borras SM, 2012, J AGRAR CHANGE, V12, P34, DOI 10.1111/j.1471-0366.2011.00339.x; Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; Breman A., 2001, COMMISSION MACROECON, VWG6, P6; Business & Human Rights Resource Centre, 2012, CORP LEG ACC ANN BRI; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Carrin G, 2007, B WORLD HEALTH ORGAN, V85, P652, DOI 10.2471/BLT.07.046664; Chakravarty S, 1993, POLICY MAKING MIXED; Chatterjee P., 2013, INTELLECTUAL PROPERT; Commission on Intellectual Property Rights Innovation and Public Health (CIPIH), 2006, PUBL HLTH INN INT PR; Corp Watch, 2007, BARR DIRT SECR COMM; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cotula, 2011, LAND DEALS AFRICA WH; Dardagan H., 2013, STOLEN FUTURES HIDDE; Dauvergne C, 2008, LAW CONTEXT, P1, DOI 10.1017/CBO9780511810473; Davies A. A., 2010, Eurohealth, V16, P10; De Schutter O., 2010, FOOD COMMODITIES SPE, V1, P14; DeSchutter O., 2009, INT TRADE AGR RIGHT; Desmarais AA, 2008, J RURAL STUD, V24, P138, DOI 10.1016/j.jrurstud.2007.12.002; Duvell F., 2011, GLOBAL MIGRATION GOV, V1st; Efrat A, 2010, INT ORGAN, V64, P97, DOI 10.1017/S0020818309990257; Eisler R, 2003, ENVIRON GEOCHEM HLTH, V25, P325, DOI 10.1023/A:1024573701073; Erturk Y, 2013, AHRC76ADD4 UN GEN AS; European Public Health Alliance, 2012, OP LETT EUR COUNC EU; FAO, FAO FOOD PRIC IND; FAO, 2011, STAT FOOD INS WORLD; Ferguson J., 2002, ANTHR POLITICS READE, P399; Fidler DP, 2010, CHALLENGES GLOBAL HL; Finnemore M, 1998, INT ORGAN, V52, P887, DOI 10.1162/002081898550789; Florini A.M., 2012, 3 FORCE RISE TRANSNA; Fong GT, 2009, B WORLD HEALTH ORGAN, V87, P640, DOI 10.2471/BLT.09.069575; Fonn S, 2011, REPROD HEALTH MATTER, V19, P11, DOI 10.1016/S0968-8080(11)38584-9; Food and Agriculture Organization, 2008, NUMB HUNGR PEOPL RIS; Freehills HS, 2013, LEXOLOGY        0821; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Friel S, 2013, CHALLENGES FOOD SOVE; Fukuda-Parr S, 2009, INT NORM DYNAMICS EN; Garret L., 2013, EXISTENTIAL CHALLENG; Global Health Watch, 2011, GLOBAL HLTH WATCH; Global Witness, 2012, COM CLEAN SUPPL CHAI; Goldman L, 2002, TOXICS POVERTY IMPAC; Gonzalez C., 2002, COLUMBIA J ENV LAW, V27, P433; Gonzalez CG, 2012, NAT RESOUR ENV, P26; Green DJ, 2001, J ASIAN EC, V12, P309; Greene O, 2011, SMALL ARMS CRIME CON, P248; Grover A., 2009, AHRC1112 UN GEN ASS; Grover A., 2013, AHRC2341 UN GEN ASS; Guiding Principles on Business and Human Rights, 2011, REV DIREITO INT; Gunnell D, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1891; Haar RJ, 2012, HLTH POSTCONFLICT FR; HAAS PM, 1992, INT ORGAN, V46, P1, DOI 10.1017/S0020818300001442; Hall GH, 2012, INDIGENOUS PEOPLES, POVERTY, AND DEVELOPMENT, P1, DOI 10.1017/CBO9781139105729; Harff B, 2009, GLOBAL RESPONSIBILIT, V1, P506; Hendrickson M, GLOBAL FOOD SYSTEM N; Hendrix C, 2011, FOOD INSECURITY VIOL; Hilden PK, 2012, DIACONIA, V3, P128; Hoad V, 2010, AUST NZ J PUBL HEAL, V34, P214, DOI 10.1111/j.1753-6405.2010.00509.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holt V, 2009, PROTECTING CIVILIANS; Holtom P., 2012, GLOBAL OBSERVATORY; Horton R, 2009, LANCET, V373, P355, DOI 10.1016/S0140-6736(09)60116-1; Howden-Chapman P, 2005, 4 MIN HLTH NZ; Human Development, 2013, RIS S HUM PROGR DIV; ICRC, 1949, CONV 3 REL TREATM PR; ICRC, 2012, DR CONG HUM SIT DET; IFAD/UNEP, 2013, SMALLH FOOD SEC ENV; IHME, 2012, FIN GLOB HLTH 2012 E; ILO, 2013, WORLD WORK REP 2013; ILO, 2011, SOC PROT FAIR INCL G; ILO, 2013, GLOB EMPL TRENDS 201; ILO (International Labour Organization), 2004, INT LAB C 92 SESS; International Coalition for the Responsibility to Protect, 2013, INT COALITION RESPON; International Conference on Primary Health Care, 1978, WHO Chron, V32, P428; International Council on Human Rights Policy, 2010, IRR MIGR MIGR SMUGGL; Kaldor M., 2007, NEW OLD WARS; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Khagram S, 2005, DAMS DEV TRANSNATION; Kickbusch I, 2006, CAN J PUBLIC HEALTH, V97, P6, DOI 10.1007/BF03405203; Kickbusch I, 2005, BRIT MED J, V331, P246, DOI 10.1136/bmj.331.7511.246; Kickbusch I, 2012, HEALTH PROMOT INT, V27, P427, DOI 10.1093/heapro/das057; Kondilis E, 2013, FISCAL POLICIES EURO; Kristiansen M, 2007, DAN MED BULL, V54, P46; Kurtz J., 2011, CONVERSATION; Labonte R, 2003, BRIT MED J, V326, P722, DOI 10.1136/bmj.326.7392.722; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; Labonte R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-21; Leaning J, 2003, GLOBAL HLTH CHALLENG, P13; Lee K, 2007, B WORLD HEALTH ORGAN, V85, P207, DOI 10.2471/BLT.06.037077; Lee K, 2010, CRIT PUBLIC HEALTH, V20, P5, DOI 10.1080/09581590903563573; Leitenberg M., 2006, DEATHS WARS CONFLICT; Lencucha R, 2011, HEALTH POLICY PLANN, V26, P405, DOI 10.1093/heapol/czq072; Leval PN, 2013, FOREIGN AFF, V92, P16; Levy BS, 2008, WAR PUBLIC HLTH; Lewis P, 2012, OPEN DEMOCRACY; Manfred H., 2008, SOCIAL AFFAIRS EQUAL; Manson, 2013, FINANC TIMES; Margulis ME, EVOLVING GLOBAL GOVE; Marmot M G, 2009, BMJ, V338, pb1314, DOI 10.1136/bmj.b1314; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; Mckeon N., 2011, GLOBAL GOVERNANCE WO; Mitchell R.B., 2006, GLOBAL ENV ASSESSMEN; Moody G., 2013, TECHDIRT        0208; Moran M, 2012, NEGLECTED DIS RES DE; Moran T., 2005, DOES FOREIGN DIRECT; Narula S., 2010, YALE HUMAN RIGHTS DE, V13, P403; NIH, 2011, NIH ALMANAC APPR; NIH, 2013, NIH PUBL ACC POL DET; O'Neill WG, 2009, GLOB RESPONSIB PROT, V1, P478; OECD, 2013, COUNTR STAT PROF IC; OECD, 2013, BETT LIF IND JOBS; OECD, 2012, THINK GLOB ACT GLOB; OECD, 2013, IC EC FOR SUMM MAY 2; Office of the Under Secretary of Defence, WELC OUSD C PUBL WEB; Oien C., 2011, NO WAY NO WAY OUT ST; Ooms G, 2010, GLOB S HLTH SYST RES; Ooms G, 2012, GLOB POLICY, V3, P476, DOI 10.1111/j.1758-5899.2012.00201.x; Ooms G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-17; Organization W. H, CONTR GLOB OB EP; Ortiz I, 2013, AG AUSTERITY REV PUB; Oslo Church City Mission, 2013, UNDOCUMENTED MIGRATI; Ottersen OP, 2011, LANCET, V378, P1612, DOI 10.1016/S0140-6736(11)61617-6; Oxfam America, 2003, INV DESTR; Paley Amit R, 2006, WASHINGTON POST; Pejic J, 2011, INT REV RED CROSS, V93, P189, DOI 10.1017/S1816383111000130; Peterson L. E., 2005, GLOBAL GOVERNANCE FO; Phillips Leigh, 2011, GUARDIAN; Prakash A., 2011, SAFEGUARDING FOOD SE; Prasad N, 2010, GLOB SOC POLICY, V10, P218, DOI 10.1177/1468018110366627; Price R, 1998, INT ORGAN, V52, P613, DOI 10.1162/002081898550671; Rechel B., 2011, MIGRATION HLTH EUROP; Robles M., 2009, IFPRI ISSUE BRIEF, V57; Rodrik D., 2012, GLOBALIZATION PARADO; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Ruckert A, 2012, CRIT PUBLIC HEALTH, V22, P267, DOI 10.1080/09581596.2012.685053; Ruggie John, 2011, REPORT SPECIAL REPRE; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Sauvant K.P., 2013, IMPROVING INT INVEST; Schoepf BG, 2000, DYING GROWTH GLOBAL, P91; Scholte J.A., 2011, BUILDING GLOBAL DEMO; Schultz M., 2013, HUMAN PROSPERITY REQ; Sell Susan, 2003, PRIVATE POWER PUBLIC; Sep?lveda, 2012, UNDERWRITING POOR GL; Silverman E., 2012, PHARMALOT       1213; Slim Hugo, 2008, KILLING CIVILIANS ME; Smith N., 2012, BBC NEWS; Sornarajah M, 2010, INT LAW FOREIGN INVE; Stahl T., 2006, HLTH ALL POLICIES PR; Steffek J, 2007, TRANSFORM STATE, P95; Stiglitz Joseph, 2012, PEOPLE POWER PROFITS; Stockholm International Peace Research Institute, SIPRI MIL EXP DAT; Stuckler D, 2013, BODY EC WHY USTERITY; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Suber P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5184; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; SZLEZAK Nicole A., 2010, PLOS MED, V7, P1, DOI DOI 10.1371/J0URNAL.PMED.1000183&TYPE=PRINTABLE; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; Taran P., 2003, GLOBALIZATION LABOUR; Thakur R, 2006, UN GLOBAL GOVERNANCE; The Harvard Library, 2012, FAC ADV COUNC MEM J; The World We Want Initiative, 2013, HLTH POST 2015 AG RE; tHoen Ellen F.M., 2009, GLOBAL POLITICS PHAR; Thow AM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-5; Torero M, 2011, 2011 GLOBAL HUNGER I; Tuncak B, 2013, PATHS GLOBAL CHEM SA; UN, 2012, RIGHT EV ENJ HIGH AT; UN Conference on Trade and Development, 2013, REF INV STAT DISP SE; UN Conference on Trade and Development, 2007, WORLD INV REP TRANSN; UN Conference on Trade and Development, RES POL AN; UN Conference on Trade and Development, 2013, GLOB INVEST TRENDS M, V11, P1; UN Department of Economic and Social Affairs Population Division, 2011, INT MIGR REP 2009 GL; UN Economic and Social Council, 2000, RIGHT HIGH ATT STAND; UN General Assembly, 1990, ARES45158 UN GEN ASS; UN General Assembly, 1966, INT CONV EC SOC CULT; UN General Assembly, 1948, UNIVERSAL DECLARATIO, V302; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; UN Secretary General, 2013, LIFE DIGN ALL ACC PR; UN Security Council, 2012, S2012376 UN SEC COUN; UNDP, 2013, CHANG NAT CONFL PRIO; UNDP, 1998, HUM DEV REP 1998 CON; UNHCR, 2012, YEAR CRIS UNCHR GLOB; United Nation, 2012, MILL DEV GOALS REP; United Nations, 2000, UN MILL DECL GEN ASS; United Nations, 2013, NEW GLOB PARTN ER PO; United Nations Department of Economic and Social Affairs, 2003, TRENDS TOT MIGR STOC; United Nations Human Rights Council, 2013, AHRC24CRP2 UN HUM RI; van der Meulen B, 2010, ERASMUS LAW REV, V3, P217; Via Campesina, 2006, RIGHT PROD ACC LAND; Von Braun J., 2008, GLOBALIZATION FOOD A; Wade RH, 2003, REV INT POLIT ECON, V10, P621, DOI 10.1080/09692290310001601902; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Waterfield B, 2013, TELEGRAPH; Watson N, 2013, WHAT NEXT BRICS BANK; Weisbrot M., 2013, GUARDIAN; Weiss T. G, 2011, THINKING GLOBAL GOVE; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; WHO, GLOB HLTH OBS GHO UN; WHO, 2013, TOB FACT SHEET 339; WHO, 2011, INT REP IMPL TALL CH; WHO, 2013, GLOB UPD HIV TREATM; WHO, 2012, RESP CRIS DEM REP CO; WHO, 2010, A6321 WHO 63 WORLD H; WHO Consultative Expert Working Group on Research and Development: Financing and Coordination, 2012, RES DEV MEET HLTH NE; Wilkinson R., 2003, Social determinants of health: the solid facts; Wilkinson R., 2010, SPIRIT LEVEL WHY EQU; Woods N, 2013, TRANSFORMING GLOBAL; Woodward D., 2013, HIGH PRICE PAY IMF G; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2009, FIN CRIS GLOB HLTH R; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2012, REP CONS EXP WORK GR; World Health Organization, 2013, CHILDR RED MORT FACT; Wright BD, 2009, FOOD CRISIS 2007 200; WTO, 2001, DECL TRIPS AGR PUBL; WTO, NONG ORG NGOS WTO NG; Yanez L, 2002, ENVIRON HEALTH PERSP, V110, P901, DOI 10.1289/ehp.02110s6901; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	255	333	339	16	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					630	667		10.1016/S0140-6736(13)62407-1	http://dx.doi.org/10.1016/S0140-6736(13)62407-1			38	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KP	24524782				2022-12-28	WOS:000331137700032
J	Allen, RP; Chen, C; Garcia-Borreguero, D; Polo, O; DuBrava, S; Miceli, J; Knapp, L; Winkelman, JW				Allen, Richard P.; Chen, Crystal; Garcia-Borreguero, Diego; Polo, Olli; DuBrava, Sarah; Miceli, Jeffrey; Knapp, Lloyd; Winkelman, John W.			Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROUP RATING-SCALE; DOUBLE-BLIND; CONTROLLED-TRIAL; CLINICAL-TRIALS; SYNDROME RLS; AUGMENTATION; LEVODOPA; VALIDATION; ROPINIROLE; EFFICACY	BackgroundDopaminergic medications relieve symptoms of the restless legs syndrome (RLS) but have the potential to cause iatrogenic worsening (augmentation) of RLS with long-term treatment. Pregabalin may be an effective alternative. MethodsIn this 52-week, randomized, double-blind trial, we assessed efficacy and augmentation in patients with RLS who were treated with pregabalin as compared with placebo and pramipexole. Patients were randomly assigned to receive 52 weeks of treatment with pregabalin at a dose of 300 mg per day or pramipexole at a dose of 0.25 mg or 0.5 mg per day or 12 weeks of placebo followed by 40 weeks of randomly assigned active treatment. The primary analyses involved a comparison of pregabalin and placebo over a period of 12 weeks with use of the International RLS (IRLS) Study Group Rating Scale (on which the score ranges from 0 to 40, with a higher score indicating more severe symptoms), the Clinical Global Impression of Improvement scale (which was used to assess the proportion of patients with symptoms that were very much improved or much improved), and a comparison of rates of augmentation with pregabalin and pramipexole over a period of 40 or 52 weeks of treatment. ResultsA total of 719 participants received daily treatment, 182 with 300 mg of pregabalin, 178 with 0.25 mg of pramipexole, 180 with 0.5 mg of pramipexole, and 179 with placebo. Over a period of 12 weeks, the improvement (reduction) in mean scores on the IRLS scale was greater, by 4.5 points, among participants receiving pregabalin than among those receiving placebo (P<0.001), and the proportion of patients with symptoms that were very much improved or much improved was also greater with pregabalin than with placebo (71.4% vs. 46.8%, P<0.001). The rate of augmentation over a period of 40 or 52 weeks was significantly lower with pregabalin than with pramipexole at a dose of 0.5 mg (2.1% vs. 7.7%, P=0.001) but not at a dose of 0.25 mg (2.1% vs. 5.3%, P=0.08). There were six cases of suicidal ideation in the group receiving pregabalin, three in the group receiving 0.25 mg of pramipexole, and two in the group receiving 0.5 mg of pramipexole. ConclusionsPregabalin provided significantly improved treatment outcomes as compared with placebo, and augmentation rates were significantly lower with pregabalin than with 0.5 mg of pramipexole. (Funded by Pfizer; ClinicalTrials.gov number, NCT00806026.)	[Allen, Richard P.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21224 USA; [Chen, Crystal; DuBrava, Sarah; Miceli, Jeffrey; Knapp, Lloyd] Pfizer Global Res & Dev, Groton, CT USA; [Garcia-Borreguero, Diego] Sleep Res Inst, Madrid, Spain; [Polo, Olli] Tampere Univ Hosp, Dept Pulm Med, Tampere, Finland; [Winkelman, John W.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Johns Hopkins University; Pfizer; Tampere University; Tampere University Hospital; Harvard University; Massachusetts General Hospital	Allen, RP (corresponding author), Johns Hopkins Univ, Dept Neurol, 5501 Hopkins Bayview Cir, Baltimore, MD 21224 USA.	richardjhu@mac.com		Garcia-Borreguerro, Diego/0000-0003-1083-9654	Pfizer	Pfizer(Pfizer)	Funded by Pfizer; ClinicalTrials.gov number, NCT00806026.	Abetz L, 2004, CLIN THER, V26, P925, DOI 10.1016/S0149-2918(04)90136-1; AKPINAR S, 1982, ARCH NEUROL-CHICAGO, V39, P739, DOI 10.1001/archneur.1982.00510230065027; Allen R, 2010, SLEEP MED, V11, P512, DOI 10.1016/j.sleep.2010.03.003; Allen RP, 2013, SLEEP MED, V14, P1229, DOI 10.1016/j.sleep.2013.08.001; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Allen RP, 2009, SLEEP MED, V10, P1097, DOI 10.1016/j.sleep.2008.10.007; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Allen RP, 1996, SLEEP, V19, P205, DOI 10.1093/sleep/19.3.205; *BOEHR ING, MIR PRESCR INF; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007; Earley CJ, 2003, NEW ENGL J MED, V348, P2103, DOI 10.1056/NEJMcp021288; Garcia-Borreguero D, 2010, SLEEP MED, V11, P956, DOI 10.1016/j.sleep.2010.08.001; Garci-Borreguero D, 2007, SLEEP MED, V8, P455, DOI 10.1016/j.sleep.2007.03.023; Garcia-Borreguero D, 2012, MOVEMENT DISORD, V27, P277, DOI 10.1002/mds.24889; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Hays R.D., 1992, MEASURING FUNCTIONIN, P235; Hening WA, 2008, SLEEP MED, V9, P283, DOI 10.1016/j.sleep.2007.04.021; Hening WA, 2010, MOVEMENT DISORD, V25, P1675, DOI 10.1002/mds.23157; Hogl B, 2007, SLEEP MED, V8, pS7, DOI 10.1016/j.sleep.2007.04.008; Hogl B, 2011, SLEEP MED, V12, P351, DOI 10.1016/j.sleep.2010.12.007; Hogl B, 2010, J NEUROL, V257, P230, DOI 10.1007/s00415-009-5299-8; Micheva KD, 2006, MOL PHARMACOL, V70, P467, DOI 10.1124/mol.106.023309; Montplaisir J, 1999, NEUROLOGY, V52, P938, DOI 10.1212/WNL.52.5.938; MONTPLAISIR J, 1991, EUR NEUROL, V31, P41, DOI 10.1159/000116643; Montplaisir J, 2006, MOVEMENT DISORD, V21, P1627, DOI 10.1002/mds.21050; Oertel W, 2011, LANCET NEUROL, V10, P710, DOI 10.1016/S1474-4422(11)70127-2; Pfizer, LYR PRESCR INF; Quilici S, 2008, SLEEP MED, V9, P715, DOI 10.1016/j.sleep.2007.11.020; Silber MH, 2003, SLEEP, V26, P819, DOI 10.1093/sleep/26.7.819; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Walters AS, 1996, NEUROLOGY, V46, P92, DOI 10.1212/WNL.46.1.92; Winkelman JW, 2004, SLEEP MED, V5, P9, DOI 10.1016/j.sleep.2003.07.005	37	124	133	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					621	631		10.1056/NEJMoa1303646	http://dx.doi.org/10.1056/NEJMoa1303646			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521108				2022-12-28	WOS:000331187500008
J	Geisberg, JV; Moqtaderi, Z; Fan, XC; Ozsolak, F; Struhl, K				Geisberg, Joseph V.; Moqtaderi, Zarmik; Fan, Xiaochun; Ozsolak, Fatih; Struhl, Kevin			Global Analysis of mRNA Isoform Half-Lives Reveals Stabilizing and Destabilizing Elements in Yeast	CELL			English	Article							EXTENSIVE ALTERNATIVE POLYADENYLATION; GENOME-WIDE MEASUREMENT; POLY(A)-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CRYSTAL-STRUCTURE; EXOSOME COMPLEX; TRIPLE-HELIX; 3' ENDS; DECAY	We measured half-lives of 21,248 mRNA 30 isoforms in yeast by rapidly depleting RNA polymerase II from the nucleus and performing direct RNA sequencing throughout the decay process. Interestingly, half-lives of mRNA isoforms from the same gene, including nearly identical isoforms, often vary widely. Based on clusters of isoforms with different half-lives, we identify hundreds of sequences conferring stabilization or destabilization upon mRNAs terminating downstream. One class of stabilizing element is a polyU sequence that can interact with poly(A) tails, inhibit the association of poly(A)-binding protein, and confer increased stability upon introduction into ectopic transcripts. More generally, destabilizing and stabilizing elements are linked to the propensity of the poly(A) tail to engage in double-stranded structures. Isoforms engineered to fold into 3' stem-loop structures not involving the poly(A) tail exhibit even longer half-lives. We suggest that double-stranded structures at 3' ends are a major determinant of mRNA stability.	[Geisberg, Joseph V.; Moqtaderi, Zarmik; Fan, Xiaochun; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ozsolak, Fatih] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu			National Institutes of Health [GM30186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030186, R37GM030186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yi Jin, Koon-Ho Wong, Andreas Janzer, and other members of the K. S. laboratory for fruitful discussions and for critical reading of the manuscript. We thank Patrice Milos for her encouragement of this work. This work was supported by grant GM30186 to K. S. from the National Institutes of Health.	Allen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055718; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Cacace F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002772; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; Gilbert Chris, 2006, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2704s75; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hitti E, 2012, FRONT BIOSCI-LANDMRK, V17, P1846, DOI 10.2741/4023; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mitton-Fry RM, 2010, SCIENCE, V330, P1244, DOI 10.1126/science.1195858; Moqtaderi Z, 2013, P NATL ACAD SCI USA, V110, P11073, DOI 10.1073/pnas.1309384110; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Munchel SE, 2011, MOL BIOL CELL, V22, P2787, DOI 10.1091/mbc.E11-01-0028; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Tycowski KT, 2012, CELL REP, V2, P26, DOI 10.1016/j.celrep.2012.05.020; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wu XH, 2011, P NATL ACAD SCI USA, V108, P12533, DOI 10.1073/pnas.1019732108; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2; Zhang CX, 2013, MOL GENET GENOMICS, V288, P401, DOI 10.1007/s00438-013-0759-3; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	148	150	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					812	824		10.1016/j.cell.2013.12.026	http://dx.doi.org/10.1016/j.cell.2013.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529382	Green Accepted, Bronze			2022-12-28	WOS:000331379800018
J	Bega, D; Krainc, D				Bega, Danny; Krainc, Dimitri			Long-term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE: Recent advances in stem cell technologies have rekindled an interest in the use of cell replacement strategies for patients with Parkinson disease. This study reports the very long-term clinical outcomes of fetal cell transplantation in 2 patients with Parkinson disease. Such long-term follow-up data can usefully inform on the potential efficacy of this approach, as well as the design of trials for its further evaluation. OBSERVATIONS: Two patients received intrastriatal grafts of human fetal ventral mesencephalic tissue, rich in dopaminergic neuroblasts, as restorative treatment for their Parkinson disease. To evaluate the very long-term efficacy of the grafts, clinical assessments were performed 18 and 15 years posttransplantation. Motor improvements gained gradually over the first postoperative years were sustained up to 18 years posttransplantation, while both patients have discontinued, and remained free of any, pharmacological dopaminergic therapy. CONCLUSIONS AND RELEVANCE: The results from these 2 cases indicate that dopaminergic cell transplantation can offer very long-term symptomatic relief in patients with Parkinson disease and provide proof-of-concept support for future clinical trials using fetal or stem cell therapies.	[Bega, Danny; Krainc, Dimitri] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Krainc, D (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, 303 E Chicago Ave,Ward 12-140, Chicago, IL 60611 USA.	krainc@northwestern.edu						[Anonymous], TRANSEURO OPEN LABEL; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; KEFALOPOULOU, JAMA NEUROLOGY; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720	7	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					617	618		10.1001/jama.2013.285516	http://dx.doi.org/10.1001/jama.2013.285516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2RE	24519302				2022-12-28	WOS:000330941000018
J	Ross, AGP				Ross, Allen G. P.			PERSONAL VIEW Research that does not consider participants' health needs is unethical	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Griffith Univ, Griffith Hlth Inst, Nathan, Qld 4111, Australia	Griffith University; Menzies Health Institute Queensland	Ross, AGP (corresponding author), Griffith Univ, Griffith Hlth Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	a.ross@griffith.edu.au		Ross, Allen/0000-0002-2329-0907				Eyal N, 2012, AM J BIOETHICS, V12, P23, DOI 10.1080/15265161.2012.665134; Ross AGP, 2013, MICROBES INFECT, V15, P858, DOI 10.1016/j.micinf.2013.07.010	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2014	348								g1423	10.1136/bmj.g1423	http://dx.doi.org/10.1136/bmj.g1423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9WS	24519539				2022-12-28	WOS:000331444300012
J	Lockwood, DNJ; Shetty, V; Penna, GO				Lockwood, Diana N. J.; Shetty, Vanaja; Penna, Gerson Oliveira			Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY; INDIA		[Lockwood, Diana N. J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Shetty, Vanaja] Fdn Med Res, Mumbai, Maharashtra, India; [Penna, Gerson Oliveira] Univ Brasilia, Trop Med Ctr, BR-70910900 Brasilia, DF, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade de Brasilia	Lockwood, DNJ (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Diana.Lockwood@lshtm.ac.uk	Penna, Gerson/AAE-5254-2020	Penna, Gerson/0000-0001-8967-536X				[Anonymous], 2005, INT J LEPROSY, V73, P25; [Anonymous], 2012, REP WHO STRAT TECHN; Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; de Oliveira MLW, 1998, WHO TECH REP SER, V874, P1; Durrheim DN, 2002, LEPROSY REV, V73, P326; Penna MLF, 2011, J EPIDEMIOL COMMUN H, V65, P473, DOI 10.1136/jech.2011.133256; FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245; G-Finder, 2009, NEGLECTED DIS RES DE, P64; Ganapati R, 2005, INT J LEPROSY, V73, P229; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Leprosy update, 2011, WKLY EPIDEMIOL REC, V86, P389; Liu DZ, 2009, LEPROSY REV, V80, P410; Lockwood D, 2012, INT HLTH, V4, P240; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; Lockwood DNJ, 2010, OXFORD TXB MED; Meima A, 2004, B WORLD HEALTH ORGAN, V82, P373; Noto S., 2011, WHY IS BRAZIL DOING; Novartis Foundation, 2013, CURB INC LEPR; Penna GO, 2011, LEPROSY REV, V82, P210; Richardus JH, 2007, LEPROSY REV, V78, P330; Schoonbaert D, 2008, LEPROSY REV, V79, P387; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Shetty VP, 2009, LEPROSY REV, V80, P22; Siddiqui MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008351; Staples J, 2011, LEPROSY REV, V82, P91; Talhari S, 2005, REV SOC BRAS MED TRO, V38, P362, DOI 10.1590/S0037-86822005000400021; WHO, 2012, ACC WORK OV GLOB IMP, P13; *WHO, 2002, FIN PUSH STRAT EL LE; WHO, WHO DON MDT; World Health Assembly, 1993, HDB RES DEC WORLD HL; World Health Organisation, 2006, GLOB STRAT FURTH RED; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P317; World Health Organization, 2005, NAT PROGR MAN LEPR E; World Health Organization Study Group, 1982, WHO TECHN REP SER, P675	34	56	57	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2014	348								g1136	10.1136/bmj.g1136	http://dx.doi.org/10.1136/bmj.g1136			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4KD	24508610	Green Accepted			2022-12-28	WOS:000331063600002
J	Thompson, DWJ; Barnes, EA				Thompson, David W. J.; Barnes, Elizabeth A.			Periodic Variability in the Large-Scale Southern Hemisphere Atmospheric Circulation	SCIENCE			English	Article							STORM-TRACKS; INDEX CYCLES; PART I; OSCILLATION; WAVES	Periodic behavior in the climate system has important implications not only for weather prediction but also for understanding and interpreting the physical processes that drive climate variability. Here we demonstrate that the large-scale Southern Hemisphere atmospheric circulation exhibits marked periodicity on time scales of approximately 20 to 30 days. The periodicity is tied to the Southern Hemisphere baroclinic annular mode and emerges in hemispheric-scale averages of the eddy fluxes of heat, the eddy kinetic energy, and precipitation. Observational and theoretical analyses suggest that the oscillation results from feedbacks between the extratropical baroclinicity, the wave fluxes of heat, and radiative damping. The oscillation plays a potentially profound role in driving large-scale climate variability throughout much of the mid-latitude Southern Hemisphere.	[Thompson, David W. J.; Barnes, Elizabeth A.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	Colorado State University	Thompson, DWJ (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	davet@atmos.colostate.edu	Thompson, David W J/F-9627-2012; Barnes, Elizabeth A/O-1790-2014	Thompson, David W J/0000-0002-5413-4376; Barnes, Elizabeth A/0000-0003-4284-9320	NSF Climate Dynamics program	NSF Climate Dynamics program(National Science Foundation (NSF))	We thank R. Garreaud and J. M. Wallace for helpful discussion of the results, R. Barnes for insight into the analytic model, S. Wills for assistance with the AMSR-E data, and three anonymous reviewers for helpful comments on the manuscript. D.W.J.T. is supported by the NSF Climate Dynamics program.	ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Feldstein SB, 2000, J CLIMATE, V13, P4430, DOI 10.1175/1520-0442(2000)013<4430:TTPSAC>2.0.CO;2; Frierson DMW, 2006, J ATMOS SCI, V63, P2548, DOI 10.1175/JAS3753.1; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hartmann DL, 1998, J ATMOS SCI, V55, P1303, DOI 10.1175/1520-0469(1998)055<1303:WDZFVI>2.0.CO;2; HELD IM, 1994, B AM METEOROL SOC, V75, P1825, DOI 10.1175/1520-0477(1994)075<1825:APFTIO>2.0.CO;2; HOSKINS BJ, 1990, J ATMOS SCI, V47, P1854, DOI 10.1175/1520-0469(1990)047<1854:OTEOST>2.0.CO;2; KIDSON JW, 1986, MON WEATHER REV, V114, P1654, DOI 10.1175/1520-0493(1986)114<1654:ICITSH>2.0.CO;2; Kushner PJ, 1998, GEOPHYS RES LETT, V25, P4213, DOI 10.1029/1998GL900142; LINDZEN RS, 1980, J ATMOS SCI, V37, P1648, DOI 10.1175/1520-0469(1980)037<1648:ASARFT>2.0.CO;2; Lorenz DJ, 2001, J ATMOS SCI, V58, P3312, DOI 10.1175/1520-0469(2001)058<3312:EZFFIT>2.0.CO;2; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; NAMIAS J, 1950, J METEOROL, V7, P130, DOI 10.1175/1520-0469(1950)007<0130:TICAIR>2.0.CO;2; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; ROSSBY CG, 1948, SCIENCE, V108, P643, DOI 10.1126/science.108.2815.643; SIMMONS AJ, 1978, J ATMOS SCI, V35, P414, DOI 10.1175/1520-0469(1978)035<0414:TLCOSN>2.0.CO;2; Thompson D. W. J., 2014, J ATMOS SCI; Thompson DWJ, 2012, J ATMOS SCI, V69, P1811, DOI 10.1175/JAS-D-11-0187.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Vallis GK, 2006, ATMOSPHERE OCEAN FLU; WALLACE JM, 1985, TELLUS A, V37, P478, DOI 10.1111/j.1600-0870.1985.tb00445.x; WEBSTER PJ, 1975, J ATMOS SCI, V32, P1283, DOI 10.1175/1520-0469(1975)032<1283:AVVAIC>2.0.CO;2; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158	26	52	55	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					641	645		10.1126/science.1247660	http://dx.doi.org/10.1126/science.1247660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503850				2022-12-28	WOS:000330724000039
J	Vecchi, GA; Villarini, G				Vecchi, Gabriel A.; Villarini, Gabriele			Next Season's Hurricanes	SCIENCE			English	Editorial Material							TROPICAL CYCLONES; CLIMATE-CHANGE; MODEL; TRACKS		[Vecchi, Gabriel A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Villarini, Gabriele] Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA 52246 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Iowa	Vecchi, GA (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA.	gabriel.a.vecchi@noaa.gov	Villarini, Gabriele/F-8069-2016; Vecchi, Gabriel/A-2413-2008	Villarini, Gabriele/0000-0001-9566-2370; Vecchi, Gabriel/0000-0002-5085-224X	Div Atmospheric & Geospace Sciences [1262099] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bell R, 2013, J CLIMATE, V26, P7966, DOI 10.1175/JCLI-D-12-00749.1; Blake E. S., 2010, 29 C HURR TROP MET O; Colbert AJ, 2012, J CLIMATE, V25, P657, DOI 10.1175/JCLI-D-11-00034.1; Delworth TL, 2012, J CLIMATE, V25, P2755, DOI 10.1175/JCLI-D-11-00316.1; Kam JH, 2013, J CLIMATE, V26, P3067, DOI 10.1175/JCLI-D-12-00244.1; Klotzbach PJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037580; Kossin JP, 2010, J CLIMATE, V23, P3057, DOI 10.1175/2010JCLI3497.1; LaRow TE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041459; Long L., 2009, WORKSH HIGH RES CLIM; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Vecchi GA, 2011, MON WEATHER REV, V139, P1070, DOI 10.1175/2010MWR3499.1; Vitart F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030740; Wang H, 2009, J CLIMATE, V22, P4481, DOI 10.1175/2009JCLI2753.1	14	27	32	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					618	619		10.1126/science.1247759	http://dx.doi.org/10.1126/science.1247759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503842				2022-12-28	WOS:000330724000029
J	Bush, A; Grigg, J; Saglani, S				Bush, Andrew; Grigg, Jonathan; Saglani, Sejal			Managing wheeze in preschool children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EPISODIC VIRAL WHEEZE; 1ST 6 YEARS; INHALED CORTICOSTEROIDS; ORAL PREDNISOLONE; LUNG-FUNCTION; HIGH-RISK; ASTHMA; INTERMITTENT; INFANTS; VIRUS		[Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, London, England; [Bush, Andrew; Saglani, Sejal] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bush, Andrew; Saglani, Sejal] Royal Brompton Harefield NHS Fdn Trust, London, England; [Grigg, Jonathan] Barts & London Hosp, Blizzard Inst, London, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; University of London; Queen Mary University London	Bush, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	a.bush@imperial.ac.uk	Saglani, Sejal/AAE-5072-2019	Grigg, Jonathan/0000-0003-3109-6028; Saglani, Sejal/0000-0001-5192-6418	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01, 10/058, MRC-AsthmaUKCentre] Funding Source: researchfish	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: AB was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London.	Andersen ZJ, 2008, THORAX, V63, P710, DOI 10.1136/thx.2007.085480; Ater D, 2012, PEDIATRICS, V129, pE1397, DOI 10.1542/peds.2011-3376; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Bush A, 2007, BMJ-BRIT MED J, V335, P1037, DOI 10.1136/bmj.39374.600081.AD; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Castro-Rodriguez JA, 2009, PEDIATRICS, V123, pe519, DOI 10.1542/peds.2008-2867; Devulapalli CS, 2008, THORAX, V63, P8, DOI 10.1136/thx.2006.060616; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Elphick HE, 2000, EUR RESPIR J, V16, P593, DOI 10.1034/j.1399-3003.2000.16d04.x; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Harris JM, 2010, THORAX, V65, pA39, DOI 10.1136/thx.2010.150938.34; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kelly YJ, 1996, ARCH DIS CHILD, V75, P489, DOI 10.1136/adc.75.6.489; Levy ML, 2004, J ASTHMA, V41, P845, DOI 10.1081/JAS-200038451; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Pool J, 2012, THORAX, V67, P926, DOI 10.1136/thoraxjnl-2012-201607; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; Saglani S, 2005, ARCH DIS CHILD, V90, P961, DOI 10.1136/adc.2004.071134; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Schultz A, 2010, ACTA PAEDIATR, V99, P56, DOI 10.1111/j.1651-2227.2009.01508.x; Sonnappa S, 2011, EUR RESPIR J, V38, P1431, DOI 10.1183/09031936.00164910; Sonnappa S, 2010, J ALLERGY CLIN IMMUN, V126, P519, DOI 10.1016/j.jaci.2010.04.018; Stevens CA, 2002, THORAX, V57, P39, DOI 10.1136/thorax.57.1.39; Valovirta E, 2011, ANN ALLERG ASTHMA IM, V106, P518, DOI 10.1016/j.anai.2011.01.017; Warner JO, 2001, J ALLERGY CLIN IMMUN, V108, P929, DOI 10.1067/mai.2001.120015; WILSON N, 1995, ARCH DIS CHILD, V72, P317, DOI 10.1136/adc.72.4.317; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647	39	32	33	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g15	10.1136/bmj.g15	http://dx.doi.org/10.1136/bmj.g15			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496166				2022-12-28	WOS:000331060200013
J	Holmes, D				Holmes, David			Profile Keertan Dheda: rising star of pulmonary medicine	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					403	403		10.1016/S0140-6736(14)60140-9	http://dx.doi.org/10.1016/S0140-6736(14)60140-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24485575				2022-12-28	WOS:000330673700015
J	Leder, K; Pitter, K; LaPlant, Q; Hambardzumyan, D; Ross, BD; Chan, TA; Holland, EC; Michor, F				Leder, Kevin; Pitter, Ken; LaPlant, Quincey; Hambardzumyan, Dolores; Ross, Brian D.; Chan, Timothy A.; Holland, Eric C.; Michor, Franziska			Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules	CELL			English	Article							CANCER STEM-CELLS; ENGINEERED MOUSE MODELS; THERAPEUTIC IMPLICATIONS; PERIVASCULAR NICHE; SIMULATION-MODEL; MALIGNANT GLIOMA; TUMOR RESPONSE; IN-VIVO; RADIOTHERAPY; GROWTH	Glioblastomas (GBMs) are the most common and malignant primary brain tumors and are aggressively treated with surgery, chemotherapy, and radiotherapy. Despite this treatment, recurrence is inevitable and survival has improved minimally over the last 50 years. Recent studies have suggested that GBMs exhibit both heterogeneity and instability of differentiation states and varying sensitivities of these states to radiation. Here, we employed an iterative combined theoretical and experimental strategy that takes into account tumor cellular heterogeneity and dynamically acquired radioresistance to predict the effectiveness of different radiation schedules. Using this model, we identified two delivery schedules predicted to significantly improve efficacy by taking advantage of the dynamic instability of radioresistance. These schedules led to superior survival inmice. Our interdisciplinary approach may also be applicable to other human cancer types treated with radiotherapy and, hence, may lay the foundation for significantly increasing the effectiveness of a mainstay of oncologic therapy.	[Leder, Kevin] Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN 55455 USA; [Pitter, Ken; LaPlant, Quincey] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Brain Tumor Ctr, New York, NY 10065 USA; [Hambardzumyan, Dolores] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44195 USA; [Hambardzumyan, Dolores] Dept Mol Med, Cleveland, OH 44195 USA; [Ross, Brian D.] Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Holland, Eric C.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Holland, Eric C.] Univ Washington, Alvord Brain Tumor Ctr, Seattle, WA 98109 USA; [Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Holland, EC (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	eholland@fhcrc.org; michor@jimmy.harvard.edu	Chan, Timothy A/ABD-5850-2021	Pitter, Kenneth/0000-0002-9450-313X	National Science Foundation [RO1 CA100688, U54 CA163167, U54 CA143798, U01 CA141502-01, NSF DMS-1224362, MSTP GM07739, F31 NS076028, P01 CA085878]; NATIONAL CANCER INSTITUTE [U54CA163167, U54CA143798, U01CA141502, R01CA100688, P01CA085878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the Holland and Michor labs and Jasmine Foo for discussions and comments and National Institutes of Health and National Science Foundation grants RO1 CA100688, U54 CA163167, U54 CA143798, U01 CA141502-01 (to E. C. H.), U54 CA143798 (to F. M.), NSF DMS-1224362, U54 CA143798 (to K. L.), MSTP GM07739, F31 NS076028 (to K. P.), and P01 CA085878 (to B. D. R.).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; BLEEHEN NM, 1991, BRIT J CANCER, V64, P769, DOI 10.1038/bjc.1991.396; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Coughlin C, 2000, INT J RADIAT ONCOL, V48, P1351, DOI 10.1016/S0360-3016(00)01412-7; DALE RG, 1985, BRIT J RADIOL, V58, P515, DOI 10.1259/0007-1285-58-690-515; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Dionysiou DD, 2004, J THEOR BIOL, V230, P1, DOI 10.1016/j.jtbi.2004.03.024; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Fowler JF, 2010, BRIT J RADIOL, V83, P554, DOI 10.1259/bjr/31372149; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao XF, 2013, CANCER RES, V73, P1481, DOI 10.1158/0008-5472.CAN-12-3429; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Greve B, 2012, CYTOM PART A, V81A, P284, DOI 10.1002/cyto.a.22022; Gupta T, 2005, ACTA ONCOL, V44, P105, DOI 10.1080/02841860510007611; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Huse JT, 2009, BRAIN PATHOL, V19, P132, DOI 10.1111/j.1750-3639.2008.00234.x; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Massey SC, 2012, J R SOC INTERFACE, V9, P1757, DOI 10.1098/rsif.2012.0030; David EM, 2009, SEMIN RADIAT ONCOL, V19, P187, DOI 10.1016/j.semradonc.2009.02.007; Morton CI, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-48; NORTON L, 1988, CANCER RES, V48, P7067; Pallini R, 2011, CANCER-AM CANCER SOC, V117, P162, DOI 10.1002/cncr.25581; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pitter KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014545; Rockne R, 2009, J MATH BIOL, V58, P561, DOI 10.1007/s00285-008-0219-6; Scopelliti A, 2009, EXPERT OPIN BIOL TH, V9, P1005, DOI 10.1517/14712590903066687; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stamatakos GS, 2006, BRIT J RADIOL, V79, P389, DOI 10.1259/bjr/30604050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261	60	173	176	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					603	616		10.1016/j.cell.2013.12.029	http://dx.doi.org/10.1016/j.cell.2013.12.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485463	Bronze, Green Accepted			2022-12-28	WOS:000330580800024
J	Nightingale, H; Pfeffer, G; Horvath, R				Nightingale, Helen; Pfeffer, Gerald; Horvath, Rita			Chronic and slowly progressive weakness of the legs and hands	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MARIE-TOOTH-DISEASE; PERIPHERAL NEUROPATHY; HEREDITARY MOTOR; MFN2 MUTATIONS; NERVOUS-SYSTEM; SENSORY NEUROPATHIES; NATURAL-HISTORY; LATE-ONSET; MITOFUSIN-2; MANAGEMENT		[Nightingale, Helen; Pfeffer, Gerald; Horvath, Rita] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK	Horvath, R (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	rita.horvath@ncl.ac.uk	Horvath, Rita/AAY-7042-2020	Horvath, Rita/0000-0002-9841-170X; Nightingale, Helen/0000-0002-1021-0437; Pfeffer, Gerald/0000-0002-7657-7098	Medical Research Council [G1000848] Funding Source: Medline; Wellcome Trust [096919] Funding Source: Medline; MRC [G1000848] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aboussouan LS, 2007, LUNG, V185, P1, DOI 10.1007/s00408-006-0053-9; Adam M. P., 1993, GENEREVIEWS R; Bosch AM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-83; Burgunder JM, 2011, EUR J NEUROL, V18, P207, DOI 10.1111/j.1468-1331.2010.03069.x; Casasnovas C, 2010, J MED GENET, V47, P249, DOI 10.1136/jmg.2009.072488; Centner CM, 2013, LANCET NEUROL, V12, P295, DOI 10.1016/S1474-4422(13)70002-4; Chance PF, 2006, NEUROMOL MED, V8, P159, DOI 10.1385/NMM:8:1:159; Chetlin RD, 2004, MUSCLE NERVE, V30, P69, DOI 10.1002/mus.20078; Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174; Collins M, 2014, NEUROMUSCULAR DISORD, P733; d'Ydewalle C, 2012, INT J BIOCHEM CELL B, V44, P1299, DOI 10.1016/j.biocel.2012.04.020; Dacci P, 2012, J PERIPHER NERV SYST, V17, P422, DOI 10.1111/j.1529-8027.2012.00443.x; Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Halperin JJ, 2008, INFECT DIS CLIN N AM, V22, P261, DOI 10.1016/j.idc.2007.12.009; Irobi J, 2006, NEUROMOL MED, V8, P131, DOI 10.1385/NMM:8:1:131; Khedr EM, 2000, NEUROPSYCHOBIOLOGY, V41, P88, DOI 10.1159/000026638; Leite ACC, 2004, J NEUROL, V251, P877, DOI 10.1007/s00415-004-0455-7; LINDEMAN E, 1995, ARCH PHYS MED REHAB, V76, P612, DOI 10.1016/S0003-9993(95)80629-6; Mallik A, 2005, J NEUROL NEUROSUR PS, V76, P23, DOI 10.1136/jnnp.2005.069138; Muglia M, 2001, NEUROLOGY, V56, P100, DOI 10.1212/WNL.56.1.100; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; Nolano M, 2013, CLIN AUTON RES, V23, P149, DOI 10.1007/s10286-013-0189-7; Ouvrier R, 2010, DEV MED CHILD NEUROL, V52, P405, DOI 10.1111/j.1469-8749.2010.03675.x; Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; Postma TJ, 2013, ANN ONCOL, V24, P1424, DOI 10.1093/annonc/mdt173; RAMIREZ JA, 1986, ANN NEUROL, V19, P162, DOI 10.1002/ana.410190209; Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x; Richardson PG, 2012, LEUKEMIA, V26, P595, DOI 10.1038/leu.2011.346; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Shen Ting-Chin David, 2012, J Clin Neuromuscul Dis, V13, P137, DOI 10.1097/CND.0b013e31821c55a1; Shy ME, 2004, BRAIN, V127, P371, DOI 10.1093/brain/awh048; Sitarz KS, 2012, BRAIN, V135, DOI 10.1093/brain/aws049; SKRE H, 1974, CLIN GENET, V6, P98; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.ne.18.030195.000401; Szigeti K, 2006, NEUROMOL MED, V8, P243, DOI 10.1385/NMM:8:1:243; Takahashi R, 2012, INTERNAL MED, V51, P791, DOI 10.2169/internalmedicine.51.6676; UK Genetic Testing Network, 2013, GEN TEST NEUR COND M; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wilder-Smith EP, 2008, NAT CLIN PRACT NEURO, V4, P656, DOI 10.1038/ncpneuro0941; WILLISON HJ, 2003, J NEUROL NEUROSUR S2, V74, P3; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797	47	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2014	348								g459	10.1136/bmj.g459	http://dx.doi.org/10.1136/bmj.g459			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AV	24473995				2022-12-28	WOS:000330647600013
J	Hira-Kazal, R; Sayar, Z; Kothari, J; Ayrton, P; Berney, S; Maher, J				Hira-Kazal, Ravina; Sayar, Zara; Kothari, Jaimal; Ayrton, Puja; Berney, Sylvia; Maher, John			Cryoglobulinaemia identified by repeated analytical failure of laboratory tests	LANCET			English	Editorial Material									[Hira-Kazal, Ravina; Maher, John] Barnet & Chase Farm NHS Trust, Barnet Hosp, Dept Immunol, Barnet, Herts, England; [Sayar, Zara; Berney, Sylvia] Barnet & Chase Farm NHS Trust, Barnet Hosp, Dept Haematol, Barnet, Herts, England; [Ayrton, Puja] Barnet & Chase Farm NHS Trust, Barnet Hosp, Dept Chem Pathol, Barnet, Herts, England; [Kothari, Jaimal] Univ Coll London Hosp, Dept Haematol, London, England; [Maher, John] Kings Coll London, Dept Res Oncol, Guys Hosp, London WC2R 2LS, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Maher, J (corresponding author), Barnet Hosp, Dept Immunol, Wellhouse Lane, Barnet EN5 3DJ, Herts, England.	john.maher@kcl.ac.uk		Maher, John/0000-0001-8275-8488; Sayar, Zara/0000-0001-8838-9257				Damoiseaux J, 2014, CLIN REV ALLERG IMMU, V47, P299, DOI 10.1007/s12016-013-8390-y; Karras A, 2002, AM J KIDNEY DIS, V40, P1091, DOI 10.1053/ajkd.2002.36350; LERNER AB, 1947, AM J MED SCI, V214, P416, DOI 10.1097/00000441-194710000-00010	3	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					382	382		10.1016/S0140-6736(13)62635-5	http://dx.doi.org/10.1016/S0140-6736(13)62635-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24461124				2022-12-28	WOS:000330212600037
J	Pickett, CJ				Pickett, Christopher J.			Making the H-Cluster from Scratch	SCIENCE			English	Editorial Material							ACTIVE-SITES; HYDROGENASES; ANALOGS		Univ E Anglia, Sch Chem, Energy Mat Lab, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Pickett, CJ (corresponding author), Univ E Anglia, Sch Chem, Energy Mat Lab, Norwich NR4 7TJ, Norfolk, England.	c.pickett@uea.ac.uk	PICKETT, CHRISTOPHER J/F-3896-2010	PICKETT, CHRISTOPHER J/0000-0003-3142-0780				Camara JM, 2012, NAT CHEM, V4, P26, DOI 10.1038/nchem.1180; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Lawrence JD, 2001, ANGEW CHEM INT EDIT, V40, P1768, DOI 10.1002/1521-3773(20010504)40:9<1768::AID-ANIE17680>3.0.CO;2-E; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Pickett CJ, 2004, CHEM-EUR J, V10, P4770, DOI 10.1002/chem.200400382; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u	12	1	1	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					378	379		10.1126/science.1249276	http://dx.doi.org/10.1126/science.1249276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458630	Green Published			2022-12-28	WOS:000330039300034
J	Antman, E				Antman, Elliott			DATA BRIEFING Data sharing in research: benefits and risks for clinicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Antman, Elliott] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Antman, Elliott] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Antman, E (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu						Bobrow M, 2013, NATURE, V500, P123, DOI 10.1038/500123a; Institute of Medicine, 2014, DISC FRAM CLIN TRIAL, DOI 10.17226/18610; Institute of Medicine (US), 2013, SHAR CLIN RES DAT WO; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; National Research Council Committee on The National Academies Collection: Reports funded by National Institutes of Health, 2011, SICHUAN BUILD RES; Spertus JA, 2012, CIRC-CARDIOVASC QUAL, V5, P143, DOI 10.1161/CIRCOUTCOMES.112.965814	6	11	11	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g237	10.1136/bmj.g237	http://dx.doi.org/10.1136/bmj.g237			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24458978				2022-12-28	WOS:000330298100008
J	Charmandari, E; Nicolaides, NC; Chrousos, GP				Charmandari, Evangelia; Nicolaides, Nicolas C.; Chrousos, George P.			Adrenal insufficiency	LANCET			English	Article							CLASSIC 21-HYDROXYLASE DEFICIENCY; CORTICOTROPIN-RELEASING-HORMONE; GENERALIZED GLUCOCORTICOID RESISTANCE; AUTOIMMUNE ADDISONS-DISEASE; PREMATURE OVARIAN FAILURE; G ACTH STIMULATION; QUALITY-OF-LIFE; REPLACEMENT THERAPY; SERUM CORTISOL; DEHYDROEPIANDROSTERONE REPLACEMENT	Adrenal insufficiency is the clinical manifestation of deficient production or action of glucocorticoids, with or without deficiency also in mineralocorticoids and adrenal androgens. It is a life-threatening disorder that can result from primary adrenal failure or secondary adrenal disease due to impairment of the hypothalamic-pituitary axis. Prompt diagnosis and management are essential. The clinical manifestations of primary adrenal insufficiency result from deficiency of all adrenocortical hormones, but they can also include signs of other concurrent autoimmune conditions. In secondary or tertiary adrenal insufficiency, the clinical picture results from glucocorticoid deficiency only, but manifestations of the primary pathological disorder can also be present. The diagnostic investigation, although well established, can be challenging, especially in patients with secondary or tertiary adrenal insufficiency. We summarise knowledge at this time on the epidemiology, causal mechanisms, pathophysiology, clinical manifestations, diagnosis, and management of this disorder.	[Charmandari, Evangelia; Nicolaides, Nicolas C.; Chrousos, George P.] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet,Dept Pediat 1, GR-11527 Athens, Greece; [Charmandari, Evangelia; Nicolaides, Nicolas C.; Chrousos, George P.] Acad Athens, Biomed Res Fdn, Clin Res Ctr, Div Endocrinol & Metab, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Academy of Athens	Charmandari, E (corresponding author), Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet,Dept Pediat 1, GR-11527 Athens, Greece.	evangelia.charmandari@googlemail.com	Charmandari, Evangelia/AAF-2038-2019; Charmandari, Evangelia/B-6701-2011	Charmandari, Evangelia/0000-0002-0851-6998				Addison T., 1855, CONSTITUTIONAL LOCAL; Agha A, 2006, J CLIN ENDOCR METAB, V91, P43, DOI 10.1210/jc.2005-1131; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Albert SG, 2011, INTENS CARE MED, V37, P901, DOI 10.1007/s00134-011-2160-1; Alkatib AA, 2009, J CLIN ENDOCR METAB, V94, P3676, DOI 10.1210/jc.2009-0672; ALLOLIO B, 1990, CLIN ENDOCRINOL, V33, P279, DOI 10.1111/j.1365-2265.1990.tb00492.x; Andrioli Massimiliano, 2006, Pituitary, V9, P289, DOI 10.1007/s11102-006-0408-5; Annetta MG, 2009, CURR DRUG TARGETS, V10, P887, DOI 10.2174/138945009789108792; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Arlt W, 2006, EUR J ENDOCRINOL, V154, P1, DOI 10.1530/eje.1.02062; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Arlt W, 2009, J CLIN ENDOCR METAB, V94, P1059, DOI 10.1210/jc.2009-0032; AVGERINOS PC, 1987, J CLIN ENDOCR METAB, V65, P24, DOI 10.1210/jcem-65-1-24; Baker PR, 2012, CLIN ENDOCRINOL, V76, P617, DOI 10.1111/j.1365-2265.2011.04276.x; Baker PR, 2011, J CLIN ENDOCR METAB, V96, P2154, DOI 10.1210/jc.2010-2964; Baker PR, 2010, J CLIN ENDOCR METAB, V95, pE263, DOI 10.1210/jc.2010-0508; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Betterle C, 2004, CLIN EXP IMMUNOL, V137, P225, DOI 10.1111/j.1365-2249.2004.02561.x; BETTERLE C, 1988, J ENDOCRINOL, V117, P467, DOI 10.1677/joe.0.1170467; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; Betterle C, 2011, ENDOCR DEV, V20, P161, DOI 10.1159/000321239; Bhagra S, 2008, CURR OPIN ENDOCRINOL, V15, P239, DOI 10.1097/MED.0b013e3282fc7049; Binder G, 2009, J CLIN ENDOCR METAB, V94, P1182, DOI 10.1210/jc.2008-1982; Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x; Bleicken B, 2008, EUR J ENDOCRINOL, V159, P811, DOI 10.1530/EJE-08-0578; Boland GWL, 2011, RADIOL CLIN N AM, V49, P511, DOI 10.1016/j.rcl.2011.02.010; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Bratland E, 2011, MOL CELL ENDOCRINOL, V336, P180, DOI 10.1016/j.mce.2010.12.015; Bratland E, 2009, J CLIN ENDOCR METAB, V94, P5117, DOI 10.1210/jc.2009-1115; Brooke AM, 2006, J CLIN ENDOCR METAB, V91, P3773, DOI 10.1210/jc.2006-0316; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; Charmandari E, 2001, J CLIN ENDOCR METAB, V86, P4679, DOI 10.1210/jc.86.10.4679; Charmandari E, 2002, J CLIN ENDOCR METAB, V87, P3031, DOI 10.1210/jc.87.7.3031; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Charmandari E, 2001, J ENDOCRINOL, V169, P65, DOI 10.1677/joe.0.1690065; Charmandari E, 2001, J CLIN ENDOCR METAB, V86, P2701, DOI 10.1210/jc.86.6.2701; Charmandari E, 2012, SCI SIGNAL 5, V5; Charmandari E, 2010, NEONATAL PEDIAT PHAR, P760; Charmandari E, 2008, J CLIN ENDOCR METAB, V93, P1563, DOI 10.1210/jc.2008-0040; Charmandari E, 2006, ANN NY ACAD SCI, V1083, P37, DOI 10.1196/annals.1367.005; Charmandari E, 2013, ENDOCR DEV, V24, P67, DOI 10.1159/000342505; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Charmandari E, 2011, HORM RES PAEDIAT, V76, P145, DOI 10.1159/000330759; Charmandari E, 2010, EUR J CLIN INVEST, V40, P932, DOI 10.1111/j.1365-2362.2010.02336.x; Christ-Crain M, 2007, J CLIN ENDOCR METAB, V92, P1729, DOI 10.1210/jc.2006-2361; Chrousos GP, 2009, NEUROIMMUNOMODULAT, V16, P272, DOI 10.1159/000216185; Cohen J, 2010, ANAESTH INTENS CARE, V38, P425, DOI 10.1177/0310057X1003800304; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Couture C, 2012, J CLIN ENDOCR METAB, V97, pE486, DOI 10.1210/jc.2011-1659; Debono M, 2009, J CLIN ENDOCR METAB, V94, P1548, DOI 10.1210/jc.2008-2380; Deutschbein T, 2009, HORM METAB RES, V41, P834, DOI 10.1055/s-0029-1225630; Drake AJ, 2002, BMJ-BRIT MED J, V324, P1081, DOI 10.1136/bmj.324.7345.1081; DUNLOP D, 1963, Br Med J, V2, P887; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; Falorni A, 2004, J CLIN ENDOCR METAB, V89, P1598, DOI 10.1210/jc.2003-030954; Falorni A, 2013, ENDOCRINE, V43, P514, DOI 10.1007/s12020-012-9835-4; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Fleseriu M, 2010, ENDOCR PRACT, V16, P64, DOI 10.4158/EP09153.OR; Fleseriu M, 2009, ENDOCR PRACT, V15, P632, DOI 10.4158/EP09180.RA; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; GOMEZ MT, 1993, J CLIN ENDOCR METAB, V77, P173, DOI 10.1210/jc.77.1.173; Gordijn MS, 2012, COCHRANE DB SYST REV, V5; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; Hahner S, 2009, BEST PRACT RES CL EN, V23, P167, DOI 10.1016/j.beem.2008.09.009; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Husebye E, 2009, BEST PRACT RES CL EN, V23, P147, DOI 10.1016/j.beem.2008.09.004; Husebye ES, 2009, ENDOCRIN METAB CLIN, V38, P389, DOI 10.1016/j.ecl.2009.01.010; Johannsson G, 2012, J CLIN ENDOCR METAB, V97, P473, DOI 10.1210/jc.2011-1926; Kazlauskaite R, 2010, ENDOCR DEV, V17, P96, DOI 10.1159/000262532; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; KENDALL EDWARD C., 1953, PROC AMER PHIL SOC, V97, P8; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; Laureti S, 1998, J CLIN ENDOCR METAB, V83, P3163, DOI 10.1210/jc.83.9.3163; le Roux CW, 2002, ANN CLIN BIOCHEM, V39, P148, DOI 10.1258/0004563021901919; Lekarev O, 2011, BEST PRACT RES CL EN, V25, P959, DOI 10.1016/j.beem.2011.08.004; Lovas K, 2005, LANCET, V365, P2058, DOI 10.1016/S0140-6736(05)66700-1; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Lovas K, 2008, EXPERT OPIN INV DRUG, V17, P497, DOI [10.1517/13543784.17.4.497, 10.1517/13543784.17.4.497 ]; Lovas K, 2009, EUR J ENDOCRINOL, V160, P993, DOI 10.1530/EJE-08-0880; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; MASON AS, 1968, LANCET, V2, P744; Merke DP, 2000, NEW ENGL J MED, V343, P1362, DOI 10.1056/NEJM200011093431903; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mishra SK, 2007, J CLIN ENDOCR METAB, V92, P1693, DOI 10.1210/jc.2006-2090; Mitchell AL, 2012, NAT REV ENDOCRINOL, V8, P306, DOI [10.1038/nrendo.2012.74, 10.1038/nrendo.2012.200, 10.1038/nrendo.2012.56, 10.1038/nrendo.2012.127, 10.1038/nrendo.2012.186, 10.1038/nrendo.2011.245]; Moraes RB, 2011, ARQ BRAS ENDOCRINOL, V55, P295, DOI 10.1590/S0004-27302011000500001; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Napier C, 2012, PRESSE MED, V41, pE626, DOI 10.1016/j.lpm.2012.09.010; Neary N, 2010, CURR OPIN ENDOCRINOL, V17, P217, DOI 10.1097/MED.0b013e328338f608; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; Newell-Price J, 2008, CLIN ENDOCRINOL, V68, P130, DOI 10.1111/j.1365-2265.2007.03011.x; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; OELKERS W, 1992, J CLIN ENDOCR METAB, V75, P259, DOI 10.1210/jc.75.1.259; Ouyang T, 2011, RADIOL CLIN N AM, V49, P549, DOI 10.1016/j.rcl.2011.02.012; Perry R, 2005, J CLIN ENDOCR METAB, V90, P3243, DOI 10.1210/jc.2004-0016; Presotto F, 2005, EUR J ENDOCRINOL, V153, P507, DOI 10.1530/eje.1.02002; Quinkler M, 2012, CLIN ENDOCRINOL, V76, P21, DOI 10.1111/j.1365-2265.2011.04103.x; Raff H, 2009, J CLIN ENDOCR METAB, V94, P3647, DOI 10.1210/jc.2009-1166; Ramon I, 2013, J CLIN ENDOCR METAB, V98, P3179, DOI 10.1210/jc.2012-4300; Reato G, 2011, J CLIN ENDOCR METAB, V96, pE1255, DOI 10.1210/jc.2011-0414; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; REICHSTEIN T, 1954, ACTA ENDOCRINOL-COP, V17, P375; Reincke Martin, 1994, Neuroimmunomodulation, V1, P14, DOI 10.1159/000095930; Reisch N, 2009, ENDOCRIN METAB CLIN, V38, pix; Reisch N, 2009, ENDOCRIN METAB CLIN, V38, P407, DOI 10.1016/j.ecl.2009.01.008; ROSE LI, 1970, ANN INTERN MED, V73, P49, DOI 10.7326/0003-4819-73-1-49; SARETT LH, 1946, J BIOL CHEM, V162, P601; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; SCHURMEYER TH, 1985, J CLIN ENDOCR METAB, V61, P22, DOI 10.1210/jcem-61-1-22; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Skinningsrud B, 2011, J CLIN ENDOCR METAB, V96, pE1703, DOI 10.1210/jc.2011-0645; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tan T, 2010, J HEPATOL, V53, P841, DOI 10.1016/j.jhep.2010.05.020; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Wade M, 2010, EUR J ENDOCRINOL, V162, P109, DOI 10.1530/EJE-09-0746; Wallace I, 2009, ANN CLIN BIOCHEM, V46, P351, DOI 10.1258/acb.2009.009101; Wass JA, 2012, BMJ-BRIT MED J, V345, pe6333; Wass JAH, 2011, ADDISONS DIS POTENTI; Weintrob N, 1998, J CLIN ENDOCR METAB, V83, P88, DOI 10.1210/jc.83.1.88; White K, 2010, EUR J ENDOCRINOL, V162, P115, DOI 10.1530/EJE-09-0559; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286; Yuen KCJ, 2013, ENDOCRINE, V44, P283, DOI 10.1007/s12020-013-9893-2; Zollner EW, 2007, PEDIATR ALLERGY IMMU, V18, P469, DOI 10.1111/j.1399-3038.2007.00539.x	137	342	366	0	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2152	2167		10.1016/S0140-6736(13)61684-0	http://dx.doi.org/10.1016/S0140-6736(13)61684-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24503135				2022-12-28	WOS:000337906600030
J	Gostin, LO				Gostin, Lawrence O.			Legal and Ethical Responsibilities Following Brain Death: The McMath and Munoz Cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 1968, JAMA, V205, P337; Fernandez M., 2014, NY TIMES, pA14; Fernandez See M., 2014, NEW YORK TIMES, pA1; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1981, DEFINING DEATH A REP	5	29	30	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					903	904		10.1001/jama.2014.660	http://dx.doi.org/10.1001/jama.2014.660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24463988	Green Published			2022-12-28	WOS:000332170800012
J	Bedzhov, I; Zernicka-Goetz, M				Bedzhov, Ivan; Zernicka-Goetz, Magdalena			Self-Organizing Properties of Mouse Pluripotent Cells Initiate Morphogenesis upon Implantation	CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; LINEAGE SEGREGATION; EPITHELIAL POLARITY; GENE-EXPRESSION; MECHANISM; ESTABLISHMENT; LETHALITY; EPIBLAST; FAILURE	Transformation of pluripotent epiblast cells intoa cup-shaped epithelium as the mouse blastocyst implants is a poorly understood and yet key developmental step. Studies of morphogenesis in embryoid bodies led to the current belief that it is programmed cell death that shapes the epiblast. However, by following embryos developing in vivo and in vitro, we demonstrate that not cell death but a previously unknown morphogenetic event transforms the amorphous epiblast into a rosette of polarized cells. This transformation requires basal membrane-stimulated integrin signaling that coordinates polarization of epiblast cells and their apical constriction, a prerequisite for lumenogenesis. We show that basal membrane function can be substituted in vitro by extracellular matrix (ECM) proteins and that ES cells can be induced to form similar polarized rosettes that initiate lumenogenesis. Together, these findings lead to a completely revised model for peri-implantation morphogenesis in which ECM triggers the self-organization of the embryo's stem cells.	[Bedzhov, Ivan; Zernicka-Goetz, Magdalena] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Bedzhov, Ivan; Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	mz205@cam.ac.uk		Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to David Glover for valuable feedback on the manuscript, Anoeska Van de Moosdijk for the contribution to the ES cell work, and to the Wellcome Trust for providing funding. beta 1-integrin null and control wild-type ES cells are a kind gift from Reinhard Faessler, Max Planck Institute of Biochemistry.	[Anonymous], 2011, PRINCIPLES DEV; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Bedzhov I, 2013, STEM CELL RES, V11, P1250, DOI 10.1016/j.scr.2013.08.009; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Donehower LA, 1996, SEMIN CANCER BIOL, V7, P269, DOI 10.1006/scbi.1996.0035; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Krupa M, 2014, DEV BIOL, V385, P136, DOI 10.1016/j.ydbio.2013.09.008; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Meilhac SM, 2009, DEV BIOL, V331, P210, DOI 10.1016/j.ydbio.2009.04.036; Morris SA, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130104; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Stemmler MP, 2010, DEV DYNAM, V239, P2330, DOI 10.1002/dvdy.22375; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wang Xiang, 2008, J Vis Exp, DOI 10.3791/825; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435	40	253	261	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1032	1044		10.1016/j.cell.2014.01.023	http://dx.doi.org/10.1016/j.cell.2014.01.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24529478	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000332083900019
J	Eggleston, EM; Finkelstein, JA				Eggleston, Emma M.; Finkelstein, Jonathan A.			Finding the Role of Health Care in Population Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Eggleston, Emma M.; Finkelstein, Jonathan A.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Eggleston, Emma M.; Finkelstein, Jonathan A.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Eggleston, Emma M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Finkelstein, Jonathan A.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Eggleston, EM (corresponding author), Dept Populat Med, 133 Brookline Ave, Boston, MA 02215 USA.	emortoneggleston@partners.org						Department of Vermont Health Access, 2013, VERMONT BLUEPRINT FO; Hacker K, 2013, AM J PUBLIC HEALTH, V103, P1163, DOI 10.2105/AJPH.2013.301254; Isham G, 2012, HEALTHPARTNERS APPRO; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Kindig DA, 2008, JAMA-J AM MED ASSOC, V299, P2081, DOI 10.1001/jama.299.17.2081; Magnan Sanne, 2012, Minn Med, V95, P37; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Shortell SM, 2013, JAMA-J AM MED ASSOC, V309, P1121, DOI 10.1001/jama.2013.887; Sox HC, 2013, JAMA-J AM MED ASSOC, V310, P1933, DOI 10.1001/jama.2013.281998	9	29	29	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					797	798		10.1001/jama.2014.163	http://dx.doi.org/10.1001/jama.2014.163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24457610				2022-12-28	WOS:000331793700016
J	Akey, DL; Brown, WC; Dutta, S; Konwerski, J; Jose, J; Jurkiw, TJ; DelProposto, J; Ogata, CM; Skiniotis, G; Kuhn, RJ; Smith, JL				Akey, David L.; Brown, W. Clay; Dutta, Somnath; Konwerski, Jamie; Jose, Joyce; Jurkiw, Thomas J.; DelProposto, James; Ogata, Craig M.; Skiniotis, Georgios; Kuhn, Richard J.; Smith, Janet L.			Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System	SCIENCE			English	Article							NONSTRUCTURAL PROTEIN NS1; WEST-NILE-VIRUS; RNA REPLICATION; MONOCLONAL-ANTIBODIES; COMPLEMENT ACTIVATION; COMMON EPITOPES; INFECTED-CELLS; PATHOGENESIS; BIOLOGY; BINDING	Flaviviruses, the human pathogens responsible for dengue fever, West Nile fever, tick-borne encephalitis, and yellow fever, are endemic in tropical and temperate parts of the world. The flavivirus nonstructural protein 1 (NS1) functions in genome replication as an intracellular dimer and in immune system evasion as a secreted hexamer. We report crystal structures for full-length, glycosylated NS1 from West Nile and dengue viruses. The NS1 hexamer in crystal structures is similar to a solution hexamer visualized by single-particle electron microscopy. Recombinant NS1 binds to lipid bilayers and remodels large liposomes into lipoprotein nanoparticles. The NS1 structures reveal distinct domains for membrane association of the dimer and interactions with the immune system and are a basis for elucidating the molecular mechanism of NS1 function.	[Akey, David L.; Brown, W. Clay; Dutta, Somnath; Konwerski, Jamie; Jurkiw, Thomas J.; DelProposto, James; Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Jose, Joyce; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ogata, Craig M.] Argonne Natl Lab, Adv Photon Source, GM CA APS, Argonne, IL 60439 USA; [Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kuhn, Richard J.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	janetsmith@umich.edu	Kuhn, Richard/AAR-2722-2021; Dutta, Somnath/AAI-2977-2020	Kuhn, Richard/0000-0003-4148-1026; Skiniotis, Georgios/0000-0003-0238-7846	NIH [P01AI055672]; Martha L. Ludwig Professorship of Protein Structure and Function; Pew Scholar Program in Biomedical Sciences; Perrigo Undergraduate Summer Fellowship; National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martha L. Ludwig Professorship of Protein Structure and Function; Pew Scholar Program in Biomedical Sciences; Perrigo Undergraduate Summer Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Raymond for characterization of initial crystals, G. Dodge for assistance with protein purification and crystallization, and A. Dosey for assistance with EM. This work was supported by a grant from the NIH (P01AI055672) to R.J.K. and J.L.S., the Martha L. Ludwig Professorship of Protein Structure and Function to J.L.S., the Pew Scholar Program in Biomedical Sciences to G. S., and a Perrigo Undergraduate Summer Fellowship to T.J.J. Beamlines of GM/CA @ APS were supported by the National Institute of General Medical Sciences ("GM," Y1-GM-1104) and the National Cancer Institute ("CA," Y1-CO-1020). Atomic coordinates and structure factor files have been deposited in the RCSB Protein Data Bank (PDB) under the accession codes 4O6B for DEN2 NS1, 4O6C for WNV NS1 crystal form 2, and 4O6D for WNV NS1 crystal form 1. J.L.S., D. L. A., W. C. B., and R.J.K. are inventors on a patent application filed by The University of Michigan in collaboration with Purdue University on four uses of the NS1 three-dimensional structure (development of flavivirus vaccines, antiviral drugs, antibody diagnostics, or liposome-based NS1-membrane interaction assays) and on the method of production of recombinant NS1.	Alcon-LePoder S, 2006, Novartis Found Symp, V277, P233, DOI 10.1002/0470058005.ch17; Alcon-LePoder S., 2006, NOVART FDN SYMP, V277, P247; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000; Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08; Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	27	230	246	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					881	885		10.1126/science.1247749	http://dx.doi.org/10.1126/science.1247749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24505133	Green Accepted			2022-12-28	WOS:000331552600045
J	Spence, D				Spence, Des			Bad medicine: nalmefene in alcohol misuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AS-NEEDED NALMEFENE; DEPENDENCE; EFFICACY					destwo@yahoo.co.uk						[Anonymous], 2014, NALMEFENE BRIT NATL; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; Gual A, 2013, EUR NEUROPSYCHOPHARM, V23, P1432, DOI 10.1016/j.euroneuro.2013.02.006; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; McAvoy BR., 2010, COCHRANE PRIMARY HLT; National Institute for Health and Care Excellence, 2014, SINGL TECHN APPR NAL; Scottish Medicines Consortium, 2013, NALM 18 MG FILM COAT; van den Brink W, 2013, ALCOHOL ALCOHOLISM, V48, P570, DOI 10.1093/alcalc/agt061	8	18	18	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2014	348								g1531	10.1136/bmj.g1531	http://dx.doi.org/10.1136/bmj.g1531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA9XG	24531208				2022-12-28	WOS:000331445700002
J	Bellassen, V; Luyssaert, S				Bellassen, Valentin; Luyssaert, Sebastiaan			Managing forests in uncertain times	NATURE			English	Editorial Material							CARBON SINK; CLIMATE; CYCLE; GROWTH		[Bellassen, Valentin] Natl Inst Agron Res INRA, Ctr Econ & Sociol Rural Areas CESAER, Dijon, France; [Luyssaert, Sebastiaan] Atom & Alternat Energy Commiss CEA, LSCE, Gif Sur Yvette, France	INRAE; Institut Agro; AgroSup Dijon; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Bellassen, V (corresponding author), Natl Inst Agron Res INRA, Ctr Econ & Sociol Rural Areas CESAER, Dijon, France.	valentin.bellassen@dijon.inra.fr	Luyssaert, Sebastiaan/F-6684-2011	Luyssaert, Sebastiaan/0000-0003-1121-1869; Bellassen, Valentin/0000-0001-8581-2814				Bellassen V, 2011, GLOBAL CHANGE BIOL, V17, P3274, DOI 10.1111/j.1365-2486.2011.02476.x; Desai AR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000264; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hudiburg TW, 2011, NAT CLIM CHANGE, V1, P419, DOI 10.1038/NCLIMATE1264; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Solberg S, 2009, FOREST ECOL MANAG, V258, P1735, DOI 10.1016/j.foreco.2008.09.057	10	198	206	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					153	155		10.1038/506153a	http://dx.doi.org/10.1038/506153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA5AK	24527499	Bronze			2022-12-28	WOS:000331107700014
J	Ohnishi, K; Semi, K; Yamamoto, T; Shimizu, M; Tanaka, A; Mitsunaga, K; Okita, K; Osafune, K; Arioka, Y; Maeda, T; Soejima, H; Moriwaki, H; Yamanaka, S; Woltjen, K; Yamada, Y				Ohnishi, Kotaro; Semi, Katsunori; Yamamoto, Takuya; Shimizu, Masahito; Tanaka, Akito; Mitsunaga, Kanae; Okita, Keisuke; Osafune, Kenji; Arioka, Yuko; Maeda, Toshiyuki; Soejima, Hidenobu; Moriwaki, Hisataka; Yamanaka, Shinya; Woltjen, Knut; Yamada, Yasuhiro			Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation	CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; EMBRYONIC STEM; WILMS-TUMOR; KIDNEY DEVELOPMENT; IPS CELLS; EXPRESSION; FIBROBLASTS; METHYLATION; GENERATION	Cancer is believed to arise primarily through accumulation of genetic mutations. Although induced pluripotent stem cell (iPSC) generation does not require changes in genomic sequence, iPSCs acquire unlimited growth potential, a characteristic shared with cancer cells. Here, we describe a murine system in which reprogramming factor expression in vivo can be controlled temporally with doxycycline (Dox). Notably, transient expression of reprogramming factors in vivo results in tumor development in various tissues consisting of undifferentiated dysplastic cells exhibiting global changes in DNA methylation patterns. The Dox-withdrawn tumors arising in the kidney share a number of characteristics with Wilms tumor, a common pediatric kidney cancer. We also demonstrate that iPSCs derived from Dox-withdrawn kidney tumor cells give rise to nonneoplastic kidney cells in mice, proving that they have not undergone irreversible genetic transformation. These findings suggest that epigenetic regulation associated with iPSC derivation may drive development of particular types of cancer.	[Ohnishi, Kotaro; Semi, Katsunori; Yamamoto, Takuya; Tanaka, Akito; Mitsunaga, Kanae; Okita, Keisuke; Osafune, Kenji; Arioka, Yuko; Yamanaka, Shinya; Woltjen, Knut; Yamada, Yasuhiro] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Ohnishi, Kotaro; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ, Dept Med, Grad Sch Med, Gifu 5011194, Japan; [Semi, Katsunori; Yamamoto, Takuya; Yamanaka, Shinya; Yamada, Yasuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068507, Japan; [Maeda, Toshiyuki; Soejima, Hidenobu] Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Woltjen, Knut] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068507, Japan; [Yamada, Yasuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Gifu University; Kyoto University; Saga University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University; Japan Science & Technology Agency (JST)	Yamada, Y (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	y-yamada@cira.kyoto-u.ac.jp	mitsunaga, kanae/GLU-2985-2022; Yamamoto, Takuya/H-2792-2017; Arioka, Yuko/M-8834-2014	Yamamoto, Takuya/0000-0002-0022-3947; Okita, Keisuke/0000-0001-5806-1090; Woltjen, Knut/0000-0003-2293-1183; Soejima, Hidenobu/0000-0001-5076-6563; Arioka, Yuko/0000-0002-1792-8812	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Ministry of Health, Labor, and Welfare of Japan; JST; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS); Takeda Science Foundation; Naito Foundation; World Premier International Research Center Initiative, MEXT, Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JST(Japan Science & Technology Agency (JST)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Taya for CGH analysis and S. Sakurai and T. Sato for RRBS analysis. We also thank S. Masui, H. Sakurai, and members in Yamada laboratory for helpful discussions and T. Ukai, K. Osugi, and N. Nishimoto for assistance. The authors were supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Ministry of Health, Labor, and Welfare of Japan; the JST; the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS); the Takeda Science Foundation; and the Naito Foundation. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation, and HEALIOS K. K. Japan. The iCeMS is supported by World Premier International Research Center Initiative, MEXT, Japan.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ohta S, 2013, CELL REP, V5, P357, DOI 10.1016/j.celrep.2013.09.016; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152	40	267	281	0	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					663	677		10.1016/j.cell.2014.01.005	http://dx.doi.org/10.1016/j.cell.2014.01.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529372	Bronze			2022-12-28	WOS:000331379800007
J	Speich, B; Ame, SM; Ali, SM; Alles, R; Huwyler, J; Hattendorf, J; Utzinger, J; Albonico, M; Keiser, J				Speich, Benjamin; Ame, Shaali M.; Ali, Said M.; Alles, Rainer; Huwyler, Joerg; Hattendorf, Jan; Utzinger, Juerg; Albonico, Marco; Keiser, Jennifer			Oxantel Pamoate-Albendazole for Trichuris trichiura Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMITTED HELMINTH INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; NEMATODE INFECTIONS; EFFICACY; SINGLE; COMBINATION; MEBENDAZOLE; CHILDREN; DRUGS	BackgroundInfections with soil-transmitted helminths (Ascaris lumbricoides, hookworm, and Trichuris trichiura) are widespread and often occur concomitantly. These parasitic-worm infections are typically treated with albendazole or mebendazole, but both drugs show low efficacy against T. trichiura. Albendazole is the drug of choice against hookworm. MethodsIn this double-blind trial conducted on Pemba Island, Tanzania, we randomly assigned children, 6 to 14 years of age, to receive one of four treatments: oxantel pamoate at a dose of 20 mg per kilogram of body weight, plus 400 mg of albendazole, administered on consecutive days; oxantel pamoate at a single dose of 20 mg per kilogram; albendazole at a single dose of 400 mg; or mebendazole at a single dose of 500 mg. We assessed the efficacy and safety profile of oxantel pamoate-albendazole when used in the treatment of T. trichiura infection (primary outcome) and concomitant soil-transmitted helminth infection (secondary outcome). Efficacy was determined by means of assessment of the cure rate and egg-reduction rate. Adverse events were assessed four times after treatment. ResultsComplete data were available for 458 children, of whom 450 were infected with T. trichiura, 443 with hookworm, and 293 with A. lumbricoides. The cure rate of T. trichiura infection was significantly higher with oxantel pamoate-albendazole than with mebendazole (31.2% vs. 11.8%, P=0.001), as was the egg-reduction rate (96.0% [95% confidence interval {CI}, 93.5 to 97.6] vs. 75.0% [95% CI, 64.2 to 82.0]). The cure rate with albendazole (2.6%) and the egg-reduction rate with albendazole (45.0%; 95% CI, 32.0 to 56.4) were significantly lower than the rates with mebendazole (P=0.02 for the comparison of cure rates). Oxantel pamoate had low efficacy against hookworm and A. lumbricoides. Adverse events (mainly mild) were reported by 30.9% of all children. ConclusionsTreatment with oxantel pamoate-albendazole resulted in higher cure and egg-reduction rates for T. trichiura infection than the rates with standard therapy. (Funded by the Medicor Foundation and the Swiss National Science Foundation; Current Controlled Trials number, ISRCTN54577342.)	[Speich, Benjamin; Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland; [Hattendorf, Jan; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Alles, Rainer; Huwyler, Joerg] Univ Basel, Dept Pharmaceut Sci, Div Pharmaceut Technol, Basel, Switzerland; [Ame, Shaali M.; Ali, Said M.] Publ Hlth Lab Ivo de Carneri, Lab Div, Chake Chake, Tanzania; [Albonico, Marco] Ivo de Carneri Fdn, Milan, Italy	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Speich, B (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.	jennifer.keiser@unibas.ch	Hattendorf, Jan/F-5371-2010; Huwyler, Joerg/C-6573-2013; McCarthy, James S/C-1681-2009	Hattendorf, Jan/0000-0002-1176-401X; Huwyler, Joerg/0000-0003-1748-5676; Speich, Benjamin/0000-0002-3301-8085; ALBONICO, Marco/0000-0002-7805-2391	Medicor Foundation; Swiss National Science Foundation	Medicor Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by the Medicor Foundation and the Swiss National Science Foundation; Current Controlled Trials number, ISRCTN54577342.	Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; Alles R, 2013, J DRUG DELIV SCI TEC, V23, P623, DOI 10.1016/S1773-2247(13)50095-5; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; DALE VME, 1995, PARASITOLOGY, V110, P437, DOI 10.1017/S0031182000064775; Efron B, 2011, J BIOPHARM STAT, V21, P1052, DOI 10.1080/10543406.2011.607736; GARCIA EG, 1976, AM J TROP MED HYG, V25, P914, DOI 10.4269/ajtmh.1976.25.914; Geary TG, 2012, CURR OPIN INFECT DIS, V25, P709, DOI 10.1097/QCO.0b013e328359f04a; Higgins JP, COCHRANE STAT METHOD; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002119; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; LEE EL, 1976, AM J TROP MED HYG, V25, P563, DOI 10.4269/ajtmh.1976.25.563; LEE S-H, 1976, Korean Journal of Parasitology, V14, P25, DOI 10.3347/kjp.1976.14.1.25; Levecke B, 2012, T ROY SOC TROP MED H, V106, P128, DOI 10.1016/j.trstmh.2011.09.007; Montresor A., 1998, WORLD HLTH ORG; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Namwanje H, 2011, T ROY SOC TROP MED H, V105, P586, DOI 10.1016/j.trstmh.2011.07.009; Page S.W., 2008, SMALL ANIMAL CLIN PH, P198; PELDAN K, 1982, SCAND J INFECT DIS, V14, P297, DOI 10.3109/inf.1982.14.issue-4.10; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Speich B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001685; Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; World Health Organization, 2010, WHO MOD LIST ESS MED; World Health Organization, 2012, SOIL TRANSM HELM EL; ZAMAN V, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P103	30	59	60	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					610	620		10.1056/NEJMoa1301956	http://dx.doi.org/10.1056/NEJMoa1301956			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521107	Bronze			2022-12-28	WOS:000331187500007
J	Marciano, WJ				Marciano, William J.			PARTICLE PHYSICS Quarks are not ambidextrous	NATURE			English	Editorial Material							ELECTRON; CONSERVATION		Brookhaven Natl Lab, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Marciano, WJ (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.	marciano@quark.phy.bnl.gov						CHRISTENSON JH, 1964, PHYS REV LETT, V13, P138, DOI 10.1103/PhysRevLett.13.138; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; HASERT FJ, 1973, PHYS LETT B, VB 46, P138, DOI 10.1016/0370-2693(73)90499-1; LEE TD, 1956, PHYS REV, V104, P254, DOI 10.1103/PhysRev.104.254; PRESCOTT CY, 1978, PHYS LETT B, V77, P347, DOI 10.1016/0370-2693(78)90722-0; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; SCHWINGER J, 1957, ANN PHYS-NEW YORK, V2, P407, DOI 10.1016/0003-4916(57)90015-5; Wang D, 2014, NATURE, V506, P67, DOI 10.1038/nature12964; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264	10	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					43	44		10.1038/506043a	http://dx.doi.org/10.1038/506043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24499915				2022-12-28	WOS:000330648100026
J	Thombs, BD; Ziegelstein, RC				Thombs, Brett D.; Ziegelstein, Roy C.			Does depression screening improve depression outcomes in primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; RECOMMENDATIONS; DIAGNOSIS		[Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada; [Thombs, Brett D.] McGill Univ, Montreal, PQ H3T 1E4, Canada; [Ziegelstein, Roy C.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	Lady Davis Institute; McGill University; McGill University; Johns Hopkins University	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada.	brett.thombs@mcgill.ca						Allaby M, 2010, SCREENING FOR DEPRES; Baas KD, 2009, BRIT J PSYCHIAT, V194, P399, DOI 10.1192/bjp.bp.107.046052; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; National Collaborating Centre for Mental Health, 2010, THE NICE GUIDELINE O; National Collaborating Centre for Mental Health, 2010, DEPRESSION IN ADULTS; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Romera I, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-83; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4	15	59	59	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2014	348								g1253	10.1136/bmj.g1253	http://dx.doi.org/10.1136/bmj.g1253			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IV	24496211	Green Submitted			2022-12-28	WOS:000331060200004
J	Carillo, GAO; Caballero, GB; Carretero, MAC				Obeso Carillo, Gerardo Andres; Caballero, Gonzalo Barge; Canizares Carretero, Miguel Angel			The Earth-Heart sign: a new diagnostic finding in a patient with tension pneumomediastinum	LANCET			English	Editorial Material							CARDIAC-TAMPONADE		[Obeso Carillo, Gerardo Andres; Canizares Carretero, Miguel Angel] Univ Vigo, Dept Thorac Surg, Clin Hosp, Vigo 36204, Pontevedra, Spain; [Caballero, Gonzalo Barge] Pontevedra Univ, Dept Cardiol, Clin Hosp, Pontevedra, Spain	Universidade de Vigo	Carillo, GAO (corresponding author), Univ Vigo, Dept Thorac Surg, Clin Hosp, Pizarro 22, Vigo 36204, Pontevedra, Spain.	andresobca@hotmail.com	Caballero, Gonzalo/GZG-3828-2022					BEG MH, 1988, THORAX, V43, P576, DOI 10.1136/thx.43.7.576; Restrepo CS, 2007, RADIOGRAPHICS, V27, P1595, DOI 10.1148/rg.276065002; Saraya T, 2012, INTERNAL MED, V51, P677, DOI 10.2169/internalmedicine.51.6903	3	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					486	486		10.1016/S0140-6736(13)62634-3	http://dx.doi.org/10.1016/S0140-6736(13)62634-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24485584				2022-12-28	WOS:000330673700039
J	Farber-Katz, SE; Dippold, HC; Buschman, MD; Peterman, MC; Xing, MK; Noakes, CJ; Tat, J; Ng, MM; Rahajeng, J; Cowan, DM; Fuchs, GJ; Zhou, HL; Field, SJ				Farber-Katz, Suzette E.; Dippold, Holly C.; Buschman, Matthew D.; Peterman, Marshall C.; Xing, Mengke; Noakes, Christopher J.; Tat, John; Ng, Michelle M.; Rahajeng, Juliati; Cowan, David M.; Fuchs, Greg J.; Zhou, Huilin; Field, Seth J.			DNA Damage Triggers Golgi Dispersal via DNA-PK and GOLPH3	CELL			English	Article							DEPENDENT PROTEIN-KINASE; POOR-PROGNOSIS; CANCER-THERAPY; CELLS; APOPTOSIS; OVEREXPRESSION; MOTIFS; ATM; GLYCOSYLTRANSFERASES; PHOSPHOPROTEIN-3	The response to DNA damage, which regulates nuclear processes such as DNA repair, transcription, and cell cycle, has been studied thoroughly. However, the cytoplasmic response to DNA damage is poorly understood. Here, we demonstrate that DNA damage triggers dramatic reorganization of the Golgi, resulting in its dispersal throughout the cytoplasm. We further show that DNA-damage-induced Golgi dispersal requires GOLPH3/MYO18A/F-actin and the DNA damage protein kinase, DNA-PK. In response to DNA damage, DNA-PK phosphorylates GOLPH3, resulting in increased interaction with MYO18A, which applies a tensile force to the Golgi. Interference with the Golgi DNA damage response by depletion of DNA-PK, GOLPH3, or MYO18A reduces survival after DNA damage, whereas overexpression of GOLPH3, as is observed frequently in human cancers, confers resistance to killing by DNA-damaging agents. Identification of the DNA-damage- induced Golgi response reveals an unexpected pathway through DNA-PK, GOLPH3, and MYO18A that regulates cell survival following DNA damage.	[Farber-Katz, Suzette E.; Dippold, Holly C.; Buschman, Matthew D.; Peterman, Marshall C.; Xing, Mengke; Noakes, Christopher J.; Tat, John; Ng, Michelle M.; Rahajeng, Juliati; Cowan, David M.; Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Fuchs, Greg J.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Field, SJ (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	sjfield@ucsd.edu	Fuchs, George/GLV-1285-2022	Fuchs, George/0000-0002-8679-8265; Buschman, Matthew/0000-0002-2949-5815; Field, Seth/0000-0002-8893-4806; Zhou, Huilin/0000-0002-1350-4430	NIH [T32-DK07541]; American Cancer Society Postdoctoral Awards [PF-11-027-01-CSM, PF-13-367-01-CDD, 115095-PF-08-228-01-CSM]; Era of Hope Scholar Award [W81XWH-10-1-0822]; NIH Director's New Innovator Award [DP2OD004265]; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007541] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Awards; Era of Hope Scholar Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Susan Ferro-Novick, M. Geoff Rosenfeld, Marilyn G. Farquhar, Jean Wang, Alexandra Newton, and Joan Heller Brown for insightful comments. We thank Jean Wang, Erin Foley, Jeffrey Esko, Eva Lee, and Katheryn Meek for helpful reagents. We acknowledge the following funding support: NIH T32-DK07541 to S.F.K.; American Cancer Society Postdoctoral Awards PF-11-027-01-CSM, PF-13-367-01-CDD, and 115095-PF-08-228-01-CSM to H. C. D., M. D. B., and M. M. N., respectively; Era of Hope Scholar Award W81XWH-10-1-0822 to S.J.F.; NIH Director's New Innovator Award DP2OD004265 to S.J.F.; and a Burroughs Wellcome Fund Career Award in the Biomedical Sciences to S.J.F.	ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; HENNEQUIN C, 1994, CANCER RES, V54, P1720; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HSIANG YH, 1989, CANCER RES, V49, P5077; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Maney SK, 2011, CARDIOVASC TOXICOL, V11, P253, DOI 10.1007/s12012-011-9119-x; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morandell S, 2012, PROG MOL BIOL TRANSL, V110, P289, DOI 10.1016/B978-0-12-387665-2.00011-0; Myers AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001251; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peng YL, 2002, CANCER RES, V62, P6400; Qian HR, 2009, ANTI-CANCER DRUG, V20, P779, DOI 10.1097/CAD.0b013e32832f4e6f; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Swain SM, 2011, ONCOLOGIST, V16, P30, DOI 10.1634/theoncologist.2011-S1-30; Tavecchio M, 2012, CANCER CHEMOTH PHARM, V69, P155, DOI 10.1007/s00280-011-1662-4; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wei JH, 2009, SEMIN CELL DEV BIOL, V20, P810, DOI 10.1016/j.semcdb.2009.03.010; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	52	145	157	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					413	427		10.1016/j.cell.2013.12.023	http://dx.doi.org/10.1016/j.cell.2013.12.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485452	Green Accepted, Bronze			2022-12-28	WOS:000330580800010
J	Lee, JH; Bhang, DH; Beede, A; Huang, TL; Stripp, BR; Bloch, KD; Wagers, AJ; Tseng, YH; Ryeom, S; Kim, CF				Lee, Joo-Hyeon; Bhang, Dong Ha; Beede, Alexander; Huang, Tian Lian; Stripp, Barry R.; Bloch, Kenneth D.; Wagers, Amy J.; Tseng, Yu-Hua; Ryeom, Sandra; Kim, Carla F.			Lung Stem Cell Differentiation in Mice Directed by Endothelial Cells via a BMP4-NFATc1-Thrombospondin-1 Axis	CELL			English	Article							THROMBIN-SENSITIVE PROTEIN; MOUSE; THROMBOSPONDIN-1; EXPRESSION; BLOOD; PROLIFERATION; HETEROGENEITY; ANGIOGENESIS; MAINTENANCE; PROGENITORS	Lung stem cells are instructed to produce lineage-specific progeny through unknown factors in their microenvironment. We used clonal 3D cocultures of endothelial cells and distal lung stem cells, bronchioalveolar stem cells (BASCs), to probe the instructive mechanisms. Single BASCs had bronchiolar and alveolar differentiation potential in lung endothelial cell cocultures. Gain-and loss-offunction experiments showed that BMP4-Bmpr1a signaling triggers calcineurin/ NFATc1-dependent expression of thrombospondin-1 (Tsp1) in lung endothelial cells to drive alveolar lineage-specific BASC differentiation. Tsp1 null mice exhibited defective alveolar injury repair, confirming a crucial role for the BMP4-NFATc1-TSP1 axis in lung epithelial differentiation and regeneration in vivo. Discovery of this pathway points to methods to direct the derivation of specific lung epithelial lineages from multipotent cells. These findings elucidate a pathway that may be a critical target in lung diseases and provide tools to understand the mechanisms of respiratory diseases at the single-cell level.	[Lee, Joo-Hyeon; Beede, Alexander; Kim, Carla F.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Lee, Joo-Hyeon; Beede, Alexander; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lee, Joo-Hyeon; Beede, Alexander; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bhang, Dong Ha; Ryeom, Sandra] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Huang, Tian Lian; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Huang, Tian Lian] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Stripp, Barry R.] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Cedars Sinai Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Kim, CF (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Tseng, Yu-Hua/AAE-6471-2021; Lee, Joo-Hyeon/AAM-2777-2020; Stripp, Barry/AAI-1467-2021	Tseng, Yu-Hua/0000-0003-2053-9559; Lee, Joo-Hyeon/0000-0002-7364-6422; Stripp, Barry/0000-0003-4348-2137	Hope Funds for Cancer Research [R01 CA118374, R01 DK077097, U01 HL100402, 1U01HL099997, NHLBI RFA-HL-09-004]; Harvard Stem Cell Institute; Foundation Leducq [RO1 HL090136]; American Cancer Society Research Scholar Grant [RSG-08-082-01-MGO]; Basil O'Conner March of Dimes Starter Award; Alfred A. and Gilda K. Slifka; NATIONAL CANCER INSTITUTE [R01CA118374] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090136, U01HL099997, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077097] Funding Source: NIH RePORTER	Hope Funds for Cancer Research; Harvard Stem Cell Institute; Foundation Leducq(Leducq Foundation); American Cancer Society Research Scholar Grant(American Cancer Society); Basil O'Conner March of Dimes Starter Award; Alfred A. and Gilda K. Slifka; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the BCH FACS facility, members of the C. F. K. lab, L. Zon, D. Scadden, P. Oh, C. Han, C. Fillmore, K. Townsend, G. Evans, and J. Sage for technical assistance and/or helpful discussions, and R. Bronson for histopathology. This work was supported by the Hope Funds for Cancer Research (JHL), R01 CA118374 (to S. R.), R01 DK077097 (to Y.-H.T.), U01 HL100402 and 1U01HL099997 under NHLBI RFA-HL-09-004 (to C. F. K., B. R. S., and A. J. W.), the Harvard Stem Cell Institute (to Y.-H. T. and C. F. K.), the Foundation Leducq (to K. D. B.), and RO1 HL090136, American Cancer Society Research Scholar Grant RSG-08-082-01-MGO, and a Basil O'Conner March of Dimes Starter Award (to C. F. K.). This research was funded by Alfred A. and Gilda K. Slifka (to C.F.K.).	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; ASO Y, 1976, LAB INVEST, V35, P558; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Ezzie ME, 2011, AM J RESP CELL MOL, V44, P556, DOI 10.1165/rcmb.2009-0019OC; GANGULY P, 1971, J BIOL CHEM, V246, P4286; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lee JH, 2013, AM J RESP CELL MOL, V48, P288, DOI 10.1165/rcmb.2011-0403OC; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Masterson JC, 2011, CELL SIGNAL, V23, P398, DOI 10.1016/j.cellsig.2010.10.010; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Otto WR, 2002, J PATHOL, V197, P527, DOI 10.1002/path.1160; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Teisanu RM, 2011, AM J RESP CELL MOL, V44, P794, DOI 10.1165/rcmb.2010-0098OC; Tropea KA, 2012, AM J PHYSIOL-LUNG C, V302, pL829, DOI 10.1152/ajplung.00347.2011; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	39	279	295	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					440	455		10.1016/j.cell.2013.12.039	http://dx.doi.org/10.1016/j.cell.2013.12.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485453	Green Accepted, Bronze			2022-12-28	WOS:000330580800012
J	Shapiro, B; Hofreiter, M				Shapiro, B.; Hofreiter, M.			A Paleogenomic Perspective on Evolution and Gene Function: New Insights from Ancient DNA	SCIENCE			English	Review							MITOCHONDRIAL GENOME SEQUENCE; NEANDERTHAL GENOME; MOLECULAR-CLONING; HUMAN DISPERSALS; ORIGIN; REVEAL; CAVE; ADMIXTURE; HISTORY; POLYMORPHISM	The publication of partial and complete paleogenomes within the last few years has reinvigorated research in ancient DNA. No longer limited to short fragments of mitochondrial DNA, inference of evolutionary processes through time can now be investigated from genome-wide data sampled as far back as 700,000 years. Tremendous insights have been made, in particular regarding the hominin lineage. With rare exception, however, a paleogenomic perspective has been mired by the quality and quantity of recoverable DNA. Though conceptually simple, extracting ancient DNA remains challenging, and sequencing ancient genomes to high coverage remains prohibitively expensive for most laboratories. Still, with improvements in DNA isolation and declining sequencing costs, the taxonomic and geographic purview of paleogenomics is expanding at a rapid pace. With improved capacity to screen large numbers of samples for those with high proportions of endogenous ancient DNA, paleogenomics is poised to become a key technology to better understand recent evolutionary events.	[Shapiro, B.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hofreiter, M.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hofreiter, M.] Univ Potsdam, Fac Math & Life Sci, Inst Biochem & Biol, Unit Gen Zool Evolutionary Adapt Genom, D-14476 Potsdam, Germany	University of California System; University of California Santa Cruz; University of York - UK; University of Potsdam	Shapiro, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	beth.shapiro@gmail.com	Hofreiter, Michael/A-3996-2017	Hofreiter, Michael/0000-0003-0441-4705; Shapiro, Beth/0000-0002-2733-7776	Natural Environment Research Council [NE/J009342/1] Funding Source: researchfish; NERC [NE/J009342/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Austin JJ, 1997, P ROY SOC B-BIOL SCI, V264, P467, DOI 10.1098/rspb.1997.0067; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Fulton TL, 2013, MOL ECOL, V22, P2540, DOI 10.1111/mec.12267; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOLOUBINOFF P, 1993, P NATL ACAD SCI USA, V90, P1997, DOI 10.1073/pnas.90.5.1997; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Greenwood AD, 2001, MOL PHYLOGENET EVOL, V18, P94, DOI 10.1006/mpev.2000.0860; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Handt O, 1996, AM J HUM GENET, V59, P368; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Khairat R, 2013, J APPL GENET, V54, P309, DOI 10.1007/s13353-013-0145-1; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Lowery RK, 2013, GENE, V530, P83, DOI 10.1016/j.gene.2013.06.005; Martin MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3172; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nicholls H, 2008, NATURE, V456, P310, DOI 10.1038/456310a; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Palmer SA, 2012, MOL BIOL EVOL, V29, P2031, DOI 10.1093/molbev/mss070; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r47; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ramirez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005670; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; ROLLO F, 1988, NATURE, V335, P774, DOI 10.1038/335774a0; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Sherkow JS, 2013, SCIENCE, V340, P32, DOI 10.1126/science.1236965; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Wales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045644; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	89	118	123	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1236573	10.1126/science.1236573	http://dx.doi.org/10.1126/science.1236573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458647	Green Published			2022-12-28	WOS:000330039300001
J	Ecker, JL				Ecker, Jeffrey L.			NEW ENGLAND JOURNAL of MEDICINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The case of Marlise Munoz, in which a Texas hospital was made to withdraw support from a pregnant woman who had been brain dead for 2 months, should underscore women's right to determine the course of their end-of-life care, whether or not they are pregnant. Marlise Munoz was 33 years old and the mother of a 15-month-old when she collapsed on November 26, 2013, from what was later determined to be a massive pulmonary embolism. Initially described as apneic but alive, she was brought to the county hospital where her family was soon told that she was brain dead. Ms. Munoz and her husband, both emergency medical technicians (EMTs), had discussed their feelings about such situations. So Erik Munoz felt confident in asserting that his wife would not want continued support. Her other family members agreed, and they requested withdrawal of ventilation and other measures ...	[Ecker, Jeffrey L.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Ecker, Jeffrey L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ecker, JL (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.							Committee on Ethics, 2008, Obstet Gynecol, V111, P1021, DOI 10.1097/AOG.0b013e3181713d92; Feldman DM, 2000, OBSTET GYNECOL SURV, V55, P708, DOI 10.1097/00006254-200011000-00023	2	10	10	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					889	891		10.1056/NEJMp1400969	http://dx.doi.org/10.1056/NEJMp1400969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24499176				2022-12-28	WOS:000332309800003
J	Cooper, KM; Kent, AJR				Cooper, Kari M.; Kent, Adam J. R.			Rapid remobilization of magmatic crystals kept in cold storage	NATURE			English	Article							U-SERIES DISEQUILIBRIA; MOUNT ST-HELENS; RESIDENCE TIMES; SIZE DISTRIBUTION; URANIUM-SERIES; PERALKALINE RHYOLITES; LESSER ANTILLES; VOLCANIC ZONE; PLAGIOCLASE; CRYSTALLIZATION	The processes involved in the formation and storage of magma within the Earth's upper crust are of fundamental importance to volcanology. Many volcanic eruptions, including some of the largest, result from the eruption of components stored for tens to hundreds of thousands of years before eruption(1-3). Although the physical conditions of magma storage and remobilization are of paramount importance for understanding volcanic processes, they remain relatively poorly known(4,5). Eruptions of crystal-rich magma are often suggested to require the mobilization of magma stored at near-solidus conditions(6-8); however, accumulation of significant eruptible magma volumes has also been argued to require extended storage of magma at higher temperatures(7-9). What has been lacking in this debate is clear observational evidence linking the thermal (and therefore physical) conditions within a magma reservoir to timescales of storage-that is, thermal histories. Here we present a method of constraining such thermal histories by combining timescales derived from uranium-series disequilibria, crystal sizes and trace-element zoning in crystals. At Mount Hood (Oregon, USA), only a small fraction of the total magma storage duration (at most 12 per cent and probably much less than 1 per cent) has been spent at temperatures above the critical crystallinity (40-50 per cent) at which magma is easily mobilized. Partial data sets for other volcanoes also suggest that similar conditions of magma storage are widespread and therefore that rapid mobilization of magmas stored at near-solidus temperatures is common. Magma storage at low temperatures indicates that, although thermobarometry calculations based on mineral compositions may record the conditions of crystallization, they are unlikely to reflect the conditions of most of the time that the magma is stored. Our results also suggest that largely liquid magma bodies that can be imaged geophysically will be ephemeral features and therefore their detection could indicate imminent eruption.	[Cooper, Kari M.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Kent, Adam J. R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Ocean Adm 104, Corvallis, OR 97331 USA	University of California System; University of California Davis; Oregon State University	Cooper, KM (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA.	kmcooper@ucdavis.edu	Cooper, Kari M/G-8261-2012; Kent, Adam/ABC-1641-2021	Kent, Adam/0000-0003-3564-6285	US NSF [EAR-0838389, EAR-0838421]	US NSF(National Science Foundation (NSF))	Funding for this project was provided by the US NSF (EAR-0838389 to KMC; EAR-0838421 to AJRK). We thank W. Bohrson for assistance with R-MELTS and measurement of CSD. F. Costa also provided assistance with diffusion modelling. We thank T. Plank for comments that improved the clarity and content of the manuscript.	Annen C, 2009, EARTH PLANET SC LETT, V284, P409, DOI 10.1016/j.epsl.2009.05.006; Annen C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005049; Armienti P, 2008, REV MINERAL GEOCHEM, V69, P623, DOI 10.2138/rmg.2008.69.16; Bachmann O, 2007, J VOLCANOL GEOTH RES, V167, P1, DOI 10.1016/j.jvolgeores.2007.08.002; Bachmann O, 2008, J PETROL, V49, P2277, DOI 10.1093/petrology/egn068; Black S, 1997, J PETROL, V38, P277, DOI 10.1093/petrology/38.2.277; Black S, 1998, J VOLCANOL GEOTH RES, V82, P97, DOI 10.1016/S0377-0273(97)00059-0; Black S, 1998, CONTRIB MINERAL PETR, V131, P364, DOI 10.1007/s004100050398; Bourdon B, 2000, CONTRIB MINERAL PETR, V139, P458, DOI 10.1007/s004100000150; BOURDON B, 1994, EARTH PLANET SC LETT, V126, P75, DOI 10.1016/0012-821X(94)90243-7; Brugger CR, 2010, EARTH PLANET SC LETT, V300, P246, DOI 10.1016/j.epsl.2010.09.046; Burgisser A, 2011, NATURE, V471, P212, DOI 10.1038/nature09799; CASHMAN KV, 1993, CONTRIB MINERAL PETR, V113, P126, DOI 10.1007/BF00320836; CASHMAN KV, 1992, CONTRIB MINERAL PETR, V109, P431, DOI 10.1007/BF00306547; Charlier BLA, 2003, EARTH PLANET SC LETT, V206, P441, DOI 10.1016/S0012-821X(02)01109-3; Cherniak DJ, 2002, GEOCHIM COSMOCHIM AC, V66, P1641, DOI 10.1016/S0016-7037(01)00866-3; Cooper K.M., 2008, VOLCANO REKINDLED 1, P827; Cooper KM, 2008, REV MINERAL GEOCHEM, V69, P479, DOI 10.2138/rmg.2008.69.13; Cooper KM, 2003, EARTH PLANET SC LETT, V213, P149, DOI 10.1016/S0012-821X(03)00262-0; Cooper KM, 2001, EARTH PLANET SC LETT, V184, P703, DOI 10.1016/S0012-821X(00)00341-1; Costa F, 2003, GEOCHIM COSMOCHIM AC, V67, P2189, DOI 10.1016/S0016-7037(02)01345-5; Costa F, 2008, REV MINERAL GEOCHEM, V69, P545, DOI 10.2138/rmg.2008.69.14; DARR C. M., 2006, THESIS OREGON STATE; Davis JW, 2012, CONTRIB MINERAL PETR, V163, P449, DOI 10.1007/s00410-011-0683-7; Druitt TH, 2012, NATURE, V482, P77, DOI 10.1038/nature10706; Eppich GR, 2012, EARTH PLANET SC LETT, V317, P319, DOI 10.1016/j.epsl.2011.11.019; Gelman SE, 2013, GEOLOGY, V41, P759, DOI 10.1130/G34241.1; GILETTI BJ, 1994, GEOCHIM COSMOCHIM AC, V58, P3785, DOI 10.1016/0016-7037(94)90363-8; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Hammer JE, 2008, REV MINERAL GEOCHEM, V69, P9, DOI 10.2138/rmg.2008.69.2; Heath E, 1998, EARTH PLANET SC LETT, V160, P49, DOI 10.1016/S0012-821X(98)00084-3; Heumann A, 2002, J PETROL, V43, P557, DOI 10.1093/petrology/43.3.557; Higgins MD, 1996, J VOLCANOL GEOTH RES, V70, P37, DOI 10.1016/0377-0273(95)00045-3; Higgins MD, 1996, B VOLCANOL, V58, P194, DOI 10.1007/s004450050135; Huber C, 2012, GEOLOGY, V40, P115, DOI 10.1130/G32425.1; Huber C, 2009, EARTH PLANET SC LETT, V283, P38, DOI 10.1016/j.epsl.2009.03.029; Jicha BR, 2005, EARTH PLANET SC LETT, V236, P195, DOI 10.1016/j.epsl.2005.05.002; Jicha BR, 2007, EARTH PLANET SC LETT, V255, P229, DOI 10.1016/j.epsl.2006.12.017; Jicha BR, 2009, EARTH PLANET SC LETT, V277, P38, DOI 10.1016/j.epsl.2008.09.035; Karlstrom L, 2012, NAT GEOSCI, V5, P402, DOI [10.1038/NGEO1453, 10.1038/ngeo1453]; Kent A. J. R., 2008, VOLCANO REKINDLED RE, V1750, P809; Kent AJR, 2007, GEOLOGY, V35, P231, DOI 10.1130/G22809A.1; Kent AJR, 2010, NAT GEOSCI, V3, P631, DOI 10.1038/NGEO924; Koleszar A. M., 2011, THESIS OREGON STATE; Koleszar AM, 2012, J VOLCANOL GEOTH RES, V219, P1, DOI 10.1016/j.jvolgeores.2012.01.003; Larsen JF, 2005, AM MINERAL, V90, P417, DOI 10.2138/am.2005.1456; Loewen MW, 2012, J ANAL ATOM SPECTROM, V27, P1502, DOI 10.1039/c2ja30075c; Marsh BD, 1998, J PETROL, V39, P553, DOI 10.1093/petrology/39.4.553; Marsh BD, 2007, J AM CERAM SOC, V90, P746, DOI 10.1111/j.1551-2916.2006.01473.x; Morgan DJ, 2004, EARTH PLANET SC LETT, V222, P933, DOI 10.1016/j.epsl.2004.03.030; Morrissey MM, 1997, J VOLCANOL GEOTH RES, V75, P321, DOI 10.1016/S0377-0273(96)00033-9; Muir DD, 2012, B VOLCANOL, V74, P1101, DOI 10.1007/s00445-012-0586-0; Pupier E, 2008, CONTRIB MINERAL PETR, V155, P555, DOI 10.1007/s00410-007-0258-9; REAGAN MK, 1992, GEOCHIM COSMOCHIM AC, V56, P1401, DOI 10.1016/0016-7037(92)90071-P; Reid MR, 2008, ELEMENTS, V4, P23, DOI 10.2113/GSELEMENTS.4.1.23; Rogers NW, 2004, J PETROL, V45, P1747, DOI 10.1093/petrology/egh032; Rubin KH, 2005, NATURE, V437, P534, DOI 10.1038/nature03993; Ruprecht P, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002022; Ruprecht P, 2013, NATURE, V500, P68, DOI 10.1038/nature12342; Ruprecht P, 2012, J PETROL, V53, P841, DOI 10.1093/petrology/egs001; Saal AE, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000620; Salisbury MJ, 2008, J PETROL, V49, P1755, DOI 10.1093/petrology/egn045; Scaillet B, 1998, J GEOPHYS RES-SOL EA, V103, P27257, DOI 10.1029/98JB02469; Schmitt AK, 2011, ANNU REV EARTH PL SC, V39, P321, DOI 10.1146/annurev-earth-040610-133330; Scott W. E., 1997, 97263 USGS, P1; Shea T, 2013, J VOLCANOL GEOTH RES, V260, P127, DOI 10.1016/j.jvolgeores.2013.04.018; Sims KWW, 2007, GEOLOGY, V35, P471, DOI 10.1130/G23381A.1; Stelten ME, 2012, EARTH PLANET SC LETT, V313, P1, DOI 10.1016/j.epsl.2011.10.035; Stewart ML, 2001, J VOLCANOL GEOTH RES, V106, P243, DOI 10.1016/S0377-0273(00)00240-7; Tepley FJ, 2006, J VOLCANOL GEOTH RES, V157, P147, DOI 10.1016/j.jvolgeores.2006.03.038; Toothill J, 2007, J PETROL, V48, P3, DOI 10.1093/petrology/egl052; Touboul M, 2007, CHEM GEOL, V246, P181, DOI 10.1016/j.chemgeo.2007.09.009; Triebold S, 2006, J VOLCANOL GEOTH RES, V154, P117, DOI 10.1016/j.jvolgeores.2005.09.023; Turner S, 2003, J PETROL, V44, P491, DOI 10.1093/petrology/44.3.491; Turner S, 2003, EARTH PLANET SC LETT, V214, P279, DOI 10.1016/S0012-821X(03)00376-5; Van Orman JA, 2001, CONTRIB MINERAL PETR, V141, P687, DOI 10.1007/s004100100269; Van Orman JA, 2006, GEOCHIM COSMOCHIM AC, V70, P4797, DOI 10.1016/j.gca.2006.07.005; VOLPE AM, 1992, J VOLCANOL GEOTH RES, V53, P227, DOI 10.1016/0377-0273(92)90083-P; VOLPE AM, 1991, EARTH PLANET SC LETT, V107, P475, DOI 10.1016/0012-821X(91)90094-X; Zellmer G, 2000, EARTH PLANET SC LETT, V174, P265, DOI 10.1016/S0012-821X(99)00266-6; Zellmer GF, 2008, EARTH PLANET SC LETT, V269, P387, DOI 10.1016/j.epsl.2008.02.026; Zellmer GF, 2003, J PETROL, V44, P1413, DOI 10.1093/petrology/44.8.1413; Zellmer GF, 1999, CONTRIB MINERAL PETR, V136, P345, DOI 10.1007/s004100050543	84	291	300	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					480	+		10.1038/nature12991	http://dx.doi.org/10.1038/nature12991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24531766				2022-12-28	WOS:000332165100036
J	Hurricane, OA; Callahan, DA; Casey, DT; Celliers, PM; Cerjan, C; Dewald, EL; Dittrich, TR; Doppner, T; Hinkel, DE; Hopkins, LFB; Kline, JL; Le Pape, S; Ma, T; MacPhee, AG; Milovich, JL; Pak, A; Park, HS; Patel, PK; Remington, BA; Salmonson, JD; Springer, PT; Tommasini, R				Hurricane, O. A.; Callahan, D. A.; Casey, D. T.; Celliers, P. M.; Cerjan, C.; Dewald, E. L.; Dittrich, T. R.; Doeppner, T.; Hinkel, D. E.; Hopkins, L. F. Berzak; Kline, J. L.; Le Pape, S.; Ma, T.; MacPhee, A. G.; Milovich, J. L.; Pak, A.; Park, H. -S.; Patel, P. K.; Remington, B. A.; Salmonson, J. D.; Springer, P. T.; Tommasini, R.			Fuel gain exceeding unity in an inertially confined fusion implosion	NATURE			English	Article							RAYLEIGH-TAYLOR INSTABILITY; NATIONAL IGNITION FACILITY	Ignition is needed to make fusion energy a viable alternative energy source, but has yet to be achieved(1). A key step on the way to ignition is to have the energy generated through fusion reactions in an inertially confined fusion plasma exceed the amount of energy deposited into the deuterium-tritium fusion fuel and hotspot during the implosion process, resulting in a fuel gain greater than unity. Here we report the achievement of fusion fuel gains exceeding unity on the US National Ignition Facility using a 'high-foot' implosion method(2,3), which is a manipulation of the laser pulse shape in a way that reduces instability in the implosion. These experiments show an order-of-magnitude improvement in yield performance over past deuterium-tritium implosion experiments. We also see a significant contribution to the yield from alpha-particle self-heating and evidence for the 'bootstrapping' required to accelerate the deuterium-tritium fusion burn to eventually 'run away' and ignite.	[Hurricane, O. A.; Callahan, D. A.; Casey, D. T.; Celliers, P. M.; Cerjan, C.; Dewald, E. L.; Dittrich, T. R.; Doeppner, T.; Hinkel, D. E.; Hopkins, L. F. Berzak; Le Pape, S.; Ma, T.; MacPhee, A. G.; Milovich, J. L.; Pak, A.; Park, H. -S.; Patel, P. K.; Remington, B. A.; Salmonson, J. D.; Springer, P. T.; Tommasini, R.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Kline, J. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Hurricane, OA (corresponding author), Lawrence Livermore Natl Lab, POB 808, Livermore, CA 94551 USA.	hurricane1@llnl.gov	Casey, Daniel/AAX-3022-2020; Tommasini, Riccardo/A-8214-2009; Ma, Tammy/F-3133-2013; Hurricane, Omar/AAJ-2862-2020; tommasini, riccardo/GYA-1981-2022; lepape, sebastien/J-3010-2015; Kline, John/ABH-9654-2020; Doeppner, Tilo/M-7435-2017; Patel, Pravesh/E-1400-2011	Casey, Daniel/0000-0003-2125-677X; Tommasini, Riccardo/0000-0002-1070-3565; Ma, Tammy/0000-0002-6657-9604; tommasini, riccardo/0000-0002-1070-3565; Kline, John/0000-0002-2271-9919; Celliers, Peter/0000-0001-7600-1227	US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	We thank P. Albright, J. Atherton, L. R. Benedetti, D. Bradley, J. A. Caggiano, R. Dylla-Spears, M. J. Edwards, W. H. Goldstein, B. Goodwin, S. Haan, A. Hamza, W. Hsing, P. Kervin, J. Kilkenny, B. Kozioziemski, O. Landen, J. Lindl, B. MacGowan, A. Mackinnon, N. Meezan, J. F. Meeker, J. Moody, E. Moses, D. Pilkington, T. Parham, J. Ralph, S. Ross, H. Robey, R. Rygg, B. Spears, R. Town, C. Verdon, A. Wan and B. Van Wonterghem, and the NIF operations, cryogenics and targets teams. We also thank V. Goncharov and J. Knauer for their advice, and R. Betti for bringing our attention to equation (3). Thanks also go to NIF's external collaborators at GA (targets), LLE (diagnostics), the MIT Plasma Science and Fusion Center (magnetic recoil spectrometer diagnostic), CEA and AWE. This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344.	Atzeni S., 2004, PHYS INERTIAL FUSION, V32, P398; Betti R, 1998, PHYS PLASMAS, V5, P1446, DOI 10.1063/1.872802; Betti R, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3380857; Bleuel D. L., 2012, REV SCI INSTRUM, V83; BODNER SE, 1974, PHYS REV LETT, V33, P761, DOI 10.1103/PhysRevLett.33.761; BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; Callahan DA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694840; Cerjan C, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802196; Dittrich TR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.055002; Edwards MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4816115; Glebov VY, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2236281; Glenzer SH, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4719686; Goncharov VN, 2003, PHYS PLASMAS, V10, P1906, DOI 10.1063/1.1562166; Gonchorov V. N., 2012, LLNLTR562104; Haan SW, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592169; Johnson MG, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4728095; Kozioziemski BJ, 2011, FUSION SCI TECHNOL, V59, P14, DOI 10.13182/FST10-3697; Krokhin O. N., 1973, Soviet Journal of Quantum Electronics, V2, P393, DOI 10.1070/QE1973v002n04ABEH004476; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; Lindl JD, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3591001; Ma T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.085004; Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740; Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733; Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004; Moody JD, 2012, NAT PHYS, V8, P344, DOI [10.1038/NPHYS2239, 10.1038/nphys2239]; Park HS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.055001; Patel P., 2013, B AM PHYS SOC, V58; Regan SP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.045001; Zimmerman G. B., 1975, COMMENTS PLASMA PHYS, V2, P85	29	655	685	20	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					343	+		10.1038/nature13008	http://dx.doi.org/10.1038/nature13008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24522535				2022-12-28	WOS:000331477800036
J	Knopman, J; Stieg, PE				Knopman, Jared; Stieg, Philip E.			Management of unruptured brain arteriovenous malformations	LANCET			English	Editorial Material							EMBOLIZATION; ONYX; RADIOSURGERY; HEMORRHAGE		[Knopman, Jared; Stieg, Philip E.] Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University	Stieg, PE (corresponding author), Weill Cornell Med Coll, New York, NY 10021 USA.	pes2008@med.cornell.edu						Florio Francesco, 2003, Radiol Med, V106, P512; Katsaridis V, 2008, NEURORADIOLOGY, V50, P589, DOI 10.1007/s00234-008-0382-x; LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Mounayer C, 2007, AM J NEURORADIOL, V28, P518; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001; Stieg PE, 2007, INTRACRANIAL ARTERIO, P135; van Rooij WJ, 2007, AM J NEURORADIOL, V28, P172; Weber W, 2007, NEUROSURGERY, V61, P244, DOI 10.1227/01.NEU.0000255473.60505.84; Wedderburn CJ, 2008, LANCET NEUROL, V7, P223, DOI 10.1016/S1474-4422(08)70026-7; Winn HR, 2011, YOUMANS NEUROLOGICAL, P4065; Yamada S, 2007, J NEUROSURG, V107, P965, DOI 10.3171/JNS-07/11/0965	14	19	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					581	583		10.1016/S0140-6736(14)60001-5	http://dx.doi.org/10.1016/S0140-6736(14)60001-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24529458				2022-12-28	WOS:000331137700008
J	Andrey, G; Duboule, D				Andrey, Guillaume; Duboule, Denis			SnapShot: Hox Gene Regulation	CELL			English	Editorial Material							COLLINEARITY; CLUSTERS		[Andrey, Guillaume; Duboule, Denis] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Andrey, G (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.		Andrey, Guillaume/AAL-4397-2020	Andrey, Guillaume/0000-0002-0911-4907; duboule, denis/0000-0001-9961-2960				Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398	9	19	19	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4							856.e1	10.1016/j.cell.2014.01.060	http://dx.doi.org/10.1016/j.cell.2014.01.060			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529385	Bronze			2022-12-28	WOS:000331379800023
J	Morton, DL; Thompson, JF; Cochran, AJ; Mozzillo, N; Nieweg, OE; Roses, DF; Hoekstra, HJ; Karakousis, CP; Puleo, CA; Coventry, BJ; Kashani-Sabet, M; Smithers, BM; Paul, E; Kraybill, WG; McKinnon, JG; Wang, HJ; Elashoff, R; Faries, MB				Morton, D. L.; Thompson, J. F.; Cochran, A. J.; Mozzillo, N.; Nieweg, O. E.; Roses, D. F.; Hoekstra, H. J.; Karakousis, C. P.; Puleo, C. A.; Coventry, B. J.; Kashani-Sabet, M.; Smithers, B. M.; Paul, E.; Kraybill, W. G.; McKinnon, J. G.; Wang, H. -J.; Elashoff, R.; Faries, M. B.		MSLT Grp	Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY-STAGE MELANOMA; PROGNOSTIC-FACTORS; REGIONAL NODES; LYMPHADENECTOMY; DISSECTION; MANAGEMENT; ACCURACY; MORBIDITY; IMMEDIATE; THICKNESS	BackgroundSentinel-node biopsy, a minimally invasive procedure for regional melanoma staging, was evaluated in a phase 3 trial. MethodsWe evaluated outcomes in 2001 patients with primary cutaneous melanomas randomly assigned to undergo wide excision and nodal observation, with lymphadenectomy for nodal relapse (observation group), or wide excision and sentinel-node biopsy, with immediate lymphadenectomy for nodal metastases detected on biopsy (biopsy group). ResultsNo significant treatment-related difference in the 10-year melanoma-specific survival rate was seen in the overall study population (20.8% with and 79.2% without nodal metastases). Mean (SE) 10-year disease-free survival rates were significantly improved in the biopsy group, as compared with the observation group, among patients with intermediate-thickness melanomas, defined as 1.20 to 3.50 mm (71.31.8% vs. 64.72.3%; hazard ratio for recurrence or metastasis, 0.76; P=0.01), and those with thick melanomas, defined as >3.50 mm (50.74.0% vs. 40.5 +/- 4.7%; hazard ratio, 0.70; P=0.03). Among patients with intermediate-thickness melanomas, the 10-year melanoma-specific survival rate was 62.1 +/- 4.8% among those with metastasis versus 85.1 +/- 1.5% for those without metastasis (hazard ratio for death from melanoma, 3.09; P<0.001); among patients with thick melanomas, the respective rates were 48.0 +/- 7.0% and 64.6 +/- 4.9% (hazard ratio, 1.75; P=0.03). Biopsy-based management improved the 10-year rate of distant disease-free survival (hazard ratio for distant metastasis, 0.62; P=0.02) and the 10-year rate of melanoma-specific survival (hazard ratio for death from melanoma, 0.56; P=0.006) for patients with intermediate-thickness melanomas and nodal metastases. Accelerated-failure-time latent-subgroup analysis was performed to account for the fact that nodal status was initially known only in the biopsy group, and a significant treatment benefit persisted. Conclusions Biopsy-based staging of intermediate-thickness or thick primary melanomas provides important prognostic information and identifies patients with nodal metastases who may benefit from immediate complete lymphadenectomy. Biopsy-based management prolongs disease-free survival for all patients and prolongs distant disease-free survival and melanoma-specific survival for patients with nodal metastases from intermediate-thickness melanomas. (Funded by the National Cancer Institute, National Institutes of Health, and the Australia and New Zealand Melanoma Trials Group; ClinicalTrials. gov number, NCT00275496.)	[Morton, D. L.; Faries, M. B.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Surg Oncol, Santa Monica, CA 90404 USA; [Wang, H. -J.; Elashoff, R.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Biostat, Santa Monica, CA 90404 USA; [Thompson, J. F.] Melanoma Inst Australia, Sydney, NSW, Australia; [Thompson, J. F.] Univ Sydney, Sydney, NSW 2006, Australia; [Coventry, B. J.] Royal Adelaide Hosp, Dept Surg, Adelaide, SA 5000, Australia; [Smithers, B. M.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Cochran, A. J.] Univ Calif Los Angeles, Dept Pathol Lab Med & Surg, Los Angeles, CA USA; [Wang, H. -J.; Elashoff, R.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Mozzillo, N.] Natl Canc Inst, Dept Surg Oncol, Naples, Italy; [Nieweg, O. E.] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands; [Roses, D. F.] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Hoekstra, H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, NL-9713 AV Groningen, Netherlands; [Hoekstra, H. J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Karakousis, C. P.] Millard Fillmore Hosp, Dept Surg, Buffalo, NY USA; [Kraybill, W. G.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Puleo, C. A.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Kashani-Sabet, M.] Calif Pacific Med Ctr, Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA; [Paul, E.] Klinikum Nord, Nurnberg, Germany; [McKinnon, J. G.] Tom Baker Canc Clin, Calgary, AB, Canada	John Wayne Cancer Institute; John Wayne Cancer Institute; Melanoma Institute Australia; University of Sydney; Royal Adelaide Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; IRCCS Fondazione Pascale; Netherlands Cancer Institute; New York University; University of Groningen; University of Groningen; State University of New York (SUNY) System; Roswell Park Cancer Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; California Pacific Medical Center; California Pacific Medical Center Research Institute; Klinikum Nurnberg Nord; Tom Baker Cancer Clinic; University of Calgary	Faries, MB (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	mark.faries@jwci.org	Nieweg, Omgo E./AAN-6887-2020; hoekstra, harald/AAR-3263-2021; Smithers, Bernard Mark/F-2060-2010	Smithers, Bernard Mark/0000-0002-8333-8685; Thompson, John/0000-0002-2816-2496	National Cancer Institute; National Institutes of Health; Australia and New Zealand Melanoma Trials Group; NATIONAL CANCER INSTITUTE [P01CA029605, R01CA189163, P30CA016042] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australia and New Zealand Melanoma Trials Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute, National Institutes of Health, and the Australia and New Zealand Melanoma Trials Group; ClinicalTrials.gov number, NCT00275496.	Altstein L, 2013, BIOMETRICS, V69, P52, DOI 10.1111/j.1541-0420.2012.01818.x; Altstein LL, 2011, STAT MED, V30, P709, DOI 10.1002/sim.4131; Balch CM, 2007, NEW ENGL J MED, V356, P420; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BALCH CM, 1979, CANCER, V43, P883, DOI 10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO;2-V; Balch CM, 2000, ANN SURG ONCOL, V7, P87, DOI 10.1007/s10434-000-0087-9; Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3; Chakera AH, 2009, EUR J NUCL MED MOL I, V36, P1713, DOI 10.1007/s00259-009-1228-4; COCHRAN AJ, 1982, INT J CANCER, V30, P295, DOI 10.1002/ijc.2910300307; Cochran AJ, 2001, MODERN PATHOL, V14, P604, DOI 10.1038/modpathol.3880358; Eggermont AMM, 2012, J CLIN ONCOL, V30, P3810, DOI 10.1200/JCO.2011.41.3799; Faries MB, 2013, J AM COLL SURGEONS, V217, P27, DOI 10.1016/j.jamcollsurg.2013.03.007; Faries MB, 2010, ANN SURG ONCOL, V17, P3324, DOI 10.1245/s10434-010-1203-0; Garreau JR, 2009, J CLIN ONCOL, V27; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; Morton DL, 1999, ANN SURG, V230, P453, DOI 10.1097/00000658-199910000-00001; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013; Morton DL, 2003, ANN SURG, V238, P538, DOI 10.1097/01.sla.0000086543.45557.cb; Morton DL, 1990, 42 ANN M SOC SURG ON; Morton DL, 2007, ANN SURG, V245, P828, DOI 10.1097/01.sla.0000261157.79250.16; Morton DL, 2007, NEW ENGL J MED, V356, P419; Morton Donald L, 2008, Nat Clin Pract Oncol, V5, P510, DOI 10.1038/ncponc1205; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Shen P, 2000, ANN SURG ONCOL, V7, P114, DOI 10.1007/s10434-000-0114-x; SIM FH, 1978, CANCER-AM CANCER SOC, V41, P948, DOI 10.1002/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z; Snow H, 1892, LANCET, V2, P1892; Thomas JM, 2004, NEW ENGL J MED, V350, P757, DOI 10.1056/NEJMoa030681; THOMPSON JF, 1995, MELANOMA RES, V5, P255, DOI 10.1097/00008390-199508000-00008; VERONESI U, 1977, NEW ENGL J MED, V297, P627, DOI 10.1056/NEJM197709222971202; Wong SL, 2012, J CLIN ONCOL, V30, P2912, DOI 10.1200/JCO.2011.40.3519	33	925	948	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2014	370	7					599	609		10.1056/NEJMoa1310460	http://dx.doi.org/10.1056/NEJMoa1310460			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA6CX	24521106	Green Accepted			2022-12-28	WOS:000331187500006
J	Wang, XH; Piao, SL; Ciais, P; Friedlingstein, P; Myneni, RB; Cox, P; Heimann, M; Miller, J; Peng, SS; Wang, T; Yang, H; Chen, AP				Wang, Xuhui; Piao, Shilong; Ciais, Philippe; Friedlingstein, Pierre; Myneni, Ranga B.; Cox, Peter; Heimann, Martin; Miller, John; Peng, Shushi; Wang, Tao; Yang, Hui; Chen, Anping			A two-fold increase of carbon cycle sensitivity to tropical temperature variations	NATURE			English	Article							ATMOSPHERIC CO2; TREE MORTALITY; CLIMATE; DROUGHT; LAND; DIOXIDE; DATASET; FEEDBACKS; ANOMALIES; EXTREMES	Earth system models project that the tropical land carbon sink will decrease in size in response to an increase in warming and drought during this century, probably causing a positive climate feedback(1,2). But available data(3-5) are too limited at present to test the predicted changes in the tropical carbon balance in response to climate change. Long-term atmospheric carbon dioxide data provide a global record that integrates the interannual variability of the global carbon balance. Multiple lines of evidence(6-8) demonstrate that most of this variability originates in the terrestrial biosphere. In particular, the year-to-year variations in the atmospheric carbon dioxide growth rate (CGR) are thought to be the result of fluctuations in the carbon fluxes of tropical land areas(6,9,10). Recently, the response of CGR to tropical climate interannual variability was used to put a constraint on the sensitivity of tropical land carbon to climate change(10). Here we use the long-term CGR record from Mauna Loa and the South Pole to show that the sensitivity of CGR to tropical temperature interannual variability has increased by a factor of 1.9 +/- 0.3 in the past five decades. We find that this sensitivity was greater when tropical land regions experienced drier conditions. This suggests that the sensitivity of CGR to interannual temperature variations is regulated by moisture conditions, even though the direct correlation between CGR and tropical precipitation is weak(9). We also find that present terrestrial carbon cycle models do not capture the observed enhancement in CGR sensitivity in the past five decades. More realistic model predictions of future carbon cycle and climate feedbacks require a better understanding of the processes driving the response of tropical ecosystems to drought and warming.	[Wang, Xuhui; Piao, Shilong; Ciais, Philippe; Peng, Shushi; Wang, Tao; Yang, Hui] Peking Univ, Sinofrench Inst Earth Syst Sci, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Piao, Shilong] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China; [Ciais, Philippe; Wang, Tao] CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Friedlingstein, Pierre; Cox, Peter] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Heimann, Martin] Max Planck Inst Biogeochem, D-07701 Jena, Germany; [Miller, John] NOAA, Global Monitoring Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Miller, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Chen, Anping] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Peking University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Exeter; Boston University; Max Planck Society; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; Princeton University	Piao, SL (corresponding author), Peking Univ, Sinofrench Inst Earth Syst Sci, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	Ciais, Philippe/A-6840-2011; wang, xuhui/H-8605-2019; Cox, Peter Michae;/B-3299-2012; Peng, Shushi/J-4779-2014; Myneni, Ranga B./AAU-6088-2021; Wang, Tao/ABE-7107-2020; Myneni, Ranga B/F-5129-2012; PENG, Shushi/AAS-2603-2020; Friedlingstein, Pierre/H-2700-2014; wang, tao/H-2830-2013; Chen, Anping/H-9960-2014; Heimann, Martin/H-7807-2016; Miller, John B./AAE-7714-2019	Ciais, Philippe/0000-0001-8560-4943; wang, xuhui/0000-0003-0818-9816; Cox, Peter Michae;/0000-0002-0679-2219; Peng, Shushi/0000-0001-5098-726X; Myneni, Ranga B/0000-0002-0234-6393; PENG, Shushi/0000-0001-5098-726X; Friedlingstein, Pierre/0000-0003-3309-4739; wang, tao/0000-0003-4792-5898; Chen, Anping/0000-0003-2085-3863; Heimann, Martin/0000-0001-6296-5113; Miller, John B./0000-0001-8630-1610	National Natural Science Foundation of China [41125004]; National Basic Research Program of China [2010CB950601, 2013CB956303]; National Youth Top-notch Talent Support Program in China; NASA Earth Science Division	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Youth Top-notch Talent Support Program in China; NASA Earth Science Division	We thank S. Seneviratne and G. Zhang for comments and J. Gash for English editing. This study was supported by the National Natural Science Foundation of China (41125004), the National Basic Research Program of China (grant nos 2010CB950601 and 2013CB956303) and the National Youth Top-notch Talent Support Program in China. R. B. M. was funded by the NASA Earth Science Division.	Adams JM, 2005, CHEMOSPHERE, V59, P1595, DOI 10.1016/j.chemosphere.2005.03.064; Alden CB, 2010, TELLUS B, V62, P369, DOI 10.1111/j.1600-0889.2010.00481.x; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Angstrom A., 1924, Q J ROY METEOR SOC, V50, P121, DOI [10.1002/qj.49705021008, DOI 10.1002/QJ.49705021008]; Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Dinku T, 2008, INT J CLIMATOL, V28, P1627, DOI 10.1002/joc.1669; Edwards DD, 1997, THESIS COLORADO STAT; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; HANSEN J, 1988, J GEOPHYS RES-ATMOS, V93, P9341, DOI 10.1029/JD093iD08p09341; Hirschi M, 2011, NAT GEOSCI, V4, P17, DOI 10.1038/NGEO1032; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Keeling CD., 2005, HIST ATMOSPHERIC CO2, P83, DOI DOI 10.1007/0-387-27048-5_5; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lee K, 1998, NATURE, V396, P155, DOI 10.1038/24139; Mahecha MD, 2007, BIOGEOSCIENCES, V4, P743, DOI 10.5194/bg-4-743-2007; Mahecha MD, 2010, PATTERN RECOGN LETT, V31, P2309, DOI 10.1016/j.patrec.2010.06.021; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Meir P, 2010, NEW PHYTOL, V187, P553, DOI 10.1111/j.1469-8137.2010.03390.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Patra PK, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002258; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Randerson JT, 2013, NATURE, V494, P319, DOI 10.1038/nature11949; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schneider U., 2013, THEOR APPL CLIMATOL; Schwalm CR, 2011, BIOGEOSCIENCES, V8, P2493, DOI 10.5194/bg-8-2493-2011; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Solomon S., 2007, CLIMATE CHANGE 2001; Solomon S., 2007, CLIMATE CHANGE 2007; Stackhouse P.W., 2004, GEWEX NEWS, V14, P10; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Vicente-Serrano SM, 2010, J HYDROMETEOROL, V11, P1033, DOI 10.1175/2010JHM1224.1; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110	51	218	226	27	497	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					212	+		10.1038/nature12915	http://dx.doi.org/10.1038/nature12915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24463514				2022-12-28	WOS:000331107700036
J	Watts, G				Watts, Geoff			Eldryd Parry: lifelong visionary in global health	LANCET			English	Biographical-Item																		PARRY E, PUBLICATIONS LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					505	505		10.1016/S0140-6736(14)60172-0	http://dx.doi.org/10.1016/S0140-6736(14)60172-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24506896	Bronze			2022-12-28	WOS:000331136400013
J	Hastings, G				Hastings, Gerard			PERSONAL VIEW Tobacco companies are still determined to get children addicted	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland	University of Stirling	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk			Medical Research Council [MR/K023195/1] Funding Source: Medline; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; McEwen, 2009, TOB J INT; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; WHO, 2008, GLOB TOB EP	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2014	348								g1439	10.1136/bmj.g1439	http://dx.doi.org/10.1136/bmj.g1439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4KD	24511090				2022-12-28	WOS:000331063600010
J	Persaud, R; Narula, A; Bradley, PJ				Persaud, Ricardo; Narula, Antony; Bradley, Patrick J.			Foreign Bodies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ESOPHAGUS		[Persaud, Ricardo; Narula, Antony] St Marys Hosp, London, England; [Bradley, Patrick J.] Univ Nottingham Hosp, Nottingham NG7 2UH, England	Imperial College London; University of Nottingham	Persaud, R (corresponding author), St Marys Hosp, London, England.		Bradley, Patrick/AAE-4485-2021	Bradley, Patrick/0000-0003-2810-5704				Belleza WG, 2006, MED CLIN N AM, V90, P329, DOI 10.1016/j.mcna.2005.12.001; Hashmi S, 2004, J ROY SOC MED, V97, P72, DOI 10.1258/jrsm.97.2.72; Lam HCK, 2001, J LARYNGOL OTOL, V115, P954; MCRAE D, 1989, J OTOLARYNGOL, V18, P317; Persaud R, 2009, HEAD NECK SURG, P1689; Persaud RAP, 2001, EMERG MED J, V18, P312, DOI 10.1136/emj.18.4.312	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2014	348								g391	10.1136/bmj.g391	http://dx.doi.org/10.1136/bmj.g391			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AY	24480100				2022-12-28	WOS:000330647900011
J	Grant, RL				Grant, Robert L.			Converting an odds ratio to a range of plausible relative risks for better communication of research findings	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Grant, Robert L.] Univ London, London SW17 0RE, England; [Grant, Robert L.] Univ Kingston, London SW17 0RE, England	University of London; Kingston University	Grant, RL (corresponding author), Univ London, London SW17 0RE, England.	robert.grant@sgul.kingston.ac.uk						Ahmed H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3996; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Fox J, 2013, CRAN PACKAGE EFFECTS; Greenland S, 1999, STAT SCI, V14, P29; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Murray RL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4004; Prasad K, 2008, J GEN INTERN MED, V23, P635, DOI 10.1007/s11606-007-0453-4; Rigotti NA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub3; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Shrier I, 2006, CLIN J SPORT MED, V16, P107, DOI 10.1097/00042752-200603000-00004; StataCorp, 2010, STAT VERS 11 2 SE	11	122	122	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2014	348								f7450	10.1136/bmj.f7450	http://dx.doi.org/10.1136/bmj.f7450			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BI	24464277	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000330298500001
J	Kmietowicz, Z				Kmietowicz, Zosia			PUBLIC HEALTH Blue sky commissioning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Kmietowicz, Z (corresponding author), BMJ, London WC1H 9JR, England.	zkmietowicz@bmj.com						Department for Communities and Local Government, 2013, COST TROUBL FAM; Department for Communities and Local Government (DCLG), 2012, WORK TROUBL FAM GUID; Lloyd C, MONITORING EVALUATIO; Thomson H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008657.pub2	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g285	10.1136/bmj.g285	http://dx.doi.org/10.1136/bmj.g285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24458839				2022-12-28	WOS:000330298100009
J	Subtelny, AO; Eichhorn, SW; Chen, GR; Sive, H; Bartel, DP				Subtelny, Alexander O.; Eichhorn, Stephen W.; Chen, Grace R.; Sive, Hazel; Bartel, David P.			Poly(A)-tail profiling reveals an embryonic switch in translational control	NATURE			English	Article							MESSENGER-RNA DEGRADATION; GENOME-WIDE ANALYSIS; CYTOPLASMIC POLYADENYLATION; OOCYTE MATURATION; GENE-EXPRESSION; TAIL; TRANSCRIPTION; MICRORNAS; YEAST; DEADENYLATION	Poly(A) tails enhance the stability and translation of most eukaryotic messenger RNAs, but difficulties in globally measuring poly(A)-tail lengths have impeded greater understanding of poly(A)-tail function. Here we describe poly(A)-tail length profiling by sequencing (PAL-seq) and apply it to measure tail lengths of millions of individual RNAs isolated from yeasts, cell lines, Arabidopsis thaliana leaves, mouse liver, and zebrafish and frog embryos. Poly(A)-tail lengths were conserved between orthologous mRNAs, with mRNAs encoding ribosomal proteins and other 'housekeeping' proteins tending to have shorter tails. As expected, tail lengths were coupled to translational efficiencies in early zebrafish and frog embryos. However, this strong coupling diminished at gastrulation and was absent in non-embryonic samples, indicating a rapid developmental switch in the nature of translational control. This switch complements an earlier switch to zygotic transcriptional control and explains why the predominant effect of microRNA-mediated deadenylation concurrently shifts from translational repression to mRNA destabilization.	[Subtelny, Alexander O.; Eichhorn, Stephen W.; Chen, Grace R.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Subtelny, Alexander O.; Eichhorn, Stephen W.; Chen, Grace R.; Sive, Hazel; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Subtelny, Alexander O.; Eichhorn, Stephen W.; Chen, Grace R.; Sive, Hazel; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Subtelny, Alexander O.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu		Sive, Hazel/0000-0002-4890-424X	NIH [GM067031]; NIH Medical Scientist Training Program [T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Weinberg, V. Auyeung, I. Ulitsky, C. Jan, J.-W. Nam, A. Shkumatava, S.-J. Hong, Y. Erlich and the Whitehead Genome Technology Core (V. Dhanapal, L. Francis, S. Gupta and T. Volkert) for discussions; J.-W. Nam, I. Ulitsky and D. Weinberg for assistance with transcript annotation; C. Bresilla, X. Guo, S.-J. Hong and A. Rothman for experimental assistance; and D. Weinberg for comments on the manuscript. Supported by NIH grant GM067031 (D. P. B.) and NIH Medical Scientist Training Program fellowship T32GM007753 (A.O.S.). D. P. B. is an investigator of the Howard Hughes Medical Institute.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Audic Y, 1997, MOL CELL BIOL, V17, P209, DOI 10.1128/MCB.17.1.209; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Braun JE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012328; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eckmann CR, 2011, WIRES RNA, V2, P348, DOI 10.1002/wrna.56; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; KANE DA, 1993, DEVELOPMENT, V119, P447; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Munchel SE, 2011, MOL BIOL CELL, V22, P2787, DOI 10.1091/mbc.E11-01-0028; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Oh B, 2000, DEVELOPMENT, V127, P3795; PALATNIK CM, 1984, CELL, V36, P1017, DOI 10.1016/0092-8674(84)90051-5; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schurer H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf055; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	57	374	375	1	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					66	+		10.1038/nature13007	http://dx.doi.org/10.1038/nature13007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24476825	Green Accepted, Green Submitted			2022-12-28	WOS:000333609900043
J	Burrows, MT; Schoeman, DS; Richardson, AJ; Molinos, JG; Hoffmann, A; Buckley, LB; Moore, PJ; Brown, CJ; Bruno, JF; Duarte, CM; Halpern, BS; Hoegh-Guldberg, O; Kappel, CV; Kiessling, W; O'Connor, MI; Pandolfi, JM; Parmesan, C; Sydeman, W; Ferrier, S; Williams, KJ; Poloczanska, ES				Burrows, Michael T.; Schoeman, David S.; Richardson, Anthony J.; Molinos, Jorge Garcia; Hoffmann, Ary; Buckley, Lauren B.; Moore, Pippa J.; Brown, Christopher J.; Bruno, John F.; Duarte, Carlos M.; Halpern, Benjamin S.; Hoegh-Guldberg, Ove; Kappel, Carrie V.; Kiessling, Wolfgang; O'Connor, Mary I.; Pandolfi, John M.; Parmesan, Camille; Sydeman, WilliamJ.; Ferrier, Simon; Williams, Kristen J.; Poloczanska, Elvira S.			Geographical limits to species-range shifts are suggested by climate velocity	NATURE			English	Article							BIODIVERSITY; CONSERVATION; MARINE; DISTRIBUTIONS; IMPACTS; ANALOG	The reorganization of patterns of species diversity driven by anthropogenic climate change, and the consequences for humans(1), are not yet fully understood or appreciated(2,3). Nevertheless, changes in climate conditions are useful for predicting shifts in species distributions at global(4) and local scales(5). Here we use the velocity of climate change(6,7) to derive spatial trajectories for climatic niches from 1960 to 2009 (ref. 7) and from 2006 to 2100, and use the properties of these trajectories to infer changes in species distributions. Coastlines act as barriers and locally cooler areas act as attractors for trajectories, creating source and sink areas for local climatic conditions. Climate source areas indicate where locally novel conditions are not connected to areas where similar climates previously occurred, and are thereby inaccessible to climate migrants tracking isotherms: 16% of global surface area for 1960 to 2009, and 34% of ocean for the 'business as usual' climate scenario (representative concentration pathway (RCP) 8.5)(8) representing continued use of fossil fuels without mitigation. Climate sink areas are where climate conditions locally disappear, potentially blocking the movement of climate migrants. Sink areas comprise 1.0% of ocean area and 3.6% of land and are prevalent on coasts and high ground. Using this approach to infer shifts in species distributions gives global and regional maps of the expected direction and rate of shifts of climate migrants, and suggests areas of potential loss of species richness.	[Burrows, Michael T.; Molinos, Jorge Garcia] Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban PA37 1QA, Argyll, Scotland; [Schoeman, David S.] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld 4558, Australia; [Richardson, Anthony J.; Poloczanska, Elvira S.] CSIRO Marine & Atmospher Res, Ecosci Precinct, Climate Adaptat Flagship, Brisbane, Qld 4001, Australia; [Richardson, Anthony J.] Univ Queensland, Sch Math & Phys, Ctr Applicat Nat Resource Math CARM, St Lucia, Qld 4072, Australia; [Hoffmann, Ary] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Buckley, Lauren B.; Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Moore, Pippa J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Dyfed, Wales; [Moore, Pippa J.] Edith Cowan Univ, Ctr Marine Ecosyst Res, Perth, WA 6027, Australia; [Brown, Christopher J.; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld 4072, Australia; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA 6009, Australia; [Duarte, Carlos M.] IMEDEA UIB CSIC, Dept Global Change Res, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Spain; [Duarte, Carlos M.] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Biol, Jeddah 21589, Saudi Arabia; [Halpern, Benjamin S.; Kappel, Carrie V.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Kiessling, Wolfgang] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Kiessling, Wolfgang] Museum Nat Kunde, D-10115 Berlin, Germany; [O'Connor, Mary I.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [O'Connor, Mary I.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Australian Res Council Ctr Excellence Coral Reef, Brisbane, Qld 4072, Australia; [Parmesan, Camille] Univ Texas Austin, Austin, TX 78712 USA; [Parmesan, Camille] Univ Plymouth, Marine Inst, Plymouth PL4 8AA, Devon, England; [Sydeman, WilliamJ.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Ferrier, Simon; Williams, Kristen J.] CSIRO Ecosyst Sci, Climate Adaptat Flagship, Canberra, ACT 2601, Australia	UHI Millennium Institute; University of the Sunshine Coast; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Melbourne; University of North Carolina; University of North Carolina Chapel Hill; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Edith Cowan University; University of Queensland; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); King Abdulaziz University; University of California System; University of California Santa Barbara; Imperial College London; University of Erlangen Nuremberg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of British Columbia; University of British Columbia; University of Queensland; University of Texas System; University of Texas Austin; University of Plymouth; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burrows, MT (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban PA37 1QA, Argyll, Scotland.	mtb@sams.ac.uk	Richardson, Anthony J/B-3649-2010; Burrows, Michael/ABF-4844-2020; Kiessling, Wolfgang/E-2259-2015; Hoffmann, Ary/C-2961-2011; poloczanska, elvira/P-5356-2014; Moore, Pippa/H-8079-2013; O'Connor, Mary/R-2933-2019; Williams, Kristen Jennifer/B-9941-2008; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Brown, Christopher J/G-4287-2011; Moore, Pippa/HCH-3738-2022; Buckley, Lauren/ABD-6759-2021; Hoegh-Guldberg, Ove/ABA-5420-2020; O'Connor, Mary I/F-2275-2010; Duarte, Carlos M/A-7670-2013; Pandolfi, John M/A-3121-2009; Poloczanska, Elvira/F-4366-2014; Molinos, Jorge García/C-9252-2015; Parmesan, Camille/GVT-5674-2022; Hoffmann, Ary/R-2972-2019; Ferrier, Simon/C-1490-2009	Richardson, Anthony J/0000-0002-9289-7366; Burrows, Michael/0000-0003-4620-5899; Kiessling, Wolfgang/0000-0002-1088-2014; Moore, Pippa/0000-0002-9889-2216; Williams, Kristen Jennifer/0000-0002-7324-5880; Brown, Christopher J/0000-0002-7271-4091; Buckley, Lauren/0000-0003-1315-3818; Hoegh-Guldberg, Ove/0000-0001-7510-6713; O'Connor, Mary I/0000-0001-9583-1592; Duarte, Carlos M/0000-0002-1213-1361; Pandolfi, John M/0000-0003-3047-6694; Molinos, Jorge García/0000-0001-7516-1835; Hoffmann, Ary/0000-0001-9497-7645; Ferrier, Simon/0000-0001-7884-2388; Parmesan, Camille/0000-0002-1515-274X; Schoeman, David/0000-0003-1258-0885; poloczanska, elvira/0000-0001-8470-0925	National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; UK Natural Environment Research Council [NE/J024082/1]; Australian Research Council's Collaborative Research Network; Australian Research Council Centre of Excellence for Coral Reef Studies; Australian Research Council [DP0879365]; Future Fellowship [FT0991722]; NERC [NE/J021938/1, NE/J024082/1, NE/J022446/1, NE/L013029/1] Funding Source: UKRI; Natural Environment Research Council [NE/J024082/1, NE/J022446/1, NE/L013029/1, NE/J021938/1] Funding Source: researchfish	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council's Collaborative Research Network(Australian Research Council); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council); Future Fellowship(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was conducted as a part of the Towards Understanding Marine Biological Impacts of Climate Change Working Group supported by the National Center for Ecological Analysis and Synthesis, a center funded by the NSF (grant no. EF-0553768), the University of California, Santa Barbara and the State of California. M. T. B., P.J.M. and J.G.M. were supported by the UK Natural Environment Research Council grant NE/J024082/1. D. S. was supported by the Australian Research Council's Collaborative Research Network. J.P. thanks the Australian Research Council Centre of Excellence for Coral Reef Studies for additional support, and A.J.R. was supported by the Australian Research Council Discovery Grant DP0879365 and Future Fellowship Grant FT0991722.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Hiddink JG, 2012, GLOBAL CHANGE BIOL, V18, P2161, DOI 10.1111/j.1365-2486.2012.02698.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; Ordonez A, 2013, CLIMATIC CHANGE, V119, P659, DOI 10.1007/s10584-013-0752-1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	24	343	355	9	534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					492	+		10.1038/nature12976	http://dx.doi.org/10.1038/nature12976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24509712	Green Submitted, Green Published			2022-12-28	WOS:000333402000039
J	Stone, NJ; Robinson, JG; Lichtenstein, AH; Goff, DC; Lloyd-Jones, DM; Smith, SC; Blum, C; Schwartz, JS				Stone, Neil J.; Robinson, Jennifer G.; Lichtenstein, Alice H.; Goff, David C., Jr.; Lloyd-Jones, Donald M.; Smith, Sidney C., Jr.; Blum, Conrad; Schwartz, J. Sanford		2013 ACC AHA Cholesterol Guideline	Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Synopsis of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline	ANNALS OF INTERNAL MEDICINE			English	Article								Description: In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce cardiovascular risk in adults. This synopsis summarizes the major recommendations. Methods: In 2008, the National Heart, Lung, and Blood Institute convened the Adult Treatment Panel (ATP) IV to update the 2001 ATP-III cholesterol guidelines using a rigorous process to systematically review randomized, controlled trials (RCTs) and meta-analyses of RCTs that examined cardiovascular outcomes. The panel commissioned independent systematic evidence reviews on low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in secondary and primary prevention and the effect of lipid drugs on atherosclerotic cardiovascular disease events and adverse effects. In September 2013, the panel's draft recommendations were transitioned to the ACC/AHA. Recommendations: This synopsis summarizes key features of the guidelines in 8 areas: lifestyle, groups shown to benefit from statins, statin safety, decision making, estimation of cardiovascular disease risk, intensity of statin therapy, treatment targets, and monitoring of statin therapy.	Northwestern Univ, Chicago, IL 60611 USA; Univ Iowa, Iowa City, IA USA; Tufts Univ, Boston, MA 02111 USA; Univ Colorado, Aurora, CO USA; Univ N Carolina, Chapel Hill, NC USA; Columbia Univ, Med Ctr, New York, NY USA; [Schwartz, J. Sanford] Univ Penn, Philadelphia, PA 19104 USA	Northwestern University; University of Iowa; Tufts University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Pennsylvania	Schwartz, JS (corresponding author), Univ Penn, Blockley 1101,423 Guardian Dr, Philadelphia, PA 19104 USA.	schwartz@wharton.upenn.edu	Stone, Neil/ABB-6039-2021; , Jennifer/AAD-8336-2019	Lloyd-Jones, Donald/0000-0003-0847-6110; Stone, Neil/0000-0002-6927-7783				American Heart Association, 2013, 2013 PREV GUID TOOLS; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Lloyd-Jones DM, 2013, LANCET; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	8	148	157	0	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					339	+		10.7326/M14-0126	http://dx.doi.org/10.7326/M14-0126			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24474185				2022-12-28	WOS:000332793900006
J	Keller, SC; Bessell, MS; Frebel, A; Casey, AR; Asplund, M; Jacobson, HR; Lind, K; Norris, JE; Yong, D; Heger, A; Magic, Z; Da Costa, GS; Schmidt, BP; Tisserand, P				Keller, S. C.; Bessell, M. S.; Frebel, A.; Casey, A. R.; Asplund, M.; Jacobson, H. R.; Lind, K.; Norris, J. E.; Yong, D.; Heger, A.; Magic, Z.; Da Costa, G. S.; Schmidt, B. P.; Tisserand, P.			A single low-energy, iron-poor supernova as the source of metals in the star SMSS J031300.36-670839.3	NATURE			English	Article							HOLE-FORMING SUPERNOVAE; GALACTIC HALO; SKY SURVEY; 1ST STARS; EVOLUTION; SPECTROGRAPH; SIGNATURES	The element abundance ratios of four low-mass stars with extremely low metallicities (abundances of elements heavier than helium) indicate that the gas out of which the stars formed was enriched in each case by at most a few-and potentially only one-low-energy supernova(1-4). Such supernovae yield large quantities of light elements such as carbon but very little iron. The dominance of low-energy supernovae seems surprising, because it had been expected that the first stars were extremely massive, and that they disintegrated in pair-instability explosions that would rapidly enrich galaxies in iron(5). What has remained unclear is the yield of iron from the first supernovae, because hitherto no star has been unambiguously interpreted as encapsulating the yield of a single supernova. Here we report the optical spectrum of SMSS J031300.36-670839.3, which shows no evidence of iron (with an upper limit of 10(-7.1) times solar abundance). Based on a comparison of its abundance pattern with those of models, we conclude that the star was seeded with material from a single supernova with an original mass about 60 times that of the Sun (and that the supernova left behind a black hole). Taken together with the four previously mentioned low-metallicity stars, we conclude that low-energy supernovae were common in the early Universe, and that such supernovae yielded light-element enrichment with insignificant iron. Reduced stellar feedback both chemically and mechanically from low-energy supernovae would have enabled first-generation stars to form over an extended period. We speculate that such stars may perhaps have had an important role in the epoch of cosmic reionization and the chemical evolution of early galaxies.	[Keller, S. C.; Bessell, M. S.; Casey, A. R.; Asplund, M.; Norris, J. E.; Yong, D.; Magic, Z.; Da Costa, G. S.; Schmidt, B. P.; Tisserand, P.] Mt Stromlo & Siding Spring Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Frebel, A.; Jacobson, H. R.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Frebel, A.; Jacobson, H. R.] Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Lind, K.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Heger, A.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Magic, Z.] Max Planck Inst Astrophys, D-85741 Garching, Germany	Australian National University; Massachusetts Institute of Technology (MIT); University of Cambridge; Monash University; Max Planck Society	Keller, SC (corresponding author), Mt Stromlo & Siding Spring Observ, Res Sch Astron & Astrophys, Cotter Rd, Weston, ACT 2611, Australia.	stefan.keller@anu.edu.au		Asplund, Martin/0000-0002-5804-3682; Bessell, Michael/0000-0001-7801-1410; Yong, David/0000-0002-6502-1406; Schmidt, Brian/0000-0002-8538-9195; Heger, Alexander/0000-0002-3684-1325; Tisserand, Patrick/0000-0003-4237-0520; Lind, Karin/0000-0002-8892-2573; Schmidt, Brian/0000-0001-6589-1287; Casey, Andrew/0000-0003-0174-0564; Da Costa, Gary/0000-0001-7019-649X	Australian Research Council [DP120101237, DP0984924, DP0878137, LF0992131]; NSF [AST-1255160]; Australian Prime Minister's Endeavour Award Research Fellowship; European Union FP7 programme through ERC [320360]; Direct For Mathematical & Physical Scien [1255160] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); Australian Prime Minister's Endeavour Award Research Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); European Union FP7 programme through ERC; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Australian access to the Magellan Telescopes was supported through the National Collaborative Research Infrastructure Strategy of the Australian Federal Government. M. A., M. S. B., A. R. C., G. D. C., S. K., J.E.N. and D.Y. acknowledge the support of Australian Research Council (grants DP120101237, DP0984924, DP0878137 and LF0992131). A. F. acknowledges support from NSF grant AST-1255160. A. R. C. acknowledges support from the Australian Prime Minister's Endeavour Award Research Fellowship. K. L. acknowledges support from the European Union FP7 programme through ERC grant number 320360.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bernstein RA, 2003, P SOC PHOTO-OPT INS, V4841, P1694, DOI 10.1117/12.461502; Bessell MS, 2007, PUBL ASTRON SOC PAC, V119, P605, DOI 10.1086/519981; Carnegie, 2012, OBS SOFTW REP MIKE P; Casagrande L, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913204; Castelli F., 2004, PREPRINT; Coc A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/158; Dopita M, 2010, ASTROPHYS SPACE SCI, V327, P245, DOI 10.1007/s10509-010-0335-9; Ekstrom S, 2008, ASTRON ASTROPHYS, V489, P685, DOI 10.1051/0004-6361:200809633; EZER D, 1971, ASTROPHYS SPACE SCI, V14, P399, DOI 10.1007/BF00653327; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Gustafsson B, 2008, ASTRON ASTROPHYS, V486, P951, DOI 10.1051/0004-6361:200809724; HARTWICK FDA, 1976, ASTROPHYS J, V209, P418, DOI 10.1086/154735; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Henden A. A., 2013, AAVSO PHOTOMETRIC AL; Hirano S., 2013, PREPRINT; Hirano S., ASTROPHYS J IN PRESS; Joggerst CC, 2009, ASTROPHYS J, V693, P1780, DOI 10.1088/0004-637X/693/2/1780; Karlsson T, 2013, REV MOD PHYS, V85, P809, DOI 10.1103/RevModPhys.85.809; Keller SC, 2007, PUBL ASTRON SOC AUST, V24, P1, DOI 10.1071/AS07001; Kulkarni G., 2013, PREPRINT; Lind K, 2009, ASTRON ASTROPHYS, V503, P541, DOI 10.1051/0004-6361/200912221; Magic Z, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321274; Munari U, 1997, ASTRON ASTROPHYS, V318, P269; Norris JE, 2007, ASTROPHYS J, V670, P774, DOI 10.1086/521919; Norris JE, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/28; Robertson BE, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/71; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Tominaga N, 2007, ASTROPHYS J, V657, pL77, DOI 10.1086/513193; Umeda H, 2003, NATURE, V422, P871, DOI 10.1038/nature01571; Wiescher M, 1999, J PHYS G NUCL PARTIC, V25, pR133, DOI 10.1088/0954-3899/25/6/201; Yong D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/26	36	250	251	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					463	+		10.1038/nature12990	http://dx.doi.org/10.1038/nature12990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24509711	Green Submitted			2022-12-28	WOS:000332165100032
J	Ho, CSH; Ho, RCM; Wilder-Smith, EP				Ho, Cyrus S. H.; Ho, Roger C. M.; Wilder-Smith, Einar P.			Stiff person syndrome masquerading as panic attacks	LANCET			English	Editorial Material									[Ho, Cyrus S. H.; Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 119074, Singapore; [Wilder-Smith, Einar P.] Natl Univ Hlth Syst, Div Neurol, Singapore, Singapore	National University of Singapore; National University of Singapore	Ho, CSH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	su_hui_ho@nuhs.edu.sg	Ho, Cyrus SH/AAN-9344-2020; Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Cyrus SH/0000-0002-7092-9566; Ho, Roger C./0000-0001-9629-4493; Wilder-Smith, Einar/0000-0003-3402-7503				Ciccotto G, 2013, NEUROL CLIN, V31, P319, DOI 10.1016/j.ncl.2012.09.005; Dalakas MC, 2009, CURR TREAT OPTION NE, V11, P102, DOI 10.1007/s11940-009-0013-9; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Dinnerstein E, 2007, COGN BEHAV NEUROL, V20, P136, DOI 10.1097/WNN.0b013e31804c701e; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279	5	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					668	668		10.1016/S0140-6736(14)60127-6	http://dx.doi.org/10.1016/S0140-6736(14)60127-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24529469				2022-12-28	WOS:000331137700033
J	Sharp, KA				Sharp, Kim A.			Protein Folding, Interrupted	SCIENCE			English	Editorial Material							MODEL		Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Sharp, KA (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.	sharpk@mail.med.upenn.edu						Ambrazi M, 2008, ACTA CRYSTALLOGR F, V64, P432, DOI 10.1107/S1744309108011342; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DeLano W.L, PYMOL MOL GRAPHICS S; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Sun TJ, 2014, SCIENCE, V343, P795, DOI 10.1126/science.1247407; Tanford C., 1973, HYDROPHOBIC EFFECT	11	3	3	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					743	744		10.1126/science.1249405	http://dx.doi.org/10.1126/science.1249405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531963				2022-12-28	WOS:000331557800030
J	Chenoweth, JG; McKay, RD				Chenoweth, Josh G.; McKay, Ronald D.			Speeding to Pluripotency	CELL			English	Editorial Material							STEM-CELLS	Finding a cell that reprograms in a nonstochastic manner without genetic manipulation has proven elusive. In this issue, Guo et al. report the identification of a cell defined by an ultrafast cycle whose progeny reprogram in a synchronous and rapid manner.	[Chenoweth, Josh G.; McKay, Ronald D.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA		McKay, RD (corresponding author), Lieber Inst Brain Dev, 855 N Wolfe St, Baltimore, MD 21205 USA.	ronald.mckay@libd.org						Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Megyola CM, 2013, STEM CELLS, V31, P895, DOI 10.1002/stem.1323; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632	10	0	0	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 13	2014	156	4					631	632		10.1016/j.cell.2014.01.046	http://dx.doi.org/10.1016/j.cell.2014.01.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AA8YB	24529370	Bronze			2022-12-28	WOS:000331379800004
J	Ottenbacher, KJ; Karmarkar, A; Graham, JE; Kuo, YF; Deutsch, A; Reistetter, TA; Al Snih, S; Granger, CV				Ottenbacher, Kenneth J.; Karmarkar, Amol; Graham, James E.; Kuo, Yong-Fang; Deutsch, Anne; Reistetter, Timothy A.; Al Snih, Soham; Granger, Carl V.			Thirty-Day Hospital Readmission Following Discharge From Postacute Rehabilitation in Fee-for-Service Medicare Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; QUALITY; PAYMENT; CARE; REHOSPITALIZATIONS; RELIABILITY; DISPARITIES; SYSTEM; RATES; COST	IMPORTANCE The Centers for Medicare & Medicaid Services recently identified 30-day readmission after discharge from inpatient rehabilitation facilities as a national quality indicator. Research is needed to determine the rates and factors related to readmission in this patient population. OBJECTIVE To determine 30-day readmission rates and factors related to readmission for patients receiving postacute inpatient rehabilitation. DESIGN, SETTING, AND PATIENTS Retrospective cohort study of records for 736 536 Medicare fee-for-service beneficiaries (mean age, 78.0 [SD, 7.3] years) discharged from 1365 inpatient rehabilitation facilities to the community in 2006 through 2011. Sixty-three percent of patients were women, and 85.1% were non-Hispanic white. MAIN OUTCOMES AND MEASURES Thirty-day readmission rates for the 6 largest diagnostic impairment categories receiving inpatient rehabilitation. These included stroke, lower extremity fracture, lower extremity joint replacement, debility, neurologic disorders, and brain dysfunction. RESULTS Mean rehabilitation length of stay was 12.4 (SD, 5.3) days. The overall 30-day readmission rate was 11.8%(95% CI, 11.7%-11.8%). Rates ranged from 5.8% (95% CI, 5.8%-5.9%) for patients with lower extremity joint replacement to 18.8% (95% CI, 18.8%-18.9%). for patients with debility. Rates were highest in men (13.0%[95% CI, 12.8%-13.1%], vs 11.0%[95% CI, 11.0%-11.1%] in women), non-Hispanic blacks (13.8% [95% CI, 13.5%-14.1%], vs 11.5%[95% CI, 11.5%-11.6%] in whites, 12.5%[95% CI, 12.1%-12.8%] in Hispanics, and 11.9%[95% CI, 11.4%-12.4%] in other races/ethnicities), beneficiaries with dual eligibility (15.1%[95% CI, 14.9%-15.4%], vs 11.1%[95% CI, 11.0%-11.2%] for no dual eligibility), and in patients with tier 1 comorbidities (25.6%[95% CI, 24.9%-26.3%], vs 18.9%[95% CI, 18.5%-19.3%] for tier 2, 15.1%[95% CI, 14.9%-15.3%] for tier 3, and 9.9% [95% CI, 9.9%-10.0%] for no tier comorbidities). Higher motor and cognitive functional status were associated with lower hospital readmission rates across the 6 impairment categories. Adjusted readmission rates by state ranged from 9.2% to 13.6%. Approximately 50% of patients rehospitalized within the 30-day period were readmitted within 11 days of discharge. Medicare Severity Diagnosis-Related Group codes for heart failure, urinary tract infection, pneumonia, septicemia, nutritional and metabolic disorders, esophagitis, gastroenteritis, and digestive disorders were common reasons for readmission. CONCLUSIONS AND RELEVANCE Among postacute rehabilitation facilities providing services to Medicare fee-for-service beneficiaries, 30-day readmission rates ranged from 5.8% to 18.8% for selected impairment groups. Further research is needed to understand the causes of readmission.	[Ottenbacher, Kenneth J.; Karmarkar, Amol; Graham, James E.; Al Snih, Soham] Univ Texas Med Branch UTMB, Div Rehabil Sci, Galveston, TX USA; [Kuo, Yong-Fang] UTMB, Dept Prevent Med & Community Hlth, Galveston, TX USA; [Deutsch, Anne] RTI Int, Washington, DC USA; [Deutsch, Anne] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Reistetter, Timothy A.] UTMB, Dept Occupat Therapy, Galveston, TX USA; [Granger, Carl V.] Uniform Data Syst Med Rehabil, Buffalo, NY USA; [Granger, Carl V.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Research Triangle Institute; Shirley Ryan AbilityLab; University of Texas System; University of Texas Medical Branch Galveston; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ottenbacher, KJ (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	kottenba@utmb.edu	Deutsch, Anne/B-7530-2017; Al Snih, Soham/ABC-2882-2020; Karmarkar, Amol/E-6030-2011	Deutsch, Anne/0000-0003-2290-7757; Karmarkar, Amol/0000-0001-8355-1585; Ottenbacher, Kenneth/0000-0001-5990-3982; Al Snih, Soham/0000-0002-0681-4641	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Medical Rehabilitation Research [R24-HD065702, R01-HD069443, K01-HD068513]; National Center for Advancing Translational Sciences [UL1RR029876]; Agency for Healthcare Research and Quality [R24-HS022134]; National Institute on Disability and Rehabilitation Research, Department of Education [H133G080163]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R24HS022134] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD068513, R24HD065702, R01HD069443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Medical Rehabilitation Research; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Disability and Rehabilitation Research, Department of Education; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Medical Rehabilitation Research (R24-HD065702, R01-HD069443, and K01-HD068513), by a Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (UL1RR029876), by the Agency for Healthcare Research and Quality (R24-HS022134), and by the National Institute on Disability and Rehabilitation Research, Department of Education (H133G080163).	3MHealth Information Systems, 2013, THE IMPACT OF DISABI; American Hospital Association, 2010, TRENDWATCH MAXIMIZIN; American Hospital Association, 2013, ISSUE BRIEF MOVING T; [Anonymous], 2001, INPATIENT REHABILITA; [Anonymous], 2011, REPORT NO 76; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Carter G, 2005, TR 201 CMS; Carter GM, 2003, HEALTH CARE FINANC R, V24, P25; Centers for Medicare & Medicaid Services, 2013, SPECIFICATIONS FOR T; Centers for Medicare & Medicaid Services (CMS) HHS, 2013, Fed Regist, V78, P47859; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Chandra A, 2013, HEALTH AFFAIR, V32, P864, DOI 10.1377/hlthaff.2012.1262; Chen LM, 2010, ARCH INTERN MED, V170, P340, DOI 10.1001/archinternmed.2009.511; DeJong G, 2010, PHYS THER, V90, P658, DOI 10.2522/ptj.2010.90.5.658; Deutsch A, 2012, REPORT 0212050; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Galloway RV, 2013, AM J PHYS MED REHAB, V92, P14, DOI 10.1097/PHM.0b013e31827441bc; Goodman D, 2013, THE REVOLVING DOOR A; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hussey P, 2012, EVIDENCE REPORT TECH; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Li Y, 2011, AM J PUBLIC HEALTH, V101, P875, DOI 10.2105/AJPH.2010.300055; Lichtman JH, 2010, STROKE, V41, P2525, DOI 10.1161/STROKEAHA.110.599159; McNutt Robert, 2010, Qual Manag Health Care, V19, P17, DOI 10.1097/QMH.0b013e3181ccbd07; Mechanic R, 2012, NEW ENGL J MED, V367, P1873, DOI 10.1056/NEJMp1210823; Medicare Payment Advisory Comission (MedPAC), 2013, REPORT TO THE CONGRE; MedPAC, 2012, REPORT TO THE CONGRE; MedPAC, 2013, REPORT TO THE CONGRE; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002	39	114	114	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2014	311	6					604	614		10.1001/jama.2014.8	http://dx.doi.org/10.1001/jama.2014.8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA2RE	24519300	Bronze, Green Accepted			2022-12-28	WOS:000330941000016
J	Conrado, RJ; Gonzalez, R				Conrado, Robert J.; Gonzalez, Ramon			Envisioning the Bioconversion of Methane to Liquid Fuels	SCIENCE			English	Editorial Material							OXIDATION		[Conrado, Robert J.; Gonzalez, Ramon] US DOE, Adv Res Projects Agcy Energy ARPA E, Washington, DC 20585 USA	United States Department of Energy (DOE)	Conrado, RJ (corresponding author), US DOE, Adv Res Projects Agcy Energy ARPA E, 1000 Independence Ave SW, Washington, DC 20585 USA.	ramon.gonzalez@doe.gov	Gonzalez, Ramon/B-1961-2010					Bagneris C, 2005, APPL ENVIRON MICROB, V71, P1570, DOI 10.1128/AEM.71.3.1570-1580.2005; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Bogorad IW, 2013, NATURE, V502, P693, DOI 10.1038/nature12575; Callaghan AV, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00089; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Hettinga WG, 2009, ENERG POLICY, V37, P190, DOI 10.1016/j.enpol.2008.08.002; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Riesenberg D, 1999, APPL MICROBIOL BIOT, V51, P422, DOI 10.1007/s002530051412; Shima S, 2012, NATURE, V481, P98, DOI 10.1038/nature10663; U. S. Energy Information Administration, 2012, EIA PUBL, V0383; Wood DA, 2012, J NAT GAS SCI ENG, V9, P196, DOI 10.1016/j.jngse.2012.07.001	12	116	121	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					621	623		10.1126/science.1246929	http://dx.doi.org/10.1126/science.1246929			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503844				2022-12-28	WOS:000330724000031
J	Kovach, JD; Lamb, RS				Kovach, Jeffery D.; Lamb, Rebecca S.			There Can Be Only One	SCIENCE			English	Editorial Material							LAND PLANTS; LEAFY; GENE; ARABIDOPSIS; BRYOPHYTES; PHYLOGENY; FAMILIES; DOMAIN		[Kovach, Jeffery D.; Lamb, Rebecca S.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Ohio State University	Kovach, JD (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	lamb.129@osu.edu						Baker CR, 2013, SCIENCE, V342, P104, DOI 10.1126/science.1240810; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; Goncalves IR, 2014, GENETICS, V196, P149, DOI 10.1534/genetics.113.157693; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; Malek O, 1996, EMBO J, V15, P1403, DOI 10.1002/j.1460-2075.1996.tb00482.x; Nickrent DL, 2000, MOL BIOL EVOL, V17, P1885, DOI 10.1093/oxfordjournals.molbev.a026290; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Siriwardana NS, 2012, PLANT J, V71, P736, DOI 10.1111/j.1365-313X.2012.05026.x; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709	12	3	3	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					623	624		10.1126/science.1250348	http://dx.doi.org/10.1126/science.1250348			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503845				2022-12-28	WOS:000330724000032
J	Zimmerman, AW; Connors, SL				Zimmerman, Andrew W.; Connors, Susan L.			Could Autism Be Treated Prenatally?	SCIENCE			English	Editorial Material							DISORDERS; BRAIN; SYSTEM; SWITCH		[Zimmerman, Andrew W.] Univ Massachusetts, Sch Med, Ctr Autism & Neurodev Disorders, Dept Pediat Neurol, Worcester, MA 01655 USA; [Connors, Susan L.] Harvard Univ, Sch Med, Lurie Ctr Autism, Massachusetts Gen Hosp Children, Lexington, MA 02421 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University	Zimmerman, AW (corresponding author), Univ Massachusetts, Sch Med, Ctr Autism & Neurodev Disorders, Dept Pediat Neurol, Worcester, MA 01655 USA.	andrew.zimmerman@umassmemorial.org; slconnors@mgh.harvard.edu						Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Flashner BM, 2013, NEUROMOL MED, V15, P339, DOI 10.1007/s12017-013-8222-5; Gregory SG, 2013, JAMA PEDIATR, V167, P959, DOI 10.1001/jamapediatrics.2013.2904; Guinchat V, 2012, ACTA OBSTET GYN SCAN, V91, P287, DOI 10.1111/j.1600-0412.2011.01325.x; He Q, 2014, J NEUROSCI, V34, P446, DOI 10.1523/JNEUROSCI.4447-13.2014; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Langridge AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050963; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Duarte ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068851; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Xu G, 2011, J NEUROPATH EXP NEUR, V70, P841, DOI 10.1097/NEN.0b013e31822f471c	15	10	11	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2014	343	6171					620	621		10.1126/science.1250214	http://dx.doi.org/10.1126/science.1250214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	304CP	24503843				2022-12-28	WOS:000330724000030
J	Allen, LA; Ambardekar, AV; Devaraj, KM; Maleszewski, JJ; Wolfel, EE				Allen, Larry A.; Ambardekar, Amrut V.; Devaraj, Kalpana M.; Maleszewski, Joseph J.; Wolfel, Eugene E.			Missing Elements of the History	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTHROPROSTHETIC COBALTISM; METAL; CARDIOMYOPATHY	A 59-year-old woman with a history of bilateral total hip replacements and a total knee replacement sees her physician for cough, exertional dyspnea, and foot swelling that had developed 2 weeks earlier while she was on vacation in Europe. ForewordIn this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.StageA 59-year-old woman presented to her primary care physician with cough, exertional dyspnea, and foot swelling that had developed 2 weeks earlier while she was vacationing in Denmark. She had no rhinorrhea, pharyngitis, fever, rash, diarrhea, or new joint symptoms. Her medical history was notable for polyarthritis, for which her rheumatologist prescribed minocycline and meloxicam. She had undergone right total hip replacement 4 years previously, left total hip replacement 3 years previously, and left total knee replacement 1 year previously. There was no history of hypertension or diabetes. She had never used tobacco, illicit drugs, or herbal supplements and ...	[Allen, Larry A.; Ambardekar, Amrut V.; Wolfel, Eugene E.] Univ Colorado, Sch Med, Dept Med, Sect Adv Heart Failure & Transplantat,Div Cardiol, Aurora, CO USA; [Devaraj, Kalpana M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Maleszewski, Joseph J.] Mayo Clin, Div Anat Pathol, Rochester, MN USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic	Allen, LA (corresponding author), 12631 E 17th Ave,Anschutz Med Campus, Aurora, CO 80045 USA.	larry.allen@ucdenver.edu	Allen, Larry/AAI-1323-2020		Johnson Johnson; Novartis; Janssen; Amgen; Medical Educational Resources; Cytokinetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL105896] Funding Source: NIH RePORTER	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Novartis(Novartis); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen(Amgen); Medical Educational Resources; Cytokinetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Allen reports receiving consulting fees from Johnson & Johnson, Novartis, Janssen, and Amgen; Dr. Wolfel, lecture fees from Medical Educational Resources; and Dr. Ambardekar, consulting fees from Cytokinetics. No other potential conflict of interest relevant to this article was reported.	Ardaugh BM, 2013, NEW ENGL J MED, V368, P97, DOI 10.1056/NEJMp1211581; Centeno JA, 1996, BIOL TRACE ELEM RES, V55, P21, DOI 10.1007/BF02784165; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Gilbert CJ, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2012.10.015; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Machado C, 2012, HEART LUNG CIRC, V21, P759, DOI 10.1016/j.hlc.2012.03.013; Medicines & Healthcare products Regulatory Agency, 2012, MED DEV AL ALL MET O; MERCIER G, 1967, CAN MED ASSOC J, V97, P884; Oldenburg M, 2009, J ARTHROPLASTY, V24; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pelclova D, 2012, CLIN TOXICOL, V50, P262, DOI 10.3109/15563650.2012.670244; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	14	46	47	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					559	566		10.1056/NEJMcps1213196	http://dx.doi.org/10.1056/NEJMcps1213196			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	24499215	Green Accepted			2022-12-28	WOS:000331073500013
J	Zhou, PH; Shaffer, DR; Arias, DAA; Nakazaki, Y; Pos, W; Torres, AJ; Cremasco, V; Dougan, SK; Cowley, GS; Elpek, K; Brogdon, J; Lamb, J; Turley, SJ; Ploegh, HL; Root, DE; Love, JC; Dranoff, G; Hacohen, N; Cantor, H; Wucherpfennig, KW				Zhou, Penghui; Shaffer, Donald R.; Arias, Diana A. Alvarez; Nakazaki, Yukoh; Pos, Wouter; Torres, Alexis J.; Cremasco, Viviana; Dougan, Stephanie K.; Cowley, Glenn S.; Elpek, Kutlu; Brogdon, Jennifer; Lamb, John; Turley, Shannon J.; Ploegh, Hidde L.; Root, David E.; Love, J. Christopher; Dranoff, Glenn; Hacohen, Nir; Cantor, Harvey; Wucherpfennig, Kai W.			In vivo discovery of immunotherapy targets in the tumour microenvironment	NATURE			English	Article							CD8+ T-CELLS; PROGNOSTIC-FACTORS; IMMUNE CELLS; CANCER; MELANOMA; PHOSPHATASE; SUPPRESSORS; LYMPHOCYTES; PROTEINS; SURVIVAL	Recent clinical trials showed that targeting of inhibitory receptors on T cells induces durable responses in a subset of cancer patients, despite advanced disease. However, the regulatory switches controlling T-cell function in immunosuppressive tumours are not well understood. Here we show that such inhibitory mechanisms can be systematically discovered in the tumour microenvironment. We devised an in vivo pooled short hairpin RNA (shRNA) screen in which shRNAs targeting negative regulators became highly enriched in murine tumours by releasing a block on T-cell proliferation upon tumour antigen recognition. Such shRNAs were identified by deep sequencing of the shRNA cassette from T cells infiltrating tumour or control tissues. One of the target genes was Ppp2r2d, a regulatory subunit of the PP2A phosphatase family. In tumours, Ppp2r2d knockdown inhibited T-cell apoptosis and enhanced T-cell proliferation as well as cytokine production. Key regulators of immune function can therefore be discovered in relevant tissue microenvironments.	[Zhou, Penghui; Shaffer, Donald R.; Arias, Diana A. Alvarez; Nakazaki, Yukoh; Pos, Wouter; Cremasco, Viviana; Elpek, Kutlu; Turley, Shannon J.; Dranoff, Glenn; Cantor, Harvey; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Torres, Alexis J.; Love, J. Christopher] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Dougan, Stephanie K.; Ploegh, Hidde L.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Cowley, Glenn S.; Root, David E.; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Brogdon, Jennifer] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Lamb, John] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novartis; Novartis	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu		zhou, penghui/0000-0003-0519-461X	National Institutes of Health [1R01CA173750]; Melanoma Research Alliance; DF/HCC-MIT Bridge Project; Lustgarten Foundation; Novartis Institutes of Biomedical Research; Koch Institute from the National Cancer Institute [P30-CA14051]; American Cancer Society; Terri Brodeur Breast Cancer Foundation; NIH [AI07386]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA173750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007386, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; DF/HCC-MIT Bridge Project; Lustgarten Foundation; Novartis Institutes of Biomedical Research; Koch Institute from the National Cancer Institute; American Cancer Society(American Cancer Society); Terri Brodeur Breast Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (Transformative Research Award 1R01CA173750 to K.W.W.), the Melanoma Research Alliance (to K.W.W.), the DF/HCC-MIT Bridge Project and the Lustgarten Foundation (to K.W.W., J.C.L. and H.L.P.), Novartis Institutes of Biomedical Research (to K.W.W.), the Koch Institute Support Grant P30-CA14051 from the National Cancer Institute, the American Cancer Society John W. Thatcher, Jr Postdoctoral Fellowship in Melanoma Research (to D.R.S.), the Terri Brodeur Breast Cancer Foundation Postdoctoral Fellowship (to P.Z.) and a NIH T32 grant (AI07386 to D.A.A.A.).	Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; FIDLER IJ, 1975, CANCER RES, V35, P218; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Oble Darryl A, 2009, Cancer Immun, V9, P3; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Paolino M, 2010, SEMIN IMMUNOPATHOL, V32, P137, DOI 10.1007/s00281-010-0197-9; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Stumpf M, 2009, BRIT J CANCER, V101, P1513, DOI 10.1038/sj.bjc.6605274; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; Tao J, 2007, EUR J IMMUNOL, V37, P818, DOI 10.1002/eji.200636726; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torres AJ, 2013, LAB CHIP, V13, P90, DOI 10.1039/c2lc40869d; Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138	48	151	158	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					52	+		10.1038/nature12988	http://dx.doi.org/10.1038/nature12988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24476824	Green Accepted, Green Submitted			2022-12-28	WOS:000330648100029
J	Teal, A				Teal, Adrian			The art of medicine Quacks and hacks: Georgian medicine and the power of advertising	LANCET			English	Editorial Material												adrian@tealcartoons.co.uk							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					404	405		10.1016/S0140-6736(14)60141-0	http://dx.doi.org/10.1016/S0140-6736(14)60141-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24494226				2022-12-28	WOS:000330673700016
J	Lehmann, CER; Anderson, TM; Sankaran, M; Higgins, SI; Archibald, S; Hoffmann, WA; Hanan, NP; Williams, RJ; Fensham, RJ; Felfili, J; Hutley, LB; Ratnam, J; San Jose, J; Montes, R; Franklin, D; Russell-Smith, J; Ryan, CM; Durigan, G; Hiernaux, P; Haidar, R; Bowman, DMJS; Bond, WJ				Lehmann, Caroline E. R.; Anderson, T. Michael; Sankaran, Mahesh; Higgins, Steven I.; Archibald, Sally; Hoffmann, William A.; Hanan, Niall P.; Williams, Richard J.; Fensham, Roderick J.; Felfili, Jeanine; Hutley, Lindsay B.; Ratnam, Jayashree; San Jose, Jose; Montes, Ruben; Franklin, Don; Russell-Smith, Jeremy; Ryan, Casey M.; Durigan, Giselda; Hiernaux, Pierre; Haidar, Ricardo; Bowman, David M. J. S.; Bond, William J.			Savanna Vegetation-Fire-Climate Relationships Differ Among Continents	SCIENCE			English	Article							GLOBAL VEGETATION; C-4 GRASSLANDS; TERRESTRIAL; DETERMINANTS; DYNAMICS; ECOLOGY; FOREST; TREES	Ecologists have long sought to understand the factors controlling the structure of savanna vegetation. Using data from 2154 sites in savannas across Africa, Australia, and South America, we found that increasing moisture availability drives increases in fire and tree basal area, whereas fire reduces tree basal area. However, among continents, the magnitude of these effects varied substantially, so that a single model cannot adequately represent savanna woody biomass across these regions. Historical and environmental differences drive the regional variation in the functional relationships between woody vegetation, fire, and climate. These same differences will determine the regional responses of vegetation to future climates, with implications for global carbon stocks.	[Lehmann, Caroline E. R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Lehmann, Caroline E. R.; Ryan, Casey M.] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JN, Midlothian, Scotland; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Sankaran, Mahesh; Ratnam, Jayashree] Tata Inst Fundamental Res, Gandhi Krishi Vignana Kendra, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Sankaran, Mahesh] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Higgins, Steven I.] Goethe Univ Frankfurt, Inst Phys Geog, D-60438 Frankfurt, Germany; [Higgins, Steven I.] Univ Otago, Dept Bot, Dunedin 9054, New Zealand; [Archibald, Sally] CSIR, Pretoria, South Africa; [Archibald, Sally] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Hoffmann, William A.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hanan, Niall P.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [Fensham, Roderick J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Felfili, Jeanine; Haidar, Ricardo] Univ Brasilia, Forestry Dept, BR-70919970 Brasilia, DF, Brazil; [Hutley, Lindsay B.; Franklin, Don; Russell-Smith, Jeremy] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT 0810, Australia; [San Jose, Jose] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Montes, Ruben] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas 1080A, Venezuela; [Durigan, Giselda] Inst Florestal, Lab Ecol & Hidrol Florestal, BR-19802970 Assis, SP, Brazil; [Hiernaux, Pierre] Univ Toulouse, CNRS, Geosci Environm Toulouse Observ Midi Pyrenees, F-31401 Toulouse, France; [Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Bond, William J.] Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa	Macquarie University; University of Edinburgh; Wake Forest University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Leeds; Goethe University Frankfurt; University of Otago; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand; University of North Carolina; North Carolina State University; South Dakota State University; University of Queensland; Universidade de Brasilia; Charles Darwin University; Venezuelan Institute Science Research; Simon Bolivar University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; University of Tasmania; University of Cape Town	Lehmann, CER (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	c.e.r.lehmann@gmail.com	Bowman, David M.J.S./A-2930-2011; Ryan, Casey/B-7967-2008; de Sanjose, Jose Juan/Y-6264-2019; Archibald, Sally/O-1659-2015; Higgins, Steven I/A-5138-2012; Durigan, Giselda/B-9657-2012; Hoffmann, William A./E-8894-2010; Franklin, Don/F-1171-2014; caputo, carlo/N-3747-2014; Lehmann, Caroline/ABD-5258-2021; Bond, William/AAY-7631-2020; Hutley, Lindsay B/A-7925-2011	Bowman, David M.J.S./0000-0001-8075-124X; Ryan, Casey/0000-0002-1802-0128; Archibald, Sally/0000-0003-2786-3976; Higgins, Steven I/0000-0001-5695-9665; Durigan, Giselda/0000-0003-0693-3154; Hoffmann, William A./0000-0002-1926-823X; Franklin, Don/0000-0002-9813-0959; Hutley, Lindsay B/0000-0001-5533-9886; Fensham, Roderick/0000-0003-3658-5867; Bond, William/0000-0002-3441-2084; Russell-Smith, Jeremy/0000-0003-1489-2866; Hanan, Niall/0000-0002-9130-5306; Lehmann, Caroline/0000-0002-6825-124X	Direct For Biological Sciences [1139096] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Bowman DMJS, 2005, AUST J BOT, V53, P379, DOI 10.1071/BT05022; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fisher R, 2010, NEW PHYTOL, V187, P666, DOI 10.1111/j.1469-8137.2010.03340.x; HARIDASAN M, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P171; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Knapp AK, 2004, FRONT ECOL ENVIRON, V2, P483, DOI 10.1890/1540-9295(2004)002[0483:GIETNA]2.0.CO;2; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lehmann CER, 2011, NEW PHYTOL, V191, P197, DOI 10.1111/j.1469-8137.2011.03689.x; Murphy BP, 2014, J BIOGEOGR, V41, P133, DOI 10.1111/jbi.12204; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Ripley B, 2010, J ECOL, V98, P1196, DOI 10.1111/j.1365-2745.2010.01700.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x	25	394	401	11	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					548	552		10.1126/science.1247355	http://dx.doi.org/10.1126/science.1247355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482480				2022-12-28	WOS:000330343700049
J	Linkermann, A; Green, DR				Linkermann, Andreas; Green, Douglas R.			Necroptosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; RENAL ISCHEMIA/REPERFUSION INJURY; EXPERIMENTAL DISEASE-MODELS; NONAPOPTOTIC CELL-DEATH; TUMOR-NECROSIS-FACTOR; MIXED LINEAGE KINASE; TNF-INDUCED NECROSIS; PROGRAMMED NECROSIS; CYCLOPHILIN-D	Cell death is regulated by a variety of mechanisms. This review focuses on one of the more recently identified forms of programmed cell death, necroptosis, and its role in normal and disease states. This pathway provides new targets for therapeutic intervention. As early as the mid-19th century, Rudolf Virchow taught that necrosis is a recognizable form of cell death; since then, pathologists have identified necrosis as both a cause and a consequence of disease. A century later, another form of cell death, apoptosis, was defined, and we now understand that this process is driven by a set of molecular mechanisms that programs the cell to die. It has often been assumed that necrosis is distinct from apoptosis, in part because of the belief that necrosis is not programmed by molecular events. It is now clear, however, that in some contexts, necrotic ...	[Linkermann, Andreas] Univ Kiel, Div Nephrol & Hypertens, D-24105 Kiel, Germany; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Kiel; St Jude Children's Research Hospital	Linkermann, A (corresponding author), Univ Kiel, Clin Nephrol & Hypertens, Campus Kiel,Schittenhelmstr 12, D-24105 Kiel, Germany.	linkermann@nephro.uni-kiel.de	Linkermann, Andreas/H-3551-2012; Green, Douglas R/N-8083-2018; Linkermann, Andreas/AAB-8308-2020	Linkermann, Andreas/0000-0001-6287-9725; Green, Douglas R/0000-0002-7332-1417; Linkermann, Andreas/0000-0001-6287-9725	NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA169291] Funding Source: Medline; NIAID NIH HHS [R01 AI044828] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burne MJ, 2001, J LEUKOCYTE BIOL, V70, P192; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; De Keyzer K, 2011, AM J KIDNEY DIS, V58, P118, DOI 10.1053/j.ajkd.2011.04.010; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Fricker M, 2013, J BIOL CHEM, V288, P9145, DOI 10.1074/jbc.M112.427880; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, CURR OPIN VIROL, V3, P296, DOI 10.1016/j.coviro.2013.05.019; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Ko GJ, 2011, J AM SOC NEPHROL, V22, P732, DOI 10.1681/ASN.2010010121; Ladoire S, 2013, ANTIOXID REDOX SIGNA; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lee YS, 2013, FEBS LETT, V587, P266, DOI 10.1016/j.febslet.2012.12.004; Li C, 2010, P NATL ACAD SCI USA, V107, P22249, DOI 10.1073/pnas.1009751108; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Linkermann A, 2013, J AM SOC NEPHROL, V24, P1545, DOI 10.1681/ASN.2012121169; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; MERION RM, 1984, NEW ENGL J MED, V310, P148, DOI 10.1056/NEJM198401193100303; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Seya T, 2012, ONCOIMMUNOLOGY, V1, P917, DOI 10.4161/onci.21244; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Silke J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003845; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sosna J., 2013, CELL MOL LIFE SCI; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Welz PS, 2012, CELL HOST MICROBE, V11, P223, DOI 10.1016/j.chom.2012.02.003; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Xie T, 2013, STRUCTURE, V21, P493, DOI 10.1016/j.str.2013.01.016; Yang B, 2005, KIDNEY INT, V68, P2050, DOI 10.1111/j.1523-1755.2005.00662.x; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zou J, 2013, IMMUNITY, V38, P717, DOI 10.1016/j.immuni.2012.12.007	89	719	772	9	240	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					455	465		10.1056/NEJMra1310050	http://dx.doi.org/10.1056/NEJMra1310050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24476434	Green Accepted			2022-12-28	WOS:000330645400010
J	Showman, AP				Showman, Adam P.			ASTROPHYSICS Portrait of a dynamic neighbour	NATURE			English	Editorial Material							BROWN DWARF; EVOLVING WEATHER; VARIABILITY		Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Showman, AP (corresponding author), Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	showman@lpl.arizona.edu						Artigau E, 2009, ASTROPHYS J, V701, P1534, DOI 10.1088/0004-637X/701/2/1534; Biller BA, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L10; Crossfield IJM, 2014, NATURE, V505, P654, DOI 10.1038/nature12955; Freytag B, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913354; Gillon M, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321620; Luhman KL, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L1; Rice JB, 2002, ASTRON NACHR, V323, P220, DOI 10.1002/1521-3994(200208)323:3/4<220::AID-ASNA220>3.0.CO;2-P; Sayanagi KM, 2013, ICARUS, V223, P460, DOI 10.1016/j.icarus.2012.12.013; Showman AP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/85; Zhang X., 2014, 223 AM ASTR SOC M WA	10	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					625	626		10.1038/505625a	http://dx.doi.org/10.1038/505625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298JV	24476884				2022-12-28	WOS:000330321000027
J	Wicks, P; Vaughan, T; Heywood, J				Wicks, Paul; Vaughan, Timothy; Heywood, James			Subjects no more: what happens when trial participants realize they hold the power?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wicks, Paul] PatientsLikeMe, Innovat, Cambridge, MA 02141 USA; [Vaughan, Timothy] PatientsLikeMe, Data Sci, Cambridge, MA 02141 USA; [Heywood, James] PatientsLikeMe, Cambridge, MA 02141 USA		Wicks, P (corresponding author), PatientsLikeMe, Innovat, Cambridge, MA 02141 USA.	pwicks@patientslikeme.com	Wicks, Paul/C-6128-2011; Vaughan, Timothy E/A-9968-2009	Wicks, Paul/0000-0002-2293-9284; Vaughan, Timothy E/0000-0003-0744-1266				[Anonymous], PAY PER VIEW; Armon C, 2010, NEUROLOGY, V75, P586, DOI 10.1212/WNL.0b013e3181ed9ef7; Bedlack R, 2013, AMYOTROPH LAT SCL FR, V14, P236, DOI 10.3109/21678421.2013.769718; Castrillo-Viguera C, 2010, AMYOTROPH LATERAL SC, V11, P178, DOI 10.3109/17482960903093710; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cox K, 2011, EUR J ONCOL NURS, V15, P124, DOI 10.1016/j.ejon.2010.06.009; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Dokser Marcus A., 2012, WALL ST J       0415; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Frost Jeana H, 2008, AMIA Annu Symp Proc, P217; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Heywood J., 2012, FIGSHARE; O'Connor D, 2013, J LAW MED ETHICS, V41, P470, DOI 10.1111/jlme.12056; Partridge AH, 2009, J CLIN ONCOL, V27, P838, DOI 10.1200/JCO.2008.20.0865; Vayena E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001402; Wicks P, 2008, AMYOTROPH LATERAL SC, V9, P43, DOI 10.1080/17482960701737716; Wicks P, 2013, QUAL LIFE RES, V22; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Workman TA., 2013, ENGAGING PATIENTS IN	19	28	28	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2014	348								g368	10.1136/bmj.g368	http://dx.doi.org/10.1136/bmj.g368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AV	24472779	Green Published, hybrid			2022-12-28	WOS:000330647600012
J	Land, MF; Osorio, D				Land, Michael F.; Osorio, Daniel			Extraordinary Color Vision	SCIENCE			English	Editorial Material							POLARIZATION VISION		[Land, Michael F.; Osorio, Daniel] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Land, MF (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	d.osorio@sussex.ac.uk		Osorio, Daniel/0000-0002-5856-527X				ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; CALDWELL RL, 1976, SCI AM, V234, P80, DOI 10.1038/scientificamerican0176-80; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; LAND MF, 1990, J COMP PHYSIOL A, V167, P155; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; POKORNY J, 1970, J OPT SOC AM, V60, P562, DOI 10.1364/JOSA.60.000562; Thoen HH, 2014, SCIENCE, V343, P411, DOI 10.1126/science.1245824; VANHATEREN JH, 1993, P ROY SOC B-BIOL SCI, V251, P61, DOI 10.1098/rspb.1993.0009; Young T., 1802, PHILOS T R SOC LONDO, V92, P2; Zhaoping L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019248	11	3	4	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					381	382		10.1126/science.1249614	http://dx.doi.org/10.1126/science.1249614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24458632				2022-12-28	WOS:000330039300036
J	Carey, LA; Winer, EP				Carey, Lisa A.; Winer, Eric P.			Defining success in neoadjuvant breast cancer trials	LANCET			English	Editorial Material							PATHOLOGICAL COMPLETE RESPONSE; CHEMOTHERAPY; BEVACIZUMAB; THERAPY		[Carey, Lisa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Winer, Eric P.] Dana Farber Canc Inst, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute	Carey, LA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	lisa_carey@med.unc.edu						Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cortazar P, 2014, LANCET; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gonzalez-Angulo AM, 2005, J CLIN ONCOL, V23, P7098, DOI 10.1200/JCO.2005.11.124; Piccart-Gebhart M, 2013, 36 ANN AACR CTRC SAN, pS1; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065	11	11	13	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					115	116		10.1016/S0140-6736(14)60034-9	http://dx.doi.org/10.1016/S0140-6736(14)60034-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24529559				2022-12-28	WOS:000338921500013
J	D'Hooghe, T; Tomassetti, C				D'Hooghe, Thomas; Tomassetti, Carla			Surgery for ectopic pregnancy: making the right choice	LANCET			English	Editorial Material							FERTILITY; SALPINGECTOMY		[D'Hooghe, Thomas] Katholieke Univ Leuven, Fertil Ctr, Dept Obstet & Gynecol, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Dept Dev & Regenerat, Grp Biomed Sci, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven	D'Hooghe, T (corresponding author), Katholieke Univ Leuven, Fertil Ctr, Dept Obstet & Gynecol, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium.	thomas.dhooghe@uzleuven.be		Tomassetti, Carla/0000-0002-5373-0811				Becker S, 2011, ARCH GYNECOL OBSTET, V283, P41, DOI 10.1007/s00404-009-1270-2; de Bennetot M, 2012, FERTIL STERIL, V98, P1271, DOI 10.1016/j.fertnstert.2012.06.041; Dubuisson JB, 1996, HUM REPROD, V11, P1199; Ego A, 2001, FERTIL STERIL, V75, P560, DOI 10.1016/S0015-0282(00)01761-1; Fernandez H, 2013, HUM REPROD, V28, P1247, DOI 10.1093/humrep/det037; Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists, 2004, GREEN TOP GUID 21 MA; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; Mol BWJ, 1998, HUM REPROD, V13, P1804, DOI 10.1093/humrep/13.7.1804; Mol F, 2011, HUM REPROD, V26, P307, DOI 10.1093/humrep/deq329; Mol F, 2014, LANCET; SILVA PD, 1993, OBSTET GYNECOL, V81, P710; van Mello NM, 2010, REPROD BIOMED ONLINE, V21, P687, DOI 10.1016/j.rbmo.2010.06.034	12	12	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1444	1445		10.1016/S0140-6736(14)60129-X	http://dx.doi.org/10.1016/S0140-6736(14)60129-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24499813				2022-12-28	WOS:000335325800007
J	Frieden, TR; Tappero, JW; Dowell, SF; Hien, NT; Guillaume, FD; Aceng, JR				Frieden, Thomas R.; Tappero, Jordan W.; Dowell, Scott F.; Hien, Nguyen T.; Guillaume, Florence D.; Aceng, Jane R.			Safer countries through global health security	LANCET			English	Editorial Material							PUBLIC-HEALTH; IMPLEMENTATION; POSTEARTHQUAKE; CAPACITY; HAITI		[Frieden, Thomas R.; Tappero, Jordan W.; Dowell, Scott F.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Hien, Nguyen T.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Guillaume, Florence D.] Minist Hlth & Populat, Port Au Prince, Haiti; [Aceng, Jane R.] Minist Hlth, Kampala, Uganda	Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE)	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Centers for Disease Control and Prevention, 2014, GLOB HLTH SEC; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Elbe S, 2011, LANCET, V378, P220, DOI 10.1016/S0140-6736(11)61114-8; Fischer JE, 2013, BIOSECUR BIOTERROR, V11, P153, DOI 10.1089/bsp.2013.0030; Hardiman MC, 2012, EMERG INFECT DIS, V18, P1041, DOI 10.3201/eid1807.120395; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732; Phu TD, 2014, MMWR-MORBID MORTAL W, V63, P77; Vertefeuille JF, 2013, LANCET, V381, P517, DOI 10.1016/S0140-6736(13)60051-3; Walldorf JA, 2012, AIDS, V26, P1431, DOI 10.1097/QAD.0b013e328352d032; WHO Collaborating Center for Reference and Research on Influenza, 2010, WHO COLL CTR GLOB DA; World Health Organization (WHO), 2013, IMPL INT HLTH REG 20	17	41	42	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					764	766		10.1016/S0140-6736(14)60189-6	http://dx.doi.org/10.1016/S0140-6736(14)60189-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3EV	24529561	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000332398700008
J	Suzuki, R; Leach, S; Liu, WH; Ralston, E; Scheffel, J; Zhang, WG; Lowell, CA; Rivera, J				Suzuki, Ryo; Leach, Sarah; Liu, Wenhua; Ralston, Evelyn; Scheffel, Joerg; Zhang, Weiguo; Lowell, Clifford A.; Rivera, Juan			Molecular Editing of Cellular Responses by the High-Affinity Receptor for IgE	SCIENCE			English	Article							FC-EPSILON-RI; ACTIVATION	Cellular responses elicited by cell surface receptors differ according to stimulus strength. We investigated how the high-affinity receptor for immunoglobulin E (IgE) modulates the response of mast cells to a high-or low-affinity stimulus. Both high-and low-affinity stimuli elicited similar receptor phosphorylation; however, differences were observed in receptor cluster size, mobility, distribution, and the cells' effector responses. Low-affinity stimulation increased receptor association with the Src family kinase Fgr and shifted signals from the adapter LAT1 to the related adapter LAT2. LAT1-dependent calcium signals required for mast cell degranulation were dampened, but the role of LAT2 in chemokine production was enhanced, altering immune cell recruitment at the site of inflammation. These findings uncover how receptor discrimination of stimulus strength can be interpreted as distinct in vivo outcomes.	[Suzuki, Ryo; Leach, Sarah; Scheffel, Joerg; Rivera, Juan] NIAMSD, Lab Mol Immunogenet, Bethesda, MD 20892 USA; [Liu, Wenhua; Ralston, Evelyn] NIAMSD, Light Imaging Sect, Off Sci & Technol, Bethesda, MD 20892 USA; [Zhang, Weiguo] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Duke University; University of California System; University of California San Francisco	Rivera, J (corresponding author), NIAMSD, Lab Mol Immunogenet, Bethesda, MD 20892 USA.	juan_rivera@nih.gov			National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases and its Laboratory Animal Care and Use Section; Flow Cytometry Group, Office of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068150, R01AI065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041132] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases and its Laboratory Animal Care and Use Section; Flow Cytometry Group, Office of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and by its Laboratory Animal Care and Use Section and Flow Cytometry Group, Office of Science and Technology. All data are provided in the main paper and supplementary materials. The authors declare no conflicts of interest.	Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; ISERSKY C, 1979, J IMMUNOL, V122, P1926; Jackola DR, 2002, MOL IMMUNOL, V39, P367, DOI 10.1016/S0161-5890(02)00108-6; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; METZGER H, 1992, J IMMUNOL, V149, P1477; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; RAZIN E, 1990, METHOD ENZYMOL, V187, P514; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550	20	63	63	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1021	1025		10.1126/science.1246976	http://dx.doi.org/10.1126/science.1246976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24505132	Green Accepted			2022-12-28	WOS:000332309600045
J	Mi, BX				Mi, Baoxia			Graphene Oxide Membranes for Ionic and Molecular Sieving	SCIENCE			English	Editorial Material							SEPARATION MEMBRANES; WATER; TECHNOLOGY; PERMEATION		Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mi, BX (corresponding author), Univ Maryland, Dept Civil & Environm Engn, 1161 Glenn L Martin Hall, College Pk, MD 20742 USA.	bmi@umd.edu	Mi, Baoxia/H-2309-2014					Boukhvalov DW, 2013, NANO LETT, V13, P3930, DOI 10.1021/nl4020292; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Gin DL, 2011, SCIENCE, V332, P674, DOI 10.1126/science.1203771; Hu M, 2013, ENVIRON SCI TECHNOL, V47, P3715, DOI 10.1021/es400571g; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Qiu L, 2011, CHEM COMMUN, V47, P5810, DOI 10.1039/c1cc10720h; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Wang EN, 2012, NAT NANOTECHNOL, V7, P552, DOI 10.1038/nnano.2012.153	9	810	845	40	1220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					740	742		10.1126/science.1250247	http://dx.doi.org/10.1126/science.1250247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531961				2022-12-28	WOS:000331557800028
J	Bredas, JL				Bredas, Jean-Luc			When Electrons Leave Holes in Organic Solar Cells	SCIENCE			English	Editorial Material							CHARGE SEPARATION		[Bredas, Jean-Luc] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Bredas, Jean-Luc] Georgia Inst Technol, Ctr Organ Photon & Elect, Atlanta, GA 30332 USA; [Bredas, Jean-Luc] King Abdulaziz Univ, Dept Chem, Jeddah 21589, Saudi Arabia	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; King Abdulaziz University	Bredas, JL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	jean-luc.bredas@chemistry.gatech.edu	Bredas, Jean-Luc E/A-3431-2008	Bredas, Jean-Luc E/0000-0001-7278-4471				Bredas JL, 2009, ACCOUNTS CHEM RES, V42, P1691, DOI 10.1021/ar900099h; Gelinas S, 2014, SCIENCE, V343, P512, DOI 10.1126/science.1246249; Gregg BA, 2011, J PHYS CHEM LETT, V2, P3013, DOI 10.1021/jz2012403; Janssen RAJ, 2013, ADV MATER, V25, P1847, DOI 10.1002/adma.201202873; SEBASTIAN L, 1981, CHEM PHYS, V61, P125, DOI 10.1016/0301-0104(81)85055-0; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Vandewal K, 2014, NAT MATER, V13, P63, DOI [10.1038/NMAT3807, 10.1038/nmat3807]; Westacott P, 2013, ENERG ENVIRON SCI, V6, P2756, DOI 10.1039/c3ee41821a	8	32	33	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					492	493		10.1126/science.1249230	http://dx.doi.org/10.1126/science.1249230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24482470				2022-12-28	WOS:000330343700029
J	Anthony, TE; Dee, N; Bernard, A; Lerchner, W; Heintz, N; Anderson, DJ				Anthony, Todd E.; Dee, Nick; Bernard, Amy; Lerchner, Walter; Heintz, Nathaniel; Anderson, David J.			Control of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit	CELL			English	Article							CORTICOTROPIN-RELEASING-FACTOR; SINGLE-UNIT ACTIVITY; LATERAL SEPTUM; PARAVENTRICULAR NUCLEUS; CRF RECEPTORS; ANIMAL-MODELS; RAT; BEHAVIORS; FEAR; NEURONS	The extended amygdala has dominated research on the neural circuitry of fear and anxiety, but the septohippocampal axis also plays an important role. The lateral septum (LS) is thought to suppress fear and anxiety through its outputs to the hypothalamus. However, this structure has not yet been dissected using modern tools. The type 2 CRF receptor (Crfr2) marks a subset of LS neurons whose functional connectivity we have investigated using optogenetics. Crfr2 + cells include GABAergic projection neurons that connect with the anterior hypothalamus. Surprisingly, we find that these LS outputs enhance stress-induced behavioral measures of anxiety. Furthermore, transient activation of Crfr2 + neurons promotes, while inhibition suppresses, persistent anxious behaviors. LS Crfr2 + outputs also positively regulate circulating corticosteroid levels. These data identify a subset of LS projection neurons that promote, rather than suppress, stressinduced behavioral and endocrinological dimensions of persistent anxiety states and provide a cellular point of entry to LS circuitry.	[Anthony, Todd E.; Lerchner, Walter; Anderson, David J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Dee, Nick; Bernard, Amy] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; [Heintz, Nathaniel; Anderson, David J.] Howard Hughes Med Inst, Chevy Chase, MD USA	California Institute of Technology; Allen Institute for Brain Science; Rockefeller University; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd,M-C 156-29, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Dee, Nick/0000-0002-2831-9254; Lerchner, Walter/0000-0003-0842-4409; Bernard, Amy/0000-0003-2540-1153	National Institutes of Heath (NIH) [5R01MH070053-10]; NIH NRSA [1F32HD055198-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD055198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085082, R01MH070053] Funding Source: NIH RePORTER	National Institutes of Heath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Deisseroth for Cre-dependent ChR2 and eNpHR AAV constructs, E. Boyden for Cre-dependent ArchT AAV construct, C. Saper for Cre-dependent hrGFP AAV construct, and L. Lo for HSV129DTK-TT; M. Martinez, H-J. Kim, J-S. Chang, and M. McCardle for technical help; M. Zelikowsky for statistics advice; and A. Colon, R. Bayon, R. Sauza, and J. Cochrane for animal care. This work was supported by National Institutes of Heath (NIH) grant 5R01MH070053-10 (D. J. A.), NIH NRSA postdoctoral fellowship grant 1F32HD055198-01 (T. E. A.), and a Beckman Fellowship (T. E. A.). D. J. A. is a Howard Hughes Medical Institute investigator.	Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; ALBERT DJ, 1978, J COMP PHYSIOL PSYCH, V92, P1062, DOI 10.1037/h0077524; ALBERT DJ, 1976, BEHAV BIOL, V18, P211, DOI 10.1016/S0091-6773(76)92118-0; Almeida-Santos AF, 2013, BEHAV BRAIN RES, V252, P10, DOI 10.1016/j.bbr.2013.05.027; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bakshi VP, 2007, J NEUROSCI, V27, P10568, DOI 10.1523/JNEUROSCI.3044-06.2007; Bakshi VP, 2002, J NEUROSCI, V22, P2926, DOI 10.1523/JNEUROSCI.22-07-02926.2002; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; BRADY JV, 1953, J COMP PHYSIOL PSYCH, V46, P339, DOI 10.1037/h0059531; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; DRUGAN RC, 1986, NEUROPHARMACOLOGY, V25, P203, DOI 10.1016/0028-3908(86)90042-0; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Herman JP, 2002, EUR J NEUROSCI, V16, P381, DOI 10.1046/j.1460-9568.2002.02133.x; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Liu J, 2004, J NEUROSCI, V24, P4020, DOI 10.1523/JNEUROSCI.5531-03.2004; Liu J, 2005, J NEUROSCI, V25, P577, DOI 10.1523/JNEUROSCI.4196-04.2005; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Mongeau R, 2003, J NEUROSCI, V23, P3855; Nieh EH, 2013, BRAIN RES, V1511, P73, DOI 10.1016/j.brainres.2012.11.001; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Radulovic J, 1999, J NEUROSCI, V19, P5016; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Sartor GC, 2012, J NEUROSCI, V32, P4623, DOI 10.1523/JNEUROSCI.4561-11.2012; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Sparks Peter D., 2000, P234; Spiegel EA, 1940, J NEUROPHYSIOL, V3, P538, DOI 10.1152/jn.1940.3.6.538; Thomas E, 2005, PHARMACOL BIOCHEM BE, V80, P151, DOI 10.1016/j.pbb.2004.10.018; Thomas E, 2013, NEUROSCI LETT, V548, P269, DOI 10.1016/j.neulet.2013.05.078; TREIT D, 1990, PHYSIOL BEHAV, V47, P365, DOI 10.1016/0031-9384(90)90155-W; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043	53	142	144	0	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					522	536		10.1016/j.cell.2013.12.040	http://dx.doi.org/10.1016/j.cell.2013.12.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24485458	Green Accepted, Bronze			2022-12-28	WOS:000330580800018
J	Atilla-Gokcumen, GE; Muro, E; Relat-Goberna, J; Sasse, S; Bedigian, A; Coughlin, ML; Garcia-Manyes, S; Eggert, US				Atilla-Gokcumen, G. Ekin; Muro, Eleonora; Relat-Goberna, Josep; Sasse, Sofia; Bedigian, Anne; Coughlin, Margaret L.; Garcia-Manyes, Sergi; Eggert, Ulrike S.			Dividing Cells Regulate Their Lipid Composition and Localization	CELL			English	Article							MASS-SPECTROMETRY; CLEAVAGE FURROW; CYTOKINESIS; FORCE; MEMBRANE; BILAYERS; NANOMECHANICS; LEUKODYSTROPHY; INHIBITION; ABSCISSION	Although massive membrane rearrangements occur during cell division, little is known about specific roles that lipids might play in this process. We report that the lipidome changes with the cell cycle. LC- MSbased lipid profiling shows that 11 lipids with specific chemical structures accumulate in dividing cells. Using AFM, we demonstrate differences in the mechanical properties of live dividing cells and their isolated lipids relative to nondividing cells. In parallel, systematic RNAi knockdown of lipid biosynthetic enzymes identified enzymes required for division, which highly correlated with lipids accumulated in dividing cells. We show that cells specifically regulate the localization of lipids to midbodies, membrane- based structures where cleavage occurs. We conclude that cells actively regulate and modulate their lipid composition and localization during division, with both signaling and structural roles likely. This work has broader implications for the active and sustained participation of lipids in basic biology.	[Atilla-Gokcumen, G. Ekin; Sasse, Sofia; Bedigian, Anne; Eggert, Ulrike S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Atilla-Gokcumen, G. Ekin; Sasse, Sofia; Bedigian, Anne; Eggert, Ulrike S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Muro, Eleonora; Eggert, Ulrike S.] Kings Coll London, Dept Chem, London SE1 1UL, England; [Muro, Eleonora; Eggert, Ulrike S.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Relat-Goberna, Josep; Garcia-Manyes, Sergi] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Relat-Goberna, Josep; Garcia-Manyes, Sergi] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Sasse, Sofia] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; [Coughlin, Margaret L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Munster; Harvard University; Harvard Medical School	Eggert, US (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ulrike.eggert@kcl.ac.uk		Eggert, Ulrike/0000-0003-0932-5525; Garcia-Manyes, Sergi/0000-0001-5140-2606	Taplin Funds for Discovery Program at Harvard Medical School; NIH [R01 GM082834, R01 GM39565]; Human Frontier Science Program Young Investigator Award [304137]; ERC [306659]; Heinrich Hertz Foundation; "La Caixa'' PhD fellowship; Marie Curie CIG grant [293462]; BBSRC [J00992X/1]; EPSRC [K00641X/1]; BBSRC [BB/J00992X/1] Funding Source: UKRI; EPSRC [EP/K00641X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00992X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K00641X/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565, R01GM082834] Funding Source: NIH RePORTER	Taplin Funds for Discovery Program at Harvard Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Young Investigator Award(Human Frontier Science Program); ERC(European Research Council (ERC)European Commission); Heinrich Hertz Foundation; "La Caixa'' PhD fellowship(La Caixa Foundation); Marie Curie CIG grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Saghatelian, Tim Mitchison, and Xin Zhang for helpful discussions. LC-MS data was acquired on an Agilent 6520 Q-TOF spectrometer supported by the Taplin Funds for Discovery Program at Harvard Medical School (PI, Suzanne Walker). We thank the Nikon Imaging Centres at King's College London and Harvard Medical School for help with light microscopy. We also thank the facilities of the EBN group of the Physics Department of King's College London. This work was funded by NIH grant R01 GM082834, Human Frontier Science Program Young Investigator Award, Marie Curie CIG grant 304137, ERC Starting Grant 306659 (to U.S.E.), the Heinrich Hertz Foundation (to S.S.), a "La Caixa'' PhD fellowship (to J. R.-G.), NIH grant R01 GM39565 (M.L.C., awarded to T.J. Mitchison), and Marie Curie CIG grant 293462, BBSRC grant J00992X/1, and EPSRC Fellowship K00641X/1 (to S.G.-M.).	Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Atilla-Gokcumen GE, 2011, J AM CHEM SOC, V133, P10010, DOI 10.1021/ja202804b; Atilla-Gokcumen GE, 2010, ACS CHEM BIOL, V5, P79, DOI 10.1021/cb900256m; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Castoreno AB, 2011, ACS CHEM BIOL, V6, P86, DOI 10.1021/cb1002976; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Echard A, 2012, CYTOSKELETON, V69, P893, DOI 10.1002/cm.21067; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2006, MOL BIOSYST, V2, P93, DOI 10.1039/b515335b; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; El Kirat K, 2010, BBA-BIOMEMBRANES, V1798, P750, DOI 10.1016/j.bbamem.2009.07.026; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Garcia-Manyes S, 2005, BIOPHYS J, V89, P1812, DOI 10.1529/biophysj.105.064030; Garcia-Manyes S, 2005, BIOPHYS J, V89, P4261, DOI 10.1529/biophysj.105.065581; Garcia-Manyes S, 2010, J AM CHEM SOC, V132, P12874, DOI 10.1021/ja1002185; Garcia-Manyes S, 2010, BBA-BIOMEMBRANES, V1798, P741, DOI 10.1016/j.bbamem.2009.12.019; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Gudejko HFM, 2012, CYTOSKELETON, V69, P1000, DOI 10.1002/cm.21078; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harris AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345102; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Ivanova PT, 2004, MOL INTERV, V4, P86, DOI 10.1124/mi.4.2.6; Kasas S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/13/133001; Kay JG, 2011, SENSORS-BASEL, V11, P1744, DOI 10.3390/s110201744; KIHARA T, 2013, J ANAL SCI METHODS I, V3, P124, DOI DOI 10.4236/JASMI.2013.32015; Lafaurie-Janvore J, 2013, SCIENCE, V339, P1625, DOI 10.1126/science.1233866; Lee WC, 2010, J NEUROSCI, V30, P5489, DOI 10.1523/JNEUROSCI.6383-09.2010; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Pietuch A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130084; Saario SM, 2012, CHEM SCI, V3, P77, DOI 10.1039/c1sc00336d; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Schultz C, 2010, NAT CHEM BIOL, V6, P473, DOI 10.1038/nchembio.389; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Sullan RMA, 2009, LANGMUIR, V25, P12874, DOI 10.1021/la903442s; Sullan RMA, 2009, LANGMUIR, V25, P7471, DOI 10.1021/la900395w; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Yokokawa M, 2008, J MICROSC-OXFORD, V232, P82, DOI 10.1111/j.1365-2818.2008.02071.x; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109	63	192	195	0	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 30	2014	156	3					428	439		10.1016/j.cell.2013.12.015	http://dx.doi.org/10.1016/j.cell.2013.12.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	302DD	24462247	Green Published, hybrid			2022-12-28	WOS:000330580800011
J	Jackson, M				Jackson, Mark			The art of medicine The stress of life: a modern complaint?	LANCET			English	Editorial Material									Univ Exeter, Ctr Med Hist, Exeter EX4 4RJ, Devon, England	University of Exeter	Jackson, M (corresponding author), Univ Exeter, Ctr Med Hist, Exeter EX4 4RJ, Devon, England.	m.a.jackson@exeter.ac.uk			Wellcome Trust [085433] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becker D., 2013, ONE NATION UNDER STR; Jackson M., 2013, THE AGE OF STRESS SC; Kugelmann R, 1992, STRESS THE NATURE AN; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Selye H, 1956, J BONE JOINT SURG; Toffler A., 1980, 3 WAVE	6	25	28	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					300	301		10.1016/S0140-6736(14)60093-3	http://dx.doi.org/10.1016/S0140-6736(14)60093-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24475483	Bronze, Green Accepted			2022-12-28	WOS:000330212600016
J	Cech, EA				Cech, Erin A.			Embed social awareness in science curricula	NATURE			English	Editorial Material									Rice Univ, Houston, TX 77005 USA	Rice University	Cech, EA (corresponding author), Rice Univ, 6100 Main St, Houston, TX 77005 USA.	ecech@rice.edu	Cech, Erin/I-6061-2012					[Anonymous], 1999, J Contemp Health Law Policy, V15, P739; Barry BE, 2012, SCI ENG ETHICS, V18, P369, DOI 10.1007/s11948-011-9255-5; Cech E. A., SCI TECHNOL IN PRESS; Cech E.A., 2013, ENG ED SOCIAL JUSTIC, P67; Cech EA., 2013, ENG ED SOCIAL JUSTIC, P67, DOI [10.1007/978-94-007-6350-0_4, DOI 10.1007/978-94-007-6350-0_4]; Cetina Karin Knorr, 2009, EPISTEMIC CULTURES S, DOI 10.2307/j.ctvxw3q7f; Faulkner W, 2000, SOC STUD SCI, V30, P759, DOI 10.1177/030631200030005005; MacKenzie Donald, 1990, INVENTING ACCURACY H; Schneider J, 2010, ENG STUD, V2, P1, DOI 10.1080/19378621003615975; Young M., 1994, RISE MERITOCRACY	10	16	16	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					477	478		10.1038/505477a	http://dx.doi.org/10.1038/505477a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	293SW	24459713	Bronze			2022-12-28	WOS:000329995000013
J	Chalmers, J				Chalmers, Jenny			Alcohol minimum unit pricing and socioeconomic status	LANCET			English	Editorial Material							DRINKING		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Drug Policy Modelling Program, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Chalmers, J (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Drug Policy Modelling Program, Sydney, NSW 2052, Australia.	Jenny.Chalmers@unsw.edu.au			MRC [G1000043] Funding Source: UKRI; Medical Research Council [G1000043] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Byrnes J, 2013, DRUG ALCOHOL REV, V32, P27, DOI 10.1111/j.1465-3362.2012.00482.x; Crawford MJ, 2012, ALCOHOL ALCOHOLISM, V47, P738, DOI 10.1093/alcalc/ags091; Forsyth AJM, 2014, ALCOHOL ALCOHOLISM, V49, P96, DOI 10.1093/alcalc/agt175; Gilmore I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g23; Griffith R., 2013, BN138 IFS; Holmes J, 2014, LANCET; Katikireddi SV, 2014, EUR J PUBLIC HEALTH, V24, P490, DOI 10.1093/eurpub/ckt206; Ludbrook A, 2012, APPL HEALTH ECON HEA, V10, P51, DOI 10.2165/11594840-000000000-00000; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Robson K., 2012, 1201 SPICE, V12; Stockwell T, 2013, CASE SETTING MINIMUM; Treasury HM, 2010, REV ALC TAX	13	3	3	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1616	1617		10.1016/S0140-6736(14)60154-9	http://dx.doi.org/10.1016/S0140-6736(14)60154-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24522179	hybrid			2022-12-28	WOS:000335670800007
J	Correia, BE; Bates, JT; Loomis, RJ; Baneyx, G; Carrico, C; Jardine, JG; Rupert, P; Correnti, C; Kalyuzhniy, O; Vittal, V; Connell, MJ; Stevens, E; Schroeter, A; Chen, M; MacPherson, S; Serra, AM; Adachi, Y; Holmes, MA; Li, YX; Klevit, RE; Graham, BS; Wyatt, RT; Baker, D; Strong, RK; Crowe, JE; Johnson, PR; Schief, WR				Correia, Bruno E.; Bates, John T.; Loomis, Rebecca J.; Baneyx, Gretchen; Carrico, Chris; Jardine, Joseph G.; Rupert, Peter; Correnti, Colin; Kalyuzhniy, Oleksandr; Vittal, Vinayak; Connell, Mary J.; Stevens, Eric; Schroeter, Alexandria; Chen, Man; MacPherson, Skye; Serra, Andreia M.; Adachi, Yumiko; Holmes, Margaret A.; Li, Yuxing; Klevit, Rachel E.; Graham, Barney S.; Wyatt, Richard T.; Baker, David; Strong, Roland K.; Crowe, James E., Jr.; Johnson, Philip R.; Schief, William R.			Proof of principle for epitope-focused vaccine design	NATURE			English	Article							SYNCYTIAL VIRUS RSV; NEUTRALIZING ANTIBODY; COMPUTATIONAL DESIGN; PROTEIN; INFECTION; MOTAVIZUMAB; INDUCTION; SCAFFOLDS; PROGRAM; BURDEN	Vaccines prevent infectious disease largely by inducing protective neutralizing antibodies against vulnerable epitopes. Several major pathogens have resisted traditional vaccine development, although vulnerable epitopes targeted by neutralizing antibodies have been identified for several such cases. Hence, new vaccine design methods to induce epitope-specific neutralizing antibodies are needed. Here we show, with a neutralization epitope from respiratory syncytial virus, that computational protein design can generate small, thermally and conformationally stable protein scaffolds that accurately mimic the viral epitope structure and induce potent neutralizing antibodies. These scaffolds represent promising leads for the research and development of a human respiratory syncytial virus vaccine needed to protect infants, young children and the elderly. More generally, the results provide proof of principle for epitope-focused and scaffold-based vaccine design, and encourage the evaluation and further development of these strategies for a variety of other vaccine targets, including antigenically highly variable pathogens such as human immunodeficiency virus and influenza.	[Correia, Bruno E.; Baneyx, Gretchen; Jardine, Joseph G.; Kalyuzhniy, Oleksandr; Vittal, Vinayak; Stevens, Eric; Schroeter, Alexandria; MacPherson, Skye; Serra, Andreia M.; Adachi, Yumiko; Klevit, Rachel E.; Baker, David; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Correia, Bruno E.] Univ Nova Lisboa, Inst Gulbenkian Ciencia, PhD Program Computat Biol, P-2780157 Oeiras, Portugal; [Correia, Bruno E.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Correia, Bruno E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bates, John T.; Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Med Ctr, Nashville, TN 37232 USA; [Loomis, Rebecca J.; Connell, Mary J.; Johnson, Philip R.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Carrico, Chris; Rupert, Peter; Correnti, Colin; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Jardine, Joseph G.; MacPherson, Skye; Serra, Andreia M.; Li, Yuxing; Wyatt, Richard T.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Kalyuzhniy, Oleksandr; MacPherson, Skye; Serra, Andreia M.; Adachi, Yumiko; Li, Yuxing; Wyatt, Richard T.; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Kalyuzhniy, Oleksandr; MacPherson, Skye; Serra, Andreia M.; Adachi, Yumiko; Li, Yuxing; Wyatt, Richard T.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Chen, Man; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA	University of Washington; University of Washington Seattle; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Scripps Research Institute; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fred Hutchinson Cancer Center; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; Vanderbilt University	Schief, WR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	schief@scripps.edu	Schief, William/ABF-3645-2020; Crowe, James/B-5549-2009; Klevit, Rachel/AAI-7038-2021; Baker, David/K-8941-2012; Bates, John/I-8628-2019; Cheng, Yushao/E-6256-2011; Graham, Barney S./AAC-5898-2019	Schief, William/0000-0002-1120-0150; Crowe, James/0000-0002-0049-1079; Klevit, Rachel/0000-0002-3476-969X; Baker, David/0000-0001-7896-6217; Bates, John/0000-0001-5545-6871; Graham, Barney S./0000-0001-8112-0853; Spencer, Skye/0000-0001-9570-9634; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Carrico, Chris/0000-0003-0939-9006	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/32958/2006]; National Institutes of Health NRSA Training Grant [T32CA080416]; Children's Hospital of Philadelphia; Bill and Melinda Gates Foundation CAVD award; International AIDS Vaccine Initiative Neutralizing Antibody Consortium; International AIDS Vaccine Initiative Neutralizing Antibody Center; March of Dimes; National Institutes of Health [2T32GM007270, U54 AI 005714]; National Institute of Allergy and Infectious Diseases [P01AI094419, 5R21AI088554, 1UM1AI100663, 1R01AI102766-01A1]; National Institute of Allergy and Infectious Diseases from the Center for AIDS Research, University of California, San Diego [P30AI36214]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102766, R21AI088554, P01AI094419, P30AI045008, U54AI057141, ZIAAI005061, P30AI036214, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health NRSA Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Philadelphia; Bill and Melinda Gates Foundation CAVD award; International AIDS Vaccine Initiative Neutralizing Antibody Consortium; International AIDS Vaccine Initiative Neutralizing Antibody Center; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases from the Center for AIDS Research, University of California, San Diego; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Menis, D. Kulp and D. Burton for comments on the manuscript, Y.-E. Ban, D. Alonso and K. E. Laidig for computing assistance, E. Gribben and R. Carnahan for assistance with mouse immunizations and C. Slaughter for assistance in statistical analysis. Adjuplex adjuvant was a gift from Advanced BioAdjuvants. The University of Washington has filed patents relating to immunogens in this manuscript. Materials and information will be provided under Materials Transfer Agreement (MTA). Support for this work was provided by Fundacao para a Ciencia e a Tecnologia fellowship SFRH/BD/32958/2006 (B. E. C.), National Institutes of Health NRSA Training Grant fellowship T32CA080416 (J.G.J.), The Children's Hospital of Philadelphia (P.R.J.), a Bill and Melinda Gates Foundation CAVD award (W. R. S., R. K. S. and D. B.), the International AIDS Vaccine Initiative Neutralizing Antibody Consortium (W. R. S. and D. B.), the International AIDS Vaccine Initiative Neutralizing Antibody Center (W. R. S. and R. T. W.), a grant from the March of Dimes (J.E.C.), National Institutes of Health grants 2T32GM007270 (V. V.) and U54 AI 005714 (R. E. K.), National Institute of Allergy and Infectious Diseases grants P01AI094419 (W. R. S. and R. K. S.), 5R21AI088554 (W. R. S.), 1UM1AI100663 (W. R. S. and R. T. W.), 1R01AI102766-01A1 (Y.L. and R. T. W.), P30AI36214 (from the Center for AIDS Research, University of California, San Diego, to Y.L.), and the National Institute of Allergy and Infectious Diseases Intramural Research Program (B. S. G.). This is manuscript 26069 from The Scripps Research Institute.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; [Anonymous], 2012, VACCINES; Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chen M, 2010, J IMMUNOL METHODS, V362, P180, DOI 10.1016/j.jim.2010.08.005; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; Correia BE, 2011, J MOL BIOL, V405, P284, DOI 10.1016/j.jmb.2010.09.061; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sheffler W, 2010, PROTEIN SCI, V19, P1991, DOI 10.1002/pro.458; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; US Food & Drug Administration, VACC BLOOD BIOL; Wen XL, 2012, NAT STRUCT MOL BIOL, V19, P461, DOI 10.1038/nsmb.2250; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	39	334	356	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					201	206		10.1038/nature12966	http://dx.doi.org/10.1038/nature12966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24499818	Green Accepted			2022-12-28	WOS:000332651800032
J	Cortijo, S; Wardenaar, R; Colome-Tatche, M; Gilly, A; Etcheverry, M; Labadie, K; Caillieux, E; Hospital, F; Aury, JM; Wincker, P; Roudier, F; Jansen, RC; Colot, V; Johannes, F				Cortijo, Sandra; Wardenaar, Rene; Colome-Tatche, Maria; Gilly, Arthur; Etcheverry, Mathilde; Labadie, Karine; Caillieux, Erwann; Hospital, Frederic; Aury, Jean-Marc; Wincker, Patrick; Roudier, Francois; Jansen, Ritsert C.; Colot, Vincent; Johannes, Frank			Mapping the Epigenetic Basis of Complex Traits	SCIENCE			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; PATTERNS; ANIMALS; PLANTS	Quantifying the impact of heritable epigenetic variation on complex traits is an emerging challenge in population genetics. Here, we analyze a population of isogenic Arabidopsis lines that segregate experimentally induced DNA methylation changes at hundreds of regions across the genome. We demonstrate that several of these differentially methylated regions (DMRs) act as bona fide epigenetic quantitative trait loci (QTL(epi)), accounting for 60 to 90% of the heritability for two complex traits, flowering time and primary root length. These QTL(epi) are reproducible and can be subjected to artificial selection. Many of the experimentally induced DMRs are also variable in natural populations of this species and may thus provide an epigenetic basis for Darwinian evolution independently of DNA sequence changes.	[Cortijo, Sandra; Etcheverry, Mathilde; Caillieux, Erwann; Roudier, Francois; Colot, Vincent] Ecole Normale Super, CNRS, UMR 8197, Inst Biol,INSERM,U1024, F-75005 Paris, France; [Wardenaar, Rene; Colome-Tatche, Maria; Jansen, Ritsert C.; Johannes, Frank] Univ Groningen, GBB, Groningen Bioinformat Ctr, NL-9747 AG Groningen, Netherlands; [Gilly, Arthur; Labadie, Karine; Aury, Jean-Marc; Wincker, Patrick] CEA, IG, Genoscope, F-91057 Evry, France; [Hospital, Frederic] INRA, UMR Genet Anim & Biol Integrat 1313, F-78352 Jouy En Josas, France; [Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Wincker, Patrick] Univ Evry, CP5706, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Groningen; CEA; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Ecole Normale Super, CNRS, UMR 8197, Inst Biol,INSERM,U1024, F-75005 Paris, France.	colot@biologie.ens.fr; f.johannes@rug.nl	Labadie, Karine/AFL-7408-2022; Aury, Jean-Marc/N-1621-2019; Labadie, Karine/AAG-7355-2022	Labadie, Karine/0000-0001-7467-8509; Aury, Jean-Marc/0000-0003-1718-3010; Labadie, Karine/0000-0001-7467-8509; Gilly, Arthur/0000-0002-3190-4358; Cortijo, Sandra/0000-0003-3291-6729; Colome Tatche, Maria/0000-0002-2224-7560; CAILLIEUX, Erwann/0000-0002-2213-4427	Netherlands Organization for Scientific Research; University of Groningen; Agence Nationale de la Recherche [ANR-09-BLAN-0237 EPIMOBILE, ANR-06-GPLA-010 TAG, ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02 PSL*]; European Union (EpiGeneSys FP7 Network of Excellence) [257082]; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); University of Groningen; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union (EpiGeneSys FP7 Network of Excellence); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank O. Bossdorf, C. Richards, T. Day, and K. Verhoeven for their input on an earlier version of this report. This work was supported by grants from the Netherlands Organization for Scientific Research (to F.J., R.C.J., R.W., and M.C.-T.); a University of Groningen Rosalind Franklin Fellowship to M.C.-T.; the Agence Nationale de la Recherche (ANR-09-BLAN-0237 EPIMOBILE to V.C. and P.W.; ANR-06-GPLA-010 TAG, Investissements d'Avenir ANR-10-LABX-54 MEMO LIFE, and ANR-11-IDEX-0001-02 PSL* Research University to V.C.); and the European Union (EpiGeneSys FP7 Network of Excellence number 257082, to V.C.). S.C. and M.E. were supported by Ph.D. studentships from the Ministere de l'Enseignement Superieur et de la Recherche, with additional support from the Fondation pour la Recherche Medicale (to S.C.). Sequence reads for the 52 epiRILs and parental lines are deposited at the European Bioinformatics Institute under accession number ERP004507.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Johannes F, 2011, GENETICS, V188, P215, DOI 10.1534/genetics.111.127118; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kakutani T, 1999, GENETICS, V151, P831; LANDER ES, 1989, GENETICS, V121, P185; Latzel V, 2012, ANN BOT-LONDON, V110, P1423, DOI 10.1093/aob/mcs088; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Roux F, 2011, GENETICS, V188, P1015, DOI 10.1534/genetics.111.128744; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	20	303	310	3	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1145	1148		10.1126/science.1248127	http://dx.doi.org/10.1126/science.1248127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24505129				2022-12-28	WOS:000332331500050
J	Rash, BG; Rakic, P				Rash, Brian G.; Rakic, Pasko			Genetic Resolutions of Brain Convolutions	SCIENCE			English	Editorial Material							NEOCORTEX; EVOLUTION; SIZE		[Rash, Brian G.; Rakic, Pasko] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA; [Rakic, Pasko] Yale Univ, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	Rash, BG (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA.	pasko.rakic@yale.edu		Rash, Brian/0000-0003-4555-4093	NIDA NIH HHS [R37 DA023999, DA023999] Funding Source: Medline; NINDS NIH HHS [NS014841] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cholfin JA, 2008, J COMP NEUROL, V509, P144, DOI 10.1002/cne.21709; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Gould S. J., 1996, MISMEASURE MAN; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hevner RF, 2012, CEREB CORTEX, V22, P465, DOI 10.1093/cercor/bhr336; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; O'Leary DDM, 2006, CEREB CORTEX, V16, pI46, DOI 10.1093/cercor/bhk019; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0	15	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					744	745		10.1126/science.1250246	http://dx.doi.org/10.1126/science.1250246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1NB	24531964				2022-12-28	WOS:000331557800031
J	Aylward, RB; Alwan, A				Aylward, R. Bruce; Alwan, Ala			Polio in Syria	LANCET			English	Editorial Material									[Aylward, R. Bruce] WHO, CH-1211 Geneva 27, Switzerland; [Alwan, Ala] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt	World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Aylward, RB (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	aylwardb@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2014, END POL SYR HOUS TO; Aylward B, 2013, E MEDITERR HEALTH J, V19, P903; Coutts AP, 2014, NY TIMES; Global Polio Eradication Initiative, 2014, POLIO THIS WEEK 0130; Reuter C, 2013, SPIEGEL; UNHCR, 2013, INT REG RESP SYR REF; United Nations Office for the Coordination of Humanitarian Affairs, 2013, SYR AR REP HUM ASS R; WHO, 2013, 60 SESS REG COMM E M; WHO, 2013, DIS OUTBREAK NE 0211; WHO, WHO RESP SYR CRIS CO; WHO, 2014, WILD POL 2009 2014; WHO, 2013, DIS OUTBREAK NE 1019; WHO UNICEF. Global Polio Eradication Initiative, 2013, STRAT PLAN POL OUTBR	13	29	29	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					489	491		10.1016/S0140-6736(14)60132-X	http://dx.doi.org/10.1016/S0140-6736(14)60132-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KH	24491482				2022-12-28	WOS:000331136400005
J	Spence, D				Spence, Des			We are all businesspeople now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hughes D, 2014, BBC; Roberts N, 2013, GP              1115; Smith R., 2011, TELEGRAPH	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2014	348								g1322	10.1136/bmj.g1322	http://dx.doi.org/10.1136/bmj.g1322			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4IR	24493690				2022-12-28	WOS:000331059800005
J	Feinmann, J				Feinmann, Jane			Why ordinary Greeks need medical aid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Chauvin P, 2013, GREEK STAT 2012 BREA	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2014	348								g1171	10.1136/bmj.g1171	http://dx.doi.org/10.1136/bmj.g1171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AW	24477024				2022-12-28	WOS:000330647700019
J	McCarthy, M				McCarthy, Michael			Quality of evidence behind FDA approvals varies widely	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Rome BN, 2014, JAMA-J AM MED ASSOC, V311, P385, DOI 10.1001/jama.2013.284986; Sacks LV, 2014, JAMA-J AM MED ASSOC, V311, P378, DOI 10.1001/jama.2013.282542	3	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2014	348								g1075	10.1136/bmj.g1075	http://dx.doi.org/10.1136/bmj.g1075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AT	24470635				2022-12-28	WOS:000330647400001
J	Roland, N; Bradley, PJ				Roland, Nick; Bradley, Patrick J.			ABC of Ear, Nose and Throat, 6th Edition Neck Swellings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUMPS		[Roland, Nick] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Bradley, Patrick J.] Queens Med Ctr Campus Nottingham Univ Hosp Nottin, Nottingham, England	Aintree University Hospitals NHS Foundation Trust; Nottingham University Hospital NHS Trust	Roland, N (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England.		Bradley, Patrick/AAE-4485-2021	Bradley, Patrick/0000-0003-2810-5704				Addams-Williams J, 2009, EUR ARCH OTO-RHINO-L, V266, P411, DOI 10.1007/s00405-008-0751-4; Cozens NJA, 2009, CLIN OTOLARYNGOL, V34, P6, DOI 10.1111/j.1749-4486.2008.01817.x; Fraser L, 2008, OTOLARYNG HEAD NECK, V138, P311, DOI 10.1016/j.otohns.2007.11.032; JONES AS, 1993, CANCER, V72, P1756, DOI 10.1002/1097-0142(19930901)72:5<1756::AID-CNCR2820720540>3.0.CO;2-5; MacGregor F, 2008, BRIT J HOSP MED, V69, P205, DOI 10.12968/hmed.2008.69.4.28989; Mahoney EJ, 2005, OTOLARYNG CLIN N AM, V38, P87, DOI 10.1016/j.otc.2004.10.014; Roland NJ, 2001, HOSP MED, V62, P205, DOI 10.12968/hosp.2001.62.4.1550	7	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2014	348								g1078	10.1136/bmj.g1078	http://dx.doi.org/10.1136/bmj.g1078			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BE	24458704				2022-12-28	WOS:000330298100001
J	Cunningham, SA; Kramer, MR; Narayan, KMV				Cunningham, Solveig A.; Kramer, Michael R.; Narayan, K. M. Venkat			Incidence of Childhood Obesity in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							US CHILDREN; OVERWEIGHT; PREVALENCE; ADOLESCENTS; HEALTH	BackgroundAlthough the increased prevalence of childhood obesity in the United States has been documented, little is known about its incidence. We report here on the national incidence of obesity among elementary-school children. MethodsWe evaluated data from the Early Childhood Longitudinal Study, Kindergarten Class of 1998-1999, a representative prospective cohort of 7738 participants who were in kindergarten in 1998 in the United States. Weight and height were measured seven times between 1998 and 2007. Of the 7738 participants, 6807 were not obese at baseline; these participants were followed for 50,396 person-years. We used standard thresholds from the Centers for Disease Control and Prevention to define overweight and obese categories. We estimated the annual incidence of obesity, the cumulative incidence over 9 years, and the incidence density (cases per person-years) overall and according to sex, socioeconomic status, race or ethnic group, birth weight, and kindergarten weight. ResultsWhen the children entered kindergarten (mean age, 5.6 years), 12.4% were obese and another 14.9% were overweight; in eighth grade (mean age, 14.1 years), 20.8% were obese and 17.0% were overweight. The annual incidence of obesity decreased from 5.4% during kindergarten to 1.7% between fifth and eighth grade. Overweight 5-year-olds were four times as likely as normal-weight children to become obese (9-year cumulative incidence, 31.8% vs. 7.9%), with rates of 91.5 versus 17.2 per 1000 person-years. Among children who became obese between the ages of 5 and 14 years, nearly half had been overweight and 75% had been above the 70th percentile for body-mass index at baseline. ConclusionsIncident obesity between the ages of 5 and 14 years was more likely to have occurred at younger ages, primarily among children who had entered kindergarten overweight. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.)	[Cunningham, Solveig A.; Narayan, K. M. Venkat] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Kramer, Michael R.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Emory University	Cunningham, SA (corresponding author), Emory Univ, Hubert Dept Global Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.	sargese@emory.edu	Kramer, Michael R/A-3195-2013; Cunningham, Solveig A/K-6760-2012; Cunningham, Solveig/W-2672-2019; Narayan, K.M. Venkat/J-9819-2012	Kramer, Michael R/0000-0002-6372-6170; Cunningham, Solveig A/0000-0002-2354-1526; Narayan, K.M. Venkat/0000-0001-8621-5405	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD060602]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD060602, K01HD074726] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD060602).	Baidal JAW, 2012, ARCH PEDIAT ADOL MED, V166, P1179, DOI 10.1001/2013.jamapediatrics.358; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Jolliffe D, 2004, INT J OBESITY, V28, P4, DOI 10.1038/sj.ijo.0802421; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Robbins JM, 2007, ARCH PEDIAT ADOL MED, V161, P17, DOI 10.1001/archpedi.161.1.17; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Szklo M, 2006, EPIDEMIOLOGY BASICS; Tourangeau K, 2009, EARLY CHILDHOOD LONG; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104; Williams R. L., 2008, ENCY SURVEY RES METH	15	503	509	4	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					403	411		10.1056/NEJMoa1309753	http://dx.doi.org/10.1056/NEJMoa1309753			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24758623	Green Accepted			2022-12-28	WOS:000330645400005
